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In the book Microbial Biofilms: Importance and applications, eminent scientists 
provide an up-to-date review of the present and future trends on biofilm-related 
research. This book is divided with four subdivisions as biofilm fundamentals, 
applications, health aspects, and their control. Moreover, this book also provides 
a comprehensive account on microbial interactions in biofilms, pyocyanin, and 
extracellular DNA in facilitating Pseudomonas aeruginosa biofilm formation, atomic 
force microscopic studies of biofilms, and biofilms in beverage industry. The book 
comprises a total of 21 chapters from valued contributions from world leading experts 
in Australia, Bulgaria, Canada, China, Serbia, Germany, Italy, Japan, the United 
Kingdom, the Kingdom of Saudi Arabia, Republic of Korea, Mexico, Poland, Portugal, 
and Turkey. This book may be used as a text or reference for everyone interested in 
biofilms and their applications.  It is also highly recommended for environmental 
microbiologists, soil scientists, medical microbiologists, bioremediation experts, 
and microbiologists working in biocorrosion, biofouling, biodegradation, water 
microbiology, quorum sensing, and many other related areas.  Scientists in academia, 
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Biofilms have a greater role to play in public health because of their involvement in various 
infectious diseases and a proper understanding of the biofilm processes would lead to find out 
novel and effective strategies for biofilm control and hence patient management improvement. 
In this context, the book on “Microbial Biofilms: Importance and Applications” edited by Dr. D. 
Dhanasekaran and Dr. N. Thajuddin is an excellent contribution and a welcome addition to the 
research field of biofilm formation and development. Editors and contributing authors deserve 
appreciation for their laudable efforts. The book is presented in four major areas namely Biofilm 
fundamentals, Biofilm applications, Biofilm in health and diseases, and Biofilm control, embrac-
ing topics on grazing effects of ciliates on microcolony formation in bacterial biofilms, role of 
the biofilms in the waste water and rain water treatment, dental biofilm formation, biofilms in 
diabetic foot ulcers, biofilm interactions in epizootic shell disease of the American lobster, and 
natural compounds for new diagnostics and drugs against biofilm infections.
As a whole, this book depicts an excellent overview, importance, and applications of biofilms 
and it will be a very useful resource for the teachers, researchers, and industries, interested in 
furthering research in the field of biofilms.  Researchers in the fields of clinical, food and water, 
and environmental microbiology have already begun to investigate microbiological processes 
from a biofilm perspective.  It is heartening to note that considerable efforts have been taken to 
control biofilms through the application of antiquorum sensing compounds by various microor-
ganisms. Hope these efforts will continue with more vigor, reaping fruits.
Dr. L. Kannan, D. Sc., 
Former Director
Centre for Advanced Studies in Marine Biology 
Parangipettai - 608 502, Tamil Nadu, India
&
Former Director – Research 
Annamalai University




Despite the discovery of microbial biofilms as far back as the seventeenth century, in recent
years, scientists have increased their attention of these dense colonies of bacteria that pro‐
duce extracellular polymeric substances that bind a community of different microorganisms
together and anchor them to both living and inanimate surfaces. Biofilms are not only re‐
sponsible for chronic bacterial infection account for more than 80% of all microbial infec‐
tions of the human body, infection on medical devises, deterioration of water quality, and
the contamination of food, but they also can promote remediation of contaminated ground‐
water and soils and they play an important natural role in cycling of nitrogen, sulfur, and
metals. The protective nature of the biofilm structure makes the bacteria embedded within
them remarkably difficult to treat with antimicrobials; biofilms are resistant to doses of anti‐
microbials 100- to 1000-fold over the minimum lethal dose for microbes outside of biofilms.
Hence, understanding “the good and the bad” characteristics of biofilms under diverse con‐
ditions is of great interest.
In this book “Microbial Biofilms: Importance and applications”, eminent scientists provide
an up-to-date review of the present and future trends on biofilm-related research. This book
is divided with four subdivisions as biofilm fundamentals, applications, health aspects, and
their control. Moreover, this book also provides a comprehensive account on microbial in‐
teractions in biofilms, pyocyanin, and extracellular DNA in facilitating Pseudomonas aerugi‐
nosa biofilm formation, atomic force microscopic studies of biofilms, biofilms in beverage
industry, Staphylococcus and Salmonella biofilms, wound biofilm and therapeutic strategies,
oral microbiome in dental biofilm formation, antimicrobial strategy against mature oral bio‐
film, and novel models to manage biofilms on microtextured dental implant surfaces.
The book comprises a total of 21 chapters from valued contributions from world–leading
experts in Australia, Bulgaria, Canada, China, Serbia, Germany, Italy, Japan, the United
Kingdom, the Kingdom of Saudi Arabia, Republic of Korea, Mexico, Poland, Portugal, and
Turkey. We are grateful to the experts who have provided state-of-the-art valued contribu‐
tions of this book. This book may be used as a text or reference for everyone interested in
biofilms and their applications. It is also highly recommended for environmental microbiol‐
ogists, soil scientists, medical microbiologists, bioremediation experts, and microbiologists
working in biocorrosion, biofouling, biodegradation, water microbiology, quorum sensing,
and many other related areas. Scientists in academia, research laboratories and industry will
also find it of interest.
We offer our special thanks and appreciation to Ms. Dajana Pemac, Publishing Process Man‐
ager for their encouragement and help in bringing out the book in the present form. We are
also indebted to InTech publisher for their concern, efforts, and encouragement in the task
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Viewing Biofilms within the Larger Context of Bacterial
Aggregations
Olena V. Moshynets and Andrew J. Spiers
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/62912
Abstract
The ‘Microbial Cities’ vision of bacterial biofilms has dominated our understanding of
the development and functioning of bacterial aggregations for the past 20 years, during
which active sludge, clumps, colonies, flocs, mats, pellicles, rafts, slimes, zooglea, etc.
have been largely forgotten or ignored. Although the medically inspired developmen‐
tal model of human pathogen biofilms has merits including providing a rationale for
the development of anti-biofilm therapeutics, it fails to provide links to other types of
bacterial aggregation that are commonly found in a wide range of natural and man-
made environments. Possibly as a result, applied and environmental microbiologists
tend to avoid the term ‘biofilm’ and use others such as ‘microbial mats’ instead. Here
we challenge the simplistic  planktonic  (independent  and free-swimming bacteria)-
biofilm (sessile and co-operative bacteria) dichotomy, and consider biofilms within the
larger context of bacterial aggregations. By placing biofilms into context, which we see
as  a  continuum  of  aggregations  or  communities  with  varying  abiotic  and  biotic
properties, fundamental physical, biological, and evolutionary ecological processes that
effect community development and function can no longer be considered unique to
biofilms, but may also be important in other aggregations that develop over time and
change in nature depending on prevailing conditions. By doing this, we will be better
able to distinguish those processes which govern bacterial colonisation and ecological
success in a wider sense from those that are unique to particular environments and
specialised strategies.
Keywords: Bacterial aggregations, Biofilms, Colonies, Communities, Planktonic and
sessile bacteria
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
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Viewing Biofilms within the Larger Context of Bacterial
Aggregations
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Abstract
The ‘Microbial Cities’ vision of bacterial biofilms has dominated our understanding of
the development and functioning of bacterial aggregations for the past 20 years, during
which active sludge, clumps, colonies, flocs, mats, pellicles, rafts, slimes, zooglea, etc.
have been largely forgotten or ignored. Although the medically inspired developmen‐
tal model of human pathogen biofilms has merits including providing a rationale for
the development of anti-biofilm therapeutics, it fails to provide links to other types of
bacterial aggregation that are commonly found in a wide range of natural and man-
made environments. Possibly as a result, applied and environmental microbiologists
tend to avoid the term ‘biofilm’ and use others such as ‘microbial mats’ instead. Here
we challenge the simplistic  planktonic  (independent  and free-swimming bacteria)-
biofilm (sessile and co-operative bacteria) dichotomy, and consider biofilms within the
larger context of bacterial aggregations. By placing biofilms into context, which we see
as  a  continuum  of  aggregations  or  communities  with  varying  abiotic  and  biotic
properties, fundamental physical, biological, and evolutionary ecological processes that
effect community development and function can no longer be considered unique to
biofilms, but may also be important in other aggregations that develop over time and
change in nature depending on prevailing conditions. By doing this, we will be better
able to distinguish those processes which govern bacterial colonisation and ecological
success in a wider sense from those that are unique to particular environments and
specialised strategies.
Keywords: Bacterial aggregations, Biofilms, Colonies, Communities, Planktonic and
sessile bacteria
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
so on, on biofilm formation and structure [23–26,32]. In addition, research focussed more on
medical and environmental microbiology, rather than on biofilm formation per se [33–37], as
well as on evolutionary ecology and social microbiology [11,38–41], are increasingly providing
explanations for the role or function of biofilms in different environments and evidence of their
ecological success.
Despite the obvious diversity in biofilm research as evidenced by publications in journals
covering a wide range of disciplines including microbiology, microbial biotechnology,
environmental science, and medical microbiology, our general understanding of biofilms is
nonetheless dominated by a few human pathogens and the submerged solid-surface interface
biofilms they produce in flow cells or microtitre plates [28,29,31] (here we refer to these as
liquid-solid surface (L-S) interface biofilms to differentiate them from other types of biofilms
or bacterial aggregations). Of these, the medically inspired developmental model of P.
aeruginosa, often chosen to represent the ‘Microbial Cities’ vision, is perhaps the most persua‐
sive, with bacteria growing in these structures almost exclusively compared to free-swimming
planktonic bacteria. We are growing concerned that this vision is beginning to dominate
biofilm research in a negative manner.
2. A continuum of aggregations
In this opinion piece, we challenge the simplistic planktonic-(sessile) biofilm dichotomy and
advocate the inclusion of biofilms within the larger context of bacterial aggregations. We
believe that by recognising biofilms within a continuum of aggregations or communities with
varying properties, it will enable a more extensive investigation of bacterial colonisation, and
in particular, allow us to distinguish those processes governing general colonisation and
ecological success from those unique to particular environments and specialised strategies.
Costerton et al. [2] defined biofilms as ‘matrix-enclosed bacterial populations adherent to each
other and/or to surfaces or interfaces ... (and) includes microbial aggregates and floccules and
also adherent populations within the pore spaces of porous media’. Although this definition
is broad (i.e. sensu lato), there is a presumption by current researchers that biofilms are those
structures formed on submerged solid surfaces (i.e. at the L-S interface) and that other
structures associated with surfaces or interfaces are somehow different or inconsequential. We
would suggest that L-S interface biofilms as observed in flow-cells and microtitre plates are a
means to investigate biofilm formation independently of natural environments or context, as
it is difficult or impossible to extrapolate from these simple in vitro systems to the more
complex natural environments from which the bacteria of interest were first isolated [29–31].
We note that in some later reviews, the description of biofilms is extended with more examples.
However, this has also lead to a more relaxed (sensu amplo) definition in which ‘biofilm’ is
frequently used as a synonym of ‘aggregation’, even though the former is often defined by the
latter (e.g. [42]). As a matter of etymology, ‘aggregation’ which originates in late Middle
English (1150–1500 AD) should take precedence over ‘biofilm’ whose usage largely stems from
the 1990s.




Modern biofilm research often acknowledges the seminal reviews of Costerton et al. [1,2] in
which a conceptual model of biofilm development and structure was first presented. In this
model, biofilm development is described as a series of linked events, from the attachment of
free-swimming planktonic bacteria to a submerged solid surface, the growth of microcolonies
in simple conical structures, and subsequent maturation as larger mushroom-shaped struc‐
tures which have been envisioned as ‘Microbial Cities’ (this appellation may derive from reviews
entitled ‘City of  Microbes’  and ‘Microbial  Metropolis’ [3,4],  but  we are unsure).  Equally
important to this description was the dichotomous differentiation between independent free-
swimming planktonic bacteria with the co-operative and co-ordinated communities of sessile
bacteria forming biofilms, and the somewhat teleological suggestion that surface-attached
communities allowed growth in harsh conditions which planktonic bacteria could not sur‐
vive [2]. This view of complex bacterial behaviour and growth strategies was in contrast with
the apparently contemporary idea that bacteria were unsophisticated organisms [5].
Since the publication of the Costerton et al. reviews, our understanding of biofilms has
developed through the study of model bacteria as well as of natural communities forming
multispecies biofilms (we direct the reader to the reviews cited in the following sections as a
means of accessing recent biofilm research and current understanding). Model human
pathogens forming biofilms important for virulence include Escherichia coli [6], Pseudomonas
aeruginosa [7], Salmonella enterica [8], Staphylococcus aureus [9], Vibrio cholera [10], etc., though
the archetype is probably P. aeruginosa, an opportunistic pathogen of the human respiratory
tract and a key factor in cystic fibrosis patient mortality [11]. As a result of an understanding
of pathogen biofilm formation, critical points in the developmental processes are now being
scrutinised as possible targets for anti-biofilm therapeutics [7]. Biofilms are also recognised as
having importance in a range of other natural and man-made environments, impacting on
crop productivity, food technology, metal corrosion, veterinary medicine, etc. [12–15], and
microbial mats, a term seemingly preferred by applied and environmental microbiologists, are
found on rock surfaces, in caves, wetlands, sediments, salt marshes, lakes and seas, thermal
springs, hypersaline ponds and lagoons, methane and petroleum seeps, oil wells, etc. [16–21].
Comparisons between pathogenic and environmental biofilm-forming bacteria highlighting
commonalities suggest that biofilm developmental pathways or responses may not be unique
to species or particular environments.
Investigations of biofilm-forming bacteria have revealed key sensory-regulatory pathways,
including intercellular communication and intracellular regulation, required to control biofilm
development by altering motility and attachment behaviour, physiology and metabolism, the
production of extracellular polymeric substances (EPS) forming the matrix of biofilms, and
dispersants required to release bacteria from mature structures [22–27]. The use of a variety of
different experimental systems, including in vitro flow cells, microtitre plates, static micro‐
cosms, etc., as well as animal models [28–31], has also identified the impact of abiotic factors
such as liquid flow and mass transport; O2 and nutrient diffusion; surface physical-chemistry
and topology; and biotic interactions between bacteria, surfaces, and matrix components; and
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so on, on biofilm formation and structure [23–26,32]. In addition, research focussed more on
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Despite the obvious diversity in biofilm research as evidenced by publications in journals
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sive, with bacteria growing in these structures almost exclusively compared to free-swimming
planktonic bacteria. We are growing concerned that this vision is beginning to dominate
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varying properties, it will enable a more extensive investigation of bacterial colonisation, and
in particular, allow us to distinguish those processes governing general colonisation and
ecological success from those unique to particular environments and specialised strategies.
Costerton et al. [2] defined biofilms as ‘matrix-enclosed bacterial populations adherent to each
other and/or to surfaces or interfaces ... (and) includes microbial aggregates and floccules and
also adherent populations within the pore spaces of porous media’. Although this definition
is broad (i.e. sensu lato), there is a presumption by current researchers that biofilms are those
structures formed on submerged solid surfaces (i.e. at the L-S interface) and that other
structures associated with surfaces or interfaces are somehow different or inconsequential. We
would suggest that L-S interface biofilms as observed in flow-cells and microtitre plates are a
means to investigate biofilm formation independently of natural environments or context, as
it is difficult or impossible to extrapolate from these simple in vitro systems to the more
complex natural environments from which the bacteria of interest were first isolated [29–31].
We note that in some later reviews, the description of biofilms is extended with more examples.
However, this has also lead to a more relaxed (sensu amplo) definition in which ‘biofilm’ is
frequently used as a synonym of ‘aggregation’, even though the former is often defined by the
latter (e.g. [42]). As a matter of etymology, ‘aggregation’ which originates in late Middle
English (1150–1500 AD) should take precedence over ‘biofilm’ whose usage largely stems from
the 1990s.




Modern biofilm research often acknowledges the seminal reviews of Costerton et al. [1,2] in
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free-swimming planktonic bacteria to a submerged solid surface, the growth of microcolonies
in simple conical structures, and subsequent maturation as larger mushroom-shaped struc‐
tures which have been envisioned as ‘Microbial Cities’ (this appellation may derive from reviews
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important to this description was the dichotomous differentiation between independent free-
swimming planktonic bacteria with the co-operative and co-ordinated communities of sessile
bacteria forming biofilms, and the somewhat teleological suggestion that surface-attached
communities allowed growth in harsh conditions which planktonic bacteria could not sur‐
vive [2]. This view of complex bacterial behaviour and growth strategies was in contrast with
the apparently contemporary idea that bacteria were unsophisticated organisms [5].
Since the publication of the Costerton et al. reviews, our understanding of biofilms has
developed through the study of model bacteria as well as of natural communities forming
multispecies biofilms (we direct the reader to the reviews cited in the following sections as a
means of accessing recent biofilm research and current understanding). Model human
pathogens forming biofilms important for virulence include Escherichia coli [6], Pseudomonas
aeruginosa [7], Salmonella enterica [8], Staphylococcus aureus [9], Vibrio cholera [10], etc., though
the archetype is probably P. aeruginosa, an opportunistic pathogen of the human respiratory
tract and a key factor in cystic fibrosis patient mortality [11]. As a result of an understanding
of pathogen biofilm formation, critical points in the developmental processes are now being
scrutinised as possible targets for anti-biofilm therapeutics [7]. Biofilms are also recognised as
having importance in a range of other natural and man-made environments, impacting on
crop productivity, food technology, metal corrosion, veterinary medicine, etc. [12–15], and
microbial mats, a term seemingly preferred by applied and environmental microbiologists, are
found on rock surfaces, in caves, wetlands, sediments, salt marshes, lakes and seas, thermal
springs, hypersaline ponds and lagoons, methane and petroleum seeps, oil wells, etc. [16–21].
Comparisons between pathogenic and environmental biofilm-forming bacteria highlighting
commonalities suggest that biofilm developmental pathways or responses may not be unique
to species or particular environments.
Investigations of biofilm-forming bacteria have revealed key sensory-regulatory pathways,
including intercellular communication and intracellular regulation, required to control biofilm
development by altering motility and attachment behaviour, physiology and metabolism, the
production of extracellular polymeric substances (EPS) forming the matrix of biofilms, and
dispersants required to release bacteria from mature structures [22–27]. The use of a variety of
different experimental systems, including in vitro flow cells, microtitre plates, static micro‐
cosms, etc., as well as animal models [28–31], has also identified the impact of abiotic factors
such as liquid flow and mass transport; O2 and nutrient diffusion; surface physical-chemistry
and topology; and biotic interactions between bacteria, surfaces, and matrix components; and
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(sessile) biofilm dichotomy. Instead, we think it is likely that there are different types of
aggregation including L-S interface biofilms attached to the vial walls at the meniscus, attached
biofilms extending out across the liquid surface, confluent colonies growing on the agar
surface, and microcolonies developing in the swarm-front as bacteria move up the agar surface
and away from the liquid media. We are interested in identifying which abiotic and biotic
factors drive growth at different points across the transitional zone, and understanding how
these might alter behaviour and gene expression patterns to produce the structures we can
observe within a few hours and over several days.
4. Colonies are not biofilms
Whilst we approve of the inclusion of A-L interface biofilms in the sensu amplo Costerton et al.
[1,2] definition, we resist the suggestion that colonies grown on agar plates should be included
too, despite the fact that investigations of colony morphology have been presented as biofilm
research (e.g. [43,56–61] etc.). In contrast, we have investigated the colony morphologies of
Wrinkly Spreader mini-Tn mutants on agar plates as a means to identify the genes required
for biofilm formation; importantly, we also tested the mutants in static microcosms to deter‐
mine the impact on biofilm formation to confirm the identity of these genes as important in
biofilm formation [48].
Our objection to the inclusion of colonies as biofilms is based on a consideration of the O2 and
nutrient gradients established in these aggregations, as well as liquid flow (Figure 1). Rather
than argue that these are insignificant differences, we would suggest that colonies, A-L and L-
S interface biofilms would be better presented within a larger continuum of aggregations in
which O2 and nutrient gradients (and other chemicals including communication signals and
waste, etc.), and liquid flow can be used to differentiate between types of aggregation. In this
way, it now becomes reasonable to ask whether the parallel O2 and nutrient gradients observed
Figure 1. Bacterial aggregations include biofilms and colonies with significant similarities and interesting differen‐
ces. Liquid-solid surface (L-S) interface biofilms (middle) are subject to physical stress and establish various chemical
gradients. Similarly, air-liquid interface (A-L) biofilms (left) or colonies (right) also experience physical stress and es‐
tablish gradients. In each type of aggregation, a layer of cells is attached to the solid surface (Zone 1) with distal re‐
gions are held in place by cell and matrix component interactions (Zone 2). In A-L interface biofilms, cells and matrix
components may also break through the interface (Zone 3). However, nutrients are supplied by capillary flow (mass
transport) from beneath colonies, whereas in A-L and L-S interface biofilms, they are transported or diffuse from the
surrounding liquid. (A, air; L, liquid; PS, permeable or porous solid; S, solid.)
Viewing Biofilms within the Larger Context of Bacterial Aggregations
http://dx.doi.org/10.5772/62912
7
As an example of how the biofilm definition has been extended following the definition of
Costerton et al. [1,2], we consider the inclusion of air-liquid (A-L) interface biofilms and agar
plate-grown colonies as suggested by Branda et al. [42].
3. Biofilms at the air-liquid interface
Material, including bacteria, accumulates at the air-liquid interface of sea or fresh water to
form surface films often subject to highly variable conditions [19]. A-L interface biofilms also
form on the surface of static liquids in experimental microcosms, and are sometimes referred
to as pellicles or floating biofilms. These are produced by a wide range of bacteria, including
Bacillus subtilis [43], Gluconacetobacter xylinus (formerly known as Acetobacter xylinum and since
reclassified as Komagataeibacter xylinus) [44], as well as numerous enteric bacteria and pseu‐
domonads [44–46].
Although A-L interface biofilms may look superficially similar, the diversity of bacteria which
form them would suggest that they vary in structure and other characteristics as well. We have
been investigating this by comparing biofilms produced by environmental Pseudomonas spp.
isolates, using relatively large static microcosms in 30-ml glass universal vials containing liquid
growth medium [44,47,48]. These allow us to undertake combined biofilm assays which
determine growth, attachment to the vial walls, and biofilm strength [49–51]. Using this
approach, we have been able to quantitatively differentiate biofilms produced at the meniscus
and A-L interface [50,52]. These include biofilms limited to the meniscus region, attached
biofilms which extend across the A-L interface, and unattached ‘floating’ biofilms (as well as
‘invisible’ attached biofilms too thin or transparent to see by eye [52]). It is possible that the
floaters and attached biofilms represent substantially different colonisation strategies, with the
former recruiting planktonic cells directly from the liquid column to the A-L interface and
growing from multiple loci, and the latter developing from sessile cells attaching in the
meniscus region and subsequently growing out across the A-L interface [52].
Although floating biofilms have been reported in which buoyancy is the result of trapped
CO2 released by respiration (e.g. G. xylinus [44]), the two different A-L interface biofilms
produced by our model environmental pseudomonad, P. fluorescens SBW25, known as the
viscous mass and Wrinkly Spreader biofilms, are not buoyant per se and readily sink when
disturbed [49,53,54]. It is likely that they are maintained at the A-L interface by hydrophobic
cell surfaces, matrix components, and surfactant which pierce or weaken the A-L interface
[53,54]. Interestingly, we have recently found that for the Wrinkly Spreader, a class of adaptive
mutants of the wild-type strain which evolves in static microcosms, drip-fed glass bead
columns, and soil [48,51,55], attached A-L interface biofilm growth can be seamlessly linked
to swarming motility and colony growth using ‘transitional microcosms’ in which a layer of
agar is set along the side of the vial, providing both liquid and dry agar surfaces for colonisation
(C. Immoor, O. Moshynets , A. Spiers, Unpublished Observations).
In these transitional microcosms, we wonder whether there is more than just planktonic
bacteria growing in the liquid column and a single, distinct structure colonising both the liquid
and agar surfaces in these simple environments, as suggested by the simplistic planktonic-
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(sessile) biofilm dichotomy. Instead, we think it is likely that there are different types of
aggregation including L-S interface biofilms attached to the vial walls at the meniscus, attached
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factors drive growth at different points across the transitional zone, and understanding how
these might alter behaviour and gene expression patterns to produce the structures we can
observe within a few hours and over several days.
4. Colonies are not biofilms
Whilst we approve of the inclusion of A-L interface biofilms in the sensu amplo Costerton et al.
[1,2] definition, we resist the suggestion that colonies grown on agar plates should be included
too, despite the fact that investigations of colony morphology have been presented as biofilm
research (e.g. [43,56–61] etc.). In contrast, we have investigated the colony morphologies of
Wrinkly Spreader mini-Tn mutants on agar plates as a means to identify the genes required
for biofilm formation; importantly, we also tested the mutants in static microcosms to deter‐
mine the impact on biofilm formation to confirm the identity of these genes as important in
biofilm formation [48].
Our objection to the inclusion of colonies as biofilms is based on a consideration of the O2 and
nutrient gradients established in these aggregations, as well as liquid flow (Figure 1). Rather
than argue that these are insignificant differences, we would suggest that colonies, A-L and L-
S interface biofilms would be better presented within a larger continuum of aggregations in
which O2 and nutrient gradients (and other chemicals including communication signals and
waste, etc.), and liquid flow can be used to differentiate between types of aggregation. In this
way, it now becomes reasonable to ask whether the parallel O2 and nutrient gradients observed
Figure 1. Bacterial aggregations include biofilms and colonies with significant similarities and interesting differen‐
ces. Liquid-solid surface (L-S) interface biofilms (middle) are subject to physical stress and establish various chemical
gradients. Similarly, air-liquid interface (A-L) biofilms (left) or colonies (right) also experience physical stress and es‐
tablish gradients. In each type of aggregation, a layer of cells is attached to the solid surface (Zone 1) with distal re‐
gions are held in place by cell and matrix component interactions (Zone 2). In A-L interface biofilms, cells and matrix
components may also break through the interface (Zone 3). However, nutrients are supplied by capillary flow (mass
transport) from beneath colonies, whereas in A-L and L-S interface biofilms, they are transported or diffuse from the
surrounding liquid. (A, air; L, liquid; PS, permeable or porous solid; S, solid.)
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As an example of how the biofilm definition has been extended following the definition of
Costerton et al. [1,2], we consider the inclusion of air-liquid (A-L) interface biofilms and agar
plate-grown colonies as suggested by Branda et al. [42].
3. Biofilms at the air-liquid interface
Material, including bacteria, accumulates at the air-liquid interface of sea or fresh water to
form surface films often subject to highly variable conditions [19]. A-L interface biofilms also
form on the surface of static liquids in experimental microcosms, and are sometimes referred
to as pellicles or floating biofilms. These are produced by a wide range of bacteria, including
Bacillus subtilis [43], Gluconacetobacter xylinus (formerly known as Acetobacter xylinum and since
reclassified as Komagataeibacter xylinus) [44], as well as numerous enteric bacteria and pseu‐
domonads [44–46].
Although A-L interface biofilms may look superficially similar, the diversity of bacteria which
form them would suggest that they vary in structure and other characteristics as well. We have
been investigating this by comparing biofilms produced by environmental Pseudomonas spp.
isolates, using relatively large static microcosms in 30-ml glass universal vials containing liquid
growth medium [44,47,48]. These allow us to undertake combined biofilm assays which
determine growth, attachment to the vial walls, and biofilm strength [49–51]. Using this
approach, we have been able to quantitatively differentiate biofilms produced at the meniscus
and A-L interface [50,52]. These include biofilms limited to the meniscus region, attached
biofilms which extend across the A-L interface, and unattached ‘floating’ biofilms (as well as
‘invisible’ attached biofilms too thin or transparent to see by eye [52]). It is possible that the
floaters and attached biofilms represent substantially different colonisation strategies, with the
former recruiting planktonic cells directly from the liquid column to the A-L interface and
growing from multiple loci, and the latter developing from sessile cells attaching in the
meniscus region and subsequently growing out across the A-L interface [52].
Although floating biofilms have been reported in which buoyancy is the result of trapped
CO2 released by respiration (e.g. G. xylinus [44]), the two different A-L interface biofilms
produced by our model environmental pseudomonad, P. fluorescens SBW25, known as the
viscous mass and Wrinkly Spreader biofilms, are not buoyant per se and readily sink when
disturbed [49,53,54]. It is likely that they are maintained at the A-L interface by hydrophobic
cell surfaces, matrix components, and surfactant which pierce or weaken the A-L interface
[53,54]. Interestingly, we have recently found that for the Wrinkly Spreader, a class of adaptive
mutants of the wild-type strain which evolves in static microcosms, drip-fed glass bead
columns, and soil [48,51,55], attached A-L interface biofilm growth can be seamlessly linked
to swarming motility and colony growth using ‘transitional microcosms’ in which a layer of
agar is set along the side of the vial, providing both liquid and dry agar surfaces for colonisation
(C. Immoor, O. Moshynets , A. Spiers, Unpublished Observations).
In these transitional microcosms, we wonder whether there is more than just planktonic
bacteria growing in the liquid column and a single, distinct structure colonising both the liquid
and agar surfaces in these simple environments, as suggested by the simplistic planktonic-
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Wrinkly Spreader genotypes which are recruited to the A-L interface through the expression
of attachment factor and cellulose which provides the main matrix component for the biofilm
[49,53,68]. Those bacteria localised to the A-L interface have access to higher levels of O2,
compared with those lower down, and consequently grow faster [69]. Higher levels of O2 might
also induce a SOS response via reactive oxygen species (ROS) leading to the expression of an
error-prone DNA polymerase, as in the case of P. aeruginosa PA01 [70], increasing mutation
rates and the appearance of Wrinkly Spreader mutants.
As a result of access to higher levels of O2, Wrinkly Spreaders have a fitness advantage over
non-biofilm-forming competitors [69]. We speculate that in colonies where Wrinkly Spreaders
still express attachment factor and cellulose, these components have no essential function and
therefore pose a fitness cost to the growing population, explaining why the Wrinkly Spreaders
are poorly adapted to growing on agar surfaces. Interestingly, improved O2 access has also
been suggested as an explanation for the wrinkled colonies produced by P. aeruginosa PA14.
However, it appears that a more complex level of redox control regulating the use of different
electron donors, including O2 diffusing into the colony from above and redox-active phena‐
zines produced by bacteria located at the base of the colony, may govern metabolism in P.
aeruginosa PA14 and other bacteria producing wrinkled colonies including B. subtilis [57,71,72].
More generally, O2 gradients determine the distribution of aerobic and anaerobic bacteria in
a wide range of environments, including water columns, sediments and soils, where it effects
growth, gene expression patterns and metabolism, and along with other competing electron
acceptors, help define aerobic, micro-aerobic (transitional) and anaerobic niches [73–76]. It is
therefore not surprising if O2 gradients also played a central role in the development and
function of a wider range of bacterial aggregations, and not just in biofilms and colonies.
6. Other terminology
As a slight digression, we present a non-exhaustive selection of vernacular and scientific
terminology used to describe bacterial aggregations which includes active sludge, biofilms,
clumps, colonies, flocs, mats, pellicles, rafts, slimes, zooglea, etc. (Table 1). We would expect
that a more extensive review of the early microbiology literature, including French, German,
and Russian publications, and of current microbiology, microbial biotechnology, environ‐
mental science, and medical microbiology publications, would result in more terms being
identified. Although the first observations of biofilms (dental plaque) were made by van
Leeuwenhoek (1683–1708) [34], microbial mats appeared much earlier, and are identified
today as the fossilised remains of 3.5-billion-year-old stromatolites [77]. Arguably the first
observation by a microbiologist was made by Pasteur (1864) [34], and by the end of the
nineteenth-century, environmental microbiologists were investigating them as well (we list
several early observations following Pasteur in Table 2). For example,Winogradsky (1895) [78]
described jelly-like masses of bacteria as ‘zooglea’, whilst Egunov (1895) [79]) and Sorokina
(1938) [80] more obviously referred to biofilms in the current sense, using terms that translate
into bacterial ‘plate’ or ‘plane’, and ‘film’, respectively.
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in L-S interface biofilms present a substantially different set of conditions for bacteria than the
opposing gradients found in colonies. Similarly, it would be interesting to compare liquid flow
within biofilms subject to external liquid currents, with the evaporation- and capillary-driven
liquid flow within colonies subject to different drying regimes.
Notably, colonies show different growth patterns, have highly structured morphologies, are
sometimes surrounded by EPS, and may show co-operative behaviour, so it is not unreason‐
able to consider that they are responding to abiotic and biotic conditions as do biofilms [6,42,
43]. In soil, water availability, often described by the matrix potential, is a significant factor
restricting bacterial motility, the formation of aggregations, and colonisation through the pore
network [62–64]. In such systems it is highly likely that contiguous bacterial populations
colonise non-permeable solid surfaces covered or linked by thin films of water with slimes or
swarms; permeable solids through which water is available with microcolonies and colonies;
and partially and fully saturated pores with A-L and L-S interface biofilms, slimes, and
planktonic bacteria.
5. Aggregations respond to different conditions
We would argue that bacteria colonising a range of environments should develop into different
aggregations in response to local conditions and opportunities. These aggregations might
appear to be superficially similar (e.g. A-L and L-S interface biofilms) or substantially different
(cf. a colony), depending on bacterial responses and colonisation strategies aimed at maxi‐
mising ecological success, as well as on our ability to recognise which abiotic and biotic factors
have the greatest impact on the developing population.
Our observations of linked Wrinkly Spreader A-L interface biofilms and colonies in the
transitional microcosms might suggest that these are very similar aggregations used to colonise
two interfaces (the liquid and agar surfaces) which do not pose significantly different chal‐
lenges to bacterial growth. However, competitive fitness assays in each environment suggests
that Wrinkly Spreaders achieve substantially different levels of ecological success in colonising
liquid and agar surfaces: they have a fitness advantage in static microcosms but are at a
disadvantage in colonies compared to wild-type P. fluorescens SBW25 [65–68]. These fitness
differences suggest that environmental conditions probably change across the transitional
zone, with the initial Wrinkly Spreader population responding to these changes to colonise
the A-L interface and agar surfaces in different manners.
We speculate that the fitness advantage of Wrinkly Spreaders is determined by the subtle
trade-off in energy expenditure needed to produce A-L interface biofilms in static microcosms
and the increased access to O2 biofilm formation allows. The growth of P. fluorescens SBW25 is
limited by O2 and it drives the evolution of the Wrinkly Spreaders [69]. Relative small numbers
of wild-type colonists rapidly generate an O2 gradient through respiration, converting the
homogeneous liquid column into a shallow upper zone having normal levels of O2 and a
deeper lower zone with rapidly diminishing O2 levels (these colonists are in effect environ‐
mental engineers) [69]. As this population rapidly expands, random mutation results in
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Wrinkly Spreader genotypes which are recruited to the A-L interface through the expression
of attachment factor and cellulose which provides the main matrix component for the biofilm
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error-prone DNA polymerase, as in the case of P. aeruginosa PA01 [70], increasing mutation
rates and the appearance of Wrinkly Spreader mutants.
As a result of access to higher levels of O2, Wrinkly Spreaders have a fitness advantage over
non-biofilm-forming competitors [69]. We speculate that in colonies where Wrinkly Spreaders
still express attachment factor and cellulose, these components have no essential function and
therefore pose a fitness cost to the growing population, explaining why the Wrinkly Spreaders
are poorly adapted to growing on agar surfaces. Interestingly, improved O2 access has also
been suggested as an explanation for the wrinkled colonies produced by P. aeruginosa PA14.
However, it appears that a more complex level of redox control regulating the use of different
electron donors, including O2 diffusing into the colony from above and redox-active phena‐
zines produced by bacteria located at the base of the colony, may govern metabolism in P.
aeruginosa PA14 and other bacteria producing wrinkled colonies including B. subtilis [57,71,72].
More generally, O2 gradients determine the distribution of aerobic and anaerobic bacteria in
a wide range of environments, including water columns, sediments and soils, where it effects
growth, gene expression patterns and metabolism, and along with other competing electron
acceptors, help define aerobic, micro-aerobic (transitional) and anaerobic niches [73–76]. It is
therefore not surprising if O2 gradients also played a central role in the development and
function of a wider range of bacterial aggregations, and not just in biofilms and colonies.
6. Other terminology
As a slight digression, we present a non-exhaustive selection of vernacular and scientific
terminology used to describe bacterial aggregations which includes active sludge, biofilms,
clumps, colonies, flocs, mats, pellicles, rafts, slimes, zooglea, etc. (Table 1). We would expect
that a more extensive review of the early microbiology literature, including French, German,
and Russian publications, and of current microbiology, microbial biotechnology, environ‐
mental science, and medical microbiology publications, would result in more terms being
identified. Although the first observations of biofilms (dental plaque) were made by van
Leeuwenhoek (1683–1708) [34], microbial mats appeared much earlier, and are identified
today as the fossilised remains of 3.5-billion-year-old stromatolites [77]. Arguably the first
observation by a microbiologist was made by Pasteur (1864) [34], and by the end of the
nineteenth-century, environmental microbiologists were investigating them as well (we list
several early observations following Pasteur in Table 2). For example,Winogradsky (1895) [78]
described jelly-like masses of bacteria as ‘zooglea’, whilst Egunov (1895) [79]) and Sorokina
(1938) [80] more obviously referred to biofilms in the current sense, using terms that translate
into bacterial ‘plate’ or ‘plane’, and ‘film’, respectively.
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in L-S interface biofilms present a substantially different set of conditions for bacteria than the
opposing gradients found in colonies. Similarly, it would be interesting to compare liquid flow
within biofilms subject to external liquid currents, with the evaporation- and capillary-driven
liquid flow within colonies subject to different drying regimes.
Notably, colonies show different growth patterns, have highly structured morphologies, are
sometimes surrounded by EPS, and may show co-operative behaviour, so it is not unreason‐
able to consider that they are responding to abiotic and biotic conditions as do biofilms [6,42,
43]. In soil, water availability, often described by the matrix potential, is a significant factor
restricting bacterial motility, the formation of aggregations, and colonisation through the pore
network [62–64]. In such systems it is highly likely that contiguous bacterial populations
colonise non-permeable solid surfaces covered or linked by thin films of water with slimes or
swarms; permeable solids through which water is available with microcolonies and colonies;
and partially and fully saturated pores with A-L and L-S interface biofilms, slimes, and
planktonic bacteria.
5. Aggregations respond to different conditions
We would argue that bacteria colonising a range of environments should develop into different
aggregations in response to local conditions and opportunities. These aggregations might
appear to be superficially similar (e.g. A-L and L-S interface biofilms) or substantially different
(cf. a colony), depending on bacterial responses and colonisation strategies aimed at maxi‐
mising ecological success, as well as on our ability to recognise which abiotic and biotic factors
have the greatest impact on the developing population.
Our observations of linked Wrinkly Spreader A-L interface biofilms and colonies in the
transitional microcosms might suggest that these are very similar aggregations used to colonise
two interfaces (the liquid and agar surfaces) which do not pose significantly different chal‐
lenges to bacterial growth. However, competitive fitness assays in each environment suggests
that Wrinkly Spreaders achieve substantially different levels of ecological success in colonising
liquid and agar surfaces: they have a fitness advantage in static microcosms but are at a
disadvantage in colonies compared to wild-type P. fluorescens SBW25 [65–68]. These fitness
differences suggest that environmental conditions probably change across the transitional
zone, with the initial Wrinkly Spreader population responding to these changes to colonise
the A-L interface and agar surfaces in different manners.
We speculate that the fitness advantage of Wrinkly Spreaders is determined by the subtle
trade-off in energy expenditure needed to produce A-L interface biofilms in static microcosms
and the increased access to O2 biofilm formation allows. The growth of P. fluorescens SBW25 is
limited by O2 and it drives the evolution of the Wrinkly Spreaders [69]. Relative small numbers
of wild-type colonists rapidly generate an O2 gradient through respiration, converting the
homogeneous liquid column into a shallow upper zone having normal levels of O2 and a
deeper lower zone with rapidly diminishing O2 levels (these colonists are in effect environ‐
mental engineers) [69]. As this population rapidly expands, random mutation results in
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Jellies and
zooglea (or zoogloea)
A slimy mass of bacteria encased in a gel-like material, often found floating in water or found
on plant stems or leaf litter.
Laminae Layers of microbial mat generations, or microbial mats overgrowing sediments.
Mats Microbial communities, often with clear layering or stratification, found in streams, lake or sea
beds; these may also contain, algae and plants, and trap small particles including sand and
stones.
Meniscus growth A mass of bacteria adhered to a solid surface in the meniscus region of static liquids (the air-
liquid-solid surface (A-L-S) interface).
Microcenosis,
microbial cenosis
Microbial communities formed in a particular niche or site.
Micro-zones and
pelogens
Microbial communities growing in thin layers structurally segregated with different
characteristics or activities in sediments or silt.
Pellicles A thin film or gel-like coating surrounding of individual bacteria, as well as air-liquid (A-L)
interface biofilms.
Phlegm balls Flocs found in underground streams.
Plaque Dental biofilms formed largely by anaerobic bacteria on the surfaces and cavities in teeth.
Rafts Flat sections on the edges of colonies, often associated with twitching motility, or flat pieces of
un-attached biofilm found at the air-liquid interface.
Remains and
remnants
A mass of bacteria and cellular debris found at a site at which they probably did not develop
or a portion of a larger mass which has been removed by physical disturbance, predation or
decay.









Pendulous or dripping masses of bacteria developing on cave walls or at the bottom of
stalactites, especially limestone cave speleothems.
Swarms Bacteria showing a particular form of surface-associated motility, moving in high densities
across moist or wet surfaces.
This is a non-exhaustive list where terms, meanings and usage varies between contexts, and grouped terms may not be
synonymous.
Table 1. Vernacular and scientific terminology used to describe bacterial aggregations
1864 Pasteur describes slimy material called Mother of Vinegar [34].
1887 Winogradsky observed bacterial growth in ring-like structures in a liquid microcosm containing H2S and
covered with a glass slide to restrict O2 diffusion [86].
1893 Beijerink observed bacteria growing in zones of enriched water microcosms, the positions of which could be
altered depending on O2 and H2 levels. Described ‘Bakterienniveau’ or ‘niveau’ as an aggregation formed by
motile bacteria [87].
1895 Winogradsky observes bacterial zoogleas on potato slices [78].





A mass of bacteria growing within another structure, including sediments, soils, plant and
animal tissues.
Active fluids Formed by motile bacteria moving together at high density in a liquid.





A mass of bacteria (and other microorganisms) having some sort of physical cohesion; these
may have developed by growth, or they may be the result of physical mixing or disturbance.
Bacterial plates A layer of bacteria formed in a water column at a certain depth depending on oxygen levels.
Biofilms A mass of bacteria enclosed in a protective matrix of EPS and associated with a surface or
interface; most often used to refer to liquid-solid surface (L-S) interface biofilms such as those





Living and fossilised microbial mats which may trap and bind sediments and/or cause mineral
precipitation, sometimes intercalated by sediment laminae; sometimes referred to as microbial-
induced sedimentary (MIS) structures.
Clusters A zone of physiologically synchronised bacteria within a lager aggregation, or a small mass of
bacteria such as a colony or floc.
Collapsed cakes Formed by the collapse of clumps or flocs on membranes during filtration.
Colonies, macro- and
micro-colonies
A mass of bacteria having some sort of physical cohesion and having developed by growth on
a solid dry surface; micro-colonies are those associated with the biofilm development process
on submerged solid surfaces, or small aggregations of bacteria not noticed as colonies unless
observed with magnification on leaf surfaces, detritus, or agar plates.
Communities and
consortia
A complex mixture of multiple bacterial species (or genotypes) and possibly other




Microbial communities developing on the surface of soils and dessert sand; also the dried
remnants of colonies etc.
Deposits and
sediments
Mass or body of bacteria that accumulate on dry or submerged surfaces due to wind or water
movement.








A thin layer or volume containing bacteria which may or may not be physically connected to
one another, solid surfaces, or other interfaces, and occurring in liquids, porous or permeable
solids.
Flocs and snow Masses of bacteria formed by growth, self-association, hydrophobic interactions, or by
attachment to suspended inert particles; flocs in sea water are referred to as snow.
Floaters Biofilms at the air-liquid interface having no appreciable attachment to a solid surface; these
may be localised at the liquid surface by buoyancy, penetration of the interface, or by
hydrophobic surfaces.
Foams Air-water emulsions containing high concentrations of bacteria and compounds such as
polymers and surfactants, which may help stabilise the structure.
Granules A mass of bacteria growing on small solid particles.
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Jellies and
zooglea (or zoogloea)
A slimy mass of bacteria encased in a gel-like material, often found floating in water or found
on plant stems or leaf litter.
Laminae Layers of microbial mat generations, or microbial mats overgrowing sediments.
Mats Microbial communities, often with clear layering or stratification, found in streams, lake or sea
beds; these may also contain, algae and plants, and trap small particles including sand and
stones.
Meniscus growth A mass of bacteria adhered to a solid surface in the meniscus region of static liquids (the air-
liquid-solid surface (A-L-S) interface).
Microcenosis,
microbial cenosis
Microbial communities formed in a particular niche or site.
Micro-zones and
pelogens
Microbial communities growing in thin layers structurally segregated with different
characteristics or activities in sediments or silt.
Pellicles A thin film or gel-like coating surrounding of individual bacteria, as well as air-liquid (A-L)
interface biofilms.
Phlegm balls Flocs found in underground streams.
Plaque Dental biofilms formed largely by anaerobic bacteria on the surfaces and cavities in teeth.
Rafts Flat sections on the edges of colonies, often associated with twitching motility, or flat pieces of
un-attached biofilm found at the air-liquid interface.
Remains and
remnants
A mass of bacteria and cellular debris found at a site at which they probably did not develop
or a portion of a larger mass which has been removed by physical disturbance, predation or
decay.









Pendulous or dripping masses of bacteria developing on cave walls or at the bottom of
stalactites, especially limestone cave speleothems.
Swarms Bacteria showing a particular form of surface-associated motility, moving in high densities
across moist or wet surfaces.
This is a non-exhaustive list where terms, meanings and usage varies between contexts, and grouped terms may not be
synonymous.
Table 1. Vernacular and scientific terminology used to describe bacterial aggregations
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altered depending on O2 and H2 levels. Described ‘Bakterienniveau’ or ‘niveau’ as an aggregation formed by
motile bacteria [87].
1895 Winogradsky observes bacterial zoogleas on potato slices [78].
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on submerged solid surfaces, or small aggregations of bacteria not noticed as colonies unless
observed with magnification on leaf surfaces, detritus, or agar plates.
Communities and
consortia
A complex mixture of multiple bacterial species (or genotypes) and possibly other
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Mass or body of bacteria that accumulate on dry or submerged surfaces due to wind or water
movement.
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Linking individuals into a group through the exchange of communication signals and/or
response to the same environmental signals, resulting in similar behaviours or activities, and
the production of common goods such as EPS and other secreted products.
Developmental
pathway
Guiding the behaviour individuals and groups through a series of defined stages and resulting





Abiotic chemical and physical factors, biotic factors; niche, opportunities, substrates, resources,
stress, variation and instability; local, large-scale and irreversible changes, depletion,
contamination.
Gene expression Controlling behaviour, communication, metabolism, the production of compounds required
for the formation of aggregations, etc.
Genotypes and
diversity
Aggregations may arise from a single individual or founder population of the same genotype,
but diversity will develop over time with radiation and immigration; single or multi-species
aggregations; cheaters, invaders and persisters.
Liquid flow Around and within aggregations, effecting the development of the physical structure,
deformation and breakage, boundary layers, mass transport and diffusion of molecules, as
well as the movement of bacteria.
Mobility Of individual bacteria, small groups and larger aggregations, over small and large-scale
distances, across interfaces, surfaces and volumes, and through environments.
Physical interactions With interfaces, surfaces, bacteria, EPS, etc., in terms of strength, elasticity or resilience,
distances, duration and reversibility.
Resilience To chemical and physical stress, external competition, predation, and in terms of physical
structure.
Sensory zones The ability of individuals to detect the presence of others using altered chemical gradients,
metabolites and communication signals (diffusion radii), and the distance separating
individuals or groups.
Stratification From homogeneous mixtures to clustered or layered differences resulting from age,
metabolism, diversity and function.
Structure and
rheology  
Aggregations having properties similar to Newtonian liquids, visco-elastic gels and solids.
Succession The diversity and function of aggregations will develop over time and with changing
environmental conditions.
Time The time-scale for the development, presence or persistence of aggregations may vary
considerably, effecting population size, radiation, succession, aggregation structure and
stratification, and environmental impact.
Table 3. Features linking bacterial aggregations within a larger continuum.
Physical interactions involving bacterial surface coatings, appendages and matrix, solid
surfaces and interfaces within A-L and L-S interface biofilms are known to be complex (Figure
2), but there is no reason to believe that all types of interactions are unique to these particular
aggregations. We therefore propose that one feature of the continuum of aggregations could
be expressed by a scale going from no interactions with solid surfaces or other interfaces, as
in the case of a population of planktonic bacteria, through short-term, weak, or distant physical
contacts with surfaces, interfaces, or material, to the complexity of interactions seen in A-L and
L-S interface biofilms, and presumably in other aggregations such as flocs, granules, and snow.
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1895 Egunov observed bacterial plates forming in microcosms containing Black Sea sediments, the position of which
depended on anaerobic conditions, O2 and H2S levels. Some of these bacteria were motile, and Egunov asked
what forces drove them to form a stationary aggregation [79,88].
1900 Egunov describes bacterial attachment during plate formation, and his ‘bioanisotropy’ concept for
environments (continuous matter exchange between an organism and its surroundings) [89].
1914 Isachenko describes ‘pink water’ caused by the aggregation of purple bacteria in sea water as well as bacteria
forming cloud-like structures in liquid microcosms [36].
1933 Henrici observed that bacteria mostly grow on submerged surfaces, not in free flowing water [34].
1935 Zobell describes marine bacteria attachment to surfaces [34].
1938 Sorokina describes a bacterial film forming on a submerged slime surface in a liquid microcosm [80].
Table 2. Early observations of bacterial aggregations.
More recently, pendulous and dripping snottites have been described on cave walls and
stalactites [81] and collapsed cakes are a problem in filtration [82]. More interesting, perhaps,
are the reports that bacterial remains have been misidentified as dinosaur soft tissues [83] and
desert varnishes are being used to train sensors for future planetary explorations [84].
Regrettably, we also note that a chance to create a more evocative science fiction term for
biofilms on the International Space Station was missed [85].
We argue that such an extensive collection of terms used to describe bacterial aggregations
should not be considered a plethora, but rather an indication that the diversity of aggregations
we are aware of may reflect the multitude of ways bacteria to respond to differing ecological
opportunities. However, we do not suggest that each of the terms are unique, as quite evidently
different types of aggregations may be associated closely or more distantly from one another,
depending on which abiotic or biotic factors are considered.
7. Key features linking aggregations
Bacteria interact with abiotic and biotic factors by responding to physical and chemical cues
according to behavioural and adaptive strategies under constant selection to maximise fitness.
When these cues and strategies are considered in the context of a larger continuum of aggre‐
gations, it is possible to identify key features that link aggregations within a larger continuum
(Table 3). Here we briefly indicate how physical interactions, diffusion radii, and increasing
genetic diversity might be used to compare different types of aggregations.
Chemical gradients Controlling the behaviour of individuals and groups, defining zones of optimal and restricted
growth, providing information about local conditions; of nutrients, O2 and other electron
acceptors and metabolites, chemosensory, regulatory and communication compounds, and
waste.
Competition Between genotypes or lineages for resources, drives adaptation, allows investment in public
goods but also results in cheaters.
Complexity Of abiotic and biotic interactions, of genotypes, metabolism, structures, etc.
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different types of aggregations may be associated closely or more distantly from one another,
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Bacteria interact with abiotic and biotic factors by responding to physical and chemical cues
according to behavioural and adaptive strategies under constant selection to maximise fitness.
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gations, it is possible to identify key features that link aggregations within a larger continuum
(Table 3). Here we briefly indicate how physical interactions, diffusion radii, and increasing
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Competition Between genotypes or lineages for resources, drives adaptation, allows investment in public
goods but also results in cheaters.
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patterns, behaviour, and metabolism. We propose that separation distance, scaled in terms of
chemical gradients, will also be a useful means of comparing and differentiating bacterial
aggregations.
Aggregations developing over significant periods of time will also gain diversity by radiation
and immigration, leading to multispecies communities subject to ecological succession, driven
by internal competitive and co-operative interactions and changing environmental conditions
(Figure 4). We propose that both diversity in terms of genotype or species composition and
community function could also be used to consider bacterial aggregations, and this perspective
is complementary to understanding the physical interactions and the molecular biology
underlying the development of these structures.
Figure 4. Bacterial aggregations gain diversity over time. An aggregation developing from a single genotype will gain
diversity through radiation (mutation), immigration, and succession. Stochastic events and changing selective pres‐
sures will result in different genotypes within the community; some genotypes may become extinct and diversity may
fall. (Key: Time progresses from left to right; colonising genotypes are shown as circles; mutation events as vertical
lines; successful genotypes are indicated by arrows and an extinction event by a truncated line.)
By considering the ability of individual bacteria to respond to their local environments via
different growth and colonisation strategies, the impact of abiotic conditions on individuals
and the structures they create, and the longer-term development of the community, it is
possible to speculate how altered environmental conditions and circumstance can lead to the
cycling between different types of aggregation (Figure 5). The ability of bacteria to move
between different types of aggregation with changing conditions or to exploit new opportu‐
nities will clearly differentiate those able to colonise a wide range of environments with those
adapted to very specific niches.
Figure 5. Bacterial aggregations change nature with altering environmental conditions. Although aggregations may
develop and persist in one site, conditions may change resulting in an aggregation with a substantially different na‐
ture. The archetypal L-S interface biofilm developmental process is shown on the left. Biofilms may dry out to form
slimes and colonies, and further drying might result in dust particulates which may rehydrate to form aggregations.
(Key: A, air; L, liquid; S, solid; bacteria are artistically depicted as bacilli with a single flagella.)
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Figure 2. Bacterial aggregations are constructed by numerous and varied physical interactions. Bacterial cells within
aggregations will interact with one another through close, intermediate, and long-range interactions involving surface
coatings and extended appendages (e.g. flagella), matrix components, solid surfaces and interfaces (e.g. the air-liquid
interface). (Key: A, air; L, liquid; S, solid; Matrix components or fibres are artistically depicted by dashed lines and
bacteria as bacilli with a single flagella.)
Interactions with surfaces and interfaces also clearly limit the ability of an aggregation to
develop, so the ability to expand across surfaces or to penetrate volumes, along with altered
mass transport and diffusion characteristics, also present other scales with which to compare
aggregations (Figure 3). In particular, diffusion radii will determine the ability of individual
bacteria to detect the proximity of others and to respond competitively or with co-operation.
Clearly, low-density planktonic and surface-attached bacteria may be beyond detection
distances, but as bacterial numbers increase, their individual and collective impacts on local
environmental conditions will lead to a situation where they are now within the same micro-
environment, and similar conditions may result in coordinated changes in gene expression
Figure 3. Bacterial aggregations develop at interfaces, within liquids, porous solids, and visco-elastic materials. Col‐
onising bacteria may develop into communities restricted primarily by diffusion or liquid flow (mass transport) of
chemicals and the ability to expand across interfaces or into spaces (radial arrows). Shown here (left to right) are colo‐
nies growing on and into a solid, biofilms growing on a solid submerged surface, flocs developing from a suspended
particle, floaters forming at the air-liquid interface, and meniscus growth occurring at the air-liquid-solid surface inter‐
face. (Key : A, air; IPS, impermeable solid; L, liquid; PS, permeable or porous solid; S, solid; arrows indicate expansion
radii and the opposite direction indicates diffusion gradients that limit growth.)
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In this opinion piece, we advocate the inclusion of biofilms within the larger context of a
continuum of bacterial aggregations. We do this because we are growing concerned that the
‘Microbial Cities’ vision originating from the seminal reviews by Costerton et al. [1,2] is
beginning to dominate biofilm research, and that such a narrow view limits our ability to better
understand bacterial colonisation of a variety of different environments. In this continuum,
we consider A-L and L-S interface biofilms to be biofilms, but argue that other aggregations
such as colonies are significantly different and should not be referred to using this particular
term. It is also possible that applied and environmental microbiologists prefer to refer to
microbial mats rather than to biofilms, because the latter is too closely associated with
experimental L-S interface biofilms produced in flow-cells or microtitre plates, and too far
removed from the aggregations found in natural and other man-made environments.
We believe that the advantages of taking a wide view will allow us to distinguish those
processes governing general colonisation through the formation of aggregations and ecolog‐
ical success, from those unique to particular environments and specialised strategies (as an
apologia, we remind readers of the sensu lato definition of biofilms, secundum Costerton et
al., which was inclusive of a number of different aggregations). By suggesting that biofilms
are better considered as one of a variety of different aggregations, the simplistic planktonic-
(sessile) biofilm dichotomy is also challenged, and perhaps the best reference or comparator
for different aggregations will not always be logarithmic phase planktonic bacteria.
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In this opinion piece, we advocate the inclusion of biofilms within the larger context of a
continuum of bacterial aggregations. We do this because we are growing concerned that the
‘Microbial Cities’ vision originating from the seminal reviews by Costerton et al. [1,2] is
beginning to dominate biofilm research, and that such a narrow view limits our ability to better
understand bacterial colonisation of a variety of different environments. In this continuum,
we consider A-L and L-S interface biofilms to be biofilms, but argue that other aggregations
such as colonies are significantly different and should not be referred to using this particular
term. It is also possible that applied and environmental microbiologists prefer to refer to
microbial mats rather than to biofilms, because the latter is too closely associated with
experimental L-S interface biofilms produced in flow-cells or microtitre plates, and too far
removed from the aggregations found in natural and other man-made environments.
We believe that the advantages of taking a wide view will allow us to distinguish those
processes governing general colonisation through the formation of aggregations and ecolog‐
ical success, from those unique to particular environments and specialised strategies (as an
apologia, we remind readers of the sensu lato definition of biofilms, secundum Costerton et
al., which was inclusive of a number of different aggregations). By suggesting that biofilms
are better considered as one of a variety of different aggregations, the simplistic planktonic-
(sessile) biofilm dichotomy is also challenged, and perhaps the best reference or comparator
for different aggregations will not always be logarithmic phase planktonic bacteria.
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Abstract
Pseudomonas aeruginosa is an opportunistic Gram‐negative bacterium that is primarily
responsible for infections related to cystic fibrosis (CF) airways, burn wounds, urinary
tract infections, surgery‐associated infections, and HIV‐related illness. Pyocyanin and
extracellular DNA (eDNA) are the major factors dictating the progression of biofilm
formation and infection. Pyocyanin is a potent virulence factor causing cell death in
infected CF patients and is associated with high mortality. eDNA is a key player in P.
aeruginosa biofilm formation and is also responsible for the high viscosity of CF sputum
that blocks the respiratory airway passages. In this chapter, we summarize our recent
findings  on  the  role  of  pyocyanin  in  facilitating  P.  aeruginosa  biofilm  formation.
Pyocyanin promotes eDNA release in P. aeruginosa by inducing cell lysis mediated via
hydrogen peroxide (H2O2)  production. Pyocyanin intercalates with the nitrogenous
bases  of  DNA  and  creates  structural  perturbation  on  the  double‐helix  structure.
Pyocyanin‐eDNA binding significantly influences P. aeruginosa cell surface hydropho‐
bicity and influences the physicochemical interactions facilitating bacterial cell‐to‐cell
interaction  (aggregation)  and  ultimately  facilitates  robust  biofilm  formation.  A
pyocyanin knockout (ΔphzA‐G) mutant is shown to have significantly reduced eDNA
release and biofilm formation in comparison to its wild‐type. To this end, we discover
that antioxidant glutathione directly binds to pyocyanin and modulates pyocyanin
structure and function, thus inhibiting pyocyanin‐eDNA binding and consequently
hampering biofilm development.
Keywords: Pseudomonas aeruginosa, Pyocyanin, extracellular DNA, glutathione, bio‐
film
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Abstract
Pseudomonas aeruginosa is an opportunistic Gram‐negative bacterium that is primarily
responsible for infections related to cystic fibrosis (CF) airways, burn wounds, urinary
tract infections, surgery‐associated infections, and HIV‐related illness. Pyocyanin and
extracellular DNA (eDNA) are the major factors dictating the progression of biofilm
formation and infection. Pyocyanin is a potent virulence factor causing cell death in
infected CF patients and is associated with high mortality. eDNA is a key player in P.
aeruginosa biofilm formation and is also responsible for the high viscosity of CF sputum
that blocks the respiratory airway passages. In this chapter, we summarize our recent
findings  on  the  role  of  pyocyanin  in  facilitating  P.  aeruginosa  biofilm  formation.
Pyocyanin promotes eDNA release in P. aeruginosa by inducing cell lysis mediated via
hydrogen peroxide (H2O2)  production. Pyocyanin intercalates with the nitrogenous
bases  of  DNA  and  creates  structural  perturbation  on  the  double‐helix  structure.
Pyocyanin‐eDNA binding significantly influences P. aeruginosa cell surface hydropho‐
bicity and influences the physicochemical interactions facilitating bacterial cell‐to‐cell
interaction  (aggregation)  and  ultimately  facilitates  robust  biofilm  formation.  A
pyocyanin knockout (ΔphzA‐G) mutant is shown to have significantly reduced eDNA
release and biofilm formation in comparison to its wild‐type. To this end, we discover
that antioxidant glutathione directly binds to pyocyanin and modulates pyocyanin
structure and function, thus inhibiting pyocyanin‐eDNA binding and consequently
hampering biofilm development.
Keywords: Pseudomonas aeruginosa, Pyocyanin, extracellular DNA, glutathione, bio‐
film
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formation in P. aeruginosa. To this end, we highlight novel strategies targeting the interaction
of pyocyanin with eDNA to prevent P. aeruginosa biofilm formation.
2. Pyocyanin production by P. aeruginosa
P. aeruginosa synthesizes a variety of phenazines; however, the most abundantly produced is
pyocyanin [5‐methyl‐1(5H)‐phenazinone]. Up to 95% of P. aeruginosa isolates preferentially
produce pyocyanin [16], which at a neutral pH is a distinctive blue in color and turns red in
acidic pH conditions. It is a small and highly diffusible nitrogen‐containing aromatic com‐
pound with a multitude of biological activities [16, 17]. In P. aeruginosa, pyocyanin production
involves a stepwise process, beginning with the synthesis of the primary quorum sensing (QS)
Figure 1. (a) Schematic of phenazine (pyocyanin) production by P. aeruginosa. Pyocyanin production is triggered at the
early stationary phase through QS molecules (AHL and PQS), phenazine‐producing genes (phzA‐G), and finally by
gene phzM. (b) Pyocyanin production by various P. aeruginosa clinical (AES‐1, AES‐2, and LESB58) and laboratory
(PA14 wild‐type, ΔphzA‐G, PAO1 wild‐type, and ΔphzSH) strains at different (0, 8, 16, and 24 h) time points. Error bars
represent standard deviations from the mean (n=4).




Pseudomonas aeruginosa is an opportunistic Gram‐negative bacterium that readily forms biofilms
and  causes  life‐threatening  infections,  particularly  in  immunocompromised  persons.  P.
aeruginosa is primarily responsible for infections related to airways in cystic fibrosis (CF) and
bronchiectasis, burns wounds, urinary tract infections (UTIs), and nosocomial infections. For
instance, P. aeruginosa infection and subsequent biofilm formation is implicated in 80% of CF
deaths worldwide [1]. In CF patients, P. aeruginosa infection is responsible for lung tissue damage,
impaired lung function, respiratory failure, and premature death [1, 2]. In spite of intensive
antibiotic therapy against infections, the mean life expectancy of CF patients is short (∼45 years)
[1]. A recent study suggests that P. aeruginosa and its associated infections are more persistent
and dominant in CF patients aged over 18 years (91%) than in patients less than 18 years (39%)
[3]. In the case of burn injury infections, P. aeruginosa along with Staphylococcus aureus are
recognized as principal pathogens responsible for serious complications in ∼20.9% and 22.9%
of patients, respectively [4]. Studies suggest that, in the United States, approximately 2.5 million
patients with burn injury requires medical attention in which it is estimated more than 100,000
hospitalizations  result  every  year,  causing  approximately  12,000  deaths  from associated
infections [5]. In hospital‐acquired UTIs, P. aeruginosa is the third most common pathogen next
to Escherichia coli and Proteus mirabilis [6]. In United States, UTI‐associated hospital admission
is estimated to be 300,000 patients every year, and urological disease costs more than 3.5 billion
dollars annually in the United States alone [6].
Persistent P. aeruginosa infections that culminate in biofilm formation are attributed to a matrix
of extracellular polymeric substances (EPS) in which bacterial cells are embedded [7, 8]. The
EPS matrix of P. aeruginosa primarily consists of biomolecules, such as polysaccharides
(alginate, lipopolysaccharides), proteins (protease, elastase), extracellular DNA (eDNA),
metabolites (phenazines), exotoxin, and siderophores [6, 7]. These molecules present in the
matrix play a significant role in the pathogenesis of P. aeruginosa infections. In addition, in
many bacterial species, the matrix as a whole provides an inherent protection against both host
immunity and traditional antibiotic therapy, which makes eradication extremely difficult [7,
9]. Previous studies acknowledge that the production of phenazines such as pyocyanin and
the release of DNA from cells, providing freely available eDNA by P. aeruginosa, are the major
factors dictating the formation of a biofilm and the persistent infection within the host [7, 8,
10, 11]. For instance, P. aeruginosa‐infected CF and bronchitis sputum contains a significant
amount of pyocyanin (up to 16 and 23 μg/ml, respectively) and eDNA (3–14 mg/ml) compared
to none in non‐CF patients [11, 12]. Pyocyanin is a highly versatile molecule recognized for its
effect as a potent virulence factor, causing cell death in chronically infected CF patients and
directly associated with decreased lung function and high mortality [11, 13]. eDNA is similarly
a key factor in P. aeruginosa biofilm formation and protecting bacteria by inducing antibiotic
resistance [8, 14, 15] and is also a contributing factor to the high viscosity of CF sputum that
blocks the respiratory airway passages [12].
In this chapter, we focus our discussion on very recent findings that elucidate the essential role
of pyocyanin in promoting eDNA production and interacting with eDNA to facilitate biofilm
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represent standard deviations from the mean (n=4).
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Figure 2. (a) Oxidation of GSH to GSSG by pyocyanin. P. aeruginosa produces pyocyanin, and pyocyanin accepts elec‐
trons (e−) from NADH and donates these electrons to oxygen to generate H2O2. Glutathione also donates electrons to
H2O2 forming GSSG. (b) Structure of pyocyanin, GSH, and GSSG.
Depleted GSH levels during the chronic stage of CF infection leads to widespread epithelial
cell death and consequently lung damage, respiratory failure, and mortality [21, 22]. Pyocyanin
also inhibits catalase activity in the airway epithelial cells and thus aggravates oxidative stress
in lung epithelial cells [23].
4. Pyocyanin promotes eDNA release in P. aeruginosa via H2O2 generation
In bacteria, eDNA release is mediated by both lytic and nonlytic mechanisms. The lytic
mechanism involves the controlled lysis of a small number of bacterial cells via the production
of various QS‐mediated cell lysing agents, such as lytic prophages, autolysin proteins,
enzymes, and H2O2. In nonlytic mechanisms, eDNA release is through bacterial outer mem‐
brane blebs/vesicles that contain large amounts of DNA [24–26]. QS‐dependent mechanisms
involve the AHL and PQS systems, whereas QS‐independent mechanisms operate via release
through flagellum and type IV pili [27, 28]. PQS in P. aeruginosa PAO1, a virulent laboratory
strain, triggers eDNA release in the early phase of planktonic culture through the induction
of prophages [27]. In accordance, a mutant for QS synthesis in pqsA and a pqsL mutant that
overproduces PQS show low and high amounts of eDNA release, respectively [27]. QS‐
independent mechanisms, which also include phage induction [28], are responsible for eDNA
release only in well‐established PAO1 biofilms (>10 days) and not in planktonic cultures.
A recent work in this field by Das and Manefield has shown that pyocyanin production in P.
aeruginosa laboratory strains PAO1 and PA14 triggers a significant increase in eDNA release
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molecule N‐acyl‐L‐homoserine lactone (AHL) during the exponential growth phase followed
by the secondary QS molecule Pseudomonas quinolone signaling (PQS) during the late expo‐
nential phase. PQS directly controls the expression of phzA‐G operons resulting in the pro‐
duction of phenazine‐1‐carboxylic acid (PCA) from its precursor chorismic acid. PCA is then
modified to produce three metabolites during the early stationary phase of which pyocyanin
is the predominant product and is regulated by the phzM gene. The two other types of
phenazine products are phenazine‐1‐carboxamide (PCN; encoded by phzH) and 1‐hydroxy‐
phenazine (1‐OHPHZ; encoded by phzS) [16, 18] (Figure 1a).
Figure 1b shows pyocyanin production by various P. aeruginosa clinical (AES‐1R, AES‐2, and
LESB58) and laboratory (PA14 wild‐type, ΔphzA‐G, PAO1 wild‐type, and PAO1 phzSH) strains
at different time points (0, 8, 16, and 24 h) grown under planktonic conditions in Luria broth
(LB) at 37°C and 150 rpm (unpublished data). The cell‐free supernatant of various bacterial
strains was used to quantify pyocyanin by absorbance at 691 nm. A standard curve for
pyocyanin was generated by addition of a known concentration (0–150 μM) of purified
pyocyanin (Sigma‐Aldrich, USA) to LB medium in a 1 ml cuvette, and absorbance was assayed
at 691 nm (λmax of pyocyanin) using Bio‐Rad Smartspec 3000 (Bio‐Rad Laboratories, Australia).
This curve was used to calibrate pyocyanin concentration in bacterial supernatants. For most
of the P. aeruginosa strains (AES‐1R, AES‐2, LESB58, PA14 wild‐type, PAO1 wild‐type, and
PAO1 phzSH) used in this study, at initial growth stage (8 h postinoculation), the concentration
of pyocyanin produced was less than 5 μM followed by a significant increase in pyocyanin
production recorded at ≥16 h of growth and reaching between 75 and 100 μM pyocyanin for
AES‐1R, LESB58, PA14 wild‐type, and PAO1 phzSH strains and ∼140 μM pyocyanin for AES‐
2 strain after 24 h growth, whereas PAO1 wild‐type produces less than (<) 15 μM pyocyanin.
In contrast, the phzSH mutant of PAO1, which is deficient of phzS and phzH genes, was unable
to convert PCA to PCN or 1‐OHPHZ [16, 19] and consequently overproduced pyocyanin,
whereas, after 24 h, phenazine‐deficient mutant (ΔphzA‐G) does not produce any pyocyanin.
3. Pyocyanin a virulence factor
Pyocyanin was formerly disregarded as a bacterial secondary metabolite but has recently been
ascribed a variety of roles in microbial ecology, and importantly a relationship with the severity
of P. aeruginosa infections [20]. Previous research has shown a correlation between pyocyanin
concentration in CF sputum and severity of infection [20]. The role of pyocyanin has been
intensively studied due to its electrochemical and redox activity. The diffusible nature of
pyocyanin means that it can easily diffuse through the host cell membrane and undergo redox
reactions with other molecules [2]. For instance, it accepts electrons from NADH and subse‐
quently donates electrons to molecular oxygen to form reactive oxygen species (ROS), such as
hydrogen peroxide (H2O2) [13]. The H2O2 generated via redox reactions has been identified as
a potent inhibitor of other bacterial and fungal species found within the microbiome of the CF
lung as well as significantly altering host cell functions [2, 21]. In CF patients, pyocyanin‐
mediated ROS oxidize host intracellular and extracellular reduced glutathione (GSH) to form
glutathione disulfide or oxidized glutathione (GSSG; Figure 2) [13].
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Figure 2. (a) Oxidation of GSH to GSSG by pyocyanin. P. aeruginosa produces pyocyanin, and pyocyanin accepts elec‐
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H2O2 forming GSSG. (b) Structure of pyocyanin, GSH, and GSSG.
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5. Pyocyanin binding to eDNA
Previous studies have demonstrated that eDNA is a key constituent in the construction and
structural integrity of the biofilm matrix in many bacterial species, and the cleaving of eDNA
by nuclease enzymes such as DNase I disintegrates the biofilm matrix, thereby increasing the
susceptibility of bacterial cells within the biofilm matrix to antimicrobial agents such as
detergents and antibiotics [33, 34]. eDNA acts as a scaffold for the whole biofilm by binding
with other biomolecules such as peptides/enzymes/proteins and polysaccharides. For exam‐
ple, in Streptococcus mutans, an oral pathogen responsible for dental plaques, the competence
stimulating peptide (CSP) and DNA‐binding protein ComGB interact with eDNA, and this
interaction is essential for the uptake of eDNA by S. mutans, which facilitates bacterial cell‐to‐
cell interaction and biofilm formation [35]. In another example, HU and IHF (DNA‐binding
proteins) produced by human pathogenic bacterium E. coli strain U93 specifically bind to
double‐stranded DNA (dsDNA) in the EPS, and by binding with eDNA, such proteins generate
specific structures within eDNA. The enzymatic digestion of these proteins makes eDNA lose
its structural stability and thereby disrupts E. coli biofilms [36]. In Listeria monocytogenes, a food‐
borne pathogen, eDNA binding with N‐acetylglucosamine, a type of peptidoglycan, has been
shown to be an essential molecular interaction that initiates L. monocytogenes adhesion to
surfaces [37]. To our knowledge, our discovery was the first to demonstrate that, apart from
biopolymers such as proteins and polysaccharides, a secondary metabolite such as pyocyanin
strongly binds with DNA to dictate the establishment of P. aeruginosa biofilm.
5.1. Mechanism of pyocyanin‐DNA binding
The mechanism of pyocyanin‐eDNA binding was elucidated using different types of spectro‐
scopic techniques by Das et al. [10]. In this study, we used P. aeruginosa pyocyanin (Sigma‐
Aldrich, USA) and calf thymus DNA sodium salt (type I fibers; 42% GC content; Sigma‐
Figure 4. Mechanism of pyocyanin‐DNA binding using spectroscopic techniques. (a) Fluorescence emission spectro‐
scopy techniques show that pyocyanin displaces EtBr bound to dsDNA, indicating that pyocyanin is an intercalating
agent. (b) UV‐vis spectra of DNA with pyocyanin showed that hyperchromic (increase in absorbance intensity) and
hypochromic (shift in wavelength of DNA peak from 259 to 253 nm) effects are indicative of the intercalation of pyo‐
cyanin between nitrogenous base pairs of DNA and exposure of nitrogenous base pairs due to the unwinding of the
DNA helix. (c) CD spectra of DNA‐pyocyanin mixtures confirm that DNA binds to pyocyanin. The increase in mdeg at
277 nm in DNA peak confirms that pyocyanin intercalates into the nitrogenous bases of DNA, whereas the shift in
DNA peak at 247 nm to 244, 243, and 242 nm in the presence of 28, 143, and 286 μM pyocyanin, respectively, confirms
that pyocyanin also binds to sugar‐phosphate backbone of DNA.
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[19]. Quantitative analysis of eDNA in PA14 wild‐type (120 h grown in LB medium) cell‐free
supernatant showed ∼20 to 25 μg eDNA/ml. In contrast, cell‐free supernatant of pyocyanin‐
deficient mutant of PA14 (ΔphzA‐G) produced 50% less eDNA. Interestingly, ΔphzA‐G culture
grown in the presence of exogenous addition of pyocyanin showed significant increase in
eDNA release [19]. In another study, Steinberger and Holden recorded up to 220 and 500 mg
eDNA/g of cellular DNA in 5‐day‐old biofilms of P. aeruginosa and Pseudomonas putida,
respectively; however, their study did not compare the link between pyocyanin and eDNA
production in P. aeruginosa and P. putida [29].
In general, phenazines such as pyocyanin induce H2O2 production and subsequently trigger
cell death in host (mammalian) and competing fungal and bacterial cells are well documented.
A recent study showed concrete evidence of P. aeruginosa strains producing the highest
concentrations of pyocyanin generated the highest concentrations of H2O2 [19]. The production
of H2O2 initiates ∼7 to 14% increase in cell lysis in planktonic cultures of P. aeruginosa and
consequently promotes eDNA release. Figure 3 shows a schematic of pyocyanin‐mediated
eDNA release via H2O2 in P. aeruginosa. H2O2‐mediated eDNA release is not limited to P.
aeruginosa strains; for instance, in oral Gram‐positive bacteria (Streptococcus sanguinis),
pyruvate oxidase activity induces ∼10% increase in cell death in its own population via H2O2
production and consequently facilitates eDNA release [30].
Figure 3. Schematic showing pyocyanin‐mediated release of eDNA via H2O2 production.
By examining pyocyanin production in different strains of P. aeruginosa in relation to H2O2
generation, cell lysis, and eDNA concentration, a clear relationship emerged. The findings in
this study demonstrate that pyocyanin is involved in eDNA release in growing P. aeruginosa
planktonic cultures, raising interesting questions about its role in biofilm biology. Pyocyanin‐
mediated eDNA production, which likely happens as a consequence of cell lysis via H2O2
generation, could possibly assist P. aeruginosa biofilm formation in several ways, as eDNA has
been shown to be an essential biomolecule that necessitates the establishment of P. aerugino‐
sa biofilm [7, 8]. Previous studies suggest that the production of phenazines enhance bacterial
adhesion, microcolony formation, and increased biomass in P. aeruginosa biofilms and current
generations of P. aeruginosa PA14 in bioelectrochemical systems [31, 32]. From previous
findings in concurrence with the current results, we hypothesized that the phenazine pyocya‐
nin may promote biofilm formation in P. aeruginosa via eDNA release through H2O2‐mediated
cell lysis. However, the exact mechanism of how pyocyanin facilitates P. aeruginosa biofilm
formation is yet to be elucidated.
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5. Pyocyanin binding to eDNA
Previous studies have demonstrated that eDNA is a key constituent in the construction and
structural integrity of the biofilm matrix in many bacterial species, and the cleaving of eDNA
by nuclease enzymes such as DNase I disintegrates the biofilm matrix, thereby increasing the
susceptibility of bacterial cells within the biofilm matrix to antimicrobial agents such as
detergents and antibiotics [33, 34]. eDNA acts as a scaffold for the whole biofilm by binding
with other biomolecules such as peptides/enzymes/proteins and polysaccharides. For exam‐
ple, in Streptococcus mutans, an oral pathogen responsible for dental plaques, the competence
stimulating peptide (CSP) and DNA‐binding protein ComGB interact with eDNA, and this
interaction is essential for the uptake of eDNA by S. mutans, which facilitates bacterial cell‐to‐
cell interaction and biofilm formation [35]. In another example, HU and IHF (DNA‐binding
proteins) produced by human pathogenic bacterium E. coli strain U93 specifically bind to
double‐stranded DNA (dsDNA) in the EPS, and by binding with eDNA, such proteins generate
specific structures within eDNA. The enzymatic digestion of these proteins makes eDNA lose
its structural stability and thereby disrupts E. coli biofilms [36]. In Listeria monocytogenes, a food‐
borne pathogen, eDNA binding with N‐acetylglucosamine, a type of peptidoglycan, has been
shown to be an essential molecular interaction that initiates L. monocytogenes adhesion to
surfaces [37]. To our knowledge, our discovery was the first to demonstrate that, apart from
biopolymers such as proteins and polysaccharides, a secondary metabolite such as pyocyanin
strongly binds with DNA to dictate the establishment of P. aeruginosa biofilm.
5.1. Mechanism of pyocyanin‐DNA binding
The mechanism of pyocyanin‐eDNA binding was elucidated using different types of spectro‐
scopic techniques by Das et al. [10]. In this study, we used P. aeruginosa pyocyanin (Sigma‐
Aldrich, USA) and calf thymus DNA sodium salt (type I fibers; 42% GC content; Sigma‐
Figure 4. Mechanism of pyocyanin‐DNA binding using spectroscopic techniques. (a) Fluorescence emission spectro‐
scopy techniques show that pyocyanin displaces EtBr bound to dsDNA, indicating that pyocyanin is an intercalating
agent. (b) UV‐vis spectra of DNA with pyocyanin showed that hyperchromic (increase in absorbance intensity) and
hypochromic (shift in wavelength of DNA peak from 259 to 253 nm) effects are indicative of the intercalation of pyo‐
cyanin between nitrogenous base pairs of DNA and exposure of nitrogenous base pairs due to the unwinding of the
DNA helix. (c) CD spectra of DNA‐pyocyanin mixtures confirm that DNA binds to pyocyanin. The increase in mdeg at
277 nm in DNA peak confirms that pyocyanin intercalates into the nitrogenous bases of DNA, whereas the shift in
DNA peak at 247 nm to 244, 243, and 242 nm in the presence of 28, 143, and 286 μM pyocyanin, respectively, confirms
that pyocyanin also binds to sugar‐phosphate backbone of DNA.
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[19]. Quantitative analysis of eDNA in PA14 wild‐type (120 h grown in LB medium) cell‐free
supernatant showed ∼20 to 25 μg eDNA/ml. In contrast, cell‐free supernatant of pyocyanin‐
deficient mutant of PA14 (ΔphzA‐G) produced 50% less eDNA. Interestingly, ΔphzA‐G culture
grown in the presence of exogenous addition of pyocyanin showed significant increase in
eDNA release [19]. In another study, Steinberger and Holden recorded up to 220 and 500 mg
eDNA/g of cellular DNA in 5‐day‐old biofilms of P. aeruginosa and Pseudomonas putida,
respectively; however, their study did not compare the link between pyocyanin and eDNA
production in P. aeruginosa and P. putida [29].
In general, phenazines such as pyocyanin induce H2O2 production and subsequently trigger
cell death in host (mammalian) and competing fungal and bacterial cells are well documented.
A recent study showed concrete evidence of P. aeruginosa strains producing the highest
concentrations of pyocyanin generated the highest concentrations of H2O2 [19]. The production
of H2O2 initiates ∼7 to 14% increase in cell lysis in planktonic cultures of P. aeruginosa and
consequently promotes eDNA release. Figure 3 shows a schematic of pyocyanin‐mediated
eDNA release via H2O2 in P. aeruginosa. H2O2‐mediated eDNA release is not limited to P.
aeruginosa strains; for instance, in oral Gram‐positive bacteria (Streptococcus sanguinis),
pyruvate oxidase activity induces ∼10% increase in cell death in its own population via H2O2
production and consequently facilitates eDNA release [30].
Figure 3. Schematic showing pyocyanin‐mediated release of eDNA via H2O2 production.
By examining pyocyanin production in different strains of P. aeruginosa in relation to H2O2
generation, cell lysis, and eDNA concentration, a clear relationship emerged. The findings in
this study demonstrate that pyocyanin is involved in eDNA release in growing P. aeruginosa
planktonic cultures, raising interesting questions about its role in biofilm biology. Pyocyanin‐
mediated eDNA production, which likely happens as a consequence of cell lysis via H2O2
generation, could possibly assist P. aeruginosa biofilm formation in several ways, as eDNA has
been shown to be an essential biomolecule that necessitates the establishment of P. aerugino‐
sa biofilm [7, 8]. Previous studies suggest that the production of phenazines enhance bacterial
adhesion, microcolony formation, and increased biomass in P. aeruginosa biofilms and current
generations of P. aeruginosa PA14 in bioelectrochemical systems [31, 32]. From previous
findings in concurrence with the current results, we hypothesized that the phenazine pyocya‐
nin may promote biofilm formation in P. aeruginosa via eDNA release through H2O2‐mediated
cell lysis. However, the exact mechanism of how pyocyanin facilitates P. aeruginosa biofilm
formation is yet to be elucidated.
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promotes bacterial aggregation through acid‐base interactions involving electron‐donating
and electron‐accepting groups [39]. Contact angle measurements on various Gram‐positive
and Gram‐negative bacterial cell surfaces revealed that eDNA significantly influences
modulation in bacterial cell surface hydrophobicity [8, 39]. For instance, the cell surface of
Streptococcus epidermidis 1457 wild‐type is more hydrophobic in the presence of eDNA (average
water contact angle of 85°), whereas S. epidermidis 1457 ∆atlE (eDNA‐deficient mutant) and
DNase I (DNA cleaving enzyme)‐treated S. epidermidis 1457 wild‐type showed significant
reduction in the water contact angle (39–44°) [39]. Based on these findings, we hypothesized
that pyocyanin is involved in facilitating eDNA binding to P. aeruginosa cells and thus possibly
influences P. aeruginosa cell surface properties such as hydrophobicity and surface energies
and consequently influences physicochemical interactions.
The hypothesis was tested by measuring contact angles of P. aeruginosa PA14 and PAO1 lawn
growths prepared by the deposition of bacteria, from a planktonic suspension, onto a 0.2 μm
pore diameter filter (nitrocellulose membrane filter; Millipore, USA) using negative pressure
[39, 40]. Contact angles were measured with standard polar (water and formamide) and
nonpolar (diiodomethane) liquids using goniometer (KSV model 200; KSV Instrumentation
Pvt. Ltd., Finland) following the sessile drop technique [39]. To remove eDNA, P. aeruginosa
strains were treated with DNase I before lawn preparation and its contact angle was measured
as above. DNase I untreated P. aeruginosa PA14 and PAO1 wild‐type showed significantly
higher degree of water contact angle in comparison to untreated ∆phzA‐G. After DNase I
treatment only, the wild‐type strains showed a significant decrease in the water contact angle
and ultimately equivalent to the water contact angle of the ∆phzA‐G mutant (Figure 5a) [40].
This result demonstrates that the interaction of pyocyanin with eDNA modulates cell surface
hydrophobicity in P. aeruginosa.
Figure 5. (a) Effect of DNase I and pyocyanin on P. aeruginosa cell surface hydrophobicity. The removal of eDNA by
DNase I treatment shows a significant decrease in cell surface hydrophobicity (water contact angle) on all pyocyanin‐
producing strains, whereas pyocyanin‐deficient strain (∆phzA‐G) showed no change in the water contact angle regard‐
less of DNase I treatment. (b) Gibbs free energy of aggregation indicates that the removal of eDNA or the absence of
pyocyanin significantly declines the efficiency of P. aeruginosa cell‐to‐cell aggregation. Error bars represent standard
deviations from the mean (n=3). Asterisks indicate statistical significance (Student's t‐test P<.05) in comparison to
DNase I treatment. PA14 strain data are taken from Das et al. [40], whereas PAO1 contact angle and Gibbs free energy
of aggregation results are unpublished.
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Aldrich, USA), which has predominantly dsDNA (∼90%) quantified using Qubit fluorescent
dye assay and Qubit 2.0 Fluorometer (Invitrogen, USA) as mentioned previously.
Using fluorescence emission spectroscopy (Varian Cary Eclipse Fluorescence Spectrophotom‐
eter, USA), it was found that pyocyanin displaces ethidium bromide (EtBr) bound to dsDNA.
All experiments were done in SHE buffer (2 mM HEPES, 10 μM EDTA, and 9.4 mM NaCl in
Milli‐Q water adjusted to pH 7 with NaOH). Light emission at 615 nm (λex=480 nm) was
quantified at room temperature in 1 ml quartz cuvette. The fluorescence emission spectra
suggest that the addition of pyocyanin (70 or 140 μM) reduced the DNA (6 ng/μl)‐EtBr (4 μM)
peak maxima to that of an EtBr solution without DNA (Figure 4a). It is well known that EtBr
is a classic intercalating agent that strongly binds to DNA via intercalation and the displace‐
ment of EtBr by pyocyanin suggests that pyocyanin can bind to DNA. However, the mecha‐
nism of pyocyanin‐DNA binding was not immediately clear.
To determine the binding mechanism between pyocyanin and DNA, a Varian Cary 100 Bio
UV‐visible (UV‐vis) spectrophotometer technique was used [10]. UV‐vis spectroscopic scans
from 200 to 800 nm were performed in 1 ml quartz cuvette on DNA, pyocyanin, and the DNA‐
pyocyanin complex in Milli‐Q water. Figure 4b shows the UV‐vis range spectra of DNA (50
ng/μl) in the presence of increasing concentrations of pyocyanin (5.6, 11.2, 16.8, or 28.0 μM).
The spectra of DNA with pyocyanin showed a gradual increase in absorbance intensity of the
DNA peak and a shift of the DNA peak from 259 to 253 nm with increasing pyocyanin
concentrations. The observed hyperchromic (due to the increase in absorbance intensity) and
hypochromic (due to the shift in wavelength of DNA peak) effects are indicative of the
intercalation of pyocyanin between nitrogenous base pairs of DNA and exposure of nitroge‐
nous base pairs due to the unwinding of the DNA helix [38].
The pyocyanin‐DNA binding mechanism was further confirmed using a Chirascan circular
dichroism (CD) spectrophotometer (Applied Photophysics, UK). The experiments were
conducted using 1 mm path length quartz cuvette, and mixtures of dsDNA at 135 ng/μl with
varying pyocyanin (0, 28, 143, and 286 μM) concentrations in 350 μl Milli‐Q water were scanned
from 200 to 320 nm after a 15‐min static incubation at 25°C. The spectra of DNA‐pyocyanin
mixtures confirm that DNA binds to pyocyanin with statistically significant changes in peak
intensity (P<0.05) at all four characteristic DNA peaks (209, 221, 247, and 277 nm) achieved
with pyocyanin concentrations above 28 μM. The significant increase in mdeg at 277 nm in
DNA peak is a clear confirmation that pyocyanin intercalates into the nitrogenous bases of
DNA. Additionally, the shift in DNA peak at 247 nm to 244, 243, and 242 nm in the presence
of 143 and 286 μM pyocyanin, respectively (Figure 4c) show that pyocyanin also binds to sugar‐
phosphate backbone of DNA and therein creates local perturbations in the DNA double‐helix
structure but, however, does not cause any significant transition in form (i.e. B‐DNA to A or
Z form).
5.2. Pyocyanin‐eDNA binding influences P. aeruginosa cell surface hydrophobicity and
physicochemical interactions
Pyocyanin is well known as an electron shuttle [18], and our recent investigation revealed that
pyocyanin intercalates with DNA [10]. In line with this, previous studies revealed that eDNA
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promotes bacterial aggregation through acid‐base interactions involving electron‐donating
and electron‐accepting groups [39]. Contact angle measurements on various Gram‐positive
and Gram‐negative bacterial cell surfaces revealed that eDNA significantly influences
modulation in bacterial cell surface hydrophobicity [8, 39]. For instance, the cell surface of
Streptococcus epidermidis 1457 wild‐type is more hydrophobic in the presence of eDNA (average
water contact angle of 85°), whereas S. epidermidis 1457 ∆atlE (eDNA‐deficient mutant) and
DNase I (DNA cleaving enzyme)‐treated S. epidermidis 1457 wild‐type showed significant
reduction in the water contact angle (39–44°) [39]. Based on these findings, we hypothesized
that pyocyanin is involved in facilitating eDNA binding to P. aeruginosa cells and thus possibly
influences P. aeruginosa cell surface properties such as hydrophobicity and surface energies
and consequently influences physicochemical interactions.
The hypothesis was tested by measuring contact angles of P. aeruginosa PA14 and PAO1 lawn
growths prepared by the deposition of bacteria, from a planktonic suspension, onto a 0.2 μm
pore diameter filter (nitrocellulose membrane filter; Millipore, USA) using negative pressure
[39, 40]. Contact angles were measured with standard polar (water and formamide) and
nonpolar (diiodomethane) liquids using goniometer (KSV model 200; KSV Instrumentation
Pvt. Ltd., Finland) following the sessile drop technique [39]. To remove eDNA, P. aeruginosa
strains were treated with DNase I before lawn preparation and its contact angle was measured
as above. DNase I untreated P. aeruginosa PA14 and PAO1 wild‐type showed significantly
higher degree of water contact angle in comparison to untreated ∆phzA‐G. After DNase I
treatment only, the wild‐type strains showed a significant decrease in the water contact angle
and ultimately equivalent to the water contact angle of the ∆phzA‐G mutant (Figure 5a) [40].
This result demonstrates that the interaction of pyocyanin with eDNA modulates cell surface
hydrophobicity in P. aeruginosa.
Figure 5. (a) Effect of DNase I and pyocyanin on P. aeruginosa cell surface hydrophobicity. The removal of eDNA by
DNase I treatment shows a significant decrease in cell surface hydrophobicity (water contact angle) on all pyocyanin‐
producing strains, whereas pyocyanin‐deficient strain (∆phzA‐G) showed no change in the water contact angle regard‐
less of DNase I treatment. (b) Gibbs free energy of aggregation indicates that the removal of eDNA or the absence of
pyocyanin significantly declines the efficiency of P. aeruginosa cell‐to‐cell aggregation. Error bars represent standard
deviations from the mean (n=3). Asterisks indicate statistical significance (Student's t‐test P<.05) in comparison to
DNase I treatment. PA14 strain data are taken from Das et al. [40], whereas PAO1 contact angle and Gibbs free energy
of aggregation results are unpublished.
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Aldrich, USA), which has predominantly dsDNA (∼90%) quantified using Qubit fluorescent
dye assay and Qubit 2.0 Fluorometer (Invitrogen, USA) as mentioned previously.
Using fluorescence emission spectroscopy (Varian Cary Eclipse Fluorescence Spectrophotom‐
eter, USA), it was found that pyocyanin displaces ethidium bromide (EtBr) bound to dsDNA.
All experiments were done in SHE buffer (2 mM HEPES, 10 μM EDTA, and 9.4 mM NaCl in
Milli‐Q water adjusted to pH 7 with NaOH). Light emission at 615 nm (λex=480 nm) was
quantified at room temperature in 1 ml quartz cuvette. The fluorescence emission spectra
suggest that the addition of pyocyanin (70 or 140 μM) reduced the DNA (6 ng/μl)‐EtBr (4 μM)
peak maxima to that of an EtBr solution without DNA (Figure 4a). It is well known that EtBr
is a classic intercalating agent that strongly binds to DNA via intercalation and the displace‐
ment of EtBr by pyocyanin suggests that pyocyanin can bind to DNA. However, the mecha‐
nism of pyocyanin‐DNA binding was not immediately clear.
To determine the binding mechanism between pyocyanin and DNA, a Varian Cary 100 Bio
UV‐visible (UV‐vis) spectrophotometer technique was used [10]. UV‐vis spectroscopic scans
from 200 to 800 nm were performed in 1 ml quartz cuvette on DNA, pyocyanin, and the DNA‐
pyocyanin complex in Milli‐Q water. Figure 4b shows the UV‐vis range spectra of DNA (50
ng/μl) in the presence of increasing concentrations of pyocyanin (5.6, 11.2, 16.8, or 28.0 μM).
The spectra of DNA with pyocyanin showed a gradual increase in absorbance intensity of the
DNA peak and a shift of the DNA peak from 259 to 253 nm with increasing pyocyanin
concentrations. The observed hyperchromic (due to the increase in absorbance intensity) and
hypochromic (due to the shift in wavelength of DNA peak) effects are indicative of the
intercalation of pyocyanin between nitrogenous base pairs of DNA and exposure of nitroge‐
nous base pairs due to the unwinding of the DNA helix [38].
The pyocyanin‐DNA binding mechanism was further confirmed using a Chirascan circular
dichroism (CD) spectrophotometer (Applied Photophysics, UK). The experiments were
conducted using 1 mm path length quartz cuvette, and mixtures of dsDNA at 135 ng/μl with
varying pyocyanin (0, 28, 143, and 286 μM) concentrations in 350 μl Milli‐Q water were scanned
from 200 to 320 nm after a 15‐min static incubation at 25°C. The spectra of DNA‐pyocyanin
mixtures confirm that DNA binds to pyocyanin with statistically significant changes in peak
intensity (P<0.05) at all four characteristic DNA peaks (209, 221, 247, and 277 nm) achieved
with pyocyanin concentrations above 28 μM. The significant increase in mdeg at 277 nm in
DNA peak is a clear confirmation that pyocyanin intercalates into the nitrogenous bases of
DNA. Additionally, the shift in DNA peak at 247 nm to 244, 243, and 242 nm in the presence
of 143 and 286 μM pyocyanin, respectively (Figure 4c) show that pyocyanin also binds to sugar‐
phosphate backbone of DNA and therein creates local perturbations in the DNA double‐helix
structure but, however, does not cause any significant transition in form (i.e. B‐DNA to A or
Z form).
5.2. Pyocyanin‐eDNA binding influences P. aeruginosa cell surface hydrophobicity and
physicochemical interactions
Pyocyanin is well known as an electron shuttle [18], and our recent investigation revealed that
pyocyanin intercalates with DNA [10]. In line with this, previous studies revealed that eDNA
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Figure 6. Confocal microscopy imaging of P. aeruginosa PA14 strains. (a) PA14 wild‐type, (b) PA14 wild‐type grown in
the presence of DNase I (40 U), (c) ΔphzA‐G, (d) ΔphzA‐G in the presence of DNase I (40 U), (e) ΔphzA‐G in the presence
of exogenous pyocyanin (200 μM), and (f) ΔphzA‐G in the presence of exogenous DNA (1 ng/μl) and exogenous pyo‐
cyanin (200 μM).
P. aeruginosa Thickness (μm) Biomass (μm3/μm2)
Wild‐type 8.3±0.3 1.4±0.4
Wild‐type+DNase I (40 U) 5.2±1.5 0.5±0.1
ΔphzA‐G 4.9±0.4 0.3±0.1
ΔphzA‐G+DNase I (40 U) 3.9±0.5 0.3±0.3
ΔphzA‐G+pyocyanin (200 μM) 7.2±1.0 0.6±0.2
ΔphzA‐G+pyocyanin (200 μM)+DNA (1 ng/μl) 7.9±0.4 1.0±0.1
Table 1. Quantification of P. aeruginosa (nonestablished) biofilm properties using ImageJ software. Significant
differences were observed in biofilm thickness and biomass between control (PA14 wild‐type) and wild‐type grown in
the presence of DNase I (40 U) and ΔphzA‐G regardless of whether they were grown in the presence of DNase I. Mean
±standard deviations (n=3). Boldfaced data indicate that the differences were statistically significant (Student's t‐test
P<0.05) in comparison to control (wild‐type), whereas boldfaced italicized data indicate that the thickness and biomass
of ΔphzA‐G grown in the presence of pyocyanin and the combination of pyocyanin+DNA is significantly (Student's t‐
test P<0.05) higher than the biofilm of ΔphzA‐G alone (control).
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The modulation in P. aeruginosa cell surface hydrophobicity has shown a direct impact on
bacterial surface energy components as determined using theoretical surface thermodynamics
(Figure 5b). Surface thermodynamics elucidated the physicochemical interactions that are
responsible for bacterial cell‐to‐cell interactions at close approach. Physicochemical interac‐
tions are nonspecific interactions forces that derive from molecules that are present on the
bacterial cell surface. In our study, pyocyanin and eDNA are the molecules that facilitate
attractive physicochemical interactions such as short‐range acid‐base and long‐range Lifshitz‐
van der Waals interactions. The removal of eDNA from P. aeruginosa wild‐type cell surface or
the absence of pyocyanin in ∆phzA‐G mutant strain showed significant impact (i.e. nonattrac‐
tive interaction, especially on the short‐range acid‐base interaction, which includes electron‐
donating and electron‐accepting parameters). However, the long‐range Lifshitz‐van der Waals
interactions remained unaffected between wild‐type and ∆phzA‐G regardless of DNase I
treatment [40]. Another important parameter that commonly exists and drives bacterial
interactions includes the presence of biopolymers (DNA, polysaccharides, and proteins) and
cell appendages (pili, fimbriae) that extend hundreds of nanometers from the cell surface [41].
These biopolymers/appendages initiate hydrogen bonding by colliding with its neighboring
cells and thereby help bacterial cells to overcome small physicochemical energy barrier and
promote bacterial cell‐to‐cell interactions [7, 41].
5.3. Pyocyanin‐eDNA binding is essential for P. aeruginosa biofilm formation
eDNA was previously acknowledged as a biofilm‐promoting factor, whereas pyocyanin was
mainly considered as a secondary metabolite essential for the persistence of P. aeruginosa cells
in highly dense biofilm by enabling maintenance of a basal rate of respiration for energy
harvesting and to maintain cytoplasmic redox homeostasis [18]. From our previous investi‐
gation, it was revealed that pyocyanin‐eDNA binding influences essential physicochemical
interactions that drive bacterial cell‐to‐cell interactions. Such findings prompted the hypoth‐
eses that pyocyanin‐eDNA binding is essential for P. aeruginosa biofilm formation.
P. aeruginosa PA14 wild‐type and ΔphzA‐G mutant biofilm formation was investigated on a
glass substratum using confocal laser scan microscopy (CLSM) technique complemented using
ImageJ software to quantify biofilm characteristic properties (Figure 6). Biofilm growth,
staining, imaging, and analysis were performed using the protocol described previously [10].
Comparative studies were undertaken between biofilms (grown for 24 h in LB medium, 37°C,
150 rpm) of wild‐type (Figure 6a and b) and ΔphzA‐G (Figure 6c and d) grown in the absence
and presence of DNase I. Findings indicated that P. aeruginosa PA14 biofilm architecture,
thickness, and biofilm biomass in wild‐type biofilms grown in the presence of DNase I are
similar in biofilms of a phenazine‐deficient mutant strain (Table 1). The removal of eDNA
reduced wild‐type biofilm thickness and biomass by ∼40% and 65%, respectively, whereas
phenazine‐deficient mutant also showed ∼40% reduction in biofilm thickness and up to 80%
reduction in biomass. This result clearly indicates that the influence of eDNA on developing
a three‐dimensional and structurally integrated biofilm is equivalent to the influence of
pyocyanin on biofilm.
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Figure 6. Confocal microscopy imaging of P. aeruginosa PA14 strains. (a) PA14 wild‐type, (b) PA14 wild‐type grown in
the presence of DNase I (40 U), (c) ΔphzA‐G, (d) ΔphzA‐G in the presence of DNase I (40 U), (e) ΔphzA‐G in the presence
of exogenous pyocyanin (200 μM), and (f) ΔphzA‐G in the presence of exogenous DNA (1 ng/μl) and exogenous pyo‐
cyanin (200 μM).
P. aeruginosa Thickness (μm) Biomass (μm3/μm2)
Wild‐type 8.3±0.3 1.4±0.4
Wild‐type+DNase I (40 U) 5.2±1.5 0.5±0.1
ΔphzA‐G 4.9±0.4 0.3±0.1
ΔphzA‐G+DNase I (40 U) 3.9±0.5 0.3±0.3
ΔphzA‐G+pyocyanin (200 μM) 7.2±1.0 0.6±0.2
ΔphzA‐G+pyocyanin (200 μM)+DNA (1 ng/μl) 7.9±0.4 1.0±0.1
Table 1. Quantification of P. aeruginosa (nonestablished) biofilm properties using ImageJ software. Significant
differences were observed in biofilm thickness and biomass between control (PA14 wild‐type) and wild‐type grown in
the presence of DNase I (40 U) and ΔphzA‐G regardless of whether they were grown in the presence of DNase I. Mean
±standard deviations (n=3). Boldfaced data indicate that the differences were statistically significant (Student's t‐test
P<0.05) in comparison to control (wild‐type), whereas boldfaced italicized data indicate that the thickness and biomass
of ΔphzA‐G grown in the presence of pyocyanin and the combination of pyocyanin+DNA is significantly (Student's t‐
test P<0.05) higher than the biofilm of ΔphzA‐G alone (control).
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The modulation in P. aeruginosa cell surface hydrophobicity has shown a direct impact on
bacterial surface energy components as determined using theoretical surface thermodynamics
(Figure 5b). Surface thermodynamics elucidated the physicochemical interactions that are
responsible for bacterial cell‐to‐cell interactions at close approach. Physicochemical interac‐
tions are nonspecific interactions forces that derive from molecules that are present on the
bacterial cell surface. In our study, pyocyanin and eDNA are the molecules that facilitate
attractive physicochemical interactions such as short‐range acid‐base and long‐range Lifshitz‐
van der Waals interactions. The removal of eDNA from P. aeruginosa wild‐type cell surface or
the absence of pyocyanin in ∆phzA‐G mutant strain showed significant impact (i.e. nonattrac‐
tive interaction, especially on the short‐range acid‐base interaction, which includes electron‐
donating and electron‐accepting parameters). However, the long‐range Lifshitz‐van der Waals
interactions remained unaffected between wild‐type and ∆phzA‐G regardless of DNase I
treatment [40]. Another important parameter that commonly exists and drives bacterial
interactions includes the presence of biopolymers (DNA, polysaccharides, and proteins) and
cell appendages (pili, fimbriae) that extend hundreds of nanometers from the cell surface [41].
These biopolymers/appendages initiate hydrogen bonding by colliding with its neighboring
cells and thereby help bacterial cells to overcome small physicochemical energy barrier and
promote bacterial cell‐to‐cell interactions [7, 41].
5.3. Pyocyanin‐eDNA binding is essential for P. aeruginosa biofilm formation
eDNA was previously acknowledged as a biofilm‐promoting factor, whereas pyocyanin was
mainly considered as a secondary metabolite essential for the persistence of P. aeruginosa cells
in highly dense biofilm by enabling maintenance of a basal rate of respiration for energy
harvesting and to maintain cytoplasmic redox homeostasis [18]. From our previous investi‐
gation, it was revealed that pyocyanin‐eDNA binding influences essential physicochemical
interactions that drive bacterial cell‐to‐cell interactions. Such findings prompted the hypoth‐
eses that pyocyanin‐eDNA binding is essential for P. aeruginosa biofilm formation.
P. aeruginosa PA14 wild‐type and ΔphzA‐G mutant biofilm formation was investigated on a
glass substratum using confocal laser scan microscopy (CLSM) technique complemented using
ImageJ software to quantify biofilm characteristic properties (Figure 6). Biofilm growth,
staining, imaging, and analysis were performed using the protocol described previously [10].
Comparative studies were undertaken between biofilms (grown for 24 h in LB medium, 37°C,
150 rpm) of wild‐type (Figure 6a and b) and ΔphzA‐G (Figure 6c and d) grown in the absence
and presence of DNase I. Findings indicated that P. aeruginosa PA14 biofilm architecture,
thickness, and biofilm biomass in wild‐type biofilms grown in the presence of DNase I are
similar in biofilms of a phenazine‐deficient mutant strain (Table 1). The removal of eDNA
reduced wild‐type biofilm thickness and biomass by ∼40% and 65%, respectively, whereas
phenazine‐deficient mutant also showed ∼40% reduction in biofilm thickness and up to 80%
reduction in biomass. This result clearly indicates that the influence of eDNA on developing
a three‐dimensional and structurally integrated biofilm is equivalent to the influence of
pyocyanin on biofilm.
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inhibition of pyocyanin binding to DNA is increased; almost complete inhibition was observed
at a molar ratio of pyocyanin/GSH of ∼1:6. A similar observation was reported recently by
Muller and Merrett [50] demonstrating that thiol concentration needs to be available in the
millimolar range to neutralize pyocyanin toxicity. Their work also suggests that GSH forms a
cell‐impermanent conjugate with pyocyanin. This suggests that thiol antioxidants could be a
potential clinical target against P. aeruginosa toxicity by preventing pyocyanin entry into host
cells and prohibiting pyocyanin‐mediated cell lysis.
Figure 7. Inhibition of pyocyanin intercalation with DNA. (a) CD spectra of DNA‐pyocyanin‐GSH mixtures confirm
that GSH inhibits pyocyanin intercalation with DNA; however, the inhibition is GSH concentration dependent. At
above 1000 μM, GSH (which is ∼1:9 ratio to pyocyanin concentration used in this study) successfully inhibits pyocya‐
nin intercalation to DNA nitrogenous base (peak 277 nm) and binding to DNA backbone (peak at 244 nm). (b) UV‐vis
spectra of DNA with pyocyanin‐GSH complex inhibit the shift of wavelength of DNA peak (i.e. retained DNA peak at
259 nm) indicative of the absence of hypochromic effect, which indicates no intercalation. (c) Proton NMR spectra of
pyocyanin (100 μM)‐GSH (50, 100, 500, or 1000 μM) mixtures indicated a considerable downfield shift of the pyocya‐
nin aromatic peaks. However, this shift was observed only at higher GSH (i.e. at 500 and 1000 μM) concentration ratios
(i.e. at pyocyanin/GSH 1:5 and 1:10), whereas, at low GSH (i.e. at 50 and 100 μM) concentrations, pyocyanin aromatic
peaks remain stable.
6.2. Glutathione disrupts clinical strains of P. aeruginosa biofilms and facilitates
bactericidal activity
Biophysical techniques confirmed that GSH inhibits pyocyanin‐eDNA intercalation. This
made us to hypothesize that GSH could disrupt biofilms, as pyocyanin and eDNA are the
crucial factors that initiate biofilm formation. Our recent investigation confirmed that inter‐
rupting the pyocyanin‐eDNA intercalation using GSH results in a significant disruption of the
biofilms of pathogenic Australian epidemic strain (AES‐1R and AES‐1M isolated from a CF
patient; unpublished data). Figure 8 shows the effect of GSH, DNase I treatment (12 h, 37°C,
150 rpm) on preestablished biofilms grown in LB medium (24 h, 37°C, 150 rpm) imaged using
CLSM.
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A previous study by Ramos et al. also showed similar results with phenazine‐deficient mutant
but could not elucidate the mechanism behind the influence of phenazine on biofilm formation
in P. aeruginosa [30]. This finding is compatible with the hypothesis that eDNA and pyocyanin
act in concert to influence P. aeruginosa biofilm formation, with a direct interaction between
pyocyanin and eDNA likely underlying the mechanism of enhanced biofilm integrity. The fact
that biofilm formation in the phenazine‐deficient mutant is partly restored by the addition of
exogenous pyocyanin (Figure 6e), with the addition of both exogenous pyocyanin and DNA
showed further enhancement in biofilms in comparison to the pyocyanin only treatment
(Figure 6f). This suggests that this particular phenazine is partly, but not wholly, responsible
for the phenomenon, and that interaction with eDNA is an essential factor to facilitate biofilm
formation.
6. Glutathione disrupts P. aeruginosa biofilm formation
With the increased tolerance of bacteria to existing antibiotic therapies [1] and the necessity to
use high doses of antibiotics with their related side effects [42, 43], there is an urgent public
health priority to identify new methods and targets for the control of P. aeruginosa biofilms.
6.1. Glutathione interacts with pyocyanin and inhibits its binding with eDNA
GSH is a thiol tripeptide (γ‐glutamylcysteinylglycine) found in all human cells and in some
bacterial species. GSH is considered to be a master antioxidant and its primary functions
include defense against ROS and free radicals and maintaining a healthy immune system [13].
In humans, intracellular GSH levels vary from 2 to 10 mM, whereas, in the extracellular lung
lining fluid (ELF), levels range from 250 to 800 μM [44]. In contrast, intracellular GSH concen‐
tration in bacterial cell differs significantly from species to species [45–47]. For instance, in E.
coli, GSH is an essential molecule and exists in the millimolar range [47], whereas, in P.
aeruginosa PAO1, intracellular GSH concentration is reported in the nanomolar range (70 nM)
[46]. However, in many Gram‐positive bacteria such as Bacillus cereus, GSH is not found [45, 48].
Pyocyanin undergoes oxidation by donating electron to molecular oxygen to form superoxides
and H2O2 [49]. GSH, being a thiol antioxidant, will donate electron/protons to pyocyanin
directly through the ‐SH group from cysteine [50], thereby interfering in the pyocyanin
oxidation process by inhibiting H2O2 generation [50]. The antioxidant property of GSH makes
it a potential inhibitor of pyocyanin toxicity.
Our recent investigation using CD and UV‐vis suggests that pyocyanin‐GSH complex
interferes with pyocyanin binding to DNA (Figure 7a and b) [10], whereas nuclear magnetic
resonance (NMR; Bruker Avance 400 spectrometer) of the pyocyanin-GSH complex at various
pyocyanin‐GSH ratios clearly indicates that GSH (with at least fivefold higher concentration
than pyocyanin) is required to modulate pyocyanin aromatic structure (Figure 7c; unpublished
data). As discussed earlier, pyocyanin is a planar molecule that intercalates into the nitroge‐
nous base of DNA. By instead conjugating with GSH, intercalation with DNA is restricted.
However, it is interesting to observe that with the increases in GSH concentration, the
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inhibition of pyocyanin binding to DNA is increased; almost complete inhibition was observed
at a molar ratio of pyocyanin/GSH of ∼1:6. A similar observation was reported recently by
Muller and Merrett [50] demonstrating that thiol concentration needs to be available in the
millimolar range to neutralize pyocyanin toxicity. Their work also suggests that GSH forms a
cell‐impermanent conjugate with pyocyanin. This suggests that thiol antioxidants could be a
potential clinical target against P. aeruginosa toxicity by preventing pyocyanin entry into host
cells and prohibiting pyocyanin‐mediated cell lysis.
Figure 7. Inhibition of pyocyanin intercalation with DNA. (a) CD spectra of DNA‐pyocyanin‐GSH mixtures confirm
that GSH inhibits pyocyanin intercalation with DNA; however, the inhibition is GSH concentration dependent. At
above 1000 μM, GSH (which is ∼1:9 ratio to pyocyanin concentration used in this study) successfully inhibits pyocya‐
nin intercalation to DNA nitrogenous base (peak 277 nm) and binding to DNA backbone (peak at 244 nm). (b) UV‐vis
spectra of DNA with pyocyanin‐GSH complex inhibit the shift of wavelength of DNA peak (i.e. retained DNA peak at
259 nm) indicative of the absence of hypochromic effect, which indicates no intercalation. (c) Proton NMR spectra of
pyocyanin (100 μM)‐GSH (50, 100, 500, or 1000 μM) mixtures indicated a considerable downfield shift of the pyocya‐
nin aromatic peaks. However, this shift was observed only at higher GSH (i.e. at 500 and 1000 μM) concentration ratios
(i.e. at pyocyanin/GSH 1:5 and 1:10), whereas, at low GSH (i.e. at 50 and 100 μM) concentrations, pyocyanin aromatic
peaks remain stable.
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was generated by 2 mM GSH after 4 h; this finding supports previous published work that
suggested that GSH undergoes auto‐oxidation to produce H2O2 [51–53]. In biological system
of healthy individuals, the production of catalase and other chelating agents inhibits the
oxidation stress generated by the auto‐oxidation of GSH [52]; however, in infected patients,
pyocyanin inhibits catalase activity in lung epithelial cells [23] and consequently inhibits the
protection against oxidative stress generated by all kinds of endogenous and exogenous
molecules.
7. Conclusion and perspective
Bacterial biofilms form a highly protective biological matrix that enables persisting popula‐
tions of bacteria to survive in otherwise highly hostile environments. These matrices vary
highly between species; however, they share a common structural element (eDNA). Within P.
aeruginosa, eDNA is both necessary and sufficient for structured biofilm formation and
maintenance. We have demonstrated that eDNA enhances intercellular aggregation by
reducing the Gibbs free energy between cells while also enhancing hydrophobicity by
increasing the water contact angle. Furthermore, these properties are enhanced by the presence
of the virulence factor pyocyanin, which is able to directly bind to nitrogenous base pairs
within dsDNA by mode of intercalation. Pyocyanin is uniquely produced by P. aeruginosa and
as such confers a unique method by which P. aeruginosa is able to strengthen its biofilm.
Biofilm formation is associated with increased resistance to antibiotic therapies and persistence
of bacterial colonization within the CF lung. Novel treatment strategies seek to act on molecules
that are essential for bacterial persistence such as biofilm constituents. Biofilm disruption is
associated with increased antibiotic susceptibility and the clearance of bacteria. We have
shown that, by disrupting the biofilm association with thiol‐based antioxidants, namely GSH,
which directly binds and clears freely available pyocyanin, intercellular aggregation and
overall biofilm structure are perturbed. This is enhanced by the activity of nucleases such as
DNase I, which remove the underlying eDNA scaffold, resulting in a complete disruption of
the biofilm structure by decreasing the water contact angle of bacterial cells and increasing the
Gibbs free energy between cells.
Thus, the intercalation between pyocyanin and eDNA is both a unique and highly exploitable
interaction in P. aeruginosa biofilms, and this interaction is necessary for any kind of structured
biofilm architecture in P. aeruginosa. By exploring the disruption of this interaction, both GSH
and DNase I have arisen as potential therapeutic candidates for the elimination of persistent
infections of P. aeruginosa existing as a biofilm. This is particularly useful for long‐term host‐
adapted strains of P. aeruginosa, such as those persisting in the CF lung, which typically develop
a multidrug‐resistant profile as the result of repeated antibiotic therapies.
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An analysis of biofilm image using ImageJ software revealed that GSH or DNase I‐treated
AES‐1R and AES‐1M biofilm showed significant difference (Student's t‐test P>0.05) of ∼30 to
40% and 60 to 80% reduction in its biofilm thickness and total biofilm biomass, respectively
(Table 2). This shows that eDNA and pyocyanin are vital molecules in the building of biofilms
of clinical strains of P. aeruginosa, and by modulating pyocyanin structure and function, biofilm
formation can be restrained while concomitantly reducing the toxicity of pyocyanin.
Figure 8. Confocal microscopy imaging of 24 h preestablished biofilms of P. aeruginosa clinical strains AES‐1R and
AES‐1M. (a) AES‐1R (control), (b) AES‐1R treated with 2 mM GSH, (c) AES‐1R treated with DNase I (40 U), (d) AES‐
1M (control), (e) AES‐1M treated with 2 mM GSH, and (f) AES‐1M treated with DNase I (40 U).
P. aeruginosa Treatment Thickness (μm) Biomass (μm3/μm2) Average Live/Dead (%)
AES‐1R — 8.6±1.1 1.8±0.4 83/17
AES‐1R GSH (2 mM) 5.1±0.8 0.5±0.2 37/63
AES‐1R DNase I (40 U) 4.9±1.0 0.7±0.3 84/16
AES‐1M — 7.4±1.4 1.1±0.3 79/21
AES‐1M GSH (2 mM) 4.1±0.7 0.7±0.4 12/88
AES‐1M DNase I (40 U) 3.9±0.6 0.2±0.1 93/7
Table 2. Quantification of P. aeruginosa (24 h preestablished) biofilm properties using ImageJ software. Significant
differences were observed in biofilm thickness, biomass, and average percentage of live and dead biomass between
control (AES‐1R and AES‐1M) and GSH (2 mM) or DNase I (40 U)‐treated biofilms. Mean±standard deviations (n=3).
Boldfaced data indicate that the differences were statistically significant (Student's t‐test P<0.05) in comparison to
control.
Biofilm image (Figure 8) and quantification of live (green) and dead (red) biofilm biomass
(Table 2) clearly show significant increase in dead biomass when biofilm exposed to GSH
treatment. GSH‐mediated bactericidal activity in P. aeruginosa is proposed through the
generation of H2O2 via the auto‐oxidation of GSH (Figure 8). H2O2 generation by GSH was
quantified using Amplex red H2O2 assay kit (Thermo Fisher Scientific, USA) as per manufac‐
turer's instruction using multi‐well plate reader (Perkin‐Elmer, USA). About 11.5 μM H2O2
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was generated by 2 mM GSH after 4 h; this finding supports previous published work that
suggested that GSH undergoes auto‐oxidation to produce H2O2 [51–53]. In biological system
of healthy individuals, the production of catalase and other chelating agents inhibits the
oxidation stress generated by the auto‐oxidation of GSH [52]; however, in infected patients,
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molecules.
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Abstract
Microbes in nature or in the human body are predominantly associated with surfaces and
living in biofilms. Species diversity, high cell density and close proximity of cells are
typical of life in biofilms, where organisms interact with each other and develop complex
interactions that can be either competitive or cooperative. Competition between species
is  a  well-recognized ecological  force  to  drive  microbial  metabolism,  diversity  and
evolution. However, it was not until recently that microbial cooperative activities are also
recognized to play important roles in microbial physiology and ecology. Importantly,
these microbial interactions in biofilms profoundly affect their overall function, biomass,
diversity  and  pathogenesis.  It  is  now  known  that  every  human  body  contains  a
personalized microbiome that is essential to maintain host health. Remarkably, the
indigenous species in most microbial communities often maintain a relatively stable and
harmless relationship with the hosts despite regular exposure to minor environmental
perturbations and host defence factors. Such stability or homeostasis results from a
dynamic balance of microbial–microbial and microbial–host interactions. Under some
circumstances, however, the homeostasis may breakdown, predisposing a site to diseases.
The evidence has accumulated that such biofilm or community-based diseases can be
prevented or treated not only by targeting putative pathogens, but also by interfering
with the processes that drive breakdown of the homeostasis in biofilms.
Keywords: biofilms, microbial interactions, microbial homeostasis, microbiome,
pathogenesis, community-based diseases
1. Introduction
The human body is host to a wide variety of microbial life, termed as the human microflora or
microbiota, or more recently microbiome [1, 2]. The human microbiome contains hundreds of
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mechanism called quorum sensing, in which bacteria secrete, detect and respond to small
signal molecules for coordinated activities in a cell density-dependent manner [15]. During
quorum sensing, bacterial cells cooperate to obtain group-specific benefits, such as signal
molecules, extracellular polymers, exoenzymes, antibiotics and virulence factors [16–18].
Structural and physiological complexities of biofilms have led to the idea that microbes in
biofilms frequently cooperate for social activities as groups, like multicellular organisms [19].
Indeed, microbiologists have discovered an unexpectedly high degree of multicellular
behaviours that have led to the perception of biofilms as “cities” of microbes [20]. Through
cooperation, microbes can impact their environments in many ways that are simply impossible
for individual cells. Clearly, microbes in such “cities” can achieve strength by increasing their
cell density and interactions or by collectively producing virulence factors required for the
pathogenesis [17–20].
3. Microbial interactions in biofilms
Microbial biofilms are characterized by species diversity, high cell density and close cell-cell
proximity [6, 9, 12]. This suggests that microbial cells in biofilms likely display intermicrobial
interactions that contribute to the formation of a highly structured community, allowing cells
to carry out metabolic activities that may enhance the overall function of the community [21].
The significance of intermicrobial interactions was first realized and thoroughly described for
microorganisms residing in the oral cavity [10, 12]. Dental plaque is a well-recognized biofilm
community characterized by its vast diversity (>700 species) and high cell density (1011 cells/
g wet wt), which allow organisms to develop complex interactions [12]. Cooperative interac‐
tions among organisms in dental biofilms have been well studied, including bacterial co-
aggregation and co-adhesion that facilitates bacterial colonization on saliva-coated teeth and
effectuates temporal and spatial formation of highly organized biofilm architectures [10, 12].
Biofilm matrix also plays important roles in promoting bacterial adhesion, trapping nutrient
molecules, forming microenvironments and protecting microbial cells from lethal challenges
or antimicrobial agents [22, 23]. Cooperative metabolic interactions are even more common
among microbial species, involving nutritional synergy or complementation enabling organ‐
isms to breakdown complex salivary components [6, 12]. Cross feeding is another type of
cooperation in which microbes obtain available nutrients, allowing formation of food chains
in the community [24]. For example, oral streptococci are well known by their ability to
generate lactic acid from sugar fermentation, whereas some neighbouring species, for example
Veillonella sp., are unable to ferment sugar but use lactic acid as a preferred carbon source to
generate energy [25]. Many bacteria in biofilms also use quorum-sensing mechanisms to
regulate biofilm development and other coordinated activities, including symbiosis, formation
of spore or fruiting bodies, bacteriocin production, genetic competence, virulence and
pathogenesis [14–18]. The processes controlled by quorum sensing are diverse and reflect the
specific needs of particular communities. In many bacteria, quorum sensing represents a
central mechanism to regulate cooperative activities, enabling bacteria to reap benefits that
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species and trillions of cells that are predominantly associated with surfaces as communities,
such as dental plaque and biofilms on many mucosal surfaces of the human body [1–3]. Species
diversity, high cell density and close proximity of microbial cells are typical of life in biofilms,
where microbes interact with each other and develop complex social interactions that can be
either competitive or cooperative among species [4, 5]. Even without physical contact, micro‐
organisms living In the same community may secrete small diffusible signal molecules to interact
with  each other  [6].  The  human microbiome,  including “core”  microbiota  shared by all
individuals and “personalized” microbiota exclusive to the individuals, plays important roles
in human health, such as breakdown of complex molecules in food, protection from exoge‐
nous pathogens and stimulation of healthy immune development [3]. One of the most strik‐
ing aspects of these complex communities is their long-term stability in healthy individuals.
The indigenous species  in  a  community often maintain a  relatively stable  and harmless
relationship with the host despite regular exposure to minor environmental perturbations and
host-defense factors [7]. Such stability or homeostasis is considered critical for host health and
wellbeing. Under some circumstances, however, such homeostasis may break down, leading
to population shifts in a community and predisposing a site to diseases [8]. What determines
such homeostasis in a community? What factors can change homeostasis and what are the
mechanisms behind? How can these changes be detected and prevented? This chapter aims to
briefly review the current advances relevant to these questions.
2. Social structure of microbial biofilms
Microorganisms in nature are predominantly associated with surfaces and live in multispecies
biofilms, which account for over 99% of microbial life on this planet [9]. Similarly, the host-
associated microbes largely reside in biofilm communities on the surfaces of human body,
including nonshedding surfaces, such as teeth, and shedding surfaces, such as the mucosa of
the mouth, upper respiratory tract, digestive tract and urogenital tracts, although large
numbers of microbial cells may be washed or shed off from these surfaces by mechanical and
biological movements [9–11]. Biofilm formation is a dynamic process that often results in a
developmental biofilm life cycle [9, 10]. During the process of biofilm formation, some
organisms are early colonizers that express biochemical components allowing them to
effectively adhere to a surface [10]. Others are the later colonizers, which often contain
components enabling them to adhere to the early colonizers, bringing metabolic and other
competitive advantages into the community [9, 12]. Biofilms are spatially structured com‐
munities that often display a high degree of organization and their functions depend on
complex webs of symbiotic interactions [11]. If viewing an intact biofilm under a microscope,
then one will immediately find that microbes in biofilms do not randomly stick together, but
rather form a well-organized community with numerous specialized configurations [10, 13].
One may also find that microbial cells in biofilms physically interact with each other and
maintain intimate relationships [12]. Even without physical contact, microbes living in the
same community may secrete small diffusible signal molecules to interact with each other [14].
For example, many bacteria are found to regulate diverse physiological processes through a
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for individual cells. Clearly, microbes in such “cities” can achieve strength by increasing their
cell density and interactions or by collectively producing virulence factors required for the
pathogenesis [17–20].
3. Microbial interactions in biofilms
Microbial biofilms are characterized by species diversity, high cell density and close cell-cell
proximity [6, 9, 12]. This suggests that microbial cells in biofilms likely display intermicrobial
interactions that contribute to the formation of a highly structured community, allowing cells
to carry out metabolic activities that may enhance the overall function of the community [21].
The significance of intermicrobial interactions was first realized and thoroughly described for
microorganisms residing in the oral cavity [10, 12]. Dental plaque is a well-recognized biofilm
community characterized by its vast diversity (>700 species) and high cell density (1011 cells/
g wet wt), which allow organisms to develop complex interactions [12]. Cooperative interac‐
tions among organisms in dental biofilms have been well studied, including bacterial co-
aggregation and co-adhesion that facilitates bacterial colonization on saliva-coated teeth and
effectuates temporal and spatial formation of highly organized biofilm architectures [10, 12].
Biofilm matrix also plays important roles in promoting bacterial adhesion, trapping nutrient
molecules, forming microenvironments and protecting microbial cells from lethal challenges
or antimicrobial agents [22, 23]. Cooperative metabolic interactions are even more common
among microbial species, involving nutritional synergy or complementation enabling organ‐
isms to breakdown complex salivary components [6, 12]. Cross feeding is another type of
cooperation in which microbes obtain available nutrients, allowing formation of food chains
in the community [24]. For example, oral streptococci are well known by their ability to
generate lactic acid from sugar fermentation, whereas some neighbouring species, for example
Veillonella sp., are unable to ferment sugar but use lactic acid as a preferred carbon source to
generate energy [25]. Many bacteria in biofilms also use quorum-sensing mechanisms to
regulate biofilm development and other coordinated activities, including symbiosis, formation
of spore or fruiting bodies, bacteriocin production, genetic competence, virulence and
pathogenesis [14–18]. The processes controlled by quorum sensing are diverse and reflect the
specific needs of particular communities. In many bacteria, quorum sensing represents a
central mechanism to regulate cooperative activities, enabling bacteria to reap benefits that
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species and trillions of cells that are predominantly associated with surfaces as communities,
such as dental plaque and biofilms on many mucosal surfaces of the human body [1–3]. Species
diversity, high cell density and close proximity of microbial cells are typical of life in biofilms,
where microbes interact with each other and develop complex social interactions that can be
either competitive or cooperative among species [4, 5]. Even without physical contact, micro‐
organisms living In the same community may secrete small diffusible signal molecules to interact
with  each other  [6].  The  human microbiome,  including “core”  microbiota  shared by all
individuals and “personalized” microbiota exclusive to the individuals, plays important roles
in human health, such as breakdown of complex molecules in food, protection from exoge‐
nous pathogens and stimulation of healthy immune development [3]. One of the most strik‐
ing aspects of these complex communities is their long-term stability in healthy individuals.
The indigenous species  in  a  community often maintain a  relatively stable  and harmless
relationship with the host despite regular exposure to minor environmental perturbations and
host-defense factors [7]. Such stability or homeostasis is considered critical for host health and
wellbeing. Under some circumstances, however, such homeostasis may break down, leading
to population shifts in a community and predisposing a site to diseases [8]. What determines
such homeostasis in a community? What factors can change homeostasis and what are the
mechanisms behind? How can these changes be detected and prevented? This chapter aims to
briefly review the current advances relevant to these questions.
2. Social structure of microbial biofilms
Microorganisms in nature are predominantly associated with surfaces and live in multispecies
biofilms, which account for over 99% of microbial life on this planet [9]. Similarly, the host-
associated microbes largely reside in biofilm communities on the surfaces of human body,
including nonshedding surfaces, such as teeth, and shedding surfaces, such as the mucosa of
the mouth, upper respiratory tract, digestive tract and urogenital tracts, although large
numbers of microbial cells may be washed or shed off from these surfaces by mechanical and
biological movements [9–11]. Biofilm formation is a dynamic process that often results in a
developmental biofilm life cycle [9, 10]. During the process of biofilm formation, some
organisms are early colonizers that express biochemical components allowing them to
effectively adhere to a surface [10]. Others are the later colonizers, which often contain
components enabling them to adhere to the early colonizers, bringing metabolic and other
competitive advantages into the community [9, 12]. Biofilms are spatially structured com‐
munities that often display a high degree of organization and their functions depend on
complex webs of symbiotic interactions [11]. If viewing an intact biofilm under a microscope,
then one will immediately find that microbes in biofilms do not randomly stick together, but
rather form a well-organized community with numerous specialized configurations [10, 13].
One may also find that microbial cells in biofilms physically interact with each other and
maintain intimate relationships [12]. Even without physical contact, microbes living in the
same community may secrete small diffusible signal molecules to interact with each other [14].
For example, many bacteria are found to regulate diverse physiological processes through a
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species of microorganisms interested. Relatively few studies have been carried out to investi‐
gate microbial interactions and their impacts at community level until recently when genomics
and metagenomics techniques are available to study communities [31]. However, detecting
these various types of interactions in natural microbial communities is far from straight
forward. Novel approaches to the investigation of community- or even ecosystem-wide
networks may open a way towards global models of community and ecosystem dynamics.
Ultimately, these studies will help to predict the outcome of community alterations and the
effects of perturbations in complex microbial communities.
4. Roles of microbial interactions in maintaining the homeostasis in
biofilms
It has been recognized that host-associated microbial communities are usually characterized
by a remarkable stability among the component species, despite regular exposure to minor
environmental perturbations and numerous host-defence factors [8, 33]. The ability of
microbes to maintain the community stability is referred to as homeostasis (Figure 1). The
homeostasis is believed to stem not from any indifference among the component species but
rather results from a dynamic balance of microbial–microbial interactions and microbial–host
interactions [8]. Interestingly, such stability in a microbial community is often associated with
a healthy condition. However, despite our rapidly increasing knowledge of the composition
of the human microbiome, we know relatively little about what determines the homeostasis
in a microbial community and what mechanisms have been involved in maintaining the
homeostasis. There are few in vivo studies on the relative significance of microbial interactions
in maintaining microbial homeostasis. Most studies have characterized potential interactions
in vitro with the assumption that they may operate similarly in vivo. It has been proposed that
the tendency of a microbial community to maintain its homeostasis often increases with species
diversity or with a greater biological complexity of the community [7, 8, 34]. This suggests that
some regulatory mechanisms must operate to favour the development of species diversity and
complexity of a microbial community. When the homeostasis is disturbed in a community, the
self-regulatory mechanisms may come to work and restore the previous homeostasis status in
the community. However, it is not always certain what regulatory mechanisms operate to
maintain the homeostasis in a community. Recent studies have revealed that most stable
microbial communities contain high levels of species diversity with complementing and
seemingly redundant metabolic capabilities [35]. Microbial interactions in these communities
can promote high species richness and bolster community stability during environmental
perturbations. Clearly, species diversity within a microbial community is an important
indicator of the homeostasis [7, 8]. The need for microbial diversity in health may suggest that
every species can carry out a specific function that is required to maintain the homeostasis in
a community.
Recent studies of microbial community dynamics show that although positive microbial
interactions or feedbacks, such as cooperation and synergism, play important roles in increas‐
ing community productivity, the positive microbial interactions can come at costs to the
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would be unattainable to them as individual cells [6]. Clearly, cooperative interactions among
species probably play important roles in biofilm development and metabolic activities.
However, microbes in most ecosystems often face major challenges of limited space and
nutritional resources, which inevitably results in competition among species. To survive and
pass their genes to the next generation, microbes have to cope with constant battles of resource
competition [26]. The potential pool of microbial competitors is vast, and a wide range of
mechanisms can be responsible for the emergency and radiation of dominant microbial
populations. Microbial ecologists have long recognized two types of competition: exploitation
competition that occurs indirectly through resource consumption and interference competi‐
tion that causes a direct, antagonistic effect on competitors [5, 27, 28]. There is good evidence
that both exploitative and interference competition are prevalent in biofilms, strongly influ‐
encing the homeostasis and outcome of natural selection of microbes in biofilms. Microbial
competition for common resources is a typical exploitative competition and can be strong in
many natural ecosystems [28]. However, microbes cannot be viewed as passive nutritional
sinks, but rather have evolved numerous strategies to augment their acquisition of resources.
Many microbial activities, such as motility, attachment, antibiotic production and secretion of
extracellular polymers, can tip the competition balance, resulting in outcomes that may differ
from those predicted in planktonic cultures (27). Particularly, biofilms often form gradients in
nutrient concentrations, oxygen tension, pH and waste products due to the thickness [12].
These factors can significantly affect the outcomes of microbial competition and compositions
in a biofilm community. Interestingly, despite high levels of competition among species, the
majority of the resident organisms in a host-associated community can co-exist and maintain
a relative stability in the community [8, 30]. This indicates that some regulatory mechanisms
must exist and play critical roles in balancing microbial cooperative and competitive activities
in microbial communities.
Based on recent community structure and dynamic studies using metagenomics and 16S
pyrosequencing, microbial interactions can have three types of outcomes: a positive impact
(win), a negative impact (loss) and no impact (neutral) on the microbial species involved [31].
The possible combinations of win (+), loss (−) and neutral (0) outcomes for two interacting
partners allow classification of various interaction types. For example, different species of
bacteria may cooperate to build a biofilm, which confers protection of the interacting members
from antibiotics, a win–win (+/+) relationship known as mutualism. Other examples for
cooperation are certain cases of cross feeding, in which two species exchange metabolic
products to the benefit of both. In contrast, competition between two species is a classic loss–
loss (−/−) relationship, which indicates that two species with similar niches exclude each other
or competitive exclusion. In addition to typical cooperation or competition, predator–prey
relationships and host–parasite relationships are considered to be win–loss (+/−) interactions,
which are also common in natural and host-associated microbial communities [30]. For
example, Streptococcus mutans in dental plaque can produce an array of bacteriocins that kill
other related species in the community, a typical win–loss interaction (+/−) [32]. In most
ecosystems, there are few cases of neutral or no (0) interaction among species in the same
community. These microbial interactions are largely based on laboratory studies of pairwise
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species of microorganisms interested. Relatively few studies have been carried out to investi‐
gate microbial interactions and their impacts at community level until recently when genomics
and metagenomics techniques are available to study communities [31]. However, detecting
these various types of interactions in natural microbial communities is far from straight
forward. Novel approaches to the investigation of community- or even ecosystem-wide
networks may open a way towards global models of community and ecosystem dynamics.
Ultimately, these studies will help to predict the outcome of community alterations and the
effects of perturbations in complex microbial communities.
4. Roles of microbial interactions in maintaining the homeostasis in
biofilms
It has been recognized that host-associated microbial communities are usually characterized
by a remarkable stability among the component species, despite regular exposure to minor
environmental perturbations and numerous host-defence factors [8, 33]. The ability of
microbes to maintain the community stability is referred to as homeostasis (Figure 1). The
homeostasis is believed to stem not from any indifference among the component species but
rather results from a dynamic balance of microbial–microbial interactions and microbial–host
interactions [8]. Interestingly, such stability in a microbial community is often associated with
a healthy condition. However, despite our rapidly increasing knowledge of the composition
of the human microbiome, we know relatively little about what determines the homeostasis
in a microbial community and what mechanisms have been involved in maintaining the
homeostasis. There are few in vivo studies on the relative significance of microbial interactions
in maintaining microbial homeostasis. Most studies have characterized potential interactions
in vitro with the assumption that they may operate similarly in vivo. It has been proposed that
the tendency of a microbial community to maintain its homeostasis often increases with species
diversity or with a greater biological complexity of the community [7, 8, 34]. This suggests that
some regulatory mechanisms must operate to favour the development of species diversity and
complexity of a microbial community. When the homeostasis is disturbed in a community, the
self-regulatory mechanisms may come to work and restore the previous homeostasis status in
the community. However, it is not always certain what regulatory mechanisms operate to
maintain the homeostasis in a community. Recent studies have revealed that most stable
microbial communities contain high levels of species diversity with complementing and
seemingly redundant metabolic capabilities [35]. Microbial interactions in these communities
can promote high species richness and bolster community stability during environmental
perturbations. Clearly, species diversity within a microbial community is an important
indicator of the homeostasis [7, 8]. The need for microbial diversity in health may suggest that
every species can carry out a specific function that is required to maintain the homeostasis in
a community.
Recent studies of microbial community dynamics show that although positive microbial
interactions or feedbacks, such as cooperation and synergism, play important roles in increas‐
ing community productivity, the positive microbial interactions can come at costs to the
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would be unattainable to them as individual cells [6]. Clearly, cooperative interactions among
species probably play important roles in biofilm development and metabolic activities.
However, microbes in most ecosystems often face major challenges of limited space and
nutritional resources, which inevitably results in competition among species. To survive and
pass their genes to the next generation, microbes have to cope with constant battles of resource
competition [26]. The potential pool of microbial competitors is vast, and a wide range of
mechanisms can be responsible for the emergency and radiation of dominant microbial
populations. Microbial ecologists have long recognized two types of competition: exploitation
competition that occurs indirectly through resource consumption and interference competi‐
tion that causes a direct, antagonistic effect on competitors [5, 27, 28]. There is good evidence
that both exploitative and interference competition are prevalent in biofilms, strongly influ‐
encing the homeostasis and outcome of natural selection of microbes in biofilms. Microbial
competition for common resources is a typical exploitative competition and can be strong in
many natural ecosystems [28]. However, microbes cannot be viewed as passive nutritional
sinks, but rather have evolved numerous strategies to augment their acquisition of resources.
Many microbial activities, such as motility, attachment, antibiotic production and secretion of
extracellular polymers, can tip the competition balance, resulting in outcomes that may differ
from those predicted in planktonic cultures (27). Particularly, biofilms often form gradients in
nutrient concentrations, oxygen tension, pH and waste products due to the thickness [12].
These factors can significantly affect the outcomes of microbial competition and compositions
in a biofilm community. Interestingly, despite high levels of competition among species, the
majority of the resident organisms in a host-associated community can co-exist and maintain
a relative stability in the community [8, 30]. This indicates that some regulatory mechanisms
must exist and play critical roles in balancing microbial cooperative and competitive activities
in microbial communities.
Based on recent community structure and dynamic studies using metagenomics and 16S
pyrosequencing, microbial interactions can have three types of outcomes: a positive impact
(win), a negative impact (loss) and no impact (neutral) on the microbial species involved [31].
The possible combinations of win (+), loss (−) and neutral (0) outcomes for two interacting
partners allow classification of various interaction types. For example, different species of
bacteria may cooperate to build a biofilm, which confers protection of the interacting members
from antibiotics, a win–win (+/+) relationship known as mutualism. Other examples for
cooperation are certain cases of cross feeding, in which two species exchange metabolic
products to the benefit of both. In contrast, competition between two species is a classic loss–
loss (−/−) relationship, which indicates that two species with similar niches exclude each other
or competitive exclusion. In addition to typical cooperation or competition, predator–prey
relationships and host–parasite relationships are considered to be win–loss (+/−) interactions,
which are also common in natural and host-associated microbial communities [30]. For
example, Streptococcus mutans in dental plaque can produce an array of bacteriocins that kill
other related species in the community, a typical win–loss interaction (+/−) [32]. In most
ecosystems, there are few cases of neutral or no (0) interaction among species in the same
community. These microbial interactions are largely based on laboratory studies of pairwise
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feedbacks. Third, the host could feed microorganisms to reduce cooperation among species
by providing alternative carbon sources, so that these species no longer rely so strongly on
their cooperative partners [34]. Analysis of mouse gut microbiome reveals that cooperative
interactions are rare in the gut microbiome (only ∼10% of pairwise interactions are mutually
beneficial), possibly because of their destabilizing effect [7].
An additional unexplored factor that could drive community stability is natural selection on
both microbiomes and hosts. The human microbiome is the product of long adaptive processes
of constituent species, their interactions and host factors governing their growth [36]. Given
the possibility of selection driving communities towards higher stability, it will be important
to ascertain not only how species interactions affect stability on average, but also what
characteristics of the most stable communities are, and whether they are achievable by
evolution. Work on animal and plant communities has shown that factors that decrease
community stability on average can also counterintuitively be over-represented in most stable
communities [34]. These approaches will be critical in understanding evolutionary ecology of
microbial communities, therefore, helping manipulation of component species in communities
to promote stable microbiomes and health in hosts.
5. Potential factors disrupting microbial homeostasis: tipping the balance
Human microbiome research reveals that every human body contains a variety of microbial
communities that consist of hundreds of microbial species important to human health [1–3].
The key to human health is an ecological-balanced microbiome that practices commensalism
or mutualism within itself and with the host [7]. Microbial–microbial and microbial–host
interactions play important roles in maintaining such a homeostasis in these microbial
communities (Figure 1). Despite these interactions, however, the homeostasis in a microbial
community can breakdown under certain circumstances, leading to population shifts and
predisposing a site to diseases [8]. What factors can disrupt the homeostasis in such stable
communities? Studies of various host-associated microbiomes, such as those in the oral cavity,
gastrointestine and vagina, have provided some clues to the type of factors indicating
homeostasis disruption in a community, including (1) a significant change in the relationship
between a microbial community and the host; (2) acquisition of a virulence factor or pathogenic
trait by a resident species in the community; (3) a sudden increase or decrease in relative
abundance of one or more species in the community and (4) more recently, “keystone” species
or pathogens that play key roles in the breakdown of host–microbial homeostasis leading to
dysbiosis in a community and diseases, based on the keystone-pathogen hypothesis [3, 8, 33,
37].
The relationships between microbiome and its hosts during health are often mutually benefi‐
cial because the host is providing its microbial communities with an environment in which
they can flourish and, in turn, keep their host healthy [34]. The presence of an immune or
physiological disorder can tip the balance of a microbial community. As the immune defense
system regulates microbial–host interactions, a compromised immune system often disrupts
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community, so potentially destabilizing the community [7, 34]. Microbial cooperation is
destabilizing the community because it introduces positive feedbacks, which can generate
runaway effects. For example, when two species cooperate, an increase in the abundance of
one species increases the abundance of the second, which in turn will increase the abundance
of the first species and so on. If these increases are not sufficiently checked by other constraints,
then this can lead to runaway increases in cooperating species that can cause the collapse of
interacting populations and destabilization of the community [7]. In contrast, negative
microbial interactions or feedbacks, such as competition and antagonism, are considered as
major and essential mechanisms in maintaining the homeostasis in microbial communities.
This means that adding species that primarily engage in competitive interactions to the
community may counterintuitively help to stabilize the community by dampening positive
feedbacks, stopping the community from cooperating its way to collapse [34]. Human and
animal hosts may also suppress positive interactions or feedbacks between cooperating species
in order to stabilize the community. Hosts could do this possibly by three mechanisms. First,
the host immune response could be a stabilizing force. When certain species in a community
rapidly increase in abundance, this could provoke a targeted host immune response, stopping
positive feedbacks between cooperating species in their tracks. Second, the host could attempt
to block cooperative interactions among species by spatially segregating them: when species
grow in separate locations, their interactions will be weakened, thereby, preventing positive
Figure 1. A schematic diagram describes microbial–microbial interactions and their roles in maintaining the homeosta‐
sis in a community. Microbial interactions include negative interactions (− feedbacks) such as competition and antago‐
nism and positive interactions (+ feedbacks) such as cooperation, synergy and mutualism. Positive interactions likely
increase the productivity of the community but potentially destabilize the community, while negative interactions of‐
ten dampen cooperative activities but favour species diversity and community stability. These interactions form com‐
plex networks that finely balance the homeostasis of the community. However, a number of ecological factors can tip
the balance of these microbial interactions, disturbing the stability of a community. Dashed arrows indicate the poten‐
tial of these factors to tip the balance of the community.
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feedbacks. Third, the host could feed microorganisms to reduce cooperation among species
by providing alternative carbon sources, so that these species no longer rely so strongly on
their cooperative partners [34]. Analysis of mouse gut microbiome reveals that cooperative
interactions are rare in the gut microbiome (only ∼10% of pairwise interactions are mutually
beneficial), possibly because of their destabilizing effect [7].
An additional unexplored factor that could drive community stability is natural selection on
both microbiomes and hosts. The human microbiome is the product of long adaptive processes
of constituent species, their interactions and host factors governing their growth [36]. Given
the possibility of selection driving communities towards higher stability, it will be important
to ascertain not only how species interactions affect stability on average, but also what
characteristics of the most stable communities are, and whether they are achievable by
evolution. Work on animal and plant communities has shown that factors that decrease
community stability on average can also counterintuitively be over-represented in most stable
communities [34]. These approaches will be critical in understanding evolutionary ecology of
microbial communities, therefore, helping manipulation of component species in communities
to promote stable microbiomes and health in hosts.
5. Potential factors disrupting microbial homeostasis: tipping the balance
Human microbiome research reveals that every human body contains a variety of microbial
communities that consist of hundreds of microbial species important to human health [1–3].
The key to human health is an ecological-balanced microbiome that practices commensalism
or mutualism within itself and with the host [7]. Microbial–microbial and microbial–host
interactions play important roles in maintaining such a homeostasis in these microbial
communities (Figure 1). Despite these interactions, however, the homeostasis in a microbial
community can breakdown under certain circumstances, leading to population shifts and
predisposing a site to diseases [8]. What factors can disrupt the homeostasis in such stable
communities? Studies of various host-associated microbiomes, such as those in the oral cavity,
gastrointestine and vagina, have provided some clues to the type of factors indicating
homeostasis disruption in a community, including (1) a significant change in the relationship
between a microbial community and the host; (2) acquisition of a virulence factor or pathogenic
trait by a resident species in the community; (3) a sudden increase or decrease in relative
abundance of one or more species in the community and (4) more recently, “keystone” species
or pathogens that play key roles in the breakdown of host–microbial homeostasis leading to
dysbiosis in a community and diseases, based on the keystone-pathogen hypothesis [3, 8, 33,
37].
The relationships between microbiome and its hosts during health are often mutually benefi‐
cial because the host is providing its microbial communities with an environment in which
they can flourish and, in turn, keep their host healthy [34]. The presence of an immune or
physiological disorder can tip the balance of a microbial community. As the immune defense
system regulates microbial–host interactions, a compromised immune system often disrupts
Microbial Interactions in Biofilms: Impacts on Homeostasis and Pathogenesis
http://dx.doi.org/10.5772/62942
49
community, so potentially destabilizing the community [7, 34]. Microbial cooperation is
destabilizing the community because it introduces positive feedbacks, which can generate
runaway effects. For example, when two species cooperate, an increase in the abundance of
one species increases the abundance of the second, which in turn will increase the abundance
of the first species and so on. If these increases are not sufficiently checked by other constraints,
then this can lead to runaway increases in cooperating species that can cause the collapse of
interacting populations and destabilization of the community [7]. In contrast, negative
microbial interactions or feedbacks, such as competition and antagonism, are considered as
major and essential mechanisms in maintaining the homeostasis in microbial communities.
This means that adding species that primarily engage in competitive interactions to the
community may counterintuitively help to stabilize the community by dampening positive
feedbacks, stopping the community from cooperating its way to collapse [34]. Human and
animal hosts may also suppress positive interactions or feedbacks between cooperating species
in order to stabilize the community. Hosts could do this possibly by three mechanisms. First,
the host immune response could be a stabilizing force. When certain species in a community
rapidly increase in abundance, this could provoke a targeted host immune response, stopping
positive feedbacks between cooperating species in their tracks. Second, the host could attempt
to block cooperative interactions among species by spatially segregating them: when species
grow in separate locations, their interactions will be weakened, thereby, preventing positive
Figure 1. A schematic diagram describes microbial–microbial interactions and their roles in maintaining the homeosta‐
sis in a community. Microbial interactions include negative interactions (− feedbacks) such as competition and antago‐
nism and positive interactions (+ feedbacks) such as cooperation, synergy and mutualism. Positive interactions likely
increase the productivity of the community but potentially destabilize the community, while negative interactions of‐
ten dampen cooperative activities but favour species diversity and community stability. These interactions form com‐
plex networks that finely balance the homeostasis of the community. However, a number of ecological factors can tip
the balance of these microbial interactions, disturbing the stability of a community. Dashed arrows indicate the poten‐
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key roles in initiating periodontitis, chronic inflammatory bowel disease, colon cancer and
obesity. For example, periodontitis is a biofilm-induced chronic inflammatory disease, which
affects the tooth-supporting tissues or periodontium (Figure 3), and also increases patients’
risk of developing atherosclerosis, diabetes and possibly rheumatoid arthritis [38, 39]. The
tooth-associated dental plaque is required but not sufficient to induce periodontitis, because
it is the host inflammatory response to this microbial challenge that ultimately can cause
destruction of the periodontium. There has been significant progress in the quest to identify
specific periodontal pathogens, including the identification of several candidates, mostly
Gram-negative anaerobic bacteria that colonize subgingival tooth sites. Foremost among this
group are three species that constitute the so-called “red complex”, are frequently isolated
together and are strongly associated with diseased sites in the mouth: Porphyromonas gingiva‐
lis, Treponema denticola and Tannerella forsythia which are the keystone pathogens in subgingival
dental biofilms [39]. Much research have been directed towards understanding the pathogenic
mechanisms and virulence determinants of these three bacterial species. Dysbiotic microbial
communities of these keystone pathogens are thought to exhibit synergistic virulence,
whereby not only they can endure the host response but can also thrive by exploiting tissue
destructive inflammation, which fuels a self-feeding cycle of escalating dysbiosis and inflam‐
matory bone loss, ultimately leading to tooth loss and systemic complications [40].
Figure 2. A schematic diagram describes an example of an ecological factor, frequent consumption of sugar (fermenta‐
ble carbohydrates), to tip the balance of the community. In the human oral cavity, frequent consumption of dietary
sugar is a powerful ecological factor that can cause population shifts and tip the balance of a dental biofilm communi‐
ty. Sugar favours the overgrowth of sugar-fermentable and acid-resistant bacteria such as Streptococcus mutans (black
circles) and Lactobacillus sp. (black ovals) in dental biofilms. This will result in population shifts characterized by domi‐
nance of S. mutans and Lactobacillus sp., but reduction or elimination of acid-sensitive bacteria (blank shapes) in the
community, leading to the homeostasis breakdown and predisposing the site to dental caries. In this case, fewer spe‐
cies remain in the imbalanced community.
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the balance relationships between microbes and the host, resulting in the homeostasis
breakdown and predisposing to disease. For example, immune-deficient or chemotherapy
patients have an increased susceptibility to opportunistic infections [11]. Individuals with
reduced saliva flow or dry mouth also have an increased susceptibility to dental caries,
periodontitis or oral candidosis caused by once-normal resident microbes within the oral
cavity [33]. Another example is that increase in female sex hormones can sometime have the
capacity to disrupt microbial homeostasis in several ecosystems of the body, predisposing or
enhancing opportunistic infections [8].
Acquisition of virulence factors or pathogenic traits via horizontal gene transfer between
microbes in biofilms is a common mechanism to trigger population shifts by antibiotic-resistant
species leading to the homeostasis breakdown in a community. For example, an antibiotic-
resistant gene transfer within or between species may lead to dominance by these populations
in the community, particularly when the community is exposed to a subinhibitory antibiotic
stress condition [38].
A sudden increase or decrease in relative abundance of one or more species in a microbial
community often indicates the homeostasis breakdown of the community [8, 33]. A common
feature is a significant change in nutrient status, for example, introduction of an excess
substrate such as sugar or a chemical compound that can disturb the ecosystem [8]. For
example, frequent consumption of fermentable dietary carbohydrates in the oral cavity may
favor the overgrowth of sugar-fermenting bacteria (Figure 2) such as S. mutans and Lactoba‐
cillus sp. in a dental biofilm [33]. Such carbohydrate metabolism from these bacteria generates
large amounts of lactic acid that acidifies the local environment, resulting in selection of acid-
resistant bacteria but elimination of acid-sensitive bacteria in the community. The dominance
by a few acid-resistant species in the community indicates the breakdown of the homeostasis,
predisposing the site to tooth decay [33]. In this case, the microbial community is often
dominated by fewer species or reduced species diversity [8]. Clearly, frequent consumption
of fermentable carbohydrates is a powerful determinant that disturbs the homeostasis in dental
biofilms. Similarly, antimicrobial agents that kill bacteria are the best-characterized mecha‐
nisms resulting in homeostasis breakdown in many host-associated microbial communities
[11]. Antibiotic treatment often causes a rapid reduction in sensitive species followed by an
emergence of resistant organisms. This inevitably results in population shifts and the homeo‐
stasis breakdown in the communities. It is then not surprising that an infectious disease may
occur due to the overgrowth of an antibiotic-resistant organism during an improper antibiotic
therapy.
More recently, a novel hypothesis, called the “keystone-pathogen hypothesis”, has been
proposed to describe mechanisms underlying the breakdown of host–microbial homeostasis
that precipitates dysbiosis (microbiota imbalance) of a community, leading to diseases [37].
The keystone-pathogen hypothesis holds that certain low-abundance microbial pathogens can
orchestrate inflammatory disease by remodeling a normally benign or resident microbiota into
a dysbiotic one in a community. Importantly, the keystone pathogens have the capacity of
instigating inflammation and triggering dysbiosis even when they are present as quantitatively
minor components in the community. Recent studies suggest that keystone pathogens play
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key roles in initiating periodontitis, chronic inflammatory bowel disease, colon cancer and
obesity. For example, periodontitis is a biofilm-induced chronic inflammatory disease, which
affects the tooth-supporting tissues or periodontium (Figure 3), and also increases patients’
risk of developing atherosclerosis, diabetes and possibly rheumatoid arthritis [38, 39]. The
tooth-associated dental plaque is required but not sufficient to induce periodontitis, because
it is the host inflammatory response to this microbial challenge that ultimately can cause
destruction of the periodontium. There has been significant progress in the quest to identify
specific periodontal pathogens, including the identification of several candidates, mostly
Gram-negative anaerobic bacteria that colonize subgingival tooth sites. Foremost among this
group are three species that constitute the so-called “red complex”, are frequently isolated
together and are strongly associated with diseased sites in the mouth: Porphyromonas gingiva‐
lis, Treponema denticola and Tannerella forsythia which are the keystone pathogens in subgingival
dental biofilms [39]. Much research have been directed towards understanding the pathogenic
mechanisms and virulence determinants of these three bacterial species. Dysbiotic microbial
communities of these keystone pathogens are thought to exhibit synergistic virulence,
whereby not only they can endure the host response but can also thrive by exploiting tissue
destructive inflammation, which fuels a self-feeding cycle of escalating dysbiosis and inflam‐
matory bone loss, ultimately leading to tooth loss and systemic complications [40].
Figure 2. A schematic diagram describes an example of an ecological factor, frequent consumption of sugar (fermenta‐
ble carbohydrates), to tip the balance of the community. In the human oral cavity, frequent consumption of dietary
sugar is a powerful ecological factor that can cause population shifts and tip the balance of a dental biofilm communi‐
ty. Sugar favours the overgrowth of sugar-fermentable and acid-resistant bacteria such as Streptococcus mutans (black
circles) and Lactobacillus sp. (black ovals) in dental biofilms. This will result in population shifts characterized by domi‐
nance of S. mutans and Lactobacillus sp., but reduction or elimination of acid-sensitive bacteria (blank shapes) in the
community, leading to the homeostasis breakdown and predisposing the site to dental caries. In this case, fewer spe‐
cies remain in the imbalanced community.
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the balance relationships between microbes and the host, resulting in the homeostasis
breakdown and predisposing to disease. For example, immune-deficient or chemotherapy
patients have an increased susceptibility to opportunistic infections [11]. Individuals with
reduced saliva flow or dry mouth also have an increased susceptibility to dental caries,
periodontitis or oral candidosis caused by once-normal resident microbes within the oral
cavity [33]. Another example is that increase in female sex hormones can sometime have the
capacity to disrupt microbial homeostasis in several ecosystems of the body, predisposing or
enhancing opportunistic infections [8].
Acquisition of virulence factors or pathogenic traits via horizontal gene transfer between
microbes in biofilms is a common mechanism to trigger population shifts by antibiotic-resistant
species leading to the homeostasis breakdown in a community. For example, an antibiotic-
resistant gene transfer within or between species may lead to dominance by these populations
in the community, particularly when the community is exposed to a subinhibitory antibiotic
stress condition [38].
A sudden increase or decrease in relative abundance of one or more species in a microbial
community often indicates the homeostasis breakdown of the community [8, 33]. A common
feature is a significant change in nutrient status, for example, introduction of an excess
substrate such as sugar or a chemical compound that can disturb the ecosystem [8]. For
example, frequent consumption of fermentable dietary carbohydrates in the oral cavity may
favor the overgrowth of sugar-fermenting bacteria (Figure 2) such as S. mutans and Lactoba‐
cillus sp. in a dental biofilm [33]. Such carbohydrate metabolism from these bacteria generates
large amounts of lactic acid that acidifies the local environment, resulting in selection of acid-
resistant bacteria but elimination of acid-sensitive bacteria in the community. The dominance
by a few acid-resistant species in the community indicates the breakdown of the homeostasis,
predisposing the site to tooth decay [33]. In this case, the microbial community is often
dominated by fewer species or reduced species diversity [8]. Clearly, frequent consumption
of fermentable carbohydrates is a powerful determinant that disturbs the homeostasis in dental
biofilms. Similarly, antimicrobial agents that kill bacteria are the best-characterized mecha‐
nisms resulting in homeostasis breakdown in many host-associated microbial communities
[11]. Antibiotic treatment often causes a rapid reduction in sensitive species followed by an
emergence of resistant organisms. This inevitably results in population shifts and the homeo‐
stasis breakdown in the communities. It is then not surprising that an infectious disease may
occur due to the overgrowth of an antibiotic-resistant organism during an improper antibiotic
therapy.
More recently, a novel hypothesis, called the “keystone-pathogen hypothesis”, has been
proposed to describe mechanisms underlying the breakdown of host–microbial homeostasis
that precipitates dysbiosis (microbiota imbalance) of a community, leading to diseases [37].
The keystone-pathogen hypothesis holds that certain low-abundance microbial pathogens can
orchestrate inflammatory disease by remodeling a normally benign or resident microbiota into
a dysbiotic one in a community. Importantly, the keystone pathogens have the capacity of
instigating inflammation and triggering dysbiosis even when they are present as quantitatively
minor components in the community. Recent studies suggest that keystone pathogens play
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6. Implications in the pathogenesis of biofilm diseases
Traditional studies on infectious diseases have focused extensively on pathogenic microbes
that directly damage tissues in hosts. It is increasingly recognized that direct attack is not the
only way that microbes cause diseases. Evidence has accumulated that some commensal
microbes living as the normal residents in a host can also induce diseases or contributes
critically to disease development. These commensal microbes that can cause or promote
diseases under certain conditions are often called opportunistic pathogens or “pathobionts”
[40]. When some species become dominant in their relative abundance in a community, the
relationships among the resident members in the community might become imbalanced called
dysbiosis, which indicates the breakdown of the homeostasis in the community. The keystone
pathogens identified from various ecosystems also play key roles in disturbing the microbial–
host homeostasis, leading to dysbiosis, which can be the cause or the consequence of diseases
and is largely dependent on microbial–host interactions in a microbial community. Recent
studies reveal that factors that can disturb the microbial homeostasis likely result in the
dominance by pathobionts in a community, predisposing a site to diseases [39, 40]. A common
feature of these diseases is that they are often associated with multiple species of pathobionts,
so these diseases are referred to as polymicrobial or community-based diseases [12, 42].
However, only certain species play major roles in driving a commensal community toward
the pathogenic shift [41]. Despite multispecies features, a major challenge using antibiotics to
treat these diseases is that wide-spectrum antibiotics may indiscriminately kill the resident
organisms in the community, resulting in ecological disruption or other negative clinical
consequences [43]. Current understanding of polymicrobial or community-based diseases has
changed the strategies for diagnosis, prevention and treatment of these diseases.
7. Strategies for diagnosis, prevention and treatment of community-based
diseases
7.1. Community-based assays of the microbiomes
It is now known that most biofilm diseases are associated with multiple species of microor‐
ganisms. These polymicrobial diseases such as dental caries, periodontitis, otitis media, cystic
fibrosis lung infection, inflammatory bowel disease and other biofilm infections are clinically
characterized by a chronic process with acute or subacute episodes [41–43]. The homeostasis
breakdown leading to dysbiosis in a community is the key step for the initiation and devel‐
opment of these diseases [40]. Because alternations in the microbiota at a given site are potential
biomarkers of disease activity, analyzing the microbiome at the early stages of diseases would
allow clinicians to diagnose, predict and prevent potential risk, severity and outcomes of these
diseases. In particular, identification of keystone pathogens could have substantial clinical
benefits, as it may facilitate the development of targeted treatment by focusing on a limited
number of pathobionts in biofilms. Since every human body contains a personalized micro‐
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Figure 3. A proposed model describes the roles of pathobionts or keystone pathogens in the initiation and develop‐
ment of periodontitis. In healthy periodontium, a commensal microbe–host relationship is maintained because of a
controlled inflammatory state. However, this balanced relationship or homeostasis can breakdown due to defects in
the immunoinflammatory state or predisposing conditions or environmental factors, leading to the balance shift to‐
wards dysbiosis, a state in which former commensal organisms become proinflammatory pathobionts. In addition, the
presence of keystone pathogens can similarly tip the balance toward dysbiosis even in hosts without apparent predis‐
posing factors. The inflammation caused by the dysbiotic microbiota depends in great part on crosstalk signaling be‐
tween complement and pattern recognition receptors (PRRs). This has two major interrelated effects: it causes
inflammatory destruction of periodontal tissue, which in turn provides nutrients (destructed tissues) further promot‐
ing dysbiosis. This generates a self-perpetuating pathogenic cycle. It should be noted that host susceptibility might not
simply be a determinant of the transition from a symbiotic to dysbiotic microbiota but it may underlie the predisposi‐
tion of the host to develop inflammation sufficient to cause irreversible tissue damage.
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required for infections, thereby, essentially disarming the bacteria and tipping the balance in
favor of the host and allowing the immune system to clear the infectious pathogen [54]. QSI
therapies that specifically block bacterial quorum sensing can make the pathogens become
‘deaf’, ‘mute’ or ‘blind’ rather than directly killing them. Therefore, QSI therapy may achieve
the treatment but much less likely cause selective pressure to create resistant microbes [54–56].
For some community-based diseases, such as periodontitis and intestine inflammatory
diseases, anti-inflammatory agents can be used to break the cycle of inflammation and tissue
destruction, both of which promote the homeostasis breakdown or dysbiosis in a community
[42, 43]. In particular, these agents combined with some antimicrobials that specifically target
the keystone pathogens or pathobionts would provide much better therapy both by targeting
the putative pathogens and by interfering with the processes that drive breakdown of the
homeostasis in the community [43].
Other strategies in regulating microbial ecology to prevent homeostasis breakdown in some
microbial communities include diet regulation such as sugar substitutes that reduce carbon
source for bacterial fermentation, increasing flow of body fluids such as saliva, use of oxygen‐
ating or redox agents that reduce the growth of obligate anaerobes in a biofilm community,
and use of nonantimicrobial agents such as fluoride, chelating agents such as EDTA, and metal
ions that compromise some metabolic activities of certain microbes [8, 33]. For example,
fluoride can inhibit enzyme activity required for bacterial metabolism, particularly under low
pH, but shows little bacterial killing, thereby, not significantly affecting community ecology
[8].
7.3. Targeted antimicrobial therapy to reduce pathobionts in a community
Currently, available antibiotics exhibit broad killing spectra with regard to bacterial genus and
species. Indiscriminate killing of microbes by these conventional antibiotics may disrupt the
ecological balance of the indigenous microflora, resulting in negative clinical consequences
[51]. To circumvent the problem, a new class of such antimicrobials, called pheromone-guided
antimicrobial peptides (PG-AMP), has been developed as potential alternatives [57, 58]. The
rationale of using such antimicrobial agents is based on the addition of a targeting domain of
a quorum-sensing signal pheromone from a target organism to the killing domain of a known
antimicrobial peptide. Both domains are fused via a small linker to generate a fusion PG-AMP
without detrimental change of their activities [58]. The targeting domain can guide such a
fusion peptide to bind selectively to the target organism, leading to selective killing [57–59].
These narrow-spectrum antimicrobials can selectively target specific organisms with little
effect on the other members of the community [51, 57–59]. Therefore, PG-AMPs have added
an exciting opportunity to develop new antimicrobials that target keystone pathogens in a
community-based disease. Recent studies explored the possibility of utilizing a pheromone
produced by S. mutans as a targeting domain to mediate S. mutans-specific delivery of an
antimicrobial peptide domain [57–59]. It is found that PG-AMPs constructed in this way are
potent against S. mutans in animal dental caries model [60]. The PG-AMPs are capable of
eliminating S. mutans from multispecies biofilms without affecting other noncariogenic
species, indicating the potential of these molecules to be developed into targeted antimicrobial
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biome, analyses of the microbiome will pave the way for more effective diagnosis, prevention
and therapies, contributing to the development of personalized medicine.
For a long time, our understanding of microbial communities has been hampered by the
intrinsic limitation of conventional culture-dependent techniques. Our views of the complexity
and genetic diversity of microbial communities based on cultivation strategies are severely
biased. Fortunately, a number of DNA-based assays or genomic approaches have been
developed to help overcome such limitation, allowing us to obtain a clearer picture of microbial
communities in terms of their structural complexity and genetic diversity. Since intermicrobial
interactions in a community often create many new physiological functions that cannot be
observed with individual species, community-based assays have emerged to analyze microbial
compositions and associated physiology, which has greatly contributed to our understanding
of the microbiomes and dysbiosis. Common strategies used to analyze microbial communities
or the microbiomes include 16S rRNA gene (pyro)sequencing [44, 45], genomic or metage‐
nomic approaches [46], checkerboard DNA–DNA hybridization [47], PCR-based denaturing
gradient gel electrophoresis (DGGE) [48] or denaturing high performance liquid chromatog‐
raphy (DHPLC) analyses [49] and terminal restriction fragment length polymorphism (T-
RFLP) analysis [50]. The application of these community-based techniques in the analysis of
the human microbiomes has revealed astonishing diversities of largely uncultivated microor‐
ganisms present in human samples. These approaches have been expanded to many clinical
samples collected from a broader patient pool with a diverse range of healthy conditions and
diseases, promoting the discovery of many new species of the human microbiome.
7.2. Modulating community ecology to reduce potential risk of a disease
With our new understanding of microbial communities and their associated diseases, there is
an increasing interest in approaches that modulate the ecology of microbial communities to
achieve reduction or control of community-based diseases. These diseases may be prevented
or treated not only by inhibiting the putative pathogens, but also by interfering with the factors
disturbing the homeostasis in microbial communities. Among them, probiotic approach has
been a popular method for modulating microbial ecology [51]. The probiotics refers to live
microorganisms that can confer health benefits on the host when administered in adequate
amounts [52]. In the past decades, there have been numerous exciting discoveries that reveal
beneficial effects resulting from administering probiotics, ranging from direct inhibition of
pathogenic microbes to improving host immune functions [53]. The rationale of using
probiotics is based on the fact that probiotics can interfere with invasion by foreign pathogens
or with pathogenic shifts by keystone pathogens in microbial communities. These may reduce
the potential of a community to become a pathogenic one or dysbiosis [51–53].
Another strategy is to interfere with microbial cell–cell communication via quorum sensing in
microbial communities, since quorum-sensing mechanisms play important roles in biofilm
formation and cell density-dependent virulence [13–18]. In recent years, scientists actively
search for natural and synthetic compounds that act as quorum-sensing inhibitors (QSIs) that
can target bacterial quorum-sensing mechanisms and their controlled pathogenic activities
[54–56]. It is believed that QSIs target bacterial cell–cell signaling and coordinated activities
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agents. This proof-of-principle strategy suggests that it may be possible to develop PG-AMPs
that specifically target other keystone pathogens and modulate microbial ecology in com‐
munity-based diseases [58–60].
8. Concluding remarks
Research over the last 30 years has generated a substantial amount of knowledge on microbial
biofilms. We have learned that microbes form highly diverse communities on surfaces of
human body, which are increasingly recognized to have profound impacts on human health
and diseases. It has been well established that microbes in such biofilm communities can
develop complex social interactions and networks, which play important roles in modulating
the community stability or homeostasis important to host health. Despite our rapidly increas‐
ing knowledge of the compositions of the human microbiome, we know little about what
determines the stability of these communities. However, significant advance has been made
to identify factors that affect microbial interactions, ecology and pathogenesis. Evidence shows
that some biofilm diseases can be prevented or treated not only by targeting the putative
pathogens, but also by interfering with the processes that drive the breakdown of the homeo‐
stasis in biofilms. Studies of the human microbiomes in health and disease will open a new
avenue for the development of more effective diagnosis, prevention and treatment of com‐
munity-based diseases, contributing to personalized medicine.
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8. Concluding remarks
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ing knowledge of the compositions of the human microbiome, we know little about what
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Abstract
Streptococcus  pyogenes  (group A streptococcus –  GAS) can cause numerous human
infections, varying from mild skin infections to life‐threatening, e.g. necrotizing fasciitis.
Adherence and biofilm production are important in streptoccocal pathogenesis. GAS
adhesins are numerous and diverse, with the ability to bind to several different receptors
at the same time, which leads to difficulties in their precise identification and classifi‐
cation. Biofilm production is one of the most probable explanation for therapeutic failure
in the treatment of GAS infections. Most researchers agreed that biofilm formation is a
trait of individual strains rather than a general serotype attribute. The aim of our study
is to investigate differences in adherence to laminin and biofilm production between
invasive and non‐invasive isolates (NI) of GAS. In this study the correlation between
adherence to laminin and invasiveness in GAS isolates is noticed. The strains isolated
from GAS carriers and highly invasive (HI) GAS strains have excellent capacity for
binding to laminin. When testing biofilm production, there was noticeable positive
correlation between adherence and biofilm production among non‐invasive isolates.
Non‐invasive isolates were stable biofilm productors. There was no correlation between
adherence and biofilm production among invasive isolates. Invasive isolates were also
unstable biofilm productors.
Keywords: Streptococcus pyogenes, Invasiveness, Adherence, biofilm production, hy‐
drophobicity
1. Introduction
Streptococcus pyogenes (group A streptococcus – GAS) is one of the most frequent exclusively
human pathogen. When speaking about human infections and clinical conditions, there are only
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originate from environment such as the substrate on which the biofilm creates, initial bacterial
layer coating the substrate, and characteristics of bacteria multiplying in this medium [5].
Adherence is complex process that includes several different steps. In the first step, bacteria
have to overcome the repulsive forces which are consequence of negative charge of the
bacterial superficial adhesins and substrate. Afterwards, in the second step positively attract‐
ing forces (such as covalent, ionic, van der Waals, hydrophobic) are established between
bacterial adhesin and compatible receptor on the human cell. These attractive forces act on the
small distance and only after bacterial surpassing of the repulsive electrostatic forces. Most of
these interactions are low affinity bonds, but acting together they turn out to be strong and
high affinity. Van der Waals forces play crucial role in protein‐protein recognition, when
complementary lock‐and‐key shapes are involved [6]. Hydrophobic side chains on the proteins
could be connected to each other also using the low affinity hydrophobic forces. This is very
plain and simple observation of adherence, and we should highlighted here that in the same
or similar environmental conditions even closely related species in genus Streptococcus could
demonstrate very diverse attractive forces [7].
Nowadays, there is proposition of two‐step adherence of S. pyogenes [6]. In the first step,
lipoteichoic acid (LTA) as amphipathic molecule, enables overcoming of the repulsive
electrostatic forces between bacteria and substrate. In the second step, microbial surface
components recognizing adhesive matrix molecules (MSCRAMMS), such as M protein,
fibronectin binding protein (SfbI), serum opacity factor (SOF), etc. adhere to specific receptor
on the human cell. Besides of the MSCRAMMS, it is demonstrated that this second step of
adherence could be provided by bacterial pili. The initial attachment is very dynamic process
in that they demonstrate on‐off kinetic effect and includes several chemical molecular inter‐
actions, such as hydrophobic, ionic and electrostatic forces. Second step of adherence probably
involves more specific, complex and irreversible interactions with higher affinity between one
or several different MSCRAMMS and human cells. Group A streptococcal ability to bind our
cells with several different MSCRAMMS at the same time make difficulties in identification of
streptococcal adhesins.
Bacterial adherence to human cells could be on the direct or indirect way. Direct way of
adherence is displayed by binding of bacterial adhesion to specific receptor on the cell surface;
e.g. capsular hyaluronic acid interacts with CD44 receptor on the surface of keratinocytes and
induces reorganization of cytoskeletal actin and rupture of intercellular bridges enabling
bacteria to penetrate the epithelium still staying extracellular and reaching deeper into the
tisssue [8]. The other, indirect way of adherence is more common. Streptococcal adhesins first
bind to proteins of extracellular matrix (ECM) such as fibrinogen, fibronectin, laminin, collagen
as bridging molecules which than attach to cell membranes integrins [9].
2.1.1. Fibronectin binding proteins
Fibronectin (Fn) is a high‐molecular weight glycoprotein that circulates free as a dimer in the
soluble form in blood plasma or as a fibrillar form is assembled by cells as major component
of the ECM. So far, fibronectin binding proteins are the best studied adhesins of S. pyogenes
and currently 11 different such adhesins have been identified [10], divided in two types. First
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few bacteria like GAS showing so much different faces and such a wide spectra of different
virulence factors. Even systematization of group A streptococcal diseases was not specified for
a long time. Classification of GAS diseases has recently been successful, clarified, and system‐
atized. Diseases caused by S. pyogenes are divided into pyogenic (superficial and invasive) and
toxemic, with autoimmune complication such as post‐infectious sequelae (acute rheumatic fever
and acute post‐streptococcal glomerulonephritis) [1]. Streptococcal carriage is a special clinical
condition, during which, this strictly human pathogen became a not precisely opportunistic
bacteria, but normal flora‐like bacteria.
S. pyogenes is a successful human pathogen and is a cause of so many diseases by virtue of its
numerous virulence factors, which in this high numbers are possessed only by few bacteria
like Staphylococcus aureus and Clostridium perfringens. Therefore, it is quite incomprehensible
that the bacteria with such numerous and different virulence factors is not expected to be the
cause of life‐threatening human diseases. Although it is so much discovered and known about
GAS pathogenesis, there is still unknown why this bacteria so rare and unexpectedly activates
his most powerful virulence factors such as toxins and hydrolytic enzymes, which are most
active in necrotizing fasciitis and streptococcal toxic shock syndrome (STSS).
On the other hand, such invasive bacteria could become normal flora‐like bacteria during
pharyngeal or nasal carriage. Streptococcal carriage has been defined as the recovery of GAS
from the nasopharynx or oropharynx in the absence of any evidence of acute infection [2].
Streptococcal carriers should not be treated with antibiotics, except in the cases of reappearance
of disease or possible occurence of post‐streptococcal sequelae. Genesis of streptococcal
carriage was for a long time poorly understood. Nowadays, there are two theories which
explain streptococcal carriage as the consequence of therapeutic failure happened after
infection of strains capable to produce biofilm [3] or internalize into epithelial cells [4].
Considering that S. pyogenes is one of the few bacteria still sensitive to penicillin in vitro, and
due to the development of new antibiotics, it would be expected that the incidence of strep‐
tococcal infections should decrease over time. But, epidemiological data suggest that percent‐
age of streptococcal carriage has remained unchanged, and also the fact that frequency of the
invasive GAS diseases have become more frequent, led to the establishment Strep‐EURO study
group for monitoring streptococcal invasive disease in 11 European countries. All these
information and facts have led to actualizations of GAS, revelation of new virulence factors
which contribute to new perspectives in the understanding of group A streptococcal patho‐
genesis.
2. Adherence and biofilm production of Streptococcus pyogenes
2.1. New insight into old problem of group A streptococcal adherence
Although sometimes not sufficiently emphasized, efficient adherence is the prime step in the
pathogenesis of infective disease. Factors that influence adherence are diverse and can
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originate from environment such as the substrate on which the biofilm creates, initial bacterial
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bacteria to penetrate the epithelium still staying extracellular and reaching deeper into the
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soluble form in blood plasma or as a fibrillar form is assembled by cells as major component
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distributed in our body, only a few laminin binding proteins are identified in GAS so far.
Currently, proteins nominated as streptococcal hemoprotein receptor (Shr), laminin binding
protein (Lbp), and streptococcal pyrogenic exotoxin B (SpeB) are identified as laminin binding
proteins for S. pyogenes.
SpeB is anchorless adhesin, with enzymatic function as cysteine protease. SpeB was first
identified as exotoxin, but this protein can be attached to the bacterial surface as adhesin. SpeB
is synthesized during early stationary phase in nutritious poor media [15]. This protein, like
M protein, has multiple functions (adhesin, proinflammatory effect, and enzymatic function).
Besides his function as laminin binding adhesin, this protein can bind to fibronectin and
vitronectin, allowing streptococcal dissemination in deep tissue [17] and activates metallo‐
proteases included in remodeling and degrading of ECM [15].
Shr is probably the protein attached to cell membrane, because it contains nor LPXTG either
QVPTG repeats, that recognize housekeeping or accessory sortases, enzymes which incorpo‐
rate proteins in the cell wall [18]. Its membrane position corresponds to the primary role of Shr
protein in uptaking of the heme and binding to its transporter in the cytoplasmic membrane
[19, 20]. In addition to its metabolic role, and by the virtue of surface position, it has been shown
that this protein have the ability to bind laminin and fibronectin, participating in this way in
adherence and acting as MSCRAMMS [21].
Lbp belongs to the group of metal‐binding receptors with modified accessory proteins. Lbp
scavenges environmental zinc and transports it to carriers of the cell membrane, to which it is
attached [22]. Also, Lbp is laminin binding adhesin [23]. This protein is not identified in the
oral streptococci, but is present in all surveyed so far M serotypes of GAS [23]. Lbp is very
short, even shorter than the thickness of the cell wall, and because of its location in the cell
membrane, it is likely to have greater importance in the metabolism of metal than in the
adherence to laminin [22].
2.1.4. Our experience with group A streptococcal adherence
Considering that the adherence of streptococci is still insufficiently examined process and that
the streptococcal adhesins are numerous and irregularly and inadequately identified, in our
study isolates were divided in three groups according to invasiveness of the disease they
caused. The aim of our study was to investigate differences in adherence to laminin between
invasive and non‐invasive isolates (NI) of GAS.
2.1.4.1. Material and methods
2.1.4.1.1. Bacterial strains
In total, 172 GAS isolates were included in the study. They were divided into three groups: (1)
100 non‐invasive isolates (NI) obtained from GAS carriers; (2) 50 low invasive (LI) isolates
obtained from patients with tonsillopharyngitis; and (3) 22 highly invasive (HI) recovered from
blood of patients with sepsis and STSS. All the isolates are part of the national collection of
GAS strains formed at the National Reference Laboratory for Streptococci, Institute of
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type proteins are SfbI, PrtF2, SOF, SfbX, Fbp54, FbaA, and FbaB and they all contain Fn‐binding
repeats. Second type proteins are M1, Shr, Scl1, and GAPDH and they do not contain these
repeats. It's estimated that 60% of initial attachment to epithelial cells is realized by strepto‐
coccal lipoteichoic acid, but afterwards MSCRAMMS, e.g. fibronectin binding proteins are the
most important in the irreversible stage of adherence. Binding of these adhesins to Fn could
result in irreversible attachment to the cell or biofilm production in tissue or bacterial inter‐
nalization. Fibronectin acts as a bridge molecule for binding to β5α1 integrins, with subse‐
quently rearrangement of cytoskeletal actin and uptake of the invading bacteria [11].
Expression of Fn‐binding proteins is regulated as response to the environmental conditions in
which streptococci survive and multiply. Protein F/SfbI, which allows binding to epithelial
cells of the dermis and Langerhans cells, show increased expression on bacterial surface with
increasing pressure of oxygen, e.g. on the cell surface, thereby enabling a better adherence of
the bacteria. When oxygen level is decreased, e.g. in deep tissue, expression of this protein is
also diminished, allowing bacterial dissemination into deeper tissues [12]. SfbI expression
could be diminished also by catalytic cleavage with serine protease streptococcal pyrogenic
exotoxin B (SpeB) or by other bacterial surface proteases where infection occurs. Protein F2,
detected in most SfbI negative‐ GAS strains, binds fibronectin with high affinity and is
homologous to Fn‐binding proteins of group C streptococci. Similarly as in protein F1/SfbI, F2
activity is also response to the environmental oxygen pressure [13]. Unlike these two proteins,
M protein expression is enhanced in the deeper tissues with increased pressure of carbon
dioxide, preventing phagocytosis and contributing to the dissemination of GAS [14].
2.1.2. Anchorless adhesins
Anchorless adhesins are attached to bacterial cell surface in the unknown mode, probably
through hydrophobic interactions. Importance of these proteins is in their ability to separate
from the cell surface, get away from the cell, detects environmental signals around streptococci
and the information transferred back to S. pyogenes [6]. The anchorless adhesins are not
grouped toghether because they are functionally and structurally diverse. Most of them have
enyzmatic functions. For example, five anchorless adhesins are enyzmes in glycolytic pathway
and they tipically are located in bacterial citosol: glyceraldehyde‐3‐phosphate dehydrogenase
(GAPDH), α‐enolase, phosphoglycerate kinase, phosphoglycerate mutase, and triose phos‐
phate isomerase [15]. GAPDH, also designed as SDH and Plr, could bind to several human
proteins (plasmin/plasminogen, fibronectin, and fibrinogen), cytoskeletal actin and myosin,
acting as an important colonization factor. These five anchorless adhesins operate together as
a complex in generating ATP molecules. As anchorless adhesins, they could produce extrac‐
ellular ATP, which is attached to P2X7 receptors on epithelial and immune cells, inducing
apoptosis of these cells. In this way, S. pyogenes establishes control on the behavior of human
cells and facilitates further progression of the infection [16].
2.1.3. Laminin binding adhesins
Laminin is high‐molecular weight ECM protein and one of the major components of the basal
lamina, which is part of the basement membrane in human cells. Although laminin is widely
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proteases included in remodeling and degrading of ECM [15].
Shr is probably the protein attached to cell membrane, because it contains nor LPXTG either
QVPTG repeats, that recognize housekeeping or accessory sortases, enzymes which incorpo‐
rate proteins in the cell wall [18]. Its membrane position corresponds to the primary role of Shr
protein in uptaking of the heme and binding to its transporter in the cytoplasmic membrane
[19, 20]. In addition to its metabolic role, and by the virtue of surface position, it has been shown
that this protein have the ability to bind laminin and fibronectin, participating in this way in
adherence and acting as MSCRAMMS [21].
Lbp belongs to the group of metal‐binding receptors with modified accessory proteins. Lbp
scavenges environmental zinc and transports it to carriers of the cell membrane, to which it is
attached [22]. Also, Lbp is laminin binding adhesin [23]. This protein is not identified in the
oral streptococci, but is present in all surveyed so far M serotypes of GAS [23]. Lbp is very
short, even shorter than the thickness of the cell wall, and because of its location in the cell
membrane, it is likely to have greater importance in the metabolism of metal than in the
adherence to laminin [22].
2.1.4. Our experience with group A streptococcal adherence
Considering that the adherence of streptococci is still insufficiently examined process and that
the streptococcal adhesins are numerous and irregularly and inadequately identified, in our
study isolates were divided in three groups according to invasiveness of the disease they
caused. The aim of our study was to investigate differences in adherence to laminin between
invasive and non‐invasive isolates (NI) of GAS.
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2.1.4.1.1. Bacterial strains
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Anchorless adhesins are attached to bacterial cell surface in the unknown mode, probably
through hydrophobic interactions. Importance of these proteins is in their ability to separate
from the cell surface, get away from the cell, detects environmental signals around streptococci
and the information transferred back to S. pyogenes [6]. The anchorless adhesins are not
grouped toghether because they are functionally and structurally diverse. Most of them have
enyzmatic functions. For example, five anchorless adhesins are enyzmes in glycolytic pathway
and they tipically are located in bacterial citosol: glyceraldehyde‐3‐phosphate dehydrogenase
(GAPDH), α‐enolase, phosphoglycerate kinase, phosphoglycerate mutase, and triose phos‐
phate isomerase [15]. GAPDH, also designed as SDH and Plr, could bind to several human
proteins (plasmin/plasminogen, fibronectin, and fibrinogen), cytoskeletal actin and myosin,
acting as an important colonization factor. These five anchorless adhesins operate together as
a complex in generating ATP molecules. As anchorless adhesins, they could produce extrac‐
ellular ATP, which is attached to P2X7 receptors on epithelial and immune cells, inducing
apoptosis of these cells. In this way, S. pyogenes establishes control on the behavior of human
cells and facilitates further progression of the infection [16].
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Laminin is high‐molecular weight ECM protein and one of the major components of the basal
lamina, which is part of the basement membrane in human cells. Although laminin is widely
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2.1.4.1.5. Statistical analysis
Student's t‐test was used to measure the differences in adherence to uncoated and laminin‐
coated plates as well as the differences in adherence to laminin before and after the penicillin
and erythromycin treatment within each group of GAS strains tested. ANOVA was used to
determine the differences in adherence to laminin among different groups of GAS strains. Data
analyses were done with the SPSS version 20. The differences were considered significant if p 
< 0.05, and highly significant if p < 0.01.
2.1.4.2. Results and discussion
To determine correlation between invasiveness of tested GAS strains and their ability to bind
to laminin, we investigated adherence of NI, LI, and HI isolates to uncoated and laminin‐coated
microtiter plates. All isolates were treated with hyaluronidase in order to eliminate the
interference of hyaluronic acid capsule on adherence. The proportions of NI, LI, and HI isolates
that displayed adherence to uncoated microtiter plates were 98%, 71%, and 91%, respectively.
In all adherent isolates the level of adherence was estimated as weak, but adherence of NI and
HI isolates to uncoated plates was significantly higher than adherence displayed by isolates
of the LI group (p ≤ 0.001). All isolates tested displayed adherence to laminin‐coated microtiter
plates (Table 1).
No (%) of weakly adherent
isolates (+)
No (%) of moderately
adherent isolates
(++)
No (%) of strongly
adherent isolates
(+++)
NI group (total 100 isolates) 13 (13) 40 (40) 47 (47)
LI group (total 50 isolates) 13 (26) 27 (54) 10 (20)
HI group (total 22 isolates) 0 5 (23) 17 (77)
Table 1. Adherence to laminin of invasive and non‐invasive GAS isolates.
The overall results showed significantly higher adherence (F = 6.952, p ≤ 0.001) of GAS strains
tested to laminin‐coated microtiter plates than adherence to uncoated plates. This was noted
in all three groups of strains, and the ratios of adherence to laminin‐coated vs. uncoated plates
were as follows: 1.86 in HI group (t = 15.603, p ≤ 0.001), 1.36 in NI (t = 19.730, p ≤ 0.001) and 1.24
in LI group (t = 13.355, p ≤ 0.001). However, the level of adherence was different in different
groups of strains, as shown in Table 1. Majority (54%) of LI isolates were moderately adherent,
while most of NI (47%) and, in particular, HI isolates (77%) were strongly adherent. To our
knowledge, this is the first study evaluating differences in adherence to laminin between
invasive and non‐invasive isolates of GAS, and, thus, there are no other previously reported
results for direct comparison. Musumeci et al. [26] showed that the proportion of S. pyogenes
strains carrying the prtF2 gene, encoding internalization‐associated fibronectin binding
protein F2, was significantly higher among asymptomatic carriers than among children with
pharyngitis. This suggests significant contribution of this adhesion to the ability of S. pyo‐
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Microbiology and Immunology, Faculty of Medicine, University of Belgrade. The NI and LI
isolates were collected during 2012, while HI isolates had been collected over the last two
decades.
2.1.4.1.2. Laminin coating of microtiter plates
We investigated adherence of GAS strains to uncoated and laminin‐coated microtiter plates.
Laminin coating of the polystyrene microtiter plates (Kartell, Italy) was performed by using
0.5 mg/ml laminin (Sigma Aldrich, USA), in accordance with the manufacturer's instructions.
The plates were coated for 2 hours at 37°C with laminin previously diluted in Hanks balanced
salt solution (Sigma Aldrich, USA) to achieve final concentration of 5 μg/ml, and afterwards
were washed three times with Hanks balanced salt solution.
2.1.4.1.3. Capsule removal by hyaluronidase
Prior to adherence testing, all isolates were treated with bovine testicular hyaluronidase, type
VI‐S, (Sigma‐Aldrich, USA) diluted in enzyme diluent (20 mM Sodium Phosphate, 77 mM
Sodium Chloride, 0.01% Bovine Albumin, pH 7.0 at 37°C) in order to remove their capsules,
as previously described [24].
2.1.4.1.4. Quantification of adherence to laminin by GAS strains
Quantification of adherence of GAS strains to uncoated and laminin‐coated microtiter plates
was based upon the protocol described by Stepanovic et al. [25]. The strains were incubated
overnight in THY at 37°C, and then diluted in fresh THY medium to achieve final concentration
of 106 CFU/ml. Aliquots of bacterial suspension (100 μL) were transferred to each well of the
96‐well microtiter plate and incubated for 30 minutes at 37°C. The content of each well was
then aspirated and wells were washed three times with sterile phosphate buffer solution (PBS).
The plates were left overnight at room temperature for drying and air fixation. The plates were
stained with 100 μL of 2% (w/v) crystal violet and, afterwards, the dye bound to the adherent
cells was solubilized with 100 μL of 33% (v/v) glacial acetic acid. The negative control wells
contained Todd Hewitt broth supplemented with 1% yeast extract (THY) broth only. Staphy‐
lococcus epidermidis ATCC 14990 was used as the positive control. The optical density (OD) of
each well was measured at 570 nm using an automated microtiter plate reader. The cut‐off
optical density OD (ODc) was defined as three standard deviations above the mean OD of the
negative control. Strains with OD above ODc were considered adherent to microtiter plates.
Strains were classified as follows:
OD ≤ ODc = non‐adherent isolates, ODc < OD ≤ (2 × ODc) = weakly adherent isolates (+), (2 ×
ODc) < OD ≤ (4 × ODc) = moderately adherent isolates (++) and OD > (4 × ODc) = strongly
adherent isolates (+++). All analyses were performed in triplicate and repeated at least two
times.
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2.1.4.1.5. Statistical analysis
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that displayed adherence to uncoated microtiter plates were 98%, 71%, and 91%, respectively.
In all adherent isolates the level of adherence was estimated as weak, but adherence of NI and
HI isolates to uncoated plates was significantly higher than adherence displayed by isolates
of the LI group (p ≤ 0.001). All isolates tested displayed adherence to laminin‐coated microtiter
plates (Table 1).
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HI group (total 22 isolates) 0 5 (23) 17 (77)
Table 1. Adherence to laminin of invasive and non‐invasive GAS isolates.
The overall results showed significantly higher adherence (F = 6.952, p ≤ 0.001) of GAS strains
tested to laminin‐coated microtiter plates than adherence to uncoated plates. This was noted
in all three groups of strains, and the ratios of adherence to laminin‐coated vs. uncoated plates
were as follows: 1.86 in HI group (t = 15.603, p ≤ 0.001), 1.36 in NI (t = 19.730, p ≤ 0.001) and 1.24
in LI group (t = 13.355, p ≤ 0.001). However, the level of adherence was different in different
groups of strains, as shown in Table 1. Majority (54%) of LI isolates were moderately adherent,
while most of NI (47%) and, in particular, HI isolates (77%) were strongly adherent. To our
knowledge, this is the first study evaluating differences in adherence to laminin between
invasive and non‐invasive isolates of GAS, and, thus, there are no other previously reported
results for direct comparison. Musumeci et al. [26] showed that the proportion of S. pyogenes
strains carrying the prtF2 gene, encoding internalization‐associated fibronectin binding
protein F2, was significantly higher among asymptomatic carriers than among children with
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Microbiology and Immunology, Faculty of Medicine, University of Belgrade. The NI and LI
isolates were collected during 2012, while HI isolates had been collected over the last two
decades.
2.1.4.1.2. Laminin coating of microtiter plates
We investigated adherence of GAS strains to uncoated and laminin‐coated microtiter plates.
Laminin coating of the polystyrene microtiter plates (Kartell, Italy) was performed by using
0.5 mg/ml laminin (Sigma Aldrich, USA), in accordance with the manufacturer's instructions.
The plates were coated for 2 hours at 37°C with laminin previously diluted in Hanks balanced
salt solution (Sigma Aldrich, USA) to achieve final concentration of 5 μg/ml, and afterwards
were washed three times with Hanks balanced salt solution.
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cells was solubilized with 100 μL of 33% (v/v) glacial acetic acid. The negative control wells
contained Todd Hewitt broth supplemented with 1% yeast extract (THY) broth only. Staphy‐
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Strains were classified as follows:
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ODc) < OD ≤ (4 × ODc) = moderately adherent isolates (++) and OD > (4 × ODc) = strongly
adherent isolates (+++). All analyses were performed in triplicate and repeated at least two
times.
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virulence factors, thus further complicating the already insufficiently elucidated process of
biofilm assembling. Doern et al. [38] suggested significance of in the timely manner production
of several enzymes, such as SpeB, which in addition to his role in adhesion, is also one of the
crucial factors in biofilm formation. SpeB expression is very high during both planktonic and
biofilm lifestyle of GAS, that is almost a unique and uncommon phenomenon, because genetic
expression is very different during this two distinct bacterial life stages. In planktonic lifestyle
SpeB is highly synthesized in the early stationary phase. In the early phase of collective lifestyle,
in order to begin with biofilm formation, it is necessary to prevent SpeB production. In the
later stages of biofilm dispersion, production of SpeB is extensive, leading to protein degra‐
dation in the biofilm matrix. SpeB expression and disintegration of matrix protein are activa‐
tion signal for other secreted proteases and nucleases, like Sda1, which degrade DNA and
proteins in biofilm, contributing to biofilm dispersal and dissemination of bacteria throughout
the body.
Fibronectin‐collagen‐T antigen (FCT) classification is only partially managed to link biofilm
production with certain FCT groups. In FCT region of S. pyogenes genome are placed genes
encoding several virulence factors important for regulation of matrix production: fibronectin
binding proteins F1 and F2 (prtF1, prtF2), pilus ‒ associated proteins (Cpa, Fca, Fcb) and RofA/
Nra regulator [39–42]. Koller et al. [43] have shown correlation between FCT type 1, 2, 5, 6, and
9 and homogenous biofilm production. FCT type 9 isolates were poor biofilm producers, while
FCT type 3 and 4 isolates were unequally and irregular biofilm producers. Manetti et al. [44]
demonstrated association between biofilm formation among FCT types 2, 3, 5, 6 and FCT subset
4 in acidic surroundings.
2.2.1. Our experience with biofilm production of Streptococcus pyogenes
Considering that biofilm production, like adherence, is still not sufficiently explained virulence
factor, we supposed that dividing isolates according to invasiveness would be interested. Like
in adherence experiments, we also divided isolates in three groups in order to show correlation
between biofilm production and invasiveness of strains tested.
Our goal was to find out whether biofilm production as virulence factor is correlated with
specific disease/clinical condition. Considering that adherence and hydrophobicity are in
relationship with biofilm production, we also wanted to show possible association between
them.
2.2.2. Material and methods
2.2.2.1. Determination of hydrophobicity
Hydrophobicity was measured by two different methods described previously by Rosenberg
et al. [45] and by Lindhal et al. [46]. Microbial adhesion to hydrocarbons (MATH) test described
by Rosenberg et al. [45] was measured with determination of percentage of bacteria adhered
to xylene and hexadecane. The salt aggregation test (SAT) described by Lindhal et al. [46] is
based on the principal of salting out of the surface proteins and bacterial precipitation with a
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genes to persist in the throat of asymptomatic carriers. Similarly, we established high adherence
ability in isolates obtained from GAS carriers. As far as highly invasive isolates are concerned,
positive correlation between invasiveness and adherence to laminin found in our study was
also shown for group B streptococcus (GBS) [27]. The surface laminin‐binding protein (Lmb)
was significantly more expressed in invasive GBS strains isolated from cerebrospinal fluid of
the neonates with meningitis than in non‐invasive strains isolated from feces or vaginal swabs
of colonized asymptomatic pregnant women [27].
In conclusion, this study showed correlation between adherence to laminin and invasiveness
in GAS isolates. The strains isolated from GAS carriers and highly invasive GAS strains have
excellent capacity for binding to laminin.div4close
2.2. Biofilm
The greatest importance of the effective bacterial adherence is in the attachment to host cells
and the aggregation of bacteria, which then create a signal for the biofilm production. In a
collective way of existence bacteria gain a protective matrix layer, which in planktonic lifestyle
does not exist and is responsible for the most of mechanisms that bacteria avoid eradication
from the infection site.
According to literature, S. pyogenes is also capable for biofilm production. Researchers have
noticed GAS microcolonies in skin lesions of patients with impetigo [28], and after that the
same was observed in experimental zebrafish skin infection [29]. Also, three‐dimensional
communities resembling biofilm were detected in pediatric tonsillar samples after tonsillec‐
tomy of patients with adenotonsillar hypertrophy, contributing to the theory that biofilm
formation is one of the probable explanations for the GAS persistence and carriage [30]. Besides
these in vivo experiments, several authors have been proven S. pyogenes biofilm production
also in vitro in static or flow conditions, e.g. in polystyrene microtiter plates, plastic coverslips
or flow chambers [31, 32].
Biofilm production is one of the most probable explanation for therapeutic failure in the
treatment of infections with this bacteria, in vitro sensitive to the tested antibiotic. Several
authors have noticed better biofilm production in non‐invasive streptococcal strains compared
to invasive strains [33, 34], and also in erythromycin‐sensitive isolates compared to erythro‐
mycin‐resistant isolates of S. pyogenes [35]. These results strongly indicate that biofilm pro‐
duction is protective mechanism enabling bacterial survival of antibiotic treatment and
immune system reaction. Also, collective lifestyle allows S. pyogenes easier horizontal gene
transfer by transformation, generating virulent clones and biofilm phenotype [36].
Although Baldassari et al. [35] have proven biofilm production in 90% of tested invasive and
non‐invasive isolates, still most researchers agreed that biofilm formation is a trait of individual
strains rather than a general serotype attribute. GAS biofilm production is complex process
influenced not only by environmental conditions such as ECM proteins, incubation tempera‐
ture and medium, but also by many bacterial virulence factors such as capsule, SpeB, M
protein, pili, etc. Manetti et al. [37] assumed that on this multifactorial process also affect
antigenic variation of M protein and pili, in addition to a variety known and poorly surveyed
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demonstrated association between biofilm formation among FCT types 2, 3, 5, 6 and FCT subset
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2.2.1. Our experience with biofilm production of Streptococcus pyogenes
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factor, we supposed that dividing isolates according to invasiveness would be interested. Like
in adherence experiments, we also divided isolates in three groups in order to show correlation
between biofilm production and invasiveness of strains tested.
Our goal was to find out whether biofilm production as virulence factor is correlated with
specific disease/clinical condition. Considering that adherence and hydrophobicity are in
relationship with biofilm production, we also wanted to show possible association between
them.
2.2.2. Material and methods
2.2.2.1. Determination of hydrophobicity
Hydrophobicity was measured by two different methods described previously by Rosenberg
et al. [45] and by Lindhal et al. [46]. Microbial adhesion to hydrocarbons (MATH) test described
by Rosenberg et al. [45] was measured with determination of percentage of bacteria adhered
to xylene and hexadecane. The salt aggregation test (SAT) described by Lindhal et al. [46] is
based on the principal of salting out of the surface proteins and bacterial precipitation with a
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genes to persist in the throat of asymptomatic carriers. Similarly, we established high adherence
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was significantly more expressed in invasive GBS strains isolated from cerebrospinal fluid of
the neonates with meningitis than in non‐invasive strains isolated from feces or vaginal swabs
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in GAS isolates. The strains isolated from GAS carriers and highly invasive GAS strains have
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The greatest importance of the effective bacterial adherence is in the attachment to host cells
and the aggregation of bacteria, which then create a signal for the biofilm production. In a
collective way of existence bacteria gain a protective matrix layer, which in planktonic lifestyle
does not exist and is responsible for the most of mechanisms that bacteria avoid eradication
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According to literature, S. pyogenes is also capable for biofilm production. Researchers have
noticed GAS microcolonies in skin lesions of patients with impetigo [28], and after that the
same was observed in experimental zebrafish skin infection [29]. Also, three‐dimensional
communities resembling biofilm were detected in pediatric tonsillar samples after tonsillec‐
tomy of patients with adenotonsillar hypertrophy, contributing to the theory that biofilm
formation is one of the probable explanations for the GAS persistence and carriage [30]. Besides
these in vivo experiments, several authors have been proven S. pyogenes biofilm production
also in vitro in static or flow conditions, e.g. in polystyrene microtiter plates, plastic coverslips
or flow chambers [31, 32].
Biofilm production is one of the most probable explanation for therapeutic failure in the
treatment of infections with this bacteria, in vitro sensitive to the tested antibiotic. Several
authors have noticed better biofilm production in non‐invasive streptococcal strains compared
to invasive strains [33, 34], and also in erythromycin‐sensitive isolates compared to erythro‐
mycin‐resistant isolates of S. pyogenes [35]. These results strongly indicate that biofilm pro‐
duction is protective mechanism enabling bacterial survival of antibiotic treatment and
immune system reaction. Also, collective lifestyle allows S. pyogenes easier horizontal gene
transfer by transformation, generating virulent clones and biofilm phenotype [36].
Although Baldassari et al. [35] have proven biofilm production in 90% of tested invasive and
non‐invasive isolates, still most researchers agreed that biofilm formation is a trait of individual
strains rather than a general serotype attribute. GAS biofilm production is complex process
influenced not only by environmental conditions such as ECM proteins, incubation tempera‐
ture and medium, but also by many bacterial virulence factors such as capsule, SpeB, M
protein, pili, etc. Manetti et al. [37] assumed that on this multifactorial process also affect
antigenic variation of M protein and pili, in addition to a variety known and poorly surveyed
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(p = 0.262). HI group of isolates constantly were low biofilm producers, which was significantly
different from two other groups (p = 0.026, p = 0.001), as it is shown in Graph 1.
Graph 1. Percentage of biofilm producers during tested periods.
2.2.3.4. Analysis of correlation between adherence, hydrophobicity and biofilm production
Adherence and hydrophobicity are very important in process of the biofilm formation. We
used various measurement methods to establish possible connection between these three traits
of bacteria.
When non‐invasive group of isolates was analyzed, positive correlations were noticed between
adherence and biofilm formation after 48 hours of incubation (r = 0.205, p = 0.040), and between
biofilm production after 12 and 24 hours (r = 0.166, p = 0.03), and after 12 and 48 hours of
incubation (r = 0.255, p = 0.001). These results indicated that isolates which adhered efficiently
and establish biofilm after 12 hours will also be good biofilm producers after 24 and 48 hours
of incubation. In this group of strains, negative correlation was noticed between hydropho‐
bicity measured with xylene and biofilm production after 12‐hours (r = -0.236, p = 0.018) and
24 hours of incubation (r = ‐0.201, p = 0.045), i.e. more hydrophobic strains were worse biofilm
producers. In NI group of strains, early biofilm producers were stabile producers during entire
examined period.
When low invasive group of strains was explored, no correlation was noticed between
adherence, hydrophobicity, and biofilm production (p > 0.05). Positive correlation was noticed
in biofilm production between 24 and 48 hours incubation (r = 0.166, p = 0.03). In LI group of
strains, late biofilm producers were stabile producers.
Adherence and Biofilm Production of Streptococcus pyogenes
http://dx.doi.org/10.5772/63490
73
series of ammonium sulfate solutions with various molarities (0.008 M to 4 M). The highest
molarity of solution giving the visible aggregation was scored as numerical value of bacterial
surface hydrophobicity or SAT value.
2.2.2.2. Biofilm production
Biofilm production was determined by the same methodology [25] as adherence testing with
modification in incubation period of 12, 24, and 48 hours. As in adherence testing, according
to ODc isolates were designed as non‐producers = OD < ODc, weak biofilm producers = ODc
< OD ≤ (2 × ODc) (+), (2 × ODc) < OD ≤ (4 × ODc) = moderate biofilm producers (++) and OD > 
(4 × ODc) = strong biofilm producers (+++).
2.2.2.3. Statistical analysis
ANOVA was used to determine the differences in hydrophobicity and biofilm production
among different groups of GAS strains. Correlation between adherence, hydrophobicity, and
biofilm production was determined by Pearson test. Data analyses were done with the SPSS




Adherence results are shown in Section 2.1.4.2.
2.2.3.2. Hydrophobicity
Measurement of bacterial hydrophobicity was first performed by MATH test using
hexadecane as hydrocarbon after removal of the capsule, which hinders superficial
hydrophobic proteins. Adherence to hexadecane was very low and with no statistical
difference between groups. After that we tested GAS adherence to xylene. In our assay
adherence to xylene were 48.49, 22.78, and 36.09 for NI, LI, and HI group, respectively. It was
noticed statistically significant difference between groups, particularly NI group isolates were
more hydrophobic in relation to other two groups (p < 0.001, p = 0.041) and HI group isolates
in relation to LI group (p = 0.044).
2.2.3.3. Biofilm production
When we did dynamic analysis of biofilm production during specified incubation periods (12–
48 hours) all three groups have shown different pattern (p = 0.040). Although NI and LI groups
started and finished at similar percentages, and as well as that NI group increased biofilm
production, and LI group decreased during the time, there was no difference between groups
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(p = 0.262). HI group of isolates constantly were low biofilm producers, which was significantly
different from two other groups (p = 0.026, p = 0.001), as it is shown in Graph 1.
Graph 1. Percentage of biofilm producers during tested periods.
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bicity measured with xylene and biofilm production after 12‐hours (r = -0.236, p = 0.018) and
24 hours of incubation (r = ‐0.201, p = 0.045), i.e. more hydrophobic strains were worse biofilm
producers. In NI group of strains, early biofilm producers were stabile producers during entire
examined period.
When low invasive group of strains was explored, no correlation was noticed between
adherence, hydrophobicity, and biofilm production (p > 0.05). Positive correlation was noticed
in biofilm production between 24 and 48 hours incubation (r = 0.166, p = 0.03). In LI group of
strains, late biofilm producers were stabile producers.
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yngeal carriage [3]. Marks et al. [36] supposed that biofilm producing bacteria down‐regulate
genes associated with dissemination and invasive disease to adapt to asymptomatic orophar‐
yngeal colonization in mice and the tonsil and adenoid tissue are less toxic to epithelia cells
and inducing less inflammation. Somewhat surprising result in this study is the negative
correlation of the hydrophobicity with biofilm production in non‐invasive isolates tested. This
could be explained by the fact that GAS posses abundance of surface adhesins, most of them
are inadequate identified and tested, but all of them could affect the hydrophobicity and
subsequent formation of biofilm. The most hydrophobic streptococcal surface adhesins are M
protein and LTA [49]. Therefore one possible explanation of our findings could be the
quantification of LTA in cell envelops of tested isolates.
In our study, we did not find any relationship between different methods of adherence and
hydrophobicity measurements for low and highly invasive isolates. Also, we showed that
highly invasive isolates have been unstable biofilm producers, contributing to previous
findings of other researchers that biofilm production is not crucial virulence factor for invasive
strains.
According to literature, this was first work about determination of the relationship between
adherence, hydrophobicity and biofilm production for S. pyogenes. Surprisingly when were
compared adherence and biofilm production, no direct correlation was found for isolates of
S. epidermidis [50] and Acinetobacter baumannii [51], indicating that adherence and biofilm
production are not always and explicitly linked.
In conclusion, it is obvious that adherence and biofilm production are not phenotypic traits of
all species, but rather individual characteristic of every strain. It is important to emphasize that
our experiments have been conducted in vitro, so in order to define the role of these three tested
virulence factors in vivo, complex interactions between various streptococcal adhesins with
ECM proteins and host cells should be considered. Due to the numerous virulence factors GAS
has excellent adherence capacity, which enables the occurrence of infections, usually not as
serious as expected.
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When highly invasive group of isolates was studied, no correlation was noticed between
adherence, hydrophobicity, and biofilm production (p > 0.05) or in biofilm production during
different incubation periods (p > 0.05). Isolates of HI group were non‐stable biofilm producers,
i.e. they formed and rapidly disbanded their biofilm and matrix.
2.2.3. Discussion
In this study it is demonstrated correlation between adherence, hydrophobicity and biofilm
production for non‐invasive isolates, while for low and highly invasive isolates no correlation
was noticed.
Group A streptococcal adherence is still unrevealed process depending on unspecific hydro‐
phobic bonds and on specific protein‐protein or protein‐carbohydrate interactions. Hydro‐
phobic interactions are weak non‐covalent interactions between water and hydrophobe (non‐
polar low‐water soluble molecules). Hydrophobic interactions are stronger than other weak
intermolecular forces (van der Waals or Hydrogen bonds) and depend on several factors:
temperature, number of carbon atoms on hydrophobe and shape of hydrophobe.
According to Rosenberg et al. [45] MATH test should be performed with phosphate buffer
molarity higher than 150 mM, because only under these conditions hydrophobic bonds are
stronger than electrostatic. We used PUM buffer containing phosphate, potassium, urea and
magnesium with recommended 150 mM molarity and pH 7.1. Even in this recommended
conditions, our isolates have not adhered to hexadecane, even after capsule removal, as
suggested by Offek et al. [47]. According to experiment performed by Nagao and Benchetritt
[48], we used xylene instead of hexadecane, afterwards our isolates adhered to this new
hydrocarbon. Hexadecane is low‐reactive saturated alkane hydrocarbon in contrast to xylene,
which is more reactive non‐saturated aromatic hydrocarbon. This structural modifications and
differences in molecular polarization could be probable explanations for low ability of GAS
strains to adhere to hexadecane. In this study it was noticed differences between groups in
hydrophobicity measured with xylene, and it was also observed that groups which were more
hydrophobic also better adhered to laminin, as expected.
Since S. pyogenes is not associated with indwelling device‐infections, it was assumed that
isolates tested will not at all or will have weak ability for adherence to uncoated microtiter
plate. Because of S. pyogenes strains weak ability to adhere we also supposed that biofilm
production will be at low level. Our assumption was approved in this study, especially for
highly invasive isolates, which were low and unstable biofilm producers during tested periods
of incubation. Similar results for invasive isolates were observed for S. pneumoniae [33, 34].
According to these results we could assume that for invasive isolates biofilm production is not
crucial virulence factor.
Non‐invasive isolates from streptococcal carriers have shown direct, positive relationship
between adherence to uncoated microtiter plate and late stage biofilm production. These
isolates were also the most stable biofilm producers during all three incubation intervals,
confirming the latest theory that biofilm production could be possible explanation for phar‐
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Abstract
The attachment to surfaces and the subsequent formation of biofilms are a life strategy
of bacteria offering several advantages for microorganisms, for example, a protection
against toxins and antibiotics and profits due to synergistic effects in biofilm environ‐
ment. Moreover, biofilm formation is thought to serve as grazing protection against
predators. From pelagic systems it is known that feeding of bacterivorous protists may
strongly influence the morphology, taxonomic composition and physiological status of
bacterial communities and thus may be an important driving force for a change in
bacterial  growth and shift  in morphology towards filaments and flocs.  Bacteria in
biofilms had to evolve several other defence strategies: production of extrapolymeric
substances (EPS) or toxins,  formation of specific growth forms with strong attach‐
ment,  specific  chemical  surface  properties  and  motility.  In  addition,  bacteria  can
communicate via quorum sensing and react on grazing pressure. The results of the case
study presented here showed that even microcolonies in bacterial biofilms are affected
by the activity of grazers, though it may depend on the nutrient supply. Feedback effects
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Abstract
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Increased swimming speed of bacteria enhanced the probability of capturing of bacteria by
flagellates, but the ingestion rates dropped down with increasing swimming speed [25].
Increased motility clearly increased the survival rate of bacteria under protozoan predation.
The surface properties of bacteria have also been shown to influence the rate of their ingestion
by protozoa. In two studies, it has been shown that gram‐positive bacteria were grazed to a
lower extant than gram‐negative bacteria by flagellates and ciliates [26, 27].
Figure 1. Defence mechanism of bacteria against grazing in biofilm communities.
Defence strategies of bacteria in biofilms are much less understood than those for the pelagial.
We summarized the potential defence phenomena that could be derived from studies of
planktonic communities (Figure 1). The importance of protozoans on biofilms has been
reviewed by Arndt et al. [28] and Ackermann et al. [29]. In biofilms, a very common phenom‐
enon is the increase in size due to the formation of microcolonies and filaments. Matz et al. [30]
reported that a wild‐type strain of Pseudomonas aeruginosa formed microcolonies if faced with
protozoan grazing by the benthic flagellate Rhynchomonas. They showed that type‐IV pili of
bacteria creating the so‐called ‘twitching motiliy’ (a certain way of movement over the
substrate) are important for microcolony formation, as bacteria lacking these pili could form
only a considerably lower number in microcolonies than the wild type. Weitere et al. [31]
showed that grazing protection due to microcolony formation in bacterial biofilms is depend‐
ent on the protozoans’ feeding mode. This was underlined by a consecutive study by Erken et
al. [32] who analysed the influence of grazing of three gliding flagellates (Neobodo, Rhyncho‐
monas and Planomonas) differing in feeding modes, that is, regarding the contactrates, handling
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and taxonomic composition of bacterial communities. While this is well known for pelagic
microbial communities [e.g. 1–4], bacterial communities in biofilms have mainly been viewed
from a microbial perspective rather than the food web perspective [5]. However, biofilm studies
have shown that bacterivorous organisms, such as protozoans, can effectively reduce the
biovolume and morphology of bacterial biofilms, too [e.g. 6, 7]. Especially, amoebae may
significantly influence biofilms [e.g. 8].
For pelagic habitats, a variety of defence mechanisms has been described: a widespread
observation is a shift to larger cells in bacterial communities that are subject to strong protozoan
grazing. In addition, several other defence strategies had been described as for example
extreme reduction in cell size, certain motility patterns, specific surface properties of the
bacteria, toxin production and the production of exopolymeric substances that surround
bacteria (for a summary see [3]).
The change of size as response to protozoan grazing has been observed in several planktonic
field studies (e.g. [9–11] as well as in laboratory experiments [12–16]). Pernthaler et al. [17]
found a shift in size classes of bacteria as result of intensive protozoan grazing in oligomeso‐
trophic lake plankton during spring and argued that small cells (<0.4 μm) and large cells (>2.4
μm) being the most resistant groups with reference to their size. Matz and Jürgens [18] found
that bacteria > 0.5 and <0.1 μm3 (the latter are called ‘ultramicrobacteria’) showed the highest
survival rates. The shift to larger cell sizes and filaments and flocs has been reported from
several laboratory studies (e.g. [15, 16, 18, 19]). These latter studies also pointed to the decrease
in cell size as a potential strategy for bacteria to escape protozoan grazing. However, Boenigk
et al. [20] could demonstrate that bacteria may even feed on this small prey size which implies
that small‐sized bacteria are not generally protected against grazing.
Furthermore, exopolymeric substances secreted by the bacteria may hinder bacterial predators
from grazing. This has been found for example in a study on batch and continuous cultures of
two pelagic bacterial species isolated from the field [21]. In this study, the extrapolymeric
substances were shown to form an essential portion of flocs and microcolonies in suspensions
at strong flagellate grazing. Grazing experiments with the flagellate Ochronomas and the
bacterium Pseudomonas as prey by Matz et al. [22] revealed that thenon‐mucoid‐producing
morph of Pseudomonas was severely affected and reduced in terms of abundance, whereas the
primary mucoid‐producing type survived due to the formation of inert suspended microcol‐
onies stabilized by an extracellular matrix.
Moreover, it could be shown that bacteria might kill their prey by producing substances that
are toxic for their potential predators. Matz et al. [23] found in a study where they analysed
grazing of different common heterotrophic flagellates on violacein‐producing bacterial strains,
a rapid cell death of the flagellates after ingestion of these bacteria.
The production of toxins was shown to be induced by quorum sensing, which emphasizes that
this kind of communication between bacterial cells plays an important role in the grazing
defence.
Motility of bacteria has been identified as another defence mechanism [24]. Small bacteria,
which increased in size under strong grazing pressure, were additionally much more motile.
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Increased swimming speed of bacteria enhanced the probability of capturing of bacteria by
flagellates, but the ingestion rates dropped down with increasing swimming speed [25].
Increased motility clearly increased the survival rate of bacteria under protozoan predation.
The surface properties of bacteria have also been shown to influence the rate of their ingestion
by protozoa. In two studies, it has been shown that gram‐positive bacteria were grazed to a
lower extant than gram‐negative bacteria by flagellates and ciliates [26, 27].
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We summarized the potential defence phenomena that could be derived from studies of
planktonic communities (Figure 1). The importance of protozoans on biofilms has been
reviewed by Arndt et al. [28] and Ackermann et al. [29]. In biofilms, a very common phenom‐
enon is the increase in size due to the formation of microcolonies and filaments. Matz et al. [30]
reported that a wild‐type strain of Pseudomonas aeruginosa formed microcolonies if faced with
protozoan grazing by the benthic flagellate Rhynchomonas. They showed that type‐IV pili of
bacteria creating the so‐called ‘twitching motiliy’ (a certain way of movement over the
substrate) are important for microcolony formation, as bacteria lacking these pili could form
only a considerably lower number in microcolonies than the wild type. Weitere et al. [31]
showed that grazing protection due to microcolony formation in bacterial biofilms is depend‐
ent on the protozoans’ feeding mode. This was underlined by a consecutive study by Erken et
al. [32] who analysed the influence of grazing of three gliding flagellates (Neobodo, Rhyncho‐
monas and Planomonas) differing in feeding modes, that is, regarding the contactrates, handling
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and taxonomic composition of bacterial communities. While this is well known for pelagic
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have shown that bacterivorous organisms, such as protozoans, can effectively reduce the
biovolume and morphology of bacterial biofilms, too [e.g. 6, 7]. Especially, amoebae may
significantly influence biofilms [e.g. 8].
For pelagic habitats, a variety of defence mechanisms has been described: a widespread
observation is a shift to larger cells in bacterial communities that are subject to strong protozoan
grazing. In addition, several other defence strategies had been described as for example
extreme reduction in cell size, certain motility patterns, specific surface properties of the
bacteria, toxin production and the production of exopolymeric substances that surround
bacteria (for a summary see [3]).
The change of size as response to protozoan grazing has been observed in several planktonic
field studies (e.g. [9–11] as well as in laboratory experiments [12–16]). Pernthaler et al. [17]
found a shift in size classes of bacteria as result of intensive protozoan grazing in oligomeso‐
trophic lake plankton during spring and argued that small cells (<0.4 μm) and large cells (>2.4
μm) being the most resistant groups with reference to their size. Matz and Jürgens [18] found
that bacteria > 0.5 and <0.1 μm3 (the latter are called ‘ultramicrobacteria’) showed the highest
survival rates. The shift to larger cell sizes and filaments and flocs has been reported from
several laboratory studies (e.g. [15, 16, 18, 19]). These latter studies also pointed to the decrease
in cell size as a potential strategy for bacteria to escape protozoan grazing. However, Boenigk
et al. [20] could demonstrate that bacteria may even feed on this small prey size which implies
that small‐sized bacteria are not generally protected against grazing.
Furthermore, exopolymeric substances secreted by the bacteria may hinder bacterial predators
from grazing. This has been found for example in a study on batch and continuous cultures of
two pelagic bacterial species isolated from the field [21]. In this study, the extrapolymeric
substances were shown to form an essential portion of flocs and microcolonies in suspensions
at strong flagellate grazing. Grazing experiments with the flagellate Ochronomas and the
bacterium Pseudomonas as prey by Matz et al. [22] revealed that thenon‐mucoid‐producing
morph of Pseudomonas was severely affected and reduced in terms of abundance, whereas the
primary mucoid‐producing type survived due to the formation of inert suspended microcol‐
onies stabilized by an extracellular matrix.
Moreover, it could be shown that bacteria might kill their prey by producing substances that
are toxic for their potential predators. Matz et al. [23] found in a study where they analysed
grazing of different common heterotrophic flagellates on violacein‐producing bacterial strains,
a rapid cell death of the flagellates after ingestion of these bacteria.
The production of toxins was shown to be induced by quorum sensing, which emphasizes that
this kind of communication between bacterial cells plays an important role in the grazing
defence.
Motility of bacteria has been identified as another defence mechanism [24]. Small bacteria,
which increased in size under strong grazing pressure, were additionally much more motile.
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2. Bacteria defence from grazing in the course of biofilm aging
Within the process of maturing, bacterial biofilms have shown to undergo certain morpho‐
logical changes (for an overview see e.g. [34]). From a scattered distribution of bacteria, this
changes to clustered microcolonies and increases in height, followed by the establishment of
mushroom‐like structures. With an increase in height, an increase in the detachment of single
bacteria or bacterial flocs into the pelagial occurs due to increasing shear stress in running
waters affecting the biofilm thickness [5, 34]. This effect is called ‘sloughing’ and may also
decrease the probability of being captured by protists (Figure 2). Ammendola et al. [35] found
that Serratia liquefaciens exposed to certain surfaces formed elongated, highly motile swarm
cells which were grazing‐resistant provided their length exceeded 15 μm.
Figure 2. Different phases of biofilm development including bacterial settlement (1), aggregation (2), EPS formation (3)
and sloughing (4).
The grazing pressure by protozoans changes with the ongoing process of biofilm maturation.
Weitere et al. [31] showed that the early formation of microcolonies in Pseudomonas aerugino‐
sa biofilms resulted in a grazing protection against early biofilm colonizers (e.g. the kineto‐
plastid flagellate Bodo saltans). In contrast to this, grazing by late biofilm colonizers such as the
browsing ciliate Tetrahymena pyriformis or the amoeba Acanthamoeba polyphaga caused high
losses of bacterial biomass. A different result was obtained by Chavez‐Dozal et al. [36] for
Vibrio fischerii biofilms. In late biofilms, the expression of antiprotozoan substances affected
the late biofilm colonizers and grazers (Tetrahymena pyriformis), whereas the flagellates
Rhynchomonas nasuta and Neobodo designis were able to graze and show significant growth in
early biofilms.
These studies suggest that the vulnerability of biofilms to grazing by protists may significantly
change in the course of biofilm aging. The production of toxins and extrapolymeric substances
may play an important role. Biofilm communities are complex systems and we are just at the
beginning to understand the interactions occurring on biofilms.
The occurrence of macroinvertebrates on biofilms and their influence on the different trophic
levels have to be considered. Ackermann et al. [29] showed that increases in macrofauna
populations increased the surface and biovolume of biofilms in a river. Multifactorial field
studies by Haglund and Hillebrand [37] found that the presence of grazers tended to increase
bacterial biomass at ambient nutrient conditions but tended to decrease bacterial biomass
under enrichment nutrient conditions. Remineralization of nutrients due to the feeding process
of macroinvertebrates may play a significant role. And there may also be another indirect effect
of metazoans by reducing bacterivorous protozoans [29].
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times and relative predation success of each species. A longer handling time, as found for
Planomonas, was shown to result in a significantly higher success in ingestion rates. However,
the lower ingestion rates of the other two species were compensated by higher contact rates.
Microscopic observations revealed that heterotrophic flagellates contacted microcolonies, but
in no case bacterial cells of these bacterial aggregations were ingested. Another study on stream
biofilms indicated that various protozoans may differently affect microcolony formation [7].
The ciliate Dexiostoma did not change biofilm volume and porosity but stimulated the forma‐
tion of larger microcolonies. In contrast to this, the heterotrophic flagellate Spumella and the
ciliate Chilodonella did not stimulate microcolony formation; however, the biofilm volume was
decreased 2.5–6.3‐fold compared to ungrazed biofilms. Contrary to this, grazing of the
raptorial feeding amoebae Vannella reduced microcolony size clearly. On the other hand, the
porosity and the ratio of biofilm surface area to biofilm volume were 1.5–3.7 and 1.2–1.8 times
higher under grazing pressure. This points to possible stimulating effects as grazing might
improve the exchange of nutrients and gases in deeper biofilm layers and enhance microbial
growth.
These examples clearly show that the formation of microcolonies may serve as defence strategy
for protozoans. However, in contrast to the pelagial, for biofilms, the reduction in individual
cell size seems not to play a role in biofilms.
The secretion of exopolymeric substances (EPS) is a typical characteristic of biofilms and is
believed to be a clue for grazing defence, as it has been shown for pelagic bacteria. Weitere et
al. [31] showed that alginate‐mediated microcolony formation served as effective defence
mechanism against grazing on Pseudomonas aeruginosa biofilms by flagellates of the following
two different feeding types: the suspension feeding Bodo saltans and the surface feeding
Rhynchomonas nasuta. In a parallel study with an alginate‐overproducing mutant strain of P.
aeruginosa, the bacteria built significantly larger microcolonies under grazing pressure of a
surface‐feeding flagellate (Rhynchomonas nasuta) compared to the wild‐type strain [30]. Hence,
the production of EPS might provide a sufficient grazing defence. Moreover, this production
was shown to be quorum‐sensing regulated, which underlines the importance of communi‐
cation between bacteria for their defence against grazing. This is supported by Sun et al. [33],
who emphasized the importance of EPS‐production and quorum sensing. Biofilms with
mutants of the pathogenic bacteria Vibrio cholera, which expressed less polysaccharides, were
also less resistant against grazing. The same was true for mutants with a deficiency in quorum‐
sensing ability.
An additional defence factor is the production of inhibitors. Weitere [31] found flagellate
growth to be affected in Pseudomonas aeruginosa biofilms in a late phase of biofilm development.
To summarize the knowledge of defence strategies of bacteria in biofilms, the most well‐known
phenomenon is the increase in size or the shift to a more grazing‐resistant morphology by the
formation of microcolonies and filaments. However, this mechanism depends on quorum‐
sensing‐mediated communication among bacteria. The production of exopolymeric substan‐
ces or toxic substances additionally may strongly affect protozoan predators or kill them,
respectively.
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2. Bacteria defence from grazing in the course of biofilm aging
Within the process of maturing, bacterial biofilms have shown to undergo certain morpho‐
logical changes (for an overview see e.g. [34]). From a scattered distribution of bacteria, this
changes to clustered microcolonies and increases in height, followed by the establishment of
mushroom‐like structures. With an increase in height, an increase in the detachment of single
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and sloughing (4).
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losses of bacterial biomass. A different result was obtained by Chavez‐Dozal et al. [36] for
Vibrio fischerii biofilms. In late biofilms, the expression of antiprotozoan substances affected
the late biofilm colonizers and grazers (Tetrahymena pyriformis), whereas the flagellates
Rhynchomonas nasuta and Neobodo designis were able to graze and show significant growth in
early biofilms.
These studies suggest that the vulnerability of biofilms to grazing by protists may significantly
change in the course of biofilm aging. The production of toxins and extrapolymeric substances
may play an important role. Biofilm communities are complex systems and we are just at the
beginning to understand the interactions occurring on biofilms.
The occurrence of macroinvertebrates on biofilms and their influence on the different trophic
levels have to be considered. Ackermann et al. [29] showed that increases in macrofauna
populations increased the surface and biovolume of biofilms in a river. Multifactorial field
studies by Haglund and Hillebrand [37] found that the presence of grazers tended to increase
bacterial biomass at ambient nutrient conditions but tended to decrease bacterial biomass
under enrichment nutrient conditions. Remineralization of nutrients due to the feeding process
of macroinvertebrates may play a significant role. And there may also be another indirect effect
of metazoans by reducing bacterivorous protozoans [29].
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ces or toxic substances additionally may strongly affect protozoan predators or kill them,
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Figure 4. Quantitative analysis of biofilms (abundance of colonies, average size of colonies and biovolume) of Acineto‐
bacter with and without grazing pressure by Tetrahymena pyriformis (average +/‐ standard deviation) after 4 and 8 days.
Quantification was made with 3D for LSM (Zeiss, Germany) and Image J (NIH, Maryland, USA). (a) Sodium benzoate
as medium, high‐medium supply rate, (b) sodium benzoate as medium, low‐medium supply rate, (c) citrate as medi‐
um, high‐medium supply rate.
Grazing of Tetrahymena led to different microcolony formation of Acinetobacter biofilms
depending on different growth conditions for bacteria and under grazing pressure of
Tetrahymena. Under high supply rate of medium and by the use of an optimal carbon source
(sodium benzoate as carbon source), round microcolonies dominated the biofilm, which were
regularly distributed over the substrate (Figure 3a). In contrast, microcolonies showed a more
irregular, elongated shape in the presence of the grazer (Figure 3b) and the size of the colonies
was significantly larger (Figure 4a). Interestingly, the biovolume of the biofilm increased under
grazing influence of Tetrahymena during the whole experiment which points to a stimulating
effect of protzoan grazing to bacterial growth (Figure 4a). In contrast, biofilms grown with low
medium supply (and sodium benzoate as carbon source) were affected by the presence of the
protozoan grazer in terms of size and biovolume. The nongrazed biofilms showed similar,
clearly visible round microcolonies as found with high medium supply (Figure 3c), being
evenly distributed over the substrate during the whole experiment. In the presence of
Tetrahymena, the microcolonies showed always an irregular shape (Figure 3d). Moreover, a
significant decrease in microcolony size and biovolume in the course of the experiment was
recorded (Figure 4b). The effect of weakening the potential to form microcolonies was even
Grazing Effects of Ciliates on Microcolony Formation in Bacterial Biofilms
http://dx.doi.org/10.5772/63516
87
3. Defence mechanisms of biofilm bacteria may change with substrate
supply
From pelagic studies, it is known that the response of bacteria to grazing is dependent on the
availability of nutrients. Matz and Jürgens [24] could demonstrate in their study on grazing of
two flagellates (Ochromonas and Spumella) on a natural bacterial community that the nutrient
quality decides how the bacterial community reacts. Small and motile bacteria dominated
under carbon limitation, whereas large and elongated bacteria occurred if phosphorous was
limited. On the other hand, Simek et al. [38] demonstrated that the portion of grazing resistant
forms (flocs and filaments) increased when bacteria were exposed to protozoan grazing at
limiting nutrient concentrations. However, up to now, this has not been analysed in detail for
biofilm communities, but a comparable influence is likely.
As it has been pointed out in the first paragraph, bacterial biofilms may show microcolony
formation as a defence mechanism against grazing by protozoans. Hence, we conducted an
experiment with a bacterium, a variant of the genus Acinetobacter, which generally forms
microcolonies during biofilm growth. We investigated whether this bacterium was affected
by grazing of the ciliate Tetrahymena pyriformis under different nutrient supply for bacteria.
We hypothesized that the microcolony‐forming Acinetobacter sp. strain C6 would be resistant
to grazing by T. pyriformis as long as microcolony formation is not affected due to limiting
nutrients, and we assumed that less optimal substrate supply will weaken this defence
mechanism. The experiments were run in flow chambers in a mineral medium [39] which was
supplemented either with sodium benzoate or with citrate as a carbon source. Citrate is known
to be a less optimal carbon source for the microcolony formation Acinetobacter[40, 41]. For the
analysis of biofilms under the laser‐scanning microscope, Acinetobacter was either tagged with
green fluorescent protein or stained with propidium iodide.
Figure 3. Structural changes of biofilms of Acinetobacter with and without grazing pressure by Tetrahymena pyriformis
(confocal laser‐scanning‐microscope pictures in x‐y direction; size: 230 μm × 230 μm; a and b: GFP‐tagged bacteria, c–e:
propidiumiodide stained bacteria). Biofilms are shown for day 4 and day 8. (a) Sodium benzoate as medium, high me‐
dium supply rate, no Tetrahymena. (b) Sodium benzoate as medium, high medium supply rate, Tetrahymena present. (c)
Sodium benzoate as medium, low medium supply rate, no Tetrahymena. (d) Sodium benzoate as medium, low medium
supply rate, Tetrahymena present. (e) Citrate as medium, high medium supply rate, no Tetrahymena. (f) Citrate as medi‐
um, high medium supply rate, Tetrahymena present.
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Figure 4. Quantitative analysis of biofilms (abundance of colonies, average size of colonies and biovolume) of Acineto‐
bacter with and without grazing pressure by Tetrahymena pyriformis (average +/‐ standard deviation) after 4 and 8 days.
Quantification was made with 3D for LSM (Zeiss, Germany) and Image J (NIH, Maryland, USA). (a) Sodium benzoate
as medium, high‐medium supply rate, (b) sodium benzoate as medium, low‐medium supply rate, (c) citrate as medi‐
um, high‐medium supply rate.
Grazing of Tetrahymena led to different microcolony formation of Acinetobacter biofilms
depending on different growth conditions for bacteria and under grazing pressure of
Tetrahymena. Under high supply rate of medium and by the use of an optimal carbon source
(sodium benzoate as carbon source), round microcolonies dominated the biofilm, which were
regularly distributed over the substrate (Figure 3a). In contrast, microcolonies showed a more
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Tetrahymena, the microcolonies showed always an irregular shape (Figure 3d). Moreover, a
significant decrease in microcolony size and biovolume in the course of the experiment was
recorded (Figure 4b). The effect of weakening the potential to form microcolonies was even
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3. Defence mechanisms of biofilm bacteria may change with substrate
supply
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forms (flocs and filaments) increased when bacteria were exposed to protozoan grazing at
limiting nutrient concentrations. However, up to now, this has not been analysed in detail for
biofilm communities, but a comparable influence is likely.
As it has been pointed out in the first paragraph, bacterial biofilms may show microcolony
formation as a defence mechanism against grazing by protozoans. Hence, we conducted an
experiment with a bacterium, a variant of the genus Acinetobacter, which generally forms
microcolonies during biofilm growth. We investigated whether this bacterium was affected
by grazing of the ciliate Tetrahymena pyriformis under different nutrient supply for bacteria.
We hypothesized that the microcolony‐forming Acinetobacter sp. strain C6 would be resistant
to grazing by T. pyriformis as long as microcolony formation is not affected due to limiting
nutrients, and we assumed that less optimal substrate supply will weaken this defence
mechanism. The experiments were run in flow chambers in a mineral medium [39] which was
supplemented either with sodium benzoate or with citrate as a carbon source. Citrate is known
to be a less optimal carbon source for the microcolony formation Acinetobacter[40, 41]. For the
analysis of biofilms under the laser‐scanning microscope, Acinetobacter was either tagged with
green fluorescent protein or stained with propidium iodide.
Figure 3. Structural changes of biofilms of Acinetobacter with and without grazing pressure by Tetrahymena pyriformis
(confocal laser‐scanning‐microscope pictures in x‐y direction; size: 230 μm × 230 μm; a and b: GFP‐tagged bacteria, c–e:
propidiumiodide stained bacteria). Biofilms are shown for day 4 and day 8. (a) Sodium benzoate as medium, high me‐
dium supply rate, no Tetrahymena. (b) Sodium benzoate as medium, high medium supply rate, Tetrahymena present. (c)
Sodium benzoate as medium, low medium supply rate, no Tetrahymena. (d) Sodium benzoate as medium, low medium
supply rate, Tetrahymena present. (e) Citrate as medium, high medium supply rate, no Tetrahymena. (f) Citrate as medi‐
um, high medium supply rate, Tetrahymena present.
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grazing pressure. This supports our hypothesis that less optimal growth conditions in bacteria
biofilms may affect the ability to defend against grazing by microcolony formation. If citrate
as alternative carbon source was used, a high structural heterogeneity occurred in the presence
of Tetrahymena for the whole course of the experiments. Such a high heterogeneity could also
be seen with biofilms of Pseudomonas aeruginosa, if grown with citrate as carbon source [40].
The results of this study thereby showed that even microcolonies in bacterial biofilms are
affected by the activity of grazers and that the interactions between biofilm bacteria and its
predators might be much more complex than currently believed.
Biofilms might serve as grazing defence, though it may differ between different species and
moreover depend on the nutrient supply. Additionally, feedback effects due to remineraliza‐
tion of nutrients as result of intensive grazing may stimulate biofilm growth and thereby
enhance grazing defence.
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more pronounced in the biofilms grown under high medium supply with citrate in comparison
to the biofilms with low medium supply of sodium benzoate (Figure 3e). In the control
treatments without ciliates, round microcolonies dominated the biofilm though with a more
irregular, larger shape compared to the sodium benzoate treatments. In the grazed biofilms,
microcolonies were severely affected and did not show any round shape, but irregular flocs
and after 8 days, the microcolony formation nearly disappeared completely. The remaining
microcolonies were smaller in size and had a lower biovolume (Figure 4c).
We hypothesized that the microcolony‐forming Acinetobacter sp. strain C6 would be resistant
to grazing by T. pyriformis as long as microcolony formation is not affected by substrate supply.
However, we found that the presence of protozoans had a considerable impact on the structure
of microcolonies of Acinetobacter sp. strain C6 in every treatment tested and thereby affect this
defence mechanisms of bacteria regardless of the available nutrient source. Without T.
pyriformis being present, we observed formation of round microcolonies in the Acinetobacter
sc. strain C6 biofilm with sodium benzoate as carbon source. After introduction of T. pyrifor‐
mis to this array at the beginning of the experiment, the shape of microcolonies was changed,
as microcolony size increased and single microcolonies connected to each other. This enlarge‐
ment of microcolonies could also be observed when Tetrahymena was added later (e.g. at day
two of biofilm formation, data not shown). This morphological change of the shape of
microcolonies probably serves as a further enhanced protection against protozoan grazing.
This structure was also found in the study of Dopheide et al. [42], who examined the effect of
Tetrahymena grazing on biofilms built by the bacterium Serratia plymuthica. This points to the
fact that the browsing feeding mechanism of this protozoan may stimulate this kind of
microcolony formation in biofilms, which is also underlined by the fact that the biovolume of
the biofilm increased in the present study with sodium benzoate as nutrient source. Here,
nutrient remineralization may be facilitated by the grazing activities of the protozoa. We
compared the loss due to grazing with the bacterial production to check whether Acinetobact‐
er may be able to grow fast enough to compensate feeding losses to predators. For this, we
considered data of grazing of Tetrahymena (Tanasescu, pers. comm.) and used published
carbon conversion factors for ciliates and bacteria [43, 44]. The calculations revealed that the
mean growth rate of Acinetobacter of 0.4 pg C μm‐3 day‐1 can match the average demand of 0.29
pg C μm‐3 day‐1 for T. pyriformis. This supports the idea that grazing losses at least can be
compensated by the growth of Acinetobacter sp. Due to sloppy feeding and excretion of
nutrients, grazers release bacteria from nutrient limitation [45]. Movements of bacterivores
within the biofilms (e.g. ciliates as T. pyriformis) may create free patches and ventilate the
bacterial biofilm. Thus, bacteria at the base of the biofilm that might otherwise starve or become
inactive might receive increased nutrient and oxygen supply. Additionally, substances
produced by either grazers or bacteria (chemical cues or quorum‐sensing signals) might have
additional growth‐stimulating effects [25, 46]. These feedback effects between grazers and
bacteria might have had a significant influence on the observed structural and quantitative
changes and thereby might result in an increased bacterial growth. The reduction in medium
supply to the bacteria enhanced the competition for substrate between the biofilm bacteria. As
a consequence, bacteria could not maintain the regular structure and distribution of micro‐
colonies, and furthermore, the biovolume of the biofilm was reduced significantly under
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grazing pressure. This supports our hypothesis that less optimal growth conditions in bacteria
biofilms may affect the ability to defend against grazing by microcolony formation. If citrate
as alternative carbon source was used, a high structural heterogeneity occurred in the presence
of Tetrahymena for the whole course of the experiments. Such a high heterogeneity could also
be seen with biofilms of Pseudomonas aeruginosa, if grown with citrate as carbon source [40].
The results of this study thereby showed that even microcolonies in bacterial biofilms are
affected by the activity of grazers and that the interactions between biofilm bacteria and its
predators might be much more complex than currently believed.
Biofilms might serve as grazing defence, though it may differ between different species and
moreover depend on the nutrient supply. Additionally, feedback effects due to remineraliza‐
tion of nutrients as result of intensive grazing may stimulate biofilm growth and thereby
enhance grazing defence.
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Abstract
Atomic force microscopy (AFM) has proven itself to be a powerful and diverse tool for
the study of microbial systems on both single and multicellular scales including complex
biofilms. This chapter will review how AFM and its derivatives have been used to
unravel the nanoscale forces governing the structure and behavior of biofilms, thus
providing unique insight into the control of microbial populations within clinical and
industrial environments. Diversification of AFM‐based technologies has allowed for the
creation of a truly multiparametric platform, enabling the interrogation of all aspects of
microbial systems. Advances in traditional AFM operation have allowed, for the first
time, insight into the topographical landscape of both microbial cells and spores, which,
when combined with high‐speed AFM's  ability  to  resolve the structure  of  surface
macromolecules, have provided, with unparalleled detail, visualization of this complex
environmental interface. The application of AFM force spectroscopies has enabled the
analysis  of  many  microbial  nanomechanical  properties  including  macromolecule
folding pathways, receptor ligand binding events, microbial adhesion forces, biofilm
mechanical  properties,  and  antimicrobial/antibiofilm  affectivities.  Thus,  AFM  has
offered an outstanding glimpse into the biofilm, how its inhabitants create and use this
complex adaptive interface, and perhaps most importantly what can be done to control
this.
Keywords: atomic force microscopy, imaging, force measurement, nanomechanical
properties, adhesion
1. Introduction
Biofilms remain a primary concern in industrial and clinical fields. The tendency of plankton‐
ic cells to form these structures in moist environments and the resulting increase in resistance
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by the displacement of a reflected laser beam and used to create a topographical image. In
contact mode, the forces of the bent cantilever keep the tip in intimate contact with the surface.
When imaging a soft sample such as a bacterial cell surface or biofilm, the tapping mode or
intermittent contact mode is used. The intermittent contact of this imaging mode reduces the
degree of friction or drag on a sample compared with imaging in contact mode. To achieve the
intermittent contact, a vibrating cantilever technique is used, and the changes in the vibrational
parameters are monitored as the cantilever scans the surface. In response to changes in
topography, the piezo‐scanner moves up and down to maintain a constant vibration of the
cantilever, and the feedback signal is used to produce the image data set. A further advantage
of this imaging mode is that measurement of the phase angle between the free oscillation at
the end of the cantilever and the imposed driving vibration provides a map of phase angle
across a surface; this data, referred to as phase imaging, is captured simultaneously as the
standard topographical data. This phase angle is often used to qualitatively distinguish
between materials on the surfaces of heterogeneous samples as the phase angle change is a
function of the mechanical properties of the surface and the area of contact between the AFM
tip and the surface.
The advantages of tapping mode have meant that this is the most frequently used method
when imaging soft biological samples. The authors have found tapping mode in combination
with phase imaging extremely useful in identifying structures on the cells and within biofilm.
Figure 2. AFM tapping mode images of microbial biofilms: (a) Candida tropicalis (50 μm2), (b) Staphylococcus aureus (10
μm2), (c) Pseudomonas aeruginosa (10 μm2), (d) mixed species biofilm at an industrially fouled reverse osmosis mem‐
brane (10 μm2).
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to antimicrobials, in combination with an increasing frequency of innate antimicrobial resist‐
ance, demonstrates the continued need for novel biofilm control strategies and innovative
methods to unravel the fundamental properties of biofilms. Atomic force microscopy (AFM)
has proven to be a useful addition to the microscopy family providing imaging and force
measurement capabilities that can interrogate the nanoscale properties of surfaces. Indeed, AFM
has been used with great success to provide novel insight into the structure of biofilms and the
interplay of interaction forces and mechanical properties that govern the behavior of biofilms
and their response to chemical and physical attack as part of control strategies. AFM can be used
to study whole biofilms or the influence of their component parts, from bacterial surface proteins
to extracellular polysaccharides (EPSs) and individual cells. This chapter will first introduce the
reader to the basic operation of the instrument relevant to the study of biofilms. The different
capabilities of the instrument and their application to biofilm will be then reviewed with examples
from the authors’ laboratory.
2. AFM basic principles
AFM was first developed as part of the family of scanning probe microscopies in 1986 [1]. It
was very quickly applied to the imaging of biological materials, including DNA, bacteria,
viruses, and mammalian cells [2]. The components of atomic force microscope is shown in
Figure 1. A very small, sharp tip held at the free end of a cantilever systematically scans a
surface of interest to generate a topographical image. The tip is held in intimate contact with
the surface, and its apex has a radius of curvature in the range of nanometers, which sets the
image resolution. As the tip is systematically scanned across the surface, it encounters surface
forces that cause the cantilever to be deflected. The deflection of the cantilever is monitored
Figure 1. A schematic representation of the AFM instrument.
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population. In addition, surface forces are measured over very small contact areas, minimizing
contamination problems. To generate a force–distance curve, the deflection of the cantilever
is recorded as a function of tip‐to‐sample separation, as the piezo‐scanner of the AFM brings
the sample and tip together. The deflection of the cantilever is converted to a value of force
using Hooke's law. Force–distance curves are characteristic of the system under study. For
biofilms, they have features that reflect the chemical and physical properties of the surfaces
that are interacting, including the substrate, the cells, EPS, and the AFM probe. Figure 3 shows
a typical force measurement between an AFM cell probe (Saccharomyces cerevisiae) and a surface
in a process‐relevant environment (10-2 M NaCl) [3]. The force is plotted as a function of
separation distance and shows some key features for the characterization of the surfaces
involved. At position D (referring to Figure 3), the cantilever and probe are moving inde‐
pendently of the surface, as the probe is brought into contact with the surface, until at position
F it encounters physiochemical forces, which in this case are repulsive and likely to be
dominated by electrostatic forces. The extension of the scanner continues to push the cell into
contact (F–G) until a predefined loading force is reached, whereupon the movement is reversed
and the probe is retracted away from the surface by the retraction of the piezo‐scanner. At
position C, the bending of the cantilever is inflected and the forces in the bent cantilever begin
to rupture the adhesion between the cell and the surface. If this was an inorganic hard particle,
a sudden break in contact would be observed. However, with the yeast cell with macromo‐
lecular tethers (and any deformable surface), a sequential breaking of contact is observed as
the forces in the bent cantilever peel the cell from the surface, until at position E the cell probe
is moving independently of the surface. The adhesion measurement is determined from the
difference in force between positions C and D. Integration between the approach and diffrac‐
tion curves gives an estimate of the energy of adhesion. The mechanical properties of the
system can be determined from the contact region (F–G and A–C) and the adhesion component
of the curve (C–D).
Operating the AFM as a nanoindenter allows the measurement of microbial cell and biofilm
mechanical properties, which include elastic moduli and turgor pressure [2]. Figure 4 shows
how the indentation depth is measured by comparison between force curves measured at a
reference hard surface and at the softer sample surface. The indentation depth can then be
plotted as a function of applied force and compared with a theoretical framework to quantify
sample mechanical properties. The most commonly used theoretical framework is based on
the Hertz model, which describes the elastic deformation of two perfectly homogeneous
smooth bodies touching under load. The geometry of the system is assumed to consist of an
indenter with a parabolic shape and a sample that is of much greater thickness than the
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Figure 2 presents AFM tapping mode images of a range of microbial biofilms. When imaging
biofilms, the mechanical robustness of a biofilm should be considered; it is simpler to image
model biofilms with minimum components, which have been grown on adhesion‐promoting
substrates, compared to biofilms that have been sampled from natural or industrial settings
that consist of multiple components (Figure 2d). As AFM imaging is a technique that relies on
surface contact, the imaging of a hydrated diffuse biofilm is very difficult without fixation
methods.
Figure 3. A typical force measurement between an AFM cell probe (Saccharomyces cerevisiae) and a surface in a process‐
relevant environment (10-2 M NaCl).
The AFM can measure the forces of interactions between surfaces, which have obvious
implications in the study of biofilms. AFM has been added to the group of instruments that
can be used to study microbial interactions involved in biofilm formation. Such instruments
include flow chambers, micropipette aspiration, and centrifugation devices. However, AFM
has the advantage of allowing the imaging and identification of points of interest on a surface
prior to the measurement of the forces of interaction. AFM also allows the direct measurement
of forces as opposed to techniques that estimate force from the application of shear to a cell
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has the advantage of allowing the imaging and identification of points of interest on a surface
prior to the measurement of the forces of interaction. AFM also allows the direct measurement
of forces as opposed to techniques that estimate force from the application of shear to a cell
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cantilever, resulting in the destruction of the sample [4, 5]. Additionally, microbial cells are
often motile with some recent papers suggesting that motility may even be the largest
governing factor in the physiological imaging of microbes [6]. Consequently, immobilization
of microbial cells prior to analysis has become imperative to the application of AFM in the
imaging of microbial systems.
3.1. Cell immobilization for single‐cell analysis
Immobilization of microbial cells has often proven to be the most problematic step in the
imaging of microbial samples under aqueous conditions. The immobilization must be secure
enough to withstand the lateral forces exerted by the tip during scanning, but benign enough
to not force physiochemical, physiological, or nanomechanical changes in the sample. As a
result, a number of different techniques have arisen; these protocols can be broadly divided
into two categories: mechanical, whereby microbial cells are physically trapped within a
porous media, and chemical, whereby chemical treatment of the substrate is used to facilitate
binding.
Initial studies into the use of mechanical protocols to immobilize microbes utilized agar or
membranes with pore diameters similar to the cell diameter of the organism to be captured [4,
7–9] (Figure 5). Later work expanded upon this through the use of more complex or function‐
alized surfaces such as lithographically patterned silica [5, 10–12]. Though, while mechanical
entrapment offers immobilization secure enough to alleviate the destructive scanning of the
cantilever, the immobilization is sporadic and unpredictable, reducing the reproducibility of
Figure 5. A yeast cell (Saccharomyces cerevisiae) trapped in a microfiltration membrane prior to AFM study.
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Figure 4. The measurement of indentation depth (δ) by comparison of the slope of the contact region of force curves at
hard and soft surfaces.
where the tip is approximated with the radius R, the depth of indentation is denoted by δ, E
is the Young's modulus of the sample surface, and ν is the Poisson ratio for the sample material
(assumed to be a value of 0.5 for biological samples). Other theoretical frameworks have been
used to interrogate AFM nanoindentation curves such as the JKR (Johnson, Kendall, Roberts)
model. When choosing which model to use and interpreting the data, a number of consider‐
ations should be taken into account. The mechanical properties of microbial cells and biofilms
will not be homogeneous across their surface and will be a convolution of whole cell com‐
pression as well as material close to the tip. In addition, nanoindentation is an invasive
technique which applies a disruptive force to the surface. Repeated indentation at the same
location on the cell or biofilm will disrupt the structure and its mechanical robustness render‐
ing subsequent measurements invalid.
3. Imaging
Examination of microbial systems in native, aqueous environments is central to the validity of
the data collected. However, AFM imaging in such environments is often difficult due to a
number of factors. For instance, microbial cells are often attached to the surface via week
Lifshitz‐Van der Waals forces, and as a result are easily disrupted by the scanning of an AFM
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membranes with pore diameters similar to the cell diameter of the organism to be captured [4,
7–9] (Figure 5). Later work expanded upon this through the use of more complex or function‐
alized surfaces such as lithographically patterned silica [5, 10–12]. Though, while mechanical
entrapment offers immobilization secure enough to alleviate the destructive scanning of the
cantilever, the immobilization is sporadic and unpredictable, reducing the reproducibility of
Figure 5. A yeast cell (Saccharomyces cerevisiae) trapped in a microfiltration membrane prior to AFM study.
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Figure 4. The measurement of indentation depth (δ) by comparison of the slope of the contact region of force curves at
hard and soft surfaces.
where the tip is approximated with the radius R, the depth of indentation is denoted by δ, E
is the Young's modulus of the sample surface, and ν is the Poisson ratio for the sample material
(assumed to be a value of 0.5 for biological samples). Other theoretical frameworks have been
used to interrogate AFM nanoindentation curves such as the JKR (Johnson, Kendall, Roberts)
model. When choosing which model to use and interpreting the data, a number of consider‐
ations should be taken into account. The mechanical properties of microbial cells and biofilms
will not be homogeneous across their surface and will be a convolution of whole cell com‐
pression as well as material close to the tip. In addition, nanoindentation is an invasive
technique which applies a disruptive force to the surface. Repeated indentation at the same
location on the cell or biofilm will disrupt the structure and its mechanical robustness render‐
ing subsequent measurements invalid.
3. Imaging
Examination of microbial systems in native, aqueous environments is central to the validity of
the data collected. However, AFM imaging in such environments is often difficult due to a
number of factors. For instance, microbial cells are often attached to the surface via week
Lifshitz‐Van der Waals forces, and as a result are easily disrupted by the scanning of an AFM
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structure running perpendicular to the long axis of the cell [27]. However, during this study
the bands were found to periodically interlink to form a net‐like structure. Imaging of other
Group B Streptococci showed that this net‐like structure, while exhibiting some variation in
pore dimensions, remained constant. The group then imaged a number of cell wall deficient
mutants in an attempt to identify structural abnormalities associated with other surface
macromolecules; however, no significant alterations in the peptidoglycan net to suggest
macromolecular anchoring were observed. Significant alterations in the solute concentration
were found to alter the net‐like structure with the group observing a near doubling (∼25 to
∼47 nm) of the peptidoglycan bands, suggesting that the net‐like structure may influence
adaptation of the cell to changes in turgor pressure. Similarly, the growth phase of the organism
was found to have a significant effect on peptidoglycan structure; topographical images of a
high proportion of Group B Streptococci grown to stationary were shown to exhibit a tenden‐
cy to express a rough peptidoglycan layer as opposed to the previously described net‐like
structure. Upon further investigation, this roughness was shown to consist of highly or‐
dered strands aligned in parallel with the divisional plane having a periodicity of approxi‐
mately 4.5 nm; the group suggests that these may in fact be glycan strands; however, the
structure and density of the strands prevented the researchers from coming to a clear
conclusion.
As outlined above, in vitro AFM has been used to map the topography on cellular structures
at a number of cell life stages, as in the work of Abscali et al. [28] who examined changes in
the macromolecular structure of the cell wall of Streptomyces coelicolor during its life cycle from
vegetative hyphae to spores. Yet, such studies merely offer a snapshot of cellular processes.
Thus, several studies have aimed to image the dynamics of cellular processes. Germination of
Bacillus atrophaeus has been successfully imaged; post exposure to a germination solution, the
rodlets comprising the spore coat were shown to disassemble and form 2–3 nm etched pits [29].
The pits were subsequently shown to mature into highly orientated fissures perpendicular to
the rodlet orientation, beneath which a highly ordered hexagonal structure was observed. The
study continued to image the germinating spore through to the emergence of the germling
cell, and the spore fissures were observed to form apertures of approximately 70 nm that
dilated with germination. In vitro analysis of the germling confirmed the presence of vegeta‐
tive cell wall structures prior to emergence, which were similar to those of mature vegeta‐
tive cells.
3.3. Microbial cellular surface layers
Microbial membranes consist of a number of surface layers, the outermost of which, the S‐
layer, consists of a monomolecular layer composed of self‐assembling single proteins, or
glycoprotein monomers exhibiting oblique, square, or hexagonal symmetry. Due to its self‐
assembling nature and its role in many innate immunities associated with microbes, S‐layers
have become the focus of many AFM studies. Initial studies into S‐layers successfully imaged
PS2 monomers of Corynebacterium glutamicum and in the process highlighted the presence of
a bilayer of hexagonally arranged monomers and a nanogrooved substrate; further work
suggests that this substrate may be involved in the creation of the monolayer [30, 31].
Atomic Force Microscopy of Biofilms—Imaging, Interactions, and Mechanics
http://dx.doi.org/10.5772/63312
103
the results. Recent work by Formosa et al. [13] developed a protocol in which selective tuning
of polydimethylsiloxane (PDMS) stamps were used to immobilize spherical microorganisms
of various sizes. The protocol requires the creation of a glass and chromium blank that holds
the microstructure, from which the pattern is transferred to a silicon wafer by deep reactive
ion etching. The dimensions of the silicon master can be varied with the group reporting
dimensions of 1.5–6 μm wide, a pitch of 0.5 μm, and a depth of 1–4 μm, accommodating a
variety of target cell sizes. A PDMS stamp is then cast from the silicon wafer master and cells
deposited through the use of convective and capillary forces. Further work by the group has
shown this immobilization technique to be an effective way to immobilize spherical cells, in
this case S. cerevisiae and Candida albicans, and, spore of Aspergillus fumigatus with no effect on
viability [14–17]. Additionally, the technique allows for the rectification of one of AFMs
greatest flaws, analysis of multiple cells to achieve statistical significance. Previously, this has
not been feasible using other immobilization techniques due to the relatively low rate and
sporadic nature of deposition; thus, the development of a platform capable of producing arrays
of uniform cells for multiparametric analysis will increase the reliability of AFM analysis.
However, this technique is limited due to its inability to immobilize nonspherical organisms.
A number of chemical fixation methods for the immobilization of microbial cells have been
used, including, poly‐L‐lysine, trimethoxysilyl‐propyl‐diethylenetriamine, mica, and carbox‐
yl group cross‐linking [18–22]. While these techniques offer a high level of immobilization,
some cross‐linking agents have been shown to negatively impact the nanocharacteristics and
viability of the immobilized cells [23]. Despite this, some techniques, such as the use of
photocatalytically active silicon, also offer a high level of cell orientation and organized
immobilization not offered by conventional mechanical techniques, which, depending on
application may be favorable over the associated reduction in viability [24]. Other recent
advances also indicate that the addition of divalent cations, such as Mg2+ and Ca2+, and glucose
may provide optimal attachment without the associated reduction in viability. In one such
study, Lonergan et al. [25] reported that Escherichia coli cells immobilized on poly‐L‐lysine in
0.01× PBS‐S, with a rehabilitation period in minimal media were sufficiently immobilized to
perform AFM analysis while maintaining membrane integrity.
3.2. Cell topography
Analysis of the topography of single cells has proven to be a powerful addition in the real‐time
visualization of cellular surface structures. However, the structural landscape of metabolical‐
ly active cells exists in a constant state of flux; thus, the ability to image surface morpholo‐
gies under physiological conditions is vital for characterization. Previous studies have utilized
AFM to image a number of key microbial features. In 2010, negative mutants of cell wall
polysaccharide (WPS-) of Lactococcus lactis were shown by AFM imaging to exhibit a 25 nm
corded like structure perpendicular to the long axis of the cell; further mutagenesis studies
confirmed that these structures were not due to hydrolysis, and AFM chemical spectroscopy
(imaging with a functionalized tip) using LysM confirmed that the bands consisted of
peptidoglycan [26]. In a more recent study, an in‐depth analysis of Streptococcus agalactiae
(Group B Streptococci) peptidoglycan confirmed the presence of approximately 25 nm corded
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structure running perpendicular to the long axis of the cell [27]. However, during this study
the bands were found to periodically interlink to form a net‐like structure. Imaging of other
Group B Streptococci showed that this net‐like structure, while exhibiting some variation in
pore dimensions, remained constant. The group then imaged a number of cell wall deficient
mutants in an attempt to identify structural abnormalities associated with other surface
macromolecules; however, no significant alterations in the peptidoglycan net to suggest
macromolecular anchoring were observed. Significant alterations in the solute concentration
were found to alter the net‐like structure with the group observing a near doubling (∼25 to
∼47 nm) of the peptidoglycan bands, suggesting that the net‐like structure may influence
adaptation of the cell to changes in turgor pressure. Similarly, the growth phase of the organism
was found to have a significant effect on peptidoglycan structure; topographical images of a
high proportion of Group B Streptococci grown to stationary were shown to exhibit a tenden‐
cy to express a rough peptidoglycan layer as opposed to the previously described net‐like
structure. Upon further investigation, this roughness was shown to consist of highly or‐
dered strands aligned in parallel with the divisional plane having a periodicity of approxi‐
mately 4.5 nm; the group suggests that these may in fact be glycan strands; however, the
structure and density of the strands prevented the researchers from coming to a clear
conclusion.
As outlined above, in vitro AFM has been used to map the topography on cellular structures
at a number of cell life stages, as in the work of Abscali et al. [28] who examined changes in
the macromolecular structure of the cell wall of Streptomyces coelicolor during its life cycle from
vegetative hyphae to spores. Yet, such studies merely offer a snapshot of cellular processes.
Thus, several studies have aimed to image the dynamics of cellular processes. Germination of
Bacillus atrophaeus has been successfully imaged; post exposure to a germination solution, the
rodlets comprising the spore coat were shown to disassemble and form 2–3 nm etched pits [29].
The pits were subsequently shown to mature into highly orientated fissures perpendicular to
the rodlet orientation, beneath which a highly ordered hexagonal structure was observed. The
study continued to image the germinating spore through to the emergence of the germling
cell, and the spore fissures were observed to form apertures of approximately 70 nm that
dilated with germination. In vitro analysis of the germling confirmed the presence of vegeta‐
tive cell wall structures prior to emergence, which were similar to those of mature vegeta‐
tive cells.
3.3. Microbial cellular surface layers
Microbial membranes consist of a number of surface layers, the outermost of which, the S‐
layer, consists of a monomolecular layer composed of self‐assembling single proteins, or
glycoprotein monomers exhibiting oblique, square, or hexagonal symmetry. Due to its self‐
assembling nature and its role in many innate immunities associated with microbes, S‐layers
have become the focus of many AFM studies. Initial studies into S‐layers successfully imaged
PS2 monomers of Corynebacterium glutamicum and in the process highlighted the presence of
a bilayer of hexagonally arranged monomers and a nanogrooved substrate; further work
suggests that this substrate may be involved in the creation of the monolayer [30, 31].
Atomic Force Microscopy of Biofilms—Imaging, Interactions, and Mechanics
http://dx.doi.org/10.5772/63312
103
the results. Recent work by Formosa et al. [13] developed a protocol in which selective tuning
of polydimethylsiloxane (PDMS) stamps were used to immobilize spherical microorganisms
of various sizes. The protocol requires the creation of a glass and chromium blank that holds
the microstructure, from which the pattern is transferred to a silicon wafer by deep reactive
ion etching. The dimensions of the silicon master can be varied with the group reporting
dimensions of 1.5–6 μm wide, a pitch of 0.5 μm, and a depth of 1–4 μm, accommodating a
variety of target cell sizes. A PDMS stamp is then cast from the silicon wafer master and cells
deposited through the use of convective and capillary forces. Further work by the group has
shown this immobilization technique to be an effective way to immobilize spherical cells, in
this case S. cerevisiae and Candida albicans, and, spore of Aspergillus fumigatus with no effect on
viability [14–17]. Additionally, the technique allows for the rectification of one of AFMs
greatest flaws, analysis of multiple cells to achieve statistical significance. Previously, this has
not been feasible using other immobilization techniques due to the relatively low rate and
sporadic nature of deposition; thus, the development of a platform capable of producing arrays
of uniform cells for multiparametric analysis will increase the reliability of AFM analysis.
However, this technique is limited due to its inability to immobilize nonspherical organisms.
A number of chemical fixation methods for the immobilization of microbial cells have been
used, including, poly‐L‐lysine, trimethoxysilyl‐propyl‐diethylenetriamine, mica, and carbox‐
yl group cross‐linking [18–22]. While these techniques offer a high level of immobilization,
some cross‐linking agents have been shown to negatively impact the nanocharacteristics and
viability of the immobilized cells [23]. Despite this, some techniques, such as the use of
photocatalytically active silicon, also offer a high level of cell orientation and organized
immobilization not offered by conventional mechanical techniques, which, depending on
application may be favorable over the associated reduction in viability [24]. Other recent
advances also indicate that the addition of divalent cations, such as Mg2+ and Ca2+, and glucose
may provide optimal attachment without the associated reduction in viability. In one such
study, Lonergan et al. [25] reported that Escherichia coli cells immobilized on poly‐L‐lysine in
0.01× PBS‐S, with a rehabilitation period in minimal media were sufficiently immobilized to
perform AFM analysis while maintaining membrane integrity.
3.2. Cell topography
Analysis of the topography of single cells has proven to be a powerful addition in the real‐time
visualization of cellular surface structures. However, the structural landscape of metabolical‐
ly active cells exists in a constant state of flux; thus, the ability to image surface morpholo‐
gies under physiological conditions is vital for characterization. Previous studies have utilized
AFM to image a number of key microbial features. In 2010, negative mutants of cell wall
polysaccharide (WPS-) of Lactococcus lactis were shown by AFM imaging to exhibit a 25 nm
corded like structure perpendicular to the long axis of the cell; further mutagenesis studies
confirmed that these structures were not due to hydrolysis, and AFM chemical spectroscopy
(imaging with a functionalized tip) using LysM confirmed that the bands consisted of
peptidoglycan [26]. In a more recent study, an in‐depth analysis of Streptococcus agalactiae
(Group B Streptococci) peptidoglycan confirmed the presence of approximately 25 nm corded
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membrane dynamics of outer‐membrane protein F (OmpF) were imaged to an optical
resolution of approximately 750 Å [38].
While initial studies using HS‐AFM revolved around its ability to resolve surface macromo‐
lecules, some focus has shifted to topographical analysis. In the first such study, the surface of
Magnetospirillum magneticum was found in contradiction to initial models to consist of a very
highly ordered series of nanometer‐sized pores consistent with that of porin molecules [34].
Further work set out to ascertain if this was in fact a characteristic of all Proteobacteria, wherein
Oestreicher et al. [39] imaged the surfaces of the E. coli and Rhodobacter sphaeroides. This was
shown to be the case, and nanometer‐sized pores of 8 and 6.6 nm were observed for E. coli and
R. sphaeroides, respectively. Oestreicher et al. [39] concluded that due to the similarities in
distribution and size when compared to M. magneticum (7 nm), and with the crystal struc‐
ture size estimation of the outer membrane proteins of E. coli (OmpF and OmpC)––7.5 and 7.38
nm, respectively––that they must also be porins.
4. Force spectroscopy
AFM force measurement has been used extensively to study biological systems. In the past,
AFM was limited to physics laboratories, and microbiologists focused on the benefits of AFM
to imaging of single bacteria; bacterial studies were restricted to model surfaces, and the
heterogeneity inherent to natural systems compromised quantification and discouraged the
use of AFM force measurement. However, AFM technology has been disseminated to
microbial laboratories that have the advantage of prior knowledge to guide AFM research
strategies. In addition, the advent of improved data capture rates has permitted statistically
viable AFM measurements to quantitatively characterize biological systems including
biofilms. Modern AFM studies of biofilm orchestrate AFM imaging of microbial surfaces with
force spectroscopy to unravel structure function relationships. The force‐curves measured at
surfaces have a number of components which can be used to characterize the mechanical and
interaction properties of biofilms that are now discussed.
4.1. Microbial surface proteins
Surface macromolecules play an essential role in a number of physiological processes essential
to the success of microbes including adhesion and existence within a biofilm; the activity of
these molecules has been shown to be dependent on a number of environmental conditions
[40–45]. Consequently, research into the nanomechanical and physiological properties of
surface macromolecules has expanded over the last decade with the fundamentals of AFM tip‐
molecule binding forces in vitro having become well documented [46–48].
Several models have been described to interpret the nanomechanical properties of long‐chain
surface macromolecules. Typically, these models revolve around the use of the Worm‐Like
Chain (WLC) and Freely Jointed Chain (FJC) models, as these allow for the description of force‐
curve profiles and the definition of tether and binding partner interaction entropy, thus leading
to contour length (L0) definition [49, 50]. Defining L0 offers a number of advantages, such as
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In a recent study, the nanomechanical and structural properties of Propionibacterium freuden‐
reichii surface layer protein A (SlpA) was characterized [32]. SlpA was found to consist of a
hexagonal p1 monomer with a high level of disorder; upon heating to 45°C, SlpA was found
to maintain structural integrity post recrystallization. However, a marked reduction in the
elasticity of the SlpA layer from 4.2 ± 0.9 MPa at 25°C to 1.8 ± 0.3 and 0.9 ± 0.1 MPa for 35
and 45°C, respectively, demonstrate that while topographically comparable, the nanomech‐
nical properties of SlpA had altered. Additional work conducted by the group showed the
SlpA exhibited the same, albeit less pronounced, behavior in response to alteration in pH. The
topographical characteristics of SlpA were maintained to pH 3; however, a corresponding
reduction in the elastic properties was observed: 5.7 ± 1.4 MPa and 5.5 ± 1.6 MPa at pH 6.7
and 5, respectively, followed by a reduction to 2.2 ± 0.3 MPa at pH 3. The group attributes this
reduction in the elastic properties to be a result of a number of physiochemical interactions
such as the reduction in pH below that of the theoretical pI of SlpA and protonation of the
disordered regions.
3.4. High‐speed AFM
While spatial resolution using AFM has remained high, the lack of high temporal resolution
has limited the application of topographical studies of microbial systems. Optimal scan speed
varies; however, the minimum is restricted to the order of approximately 30 s for an AFM
image. This level of temporal resolution is sufficient for the imaging of relatively low
fluctuating structures and processes, such as S‐layers and cell division. The high‐resolution
imaging of surface macromolecules has remained elusive due to the limited speed of standard
AFM imaging. However, the recent development of high‐speed AFM (HS‐AFM) has enabled
the resolution of such structures primarily due to HS‐AFMs to show exceptional temporal
resolution (>100 ms) and significantly reduced scanning forces [33–35].
In one such series of studies, the dynamics of conformational changes of bacteriorhodopsin
(bR) was successfully imaged in response to electrochemical radiation stimulation [33, 36, 37].
During initial studies, the group observed conformational changes in the form of a 0.69 ± 0.15
nm displacement of the center mass of the trimer structure when exposed to green light.
Furthermore, the group was able to ascertain that these changes in the center mass were
actually the result of the displacement of trimer monomers into close proximity with mono‐
mers of neighboring trimers via displacement of the E–F loop. Through combination of
selective mutagenesis and HS‐AFM, Yamashita et al. [33] were able to characterize the
monomer association of bR trimers. During the study, five bR mutants were created: W10I,
Y131I, W12I, F135I, and W12F, and HS‐AFM used to image the structure of each trimer within
the membrane. The study showed that W12I and F135I mutants were unable to form mem‐
brane‐stable trimers, with only a small number of trimers assembling and quickly dissipat‐
ing. Conversely, W10I, Y131I, and W12F were able to form a stable trimer structure, suggesting
the presence of an aromatic residue at positions 12 and 135, which is essential to the forma‐
tion of a stable trimer.
Further HS‐AFM studies have been able to track the motion of membrane‐bound macromo‐
lecules through three‐dimensional space. In one such study, the rotational and translational
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membrane dynamics of outer‐membrane protein F (OmpF) were imaged to an optical
resolution of approximately 750 Å [38].
While initial studies using HS‐AFM revolved around its ability to resolve surface macromo‐
lecules, some focus has shifted to topographical analysis. In the first such study, the surface of
Magnetospirillum magneticum was found in contradiction to initial models to consist of a very
highly ordered series of nanometer‐sized pores consistent with that of porin molecules [34].
Further work set out to ascertain if this was in fact a characteristic of all Proteobacteria, wherein
Oestreicher et al. [39] imaged the surfaces of the E. coli and Rhodobacter sphaeroides. This was
shown to be the case, and nanometer‐sized pores of 8 and 6.6 nm were observed for E. coli and
R. sphaeroides, respectively. Oestreicher et al. [39] concluded that due to the similarities in
distribution and size when compared to M. magneticum (7 nm), and with the crystal struc‐
ture size estimation of the outer membrane proteins of E. coli (OmpF and OmpC)––7.5 and 7.38
nm, respectively––that they must also be porins.
4. Force spectroscopy
AFM force measurement has been used extensively to study biological systems. In the past,
AFM was limited to physics laboratories, and microbiologists focused on the benefits of AFM
to imaging of single bacteria; bacterial studies were restricted to model surfaces, and the
heterogeneity inherent to natural systems compromised quantification and discouraged the
use of AFM force measurement. However, AFM technology has been disseminated to
microbial laboratories that have the advantage of prior knowledge to guide AFM research
strategies. In addition, the advent of improved data capture rates has permitted statistically
viable AFM measurements to quantitatively characterize biological systems including
biofilms. Modern AFM studies of biofilm orchestrate AFM imaging of microbial surfaces with
force spectroscopy to unravel structure function relationships. The force‐curves measured at
surfaces have a number of components which can be used to characterize the mechanical and
interaction properties of biofilms that are now discussed.
4.1. Microbial surface proteins
Surface macromolecules play an essential role in a number of physiological processes essential
to the success of microbes including adhesion and existence within a biofilm; the activity of
these molecules has been shown to be dependent on a number of environmental conditions
[40–45]. Consequently, research into the nanomechanical and physiological properties of
surface macromolecules has expanded over the last decade with the fundamentals of AFM tip‐
molecule binding forces in vitro having become well documented [46–48].
Several models have been described to interpret the nanomechanical properties of long‐chain
surface macromolecules. Typically, these models revolve around the use of the Worm‐Like
Chain (WLC) and Freely Jointed Chain (FJC) models, as these allow for the description of force‐
curve profiles and the definition of tether and binding partner interaction entropy, thus leading
to contour length (L0) definition [49, 50]. Defining L0 offers a number of advantages, such as
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elasticity of the SlpA layer from 4.2 ± 0.9 MPa at 25°C to 1.8 ± 0.3 and 0.9 ± 0.1 MPa for 35
and 45°C, respectively, demonstrate that while topographically comparable, the nanomech‐
nical properties of SlpA had altered. Additional work conducted by the group showed the
SlpA exhibited the same, albeit less pronounced, behavior in response to alteration in pH. The
topographical characteristics of SlpA were maintained to pH 3; however, a corresponding
reduction in the elastic properties was observed: 5.7 ± 1.4 MPa and 5.5 ± 1.6 MPa at pH 6.7
and 5, respectively, followed by a reduction to 2.2 ± 0.3 MPa at pH 3. The group attributes this
reduction in the elastic properties to be a result of a number of physiochemical interactions
such as the reduction in pH below that of the theoretical pI of SlpA and protonation of the
disordered regions.
3.4. High‐speed AFM
While spatial resolution using AFM has remained high, the lack of high temporal resolution
has limited the application of topographical studies of microbial systems. Optimal scan speed
varies; however, the minimum is restricted to the order of approximately 30 s for an AFM
image. This level of temporal resolution is sufficient for the imaging of relatively low
fluctuating structures and processes, such as S‐layers and cell division. The high‐resolution
imaging of surface macromolecules has remained elusive due to the limited speed of standard
AFM imaging. However, the recent development of high‐speed AFM (HS‐AFM) has enabled
the resolution of such structures primarily due to HS‐AFMs to show exceptional temporal
resolution (>100 ms) and significantly reduced scanning forces [33–35].
In one such series of studies, the dynamics of conformational changes of bacteriorhodopsin
(bR) was successfully imaged in response to electrochemical radiation stimulation [33, 36, 37].
During initial studies, the group observed conformational changes in the form of a 0.69 ± 0.15
nm displacement of the center mass of the trimer structure when exposed to green light.
Furthermore, the group was able to ascertain that these changes in the center mass were
actually the result of the displacement of trimer monomers into close proximity with mono‐
mers of neighboring trimers via displacement of the E–F loop. Through combination of
selective mutagenesis and HS‐AFM, Yamashita et al. [33] were able to characterize the
monomer association of bR trimers. During the study, five bR mutants were created: W10I,
Y131I, W12I, F135I, and W12F, and HS‐AFM used to image the structure of each trimer within
the membrane. The study showed that W12I and F135I mutants were unable to form mem‐
brane‐stable trimers, with only a small number of trimers assembling and quickly dissipat‐
ing. Conversely, W10I, Y131I, and W12F were able to form a stable trimer structure, suggesting
the presence of an aromatic residue at positions 12 and 135, which is essential to the forma‐
tion of a stable trimer.
Further HS‐AFM studies have been able to track the motion of membrane‐bound macromo‐
lecules through three‐dimensional space. In one such study, the rotational and translational
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5. Adhesion studies
Biofilm adhesion qualities have been measured through AFM in a number of ways. EPS has
been confirmed as a major mechanism controlling biofilm adhesion [59–62]. As a result, a
number of studies have been undertaken to assess the effect of growth conditions, chemical
treatments, and novel antimicrobials on the production of EPS and the reduction in adhe‐
sion. Oh et al. [61] used AFM force spectroscopy to study the influence of nutrient concentra‐
tions on E. coli biofilm maturation. The adhesion of an AFM tip at the surface of the biofilm
increased as biofilms matured, indicating a release and accumulation of extracellular poly‐
meric substances over the cell surface after primary colonization. Nunez et al. [63] used AFM
imaging and force measurement to study the action of Bdellovibrio bacteriovorus on E. coli
biofilms. AFM characterized the change in E. coli cells, as they were attacked by the predato‐
ry bacterium with cells changing from rod‐shaped to a round shape, with a shrunken texture
and the visible coil of B. bacteriovorus growing inside. Bdellovibrio bacteriovorus was shown to
prevent biofilm formation and destroy established biofilms. This work was extended by Volle
et al. [64] who used force spectroscopy to observe that the spring constant of predated E. coli
cells was three times softer than that of normal cells and that there was change in cell wall
morphology on predation, as there was much larger adhesion forces between an AFM tip and
predated cells. This important work demonstrates that dynamic events in living unfixed cells
can be characterized and investigated using AFM. Rodriguez et al. [65] used AFM force
measurements to study the formation of Listeria monocytogenes biofilms at stainless steel
surfaces. They found that the adhesiveness of biofilms was not influenced by contact time,
loading force, or relative humidity, but surface chemistry is important; force measurements
using SiO2 and polyethylene colloid probes showed that L. monocytogenes cells within a biofilm
adhered more strongly to hydrophobic surfaces. The mechanical properties of the surface that
biofilms form at are important determinants on the properties of the biofilm.
Oh et al. [66] studied the formation of Pseudomonas aeruginosa biofilms at a range of surfaces
including steel, rubber, and polypropylene. Biofilms were treated with hot water, and all
surfaces with and without biofilms were characterized using AFM. Force spectroscopy
revealed that adhesion was greatest at the untreated biofilm surfaces and that the reduction
of adhesion after hot water treatment indicated the removal of extracellular matrix from the
biofilm.
6. Indentation studies
AFM has been implemented to analyze several mechanical properties of microbial cells, such
as elasticity and hardness [56, 67, 68]. Typically, this is done using the Hertz model, wherein
the indentation of a material by a nonadherent probe can be used to calculate the elastic
modulus of the substrate. Volle et al. [69] measured cell spring constants and AFM tip adhesion
on cells within the biofilms of E. coli, Pseudomonas putida, Bacillus subtilis, and Micrococcus luteus.
Gram‐positive bacteria were observed to have largest spring constants with all cells having
values in the range 0.16 ± 0.01 to 0.41 ± 0.01 N/m. These workers also demonstrated that the
mechanical properties of chemically fixed cells are significantly different. Fang et al. [60] also
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the filtering of noise and predictions in the unfolding pathways of uncharacterized protein
complexes [51, 52]. If the structure is unknown, L0 allows collaboration of experimentally
derived data to a theoretical value defined from the estimation of the sum of individual
components fitted to a normal (Gaussian) distribution, therefore acting as a confirmation that
the interaction is the one of interest, while offering a level of insight into the unbinding
pathway. Studies conducted by Farrance et al. [53] expanded on traditional models, where‐
by a physical basis for the prediction of L0 was described. The model, through the use of
theoretically idealized tethering surfaces and the probability of two such chains meeting, is
able to predict the distributions expected from experimentally derived data with a high level
of agreement to existing studies.
4.2. Functional proteins at microbial surfaces
Microbial adhesion to biotic and abiotic surfaces is reliant on a number of macromolecular
interaction including binding of small microbial peptides (SMPs), capsules, recognition
proteins, fimbriae, and flagella. Single‐molecule force spectroscopy (SMFS) has been used to
characterize a number of microbial surface‐bound receptors including antibiotic receptor
ligand sites, fimbriae, flagella, and adhesins [54–56]. In an interesting example of the use of
SMFS, the holdfast proteins of Caulobacter crescentus were characterized for adhesion to
surfaces of varying polarities [57]. Holdfasts were allowed to adhere to each surface for an
extended period of time greater than 16 h and imaged via AFM to determine the height and
diameter; it was found that the holdfast height varied independently of the surface polarity;
from 5 to 100 nm, however, the average height varied between 30.6 ± 2.4 nm and 21.5 ± 0.9 nm
for mica and graphite, respectively. Holdfast foot diameter was also found to vary on both
surfaces: 90.2 ± 2.7 nm for mica and 119.2 ± 4.1 nm for graphite; however, both showed large
distributions in the data––30–280 nm and 45–450 nm, respectively. The group then proceed‐
ed to access the binding strength on holdfast‐coated cantilevers to mica, graphite, clean glass,
and 3‐TMSM‐treated glass, and the maximum adhesion force was measured––0.05, 0.08, 0.13,
and 0.66 nm, respectively. Adhesion was concluded to be primarily a result of residence time
and surface polarity.
4.3. Microbial mechanical properties
One of the distinct features of AFM over other SPMs is its ability to quantifiably resolve
physiochemical properties of materials at the nanoscale. To date, AFM has been used to resolve
the nanomechanical behaviours of a bacteria in a number of ways, from single‐cell indenta‐
tion studies to the characterization of molecular appendages such as pili and flagellum [58].
A number of techniques can be employed dependent on the type of nanomechanical meas‐
urement that is required, with most alterations involving functionalization of the cantilever.
All nanomechanical studies revolve around the use of the force‐curve analysis as detailed
earlier in this review.
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lar importance in the field of biofilm formation as the forces governing such interactions are
pertinent in the initiation of a biofilm. The research was pioneered by Bowen et al. [76] who
first constructed a cell probe to measure the adhesion of S. cerevisiae cells at surfaces (Figure 6).
The author then moved this on to look at the adhesion of fungal and bacterial spores [77, 78].
Protocols for the construction of cell probes have varied in the method of cantilevers func‐
tionalization: electrostatic compounds; poly(ethyleneimine) (PEI), poly‐L‐lysine, or hydropho‐
bic substances, and the use of glue, chemical fixation, and bio‐inspired wet adhesives have all
been used, and in the type of probe that was created: single versus multicellular [3, 79–85].
While all methods succeeded in the creation of a cellular functionalized tip and the acquisi‐
tion of adhesive force‐curve data, the results and validity of the techniques varied.
Figure 6. Scanning electron images of AFM probes used in single cell force spectroscopy (SCFS). (a) Saccharomyces cere‐
visiae and (b) Aspergillus niger.
Recently, a method for the direct immobilization of single microbial cells was developed [86].
A colloidal probe was attached to the tip of a cantilever and coated in polydopamine, and a
single microbial cell was then attached to the colloid particle. Fluorescence microscopy
validated the viability and orientation of the microbial cell, and force‐curve analysis was
performed across a number of surfaces and a number of probes to ensure reproducibility of
results. The technique was shown to offer a high level of cell orientation; thus, a high level of
control of the surface area, ensuring reproducibility of results and enabling statistical analy‐
sis of force curves. The group went on to create cellular probes functionalized with Lactococ‐
cus plantarum, C. albicans, and Staphylococcus epidermidis to prove the versatility of the
technique [84].
Studies using SCFS have characterized a number of microbial binding structures, such as
bacterial pili, to show how these structures influence microbial adhesion. During one such
study, the nanomechanical binding of P. aeruginosa type IV pili to a hydrophobic substrate was
examined. During the study, type IV pili were shown to have the same constant force plateaus
associated with a nanospring‐like mechanism; this may be explained by the fracturing of
internal amino acid bonds and the unravelling of the three‐dimensional structure to resist the
increase in mechanical force. This model is consistent with the previous interpretations of
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used AFM force spectroscopy to quantify tip‐cell adhesion and surface elasticity of sulfate‐
reducing bacteria (SRB) biofilms. To achieve this, they used a force volume technique to map
forces across the biofilm surface. Greater adhesion was measured at the cell–cell and cell–
substratum interfaces; this was compared to a smaller and constant force at the bacterial cell
surfaces and argued to be due to the accumulation of EPS at the interfaces. Another interest‐
ing study conducted by Longo et al. [70] demonstrated that AFM can be used to characterize
the variations in nanomechanical properties across a single cell membrane. In the study,
nanoindentation was performed across the surface of an immobilized E. coli cell, and it was
found that there was a variation in the Young's modulus of the cell membrane. Upon further
analysis, this heterogeneity was attributed to the presence of submembranous structures,
hinting at the possibility that AFM may be capable of resolving the organization of such
structures.
As confidence in the technique grew, focus of nanoindentation studies shifted from single cells
to biofilms. However, use of the classic Hertz model to interpret the viscoelastic properties of
biofilms, until recently, remained problematic [71, 72]. In a recent example of one such study,
the elastic moduli of P. aeruginosa was found to be heterogeneous in nature, varying between
approximately 40 and 45 kPa [73]. SEM and AFM topographical studies of the same sample
showed variations in packing density of the cells throughout the biofilm, offering possible
insight into the cause of the variation in mechanical properties. However, these variations may
also be the result of underlying physiological structures such as nutrient channels. Finite
element analysis performed by the group showed that the variation may be a result of the
combined effect of the EPS and cell orientation.
There have been further studies into the nanomechanical properties of biofilms that have
focused on the effect of growth conditions and novel antimicrobials on the nanostructure of
biofilms. One such study showed that increasing concentrations of CaCl2 resulted in not only
an increase in EPS production but also alterations in EPS structure of Pseudomonas fluoro‐
scenes biofilms [74]. Consequently, a reduction in stiffness and increase in both viscosity and
adhesive forces were observed. In another study, AFM was used to assess the changes in the
nanomechanical properties of P. aeruginosa and Acinetobacter baumannii biofilms after treat‐
ment with OligoG. During the study, OligoG was found to significantly lower Young's moduli
and increase the surface roughness (Ra) when compared to untreated biofilms [75]. However,
this study highlights one of the main challenges facing the characterization of biofilms via
AFM: continuity of sample preparation. In the aforementioned study, the biofilms were dried
prior to analysis, while others made use of hydrated samples. While both techniques remain
valid, interstudy comparisons will remain difficult until a level of interstudy continuity is
achieved.
7. Single‐cell force spectroscopy
Single‐cell force spectroscopy (SCFS) has become an essential tool in unravelling the forces
involved in intermicrobial, host–microbe, and substrate–microbe binding. This is of particu‐
Microbial Biofilms - Importance and Applications108
lar importance in the field of biofilm formation as the forces governing such interactions are
pertinent in the initiation of a biofilm. The research was pioneered by Bowen et al. [76] who
first constructed a cell probe to measure the adhesion of S. cerevisiae cells at surfaces (Figure 6).
The author then moved this on to look at the adhesion of fungal and bacterial spores [77, 78].
Protocols for the construction of cell probes have varied in the method of cantilevers func‐
tionalization: electrostatic compounds; poly(ethyleneimine) (PEI), poly‐L‐lysine, or hydropho‐
bic substances, and the use of glue, chemical fixation, and bio‐inspired wet adhesives have all
been used, and in the type of probe that was created: single versus multicellular [3, 79–85].
While all methods succeeded in the creation of a cellular functionalized tip and the acquisi‐
tion of adhesive force‐curve data, the results and validity of the techniques varied.
Figure 6. Scanning electron images of AFM probes used in single cell force spectroscopy (SCFS). (a) Saccharomyces cere‐
visiae and (b) Aspergillus niger.
Recently, a method for the direct immobilization of single microbial cells was developed [86].
A colloidal probe was attached to the tip of a cantilever and coated in polydopamine, and a
single microbial cell was then attached to the colloid particle. Fluorescence microscopy
validated the viability and orientation of the microbial cell, and force‐curve analysis was
performed across a number of surfaces and a number of probes to ensure reproducibility of
results. The technique was shown to offer a high level of cell orientation; thus, a high level of
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examined. During the study, type IV pili were shown to have the same constant force plateaus
associated with a nanospring‐like mechanism; this may be explained by the fracturing of
internal amino acid bonds and the unravelling of the three‐dimensional structure to resist the
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In conclusion, microbiology and the study of biofilms is no longer a microscience. The
elucidation of microbial behavior at the nanoscale has now become an essential avenue of
research in the understanding of the complex interplay of the microbial world, and AFM has
proved itself to be an essential tool in this endeavor. The increase in sensitivity and analyti‐
cal power, as well as ingenuity shown by researchers in the creation of more imaginative probes
will ensure that unique insights into biofilms through AFM will continue.
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Gram‐negative pili structure [87–89]. In a similar study, strains of Lactococcus lactis were
immobilized onto polyethyleneimine (PEI)‐coated cantilever, and adhesion to a pig gastric
mucin‐coated substrate was characterized [90]. In the study, long‐range adhesion was found
to be predominantly the result of pili‐mediated binding, while surface adhesion was primar‐
ily mediated by mucus‐binding adhesins.
The implementation of SCFS has not been limited to the characterization of microbial binding
to surfaces. While uncommon, the use of SCFS to characterize microbial aggregation and the
formation of heterogeneous biofilms has grown as a field in recent years. One such interac‐
tion to be studied is the common co‐colonization of S. epidermidis and C. albicans; a recent study
attempting to characterize such an interaction showed that despite the complex nature, SCFM
is able to offer a window of insight into the adhesion forces at work [91]. During the study, the
group was able to establish that S. epidermidis adhesion was strongly influenced by the life
stage of C. albicans and primarily mediated by the binding of long‐range macromolecules.
SCFS techniques have been used to study the mechanisms of biofilm control agents. Chaw et
al. [92] measured the adhesion between S. epidermidis‐coated AFM tips and a substrate before
and after addition of silver ions (50 ppb) to the liquid medium. For both S. epidermis strains
studied, the adhesion decreased and was argued to demonstrate how the biofilm matrix is
destabilized in the presence of silver ions.
8. Conclusion
AFM has provided researchers with the tools necessary to unravel the intimate, complex, and
traditionally illusive processes governing the formation and resilience of biofilms. AFM has
provided the platform necessary for the application of classical engineering techniques, such
as indentation analysis in the exploration of microbial nanomechanics with unprecedented
resolution. Nanoindentation studies have elucidated the heterogeneity of the microbial
membrane landscape. Studies utilizing nanoindentation have provided evidence of the
variation in Young's moduli of both single cells and biofilms, while also hinting at the possible
application of the technique in the visualization of the assembly of submembranous struc‐
tures. AFM studies have also demonstrated the importance of such measurements in the
evaluation of novel antimicrobial and other therapeutics.
Through the use of functionalized cantilevers, SMFS has revolutionized our understanding of
microbial cell surface topography and nanomechanical properties. Tips functionalized with
ligands or with alterations in hydrophobicity have been used to not only map the receptor
landscape at the macroscale, but also to visualize the structure of individual membrane‐bound
protein complexes. AFM quantification of the nanoscale forces of adhesion has offered
unparalleled insight into the forces governing microbial adhesion, a crucial event in biofilm
formation, and how these individual forces may be manipulated to promote dissolution. The
formation of cellular probes has been a mainstay of microbial‐based AFM, and this contin‐
ues with the recent development of protocols for the immobilization of a singular, highly
orientated bacterial cells.
Microbial Biofilms - Importance and Applications110
In conclusion, microbiology and the study of biofilms is no longer a microscience. The
elucidation of microbial behavior at the nanoscale has now become an essential avenue of
research in the understanding of the complex interplay of the microbial world, and AFM has
proved itself to be an essential tool in this endeavor. The increase in sensitivity and analyti‐
cal power, as well as ingenuity shown by researchers in the creation of more imaginative probes
will ensure that unique insights into biofilms through AFM will continue.
Author details
Sean A. James, Lydia C. Powell and Chris J. Wright*
*Address all correspondence to: c.wright@swansea.ac.uk
Biomaterials, Biofouling and Biofilms Engineering Laboratory (B3EL) Systems and Process
Engineering Centre, College of Engineering, Swansea University, Swansea, UK
References
[1] Binnig C, Quate CF, Gerber C. Atomic force microscope. Phys. Rev. Lett. 1986; 56: 930–
933.
[2] Bowen WR, Lovitt RW, Wright CJ. Application of atomic force microscopy to the study
of micromechanical properties of biological materials. Biotechnol. Lett. 2000; 22: 893–
903.
[3] Bowen WR, Lovitt RW, Wright CJ. Atomic force microscopy study of the adhesion of
Saccharomyces cerevisiae. J. Colloid Interface Sci. 2001; 237: 54–61.
[4] Touhami A, Jericho MH, Beveridge TJ. Atomic force microscopy of cell growth and
division in Staphylococcus aureus. J. Bacteriol. 2004; 186: 3286–3295.
[5] Kailas L, Ratcliffe EC, Hayhurst EJ, Walker MG, Foster SJ, Hobbs JK. Immobilizing live
bacteria for AFM imaging of cellular processes. Ultramicroscopy 2009; 109: 775–780.
[6] Dhahri S, Ramonda M, Marlière C. In‐situ determination of the mechanical proper‐
ties of gliding or non‐motile bacteria by atomic force microscopy under physiological
conditions without immobilization. PLoS One 2013; 8: e61663.
[7] Gad M, Ikai A. Method for immobilizing microbial cells on gel surface for dynamic
AFM studies. Biophys. J. 1995; 69: 2226–2233.
[8] Kasas S, Ikai A. A method for anchoring round shaped cells for atomic force micro‐
scope imaging. Biophys. J. 1995; 68: 1678–1680.
Atomic Force Microscopy of Biofilms—Imaging, Interactions, and Mechanics
http://dx.doi.org/10.5772/63312
111
Gram‐negative pili structure [87–89]. In a similar study, strains of Lactococcus lactis were
immobilized onto polyethyleneimine (PEI)‐coated cantilever, and adhesion to a pig gastric
mucin‐coated substrate was characterized [90]. In the study, long‐range adhesion was found
to be predominantly the result of pili‐mediated binding, while surface adhesion was primar‐
ily mediated by mucus‐binding adhesins.
The implementation of SCFS has not been limited to the characterization of microbial binding
to surfaces. While uncommon, the use of SCFS to characterize microbial aggregation and the
formation of heterogeneous biofilms has grown as a field in recent years. One such interac‐
tion to be studied is the common co‐colonization of S. epidermidis and C. albicans; a recent study
attempting to characterize such an interaction showed that despite the complex nature, SCFM
is able to offer a window of insight into the adhesion forces at work [91]. During the study, the
group was able to establish that S. epidermidis adhesion was strongly influenced by the life
stage of C. albicans and primarily mediated by the binding of long‐range macromolecules.
SCFS techniques have been used to study the mechanisms of biofilm control agents. Chaw et
al. [92] measured the adhesion between S. epidermidis‐coated AFM tips and a substrate before
and after addition of silver ions (50 ppb) to the liquid medium. For both S. epidermis strains
studied, the adhesion decreased and was argued to demonstrate how the biofilm matrix is
destabilized in the presence of silver ions.
8. Conclusion
AFM has provided researchers with the tools necessary to unravel the intimate, complex, and
traditionally illusive processes governing the formation and resilience of biofilms. AFM has
provided the platform necessary for the application of classical engineering techniques, such
as indentation analysis in the exploration of microbial nanomechanics with unprecedented
resolution. Nanoindentation studies have elucidated the heterogeneity of the microbial
membrane landscape. Studies utilizing nanoindentation have provided evidence of the
variation in Young's moduli of both single cells and biofilms, while also hinting at the possible
application of the technique in the visualization of the assembly of submembranous struc‐
tures. AFM studies have also demonstrated the importance of such measurements in the
evaluation of novel antimicrobial and other therapeutics.
Through the use of functionalized cantilevers, SMFS has revolutionized our understanding of
microbial cell surface topography and nanomechanical properties. Tips functionalized with
ligands or with alterations in hydrophobicity have been used to not only map the receptor
landscape at the macroscale, but also to visualize the structure of individual membrane‐bound
protein complexes. AFM quantification of the nanoscale forces of adhesion has offered
unparalleled insight into the forces governing microbial adhesion, a crucial event in biofilm
formation, and how these individual forces may be manipulated to promote dissolution. The
formation of cellular probes has been a mainstay of microbial‐based AFM, and this contin‐
ues with the recent development of protocols for the immobilization of a singular, highly
orientated bacterial cells.
Microbial Biofilms - Importance and Applications110
[21] Doktycz MJ, Sullivan CJ, Hoyt PR, Pelletier DA, Wu S, Allison DP. AFM imaging of
bacteria in liquid media immobilized on gelatin coated mica surfaces. Ultramicrosco‐
py 2003; 97: 209–216.
[22] Camesano TA, Liu Y, Datta M. Measuring bacterial adhesion at environmental
interfaces with single‐cell and single‐molecule techniques. Adv. Water Resour. 2007;
30: 1470–1491.
[23] D'Souza SF. Microbial biosensors. Biosens. Bioelectron. 2001; 16: 337–353.
[24] Bearinger JP, Dugan LC, Wu L, Hill H, Christian AT, Hubbell JA. Chemical tethering
of motile bacteria to silicon surfaces. Biotechniques 2009; 46: 209–216.
[25] Lonergan NE, Britt LD, Sullivan CJ. Immobilizing live Escherichia coli for AFM studies
of surface dynamics. Ultramicroscopy 2014; 137: 30–39.
[26] Andre G, Kulakauskas S, Chapot‐Chartier MP, Navet B, Deghorain M, Bernard E, Hols
P, Dufrêne YF. Imaging the nanoscale organization of peptidoglycan in living
Lactococcus lactis cells. Nat. Commun. 2010; 1: 27.
[27] Saar Dover R, Bitler A, Shimoni E, Trieu‐Cuot P, Shai Y. Multiparametric AFM reveals
turgor‐responsive net‐like peptidoglycan architecture in live streptococci. Nat.
Commun. 2015; 6: 7193.
[28] Abscali R, Armstrong I, Wright C, Dyson P. Characterization of changes to the cell
surface during the life cycle of Streptomyces coelicolor: atomic force microscopy of
living cells. J. Bacteriol. 2007; 189: 2219–2225.
[29] Plomp M, Leighton TJ, Wheeler KE, Hill HD, Malkin AJ. In vitro high‐resolution
structural dynamics of single germinating bacterial spores. Proc. Natl. Acad. Sci. 2007;
104: 9644–9649.
[30] Dupres V, Alsteens D, Pauwels K, Dufrêne YF. In vivo imaging of S‐layer nanoarrays
on Corynebacterium glutamicum. Langmuir 2009; 25: 9653–9655.
[31] Sleytr UB, Sára M, Pum D, Schuster B. Characterization and use of crystalline bacteri‐
al cell surface layers. Prog. Surf. Sci. 2001; 68: 231–278.
[32] de sa Peixoto P, Roiland C, Thomas D, Briard‐Bion V, Le Guellec R, Parayre S, Deutsch
S‐M, Jan G, Guyomarc'h F. Recrystallized S‐layer protein of a probiotic Propionibacte‐
rium: structural and manomechanical changes upon temperature or pH shifts probed
by solid‐state NMR and AFM. Langmuir 2015; 31: 199–208.
[33] Yamashita H, Inoue K, Shibata M, Uchihashi T, Sasaki J, Kandori H, Ando T. Role of
trimer‐trimer interaction of bacteriorhodopsin studied by optical spectroscopy and
high‐speed atomic force microscopy. J. Struct. Biol. 2013; 184: 2–11.
[34] Yamashita H, Taoka A, Uchihashi T, Asano T, Ando T, Fukumori Y. Single‐molecule
imaging on living bacterial cell surface by high‐speed AFM. J. Mol. Biol. 2012; 422: 300–
309.
Atomic Force Microscopy of Biofilms—Imaging, Interactions, and Mechanics
http://dx.doi.org/10.5772/63312
113
[9] Ahimou F, Touhami A, Dufrêne YF. Real‐time imaging of the surface topography of
living yeast cells by atomic force microscopy. Yeast 2003; 20: 25–30.
[10] Yao X, Walter J, Burke S, Stewart S, Jericho MH, Pink D, Hunter R, Beveridge TJ. Atomic
force microscopy and theoretical considerations of surface properties and turgor
pressures of bacteria. Colloids Surf. B 2002; 23: 213–230.
[11] Vadillo‐Rodríguez V, Busscher HJ, Norde W, De Vries J, Dijkstra RJB, Stokroos I, Van
Der Mei HC. Comparison of atomic force microscopy interaction forces between
bacteria and silicon nitride substrata for three commonly used immobilization
methods. Appl. Environ. Microbiol. 2004; 70: 5441–5446.
[12] Cerf A, Cau JC, Vieu C, Dague E. Nanomechanical properties of dead or alive single‐
patterned bacteria. Langmuir 2009; 25: 5731–5736.
[13] Formosa C, Pillet F, Schiavone M, Duval RE, Ressier L, Dague E. Generation of living
cell arrays for atomic force microscopy studies. Nat. Protoc. 2014; 10: 199–204.
[14] Formosa C, Schiavone M, Martin‐Yken H, François JM, Duval RE, Dague E. Nano‐
scale effects of caspofungin against two yeast species, saccharomyces cerevisiae and
candida albicans. Antimicrob. Agents Chemother. 2013; 57: 3498–3506.
[15] Pillet F, Lemonier S, Schiavone M, Formosa C, Martin‐Yken H, Francois JM, Dague E.
Uncovering by atomic force microscopy of an original circular structure at the yeast
cell surface in response to heat shock. BMC Biol. 2014; 12: 6.
[16] Beauvais A, Bozza S, Kniemeyer O, Formosa C, Balloy V, Henry C, Roberson RW,
Dague E, Chignard M, Brakhage AA, Romani L, Latgé J‐P. Deletion of the α‐(1,3)‐
Glucan synthase genes induces a restructuring of the conidial cell wall responsible for
the avirulence of Aspergillus fumigatus. PLoS Pathog. 2013; 9: e1003716.
[17] Chopinet L, Formosa C, Rols MP, Duval RE, Dague E. Imaging living cells surface and
quantifying its properties at high resolution using AFM in QITM mode. Micron 2013; 48:
26–33.
[18] Bolshakova AV, Kiselyova OI, Filonov AS, Frolova OY, Lyubchenko YL, Yaminsky IV.
Comparative studies of bacteria with an atomic force microscopy operating in different
modes. Ultramicroscopy 2001; 86: 121–128.
[19] Micic M, Hu D, Suh YD, Newton G, Romine M, Lu HP. Correlated atomic force
microscopy and fluorescence lifetime imaging of live bacterial cells. Colloids Surf. B
2004; 34: 205–212.
[20] Arnoldi M, Fritz M, Bäuerlein E, Radmacher M, Sackmann E, Boulbitch A. Bacterial
turgor pressure can be measured by atomic force microscopy. Phys. Rev. E 2000; 62:
1034–1044.
Microbial Biofilms - Importance and Applications112
[21] Doktycz MJ, Sullivan CJ, Hoyt PR, Pelletier DA, Wu S, Allison DP. AFM imaging of
bacteria in liquid media immobilized on gelatin coated mica surfaces. Ultramicrosco‐
py 2003; 97: 209–216.
[22] Camesano TA, Liu Y, Datta M. Measuring bacterial adhesion at environmental
interfaces with single‐cell and single‐molecule techniques. Adv. Water Resour. 2007;
30: 1470–1491.
[23] D'Souza SF. Microbial biosensors. Biosens. Bioelectron. 2001; 16: 337–353.
[24] Bearinger JP, Dugan LC, Wu L, Hill H, Christian AT, Hubbell JA. Chemical tethering
of motile bacteria to silicon surfaces. Biotechniques 2009; 46: 209–216.
[25] Lonergan NE, Britt LD, Sullivan CJ. Immobilizing live Escherichia coli for AFM studies
of surface dynamics. Ultramicroscopy 2014; 137: 30–39.
[26] Andre G, Kulakauskas S, Chapot‐Chartier MP, Navet B, Deghorain M, Bernard E, Hols
P, Dufrêne YF. Imaging the nanoscale organization of peptidoglycan in living
Lactococcus lactis cells. Nat. Commun. 2010; 1: 27.
[27] Saar Dover R, Bitler A, Shimoni E, Trieu‐Cuot P, Shai Y. Multiparametric AFM reveals
turgor‐responsive net‐like peptidoglycan architecture in live streptococci. Nat.
Commun. 2015; 6: 7193.
[28] Abscali R, Armstrong I, Wright C, Dyson P. Characterization of changes to the cell
surface during the life cycle of Streptomyces coelicolor: atomic force microscopy of
living cells. J. Bacteriol. 2007; 189: 2219–2225.
[29] Plomp M, Leighton TJ, Wheeler KE, Hill HD, Malkin AJ. In vitro high‐resolution
structural dynamics of single germinating bacterial spores. Proc. Natl. Acad. Sci. 2007;
104: 9644–9649.
[30] Dupres V, Alsteens D, Pauwels K, Dufrêne YF. In vivo imaging of S‐layer nanoarrays
on Corynebacterium glutamicum. Langmuir 2009; 25: 9653–9655.
[31] Sleytr UB, Sára M, Pum D, Schuster B. Characterization and use of crystalline bacteri‐
al cell surface layers. Prog. Surf. Sci. 2001; 68: 231–278.
[32] de sa Peixoto P, Roiland C, Thomas D, Briard‐Bion V, Le Guellec R, Parayre S, Deutsch
S‐M, Jan G, Guyomarc'h F. Recrystallized S‐layer protein of a probiotic Propionibacte‐
rium: structural and manomechanical changes upon temperature or pH shifts probed
by solid‐state NMR and AFM. Langmuir 2015; 31: 199–208.
[33] Yamashita H, Inoue K, Shibata M, Uchihashi T, Sasaki J, Kandori H, Ando T. Role of
trimer‐trimer interaction of bacteriorhodopsin studied by optical spectroscopy and
high‐speed atomic force microscopy. J. Struct. Biol. 2013; 184: 2–11.
[34] Yamashita H, Taoka A, Uchihashi T, Asano T, Ando T, Fukumori Y. Single‐molecule
imaging on living bacterial cell surface by high‐speed AFM. J. Mol. Biol. 2012; 422: 300–
309.
Atomic Force Microscopy of Biofilms—Imaging, Interactions, and Mechanics
http://dx.doi.org/10.5772/63312
113
[9] Ahimou F, Touhami A, Dufrêne YF. Real‐time imaging of the surface topography of
living yeast cells by atomic force microscopy. Yeast 2003; 20: 25–30.
[10] Yao X, Walter J, Burke S, Stewart S, Jericho MH, Pink D, Hunter R, Beveridge TJ. Atomic
force microscopy and theoretical considerations of surface properties and turgor
pressures of bacteria. Colloids Surf. B 2002; 23: 213–230.
[11] Vadillo‐Rodríguez V, Busscher HJ, Norde W, De Vries J, Dijkstra RJB, Stokroos I, Van
Der Mei HC. Comparison of atomic force microscopy interaction forces between
bacteria and silicon nitride substrata for three commonly used immobilization
methods. Appl. Environ. Microbiol. 2004; 70: 5441–5446.
[12] Cerf A, Cau JC, Vieu C, Dague E. Nanomechanical properties of dead or alive single‐
patterned bacteria. Langmuir 2009; 25: 5731–5736.
[13] Formosa C, Pillet F, Schiavone M, Duval RE, Ressier L, Dague E. Generation of living
cell arrays for atomic force microscopy studies. Nat. Protoc. 2014; 10: 199–204.
[14] Formosa C, Schiavone M, Martin‐Yken H, François JM, Duval RE, Dague E. Nano‐
scale effects of caspofungin against two yeast species, saccharomyces cerevisiae and
candida albicans. Antimicrob. Agents Chemother. 2013; 57: 3498–3506.
[15] Pillet F, Lemonier S, Schiavone M, Formosa C, Martin‐Yken H, Francois JM, Dague E.
Uncovering by atomic force microscopy of an original circular structure at the yeast
cell surface in response to heat shock. BMC Biol. 2014; 12: 6.
[16] Beauvais A, Bozza S, Kniemeyer O, Formosa C, Balloy V, Henry C, Roberson RW,
Dague E, Chignard M, Brakhage AA, Romani L, Latgé J‐P. Deletion of the α‐(1,3)‐
Glucan synthase genes induces a restructuring of the conidial cell wall responsible for
the avirulence of Aspergillus fumigatus. PLoS Pathog. 2013; 9: e1003716.
[17] Chopinet L, Formosa C, Rols MP, Duval RE, Dague E. Imaging living cells surface and
quantifying its properties at high resolution using AFM in QITM mode. Micron 2013; 48:
26–33.
[18] Bolshakova AV, Kiselyova OI, Filonov AS, Frolova OY, Lyubchenko YL, Yaminsky IV.
Comparative studies of bacteria with an atomic force microscopy operating in different
modes. Ultramicroscopy 2001; 86: 121–128.
[19] Micic M, Hu D, Suh YD, Newton G, Romine M, Lu HP. Correlated atomic force
microscopy and fluorescence lifetime imaging of live bacterial cells. Colloids Surf. B
2004; 34: 205–212.
[20] Arnoldi M, Fritz M, Bäuerlein E, Radmacher M, Sackmann E, Boulbitch A. Bacterial
turgor pressure can be measured by atomic force microscopy. Phys. Rev. E 2000; 62:
1034–1044.
Microbial Biofilms - Importance and Applications112
[50] Flory PJ, Volkenstein M. Statistical mechanics of chain molecules. Biopolymers 1969; 8:
699–700.
[51] Sandal M, Valle F, Tessari I, Mammi S, Bergantino E, Musiani F, Brucale M, Bubacco L,
Samorì B. Conformational equilibria in monomeric alpha‐synuclein at the single‐
molecule level. PLoS Biol. 2008; 6: e6.
[52] Dougan L, Li J, Badilla CL, Berne BJ, Fernandez JM. Single homopolypeptide chains
collapse into mechanically rigid conformations. Proc. Natl. Acad. Sci. 2009; 106: 12605–
12610.
[53] Farrance OE, Paci E, Radford SE, Brockwell DJ. Extraction of accurate biomolecular
parameters from single‐molecule force spectroscopy experiments. ACS Nano 2015; 9:
1315–1324.
[54] Gilbert Y, Deghorain M, Wang L, Xu B, Pollheimer PD, Gruber HJ, Errington J, Hallet
B, Haulot X, Verbelen C, Hols P, Dufrêne YF. Single‐molecule force spectroscopy and
imaging of the vancomycin/D‐Ala‐D‐Ala interaction. Nano Lett. 2007; 7: 796–801.
[55] Abu‐Lail NI, Camesano TA. Elasticity of pseudomonas putida KT2442 surface
polymers probed with single‐molecule force microscopy. Langmuir. 2002; 18: 4071–
4081.
[56] Touhami A, Nysten B, Dufrêne YF. Nanoscale mapping of the elasticity of microbial
cells by atomic force microscopy. Langmuir 2003; 19: 4539–4543.
[57] Berne X, Ma X, Licata NA, Neves BRA, Setayeshgar S, Brun YV, Dragnea B. Physio‐
chemical properties of caulobacter crescentus holdfast: a localized bacterial adhesive.
J. Phys. Chem. B 2013; 117: 10492–10503.
[58] Dufrene YF. Recent progress in the application of atomic force microscopy imaging and
force spectroscopy to microbiology. Curr. Opin. Microbiol. 2003; 6: 317–323.
[59] Auerbach ID, Sorensen C, Hansma HG, Holden PA. Physical morphology and surface
properties of unsaturated Pseudomonas putida biofilms. J. Bacteriol. 2000; 182: 3809–
3815.
[60] Fang HH, Chan KY, Xu LC. Quantification of bacterial adhesion forces using atomic
force microscopy (AFM). J. Microbiol. Methods 2000; 40: 89–97.
[61] Oh YJ, Jo W, Yang Y, Park S. Influence of culture conditions on Escherichia coli O157:H7
biofilm formation by atomic force microscopy. Ultramicroscopy 2007; 107: 869–874.
[62] Tsoligkas AN, Bowen J, Winn M, Goss RJM, Overton TW, Simmons MJH. Characteri‐
sation of spin coated engineered Escherichia coli biofilms using atomic force micro‐
scopy. Colloids Surf. B 2012; 89: 152–160.
[63] Nunez ME, Martin M, Chan PH, Spain EM. Predation, death, and survival in a biofilm:
Bdellovibrio investigated by atomic force microscopy. Colloids Surf. B 2005; 42: 263–271.
Atomic Force Microscopy of Biofilms—Imaging, Interactions, and Mechanics
http://dx.doi.org/10.5772/63312
115
[35] Ando T, Kodera N, Naito Y, Kinoshita T, Furuta K, Toyoshima YY. A high‐speed atomic
force microscope for studying biological macromolecules in action. ChemPhysChem
2003; 4: 1196–1203.
[36] Shibata M, Yamashita H, Uchihashi T, Kandori H, Ando T. High‐speed atomic force
microscopy shows dynamic molecular processes in photoactivated bacteriorhodop‐
sin. Nat. Nanotechnol. 2010; 5: 208–212.
[37] Shibata M, Uchihashi T, Yamashita H, Kandori H, Ando T. Structural changes in
bacteriorhodopsin in response to alternate illumination observed by high‐speed atomic
force microscopy. Angew. Chem. Int. Ed. 2011; 50: 4410–4413.
[38] Casuso I, Khao J, Chami M, Paul‐Gilloteaux P, Husain M, Duneau J‐P, Stahlberg H,
Sturgis JN, Scheuring S. Characterization of the motion of membrane proteins using
high‐speed atomic force microscopy. Nat. Nanotechnol. 2012; 7: 525–529.
[39] Oestreicher Z, Taoka A, Fukumori Y. A comparison of the surface nanostructure from
two different types of gram‐negative cells: Escherichia coli and Rhodobacter sphaeroides.
Micron 2015; 72: 8–14.
[40] Benoit M, Gabriel D, Gerisch G, Gaub HE. Discrete interactions in cell adhesion
measured by single‐molecule force spectroscopy. Nat. Cell Biol. 2000; 2: 313–317.
[41] Helenius J, Heisenberg CP, Gaub HE, Muller DJ. Single‐cell force spectroscopy. J. Cell
Sci. 2008; 121: 1785–1791.
[42] Williams V, Fletcher M. Pseudomonas fluorescens adhesion and transport through
porous media are affected by lipopolysaccharide composition. Appl. Environ.
Microbiol. 1996; 62: 100–104.
[43] Savage DC, Fletcher M, editors. Bacterial Adhesion. Boston, MA: Springer US; 1985.
[44] Bullitt E, Makowski L. Bacterial adhesion pili are heterologous assemblies of similar
subunits. Biophys. J.1998; 74: 623–632.
[45] Bayer ME, Carlemalm E, Kellenberger E. Capsule of Escherichia coli K29: ultrastructur‐
al preservation and immunoelectron microscopy. J. Bacteriol. 1985; 162: 985–991.
[46] Engel A, Gaub HE, Müller DJ. Atomic force microscopy: a forceful way with single
molecules. Curr. Biol. 1999; 9: R133–R136.
[47] Engel A, Müller DJ. Observing single biomolecules at work with the atomic force
microscope. Nat. Struct. Biol. 2000; 7: 715–718.
[48] Dupres V, Alsteens D, Andre G, Verbelen C, Dufrêne YF. Fishing single molecules on
live cells. Nano Today 2009; 4: 262–268.
[49] Fredrickson GH. The theory of polymer dynamics. Curr. Opin. Solid State Mater. Sci.
1996; 1: 812–816.
Microbial Biofilms - Importance and Applications114
[50] Flory PJ, Volkenstein M. Statistical mechanics of chain molecules. Biopolymers 1969; 8:
699–700.
[51] Sandal M, Valle F, Tessari I, Mammi S, Bergantino E, Musiani F, Brucale M, Bubacco L,
Samorì B. Conformational equilibria in monomeric alpha‐synuclein at the single‐
molecule level. PLoS Biol. 2008; 6: e6.
[52] Dougan L, Li J, Badilla CL, Berne BJ, Fernandez JM. Single homopolypeptide chains
collapse into mechanically rigid conformations. Proc. Natl. Acad. Sci. 2009; 106: 12605–
12610.
[53] Farrance OE, Paci E, Radford SE, Brockwell DJ. Extraction of accurate biomolecular
parameters from single‐molecule force spectroscopy experiments. ACS Nano 2015; 9:
1315–1324.
[54] Gilbert Y, Deghorain M, Wang L, Xu B, Pollheimer PD, Gruber HJ, Errington J, Hallet
B, Haulot X, Verbelen C, Hols P, Dufrêne YF. Single‐molecule force spectroscopy and
imaging of the vancomycin/D‐Ala‐D‐Ala interaction. Nano Lett. 2007; 7: 796–801.
[55] Abu‐Lail NI, Camesano TA. Elasticity of pseudomonas putida KT2442 surface
polymers probed with single‐molecule force microscopy. Langmuir. 2002; 18: 4071–
4081.
[56] Touhami A, Nysten B, Dufrêne YF. Nanoscale mapping of the elasticity of microbial
cells by atomic force microscopy. Langmuir 2003; 19: 4539–4543.
[57] Berne X, Ma X, Licata NA, Neves BRA, Setayeshgar S, Brun YV, Dragnea B. Physio‐
chemical properties of caulobacter crescentus holdfast: a localized bacterial adhesive.
J. Phys. Chem. B 2013; 117: 10492–10503.
[58] Dufrene YF. Recent progress in the application of atomic force microscopy imaging and
force spectroscopy to microbiology. Curr. Opin. Microbiol. 2003; 6: 317–323.
[59] Auerbach ID, Sorensen C, Hansma HG, Holden PA. Physical morphology and surface
properties of unsaturated Pseudomonas putida biofilms. J. Bacteriol. 2000; 182: 3809–
3815.
[60] Fang HH, Chan KY, Xu LC. Quantification of bacterial adhesion forces using atomic
force microscopy (AFM). J. Microbiol. Methods 2000; 40: 89–97.
[61] Oh YJ, Jo W, Yang Y, Park S. Influence of culture conditions on Escherichia coli O157:H7
biofilm formation by atomic force microscopy. Ultramicroscopy 2007; 107: 869–874.
[62] Tsoligkas AN, Bowen J, Winn M, Goss RJM, Overton TW, Simmons MJH. Characteri‐
sation of spin coated engineered Escherichia coli biofilms using atomic force micro‐
scopy. Colloids Surf. B 2012; 89: 152–160.
[63] Nunez ME, Martin M, Chan PH, Spain EM. Predation, death, and survival in a biofilm:
Bdellovibrio investigated by atomic force microscopy. Colloids Surf. B 2005; 42: 263–271.
Atomic Force Microscopy of Biofilms—Imaging, Interactions, and Mechanics
http://dx.doi.org/10.5772/63312
115
[35] Ando T, Kodera N, Naito Y, Kinoshita T, Furuta K, Toyoshima YY. A high‐speed atomic
force microscope for studying biological macromolecules in action. ChemPhysChem
2003; 4: 1196–1203.
[36] Shibata M, Yamashita H, Uchihashi T, Kandori H, Ando T. High‐speed atomic force
microscopy shows dynamic molecular processes in photoactivated bacteriorhodop‐
sin. Nat. Nanotechnol. 2010; 5: 208–212.
[37] Shibata M, Uchihashi T, Yamashita H, Kandori H, Ando T. Structural changes in
bacteriorhodopsin in response to alternate illumination observed by high‐speed atomic
force microscopy. Angew. Chem. Int. Ed. 2011; 50: 4410–4413.
[38] Casuso I, Khao J, Chami M, Paul‐Gilloteaux P, Husain M, Duneau J‐P, Stahlberg H,
Sturgis JN, Scheuring S. Characterization of the motion of membrane proteins using
high‐speed atomic force microscopy. Nat. Nanotechnol. 2012; 7: 525–529.
[39] Oestreicher Z, Taoka A, Fukumori Y. A comparison of the surface nanostructure from
two different types of gram‐negative cells: Escherichia coli and Rhodobacter sphaeroides.
Micron 2015; 72: 8–14.
[40] Benoit M, Gabriel D, Gerisch G, Gaub HE. Discrete interactions in cell adhesion
measured by single‐molecule force spectroscopy. Nat. Cell Biol. 2000; 2: 313–317.
[41] Helenius J, Heisenberg CP, Gaub HE, Muller DJ. Single‐cell force spectroscopy. J. Cell
Sci. 2008; 121: 1785–1791.
[42] Williams V, Fletcher M. Pseudomonas fluorescens adhesion and transport through
porous media are affected by lipopolysaccharide composition. Appl. Environ.
Microbiol. 1996; 62: 100–104.
[43] Savage DC, Fletcher M, editors. Bacterial Adhesion. Boston, MA: Springer US; 1985.
[44] Bullitt E, Makowski L. Bacterial adhesion pili are heterologous assemblies of similar
subunits. Biophys. J.1998; 74: 623–632.
[45] Bayer ME, Carlemalm E, Kellenberger E. Capsule of Escherichia coli K29: ultrastructur‐
al preservation and immunoelectron microscopy. J. Bacteriol. 1985; 162: 985–991.
[46] Engel A, Gaub HE, Müller DJ. Atomic force microscopy: a forceful way with single
molecules. Curr. Biol. 1999; 9: R133–R136.
[47] Engel A, Müller DJ. Observing single biomolecules at work with the atomic force
microscope. Nat. Struct. Biol. 2000; 7: 715–718.
[48] Dupres V, Alsteens D, Andre G, Verbelen C, Dufrêne YF. Fishing single molecules on
live cells. Nano Today 2009; 4: 262–268.
[49] Fredrickson GH. The theory of polymer dynamics. Curr. Opin. Solid State Mater. Sci.
1996; 1: 812–816.
Microbial Biofilms - Importance and Applications114
[77] Bowen WR, Lovitt RW, Wright CJ. Direct quantification of Aspergillus niger spore
adhesion in liquid using an atomic force microscope. J. Colloid Interface Sci. 2000; 228:
428–433.
[78] Bowen WR, Lovitt RW, Wright CJ. The measurement of Bacillus mycoides spore
adhesion using atomic force microscopy, simple counting methods and a spinning disc
technique. Biotech. Bioeng. 2002; 79: 170–179.
[79] Le DTL, Guérardel Y, Loubière P, Mercier‐Bonin M, Dague E. Measuring kinetic
dissociation/association constants between Lactococcus lactis bacteria and mucins using
living cell probes. Biophys. J. 2011; 101: 2843–2853.
[80] Ovchinnikova ES, Krom BP, van der Mei HC, Busscher HJ. Force microscopic and
thermodynamic analysis of the adhesion between Pseudomonas aeruginosa and Candida
albicans. Soft Matter 2012; 8: 24.
[81] Emerson IV RJ, Bergstrom TS, Liu Y, Soto ER, Brown CA, McGimpsey WG, Camesa‐
no TA. Microscale correlation between surface chemistry, texture, and the adhesive
strength of Staphylococcus epidermidis. Langmuir 2006; 22: 11311–11321.
[82] Razatos A, Ong YL, Sharma MM, Georgiou G. Molecular determinants of bacterial
adhesion monitored by atomic force microscopy. Proc. Natl. Acad. Sci. 1998; 95: 11059–
11064.
[83] Kang S, Elimelech M. Bioinspired single bacterial cell force spectroscopy. Langmuir
2009; 25: 9656–9659.
[84] Beaussart A, El‐Kirat‐Chatel S, Herman P, Alsteens D, Mahillon J, Hols P, Dufrêne YF.
Single‐cell force spectroscopy of probiotic bacteria. Biophys. J. 2013; 104: 1886–1892.
[85] Diao M, Taran E, Mahler S, Nguyen TAH, Nguyen AV. Quantifying adhesion of
acidophilic bioleaching bacteria to silica and pyrite by atomic force microscopy with a
bacterial probe. Colloids Surf. B 2014; 115: 229–236.
[86] Beaussart A, El‐Kirat‐Chatel S. Quantifying the forces guiding microbial cell adhe‐
sion using single‐cell force spectroscopy. Nat. Protoc. 2014; 9: 1049–1055.
[87] Miller E, Garcia T, Hultgren S, Oberhauser AF. The mechanical properties of E. coli
type 1 pili measured by atomic force microscopy techniques. Biophys. J. 2006; 91: 3848–
3856.
[88] Biais N, Higashi DL, Brujic J, So M, Sheetz MP. Force‐dependent polymorphism in type
IV pili reveals hidden epitopes. Proc. Natl. Acad. Sci. 2010; 107: 11358–11363.
[89] Lugmaier RA, Schedin S, Kühner F, Benoit M. Dynamic restacking of Escherichia coli P‐
pili. Eur. Biophys. J. 2008; 37: 111–120.
[90] Le DTL, Tran TL, Duviau MP, Meyrand M, Guérardel Y, Castelain M, Loubière P,
Chapot‐Chartier MP, Dague E, Mercier‐Bonin M. Unraveling the role of surface mucus‐
binding protein and pili in muco‐adhesion of Lactococcus lactis. PLoS One 2013; 8: 11.
Atomic Force Microscopy of Biofilms—Imaging, Interactions, and Mechanics
http://dx.doi.org/10.5772/63312
117
[64] Volle CB, Ferguson MA, Aidala KE, Spain EM, Nunez ME. Quantitative changes in the
elasticity and adhesive properties of Escherichia coli ZK1056 prey cells during
predation by Bdellovibrio bacteriovorus 109J. Langmuir 2008; 24: 8102–8110.
[65] Rodriguez A, Autio WR, Mc Landsborough LA. Effects of contact time, pressure,
percent relative humidity (%RH), and material type on Listeria biofilm adhesive
strength at a cellular level using atomic force microscopy (AFM). Food Biophys. 2008;
3: 305–311.
[66] Oh YJ, Lee NR, Jo W, Jung WK, Lim JS. Effects of substrates on biofilm formation
observed by atomic force microscopy. Ultramicroscopy 2009; 109: 874–880.
[67] Chen Y, Norde W, Van der Mei HC, Busscher HJ. Bacterial cell surface deformation
under external loading. MBio 2012; 3: 1–8.
[68] Francius G, Lebeer S, Alsteens D, Wildling L, Gruber HJ, Hols P, De Keersmaecker S,
Vanderleyden J, Dufrêne YF. Detection, localization, and conformational analysis of
single polysaccharide molecules on live bacteria. ACS Nano 2008; 2: 1921–1929.
[69] Volle CB, Ferguson MA, Aidala KE, Spain EM, Nunez ME. Spring constants and
adhesive properties of native bacterial biofilm cells measured by atomic force micro‐
scopy. Colloids Surf. B 2008; 67: 32–40.
[70] Longo G, Rio LM, Roduit C, Trampuz A, Bizzini A, Dietler G, Kasas S. Force volume
and stiffness tomography investigation on the dynamics of stiff material under bacterial
membranes. J. Mol. Recognit. 2012; 25: 278–284.
[71] adotić K, Roduit C, Simonović J, Hornitschek P, Fankhauser C, Mutavdžić D, Steinbach
G, Dietler G, Kasas S. Atomic force microscopy stiffness tomography on living
Arabidopsis thaliana cells reveals the mechanical properties of surface and deep cell‐wall
layers during growth. Biophys. J. 2012; 103: 386–394.
[72] Kasas S, Longo G, Dietler G. Mechanical properties of biological specimens explored
by atomic force microscopy. J. Phys. D Appl. Phys. 2013; 46: 133001.
[73] Baniasadi M, Xu Z, Gandee L, Du Y, Lu H, Zimmern P, Minary‐Jolandan M.
Nanoindentation of Pseudomonas aeruginosa bacterial biofilm using atomic force
microscopy. Mater. Res. Express. 2014; 1: 4.
[74] Safari A, Habimana O, Allen A, Casey E. The significance of calcium ions on Pseudo‐
monas fluorescens biofilms – a structural and mechanical study. Biofouling 2014; 30: 859–
869.
[75] Powell LC, Sowedan A, Khan S, Wright CJ, Hawkins K, Onsøyen E, Myrvold R, Hill
KE, Thomas DW. The effect of alginate oligosaccharides on the mechanical proper‐
ties of Gram‐negative biofilms. Biofouling 2013; 29: 413–421.
[76] Bowen WR, Hilal N, Lovitt RW, Wright CJ. Direct measurement of the force of adhesion
of a single cell using an atomic force microscope. Colloids Surf. A 1998; 136: 231–234.
Microbial Biofilms - Importance and Applications116
[77] Bowen WR, Lovitt RW, Wright CJ. Direct quantification of Aspergillus niger spore
adhesion in liquid using an atomic force microscope. J. Colloid Interface Sci. 2000; 228:
428–433.
[78] Bowen WR, Lovitt RW, Wright CJ. The measurement of Bacillus mycoides spore
adhesion using atomic force microscopy, simple counting methods and a spinning disc
technique. Biotech. Bioeng. 2002; 79: 170–179.
[79] Le DTL, Guérardel Y, Loubière P, Mercier‐Bonin M, Dague E. Measuring kinetic
dissociation/association constants between Lactococcus lactis bacteria and mucins using
living cell probes. Biophys. J. 2011; 101: 2843–2853.
[80] Ovchinnikova ES, Krom BP, van der Mei HC, Busscher HJ. Force microscopic and
thermodynamic analysis of the adhesion between Pseudomonas aeruginosa and Candida
albicans. Soft Matter 2012; 8: 24.
[81] Emerson IV RJ, Bergstrom TS, Liu Y, Soto ER, Brown CA, McGimpsey WG, Camesa‐
no TA. Microscale correlation between surface chemistry, texture, and the adhesive
strength of Staphylococcus epidermidis. Langmuir 2006; 22: 11311–11321.
[82] Razatos A, Ong YL, Sharma MM, Georgiou G. Molecular determinants of bacterial
adhesion monitored by atomic force microscopy. Proc. Natl. Acad. Sci. 1998; 95: 11059–
11064.
[83] Kang S, Elimelech M. Bioinspired single bacterial cell force spectroscopy. Langmuir
2009; 25: 9656–9659.
[84] Beaussart A, El‐Kirat‐Chatel S, Herman P, Alsteens D, Mahillon J, Hols P, Dufrêne YF.
Single‐cell force spectroscopy of probiotic bacteria. Biophys. J. 2013; 104: 1886–1892.
[85] Diao M, Taran E, Mahler S, Nguyen TAH, Nguyen AV. Quantifying adhesion of
acidophilic bioleaching bacteria to silica and pyrite by atomic force microscopy with a
bacterial probe. Colloids Surf. B 2014; 115: 229–236.
[86] Beaussart A, El‐Kirat‐Chatel S. Quantifying the forces guiding microbial cell adhe‐
sion using single‐cell force spectroscopy. Nat. Protoc. 2014; 9: 1049–1055.
[87] Miller E, Garcia T, Hultgren S, Oberhauser AF. The mechanical properties of E. coli
type 1 pili measured by atomic force microscopy techniques. Biophys. J. 2006; 91: 3848–
3856.
[88] Biais N, Higashi DL, Brujic J, So M, Sheetz MP. Force‐dependent polymorphism in type
IV pili reveals hidden epitopes. Proc. Natl. Acad. Sci. 2010; 107: 11358–11363.
[89] Lugmaier RA, Schedin S, Kühner F, Benoit M. Dynamic restacking of Escherichia coli P‐
pili. Eur. Biophys. J. 2008; 37: 111–120.
[90] Le DTL, Tran TL, Duviau MP, Meyrand M, Guérardel Y, Castelain M, Loubière P,
Chapot‐Chartier MP, Dague E, Mercier‐Bonin M. Unraveling the role of surface mucus‐
binding protein and pili in muco‐adhesion of Lactococcus lactis. PLoS One 2013; 8: 11.
Atomic Force Microscopy of Biofilms—Imaging, Interactions, and Mechanics
http://dx.doi.org/10.5772/63312
117
[64] Volle CB, Ferguson MA, Aidala KE, Spain EM, Nunez ME. Quantitative changes in the
elasticity and adhesive properties of Escherichia coli ZK1056 prey cells during
predation by Bdellovibrio bacteriovorus 109J. Langmuir 2008; 24: 8102–8110.
[65] Rodriguez A, Autio WR, Mc Landsborough LA. Effects of contact time, pressure,
percent relative humidity (%RH), and material type on Listeria biofilm adhesive
strength at a cellular level using atomic force microscopy (AFM). Food Biophys. 2008;
3: 305–311.
[66] Oh YJ, Lee NR, Jo W, Jung WK, Lim JS. Effects of substrates on biofilm formation
observed by atomic force microscopy. Ultramicroscopy 2009; 109: 874–880.
[67] Chen Y, Norde W, Van der Mei HC, Busscher HJ. Bacterial cell surface deformation
under external loading. MBio 2012; 3: 1–8.
[68] Francius G, Lebeer S, Alsteens D, Wildling L, Gruber HJ, Hols P, De Keersmaecker S,
Vanderleyden J, Dufrêne YF. Detection, localization, and conformational analysis of
single polysaccharide molecules on live bacteria. ACS Nano 2008; 2: 1921–1929.
[69] Volle CB, Ferguson MA, Aidala KE, Spain EM, Nunez ME. Spring constants and
adhesive properties of native bacterial biofilm cells measured by atomic force micro‐
scopy. Colloids Surf. B 2008; 67: 32–40.
[70] Longo G, Rio LM, Roduit C, Trampuz A, Bizzini A, Dietler G, Kasas S. Force volume
and stiffness tomography investigation on the dynamics of stiff material under bacterial
membranes. J. Mol. Recognit. 2012; 25: 278–284.
[71] adotić K, Roduit C, Simonović J, Hornitschek P, Fankhauser C, Mutavdžić D, Steinbach
G, Dietler G, Kasas S. Atomic force microscopy stiffness tomography on living
Arabidopsis thaliana cells reveals the mechanical properties of surface and deep cell‐wall
layers during growth. Biophys. J. 2012; 103: 386–394.
[72] Kasas S, Longo G, Dietler G. Mechanical properties of biological specimens explored
by atomic force microscopy. J. Phys. D Appl. Phys. 2013; 46: 133001.
[73] Baniasadi M, Xu Z, Gandee L, Du Y, Lu H, Zimmern P, Minary‐Jolandan M.
Nanoindentation of Pseudomonas aeruginosa bacterial biofilm using atomic force
microscopy. Mater. Res. Express. 2014; 1: 4.
[74] Safari A, Habimana O, Allen A, Casey E. The significance of calcium ions on Pseudo‐
monas fluorescens biofilms – a structural and mechanical study. Biofouling 2014; 30: 859–
869.
[75] Powell LC, Sowedan A, Khan S, Wright CJ, Hawkins K, Onsøyen E, Myrvold R, Hill
KE, Thomas DW. The effect of alginate oligosaccharides on the mechanical proper‐
ties of Gram‐negative biofilms. Biofouling 2013; 29: 413–421.
[76] Bowen WR, Hilal N, Lovitt RW, Wright CJ. Direct measurement of the force of adhesion
of a single cell using an atomic force microscope. Colloids Surf. A 1998; 136: 231–234.
Microbial Biofilms - Importance and Applications116
Section 2
Biofilm Applications
[91] Beaussart A, Herman P, El‐Kirat‐Chatel S, Lipke PN, Kucharíková S, Van Dijck P,
Dufrêne YF. Single‐cell force spectroscopy of the medically important Staphylococcus
epidermidis‐Candida albicans interaction. Nanoscale 2013; 5: 10894–10900.
[92] Chaw KC, Manimaran M, Tay FEH. Role of silver ions in destabilization of intermo‐
lecular adhesion forces measured by atomic force microscopy in Staphylococcus
epidermidis biofilms. Antimicrob. Agents Chemother. 2005; 49: 4853–4859.
Microbial Biofilms - Importance and Applications118
Section 2
Biofilm Applications
[91] Beaussart A, Herman P, El‐Kirat‐Chatel S, Lipke PN, Kucharíková S, Van Dijck P,
Dufrêne YF. Single‐cell force spectroscopy of the medically important Staphylococcus
epidermidis‐Candida albicans interaction. Nanoscale 2013; 5: 10894–10900.
[92] Chaw KC, Manimaran M, Tay FEH. Role of silver ions in destabilization of intermo‐
lecular adhesion forces measured by atomic force microscopy in Staphylococcus
epidermidis biofilms. Antimicrob. Agents Chemother. 2005; 49: 4853–4859.
Microbial Biofilms - Importance and Applications118
Chapter 7
Role of the Biofilms in Wastewater Treatment
Shama Sehar and Iffat Naz
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/63499
Abstract
Biological wastewater treatment systems play an important role in improving water
quality  and human health.  This  chapter  thus  briefly  discusses  different  biological
methods, specially biofilm technologies, the development of biofilms on different filter
media, factors affecting their development as well as their structure and function. It also
tackles various conventional and modern molecular techniques for detailed explora‐
tion of the composition, diversity and dynamics of biofilms. These data are crucial to
improve  the  performance,  robustness  and  stability  of  biofilm-based  wastewater
treatment technologies.
Keywords: biofilm, wastewater treatment, biofilm technologies, molecular methods,
biofilter media
1. Introduction
Water is a basic necessity, but its availability for human use is hardly about 1%. Current global
water crises are due to a rapid increase in population, climatic variation, environmental pollution,
urbanization, industrialization and contamination of existing water reservoirs. The quality of
freshwater in rivers and streams is affected because much of the wastage is discharged without
prior treatment from industries,  municipal  sewers and agricultural  areas.  The quality of
groundwater is declining due to unprocessed sewage containing domestic waste along with
human and animal excretion products, leading to worldwide deaths and other environmental
factors, including biodiversity reduction and an increasing number of water-related infec‐
tions, among others. According to WHO, approximately 30% of all diseases and 40% of deaths
throughout the world are due to polluted water [1].
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
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by being resuspended. In dispersed growth systems, the density of dispersed biomass is close
to the sewage and moves in the same direction and velocity thereof. Thus, biomass is ex‐
posed to the same fraction of liquid for a larger interval with less substrate concentration in
the neighboring cell, leading to low bacterial activity and substrate removal rate. The hydraul‐
ic retention time (average time water molecules stay in the system) has to be greater than the
doubling time of microorganisms (time required to generate new cells) to increase bacterial
activity and population size. Bacteria can easily be “washed out” of the system if the hydraul‐
ic retention time is shorter than the bacterial doubling time [4]. This is the main hurdle in sizing
biological reactors, as reactor volume and retention time are directly related to each other.
Some of the commonly used dispersed growth systems are described in the following
subsections.
2.1.1. Activated sludge technology
Activated sludge systems comprise a multichamber reactor unit in which aerobic microor‐
ganisms are used to degrade organic components of wastewater to produce a high-quality
effluent. Constant supply of oxygen is required to maintain aerobic conditions in an aeration
tank. Besides aerobic bacteria, anaerobic and/or nitrifying bacteria along with higher organ‐
isms can be present. These microorganisms oxidize the organic carbon present in wastewa‐
ter to produce carbon dioxide, water and new cells that form small clusters or flocs during the
aeration and mixing process. After aeration, the mixture is transferred to a secondary clarifier
for settling of floc particles and the effluent moves on for further treatment or discharge. The
sludge is then recycled back to the aeration tank, where the process is repeated. A schematic
of the entire process is shown in Figure 2. Activated sludge technology is most commonly used
Figure 2. Schematic of a typical activated sludge system [6].
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Wastewater is a broad term comprising effluents or discharge from household seepage,
agriculture, industries and storm water [2]. The organic material present in wastewater
includes detergents, pesticides, fats and oils. In addition, many types of microorganisms,
including bacteria, viruses, protozoa and helminths, can be present in wastewater. Basic
nutrients (nitrogen, phosphorous and ammonia, etc.) as well as metals and inorganic materi‐
als (mercury, lead, cadmium, nickel and hydrogen sulfide, etc.) are also present in wastewa‐
ter. By keeping the hazardous effects of wastewater and its usage for daily lives, wastewater
treatment plants have become a focal path in securing our future water supply.
2. Types of biological wastewater treatment systems
There are a number of wastewater treatment processes based on the physical and chemical
removal of contaminants. These processes offer varying degrees of effectiveness in addition
to presenting environmental and economic disadvantages. However, biological wastewater
treatment technologies have been gaining much attention in recent years. They offer low
operational costs, provide easy handling and have comparatively less harmful effects on the
corresponding environment. On the basis of structural configuration of biomass, biological
wastewater treatment processes can be divided into two basic configurations: dispersed
growth system and attached growth system.
2.1. Dispersed growth system
In dispersed/suspended growth systems, biomass grows in suspended or dispersed form in
liquid medium without any attachment to the surface (Figure 1).
Figure 1. Typical examples of biomass growth [3].
Microorganisms in biomass absorb organic matter and nutrients in their vicinity, which allows
them to grow and reproduce to form microcolonies. These microcolonies settle as sludge,
which is then either removed or treated in a sludge treatment process or reused in the process
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the microbes that absorb dissolved organic matter for their growth and reproduction as the
wastewater cascades randomly through the voids between the media [8]. A schematic of the
entire process is shown in Figure 3. TFs are suitable for small- to medium-sized communi‐
ties with a high filter loading rate and marked by their ease of operation, self-cleaning capacity
and efficient removal of ammonia. However, additional treatment may be needed for the
effluent to meet strict discharge standards as it generates large amounts of sludge and a
relatively high incidence of clogging [9].
Figure 3. Schematic of a typical trickling filter system [10].
2.2.2. Rotating biological contactor (RBC) system
The rotating biological contactor (RBC) is an efficient attached growth system that purifies
wastewater from different industries, namely food and beverage, refinery and petrochemi‐
cal, pulp and paper industries. In addition, it is efficient in purifying municipal wastewater,
landfill leachate and lagoon effluent. The system consists of biomass media, usually plastic
(polyethylene, polyvinyl chloride [PVC] and expanded polystyrene), that are partially
immersed in wastewater. As it slowly rotates, it lifts a film of wastewater into the air. The
wastewater trickles down across the media and absorbs oxygen from the air provided by the
rotating action. A living biomass (biofilm) attached to the discs assimilates the organic
materials and nutrients in the wastewater. Any excess biomass that sloughs off the discs by
shearing forces exerted with disc rotation and gravitational force is then removed from clear
water through a conventional clarification process. A schematic of the entire process is shown
in Figure 4. The RBC system has an edge over suspended growth systems in terms of reduced
life cycle costs, less sludge production, less space requirement, ease of operation and high
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in industrialized countries for the removal of biological solids by sedimentation. Poor settling
of these solid pollutants can lead to increased solid treatment costs, increased effluent solid
concentrations, decreased disinfection efficiencies, washout/low biomass concentration and
increased risks to downstream ecosystems and public health [5].
2.1.2. Extended aeration system
The extended aeration system is one of the modifications of the activated sludge process. It is
a complete mixed system that provides biological treatment for the removal of biodegrada‐
ble organic waste under aerobic conditions. Air may be supplied by mechanical or diffused
aeration means. The raw sewage directly flows into the aerobic digestion chamber where all
the solids are digested by aerobic bacteria. This is possible because the sewage is aerated for
a minimum of 24 h, giving vastly increased time for almost complete digestion of all solids.
Since there is complete stabilization in the aeration tank, there is no need for a separate sludge
digester. Furthermore, there is no need for a primary settling tank as organic solids are allowed
to settle in the aeration tank due to their long detention time. The major advantages of extended
aeration include ease of construction as well as operation, high oxygen transfer efficiency,
absence of odor, less sludge yield and exceptional mixing energy from a controlled aeration
chain environment. However, extended aeration plants do not achieve denitrification and
phosphorus removal without additional unit processes.
2.2. Attached growth system
In attached growth systems, the biomass grows attached to a support medium to create a
biofilm. Attachment to the support medium is influenced by composition of the media used,
cell-cell interactions and the presence of polymer molecules on the surface [7]. The support
medium can be immersed in the liquid medium or receive continuous or intermittent
discharges. The support medium can be of any nature, such as solid natural (rocks, stones,
gravels, sand and soil), artificial (rubber, plastic) or agglomerates of the biomass itself
(granules). These biofilms grow on support media by feeding off the organic matter and
nutrients in the wastewater that flows over them. In attached growth systems, there is a
difference in the density gradient of the support medium together with biomass and the
density of the liquid inside the reactor that allows the velocity gradient between the liquid and
the external layer of biofilm. Therefore, bacterial cells being continually exposed to new
substrates tend to increase their activity. Some of the commonly used attached growth systems
are described in the following subsections.
2.2.1. Trickling filters
Wastewater treatment through trickling filters (TFs) is among the oldest and most well
characterized treatment technologies. TFs generally comprise a vessel packed with inert
media (rocks, coke, lava, slag, gravel, polyurethane foam, ceramic, sphagnum peat moss or
plastic media). The distribution system is used to sprinkle wastewater over filter media, and
the wastewater trickles through the filter media supporting biomass under the influence of
gravitational force. A biological slime layer grows on the media, and treatment is provided by
Microbial Biofilms - Importance and Applications124
the microbes that absorb dissolved organic matter for their growth and reproduction as the
wastewater cascades randomly through the voids between the media [8]. A schematic of the
entire process is shown in Figure 3. TFs are suitable for small- to medium-sized communi‐
ties with a high filter loading rate and marked by their ease of operation, self-cleaning capacity
and efficient removal of ammonia. However, additional treatment may be needed for the
effluent to meet strict discharge standards as it generates large amounts of sludge and a
relatively high incidence of clogging [9].
Figure 3. Schematic of a typical trickling filter system [10].
2.2.2. Rotating biological contactor (RBC) system
The rotating biological contactor (RBC) is an efficient attached growth system that purifies
wastewater from different industries, namely food and beverage, refinery and petrochemi‐
cal, pulp and paper industries. In addition, it is efficient in purifying municipal wastewater,
landfill leachate and lagoon effluent. The system consists of biomass media, usually plastic
(polyethylene, polyvinyl chloride [PVC] and expanded polystyrene), that are partially
immersed in wastewater. As it slowly rotates, it lifts a film of wastewater into the air. The
wastewater trickles down across the media and absorbs oxygen from the air provided by the
rotating action. A living biomass (biofilm) attached to the discs assimilates the organic
materials and nutrients in the wastewater. Any excess biomass that sloughs off the discs by
shearing forces exerted with disc rotation and gravitational force is then removed from clear
water through a conventional clarification process. A schematic of the entire process is shown
in Figure 4. The RBC system has an edge over suspended growth systems in terms of reduced
life cycle costs, less sludge production, less space requirement, ease of operation and high
Role of the Biofilms in Wastewater Treatment
http://dx.doi.org/10.5772/63499
125
in industrialized countries for the removal of biological solids by sedimentation. Poor settling
of these solid pollutants can lead to increased solid treatment costs, increased effluent solid
concentrations, decreased disinfection efficiencies, washout/low biomass concentration and
increased risks to downstream ecosystems and public health [5].
2.1.2. Extended aeration system
The extended aeration system is one of the modifications of the activated sludge process. It is
a complete mixed system that provides biological treatment for the removal of biodegrada‐
ble organic waste under aerobic conditions. Air may be supplied by mechanical or diffused
aeration means. The raw sewage directly flows into the aerobic digestion chamber where all
the solids are digested by aerobic bacteria. This is possible because the sewage is aerated for
a minimum of 24 h, giving vastly increased time for almost complete digestion of all solids.
Since there is complete stabilization in the aeration tank, there is no need for a separate sludge
digester. Furthermore, there is no need for a primary settling tank as organic solids are allowed
to settle in the aeration tank due to their long detention time. The major advantages of extended
aeration include ease of construction as well as operation, high oxygen transfer efficiency,
absence of odor, less sludge yield and exceptional mixing energy from a controlled aeration
chain environment. However, extended aeration plants do not achieve denitrification and
phosphorus removal without additional unit processes.
2.2. Attached growth system
In attached growth systems, the biomass grows attached to a support medium to create a
biofilm. Attachment to the support medium is influenced by composition of the media used,
cell-cell interactions and the presence of polymer molecules on the surface [7]. The support
medium can be immersed in the liquid medium or receive continuous or intermittent
discharges. The support medium can be of any nature, such as solid natural (rocks, stones,
gravels, sand and soil), artificial (rubber, plastic) or agglomerates of the biomass itself
(granules). These biofilms grow on support media by feeding off the organic matter and
nutrients in the wastewater that flows over them. In attached growth systems, there is a
difference in the density gradient of the support medium together with biomass and the
density of the liquid inside the reactor that allows the velocity gradient between the liquid and
the external layer of biofilm. Therefore, bacterial cells being continually exposed to new
substrates tend to increase their activity. Some of the commonly used attached growth systems
are described in the following subsections.
2.2.1. Trickling filters
Wastewater treatment through trickling filters (TFs) is among the oldest and most well
characterized treatment technologies. TFs generally comprise a vessel packed with inert
media (rocks, coke, lava, slag, gravel, polyurethane foam, ceramic, sphagnum peat moss or
plastic media). The distribution system is used to sprinkle wastewater over filter media, and
the wastewater trickles through the filter media supporting biomass under the influence of
gravitational force. A biological slime layer grows on the media, and treatment is provided by
Microbial Biofilms - Importance and Applications124
efficiency of CWs, including hydraulic retention time, temperature, macrophytes, composi‐
tion of substrate or fill media and microorganisms [14]. In CWs, the role of macrophytes is very
important for the removal of nutrients from wastewater, and they also speed up the purifica‐
tion process by increasing the chemical and biological reactions in the rhizosphere. CWs
require low operational and maintenance costs, less energy consumption and a reduced
amount of sludge, and they are environmentally friendly [15].
Figure 5. Schematic of a constructed wetland system for wastewater treatment [14].
2.2.4. Membrane bioreactors (MBRs)
Membrane bioreactors (MBRs), which are used for municipal/industrial wastewater treat‐
ment, are a combination of a suspended growth treatment method with membrane filtration
equipped with low-pressure microfiltration (MF) or ultrafiltration (UF) membranes. A
membrane is simply a two-dimensional material used to separate components of fluids usually
on the basis of their relative size or electrical charge. MBRs are generally categorized into the
following: (i) vacuum or gravity-driven systems, immersed and normally employing hollow
fiber or flat sheet membranes installed in bioreactors or a subsequent membrane tank and (ii)
pressure-driven systems or pipe cartridge systems located external to the bioreactor. A
schematic of MBRs is depicted in Figure 6.
An MBR system is often composed of 10 or 11 subsystems and includes fine screening, the
membrane zone and, in most cases, some type of post-disinfection process. The initial step in
a biological process occurs in membrane zones where microbes are used to degrade pollu‐
tants that are then filtered by a series of submerged membranes. The individual membranes
are housed in units known as modules, cassettes or racks, and a combined series of these
modules is referred to as a working membrane unit. Air is introduced through integral
diffusers to continually scour membrane surfaces during filtration, facilitate mixing and, in
some cases, contribute oxygen to the biological process. The major advantage of MBRs is that
they allow high concentrations of mixed liquor suspended solids (MLSSs) with low sludge
production, increased removal efficiencies of BOD and COD, water reclamation, reduced
footprints and no further polishing requirement for disinfection/clarification. However,
membrane surface fouling is a major obstacle to the wide application of MBRs. Additionally,
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process stability with load variations as well as high effluent quality with regard to both
biological oxygen demand (BOD) and nutrients. However, RBC system optimization and
adaptability under different environmental conditions and influent characteristics still pose
challenges for the efficient design and use of this technology.
Figure 4. Schematic of a typical rotating biological contactor (RBC) [11].
2.2.3. Constructed wetland system
Constructed wetlands (CWs) are engineered attached growth or fixed film systems compris‐
ing beds loaded with inadequately sapped graded medium (sand, soil, gravel, etc.) and planted
with suitable vegetation and their microbial inhabitants to treat contaminants in surface water,
groundwater or waste streams. CWs generally may be categorized into two major groups:
surface flow and subsurface flow. In the case of surface flow, the water runs over the surface,
while for subsurface flow, it runs beneath the surface to overcome the issues of odor. In surface
flow, the bacteria and substrate contact angle with water is lower than that in subsurface flow,
resulting in the much enhanced treatment efficiency of subsurface flow systems [12]. Further
subsurface flow systems are categorized into horizontal and vertical subsurface flow wet‐
lands depending on the flow path. All these systems are efficient in removing contaminants
and pathogens from wastewater; however, the evaporation rate of CWs in general is much
higher than that of ponds or lagoons, thus posing a low potential for irrigation. The configu‐
ration of hybrid CWs (combination of vertical and horizontal flows) is considered to be an
appropriate choice that has minimum water loss to overcome this flaw (Figure 5). Hence, the
discharge of nitrified and partly denitrified effluents is possible with lower total N contents
[13].
Generally, water purification in constructed wetlands involves a series of physical, chemical
and biological processes, such as adsorption, filtration, sedimentation, chemical precipita‐
tion, microbial activities and macrophyte uptake. Various factors contribute to the removal
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amount of sludge, and they are environmentally friendly [15].
Figure 5. Schematic of a constructed wetland system for wastewater treatment [14].
2.2.4. Membrane bioreactors (MBRs)
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equipped with low-pressure microfiltration (MF) or ultrafiltration (UF) membranes. A
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on the basis of their relative size or electrical charge. MBRs are generally categorized into the
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fiber or flat sheet membranes installed in bioreactors or a subsequent membrane tank and (ii)
pressure-driven systems or pipe cartridge systems located external to the bioreactor. A
schematic of MBRs is depicted in Figure 6.
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are housed in units known as modules, cassettes or racks, and a combined series of these
modules is referred to as a working membrane unit. Air is introduced through integral
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some cases, contribute oxygen to the biological process. The major advantage of MBRs is that
they allow high concentrations of mixed liquor suspended solids (MLSSs) with low sludge
production, increased removal efficiencies of BOD and COD, water reclamation, reduced
footprints and no further polishing requirement for disinfection/clarification. However,
membrane surface fouling is a major obstacle to the wide application of MBRs. Additionally,
Role of the Biofilms in Wastewater Treatment
http://dx.doi.org/10.5772/63499
127
process stability with load variations as well as high effluent quality with regard to both
biological oxygen demand (BOD) and nutrients. However, RBC system optimization and
adaptability under different environmental conditions and influent characteristics still pose
challenges for the efficient design and use of this technology.
Figure 4. Schematic of a typical rotating biological contactor (RBC) [11].
2.2.3. Constructed wetland system
Constructed wetlands (CWs) are engineered attached growth or fixed film systems compris‐
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flow, the bacteria and substrate contact angle with water is lower than that in subsurface flow,
resulting in the much enhanced treatment efficiency of subsurface flow systems [12]. Further
subsurface flow systems are categorized into horizontal and vertical subsurface flow wet‐
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higher than that of ponds or lagoons, thus posing a low potential for irrigation. The configu‐
ration of hybrid CWs (combination of vertical and horizontal flows) is considered to be an
appropriate choice that has minimum water loss to overcome this flaw (Figure 5). Hence, the
discharge of nitrified and partly denitrified effluents is possible with lower total N contents
[13].
Generally, water purification in constructed wetlands involves a series of physical, chemical
and biological processes, such as adsorption, filtration, sedimentation, chemical precipita‐
tion, microbial activities and macrophyte uptake. Various factors contribute to the removal
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medium; (2) irreversible adhesion upon the production of microorganism-mediated EPSs as
polyhydroxyl groups in EPSs colonize bacteria to the surface via hydrogen bonding [18]; (3)
formation of monolayer microcolonies on the fixed surface due to replication of early
colonizers; (4) maturation of biofilm into a three-dimensional arrangement by attaching debris
from the adjacent environment and by employing new planktonic bacteria and (5) disper‐
sion or expansion by active and passive processes in which sessile, matrix-encased biofilm cells
convert to freely swimming planktonic bacteria through quorum sensing (QS) or a cell-to-cell
signaling mechanism [19].
3.1. Factors effecting biofilm formation
The following subsections discuss the factors that help in promoting the process of biofilm
formation.
3.1.1. Effects of nutrients, pH and temperature
Biofilm formation varies under diverse nutrient conditions ranging from high to almost non-
detectable. However, they are more abundant and dense in a nutrient-rich environment as it
promotes the transition of bacterial cells from planktonic to biofilm state, while depletion of
these nutrients causes detachment of biofilm cells from surfaces. There are different means by
which bacterial biofilms obtain nutrients: (i) concentrating trace organics on surfaces through
extracellular polymer, (ii) using the waste products from secondary colonizers and (iii) pooling
the biochemical resources with the help of different enzymes to break down food supplies.
Any change in pH greatly affects the growth and development of bacterial and biofilm
formation as it can overwhelm different mechanisms and have negative or killing effects on
the microorganisms. In response to internal or external changes in pH, bacteria quickly adjust
the activity and synthesis of proteins that are associated with different cellular processes.
However, some of the cellular processes, including excretion of exopolymeric substances or
polysaccharides, do not adapt to pH variations so easily. The optimum pH for polysacchar‐
ide production varies among different species, but for the majority of bacteria, it is around 7
[21]. Microbial activities are very sensitive to change in temperature. Optimum temperature
results in healthy growth of bacterial populations, whereas a slight variation may reduce
bacterial growth efficiency. The reason for this is a reduction in bacterial enzyme reaction rates.
For many bacteria found in cooling water systems, the optimum temperature for maximum
growth is about 40°C [22].
3.1.2. Surface topography
Surface topography greatly influences the ability of bacteria to adhere to a surface. During the
initial steps of colonization, surface roughness at nanoscale and microscale levels enhances the
adhesion of bacteria to substrates by providing more surface area for cell attachment. Surface
roughness reduces the shear force on bacterial cells and communities present in flowing liquids
at high flow rates, such as water pipes in industrial plants. A material surface exposed in an
aqueous medium will inevitably become conditioned or coated by polymers from the medium,
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membrane channel clogging and process complexity are the main cause of increased capital
as well as running costs of the entire system [16].
Figure 6. Typical schematic for a membrane bioreactor [17].
3. Biofilm development: structure and function
An assemblage of microbial cells enclosed in a matrix of bacterial self-generated extracellu‐
lar polymeric substances (EPSs) irreversibly associated with a surface is termed a biofilm.
Generally, the development of biofilms is composed of five main stages (Figure 7): (1) initial
attachment of planktonic microorganisms with the exposure of a surface to an aqueous
Figure 7. Stages of biofilm development [20]: (1) initial attachment; (2) irreversible attachment; (3) replication; (4) matu‐
ration and (5) dispersion.
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surroundings [29]. Different biofilms produce different amounts of EPSs, and the amount of
EPSs increases with the age of biofilms [30].
3.1.6. Extracellular DNA (eDNA)
Extracellular DNA (eDNA) has been reported to be a major constituent of various single and
multispecies biofilms. eDNA or naked DNA is a central part of bacterial self-produced
extracellular polymeric substances (EPSs) and has similarity to chromosomal DNA in its
primary sequence [31]. Its role is very important in various stages of biofilm formation, such
as initial bacterial adhesion, aggregation and microcolony formation that favors wastewater
treatment. eDNA also helps strengthen biofilms, provides protection to biofilms from physical
stress, antibiotics and detergents as well as serves as an excellent source of nutrients for biofilm
growth [32]. In addition, eDNA can be utilized in engineering of biofilms for beneficial
purposes, such as remediation of environmental pollutants and electricity or fuel production
in bioelectrochemical systems or bioreactors.
3.1.7. Divalent cations
Divalent cations such as Ca2+ are abundant in terrestrial and aquatic environments; therefore,
calcium may be one of the factors that bacteria sense during biofilm-associated growth. Recent
studies showed that eDNA chelates divalent cations that help in the modification of bacteri‐
al cell surface properties and thus favor resistance of biofilms to detergents and antimicrobi‐
al agents [33]. Divalent cations, such as those of calcium, play a critical role in the initial
attachment of microbial aggregates of activated sludge flocs, anaerobic sludge granules and
biofilms by bridging negatively charged sites on extracellular polymers [34]. Recent studies
have shown that the thickness of a biofilm can be enhanced by introducing more divalent
cations, as a result of which the biofilm becomes denser and mechanically more stable [35].
Calcium has been found to not only act as a cofactor for certain proteins but also act in cell
signaling, biofilm virulence, cellular and extracellular product formation and alginate
regulation [36].
4. Biofilm in wastewater treatment
Biofilm system is a well-developed technology in which solid media are added to suspend‐
ed growth reactors to provide attachment surfaces for biofilms, so as to increase the microbi‐
al concentration as well as rates of contaminant degradation biofilms to take advantage of a
number of removal mechanisms, including biodegradation, bioaccumulation, biosorption and
biomineralization [8]. The microbial communities in the biofilm break down different
nutrients, such as phosphorous and nitrogen-containing compounds, carbonaceous materi‐
als as well as trapped pathogens from the wastewater. Once pollutants are removed, treated
water of a biofilter is either released to the environment or used for agriculture and other
recreational purposes. Removal of the pollutants from wastewater by biofilm on the filter
media is schematically represented in Figure 8.
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and the resulting chemical modification will affect the rate and extent of microbial attach‐
ment. Moreover, other factors such as charge, hydrophobicity and elasticity are also influen‐
tial in microbial attachment [23].
3.1.3. Velocity, turbulence and hydrodynamics
The area from the surface where no turbulent flow is experienced is known as the boundary
layer. Within this area, the flow velocity has been shown to be insufficient to remove bio‐
films. The area outside this layer is characterized by high levels of turbulent flow and has an
influence on the attachment of cells to the surface. The size of the boundary layer is depend‐
ent on the flow velocity of water. At high velocities, the boundary layer decreases in size and
the cells are exposed to a high turbulence level. Hydrodynamic conditions can influence the
formation, structure, EPS production, thickness, mass and metabolic activities of biofilms
[24].
3.1.4. Gene regulation and quorum sensing (QS)
Studies have shown that up-regulation and down-regulation of a number of genes are involved
in the initial attachment of cells with the substratum. Approximately 22% of genes were up-
regulated and 16% were down-regulated in the biofilm formation of Pseudomonas aeruginosa
[25]. In addition, algD, algU, rpoS and genes controlling polyphosphokinase synthesis were
also up-regulated in the biofilm formation of P. aeruginosa [23]. Biofilms of Staphylococcus aureus
were up-regulated for genes encoding enzymes involved in glycolysis or fermentation, such
as phosphoglycerate mutase, triphosphate and alcohol dehydrogenase [26]. Cell-to-cell
signaling, also termed QS, has recently been proven to play a significant role in cell attach‐
ment and detachment from biofilms. Growth and development of biofilms on different
surfaces are mediated by a density-dependent chemical signal released by bacterial cells
densely packed with an EPS matrix. QS makes use of a transcriptional activator protein that
acts in concert with small autoinducers (AIs) signaling molecules to stimulate expression of
target genes, resulting in changes in chemical behavior. After accumulation of sufficient AIs,
this form of intercellular communication serves to coordinate gene expression, morphologi‐
cal differentiation and the development responses of bacterial cells [27].
3.1.5. Production of extracellular polymeric substances (EPSs)
Extracellular polymeric substances (EPSs) are a complex mixture of high-molecular-weight
polymer (Mw = 10,000) excreted by microorganisms, products from lysis and hydrolysis as well
as adsorbed organic matters from wastewater. Generally, EPSs have been shown to be a rich
matrix of polymers, including polysaccharides, proteins, glycoproteins, DNA oligomers,
phospholipids and humic acids [28]. EPSs are also highly hydrated because they can incorpo‐
rate large amounts of water into their structure by hydrogen bonding. EPSs are typically
reported to aid in the formation of a gel-like network that keeps bacteria together in biofilms
due to bridging with multivalent cations and hydrophobic interactions. In addition, EPSs also
cause the adherence of biofilms to surfaces, flocculation and granulation, protect bacteria
against noxious environmental conditions and enable bacteria to capture nutrients from the
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have shown that the thickness of a biofilm can be enhanced by introducing more divalent
cations, as a result of which the biofilm becomes denser and mechanically more stable [35].
Calcium has been found to not only act as a cofactor for certain proteins but also act in cell
signaling, biofilm virulence, cellular and extracellular product formation and alginate
regulation [36].
4. Biofilm in wastewater treatment
Biofilm system is a well-developed technology in which solid media are added to suspend‐
ed growth reactors to provide attachment surfaces for biofilms, so as to increase the microbi‐
al concentration as well as rates of contaminant degradation biofilms to take advantage of a
number of removal mechanisms, including biodegradation, bioaccumulation, biosorption and
biomineralization [8]. The microbial communities in the biofilm break down different
nutrients, such as phosphorous and nitrogen-containing compounds, carbonaceous materi‐
als as well as trapped pathogens from the wastewater. Once pollutants are removed, treated
water of a biofilter is either released to the environment or used for agriculture and other
recreational purposes. Removal of the pollutants from wastewater by biofilm on the filter
media is schematically represented in Figure 8.
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the cells are exposed to a high turbulence level. Hydrodynamic conditions can influence the
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regulated and 16% were down-regulated in the biofilm formation of Pseudomonas aeruginosa
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were up-regulated for genes encoding enzymes involved in glycolysis or fermentation, such
as phosphoglycerate mutase, triphosphate and alcohol dehydrogenase [26]. Cell-to-cell
signaling, also termed QS, has recently been proven to play a significant role in cell attach‐
ment and detachment from biofilms. Growth and development of biofilms on different
surfaces are mediated by a density-dependent chemical signal released by bacterial cells
densely packed with an EPS matrix. QS makes use of a transcriptional activator protein that
acts in concert with small autoinducers (AIs) signaling molecules to stimulate expression of
target genes, resulting in changes in chemical behavior. After accumulation of sufficient AIs,
this form of intercellular communication serves to coordinate gene expression, morphologi‐
cal differentiation and the development responses of bacterial cells [27].
3.1.5. Production of extracellular polymeric substances (EPSs)
Extracellular polymeric substances (EPSs) are a complex mixture of high-molecular-weight
polymer (Mw = 10,000) excreted by microorganisms, products from lysis and hydrolysis as well
as adsorbed organic matters from wastewater. Generally, EPSs have been shown to be a rich
matrix of polymers, including polysaccharides, proteins, glycoproteins, DNA oligomers,
phospholipids and humic acids [28]. EPSs are also highly hydrated because they can incorpo‐
rate large amounts of water into their structure by hydrogen bonding. EPSs are typically
reported to aid in the formation of a gel-like network that keeps bacteria together in biofilms
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analyze the surface chemistry of a material. It measures the elemental composition at the parts
per thousand range, empirical formulas, chemical state and electronic state of the elements
that exist within a material [46]. On the other hand, EDS is a useful technique applied for the
elemental analysis/chemical characterization of filter media [47].
6. Biofilm community characterization approaches
The following subsections discuss various biofilm community characterization approaches.
6.1. Traditional methods
6.1.1. Determination of biofilm weight (wet weight and dry weight)
Biofilm weight can be determined in terms of dry weight and wet weight by using a digital
weighing balance. The wet weight of the biofilm is measured after soft rinsing with distilled
water. However, the dry weight of the biofilm is estimated by allowing it to dry under aseptic
conditions in laminar flow until the attainment of the constant weight of polypropylene and
polystyrene filter media [41, 42]. On the other hand, natural filter media, such as rock, granite
or stone media, should be dried in the oven at 60°C to constant weight [44]. The weight of the
biofilm is then calculated from the difference between the weight of medium with biofilm and
that of medium without biofilm.
6.1.2. Determination of the biofilm optical density (OD)
The biofilm is also measured by the OD method. The filter media supporting biofilms are first
rinsed with sterilized water to ensure the removal of any material on their surface. The biofilm
is then removed from the filter media in 0.9% saline by sonication for 15 min. Finally, the
spectrophotometric absorbance of dissolved biofilms is recorded at 550 nm wavelength
(OD550) using saline as blank [41, 42, 44].
6.1.3. Determination of heterotrophic plate count (HPC)
The HPC concentration (HPC/mL) of biofilms on filter media is determined by the conven‐
tional serial dilution method. The biofilm dissolved in 0.9% saline is serially diluted (up to
10−5) and then spread on the selective growth media plates and incubated at 37°C for a specific
period (24–48 h). The microbial growth appearing on specific media is enumerated in terms
of HPC/mL (pathogen indicators). Pure cultures from these plates are further identified by
colony morphology as well as microscopic and biochemical tests.
6.1.4. Microscopic analysis of biofilms
Non-invasive microscopic techniques provide a more accurate way of visualizing biofilms
without disturbing their structure. The traditional microscopic techniques involve light
microscopy (LM) and electron microscopy (SM), used for imaging analysis of biofilm sam‐
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Wastewater treatment with biofilm systems has several advantages, including operational
flexibility, low space requirements, reduced hydraulic retention time, resilience to changes in
the environment, increased biomass residence time, high active biomass concentration,
enhanced ability to degrade recalcitrant compounds as well as a slower microbial growth rate,
resulting in lower sludge production.
Figure 8. Removal of the pollutants from wastewater by biofilm on the filter media [37].
5. Biofilm development on different filter media
Packing or filter medium is the basic unit of attached growth wastewater treating technolo‐
gies. It provides a surface for the growth of the biofilm. The filter medium needs to be durable,
insoluble and resistant to chemicals. Its selection is based on size, porosity, density as well as
resistance to erosion and chemicals [38]. The ideal medium provides a high specific surface
area, low cost and porosity high enough to avoid clogging and promote ventilation. The surface
area and geometry of the support materials affect the hydrodynamic conditions in the reactor
and thus affect biofilm formation, which in turn affects wastewater treatment [39, 40].
Presently, different synthetic and natural materials have been employed. Various research‐
ers have used polystyrene [41], polypropylene [42], tire-derived rubber [43] and pebbles [44,
45] as bio-filter media in fixed biofilm reactors for wastewater treatment. The chemical
composition of the filter media is very critical, with respect to its compatibility with the
developing biofilms; its elemental composition should be evaluated. For the detection and
quantification of the elements in a filter medium, different spectroscopic techniques can be
applied, such as X-ray photoelectron spectroscopy (XPS) and energy-dispersive X-ray
spectroscopy (EDS or EDX or XEDS). XPS is a surface chemical analysis technique used to
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gies. It provides a surface for the growth of the biofilm. The filter medium needs to be durable,
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resistance to erosion and chemicals [38]. The ideal medium provides a high specific surface
area, low cost and porosity high enough to avoid clogging and promote ventilation. The surface
area and geometry of the support materials affect the hydrodynamic conditions in the reactor
and thus affect biofilm formation, which in turn affects wastewater treatment [39, 40].
Presently, different synthetic and natural materials have been employed. Various research‐
ers have used polystyrene [41], polypropylene [42], tire-derived rubber [43] and pebbles [44,
45] as bio-filter media in fixed biofilm reactors for wastewater treatment. The chemical
composition of the filter media is very critical, with respect to its compatibility with the
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applied, such as X-ray photoelectron spectroscopy (XPS) and energy-dispersive X-ray
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library construction have been applied in combination with other advanced techniques in
wastewater treatment for the exploration of biofilm communities.
6.2.2. Microbial fingerprinting methods
Microbial fingerprinting methods provide the overall profile of a biofilm community by
making a distinction between microorganisms and groups of microorganisms on the basis of
their distinctive characteristics of a universal component/section of a biomolecule, such as
phospholipids, DNA or RNA [52, 53]. These methods include phospholipid fatty acid
analysis (PLFA), denaturing gradient gel electrophoresis (DGGE) and terminal restriction
fragment length polymorphism (T-RFLP).
6.2.2.1. Phospholipid ester-linked fatty acid analysis (PLFA)
Phospholipids are a structural component of all cell membranes, but their type and propor‐
tion are distinctive to different microorganisms and break down rapidly upon cell death. Thus,
the mass of PLFAs in a biofilm sample is directly proportional to viable biomass. Some groups
of organisms have unique or “signature” types of PLFA [54]. PLFA analysis of the biofilm
involves (1) extraction of phospholipids from the biofilm sample; (2) separation by gas
chromatography with flame ionization detection; and, if required, (3) confirmation and
identification by mass spectroscopy. It is not a good choice as a stand-alone method and can
be combined with stable isotope probing (SIP). The SIP technique includes (1) incorporation
of the stable isotope label (typically 13C) into biomass, (2) incubation of microorganisms to
metabolize for a specific time, (3) extraction of biomolecules from the incubated biofilm
sample, (4) quantification of the extracted biomolecules by 13C-PLFA using GC/IRMS and
separation of unlabeled nucleic acids by density gradient ultracentrifugation and (5) identifi‐
cation of the genes/microorganisms by PCR or fingerprinting or sequencing.
6.2.2.2. Denaturing gradient gel electrophoresis (DGGE)
DGGE is a nucleic acid-based technique employed to generate a genetic fingerprint of a
complex microbial community [51]. It encompasses the following steps: (1) extraction of the
DNA or RNA from the biofilm sample; (2) amplification of the extracted nucleic acids by PCR,
generating a multitude of copies of a variable region within a target gene usually with universal
primers to give a mixture of DNA fragments, all of the same length and each representing a
species present in the original sample; (3) separation of the DNA mixture by denaturant
gradient electrophoresis on an acrylamide gel with an increasing urea/formamide gradient,
with the DNA molecules migrating toward the positive pole and halting on the gel upon
reaching their corresponding denaturant force (Tm), depending on the DNA sequence, with
every band on the gel corresponding to a different microorganism in the sample; (4) visuali‐
zation of these bands and (5) sequence identification by excision of the individual “bands”
from the gel and its comparison with the 16S rDNA database for the phylogenetic affiliation
of the microorganism.
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ples. However, scanning electron microscopy (SEM) is a well-established fundamental
technique to examine the morphology of bacteria and the topography of the material surface,
and it is even capable of demonstrating the relation of biofilms to surfaces. On the other hand,
other new advanced techniques have been established, including laser scanning microscopy
(LSM), confocal laser scanning microscopy (CLSM), magnetic resonance imaging (MRI) and
scanning transmission X-ray microscopy (STXM). These new techniques allow in situ analy‐
sis of the structure, composition, processes and dynamics of microbial communities. These
techniques represent powerful tools for the examination of mixed microbial communities,
those usually in the form of aggregates and biofilms [48].
6.1.5. Determination of biofilm activity
The metabolic activity of the microorganisms constituting biofilms can be estimated by
considering the rate of the conversion of the specific substrate after inoculation with the seed
of the biomass. For example, the physiological activity of Nitrosomonas spp. can be deter‐
mined by measuring the strength of the nitrites (NO2-N) formed in the growth medium from
the known concentration of (NH4)2SO4 after a specific period [49]. Similarly, the removal of
carbonaceous (COD and BOD) and nitrogenous (NH4─N) pollutants by biofilms can be
estimated.
6.2. Advanced methods
6.2.1. Clone library technique
Cloning and sequencing of the 16S rRNA gene have been extensively and successfully
employed for the study of microbial biofilms since the beginning of the 1990s, and this
technique is still most widely used [50]. The cloning methodology for studying a biofilm
community involves (1) extraction of the nucleic acid from the biofilm sample; (2) amplifica‐
tion of the 16S rRNA gene by polymerase chain reaction (PCR), usually using universal primers
for bacteria or archaea, for obtaining a mixture of rDNA copies of the microorganisms; (3)
cloning of the PCR products into an appropriately high number of copies of plasmid and then
transformation of competent Escherichia coli cells with this vector; (4) selection of the trans‐
formed clones on the basis of an indicator contained in the plasmid; (5) extraction of the
plasmid DNA from the colons; (6) creating a cone library by sequencing of the cloned gene
and finally (7) identification and affiliation of the isolated cloned sequence with the aid of
phylogenetic software and various dedicated computer programs (ARB, Seqlab, PAUP,
PHYLIP).
These illustrate that the clone library method allows complete 16S rRNA sequencing and
identification with very precise taxonomic studies of both cultured and non-cultured micro‐
organisms in biofilms, design of primers for PCR and probes for fluorescence in situ hybridi‐
zation (FISH) [51]. However, cloning is a time-consuming method, impractical for a high
sample throughput and non-quantitative; in addition, extraction of a DNA pool from a
microbial community can be difficult and the PCR steps are also biased. Furthermore, this
technique needs specialized personnel and equipment [52]. In general, cloning and rRNA gene
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library construction have been applied in combination with other advanced techniques in
wastewater treatment for the exploration of biofilm communities.
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fragment length polymorphism (T-RFLP).
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generating a multitude of copies of a variable region within a target gene usually with universal
primers to give a mixture of DNA fragments, all of the same length and each representing a
species present in the original sample; (3) separation of the DNA mixture by denaturant
gradient electrophoresis on an acrylamide gel with an increasing urea/formamide gradient,
with the DNA molecules migrating toward the positive pole and halting on the gel upon
reaching their corresponding denaturant force (Tm), depending on the DNA sequence, with
every band on the gel corresponding to a different microorganism in the sample; (4) visuali‐
zation of these bands and (5) sequence identification by excision of the individual “bands”
from the gel and its comparison with the 16S rDNA database for the phylogenetic affiliation
of the microorganism.
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mined by measuring the strength of the nitrites (NO2-N) formed in the growth medium from
the known concentration of (NH4)2SO4 after a specific period [49]. Similarly, the removal of
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estimated.
6.2. Advanced methods
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technique is still most widely used [50]. The cloning methodology for studying a biofilm
community involves (1) extraction of the nucleic acid from the biofilm sample; (2) amplifica‐
tion of the 16S rRNA gene by polymerase chain reaction (PCR), usually using universal primers
for bacteria or archaea, for obtaining a mixture of rDNA copies of the microorganisms; (3)
cloning of the PCR products into an appropriately high number of copies of plasmid and then
transformation of competent Escherichia coli cells with this vector; (4) selection of the trans‐
formed clones on the basis of an indicator contained in the plasmid; (5) extraction of the
plasmid DNA from the colons; (6) creating a cone library by sequencing of the cloned gene
and finally (7) identification and affiliation of the isolated cloned sequence with the aid of
phylogenetic software and various dedicated computer programs (ARB, Seqlab, PAUP,
PHYLIP).
These illustrate that the clone library method allows complete 16S rRNA sequencing and
identification with very precise taxonomic studies of both cultured and non-cultured micro‐
organisms in biofilms, design of primers for PCR and probes for fluorescence in situ hybridi‐
zation (FISH) [51]. However, cloning is a time-consuming method, impractical for a high
sample throughput and non-quantitative; in addition, extraction of a DNA pool from a
microbial community can be difficult and the PCR steps are also biased. Furthermore, this
technique needs specialized personnel and equipment [52]. In general, cloning and rRNA gene
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results are carried out with a conventional epifluorescence microscope for multicolor FISH.
However, a charged coupled device (CCD) camera and appropriate image analysis software
can be used for the digitalization/manipulation of images, enumeration of microorganisms
and measurement of the activity of single cells in biofilms by quantification of their rRNA
content.
On the other hand, CLSM is used with FISH analysis for thick samples with a high back‐
ground (sludge flocs, biofilms) and for obtaining three-dimensional images. Different software
packages are also available.
FISH is an easy and fast technique, and, if required, probes are available for direct visualiza‐
tion and quantification of microorganisms. This technique is apt for routine analyses, highly
trained/specialized personnel are not necessary, and only basic knowledge of microscopy and
laboratory experience is required. However, prior knowledge of the microbial habitat/
environment conditions and the target microorganisms to be detected is necessary. The rRNA
sequence for a particular microorganism to be detected and quantified must also be known
[51].
FISH is a widely applied technique and can be combined with other techniques to increase its
sensitivity and upgrade it to overcome some of its pitfalls. FISH-based methods have revolu‐
tionized investigations into the morphology and microbial composition of biofilms and enable
bacteria to be mapped [58]. These methods include FISH-MAR (FISH with micro-autoradiog‐
raphy, CARD-FISH (FISH with catalyzed reporter deposition), Clone-FISH (FISH preceded by
generating the expression of the 16S or 18S rRNA targeted gene), CLASI (combinatorial
labeling and spectral imaging with FISH), DOPE-FISH (double labeling of oligonucleotide
probes with FISH), RING-FISH (recognition of individual genes with FISH), DVC-FISH
(FISH with direct viable count) and RCA-FISH (FISH with rolling circle amplification). In the
FISH-BrdU method, identification of the microbes is carried out by using 5-bromo-2′-deoxy‐
uridine (BrdU) without any need for paraformaldehyde for cell fixation or formamide for DNA
denaturation. In a technique called Spike-FISH, quantification based on an internal standard
(E. coli) is introduced by spiking the biofilm samples with known amounts of E. coli cells. In
RAMAN-FISH, Raman microspectroscopy is combined with FISH. NanoSIMS is based on the
visualization of oligonucleotide probe-conferred hybridization signals in single microbial cells
and isotopic measurement using high-resolution ion microprobes [58].
6.2.4. DNA microarray technology
DNA microarray technology detects hundreds or even thousands of DNA sequences simul‐
taneously and rapidly [59]. It involves (1) extraction of DNA from the sample, (2) amplifica‐
tion by PCR, (3) direct hybridization of the amplified PCR products from total DNA to known
molecular probes attached on the microarrays and (4) scoring of positive signals using CLSM
after hybridization of the fluorescently labeled PCR amplicons to the probes. Generally, the
hybridization signal intensity on microarrays is directly proportional to the abundance of the
target organism. The main pitfalls of this technique are cross-hybridization and that it is not
useful in identifying and detecting novel prokaryotic taxa. Moreover, if the genus does not
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DGGE is the fastest and most economical way of comparing large numbers of samples without
culturing on expensive media, isolations and analysis, and it permits rapid/simple monitor‐
ing of the spatial-temporal distribution of microbial populations by only considering band.
However, depending on the nature of the sample, extraction and amplification of representa‐
tive genomic DNA can be difficult. The DNA copy number, proportional to the abundance of
a particular microorganism, can be very different after amplification by PCR, and thus the
intensity of the bands on a DGGE gel is not quantitative. Furthermore, the sequences of the
bands obtained from a gel correspond to short DNA fragments (200–600 bp), and so phyloge‐
netic relations are less reliably established and short sequences are less useful for designing
new specific primers (for PCR) and probes (for FISH).
6.2.2.3. Terminal restriction fragment length polymorphism (T-RFLP)
T-RFLP is a nucleic acid-based method and provides the profile of a microbial community,
which is used to identify specific microbial populations [55]. It has four steps: (1) total
community DNA or RNA extraction from a sample; (2) PCR amplification with a fluorescent
PCR primer to make multiple copies of a target gene; (3) enzymatic digestion of the PCR
products with restriction enzymes to cut the DNA molecule at known sequences, indicative
of a specific microorganism and finally (4) fragment identification by electrophoretically
separating the amplified gene sequences of different sizes.
Furthermore, it is also possible to sequence and identify the generated sequences by compar‐
ison with a sequence database. The strength of the fluorescent signal yields additional
information regarding the abundance of the different species, similar to the band intensity in
the patterns of a DGGE gel. T-RFLP offers more sensitivity than DGGE, and it may detect the
lower number sequences in a sample and is commercially available. However, sometimes, the
heterogeneous size of fragments makes phylogenetic analysis less confident [56].
6.2.3. Fluorescence in situ hybridization (FISH)
For FISH, the most commonly used target molecules are 16S rRNA, 18S rRNA, 23S rRNA and
mRNA. FISH is an excellent method for the identification, localization, visualization and
quantification of non-cultured microorganisms in their microcosm. The specificity of the
florescent probe enables detection/identification on any desired taxonomic level, from domain
down to a resolution suitable for differentiating between individual species [57].
FISH is carried out in a few steps: (1) the specimen is fixed by precipitating agents (ethanol or
methanol), cross-linking agents (aldehydes) or a mixture depending on the target organism
and the type of sample; (2) the sample is prepared, with the process including specific
pretreatment steps. For better attachment of specimens to glass slides, their surfaces should
be treated with coating (gelatin, poly-L lysine) or silanising agents; (3) hybridization is directly
carried out on the fixed sample by addition of a mixture of salts, formamide, detergents and
fluorescent probe in a dark humid chamber, usually at temperatures between 37°C and 50°C.
Its time varies between 30 min and several hours; (4) slides are rinsed with distilled water to
remove unbound probe, dried and mounted and (5) visualization and documentation of
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results are carried out with a conventional epifluorescence microscope for multicolor FISH.
However, a charged coupled device (CCD) camera and appropriate image analysis software
can be used for the digitalization/manipulation of images, enumeration of microorganisms
and measurement of the activity of single cells in biofilms by quantification of their rRNA
content.
On the other hand, CLSM is used with FISH analysis for thick samples with a high back‐
ground (sludge flocs, biofilms) and for obtaining three-dimensional images. Different software
packages are also available.
FISH is an easy and fast technique, and, if required, probes are available for direct visualiza‐
tion and quantification of microorganisms. This technique is apt for routine analyses, highly
trained/specialized personnel are not necessary, and only basic knowledge of microscopy and
laboratory experience is required. However, prior knowledge of the microbial habitat/
environment conditions and the target microorganisms to be detected is necessary. The rRNA
sequence for a particular microorganism to be detected and quantified must also be known
[51].
FISH is a widely applied technique and can be combined with other techniques to increase its
sensitivity and upgrade it to overcome some of its pitfalls. FISH-based methods have revolu‐
tionized investigations into the morphology and microbial composition of biofilms and enable
bacteria to be mapped [58]. These methods include FISH-MAR (FISH with micro-autoradiog‐
raphy, CARD-FISH (FISH with catalyzed reporter deposition), Clone-FISH (FISH preceded by
generating the expression of the 16S or 18S rRNA targeted gene), CLASI (combinatorial
labeling and spectral imaging with FISH), DOPE-FISH (double labeling of oligonucleotide
probes with FISH), RING-FISH (recognition of individual genes with FISH), DVC-FISH
(FISH with direct viable count) and RCA-FISH (FISH with rolling circle amplification). In the
FISH-BrdU method, identification of the microbes is carried out by using 5-bromo-2′-deoxy‐
uridine (BrdU) without any need for paraformaldehyde for cell fixation or formamide for DNA
denaturation. In a technique called Spike-FISH, quantification based on an internal standard
(E. coli) is introduced by spiking the biofilm samples with known amounts of E. coli cells. In
RAMAN-FISH, Raman microspectroscopy is combined with FISH. NanoSIMS is based on the
visualization of oligonucleotide probe-conferred hybridization signals in single microbial cells
and isotopic measurement using high-resolution ion microprobes [58].
6.2.4. DNA microarray technology
DNA microarray technology detects hundreds or even thousands of DNA sequences simul‐
taneously and rapidly [59]. It involves (1) extraction of DNA from the sample, (2) amplifica‐
tion by PCR, (3) direct hybridization of the amplified PCR products from total DNA to known
molecular probes attached on the microarrays and (4) scoring of positive signals using CLSM
after hybridization of the fluorescently labeled PCR amplicons to the probes. Generally, the
hybridization signal intensity on microarrays is directly proportional to the abundance of the
target organism. The main pitfalls of this technique are cross-hybridization and that it is not
useful in identifying and detecting novel prokaryotic taxa. Moreover, if the genus does not
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a particular microorganism, can be very different after amplification by PCR, and thus the
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bands obtained from a gel correspond to short DNA fragments (200–600 bp), and so phyloge‐
netic relations are less reliably established and short sequences are less useful for designing
new specific primers (for PCR) and probes (for FISH).
6.2.2.3. Terminal restriction fragment length polymorphism (T-RFLP)
T-RFLP is a nucleic acid-based method and provides the profile of a microbial community,
which is used to identify specific microbial populations [55]. It has four steps: (1) total
community DNA or RNA extraction from a sample; (2) PCR amplification with a fluorescent
PCR primer to make multiple copies of a target gene; (3) enzymatic digestion of the PCR
products with restriction enzymes to cut the DNA molecule at known sequences, indicative
of a specific microorganism and finally (4) fragment identification by electrophoretically
separating the amplified gene sequences of different sizes.
Furthermore, it is also possible to sequence and identify the generated sequences by compar‐
ison with a sequence database. The strength of the fluorescent signal yields additional
information regarding the abundance of the different species, similar to the band intensity in
the patterns of a DGGE gel. T-RFLP offers more sensitivity than DGGE, and it may detect the
lower number sequences in a sample and is commercially available. However, sometimes, the
heterogeneous size of fragments makes phylogenetic analysis less confident [56].
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For FISH, the most commonly used target molecules are 16S rRNA, 18S rRNA, 23S rRNA and
mRNA. FISH is an excellent method for the identification, localization, visualization and
quantification of non-cultured microorganisms in their microcosm. The specificity of the
florescent probe enables detection/identification on any desired taxonomic level, from domain
down to a resolution suitable for differentiating between individual species [57].
FISH is carried out in a few steps: (1) the specimen is fixed by precipitating agents (ethanol or
methanol), cross-linking agents (aldehydes) or a mixture depending on the target organism
and the type of sample; (2) the sample is prepared, with the process including specific
pretreatment steps. For better attachment of specimens to glass slides, their surfaces should
be treated with coating (gelatin, poly-L lysine) or silanising agents; (3) hybridization is directly
carried out on the fixed sample by addition of a mixture of salts, formamide, detergents and
fluorescent probe in a dark humid chamber, usually at temperatures between 37°C and 50°C.
Its time varies between 30 min and several hours; (4) slides are rinsed with distilled water to
remove unbound probe, dried and mounted and (5) visualization and documentation of
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about the composition of filter media and developing biofilms is highly necessary. The
composition and quantification of different elements in filter media can be determined using
spectroscopic techniques, such as X-ray photoelectron spectroscopy (XPS) and energy-
dispersive X-ray spectroscopy (EDS). The traditional methods used for the study of biofilms
include analyses of their gravimetric weight spectroscopic absorbance, substrate utilization
activity and viable plate count as well as microscopic techniques. Complete biofilm commun‐
ity profiling is carried out by advanced techniques such as microbial sequencing, clone library
generation, genetic fingerprinting, DNA microarray, denaturant gradient electrophoresis
(DGGE) and next-generation sequencing (NGS), on the basis of their availability, to increase
the performance, stability and robustness of biofilm reactors.
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have a corresponding probe on the microarray, then the biological significance of a genus could
be totally missed. The application of this technique is comparatively less in the study of
wastewater treating biofilms.
6.2.5. Next-generation sequencing (NGS) technology
NGS, such as pyrosequencing, is a novel DNA sequencing technology developed at the Royal
Institute of Technology (KTH) based on the sequencing-by-synthesis principle [60] and on the
detection of released pyrophosphate (PPi) during DNA synthesis [61]. This technology
transforms microbial ecology, explores deeper layers of microbial communities and is vital in
presenting an unbiased view of the composition and diversity of communities [62]. NGS
platforms such as Roche/454, Illumina/Solexa, Life/APG and HeliScope/Helicos BioSciences
are much faster and less expensive than the first-generation Sanger sequencing technology
[63].
The steps in pyrosequencing techniques include the following:(1) extraction of the DNA from
the biofilm samples; (2) quantification and detection of the purity of the extracted DNA using
a NanoDrop spectrophotometer; (3) amplification of the sample 16S rRNA gene by using
universal PCR primers (28F and 519R) and incorporation of different barcodes between the
454 adaptor and the forward primer, with the duplicate PCR products pooled and purified
using the QIAquick Gel Extraction Kit; (4) use of the purified PCR products for pyrosequenc‐
ing and then ligation of short adaptors onto both ends for the segregation of the sequences; (5)
attachment of the modified products to DNA capture beads, followed by emulsion-based
clonal amplification, with the beads set into the wells of a PicoTiterPlate device, with appro‐
priate chemicals, four enzymes (DNA polymerase, ATP sulfurylase, luciferase, apyrase),
adenosine 5′-phosphosulfate (APS) and luciferin, and then inserted into the Genome
Sequencer according to the manufacturer’s directions to record programs; (6) preprocessing
of all partial 16S rRNA gene sequences using the pyrosequencing pipeline at the Ribosomal
Database Project (RDP) to trim barcodes, remove primers from the partial ribotags and discard
low-quality and short (<250 bp long) sequences; (7) denoising and assemblage of the sequen‐
ces into clusters using the precluster command, thus generating the FASTA file data sets
(*.fna and *.qual files) and (8) further analysis of these sequences through MOTHUR, with
MOTHUR analysis pipeline and R-Scripts used to start sequencing the taxonomy and analyze
the data
The technique of pyrosequencing has the potential advantages of accuracy, flexibility, parallel
processing and easy automation. It has no need for labeled primers, labeled nucleotides and
gel electrophoresis. It has been successful for both confirmatory sequencing and de novo
sequencing [61].
7. Conclusions
Of the different wastewater treatment technologies, biofilm-based systems have potential
advantages. For better designing of these biofilm wastewater treatment systems, knowledge
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about the composition of filter media and developing biofilms is highly necessary. The
composition and quantification of different elements in filter media can be determined using
spectroscopic techniques, such as X-ray photoelectron spectroscopy (XPS) and energy-
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Abstract
In order to establish the role of  biofilm in rainwater tank,  it  was investigated the
phylogenetic distribution of the bacteria present in an operating rainwater tank. Most
of the bacteria were closely related to fresh water, soil, and biofilm bacteria found in
natural environments. The high proportion of proteobacteria indicates the generally
clean oligotrophic nature of the tank water. To better understand the environmental
conditions in rainwater tanks and the development of biofilms therein, the changes in
biofilm cells and the bacterial community were investigated during biofilm develop‐
ment. We confirmed that the biofilm development process takes place in three stages:
an initial stage characterized by the colonization of different populations, an intermedi‐
ate stage characterized by a limited number of dominant populations utilizing similar
resources, and a late/mature stage characterized by mature biofilms of a complex spatial
structure. It was investigated microbial behaviour after inoculation of the bacterium,
Pseudomonas aeruginosa, in pilot and full-scale rainwater tanks with different surface-to-
volume (S/V) ratios. Ninety-nine percentage of the inoculated P. aeruginosa had been
removed from the water phase. The faster removal rate in pilot and full-scale tank was
due to its higher S/V ratio. From the results, several recommendations for tank design
and management were suggested.
Keywords: bacterial composition, bacterial community, biofilm, biofilm development,
CLSM, DGGE, microbial quality, P. aeruginosa, rainwater tank, surface-to-volume ra‐
tio
1. Introduction
Almost about one billion people in developing country suffer from water problem. According‐
ly, rainwater harvesting is becoming now one of the major alternatives to tackle water scarci‐
ty and spreading to not only in developing country but also urban and remote rural communities
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rainwater tank, the choice of sites for sample collection was made mainly with regard to the
availability of the rainwater facility.
The system 1 was built in November 2003 and consists of a 200 m3 concrete storage tank located
underground and a 2098 m2 roof catchment area. The harvested rainwater supplies to the toilets
of 167 households and a garden [10]. In this system, the study about microbial community was
performed.
The system 2, which was constructed in October 2005, comprises a 250 m3 main storage tank,
a 27 m3 smaller extra tank, and a 4 m3 supply tank located underground. The catchment area
is a concrete roof surface with a total area of 2828 and 824 m2 terrace. Rainwater collected from
the roof of one part of the building (960 m2) flows into the main tank and that from the roof of
another part of the building (1868 m2) and the aforementioned terrace flows into the extra tank.
When the water in the extra tank reaches 1.2 m in depth, it is pumped into the main tank.
About 1000 full-time staff and students occupy the building, and the amount of water used
each day to flush the toilet is approximately 60–90 m3. In this system, study about biofilm
development process in rainwater tank was performed.
System 3 and system 4 were installed at Buddle-gol, Seoul National University in October 2007,
which collects rainwater from the valley of Mount Gwanak. Tank 3 was designed a concrete
square with a storage volume of 20 m3. Tank 4 was assembled from polypropylene units
with 95% pore space and has a storage volume of 20 m3. In these systems, study about microbial
behaviour by full-scale spike test described was performed.
Figure 1. Schematic diagram of the four study sites in SNU campus.
Role of Biofilm in Rainwater Tank
http://dx.doi.org/10.5772/63373
147
in developed country in the world. Rainwater management system has an advantages such as
simple technology, low cost and low-energy consuming, but rainwater use is limited by
uncertainty about rainwater quality, and especially its microbial quality [1, 2].
Krampitz and Holländer [1] concluded that tank cleaning was contra-productive and
Deutsches Institut für Normung (DIN; in English, the German Institute for Standardization)
recommend that people do not clean the rainwater tank <10 years. About 13% of all Australian
households use rainwater tanks as a source of drinking water [3]. This study was motivated
by those questions why the water quality was poorer after cleaning tank and why they are safe
in spite of using untreated rainwater.
In the case of roof-harvested water, contamination could mainly occur on the roof collection
system or in the storage facility [4]. The contaminant input is limited only from catchment area,
and its management is very important for water quality in rainwater tank. Most of the
contaminants come into the rainwater tank which is removed by sedimentation [5] and sludge
generated thereby is able to lower the water quality by resuspension. Application of simple
design such as sludge drain, calm inlet, intermediate wall, and baffle can control the contam‐
inant in rainwater tank to the certain level [6].
Biofilm is one of the factors influencing the rainwater quality in tank. Many researches showed
that presence of biofilm includes negative effects, such as biofouling in filter and biocorro‐
sion and biocontamination in drinking water distribution networks, but also positive effects
such as biofilm reactors for the degradation or production of chemical substances in waste‐
water treatment process [7–9]. It has been suggested that biofilm may have a function of self-
cleaning of the tank and regulation of the microbial quality in rainwater [1, 2]. Although biofilm
might have a positive impact on stored rainwater quality, only few studies investigated
bacterial composition and distribution, its development and role in this particular environ‐
ment. Through the research on these characteristics of biofilm in rainwater tank, it is possi‐
bly suggested a better information to improve the rainwater system in management and design
perspectives
In this chapter, to establish the role of biofilm in rainwater tank, (1) it was investigated the
kinds of bacteria that inhabit rainwater tanks, (2) the changes in the biofilm cells and the
bacterial community during biofilm development, (3) the microbiological characteristics of
rainwater in two tanks with different S/V ratios to identify how the internal design features of
storage tanks affect the microbial quality of rainwater, and then (4) suggested design and
maintenance guideline for rainwater tank.
2. Method and materials
2.1. Study sites
This study was carried out at Seoul National University in Seoul, Korea (Figure 1). In order to
investigate the microbial community and how biofilms are developed and in operating
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rainwater tank, the choice of sites for sample collection was made mainly with regard to the
availability of the rainwater facility.
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a 27 m3 smaller extra tank, and a 4 m3 supply tank located underground. The catchment area
is a concrete roof surface with a total area of 2828 and 824 m2 terrace. Rainwater collected from
the roof of one part of the building (960 m2) flows into the main tank and that from the roof of
another part of the building (1868 m2) and the aforementioned terrace flows into the extra tank.
When the water in the extra tank reaches 1.2 m in depth, it is pumped into the main tank.
About 1000 full-time staff and students occupy the building, and the amount of water used
each day to flush the toilet is approximately 60–90 m3. In this system, study about biofilm
development process in rainwater tank was performed.
System 3 and system 4 were installed at Buddle-gol, Seoul National University in October 2007,
which collects rainwater from the valley of Mount Gwanak. Tank 3 was designed a concrete
square with a storage volume of 20 m3. Tank 4 was assembled from polypropylene units
with 95% pore space and has a storage volume of 20 m3. In these systems, study about microbial
behaviour by full-scale spike test described was performed.
Figure 1. Schematic diagram of the four study sites in SNU campus.
Role of Biofilm in Rainwater Tank
http://dx.doi.org/10.5772/63373
147
in developed country in the world. Rainwater management system has an advantages such as
simple technology, low cost and low-energy consuming, but rainwater use is limited by
uncertainty about rainwater quality, and especially its microbial quality [1, 2].
Krampitz and Holländer [1] concluded that tank cleaning was contra-productive and
Deutsches Institut für Normung (DIN; in English, the German Institute for Standardization)
recommend that people do not clean the rainwater tank <10 years. About 13% of all Australian
households use rainwater tanks as a source of drinking water [3]. This study was motivated
by those questions why the water quality was poorer after cleaning tank and why they are safe
in spite of using untreated rainwater.
In the case of roof-harvested water, contamination could mainly occur on the roof collection
system or in the storage facility [4]. The contaminant input is limited only from catchment area,
and its management is very important for water quality in rainwater tank. Most of the
contaminants come into the rainwater tank which is removed by sedimentation [5] and sludge
generated thereby is able to lower the water quality by resuspension. Application of simple
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2. Method and materials
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Figure 3. Schematic diagram of system 3 and system 4 used in full-scale experiments.
2.2.2. Coupon preparation and sampling
2.2.2.1. Characteristics of biofilm development on the surface
To study the biofilm formation on the surface, 3 × 8 × 0.5 cm acrylic coupons were prepared
(Figure 4). These coupons were immersed at the inlet and outlet of the system 2 tied to an
acrylic support placed in the middle of the tank at a depth of 2 m from the bottom (Figure 5).
Figure 5 shows the plans and cross-sectional views of the tank, and sampling points in
system 2. To minimize the influence of flow velocity during the experiment period, no
rainwater was supplied, but overflow was permitted.
To evaluate biofilm growth, several tests were carried out with quantify the biofilm develop‐
ment on the surface, following the schedule presented in Table 1.
Figure 4. Picture for coupon prepared and set up in the tank.
Water samples were collected from the inlet and outlet portions of the tank once a month in
two 1 L sterile screw-cap containers. The samples were taken at a depth of 2 m from the bottom
of the tank to collect data on the coupons’ environment. The samples were transported to the
laboratory and analysed within 30 min of collection.




2.2.1. Sampling and sample preparation for PCR-DGGE
In the system 1, the rainwater from the roof flows through a filter (VF6 type with a mesh size
of 0.65 mm and a capacity of 70.5 L/s) at first, and then enters the main tank through a calm
inlet. Inside the tank, the W × L × H ratio changes from 7.4 × 15.4 × 2 to 3.7 × 30.8 × 2 due to the
installation of a baffle.
The sampling points were indicated in Figure 2. Rainwater of 1.5 L was sampled at a depth
of 50 cm in the tank and was carried directly to the lab in a sterile water bottle. Biofilm was
collected from 0.04 m2 of the wall surface in the tank and placed in a sterile tube containing 20
ml of distilled water.
Figure 2. Schematic diagram and description of the sampling points in system 1.
Water samples in system 3 and system 4 were collected for physicochemical monitoring and
after spiking test at a depth of 1.3 m from the bottom, around the point of supply in each
tank (Figure 3). Three replicate samples were taken on four different occasions between May
and August 2010.
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2.4. Enumeration of bacteria
The heterotrophic bacteria were quantified using the conventional microbiological culture
method. Faecal coliform tests were carried out through membrane filtration procedure,
Standard method 9222D (APHA, 1998).
2.5. PCR-DGGE analysis
2.5.1. DNA extraction
The sample of rainwater and the detached biofilm sample in the PBS were separately passed
through a filter, and genomic DNA was isolated with a water RNA/DNA purification kit
(Norgen, Canada) according to the manufacturer’s instructions.
2.5.2. Polymerase chain reaction (PCR)
The EUB 341F-GC and PRUN518R primer pair, comprising universal primers specific to
bacteria, was used [11] for PCR, which was performed with a thermal cycler (GeneAmp PCR
System 9700, Perkin Elmer). The PCR conditions are described in Table 2.
Primer set Operation temperature and thermal cycler time (Temp., Time) Cycles














Table 2. Reaction conditions for the PCR.
2.5.3. Denaturing gradient gel electrophoresis (DGGE)
DGGE analysis was performed using a D-Code system (Bio-Rad, USA). The 8% polyacryla‐
mide gel contained a series of denaturant concentrations ranging from 30 to 60% (forma‐
mide and urea). The gels were run at 70 V for 11 h in a 1 × TAE buffer at 60°C. After
electrophoresis, the gels were stained with ethidium bromide in a 1 × TAE buffer for 15 min
and then destained in DDW(Deionized distiled water) for 20 min. The DGGE gels were
visualized with a UV transilluminator (302 nm) mounted with a digital camera to capture
photographs of them.
2.5.4. Re-amplification of the DGGE bands and sequencing
The DNA bands on the DGGE gels were excised under UV transillumination using sterile
scalpels and then soaked overnight in 50 μL of sterile DDW at 4°C. Two μL of DNA solution
was used for re-amplification with the same primer pair without a GC clamp. The reaction
conditions for the PCR were the same as those described in Table 2. The PCR products were
purified using a kit (AccuPrep PCR purification kit, Bioneer, Korea) and then sequenced using
EUB341F (for bacteria) and F984 (for actinomycetes) in an automatic DNA sequencer (ABI
Role of Biofilm in Rainwater Tank
http://dx.doi.org/10.5772/63373
151
Figure 5. Schematic diagram and description of the sampling points in system 2.
Weeks (after immersion in the tank) 0 1 4 5 8 9 12 15 16
Coupon samples for HPC ✔ ✔ ✔ ✔
Coupon samples for CLSM ✔ ✔ ✔ ✔
Coupon samples for PCR-DGGE ✔ ✔ ✔ ✔
Water samples for pH, turbidity,
EC, DO, Temp., SS, TN,
TP, TOC, HPC
✔ ✔ ✔ ✔ ✔
Water samples for PCR-DGGE ✔
CLSM, confocal laser scanning microscopy; EC, electric conductivity; HPC, heterotrophic plate count; SS: suspended
solids.
Table 1. Experimental schedule for coupons and water sampling in system 2.
2.3. Physicochemical characteristics
The various physicochemical parameters of the rainwater, such as temperature (Sension 1,
Hatch, Japan), pH (Sension 1, Hatch, Japan), dissolved oxygen (DO) (ProODO, YSI, USA),
electric conductivity (EC) (Sension 378, Hatch, Japan), turbidity (2100P, Hatch, Japan),
suspended solid (SS) total nitrogen (TN) (HS-TN-L kit, Humas, Korea), total phosphate (TP)
(HS-TP-L kit, Humas, Korea), and total organic carbon (TOC) (V CPH kit, Shimadzu, Japan)
were measured.
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the spike test, the tanks were filled with 100 L of rainwater and stored for 4 weeks. Ten litres
of rainwater per day were then replaced, and the retention time was controlled at 10 days. The
water was stored in the dark at room temperature (20°C).
2.7.2. Full-scale tanks
Two full-scale rainwater tanks of system 3 and system 4 were employed to investigate the
behaviour of the microbial populations in spike tests carried out with different S/V ratios
(Figure 3). The S/V ratio was 2 m−1 in system 3 and 15 m−1 in system 4. The retention time was 10
days. The difference of tank material between two tanks was assumed to be negligible because
material for biofilm formation primarily affects in the initial steps [13] and the two rainwater
tanks used in this study had been in operation for 3 years.
2.7.3. Bacteria preparation and inoculation
Pseudomonas aeruginosa (KCTC #1636), a ubiquitous environmental bacterium that forms
biofilms on wet surfaces such as those of rocks and soil, was used in the spike tests. The P.
aeruginosa were grown to an exponential phase (OD600 = 1.2, containing approximately 5 ×
107 CFU/mL) in Luria-Bertani (LB) broths and washed twice with phosphate-buffered saline
(PBS) (centrifuge at 8000 rpm, 4°C for 10 min). P. aeruginosa was put into the tanks at a final
concentration in rainwater of about 5 × 105 CFU/mL for the pilot tests and 1.3 × 104 CFU/mL
for the full-scale tests.
2.7.4. Sampling
Fifty microlitres of water samples were taken in duplicate from the bottom and middle sections
of the two pilot tanks, and coupons were tested randomly every day for 8 days (Figure 6). In
the full-scale test, 1 L rainwater samples were taken in duplicate from the two tanks every day
for 10 days. The pH value in both pilot tanks was 7.1 ± 0.1; the DO was 7.9 ± 0.5 mg/L in Pilot
Tank 1 and 6.7 ± 0.4 mg/L in Pilot Tank 2.
3. Results and discussions
3.1. Composition and distribution of bacteria in an operating rainwater harvesting tank
3.1.1. Physicochemical conditions in rainwater tanks create a distinct microbial habitat
The turbidity, EC, SS and VSS were lower at the outlet than at inlet, and the DO was slightly
lower at the inlet than at the outlet. The TN and total phosphorous were 4.9 ± 0.4 and 0.08 ±
0.04 mg/L at the inlet but decreased at the outlet to 4.4 ± 0.2 and 0.05 ± 0.01 mg/L. The COD
was 1.9 ± 1.12 and 0.9 ± 0.01 mg/L, and the TOC was 0.78 ± 0.03 and 0.26 ± 0.15 mg/L at the inlet
and outlet, respectively. The values of the parameters were better at the outlet than at the inlet.
Because the rainwater tank under study is installed underground, the lack of sunlight and the
average water temperature of as low as 19°C led to the absence of photosynthetic microbes
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Prism 3730 XL DNA Analyzer, PE Applied Biosystems). The DGGE band sequences were
compared with 16S rDNA sequences obtained through a BLAST search from the database of
the DNA Data Bank of Japan (http://blast.ddbj.nig.ac.jp/top-e.html).
2.6. CLSM analysis
To observe the thickness of the biofilm via CLSM, two coupons from each part of the tank were
sampled in sterile Petri dishes, and a BacLight Live/Dead bacterial viability kit (L-7012,
Molecular Probes, USA) was employed to stain the live and dead cells. Photographs of two
random locations on each coupon were taken with a Carl Zeiss LSM 510 microscope. The CLSM
images were analysed with an Image Structure Analyzer (ISA) [12].
2.7. Spike test
2.7.1. Pilot-batch tanks
To investigate the behaviour of microbial populations in spike tests in pilot-scale batch tanks
with different S/V ratios, 200-liter (L) polyethylene (PE) tanks were filled with 100 L of
rainwater. The S/V ratios were set to 10 and 50 m−1 by installing acrylic plates (50 × 20 × 0.2
cm) (Figure 6). To ensure that a sufficient amount of biofilm attached to the tank walls before
Figure 6. Schematic diagram for the pilot-scale batch experiments.
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such as Sphingopyxis sp., Sphingomonas sp., Novosphingobium resinovorum and Sphingobium
yanoikuyae were found in the both rainwater and biofilm samples.
The bacterial composition in the biofilm differed according to the location. Sphingopyxis sp.
(Band No. 7) and Blastochloris sulfoviridis (Band No. 9) were detected in the inlet samples,
whereas Ralstonia insidiosa(Band No. 4), Novosphingobium resinovorum (Band No. 6), Sphingo‐
monas sp. (Band No. 8), Sphingobium sp. (Band No. 15) were found only in the outlet samples.
Sphingobium yanoikuyae (Band No. 12), Bacillus sp. (Band No. 13), Sphingomonas sp. (Band No.
14), and Beijerinckiaceae bacterium (Band No. 17) were detected in both locations. Similar
bacterial composition indicated at the inlet and outlet rainwater samples.
The samples contained mostly nonpathogenic proteobacteria. Many of the bacteria identi‐
fied were closely related to fresh water, soil and biofilm bacteria found in natural environ‐
ments [15–20]. Eighty-eight percentage of the identified bacteria were proteobacteria. It have
been reported that proteobacteria are consistently more abundant at pristine sites, whereas
Firmicutes and Actionobacteria are dominant at polluted sites [21]. Though estimates were
made in terms of detection ratio only in this study and the species were not quantified, the
results still indicate the clean oligotrophic nature of the tank water.
The bacterial composition in the biofilm was different from that in the rainwater. It is known
that biofilm formation provides an advantage for bacteria that exist in oligotrophic environ‐
ments [22]. Some of the species identified in the biofilm in this study, such as Bacillus sp.,
Sphingomonas sp. and Sphingobium sp., have been demonstrated to degrade certain contami‐
nants and to act as bio-control agents [17, 18, 23]. These species may be relatively sensitive to
nutrients in oligotrophic conditions and thus tend to develop a biofilm to survive. Therefore,
in oligotrophic rainwater tanks, microbial species possibly remain constant in rainwater tank
through biofilm formation.
3.1.3. Self-purification possibility of rainwater tanks and implications for rainwater quality
Bacterial communities in nature play a key role in the production and degradation of organ‐
ic matter and many types of environmental contamination, and the cycling of nitrogen,
sulphur, and many metals [24]. In addition, the sorptive capacity of biofilm for dissolved
organic matter and metals has been widely demonstrated in sewage and marine systems [25,
26]. Thus, biofilm formation in rainwater tanks seems not only to promote the survival of
bacteria, but also serves as a natural filter by removing contaminants and bacteria from
rainwater.
3.2. Characteristics of biofilm development in rainwater tank
3.2.1. Physicochemical and microbial conditions in rainwater
The temperature of the stored rainwater ranged from 16 to 22°C, and the pH was around 7. At
the inlet and outlet of the tank, the turbidity was 2.9 ± 1.6 and 2.1 ± 1.0 NTUs, respectively; the
SS count was 3.2 ± 1.8 and 1.3 ± 0.8 mg/L, respectively; the TOC was 1.56 ± 0.54 and 0.91 ± 0.97
mg/L, respectively; and the TP count was 0.07 ± 0.04 and 0.04 ± 0.01 mg/L, respectively. Thus,
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such as algae. The nutrient input depended on rainfall. Rainwater tanks indicated an oligo‐
trophic environment, as the concentration of dissolved organic matter in these habitats is
commonly <10 mg/L [14]. The inflow and outflow of rainwater in such tanks change accord‐
ing to the precipitation and rainwater usage. Thus, rainwater tanks constitute a unique habitat
for microbes.
3.1.2. Bacterial composition and distribution
The bacterial composition in the rainwater and biofilm samples showed different tendencies.
Seventeen species were identified from the selected DGGE bands (Figure 7). According to the
standard phylogenetic classification of prokaryotes, the species belonged to 13 genera, 10
families, 8 orders, 5 classes and 3 phyla. Proteobacteria accounted for 88% of the species
identified, with the remainder being Bacteroidetes and Firmicutes.
Figure 7. DGGE profiles at each sampling point and closest identified phylogenetic relatives found in the DGGE
bands.
The DGGE profiles showed a clear difference between the planktonic bacterial community and
the community in the biofilm (Figure 7). The bacterial composition tended to differ across the
biofilm samples, but was similar across the rainwater samples. Rubrivivax gelatinosus, Roseivirga
ehrenbergii, Limnohabitans sp., Aquaspirillum sp. and Rhodobacter gluconicum were identified only
in the rainwater, whereas Sphingomonas sp., Sphingobium sp., Ralstonia insidiosa, Blastochloris
sulfoviridis, Bacillus sp. and Beijerinckiaceae bacterium were found in the biofilm. Some species,
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such as Sphingopyxis sp., Sphingomonas sp., Novosphingobium resinovorum and Sphingobium
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mg/L, respectively; and the TP count was 0.07 ± 0.04 and 0.04 ± 0.01 mg/L, respectively. Thus,
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suggesting there was greater biofilm growth at the former. After 15 weeks, the correspond‐
ing figures were 3.6 CFU/cm2 at the inlet and 3.0 CFU/cm2 at the outlet, and the difference in
cell numbers between the two sites had been reduced to 1.2 times.
Figure 9. Number of viable cells on the coupons immersed at the tank inlet and outlet for 15 weeks.
Mature biofilm development may take anywhere from several hours to several weeks,
depending on the system [27]. Biofilm formation is one possible survival strategy for bacte‐
ria, and one of the advantages of bacterial adherence is the greater availability of nutrients
attached to the surface [28]. Geesey et al. [29] reported high rates of biofilm development in
oligotrophic environments. In the current study, biofilm formation was observed on the
coupons after 1 week of immersion. Considering the oligotrophic nature of rainwater tanks [2],
it appears that biofilms develop within 1 week in this environment.
In this study, cell number in outlet site would be smaller than that in inlet part because of
attachment to the existing biofilms on the wall in inlet part and sedimentation with small
particles. The difference in biofilm formation between inlet and outlet part would be results
of nutrient concentration and planktonic cell number in rain water flowing from inlet part. The
influence of flow velocity and the substratum effect was most likely excluded in this study
because, during the experiment period, a coupon of identical material was placed in the middle
of the tank and to minimize the effect of water flow, the water flow was controlled without
supply by overflowing.
3.2.3. Biofilm thickness
The CLSM images of the biofilm thickness on the coupons exhibited similar viable cell
patterns (Figure 10). At the tank inlet, the thickness was 4.5 ± 0.1 μm at the end of the first
week, increasing to 48.4 ± 1.3 μm at week 9 and then decreasing to 25.0 ± 2.8 μm at week 15.
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the particle and nutrient parameters of the rainwater, namely turbidity, SS, TOC, and TP, at
the outlet of the tank were slightly lower than those at the inlet.
Figure 8 shows the number of viable cells at the inlet and outlet of the tank during the
experimental period. The difference between the two sites was significant (P < 0.05): the
number of viable cells at the inlet was triple that at the outlet (3 × 105versus 1 × 105 CFU/mL,
respectively).
Figure 8. Comparison of the viable cell quantities at the tank inlet and outlet. The difference between them is statisti‐
cally significant (Student’s t-test; P < 0.05, n = 12).
The rainwater tank used in this study was designed with an internal wall in the inlet section
and a baffle in the middle to improve sediment efficiency. Ryu [6] reported that such design
factors as inlet barrier and baffles can affect the removal of the particles that come into a
rainwater tank. Hence, the slight differences in the physicochemical characteristics identi‐
fied at the tank inlet and outlet in this study appear to be due to these design factors. In addition,
the physicochemical conditions appear to influence the microbes in the water, as can be seen
in the different microbial numbers.
3.2.2. Comparing cell dynamics on coupon: cell number
To compare the biofilm development at the tank inlet and outlet, we also investigated the
number of viable cells on the coupons immersed at each site (Figure 9). The two sites exhibit‐
ed a similar number of cells until the fourth week. At week 9, however, the number at the inlet
was 2.5 times higher than that at the outlet (2.7 × 105 and 1.1 × 105 CFU/cm2, respectively),
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ed a similar number of cells until the fourth week. At week 9, however, the number at the inlet
was 2.5 times higher than that at the outlet (2.7 × 105 and 1.1 × 105 CFU/cm2, respectively),
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Figure 11. DGGE profiles at each sampling time point and the closest phylogenetic relatives found in the DGGE bands.
Following a high number of bands at the initial stage, reductions occurred later, possibly
arising from the competitive dominance of a few populations. The biofilms at the inlet and
outlet demonstrated a reduction in the number of bands after the first sample date. The
populations that were initially detected may still have been present in later biofilms, but the
rapid growth of other populations made them more difficult to detect. As biofilm matures, the
number of available microhabitats may increase (for example, from the formation of an
anaerobic pocket within the biofilm), thereby supporting a greater number of bacterial
populations.
Despite the overall differences in banding patterns, a number of bands appeared at the same
position in the DGGE gels in almost all of the samples, including Methylophilus methylotro‐
phus (Band No. 1), Methylocella palustris (Band No. 9) and Nitrospira sp. (Band No. 10), although
their intensity differed. Methylophilus sp. (Band No. 2) was found only at the outlet site at all
stages, whereas Methylotenera mobilis (Band No. 5), Microbacterium pumilum (Band No. 6) and
Bacillus sp. (Band No. 8) were identified in the earlier samples (week 1 and/or week 4). Some
bands, such as Nitrospira sp. (Band No. 10), faded over time.
In the initial stage of biofilm formation, free-swimming bacteria attach to the surface through
hydrophobic and electrostatic interactions and through the use of flagella [32]. In this study,
for example, both Methylotenera mobilis (Band No. 5) and Microbacterium pumilum (Band No. 6)
were detected in the earlier samples. The former is mobile by means of a single flagellum [33],
and the latter is non-motile [34]. Initial colonization on the surface may not be entirely random,
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Apilanez et al. [30] demonstrated that once biofilm has attained a certain weight, which can
be related to a certain thickness, detachment occurs. The development of greater biofilm
thickness can thus lead to earlier, and a great extent of detachment. Several processes can lead
to detachment: erosion or shearing, and sloughing and abrasion. Donlan [31] wrote that when
biofilm increases in thickness, its rate of erosion also increases. The detached biofilm possi‐
bly settles at the bottom of the tank, but it also provides a way for cells to migrate and colonize
a less populated area.
At the tank outlet, in contrast, a biofilm thickness of 5.7 ± 0.7 μm was seen at the end of the
first week and that thickness continued to increase until it reached 29.5 ± 2.0 μm at week 15.
No detachment phase was observed at the outlet in this study. It seems that because the
nutrient concentration is lower at the outlet, biofilm development is slower at that site.
Figure 10. Comparison of biofilm thickness obtained by CSLM (average ± standard deviation, n = 4).
3.2.4. Dynamics in bacterial community
Two sets of biofilms displayed changes in their DGGE banding patterns and number of bands
as they developed (Figures 11 and 12). Differences were apparent between the inlet and outlet
samples, both in the individual samples of a specific age and in the overall pattern of bacteri‐
al community development. The biofilm at the inlet exhibited a greater number of bands in
the earliest sample (1 week), displaying a decrease by the fourth week and then increasing
again. At the outlet, there were also a greater number of bands after 1 week, a decrease by the
ninth week, and then a slight increase. The band patterns appeared similar between the initial
two stages (weeks 1 and 4) and later two stages (weeks 9 and 15), and seemed to simplify over
time as the biofilm developed.
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outlet site, most likely due to the difference in nutrient concentrations. As the biofilm
development process was faster at the tank inlet, more sludge from the detachment was also
seen at this site.
Figure 13. Rank-abundance distributions of bacteria in different periods of biofilm development.
Sample Inlet Outlet
Slope r2 Slope r2
1 week −0.113 0.90 −0.106 0.96
4 weeks −0.194 0.89 −0.105 0.97
9 weeks −0.111 0.84 −0.150 0.98
15 weeks −0.141 0.81 −0.123 0.88
Table 3. Regression statistics for rank-abundance distributions of bacteria in the biofilm at different sites and stages of
development (P < 0.05; n varies by sample).
3.3. The effect of biofilms on microbial quality in rainwater tanks
3.3.1. P. aeruginosa removal in water
The persistence of the P. aeruginosa cells inoculated into the pilot tanks resulted from the
interaction between the cell growth and death rates and from that among the attachment,
detachment, and sedimentation processes. The total number of inoculated cells in the water
samples and on the bottoms and walls of the tanks decreased in both tanks (Figure 14). Cell
death contributed more to the observed cell decline than did growth in the tanks due to low-
nutrient conditions.
Figure 15 shows the removal rate of P. aeruginosa from the water of the two pilot tanks. Ninety-
nine percent of the inoculated P. aeruginosa was removed after 4 days in Pilot Tank 2 and after 5
days in Pilot Tank 1. The faster removal rate in Pilot Tank 2 was due to its higher S/V ratio.
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in that certain bacterial species may have greater colonization aptitude than others, such as
greater mobility.
Figure 12. Changes in the number of DGGE bands in the biofilm during the experimental period.
Rank-abundance distributions provide insights into both richness and evenness. In this study,
the rank-abundance plots displayed a trend towards a geometric distribution (Figure 13), and
linear regression was performed to examine changes in the pattern of evenness during biofilm
development (Table 3). Lower slope values indicate greater evenness, and higher values
indicate greater dominance by certain populations. At the tank inlet, the slope value was −0.113
at the end of the first week. It then increased steeply after 4 weeks, decreased after the ninth
week, and then increased again. At the outlet, in contrast, the slope value increased sharply at
the 9-week sample and then exhibited a decrease at the last sample.
The pattern of biofilm development seems to follow three major stages. Jackson et al. [35]
suggested an initial stage characterized by the colonization of different populations, an
intermediate stage characterized by a limited number of dominant populations utilizing
similar resources, and a late or mature stage characterized by mature biofilm of a complex
spatial structure that facilitates greater diversity through increased variation in habitat and
available resources. However, in the current study, this characterization appeared to apply
only up until the mature stage, after which detachment occurred. Following detachment,
biofilm development appeared to return to the intermediate and/or mature stage, and the
process was then repeated. In this study, this pattern/cycle was confirmed at the tank inlet site,
where biofilm development was more rapid throughout the experimental period than at the
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3.3.2. Microbial behaviour of P. aeruginosa put into the rainwater tanks
The number of P. aeruginosa in the water decreased by 3–4 log units, indicating that the death,
attachment and sedimentation processes dominated the overall dynamics (Figure 16A). The
removal rate of P. aeruginosa in the water phase was −0.57 log10 cells ml−1 day−1 (r2 = 0.93) in
Pilot Tank 1 and −0.74 log10 cells ml−1 day−1 (r2 = 0.98) in Pilot Tank 2. A faster removal rate was
shown in the tanks with higher S/V ratios.
Figure 16. Behavior of Pseudomonas aeruginosa inoculated in (A) the water and on the (B) wall and (C) bottom of the8
pilot-scale tanks. [Student’s t-test; (A) P < 0.05 except Day 0 (P = 0.51); (B) P < 0.1 except Day 0 (P = 0.17) and 1 (P =
0.14); (C) P < 0.01 except Day 7 (P = 0.10)].
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Figure 14. Total amount of Pseudomonas aeruginosa inoculated in pilot-scale tanks. . [Student’s t-test; P < 0.05 except Day
0 (P = 0.55) and 3 (P = 0.15)].
Figure 15. Removal rate of Pseudomonas aeruginosa inoculated in the water of the two pilot tanks.
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Figure 17. Number of Pseudomonas aeruginosa inoculated in the rainwater of the full-scale tanks. [Student’s t-test; P < 0.1
except Day 0 (P = 0.67)].
3.3.4. Biofilm’s role in rainwater tank
It has been suggested that rainwater tanks are unique ecosystems that support functional
ecosystems comprising complex communities of environmental bacteria [2]. This study
showed that a wider surface area for biofilm formation led to a higher removal rate of P.
aeruginosa in rainwater. When opportunistic pathogens such as P. aeruginosa introduced to
rainwater tanks with limited nutrient conditions, it seem to be removed due to their attach‐
ment to biofilms and die both naturally because of competition with indigenous microbial
communities for nutrients.
4. Suggestion of a design and maintenance guideline for rainwater system
From this study, it was suggested the expected role of biofilms for improving water quality in
rainwater tank. Contaminants including microorganisms in rainwater are possibly attached
on biofilm, and the biofilms are grown by nutrient degradation and additional attachment.
Then, followed sloughing and sedimentation processes, the rainwater quality seemed be
sustained by certain level.
In addition, four recommendations were suggested for design and maintenance of RWH
system as followed description.
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The number of attached P. aeruginosa cells increased over 4 days in Pilot Tank 1 and over 3
days in Pilot Tank 2 (Figure 16B). Their attachment to the biofilm on the wall was initially
dominant, and more bacteria were attached in Pilot Tank 2 because of the higher S/V ratio.
After 4 days, the number of attached P. aeruginosa cells declined by 2–3 log units, indicating
that the death or detachment processes were the dominant bacterial dynamics on the wall
(Figure 16B). Established biofilms developed from indigenous river water bacteria have been
shown to reduce the persistence of introduced E. coli and other enteric pathogens [36]. Banning
et al. [37] showed that, under certain conditions, the presence of mixed-populated biofilms
may limit the survival potential of enteric bacteria pathogens introduced into groundwater.
In addition, biofilm dynamics changes and pathogen persistence are affected by increasing in
nutrient levels. It was reported that a significant decrease in the survival rate of the Campylo‐
bacter jejuni strain in heterogeneous tap-water biofilms following the addition of serine, a
carbon source favoured by C. jejuni, and a concurrent increase in the number of indigenous
biofilm microflora [38]. These studies demonstrate that, under certain conditions, biofilms
represent sites of intensified competition for limited nutrients. Therefore, for the biofilms in
oligotrophic rainwater tanks, a decrease in P. aeruginosa cells may result from the nutrients
competition with indigenous microbial communities.
Inoculated P. aeruginosa were found on the bottom in tanks and decayed over time (Figure
16C). More bacteria observed at the bottom of Tank 1, which had a lower S/V ratio, and more
bacteria observed on the wall in Tank 2. The number of P. aeruginosa increased slightly on
days 3 and 6 in Tank 2, probably due to detachment from the wall rather than bacterial
regrowth, as this effect was not observed in Tank 1.
3.3.3. Microbial behaviour of P. aeruginosa put into the full-scale tanks
The number of P. aeruginosa in the water decreased by 1.5 log units in Tank 1 and by 2 log units
in Tank 2 (Figure 17). The removal rate was −0.604 log10 cells ml−1 day−1 (r2 = 0.99) in Tank 1
and −0.854 log10 cells ml−1 day−1 (r2 = 0.98) in Tank 2. In line with the results of the pilot test, a
faster removal rate was shown in Tank 2 due to its higher S/V ratio. Thus, it can be conclud‐
ed that increasing the S/V ratio in rainwater tanks to a certain level is possibly effective to
remove bacteria from rainwater.
In this study, the removal rates of P. aeruginosa were determined by calculating the slope and
correlation coefficient (r2) of the linear regression of the log-transformed cell concentration data
according to the first-order decay equation. Crane and Moore [39] reviewed a variety of
modified models of first-order decay kinetics and concluded that the simplest model is the
most advantageous. As noted, the findings of the current study suggest that increasing the S/
V ratio in rainwater tanks is an effective way of improving their microbial quality. Accord‐
ingly, additional research aimed at identifying which range of S/V ratios is most effective in
improving such quality may benefit from modifying the first-order kinetics. The resulting
information would help in the development of appropriate guidelines for the design of
rainwater tanks.
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Figure 17. Number of Pseudomonas aeruginosa inoculated in the rainwater of the full-scale tanks. [Student’s t-test; P < 0.1
except Day 0 (P = 0.67)].
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4. Suggestion of a design and maintenance guideline for rainwater system
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on biofilm, and the biofilms are grown by nutrient degradation and additional attachment.
Then, followed sloughing and sedimentation processes, the rainwater quality seemed be
sustained by certain level.
In addition, four recommendations were suggested for design and maintenance of RWH
system as followed description.
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1. There seems to be a unique microbial ecosystem which is able to control the microbial
quality to the certain level by themselves. Thus, it is recommended that avoid mixing with
chlorinated tap water which might disturb the microbial ecosystem in rainwater tank.
When rainwater and tap water connected system designs, it is advisable to arrange
separate supply tank without direct connection of tap water to the main storage tank.
2. Design of baffle and inlet barrier is recommended because they not only induce the
sedimentation of inflow particle but also control bacterial quality in rainwater by
increasing the surface for biofilm development.
3. Increasing the S/V ratio bacterial quality is possibly controlled by inducing more bio‐
film development. Therefore, it is recommended to consider the parameter of S/V ratio
when rainwater tank is designed.
4. Frequent cleaning and/or disinfection of rainwater tank inside seems to be counterpro‐
ductive because biofilm developed in rainwater tank improve the bacterial quality in
rainwater tank by adhesion of bacteria in rainwater.
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Abstract
Over the years, numerous studies have been conducted into the possible links between
biofilms in beverage industry and health safety. Consumers trust that the soft drinks they
buy are safe and their quality is guaranteed. This chapter provides an overview of available
scientific knowledge and cites numerous studies on various aspects of biofilms in drinking
water technology and soft drinks industry and their implications for health safety.
Particular attention is given to Proteobacteria, including two different genera: Aeromo‐
nas, which represents Gammaproteobacteria, and Asaia, a member of Alphaproteobacteria.
Keywords: biofilms, water, soft drinks, Aeromonas , Asaia
1. Drinking water systems
In water systems, both natural and industrial dominate Proteobacteria. This is the main group
(phylum) of Gram-negative bacteria, taxonomically very diverse, consisting of more than 200
genera. Its membership includes both pathogenic bacteria of the genera Escherichia, Salmonel‐
la, Vibrio, Helicobacter, and many other types of free-living or symbiotic, motile or nonmotile,
chemoautotrophic or heterotrophic bacteria from outstanding aerobes to obligatory anaerobes.
Although bacteria are physiologically and morphologically diverse, they constitute a coher‐
ent set of six main classes: Alphaproteobacteria, Betaproteobacteria, Gammaproteobacteria,
Deltaproteobacteria, Epsilonproteobacteria, and Zetaproteobacteria. Taxonomy of the group is
determined primarily on the basis of ribosomal RNA sequences [1]. Species belonging to the
classes Alphaproteobacteria, Betaproteobacteria, and Gammaproteobacteria are very heterogene‐
ous in their physiological characteristics. Each of the three classes includes aerobes and
anaerobes, photosynthetic and nonphotosynthetic cells. They are distributed in both terres‐
trial and aquatic environments in very high abundance.
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(phylum) of Gram-negative bacteria, taxonomically very diverse, consisting of more than 200
genera. Its membership includes both pathogenic bacteria of the genera Escherichia, Salmonel‐
la, Vibrio, Helicobacter, and many other types of free-living or symbiotic, motile or nonmotile,
chemoautotrophic or heterotrophic bacteria from outstanding aerobes to obligatory anaerobes.
Although bacteria are physiologically and morphologically diverse, they constitute a coher‐
ent set of six main classes: Alphaproteobacteria, Betaproteobacteria, Gammaproteobacteria,
Deltaproteobacteria, Epsilonproteobacteria, and Zetaproteobacteria. Taxonomy of the group is
determined primarily on the basis of ribosomal RNA sequences [1]. Species belonging to the
classes Alphaproteobacteria, Betaproteobacteria, and Gammaproteobacteria are very heterogene‐
ous in their physiological characteristics. Each of the three classes includes aerobes and
anaerobes, photosynthetic and nonphotosynthetic cells. They are distributed in both terres‐
trial and aquatic environments in very high abundance.
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Physicochemical nature of such consortia implies differentiation of the physiological condi‐
tion of individuals forming them [8]. Creating consortium is an effective adaptation strategy,
including cell protection against adverse environmental factors; increased nutrient availabil‐
ity; increased binding of water molecules, thereby reducing the risk of dehydration; and
increased ability to transfer DNA.
Microbial consortia exhibit altered phenotypic characteristics compared to planktonic cells,
particularly with respect to growth and gene expression. All these factors increase the survival
of cells forming biofilms. As a result, the inactivation of bacterial cells by conventional methods
such as the use of antibiotics and disinfectants is often ineffective [9]. Especially this exopoly‐
mer matrix confers resistant properties to the whole system via the limitation of the effective‐
ness of disinfection by consuming the oxidants used, such as chlorine and chloramines [10].
At high cell concentration, a series of cell signaling mechanisms are employed by the biofilm,
and this is collectively termed quorum sensing. Quorum sensing describes a process where a
number of autoinducers (chemical and peptide signals in high concentrations, e.g., homoser‐
ine lactones) are used to stimulate genetic expression of both mechanical and enzymatic
processes. In mature biofilms, enzymes are produced by the community itself which break‐
down polysaccharides holding the biofilm together, actively releasing surface bacteria for
colonization of fresh substrates. For example, alginate lyase produced by Pseudomonas
fluorescens and Pseudomonas aeruginosa, N-acetyl-heparosan lyase by Escherichia coli, and
hyaluronidase by Streptococcus equi are used in the breakdown of the biofilm matrix [6].
Biofilms are polymicrobial communities, therefore the potential for cell coaggregation plays
an integral role in spatiotemporal biofilm development and the moderation of biofilm
composition. Coaggregation is mediated by the interaction between specific macromolecules
on the cell surface of one species and cognate macromolecules expressed on the cell surface of
the partner species. Microbial cells may also come into contact through hydrophobic interac‐
tions or electrostatic forces, but these last associations are relatively weak. Coaggregation-
mediating proteins are referred as adhesins. Coaggregation may occur between lectin-like
protein adhesins and their polysaccharide receptors or by protein–protein (adhesin–adhesin)
interactions. These interactions may be unimodal, but in some cases are bimodal, involving
two different interacting pairs of macromolecules [7].
Cell aggregation, as well as biofilm formation may have both intrageneric and intergeneric
character [11]. Consortia are very changeable and their components depend on the environ‐
mental conditions. The study conducted by Rickard et al. [12] revealed that intergeneric and
intraspecies coaggregation between water bacteria are common phenomena, and expression
of coaggregation is dependent on cells being in the optimum physiological state for coaggre‐
gation, which usually occurs in stationary phase. Therefore, it is possible that since cells grow
very slowly in nutrient-limited biofilms, these biofilms would provide suitable conditions for
expression of coaggregation.
Different materials such as cast iron galvanized steel, stainless steel, copper, and polyethy‐
lene are used to manufacture water distribution pipes. It is worth noting that these materials
favor biofilm formation in the water distribution systems. The presence of biofilms in drinking
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dominate (87–99%), while Alphaproteobacteria are in marine waters [2]. Proteobacteria predomi‐
nated in biofilms present in drinking water distribution systems, but the compositions of the
dominant proteobacterial classes and genera and their proportions varied among biofilm
samples [3]. The majority of strains isolated from biofilms in water distribution networks is
Alpha- or Gammaproteobacteria [4]. Except Proteobacteria, Firmicutes, Bacteroidetes, Actinobacte‐
ria, Nitrospirae, and Cyanobacteria are usually the major components of biofilm bacterial
community.
One of the common features of Proteobacteria is the ability of biofilm formation and/or
aggregation and formation of the so-called “flocs”. An important component of such struc‐
tures, in addition to microbial cells, is water – it represents about 97%. Besides water, the
biofilm or flocs matrix are extracellular polymeric substances (EPSs). The bacterial cells in
biofilms are embedded in a heteropolymeric matrix containing humic substances, glycopro‐
teins, polysaccharides, and nucleic acids [5].
A first step in the successional development of biofilms is the coating of uncolonized surfa‐
ces with many particles, organic or inorganic (conditioning film), which enhances attach‐
ment of initial colonizing bacteria. Anything that may be present within the bulk fluid can
through gravitational force or movement of flow settle onto a surface and become part of a
conditioning layer. Surface charge, potential, and tensions can be altered favorably by the
interactions between the conditioning layer and the surface. Factors such as available energy,
surface functionality, bacterial orientation, temperature and pressure conditions are local
environmental variables which contribute to bacterial adhesion. Physical forces associated to
bacterial adhesion include the van der Waals’ forces, steric interactions, and electrostatic
(double layer) interactions, collectively known as the DVLO (Derjaguin, Verwey, Landau, and
Overbeek) forces [6]. An extended DVLO theory takes into consideration hydrophobic/
hydrophilic and osmotic interactions.
In real time, a number of the reversibly adsorbed cells remain immobilized and become
irreversibly adsorbed. The physical appendages of bacteria (flagella, fimbriae, and pili)
overcome the physical repulsive forces of the electrical double layer. Some evidence has shown
that microbial adhesion strongly depends on the hydrophobic–hydrophilic properties of
interacting surfaces. The first colonizers grow in surface-attached microcolonies and pro‐
duce EPS. After an initial lag phase, a rapid increase in population is observed, which is
described as the exponential growth phase. As the microcolonies develop, additional species,
the so-called secondary colonizers, are recruited through coaggregation and nonspecific
aggregation interactions, increasing the biofilm biomass and species complexity [7].
Simultaneously, expression of a number of genes for the production of cell surface proteins
and excretion products increases. Surface proteins (porins) such as Opr C and Opr E allow the
transport of extracellular products into the cell and excretion materials out of the cell, e.g.,
polysaccharides. EPS molecules impart mechanical stability and are pivotal to biofilm
adhesion and cohesion, and evasion from harsh dynamic environmental conditions. The
differences in gene expression of planktonic and sessile cells were identified, and as many as
57 biofilm-associated proteins were not found in the planktonic profile [6].
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Figure 1. Gram-negative rods of Aeromonas hydrophila.
The vast majority of bacteria isolated from biofilms belonged to Aeromonas hydrophila. They
showed the major virulence factors such as surface polysaccharides (capsule, lipopolysac‐
charide, and glucan), S-layers, iron-binding systems, exotoxins and extracellular enzymes,
secretion systems, fimbriae, and other nonfilamentous adhesins, motility, and flagella [21, 22].
Despite the demonstration of the enterotoxic potential of some Aeromonas spp. strains, there
is still a debate on its consideration as an etiological agent, as there were no big epidemical
outbreaks described and no adequate animal model is available to reproduce the
gastroenteritis caused by Aeromonas.
In clinical and environmental isolates of Aeromonas species, two distinct types of fimbriae have
been found based on their morphology: short, rigid fimbriae (0,6–2 μm) that can be found in
high numbers on the bacterial cell and long, wavy fimbriae (4–7 nm) found in smaller numbers.
The short fimbriae are able to cause autoaggregation, and large ones considered hemaggluti‐
nins. Amino-acid sequence analysis indicates that they correspond to type IV pili, known as
important structures for adhesion to epithelial cells and involved in biofilm formation. Some
of them exhibit highest homology with the type IV pili of Pseudomonas and Neisseria species
[22].
In studies conducted by Kregiel et al., A. hydrophila isolated from water distribution system,
adhered to different abiotic surfaces such as glass, polystyrene, polyvinyl chloride, and
gumosil, commonly used as packaging and installation materials [23–25]. After 3 weeks in an
aqueous environment with a small amount of organic matter, bacteria formed numerous
microcolonies surrounded extracellular mucilaginous substance (Figure 2). The results of
microscopic examination demonstrated the strong adhesion properties of A. hydrophila and
they were confirmed by luminometric measurements.
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water distribution pipes usually leads to a number of undesirable effects on the quality of water
that is supplied to consumers. For example, the development of biofilms in copper pipes
facilitates cuprosolvency which increases the release of copper into the distribution system.
What's more, increased carbon influences the growth of heterotrophic plate count bacteria
which are also involved in the corrosion of copper [13]. Silhan et al. [14] showed that among
drinking water pipe materials such as galvanized steel, cross-linked polyethylene, copper
pipes, and medium-density polyethylene, the most dense biofilm of E. coli was formed on the
steel surface.
Molecular analysis of microbial communities by Yu et al. [15] indicated the presence of Alpha-
and Betaproteobacteria, Actinobacteria, and Bacteroidetes in biofilms on the pipe materials.
Moreover, the DGGE profile of bacterial 16S rDNA fragments showed significant differen‐
ces among different surfaces, suggesting that the pipe materials affect not only biofilm
formation potential but also microbial diversity.
The development of biofilms inside water distribution pipes facilitates the propagation of
mixed microbial populations and is considered the main source of planktonic bacteria in water
supply systems. Among the heterotrophic bacteria in drinking water systems, the pathogen‐
ic bacteria or at least opportunistic pathogens often appear. Enteropathogenic E. coli or other
members of Enterobacteriaceae may appear in water supply systems due to contamination as a
result of flooding, water supply failure, or insufficient disinfection. Other opportunistic
bacteria such as P. aeruginosa, Burkholderia spp., Stenotrophomonas maltophilia, and Legionella
spp. were quite often detected [16]. They increase the health risks associated with the con‐
sumption of water [13].
In the last decade, a group of new, potentially dangerous pathogens forming biofilms were
classified as Aeromonas spp. rods from class Gammaproteobacteria [17, 18] (Figure 1). The
experimental data and clinical and epidemiological evidence show that Aeromonas spp. may
be an etiological factor of bacterial gastroenteritis in children and people with reduced
immunity.
Bacteria Aeromonas spp. are capable not only of survival, but also propagation in water at
temperatures up to 10°C and show a greater ability to utilize different carbon compounds than
other Gram-negative bacteria.
According to Sautour et al. [19], the genus Aeromonas shows the ability to use not only
carbohydrates, amino acids, and carboxylic acids, but also fatty acids and saturated hydro‐
carbons. Growth of these bacteria in an aqueous medium follows in the presence of even a
small amount of biodegradable dissolved organic carbon compounds.
It was noted that there was an intense increase in the number of heterotrophic bacteria in the
summer months. The results obtained by Craveiro et al. [20] demonstrated that Aeromonas spp.
strains were able to form biofilm at both room and refrigeration temperatures. The chlorine-
based disinfectant demonstrated to be efficient in removing preformed biofilm, but both were
unsuccessful in preventing biofilm formation, highlighting the importance of adequate
cleaning and disinfection procedures, with emphasis on food processing surfaces.
Microbial Biofilms - Importance and Applications174
Figure 1. Gram-negative rods of Aeromonas hydrophila.
The vast majority of bacteria isolated from biofilms belonged to Aeromonas hydrophila. They
showed the major virulence factors such as surface polysaccharides (capsule, lipopolysac‐
charide, and glucan), S-layers, iron-binding systems, exotoxins and extracellular enzymes,
secretion systems, fimbriae, and other nonfilamentous adhesins, motility, and flagella [21, 22].
Despite the demonstration of the enterotoxic potential of some Aeromonas spp. strains, there
is still a debate on its consideration as an etiological agent, as there were no big epidemical
outbreaks described and no adequate animal model is available to reproduce the
gastroenteritis caused by Aeromonas.
In clinical and environmental isolates of Aeromonas species, two distinct types of fimbriae have
been found based on their morphology: short, rigid fimbriae (0,6–2 μm) that can be found in
high numbers on the bacterial cell and long, wavy fimbriae (4–7 nm) found in smaller numbers.
The short fimbriae are able to cause autoaggregation, and large ones considered hemaggluti‐
nins. Amino-acid sequence analysis indicates that they correspond to type IV pili, known as
important structures for adhesion to epithelial cells and involved in biofilm formation. Some
of them exhibit highest homology with the type IV pili of Pseudomonas and Neisseria species
[22].
In studies conducted by Kregiel et al., A. hydrophila isolated from water distribution system,
adhered to different abiotic surfaces such as glass, polystyrene, polyvinyl chloride, and
gumosil, commonly used as packaging and installation materials [23–25]. After 3 weeks in an
aqueous environment with a small amount of organic matter, bacteria formed numerous
microcolonies surrounded extracellular mucilaginous substance (Figure 2). The results of
microscopic examination demonstrated the strong adhesion properties of A. hydrophila and
they were confirmed by luminometric measurements.
Biofilms in Beverage Industry
http://dx.doi.org/10.5772/62940
175
water distribution pipes usually leads to a number of undesirable effects on the quality of water
that is supplied to consumers. For example, the development of biofilms in copper pipes
facilitates cuprosolvency which increases the release of copper into the distribution system.
What's more, increased carbon influences the growth of heterotrophic plate count bacteria
which are also involved in the corrosion of copper [13]. Silhan et al. [14] showed that among
drinking water pipe materials such as galvanized steel, cross-linked polyethylene, copper
pipes, and medium-density polyethylene, the most dense biofilm of E. coli was formed on the
steel surface.
Molecular analysis of microbial communities by Yu et al. [15] indicated the presence of Alpha-
and Betaproteobacteria, Actinobacteria, and Bacteroidetes in biofilms on the pipe materials.
Moreover, the DGGE profile of bacterial 16S rDNA fragments showed significant differen‐
ces among different surfaces, suggesting that the pipe materials affect not only biofilm
formation potential but also microbial diversity.
The development of biofilms inside water distribution pipes facilitates the propagation of
mixed microbial populations and is considered the main source of planktonic bacteria in water
supply systems. Among the heterotrophic bacteria in drinking water systems, the pathogen‐
ic bacteria or at least opportunistic pathogens often appear. Enteropathogenic E. coli or other
members of Enterobacteriaceae may appear in water supply systems due to contamination as a
result of flooding, water supply failure, or insufficient disinfection. Other opportunistic
bacteria such as P. aeruginosa, Burkholderia spp., Stenotrophomonas maltophilia, and Legionella
spp. were quite often detected [16]. They increase the health risks associated with the con‐
sumption of water [13].
In the last decade, a group of new, potentially dangerous pathogens forming biofilms were
classified as Aeromonas spp. rods from class Gammaproteobacteria [17, 18] (Figure 1). The
experimental data and clinical and epidemiological evidence show that Aeromonas spp. may
be an etiological factor of bacterial gastroenteritis in children and people with reduced
immunity.
Bacteria Aeromonas spp. are capable not only of survival, but also propagation in water at
temperatures up to 10°C and show a greater ability to utilize different carbon compounds than
other Gram-negative bacteria.
According to Sautour et al. [19], the genus Aeromonas shows the ability to use not only
carbohydrates, amino acids, and carboxylic acids, but also fatty acids and saturated hydro‐
carbons. Growth of these bacteria in an aqueous medium follows in the presence of even a
small amount of biodegradable dissolved organic carbon compounds.
It was noted that there was an intense increase in the number of heterotrophic bacteria in the
summer months. The results obtained by Craveiro et al. [20] demonstrated that Aeromonas spp.
strains were able to form biofilm at both room and refrigeration temperatures. The chlorine-
based disinfectant demonstrated to be efficient in removing preformed biofilm, but both were
unsuccessful in preventing biofilm formation, highlighting the importance of adequate
cleaning and disinfection procedures, with emphasis on food processing surfaces.
Microbial Biofilms - Importance and Applications174
For example, the flavored drinking water samples with sucrose and natural fruit flavors
showing signs of turbidity and the characteristic "flocs" formed by heterotrophic bacteria [28].
The developed specific methods allowed for the isolation of bacteria belonging to the Asaia
spp. – a new, previously unknown in Poland, microbial contamination of mineral water and
flavored beverages. Isolated bacteria were Gram-negative, aerobic rods with dimensions of
0.4–1.0 × 08–2.5 μm. These bacteria formed characteristic small (1–3 mm in diameter), pale pink
or pink colonies in agar plates. The isolates were identified based on 16S rRNA gene sequen‐
ces. It is worth noting that the same morphotypes and genotypes were isolated from fruit
concentrates, which were previously used for production of flavored waters.
Asaia sp. was established in 2000 as the fifth genera of acetic acid bacteria of the class
Alphaproteobacteria. Bacteria Asaia sp. were first isolated from the orchid tree flower (Bauhinia
purpurea) and flowers of Pueraria (Plumbago), growing in tropical climates. Currently, Genera
Asaia contains eight species named as: As. bogorensis, As. siamensis, As. krungthhepensis, As.
lannensis, As. spathodeae, As. astilbis, As. platycodi and As. prunellae.. It is distinguished from
other types of acetic acid bacteria not only by genetic features, but also by biochemical
properties. The optimum pH and temperature of these bacteria are 5.5 and 30°C, respective‐
ly. Nevertheless, the strains belonging to Asaia sp. isolated from environments in tropical
Indonesia, Thailand, and Japan have optimum growth even at 37°C [29].
Asaia spp. belongs to the risk 1 group, which means that it is a group of saprophytic microor‐
ganisms without causing diseases in humans. However, according to the literature, these
bacteria can cause opportunistic infections when they get into the bloodstream of a man with
weakened immune systems. Several cases of bacteremia caused by Asaia spp. were document‐
ed, especially in chronically ill adults and pediatric patients with cardiomyopathy or cancer.
The first documented case of bacteremia caused by As. bogorensis was reported in a young
patient with a history of intravenous-drug abuse. As. bogorensis was identified by sequenc‐
ing the 16S rRNA gene. The isolate was resistant to almost all antibiotics routinely tested for
Gram-negative rods, but was susceptible to gentamicin and doxycycline [30]. One of the last
reports describes transient bacteremia due to As. lannensis in a patient with a psychiatric
disorder and compulsive self-injection of different substances. Only restriction fragment
length polymorphism of PCR-amplified 16S rRNA gene allowed for proper identification of
isolate. The strain was also highly resistant to most antibiotics [31].
Asaia spp. show strong ability to aggregate and form characteristic "flocs" and to create biofilms
on selected surfaces commonly used in the food industry: glass, polyethylene terephthalate,
and polypropylene [32] (Figure 3).
It was found that the hydrophobicity of the cells decreased with increasing the age of the
population. The higher hydrophobicity of young cells stimulates the process of aggregation
and formation of flocs. The studies proved that the adhesive abilities of As. lannensis depend
on the carbon source, nutrient availability, and physicochemical properties of abiotic surface.
The strongest adhesion properties were characterized by cells in the minimal medium with
sucrose.
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Figure 2. Biofilm of Aeromonas hydrophila on a glass surface.
The studies have found that both due to the strong adhesive properties of A. hydrophila, and
the possibility of the virulence factors determining its pathogenicity, it should be considered
the inclusion of Aeromonas rods for routine microbiological water analysis, especially for
monitoring water or beverage distribution systems.
2. Soft drinks
When a change in the chemical nature of a fluid occurred, there is usually a qualitative shift
created microbial consortia [8]. While the succession is a well-known process in classical
ecology, in the case of biofilms or cell aggregates it is not fully understood. Despite many
researches, the full knowledge on the formation of microbial consortia is still lacking. However,
succession processes seem to be rather stochastic (reproduction and death) [26]. During growth
of consortia, competition for resources makes that weak individuals are eliminated, and
stronger competitors become dominant. Finally, in the mature consortia, cells are becoming
more diverse by individual differences and “internal recycling.”
Environmental factors may also shape the succession in microbial consortia. Changes in pH,
the presence of carbon sources in the form of saccharides, and other additional substances
cause significant qualitative changes in biofilms [27].
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Figure 2. Biofilm of Aeromonas hydrophila on a glass surface.
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stronger competitors become dominant. Finally, in the mature consortia, cells are becoming
more diverse by individual differences and “internal recycling.”
Environmental factors may also shape the succession in microbial consortia. Changes in pH,
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3. New antiadhesion strategy: organosilanes
It is known that it is best to prevent than to fight against biofilm formed on the internal surface
of a distribution system. For drinking waters and soft drinks, reduction or elimination of the
formation of cell consortia can be obtained only by changing the physicochemical properties
of abiotic surfaces or bioactive properties of consumption waters.
Compounds of the biocidal and/or antiadhesive properties applied in potable water systems
have to inhibit effectively the growth of microorganisms without releasing toxic compounds
with low molecular weight into aquatic environment. Such compounds may be organosi‐
lanes containing at least one bond between the carbon and silicon atom Si–CH3. A carbon–
silicon bond is very durable, and the presence of an alkyl group causes a change in surface
tension. Additionally, organosilanes can contain other functional groups with antimicrobial
properties, for example, methoxy, ethoxy, amino, methacrylic, and sulfide [35].
Organofunctional silanes are hybrid compounds that combine the functionality of a reactive
organic group and the inorganic functionality of an alkyl silicate in a single molecule. This
special property means they can be used as ‘molecular bridges’ between organic substrates
and inorganic materials (Figure 4).
Figure 4. Model structure of organosilanes.
These compounds are relatively environmentally friendly, improve adhesion, and provide
better protection against corrosion. Surfaces on which they can be used include metal, plastic,
glass, rubber, ceramic, porcelain, marble, cement, granite, tile, silica, sand, appliances that have
been enameled, polyester, polyurethane, polyacrylic, resins that are melamine or phenolic,
siliceous, polycarbonate and wood, as well as painted surfaces.
The growth of many microorganisms can be reduced on surfaces treated with alkylsilanes. In
general, the reactivity of hydroxylated surfaces with organofunctional silanes decreases in the
following order: Si–NR2 > Si–Cl > Si–NH–Si > Si–O2CCH3 > Si–OCH3 > Si–OCH2CH3. The
methoxy and ethoxysilanes are the most widely used organofunctional silanes for surface
modification. The methoxysilanes are capable of reacting with substrates under dry, protic
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Figure 3. “Flocs” formed by cells of Asaia spp.
Definitely, the level of cell adhesion decreased in media that is rich in nutrients. Biofilm
creation in a specific medium which was the commercial mineral flavored water had a dynamic
character [32].
It is difficult to determine the origin of the contamination of soft drinks with the Asaia spp.
However, the fruits and fruit concentrates are regarded as the source of the contamination [28,
33]. Most strains were isolated from the reclaimed fruit beverages and flavored mineral waters.
This spoilage often occurs in the acid products preserved by the benzoate, sorbate, and
dimethyldicarbonate. Horsakova et al. [34] found that these bacteria occur in the processing
equipment in the form of biofilm, which is persistent and hardly removable by the common
sanitation. The isolated bacteria Asaia spp. exhibit the polysaccharide encapsulation. The
presence of preservatives is almost no effect on the Asaia spp. growth. The minimum inhibi‐
tion concentration for sorbic and benzoic acid under the conditions of the model fruit drink
(pH 3.45; Rf 10 Brix) were between 250 and 500 mg/l, while the concentration 250 mg/l is used
for the stabilization of similar fruit beverage production.
The resistance of Asaia spp. to common preservatives limits the available possibilities to
prevent spoilage of similar drinks. Additionally, the contamination of the technological
equipment always brings the serious problem. The common sanitation procedures used in the
beverage production may be insufficient to eliminate the very rigid biofilm, which is formed
by Asaia spp. in the equipment. According to Horsakova et al. [34], the reliable elimination of
such biofilm may require more forcing condition (e.g., hot sodium hydroxide and detergent
and enzyme solutions) and in any hardly accessible points (pipe bends, branches, connec‐
tions, and valves) mechanical treatment is the only possibility.
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ries: fructose, which inhibits the adherence of type 1 fimbriae, and proanthocyanidins, which
inhibits the adherence of p-fimbriae. The binding of the proteinaceous bacterial fimbrial tips
to mucosal surfaces on the uroepithelium occurs as a specific receptor‐ligand association
favored by hydrophobic interactions. This possible mechanism is that the cranberry com‐
pounds, acting as receptor analogs, competitively inhibit the adhesion of E. coli to host cells
by binding to the fimbrial tips. Another mechanism of cranberry activity is the in vitro
reduction in the expression of p-fimbriae in E. coli by changing the conformation of surface
molecules [38]. Zafriri et al. were the first to postulate that compounds in cranberry could affect
p and type 1 fimbriae of E. coli [39]. In 1998, Howell et al. [40] identified specific proanthocya‐
nidin compounds in cranberry responsible to antiadhesive properties.
Proanthocyanidins are one of many plant phenols, which are aromatic secondary metabo‐
lites found in the plant kingdom. They are mainly found in Vaccinium berries such as cran‐
berries and blueberries. They are dimers or oligomers of catechin and epicatechin and their
gallic acid esters. Proanthocyanidins are in the first place very strong antioxidants. Studies
have shown that proanthocyanidins act as anticancer and antiallergic agents, and that they
improve heart health. These flavonoids have several potential clinical effects, including
antiatherosclerotic, anti-inflammatory, antitumor, antithrombogenic, antiosteoporotic, and
antiviral. Some of these effects, such as antitumor, are still up for discussion, and the role of
flavonoids in different effects is not fully known.
They are also known as olgoflavanoids, and consist of monomer flavan-3-ol units. When linked
through either C4 to C8 or C4 to C6 bonds, the linkages are called B-linked. When the linkages
were through a C2 and C7 compound, they are called A type [41]. While B-linked proantho‐
cyanidins can be found in different fruit products including apple juice, purple grape juice,
green tea, and dark chocolate, A-linked ones are found in cranberries and it is a linkage with
unique antiadhesion properties associated with them [42] (Figure 5).
Figure 5. Proanthocyanidins: type A (left) and type B (right).
The antiadhesive properties of cranberry were demonstrated against different microorgan‐
isms: E. coli, Proteus mirabilis, or Helicobacter pylori, responsible for urinary tract infections and
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conditions, while the less reactive ethoxysilanes require catalysis. The low toxicity of ethanol,
a byproduct of the reaction, favors the use of ethoxysilanes in many commercial applications
[35].
One of the most established and successful uses of the application of organosilanes is preven‐
tion against biofilm formation. The use of the proper quaternary amine-based organosilane
can provide durable antimicrobial protection against a wide variety of microorganisms [36].
Adhesion abilities of A. hydrophila to the glass surface modified by coating with four differ‐
ent organosilanes with active functional groups were described by Kregiel [23]. The pres‐
ence of active functional groups had an impact on a significant reduction in the surface tension
of the test surfaces due to reduced participation polar forces – one of the components of surface
forces. Among the modifiers, organosilanes containing methoxy groups and quaternary
ammonium salts showed the best antiadhesive and antibacterial properties. Organosilanes
were stable in an aqueous environment. Interesting results from the modification of the surface
of the glass gave impulsion to extend the study on modification of plastic materials common‐
ly used as pipe materials in water systems [24, 25]. The modified PVC surfaces were made by
silane coupling on the native material. Modifications of silicone elastomer were carried by
cocrosslinking organosilane with silicone. Almost all of the modified surfaces were character‐
ized by antimicrobial and antiadhesive features. Among the modifications, especially
polydimethylsiloxane with a quaternary ammonium salt and a methoxy group in the silicone
elastomer showed the greatest antiadhesive and antibacterial properties against A. hydrophila.
4. New antiadhesion strategy: proanthocyanidins
Scientific studies showed that natural compounds from different fruits have potential health
benefits against cancer, aging and neurological diseases, inflammation, diabetes, and bacteri‐
al infections. For example, cranberry juice was recognized for benefits of maintenance of a
healthy urinary tract. Cranberry is a term derived from the contraction of “crane berry.” This
name is derived from the nickname of the bilberry flower, and the sand crane, a bird that often
feeds on the berries of this plant. The cranberry is part of the Ericaceae family and naturally
grows in acidic swamps full of peat moss in humid forests [37].
Bacterial adhesion is accomplished by the binding of lectins exposed on the cell surfaces of pili
and fimbriae to complementary carbohydrates on the host tissues. Pili are small filaments that
can be either mannose-resistant or mannose-sensitive. The mannose-sensitive pili, called type 1
pili, permit bacterial adhesion to the urothelium. The fimbriae (p-fimbriae) are inhibited by
fructose, present in cranberries. The more virulent strains of E. coli, isolated from patients with
urinary tract infections, have other types of these structures that bind to glycosphingolipids
of the lipid double membrane of renal cells, which precedes renal parenchymal invasion.
The current hypothesis is that cranberries work principally by preventing the adhesion of
type 1 and p-fimbriae E. coli strains to the urothelium. Without adhesion, the bacteria cannot
infect the mucosal surface. In vitro, this adhesion is mediated by two components of cranber‐
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gastritis, as well as other pathogenic Gram-negative and Gram-positive bacteria: P. aerugino‐
sa, Staphylococcus aureus, or Listeria monocytogenes [43–45].
It was also noted that the adhesion of Asaia spp. cells in the presence of cranberry juice was
much lower, especially for the packaging material – polystyrene [37]. In the presence of 10%
cranberry juice, attachment of bacterial cells was three times lower. The obtained results
suggested that compounds of cranberry inhibit both biofilm formation and coaggregation of
microbial cells. This fact would help to utilize antioxidant-rich cranberry juice as a natural
antiadhesive protectant and microbiological stability enhancing agent for functional soft
drinks.
5. Conclusion
Problems related to microbial contamination in the beverage industry have been studied for
more than a century. However, most of the knowledge acquired over the years relates to single-
cells, but today it is generally accepted that microorganisms grow and survive in organized
communities where their physiology is very different. This paper has given an overview of
the most widely used research on the controlled attachment of specific bacteria present in
drinking water or soft drinks. Both surfaces modified by organosilanes and cranberry juice
supplementation are the latest developments in this area. Particularly, cranberry juice and
cranberry extracts may be investigated as a natural solution for food industry by creating an
additional barrier to inhibit the growth of spoilage bacteria and providing additional health
benefits.
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Abstract
Staphylococcal infections are reported to cause very important problems in hospital‐
ized and immunocompressed patients worldwide due to their tough and irresponsive
treatment by antibiotics. Biofilm-embedded bacteria that gain resistance to immune
defense and antibiotics by antibiotic degrading enzymes, efflux pumps, and certain gene
products of which expression are changed by the quorum sensing cause chronic and
recurrent infections such as indwelling device–associated infections. Biofilm-embed‐
ded sessile  community  has  heterogeneous  cells  that  have  wide  range  of  different
responds  to  each  antimicrobials.  Staphylococcus  epidermidis  (S.  epidermidis)  and
Staphylococcus aureus (S. aureus) that are mostly known pathogenic strains can induce
gene expression of biofilm that has an important role in the pathogenesis of staphylo‐
coccal infections and causes bacterial attachment and colonization on biotic such as
tissues or abiotic surfaces such as prosthetic surfaces that may act as a substrate for
microbial  adhesion  when  microorganisms  exposed  to  stress  conditions.  This  ex‐
pressed and matured biofilm causes bacterial spread to whole body, consequently,
spread of infection in to whole body. It is hard to treat biofilm infections, and new agents
are being researched to prevent formation and dissemination of biofilm. Defining the
virulence and the role of biofilm of S. epidermidis and S. aureus in chronic and recur‐
rent infections such as indwelling device–associated infections, the mechanism and the
global  regulation of biofilm production by quorum-sensing system, inactivation of
biofilm formation, and the resistance patterns of biofilm-embedded microorganism
against antimicrobials are important.
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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bic conditions, acid exposure, salinity, pH gradients, desiccation, bacteriophages, and amoebae
and to resist antibiotics, antimicrobials, and host immune defense [5–8]. The main pathogen
of implant infections is staphylococci that cause 80% of all prosthetic infections [9]. The biofilm
of bacteria causes chronic infections such as indwelling device–related infections, chronic
wound infections, chronic urinary tract infections (UTI), cystic fibrosis pneumonia, chronic
otitis media (OM), chronic rhinosinusitis, periodontitis, and recurrent tonsillitis [10]. The
biofilm infections are the main important problems in hospitalized and immunocompressed
patients in worldwide due to their tough and irresponsive treatment by antibiotics. In biofilm,
bacteria are not distrupted completely by antibiotics even high doses of antibiotics used in vivo
[3, 11, 12]. Infected device can expose the patient to a higher risk of mortality. Orthopedic
surgery and trauma indwelling device-related infections that make treatment difficult by
antibiotics [13] cause removal of implant out of the body to eradicate biofilm and overcome
biofilm-related infections [14] and may cause functional loss of the infected limb [15, 16].
2.2. Staphylococcal biofilms as a virulence factor
The biofilm that anchored to abiotic or biotic surfaces is a slime-like glycocalyx in which sessile
community of microorganisms embedded. This extracellular polymeric substance that is
constituted by matrix of polysaccharide, teichoic acids, extracellular DNA (eDNA), and
staphylococcal proteins is produced by biofilm producing microorganisms [4, 17, 18].
Polysaccharide intracellular adhesin (PIA) is a specific polysaccharide in glycocalyx com‐
posed of β-1,6–linked N-acetylglucosamine residues (80–85%) and non-N-acetylated D-
glucosaminyl residues that are an anionic fraction and contain phosphate and ester-linked
succinate (15–20%) [18]. Although PIA is a main mechanism of biofilm formation in S. aureus
and S. epidermidis, surface proteins are the other alternative mechanism of biofilm formation.
Extracellular matrix has large water-filled channels, accumulates antibiotic-degrading
enzymes such as β-lactamases [19], and plays a role in the adaptive resistance mechanisms
due to eDNA constituent [20] (Figure 3).
2.3. Mechanisms of biofilm formation
Bacterial biofilm formation is a complex and multifactorial process. The biofilm formation
process consists of adherence/adhesion/attachment, aggregation/maturation/accumulation,
and detachment/dispersal phase. The last step is the dispersal of mature biofilm-embedded
bacteria out of the biofilm [21] (Figure 1).
2.3.1. Attachment (adhesion or adherence) phase
When conditions favor biofilm formation, biofilm formation that begins with the adherence
of the bacteria to a surface that act as a substrate for microbial adhesion continues with the
aggregation formed by cell–cell adhesion [22] (Figure 1).
Staphylococcal adherence to an abiotic surface of indwelling prosthetic device depends on
physico-chemical structure of medical device and surface components of Staphylococci such
as wall teichoic acid (WTA) [23], lipoteichoic acid (LTA) [23], accumulation-associated
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1. Introduction
Staphylococcus epidermidis (S. epidermidis) and Staphylococcus aureus (S. aureus) are the most
common causes of indwelling device–associated infections, and nosocomial and community
acquired infections can produce biofilm as a virulence factor [1]. The biofilm infections such
as S. epidermidis and S. aureus infections are important problems in hospitalized and immu‐
nocompressed patients worldwide due to their tough and irresponsive treatment by antibi‐
otics.  Biofilm-producing  bacteria  resist  to  immune  defense,  antibiotics,  and  many
antimicrobial  agents.  Biofilm-embedded  bacteria  gain  antibiotic  resistance  by  antibiotic-
degrading enzymes, efflux pumps, and certain gene products of which expression are changed
by the quorum sensing [2, 3]. Biofilm-embedded sessile community has heterogeneous cells
that have wide range of different responds to each antimicrobials [2]. So, every antibiotic has
a different effect against different metabolically active cells that are present in the different
layers of biofilm and persister cells that are evolved to survive in biofilm. It is hard to treat
biofilm infections that are generally recurrent infections and of which treatments are tough
and irresponsive [3].
Staphylococci that construct the human skin flora can contaminate indwelling devices. By this
way, they are inserted to human by contaminated indwelling devices. When microorgan‐
isms exposed to stress conditions, gene expression of biofilm is induced as a stress response.
The biofilm that is a slime-like glycocalyx causes bacteria to survive in the stress conditions.
Staphylococci adhere, colonize, and infect biotic surfaces such as tissue or abiotic surfaces such
as prosthetic surfaces that may act as a substrate for microbial adhesion and causes bacterial
spread to whole body by forming biofilm that is a slime-like glycocalyx [1, 4, 5]. The viru‐
lence and the role of biofilm of S. epidermidis and S. aureus in chronic and recurrent infec‐
tions such as indwelling device–associated infections, the mechanism, and the global
regulation of biofilm production by quorum-sensing system, especially agr-quorum-sensing
system, inactivation of biofilm formation, and the resistance patterns of biofilm-embedded
microorganism against antimicrobials are discussed in this chapter.
2. The biofilm, virulence, and Staphylococcus
2.1. The pathogenesis of Staphylococcus biofilm
The biofilm has an important role in the pathogenesis of staphylococcal infections. The biofilm
causes bacteria to survive in the stress conditions such as UV damage, metal toxicity, anaero‐
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bic conditions, acid exposure, salinity, pH gradients, desiccation, bacteriophages, and amoebae
and to resist antibiotics, antimicrobials, and host immune defense [5–8]. The main pathogen
of implant infections is staphylococci that cause 80% of all prosthetic infections [9]. The biofilm
of bacteria causes chronic infections such as indwelling device–related infections, chronic
wound infections, chronic urinary tract infections (UTI), cystic fibrosis pneumonia, chronic
otitis media (OM), chronic rhinosinusitis, periodontitis, and recurrent tonsillitis [10]. The
biofilm infections are the main important problems in hospitalized and immunocompressed
patients in worldwide due to their tough and irresponsive treatment by antibiotics. In biofilm,
bacteria are not distrupted completely by antibiotics even high doses of antibiotics used in vivo
[3, 11, 12]. Infected device can expose the patient to a higher risk of mortality. Orthopedic
surgery and trauma indwelling device-related infections that make treatment difficult by
antibiotics [13] cause removal of implant out of the body to eradicate biofilm and overcome
biofilm-related infections [14] and may cause functional loss of the infected limb [15, 16].
2.2. Staphylococcal biofilms as a virulence factor
The biofilm that anchored to abiotic or biotic surfaces is a slime-like glycocalyx in which sessile
community of microorganisms embedded. This extracellular polymeric substance that is
constituted by matrix of polysaccharide, teichoic acids, extracellular DNA (eDNA), and
staphylococcal proteins is produced by biofilm producing microorganisms [4, 17, 18].
Polysaccharide intracellular adhesin (PIA) is a specific polysaccharide in glycocalyx com‐
posed of β-1,6–linked N-acetylglucosamine residues (80–85%) and non-N-acetylated D-
glucosaminyl residues that are an anionic fraction and contain phosphate and ester-linked
succinate (15–20%) [18]. Although PIA is a main mechanism of biofilm formation in S. aureus
and S. epidermidis, surface proteins are the other alternative mechanism of biofilm formation.
Extracellular matrix has large water-filled channels, accumulates antibiotic-degrading
enzymes such as β-lactamases [19], and plays a role in the adaptive resistance mechanisms
due to eDNA constituent [20] (Figure 3).
2.3. Mechanisms of biofilm formation
Bacterial biofilm formation is a complex and multifactorial process. The biofilm formation
process consists of adherence/adhesion/attachment, aggregation/maturation/accumulation,
and detachment/dispersal phase. The last step is the dispersal of mature biofilm-embedded
bacteria out of the biofilm [21] (Figure 1).
2.3.1. Attachment (adhesion or adherence) phase
When conditions favor biofilm formation, biofilm formation that begins with the adherence
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1. Introduction
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common causes of indwelling device–associated infections, and nosocomial and community
acquired infections can produce biofilm as a virulence factor [1]. The biofilm infections such
as S. epidermidis and S. aureus infections are important problems in hospitalized and immu‐
nocompressed patients worldwide due to their tough and irresponsive treatment by antibi‐
otics.  Biofilm-producing  bacteria  resist  to  immune  defense,  antibiotics,  and  many
antimicrobial  agents.  Biofilm-embedded  bacteria  gain  antibiotic  resistance  by  antibiotic-
degrading enzymes, efflux pumps, and certain gene products of which expression are changed
by the quorum sensing [2, 3]. Biofilm-embedded sessile community has heterogeneous cells
that have wide range of different responds to each antimicrobials [2]. So, every antibiotic has
a different effect against different metabolically active cells that are present in the different
layers of biofilm and persister cells that are evolved to survive in biofilm. It is hard to treat
biofilm infections that are generally recurrent infections and of which treatments are tough
and irresponsive [3].
Staphylococci that construct the human skin flora can contaminate indwelling devices. By this
way, they are inserted to human by contaminated indwelling devices. When microorgan‐
isms exposed to stress conditions, gene expression of biofilm is induced as a stress response.
The biofilm that is a slime-like glycocalyx causes bacteria to survive in the stress conditions.
Staphylococci adhere, colonize, and infect biotic surfaces such as tissue or abiotic surfaces such
as prosthetic surfaces that may act as a substrate for microbial adhesion and causes bacterial
spread to whole body by forming biofilm that is a slime-like glycocalyx [1, 4, 5]. The viru‐
lence and the role of biofilm of S. epidermidis and S. aureus in chronic and recurrent infec‐
tions such as indwelling device–associated infections, the mechanism, and the global
regulation of biofilm production by quorum-sensing system, especially agr-quorum-sensing
system, inactivation of biofilm formation, and the resistance patterns of biofilm-embedded
microorganism against antimicrobials are discussed in this chapter.
2. The biofilm, virulence, and Staphylococcus
2.1. The pathogenesis of Staphylococcus biofilm
The biofilm has an important role in the pathogenesis of staphylococcal infections. The biofilm
causes bacteria to survive in the stress conditions such as UV damage, metal toxicity, anaero‐
Microbial Biofilms - Importance and Applications190
2.3.2. Accumulation (aggregation or maturation) phase
After adherence of staphylococcus to biotic and abiotic surfaces, exopolysaccharide (EPS) such
as PIA or PNAG that are produced by ica operon (ica-dependent form) starts to be produced,
extracellular matrix (ECM) is constructed by PIA/PNAG, extracellular DNA (eDNA), and
surface proteins [cell wall-anchored (CWA) proteins] in ica-independent form, and bacterial
colonies become mature [2, 27]. The cell wall-anchored (CWA) proteins not only provide
bacterial adherence but also provide intercellular adhesion, biofilm accumulation, and
maturation [27]. Aggregation that is mediated by the synthesis of either polysaccharide
intercellular adhesion/poly-N-acetylglucosamine (PIA/PNAG) [30, 32] is formed in cell
clusters till multi-layer-structured biofilms formed. Several staphylococcal surface proteins
that mediate primary attachment of bacteria such as clumping factors A and B, fibrinogen-/
fibronectin-binding proteins FnbA and FnbB of S. aureus or the fibrinogen-binding protein
SdrG/Fbe of S. epidermidis that are cell wall-anchored proteins (CWA) also promote intercel‐
lular adhesion and construct the aggregation of bacteria in ica-independent biofilm forma‐
tion rather than PIA [33] (Figure 1).
In the initial cell-surface interaction of motile bacteria, adherence of motile cell to surface is
facilitated by flagella of motile cell. After adherence motile species that undergo cellular
differentiation in biofilm lose their motility by paralyzing their flagella and become nonmo‐
tile [34]. Klausen et al. [35] revealed that wild-type strain and isogenic flagellar mutant of
Pseudomonas aeroginosa both forms biofilms which have structural differences.
2.3.3. The detachment (or dispersal) phase
In the detachment stage, sessile cells turn into planktonic state that can spread and colonize
other surfaces and form biofilm on these infected regions [2] (Figure 1). Detachment of
microorganisms from biofilm can be caused by bacteria themselves, such as enzymatic
degradation of the biofilm matrix such as dissolution of adhesins by proteases, nucleases, and
a group of small amphiphilic α-helical peptides, known as phenol-soluble modulins (PSMs)
functioning as surfactants [27], and quorum sensing or by external forces such as fluid shear
forces, corrosion, and human intervention [36] (Figure 2). During detachment of motile
microorganism rather than staphylococcus, cells express genes that are for motility such as
transcription of pilus and ribosomal proteins and are almost seen in planktonic cells [37].
2.4. Types of biofilm formation
2.4.1. PIA-dependent biofilm formation
Positively charged PIA provides intercellular attachment via binding to bacteria of which
surface is negatively charged [27]. All S. aureus strains contain icaADBC gene of which product
is PIA constructs biofilm formation [31]. Ica locus have been identified in many staphylococ‐
cus species like S. aureus and S. epidermidis but except S. haemolyticus and S. saphrophyticus [9].
ica is regulated by stress conditions, such as anaerobic conditions, extreme temperature,
osmolarity, ethanol, and antibiotics. icaA, icaD, icaC, and icaB are the genes of icaADBC locus.
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protein (Aap) [24], autolysins AtlA [25] and AtlE [26]. The staphylococcal adherence to a biotic
surfaces such as host cells and plasma protein-coated prosthetic surface is mediated by cell
wall-anchored (CWA) proteins such as the fibrinogen-binding protein SdrG/Fbe of S.
epidermidis and fibrinogen-/fibronectin-binding proteins FnBPA and FnBPB and clumping
factors A and B of S. aureus [27].
Several microbial surface components recognizing adhesive matrix molecules (MSCRAMMs)
that are able to bind to human matrix proteins such as fibronectin and fibrinogen and colonize
are expressed in S. epidermidis and S. aureus at the first step [28]. Adherence of bacteria to an
extracellular matrix component, fibronectin, fibrinogen, and plasma clot is mediated by
expressed surface adhesins such as Bap coded by bap gene [29], surface protein G (SasG) [22],
fibronectin-binding proteins (FnbA and FnbB) of S. aureus [30], and the fibrinogen-binding
protein SdrG/Fbe of S. epidermidis [27]. Adherence of S. aureus to collagenous tissues and
cartilage is mediated by collagen-binding protein, Cna. Some antibodies can block bacterial
attachment to these tissues by blocking Cna. Adherence of S. aureus to fibrinogen in the
presence of fibronectin is mediated by clumping factor A and B (ClfA, ClfB) that are effec‐
tive in foreign body and wound infections. Also, plasma-sensitive surface protein (Pls)
participates in the attachment to fibrinogen and fibronectin. Protein A that is present in cell
wall and encoded by spa gene in S. aureus impair opsonization and phagocytosis by binding
to Fc domain of immunoglobulin G (IgG) in the wrong orientation. Endovascular diseases are
emerged by S. aureus as a result of the binding of protein A to von Willebrand factor in damaged
endothelium [31].
Figure 1. The stages of biofilm formation.
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Autolysin Atl that is a wall-anchored protein of S. aureus and causes initial attachment of S.
aureus to surfaces can be cleaved into amidase and glucosaminidase that cause cell lysis, eDNA
release, and cell accumulation. Then, biofilm maturation of FnBP-dependent biofilm pheno‐
type is constructed by FnBPs [25].
In biofilm production of S. aureus, cell-cell interactions are facilitated by α-toxin that is a
haemolytic toxin. Nevertheless, the mechanism of integral role of α-toxin has not been known
clearly. β-toxin that is a sphingomyelinase and causes hemolysis and lyse lymphocytes plays
a stimulative role in the biofilm production of S. aureus by covalently cross-linking to itself in
the occurrence of DNA in matrix of staphylococcal biofilms [40].
S. aureus biofilms can be stabilized by amyloid fibrils that are formed by aggregated PSM on
the surface of bacteria and aggregated signal peptide AgrD [41].
2.5. The global regulation of biofilm formation
2.5.1. The regulation of Staphylococcal biofilm by agr-quorum-sensing system
Biofilm production is provided by the equilibrium between the productions of amyloid fibrils
and phenol soluble modulins (PSMs) that are extracellular polymeric substances and their
catabolism by enzymes such as nucleases and proteases that are expressed by agr-QS regulator
system that use two-component system signal transduction system (TCS). The control of
planktonic and sessile bacteria and the biofilm expression is regulated by coordinated
mechanisms [41] (Figure 2).
Figure 2. The regulation of biofilm formation by agr-quorum-sensing system.
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icaA and icaD contribute to exopolysaccharide synthesis and encode N-acetylglucosaminyl
transferase as a transmembrane enzyme to synthesize poly-N-acetylglucosamine polymer.
While poly-N-acetylglucosamine polymer is translocated to cell surface of bacteria by icaD
gene, the polymer is fixed to the outer surface of bacteria by deacylation of poly-N-acetylglu‐
cosamine polymer by the product of icaB gene [9]. Regulator gene icaR that is located up‐
stream of the icaADBC operon encodes a transcriptional repressor in both S. epidermidis and S.
aureus and icaADBC genes are upregulated in response to anaerobic growth such as inside of
biofilm. Under anaerobic conditions, PIA is induced by SrrAB (the staphylococcal respirato‐
ry response regulator) that binds to upstream of the icaADBC operon. Insertion sequence
(IS256) can regulate ica by reversible inactivation in S. epidermidis and some strains of S. aureus.
TcaR (transcriptional regulator of the teicoplanin-associated locus) and IcaR are repressors of
ica operon transcription and repress PIA expression. While deletion of icaR gene increases ica
gene expression, PIA production, deletion of tcaR gene had no effect against ica gene, PIA
production. Transcription of IcaR is repressed by Rbf that is a protein regulator of biofilm
formation and leads expression of ica gene, PIA production, whereas transcription of IcaR is
induced by Spx that is a global regulator of stress response genes and regulates biofilm
formation negatively [18].
2.4.2. PIA-independent biofilm formation
Biofilms not only can be constructed by ica gene of which product is PIA, but also construct‐
ed by ica-independent (PIA-independent) form. Biofilm is generated not only by PIA that is a
main component of biofilm production but also by a number of proteins. When icaADBC is
deleted, PIA is not produced but the biofilm formation so, virulence is not affected. In this case,
biofilm formation can be constructed rather than PIA. In the catheter infection, biofilm
formation of clinical isolates of S. aureus of which ica cluster is mutated is not reduced [18].
Fitzpatrick et al. revealed that biofilm formation of the icaADBC operon-deleted MRSA
mutants was not affected, whereas biofilm formation of the icaADBC operon-deleted MSSA
mutants was impaired. This study showed that ica-independent biofilm formation is strain
specific [38].
PIA-independent biofilms were constructed by accumulation-associated proteins (Aap) of S.
epidermidis, biofilm-associated protein (Bap) that is a surface protein of S. epidermidis and S.
aureus and Bap-related proteins of S. aureus [18]. Other surface proteins that involve in the PIA-
independent biofilm formation are SasG, SasC, protein A, fibronectin-binding proteins FnBPA
and FnBPB, cell wall-anchored (CWA) proteins including clumping factors A and B, autoly‐
sins AtlA and AtlE or wall teichoic acid (WTA), the fibrinogen-binding protein SdrG/Fbe,
lipoteichoic acids (LTA) of S. aureus and the fibrinogen-binding protein SdrG/Fbe of S.
epidermidis [27].
Scientists determined that medical MRSA isolates produce protein-dependent biofilm such as
FnBP- and Aap-dependent biofilms in animal models that have indwelling device–associat‐
ed infection. O’Neill et al. [30] and McCourt et al. [39] revealed that biofilms of certain isolates
of HA-MRSA from CC8 and CC22 and CA-MRSA from USA300 lineage (CC8) were FnBPs-
dependent.
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The regulation mechanisms of RNAIII for target genes can be at transcriptional and transla‐
tional level, and its regulation can be direct or indirect. Fourteen stem-loop and two long helices
construct structure of RNAIII. Each domain regulates the expression of each target gene.
Translation of α-hemolysin (hla) upregulated by hairpin loop H2 and H3. In contrast to this,
the repression of early expressed virulence genes of S. aureus such as coagulase, protein A, and
the repressor of toxins (Rot) is comprised by hairpin H13, H14, and H7 of RNAIII. Hairpins
such as H7, H13, and H14 that are complementary to Shine-Dalgarno sequences (SD) of target
mRNA act as an antisense RNA and inhibit initiation of translation and cause RNAaseIII-
mediated degradation of target mRNA [45] (Figure 4).
Figure 4. The structure of RNAIII [44]
Staphylococcal virulence factors are expressed with accessory gene regulator (agr) system in
response to cell density [9]. During the beginning of the biofilm-related staphylococcal
infection, adhesion factors (surface proteins) such as MSCRAMMs are upregulated. After
initial attachment and colonization had been happened, during early stationary growth phase
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The biofilm formation of staphylococci is fully expressed in vivo, whereas the biofilm forma‐
tion of staphylococci is not fully expressed all the time in vitro unless nutrient supplementa‐
tions are added to growth media and is provided. Increased amount of biofilm formation due
to fully expression occurs in stress conditions such as starvation, thermal stress, heat shock,
salt, certain antibiotics, iron limitation, subinhibitory concentrations of ethanol, accumula‐
tions of metabolites, oxidative stress, low pH, and changes in osmolarity in vitro. Bacteria sense
stimuli from the environment and bacterial density and then respond to stimuli by upregu‐
lating expression of biofilm formation, virulence factors production such as toxins, etc. [9].
Staphylococcus use quorum-sensing systems (QS) for intercellular communication and biofilm
formation. Accessory gene regulator (Agr) system regulates cell density-dependent gene
expression using two-component signal transduction system [42]. Agr and LuxS systems that
are required for autoinducer peptide (AIP) production as a pheromone are quorum-sensing
systems in staphylococci [43]. Bacteria sense pheromones as stimuli that are released by the
density of bacteria belonging to the same group and express biofilm formation [9]. AIP
production starts in exponential phase of bacterial growth [44]. There are four proteins that
are sensor histidine protein kinase AgrC, DNA-binding response regulator AgrA, AgrD that
is a prepheromone, and AgrB that exports and modifies AgrD, present in this system. The
signal is transported to bacteria by binding of AIP to AgrC. When AIP binds to AgrC, DNA-
binding regulator AgrA is activated by His-dependent phosphorylation of AgrC [42]. By the
binding of activated DNA-binding regulator AgrA to P2 and P3 promoters in agr operon
(agrBDCA), RNAII and RNAIII are transcripted, respectively [44]. The agrBDCA operon codes
RNAII transcript that encodes AgrB, D, C, A from agrB, D, C, A genes as a components of agr
system, and RNAIII transcript that include hld gene encodes the δ-hemolysin (termed δ-toxin
or δ-PSM) [42]. RNAIII regulates the expression of agr-governed virulence factors such as
CWA proteins as a surface proteins and exotoxins at transcriptional and translational level.
Independently of RNAIII (RNAIII independent control), AgrA also directly regulates the
expression of α-PSMs and β-PSMs by binding to their promoters in psm operon in S. aureus
and involves in the downregulation of genes contribute carbohydrate and amino acid
metabolism [44] (Figure 2).
Figure 3. The biofilm-embedded bacteria. (a) The heterogeneous sessile community of biofilm. (b) Antibiotic resistance
mechanisms of biofilm-embedded bacteria.
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Figure 3. The biofilm-embedded bacteria. (a) The heterogeneous sessile community of biofilm. (b) Antibiotic resistance
mechanisms of biofilm-embedded bacteria.
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To control biofilm-associated staphylococcal infections, production of virulence factors and
antibiotic resistance, QS can be disrupted by inhibition of signal production, degrading signals,
and suppressing synthase and receptors [9].
2.5.2. The regulation of Staphylococcal biofilm by other than Agr
2.5.2.1. sarA
Two-component regulator gene locus encoded by arlRS is regulated by agr and sarA loci. sarA
and agr have opposite functions in staphylococcal global regulation. When enough quorum
population is present, at the beginning of attachment phase sarA is upregulated. During the
initial stages, SarA enhances expression of PIA, adhesions, and EPS, by the way, induces
attachment and early biofilm formation. SarA also represses nuclease and protease synthesis.
After attachment of bacteria, agr system works and virulence factors that cause dispersal,
nucleases and proteases and PSMs are produced [18].
2.5.2.2. sigB
The sigB operon of which product is σB in S. aureus upregulates ica transcription, and the factors
for early stages of biofilm formation including FnbpA, clumbing factor, and coagulase and
downregulates factors that are efficient in dispersal and in passing to planktonic state such
as β-hemolysin, enterotoxin B, serine protease (SplA), cysteine protease (SplB), the metallo‐
protease Aur, staphopain, and leukotoxin D [18].
2.5.2.3. ArIRS
The biofilm formation of S. epidermidis [57] and S. aureus [58] can be also regulated by ArIRS
that uses TCS. The biofilm formation of S. epidermidis is regulated by ArIRS in ica-dependent
manner, whereas in S. aureus, this is ica-independent manner [59]. ArlRS also plays a role in
the modulation of bacterial autolysis, as a result of eDNA release that participates in biofilm
matrix [9].
2.5.2.4. lytSR
LytSR operon that is the other TCS of S. aureus plays a role in the activity of murein hydro‐
lase that is an autolysin and distrupt structural components of the bacterial cell wall, conse‐
quently, autolysis. Lrg/cid operon that is a target of this system regulates lysis of cell during
biofilm formation [60]. The regulator LytR that is effected by stimuli bound LytS sensor
histidine kinase protein activates transcription of genes under its control. The regulator LytR
upregulates the expression of lrgA and lrgB genes [61]. Encoded LrgA by lrgA is an antiholin
and inhibits the extracellular activity of murein hydrolases, whereas cidA gene encodes holin
protein that effects the activity of murein hydrolase, consequently, cell lysis and release of
eDNA that participate in biofilm matrix [9].
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of bacteria, toxins and other acute virulence factors such as degradative exoenzymes (such
as δ-hemolysin, lipases and proteases that disperse bacteria) are upregulated and non-
aggressive colonization surface proteins such as MSCRAMMs are downregulated by agr-QS
regulator system [1, 46]. Adherence is reduced by downregulated genes of CWA, due to surface
proteins are no longer needed after colonization, by the way initial biofilm formation is
decreased indirectly [5]. Expression of staphylococcal toxins such as enterotoxin B, toxic shock
syndrome toxin-1, exfoliative toxins, fibrinolysin, α, β, γ, and δ hemolysins, other phenol-
soluble modulins (PSMs), leucocidin, capsular polysaccharide (type 5 and 8), serine protease,
and DNase is increased (upregulated), and expression of surface proteins and biofilm
formation is decreased (downregulated) by agr of S. aureus and S. epidermidis [9, 44]. Infec‐
tion is dispersed to other surfaces by the detachment of biofilm that is caused by the upregu‐
lation of the expression of PSMs that have an important role in acute infection [1]. In chronic
biofilm-associated infection of S. aureus high amount of QS or psm gene mutants are present,
by the way, mutants favor compact biofilm development and biofilm/infection cannot be
dispersed to other surfaces [46, 47].
The production of PIA/PNAG, PIA/PNAG-degrading enzymes, and matrix components of
staphylococcal biofilm is not regulated by QS [44, 46].
Phenol-soluble modulins (PSMs) are surfactant-like staphylococcal peptides and are control‐
led by agr locus function in biofilm maturation, biofilm structuring/destructuring, dispersal,
and dissemination by distruption of non-covalent interactions between biofilm matrix
molecules. PSMs have a role in the pathogenesis of S. aureus and S. epidermidis biofilm-
associated infections [9, 21, 46]. In contrast to soluble PSMs, PSMs that are aggregated form
amyloid fibrils that contribute to stability of the biofilm [27, 41]. S. aureus and S. epidermidis
catheter-related infections can be controlled by PSM surfactant-mediated QS control of
biofilms for biofilm maturation and dissemination [48, 49]. The biofilm maturation is not only
caused by PSM surfactants but also enzymatic degradation of biofilm matrix components by
proteases and nucleases [46]. But Beenken et al. [50] revealed that nuclease did not disperse S.
aureus in vitro. Hochbaum et al. [51] revealed that D-amino acids trigger biofilm dispersal of
S. aureus.
Agr (AIPs) of each strain belongs to different agr classes of which biofilm-forming capacities
and syndromes are different. Four main classes of AIPs (Agr) are present in S. aureus and S.
epidermidis. S. aureus strains of which agr classes are agr II and agr III are high and medium
biofilm formers due to having defective and inactive agr, respectively. Non-defective and
active agr is present in agr I and agr IV strains that are weak biofilm producers [52]. agr IV S.
aureus strains are more associated with exfoliative syndromes. agr I S. aureus strains are isolated
from endocarditis and superficial infections. agr II and agr III S. aureus strains are isolated from
endocarditis and nasal colonization, respectively [53]. Mortality due to agr II–caused infec‐
tions is higher than agr I–caused infections [54]. The prevalences of agr I type among the S.
epidermidis clinical isolates and S. epidermidis localized in skin flora are approximately 89%
and 52%, respectively [55]. The sequences of AIPs that belong to agr I, II, III, and IV classes in
S. aureus and S. epidermidis are YSTCDFTM, GVNACSSLF, YINCDFLL, YSTCYFTM, YNPCA‐
SYL, DSVCASYF, YNPCSNYL, YNPCANYL, respectively [55, 56].
Microbial Biofilms - Importance and Applications198
To control biofilm-associated staphylococcal infections, production of virulence factors and
antibiotic resistance, QS can be disrupted by inhibition of signal production, degrading signals,
and suppressing synthase and receptors [9].
2.5.2. The regulation of Staphylococcal biofilm by other than Agr
2.5.2.1. sarA
Two-component regulator gene locus encoded by arlRS is regulated by agr and sarA loci. sarA
and agr have opposite functions in staphylococcal global regulation. When enough quorum
population is present, at the beginning of attachment phase sarA is upregulated. During the
initial stages, SarA enhances expression of PIA, adhesions, and EPS, by the way, induces
attachment and early biofilm formation. SarA also represses nuclease and protease synthesis.
After attachment of bacteria, agr system works and virulence factors that cause dispersal,
nucleases and proteases and PSMs are produced [18].
2.5.2.2. sigB
The sigB operon of which product is σB in S. aureus upregulates ica transcription, and the factors
for early stages of biofilm formation including FnbpA, clumbing factor, and coagulase and
downregulates factors that are efficient in dispersal and in passing to planktonic state such
as β-hemolysin, enterotoxin B, serine protease (SplA), cysteine protease (SplB), the metallo‐
protease Aur, staphopain, and leukotoxin D [18].
2.5.2.3. ArIRS
The biofilm formation of S. epidermidis [57] and S. aureus [58] can be also regulated by ArIRS
that uses TCS. The biofilm formation of S. epidermidis is regulated by ArIRS in ica-dependent
manner, whereas in S. aureus, this is ica-independent manner [59]. ArlRS also plays a role in
the modulation of bacterial autolysis, as a result of eDNA release that participates in biofilm
matrix [9].
2.5.2.4. lytSR
LytSR operon that is the other TCS of S. aureus plays a role in the activity of murein hydro‐
lase that is an autolysin and distrupt structural components of the bacterial cell wall, conse‐
quently, autolysis. Lrg/cid operon that is a target of this system regulates lysis of cell during
biofilm formation [60]. The regulator LytR that is effected by stimuli bound LytS sensor
histidine kinase protein activates transcription of genes under its control. The regulator LytR
upregulates the expression of lrgA and lrgB genes [61]. Encoded LrgA by lrgA is an antiholin
and inhibits the extracellular activity of murein hydrolases, whereas cidA gene encodes holin
protein that effects the activity of murein hydrolase, consequently, cell lysis and release of
eDNA that participate in biofilm matrix [9].
Staphylococcal Biofilms: Pathogenicity, Mechanism and Regulation of Biofilm Formation by Quorum-Sensing System
and Antibiotic Resistance Mechanisms of Biofilm-Embedded Microorganisms
http://dx.doi.org/10.5772/62943
199
of bacteria, toxins and other acute virulence factors such as degradative exoenzymes (such
as δ-hemolysin, lipases and proteases that disperse bacteria) are upregulated and non-
aggressive colonization surface proteins such as MSCRAMMs are downregulated by agr-QS
regulator system [1, 46]. Adherence is reduced by downregulated genes of CWA, due to surface
proteins are no longer needed after colonization, by the way initial biofilm formation is
decreased indirectly [5]. Expression of staphylococcal toxins such as enterotoxin B, toxic shock
syndrome toxin-1, exfoliative toxins, fibrinolysin, α, β, γ, and δ hemolysins, other phenol-
soluble modulins (PSMs), leucocidin, capsular polysaccharide (type 5 and 8), serine protease,
and DNase is increased (upregulated), and expression of surface proteins and biofilm
formation is decreased (downregulated) by agr of S. aureus and S. epidermidis [9, 44]. Infec‐
tion is dispersed to other surfaces by the detachment of biofilm that is caused by the upregu‐
lation of the expression of PSMs that have an important role in acute infection [1]. In chronic
biofilm-associated infection of S. aureus high amount of QS or psm gene mutants are present,
by the way, mutants favor compact biofilm development and biofilm/infection cannot be
dispersed to other surfaces [46, 47].
The production of PIA/PNAG, PIA/PNAG-degrading enzymes, and matrix components of
staphylococcal biofilm is not regulated by QS [44, 46].
Phenol-soluble modulins (PSMs) are surfactant-like staphylococcal peptides and are control‐
led by agr locus function in biofilm maturation, biofilm structuring/destructuring, dispersal,
and dissemination by distruption of non-covalent interactions between biofilm matrix
molecules. PSMs have a role in the pathogenesis of S. aureus and S. epidermidis biofilm-
associated infections [9, 21, 46]. In contrast to soluble PSMs, PSMs that are aggregated form
amyloid fibrils that contribute to stability of the biofilm [27, 41]. S. aureus and S. epidermidis
catheter-related infections can be controlled by PSM surfactant-mediated QS control of
biofilms for biofilm maturation and dissemination [48, 49]. The biofilm maturation is not only
caused by PSM surfactants but also enzymatic degradation of biofilm matrix components by
proteases and nucleases [46]. But Beenken et al. [50] revealed that nuclease did not disperse S.
aureus in vitro. Hochbaum et al. [51] revealed that D-amino acids trigger biofilm dispersal of
S. aureus.
Agr (AIPs) of each strain belongs to different agr classes of which biofilm-forming capacities
and syndromes are different. Four main classes of AIPs (Agr) are present in S. aureus and S.
epidermidis. S. aureus strains of which agr classes are agr II and agr III are high and medium
biofilm formers due to having defective and inactive agr, respectively. Non-defective and
active agr is present in agr I and agr IV strains that are weak biofilm producers [52]. agr IV S.
aureus strains are more associated with exfoliative syndromes. agr I S. aureus strains are isolated
from endocarditis and superficial infections. agr II and agr III S. aureus strains are isolated from
endocarditis and nasal colonization, respectively [53]. Mortality due to agr II–caused infec‐
tions is higher than agr I–caused infections [54]. The prevalences of agr I type among the S.
epidermidis clinical isolates and S. epidermidis localized in skin flora are approximately 89%
and 52%, respectively [55]. The sequences of AIPs that belong to agr I, II, III, and IV classes in
S. aureus and S. epidermidis are YSTCDFTM, GVNACSSLF, YINCDFLL, YSTCYFTM, YNPCA‐
SYL, DSVCASYF, YNPCSNYL, YNPCANYL, respectively [55, 56].
Microbial Biofilms - Importance and Applications198
enzymes) and disinfectants such as triclosan with antibiotics that are used in the treatment of
wound and skin infections provides synergistic removal of biofilms [71].
3. The mechanisms of antibiotic resistance in biofilm-embedded
microorganism
Biofilm-embedded bacteria are more resistant to antimicrobial agents than planktonic bacteria.
It is difficult to eradicate biofilm, and this causes serious clinical problem [72].
Antibiotic resistance (tolerance) that is caused by biofilm and permit bacteria to survive is a
physiological state by which mutational changes not caused [73]. Impermeability of peptido‐
glycan by efflux pumps, antibiotic-degrading enzymes, the charge of polymers [73], and
certain gene products that are produced in biofilms [3] are the other antibiotic resistance
mechanisms of bacteria rather than the biofilm [3]. Biofilm can gain higher antibiotic toler‐
ance by antibiotic degrading enzymes such as beta-lactamases, efflux pumps, and certain gene
products of which expression are changed by the quorum sensing as a stress response [3, 74].
Biofilms resist to beta-lactam antibiotics by beta-lactamases. Beta-lactamases that are pro‐
duced by bacteria play a key factor in the biofilm caused resistance to beta-lactam antibiotics
[3].
3.1. The heterogeneous sessile community and the physiology of biofilm
Biofilm-embedded sessile community has heterogeneous cells that are in the different growth
states. Bacterial growth rate is reduced by stress conditions such as nutrient and oxygen
limitation at the lower parts of the biofilm, and low metabolic activity. Low metabolically active
cells (slow growing cells) are seen at the deeper parts of the biofilm, whereas high metabol‐
ically active cells (rapid growing cells) are seen at the surfaces of the biofilm. These heteroge‐
neous cells that consist of low and high metabolically active cells have wide range of different
responds to each antimicrobial. Antibiotic penetration through the biofilm is reduced by
reduced bacterial growth rate. The biofilm-related resistance mechanisms such as oxygen
limitation and low metabolic activity, reduced antibiotic penetration through the biofilm, and
gaining genetic adaptations such as increased changes in the genes of the DNA repair systems
play a key factor in the biofilm tolerance to antibiotics [3]. But some antibiotics such as colistin
are just effective against slow-growing cells seen at the deeper parts of the biofilm not against
rapid growing cells that acquired adaptive resistance by upregulation of the LPS-modifica‐
tion (arn) operon [75]. Persister cell population that is present in the biofilms of S. epidermidis
can withstand to inhibitory concentrations of antibiotics [76] (Figure 3).
3.2. Nutrient limitation
Some researchers demonstrated that nutrient limitation-related antibiotic resistance is not due
to the reduced growth rate of microorganism, but rather to the activation of regulated stress
responses. Nutrient limitation-related antibiotic resistance is controlled by complex regulato‐
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2.5.3. Inactivation of ica by sequences
2.5.3.1. IS256
Although S. epidermidis strains are ica positive, they cannot produce biofilm due to IS256
insertion sequence that is inserted within the ica operon. Ziebuhr et al.[62] revealed that if
bacterial genomic DNA contained IS256, IS256 was not seen within ica locus. They also revealed
that although S. epidermidis strains that caused indwelling device–associated infection was ica
positive and the insertion of IS256 is not seen within ica locus, strains did not produce
biofilm (“off switch”) [62]. These results showed that IS256 is not a natural occurring global
regulator mechanism of biofilm production. The similar results were gained for S. aureus. IS256
that was inserted within icaC gene of S. aureus strain prevented biofilm formation by inacti‐
vating icaC gene [63].
2.5.3.2. Tetranucleotide tandem repeat
icaC inactivation caused by the expansion or contraction of tetranucleotide tandem repeat
inhibits PIA/PNAG formation in S. aureus [64]. The reading frame of icaC is shifted by
tetranucleotide tandem repeat (“ttta”), and this contributes premature stop of IcaC protein,
consequently, inhibited PIA/PNAG production (“off switch”). Mutated icaC is preferred for
the indwelling device-associated infections due to off switching of PIA/PNAG production.
2.6. Treatment of biofilm
To provide protection against S. aureus and S. epidermidis biofilm-associated infections vaccine
that causes production of antibodies against PNAG and PSM peptides can be used. Research‐
ers had revealed that mutant S. aureus of which icaB is over-expressed and produces high
amount of surface associated PNAG was more opsonized by antibodies and undergoes to
phagocytosis. But immune response is ineffective antibodies produced against PIA/PNAG of
vaccine bind secreted PIA/PNAG of bacteria rather than surface-associated PIA/PNAG of
bacteria [65]. Conjugate vaccine that contains S. aureus PNAG and clumping factor A can
accelerate immune response [66]. Bacterial dispersal from indwelling medical devices can be
prevented by antibodies against PSM peptides [48]. Brady et al. [67] had treated chronic
osteomyelitis with a combination of antibiotic and quadrivalent vaccine that contains four
antigens, which are glucosaminidase, an ABC transporter lipoprotein, a conserved hypothet‐
ical protein, and a conserved lipoprotein. By this way, Brady et al. [67] had reduced biofilm
formation of S. aureus on infected tibias.
Kaplan et al. [68] and Whitchurch et al. [69] concluded that DNase I in human serum can
degrade eDNA in biofilm matrix, by the way bacterial biofilms are degreased.
Nitric oxide (NO) that is a product of anaerobic respiration can cause dispersal of microor‐
ganism from mature biofilm by stimulation of c-di-GMP phosphodiesterases activity [70]. c-
di-GMP biosynthesis inhibitors can be an alternative treatment for preventing biofilm
formation and mature biofilm dispersal. The combinations of dispersin B (EPS-degrading
Microbial Biofilms - Importance and Applications200
enzymes) and disinfectants such as triclosan with antibiotics that are used in the treatment of
wound and skin infections provides synergistic removal of biofilms [71].
3. The mechanisms of antibiotic resistance in biofilm-embedded
microorganism
Biofilm-embedded bacteria are more resistant to antimicrobial agents than planktonic bacteria.
It is difficult to eradicate biofilm, and this causes serious clinical problem [72].
Antibiotic resistance (tolerance) that is caused by biofilm and permit bacteria to survive is a
physiological state by which mutational changes not caused [73]. Impermeability of peptido‐
glycan by efflux pumps, antibiotic-degrading enzymes, the charge of polymers [73], and
certain gene products that are produced in biofilms [3] are the other antibiotic resistance
mechanisms of bacteria rather than the biofilm [3]. Biofilm can gain higher antibiotic toler‐
ance by antibiotic degrading enzymes such as beta-lactamases, efflux pumps, and certain gene
products of which expression are changed by the quorum sensing as a stress response [3, 74].
Biofilms resist to beta-lactam antibiotics by beta-lactamases. Beta-lactamases that are pro‐
duced by bacteria play a key factor in the biofilm caused resistance to beta-lactam antibiotics
[3].
3.1. The heterogeneous sessile community and the physiology of biofilm
Biofilm-embedded sessile community has heterogeneous cells that are in the different growth
states. Bacterial growth rate is reduced by stress conditions such as nutrient and oxygen
limitation at the lower parts of the biofilm, and low metabolic activity. Low metabolically active
cells (slow growing cells) are seen at the deeper parts of the biofilm, whereas high metabol‐
ically active cells (rapid growing cells) are seen at the surfaces of the biofilm. These heteroge‐
neous cells that consist of low and high metabolically active cells have wide range of different
responds to each antimicrobial. Antibiotic penetration through the biofilm is reduced by
reduced bacterial growth rate. The biofilm-related resistance mechanisms such as oxygen
limitation and low metabolic activity, reduced antibiotic penetration through the biofilm, and
gaining genetic adaptations such as increased changes in the genes of the DNA repair systems
play a key factor in the biofilm tolerance to antibiotics [3]. But some antibiotics such as colistin
are just effective against slow-growing cells seen at the deeper parts of the biofilm not against
rapid growing cells that acquired adaptive resistance by upregulation of the LPS-modifica‐
tion (arn) operon [75]. Persister cell population that is present in the biofilms of S. epidermidis
can withstand to inhibitory concentrations of antibiotics [76] (Figure 3).
3.2. Nutrient limitation
Some researchers demonstrated that nutrient limitation-related antibiotic resistance is not due
to the reduced growth rate of microorganism, but rather to the activation of regulated stress
responses. Nutrient limitation-related antibiotic resistance is controlled by complex regulato‐
Staphylococcal Biofilms: Pathogenicity, Mechanism and Regulation of Biofilm Formation by Quorum-Sensing System
and Antibiotic Resistance Mechanisms of Biofilm-Embedded Microorganisms
http://dx.doi.org/10.5772/62943
201
2.5.3. Inactivation of ica by sequences
2.5.3.1. IS256
Although S. epidermidis strains are ica positive, they cannot produce biofilm due to IS256
insertion sequence that is inserted within the ica operon. Ziebuhr et al.[62] revealed that if
bacterial genomic DNA contained IS256, IS256 was not seen within ica locus. They also revealed
that although S. epidermidis strains that caused indwelling device–associated infection was ica
positive and the insertion of IS256 is not seen within ica locus, strains did not produce
biofilm (“off switch”) [62]. These results showed that IS256 is not a natural occurring global
regulator mechanism of biofilm production. The similar results were gained for S. aureus. IS256
that was inserted within icaC gene of S. aureus strain prevented biofilm formation by inacti‐
vating icaC gene [63].
2.5.3.2. Tetranucleotide tandem repeat
icaC inactivation caused by the expansion or contraction of tetranucleotide tandem repeat
inhibits PIA/PNAG formation in S. aureus [64]. The reading frame of icaC is shifted by
tetranucleotide tandem repeat (“ttta”), and this contributes premature stop of IcaC protein,
consequently, inhibited PIA/PNAG production (“off switch”). Mutated icaC is preferred for
the indwelling device-associated infections due to off switching of PIA/PNAG production.
2.6. Treatment of biofilm
To provide protection against S. aureus and S. epidermidis biofilm-associated infections vaccine
that causes production of antibodies against PNAG and PSM peptides can be used. Research‐
ers had revealed that mutant S. aureus of which icaB is over-expressed and produces high
amount of surface associated PNAG was more opsonized by antibodies and undergoes to
phagocytosis. But immune response is ineffective antibodies produced against PIA/PNAG of
vaccine bind secreted PIA/PNAG of bacteria rather than surface-associated PIA/PNAG of
bacteria [65]. Conjugate vaccine that contains S. aureus PNAG and clumping factor A can
accelerate immune response [66]. Bacterial dispersal from indwelling medical devices can be
prevented by antibodies against PSM peptides [48]. Brady et al. [67] had treated chronic
osteomyelitis with a combination of antibiotic and quadrivalent vaccine that contains four
antigens, which are glucosaminidase, an ABC transporter lipoprotein, a conserved hypothet‐
ical protein, and a conserved lipoprotein. By this way, Brady et al. [67] had reduced biofilm
formation of S. aureus on infected tibias.
Kaplan et al. [68] and Whitchurch et al. [69] concluded that DNase I in human serum can
degrade eDNA in biofilm matrix, by the way bacterial biofilms are degreased.
Nitric oxide (NO) that is a product of anaerobic respiration can cause dispersal of microor‐
ganism from mature biofilm by stimulation of c-di-GMP phosphodiesterases activity [70]. c-
di-GMP biosynthesis inhibitors can be an alternative treatment for preventing biofilm
formation and mature biofilm dispersal. The combinations of dispersin B (EPS-degrading
Microbial Biofilms - Importance and Applications200
References
[1] Otto M. Staphylococcal biofilms. In: Romeo T (ed), Bacterial Biofilms. Current Topics
in Microbiology and Immunology. Springer Berlin Heidelberg. 2008;322:207–228.
DOI: 10.1007/978-3-540-75418-3_1 Online ISBN: 978-3-540-75418-3
[2] Stoodley P, Sauer K, Davies DG and Costerton JW. Biofilms as complex differentiat‐
ed communities. Annu Rev Microbiol. 2002;56:187–209.
[3] Bjarnsholt T, Moser C, Jensen PO and Hoiby N. Biofilm Infections. New York Dordrecht
Heidelberg London: Springer Science Business Media, LLC; 2011. 215–225 p.
[4] Donlan RM and Costerton JW. Biofilms: survival mechanisms of clinically relevant
microorganisms. Clin Microbiol Rev. 2002;15:167–193.
[5] Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME and Shirtliff ME.
Staphylococcus aureus biofilms: properties, regulation, and roles in human disease.
Virulence. 2011;2:445–459.
[6] Römling U and Balsalobre C. Biofilm infections, their resilience to therapy and
innovative treatment strategies. J Intern Med. 2012;272(6):541–561.
[7] Hall-Stoodley L, Costerton JW and Stoodley P. Bacterial biofilms: from the natural
environment to infectious diseases. Nat Rev Microbiol. 2004;2:95–108.
[8] Costerton JW, Stewart PS and Greenberg EP. Bacterial biofilms: a common cause of
persistent infections. Science. 1999;284:1318–1322.
[9] Arciola CR, Campoccia D, Ravaioli S and Montanaro L. Polysaccharide intercellular
adhesin in biofilm: structural and regulatory aspects. Front Cell Infect Microbiol.
2015;5:1–10.
[10] Hall-Stoodley L and Stoodley P. Evolving concepts in biofilm infections. Cell
Microbiol. 2009;11(7):1034–1043.
[11] Harbarth S, Masuet-Aumatell C, Schrenzel J, Francois P, Akakpo C, Renzi G, et al.
Evaluation of rapid screening and pre-emptive contact isolation for detecting and
controlling methicillin-resistant Staphylococcus aureus in critical care: an intervention‐
al cohort study. Crit Care. 2006;10(1):R25.
[12] Darouiche RO. Treatment of infections associated with surgical implants. N Engl J
Med. 2004;350:1422–1429.
[13] Costerton JW. Biofilm theory can guide the treatment of device related orthopaedic
infections. Clin Orthop Relat Res. 2005;437:7–11.
[14] Gandelman G, Frishman WH, Wiese C, Green-Gastwirth V, Hong S, Aronow WS, et
al. Intravascular device infections: epidemiology, diagnosis, and management. Cardiol
Rev. 2007;15:13–23.
Staphylococcal Biofilms: Pathogenicity, Mechanism and Regulation of Biofilm Formation by Quorum-Sensing System
and Antibiotic Resistance Mechanisms of Biofilm-Embedded Microorganisms
http://dx.doi.org/10.5772/62943
203
ry pathways [77]. During starvation, the activation of the stringent response participates in
antibiotic resistance such as fluoroquinolone resistance in E. coli biofilms [23]. Also, some
researchers demonstrated that certain efflux pumps in P. aeruginosa are upregulated in the low-
oxygen conditions [78] (Figure 3).
3.3. Biofilm matrix
Usually, the decreased antibiotic penetration through the biofilm is caused by antibiotics that
may bind to the structural contents of biofilm matrix [3] rather than reduced diffusion of
antibiotics through the biofilm matrix [10] (Figure 3).
3.4. Agr expression
Antibiotic susceptibility of biofilm-embedded bacteria decreases according to the planktonic
state. The virulence of agr defective strains is lesser than the wild type. Expression of agr that
imposes a fitness cost on S. aureus effects drug resistance of staphylococcal biofilm. It has been
revealed that RNAIII production (provides fitness cost of bacteria) of agr-positive bacteria is
induced by subletal doses of ciprofloxacin, mupirocin, and rifampin [79]. The adaptability of
S. aureus to antibiotics involves the agr locus. S. aureus resists to drugs by adapting to antibi‐
otics with agr locus. Ciprofloxacin, mupirocin, and rifampin are more effective against agr-
defective bacteria. These antibiotics just must be used in agr-deficient mutants or agr-negative
S. aureus when designing antimicrobial chemotherapy. agr-defective strains are isolated
frequently in hospital-acquired S. aureus (HA-S. aureus) infections. Due to broad antibiotic
usage in hospitals, the prevalence of agr-defective strains among hospital-acquired S. aureus
infections is high and ranges between 15% and 60% [80].
Agr expression of biofilm producer staphylococcus has also been associated with the drug
resistance of some antibiotics. It has been also revealed that the effect of rifampin against agr-
defective S. aureus mutants was increased, whereas the effect of oxacilline unchanged [79]. agr
negative or agr dysfunction strains have a fitness advantage over agr positive strains in the
presence of some antibiotics such as vancomycin. Vancomycin susceptibility is reduced in
VISA (vancomycin-intermediate S. aureus) due to the thickening of cell wall that is the result
of the combination of cell wall biosynthesis activation and decreased autolytic activity. agr
mutations have been correlated with the rise of VISA. agr defects that reduce autolysis decrease
susceptibility of vancomycin of VISA [81].
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Abstract
The majority of staphylococci produce biofilm on medical devices, which is the main
mechanism to infect humans. Staphylococcal biofilms attach to abiotic or biotic surfaces,
forming aggregates and protecting themselves against the immune system and the
antimicrobial compounds of the host. Few studies on biofilm formation mechanism in
Staphylococcus epidermidis and other coagulase-negative staphylococci (CNS) have been
performed; however, there is a great interest in studying and controlling biofilm formation
of this genus. This chapter exhibits the state of the art on biofilm formation in S. epidermidis
and other staphylococcal species. The main goal of this chapter is to recognize the
importance  of  biofilm  formation  in  Staphylococcus.  The  participating  molecules  in
staphylococcal biofilm formation are described. Currently, biofilm producer strains of
Staphylococcus  and mainly CNS have been frequently isolated at hospitals,  causing
significant economic losses. This chapter includes promising solutions in order to prevent
medical device-associated infections, as the development of medical devices possessing
anti-biofilm materials  or  surfaces  that  act  against  the  adhesion  or  viability  of  the
microorganisms.




During the last years, the study of biofilms has become relevant due to their significance on
many microbiology areas. In the health field, biofilms have been of great relevance because
many pathogenic and non-pathogenic bacteria can produce biofilm as a part of its virulence
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epidermidis isolates with both positive- and negative-biofilm phenotypes failed to show
evidence that could demonstrate that biofilm-forming isolates are more virulent in compar‐
ing with those possessing a biofilm-negative phenotype. Nevertheless, compelling results
were obtained on subsequent studies using genetically defined strains and comparing the
wild-type strain with its respective isogenic mutant strain. Using a mouse model of subcuta‐
neous catheter infection and a rat model of venous catheter infection, the polysaccharide
intercellular adhesion (PIA)-producing S. epidermidis 1457 strain was more virulent than its
isogenic counterpart, the biofilm-negative 1457-M10 strain [3]. In a different model of CVC
infection, the icaRADBC-expressing S. epidermidis strain and its icaRADBC-negative isogenic
mutant displayed the same result [4]. An infection model of Caenorhabditis elegans was used in
order to study the biofilm-positive phenotype of the S. epidermidis 9142 strain, in comparison
to the icaA mutant, resulting in a higher virulence of the wild type than the mutant [5]. Recently,
using a catheter infection model, icaADBC inactivation apparently had no effect on coloniza‐
tion, whereas aap inactivation completely abolished S. epidermidis ability to establish the
infection [6]. One explanation for the null pathogenicity of the mutant strain regarding biofilm
formation is the lack of protection against the innate immune system. Experiments conduct‐
ed with cell culture showed that the biofilm-positive 1457 strain was less susceptible to
antimicrobial peptides (AMPs) and to phagocytosis performed by polymorphonuclear
granulocytes (PMNs) compared to the biofilm-negative 1457-M10 isogenic strain [7].
Physiological status is also important, when S. epidermidis 1457 grown on biofilm conditions
was less susceptible to phagocytes than it was grown on planktonic conditions [8].
PIA-dependent biofilm formation also interferes with the host’s complement activation.
Biofilm-positive wild-type bacteria pre-opsonized with normal human serum are more
resistant to complement-mediated elimination than the corresponding biofilm-negative
isogenic bacteria [8]. It has been also shown that S. epidermidis biofilm formation interferes with
the phagocytosis process and macrophage activation. This biofilm-forming phenotype may
contribute to the chronic persistence of S. epidermidis in inflammatory conditions.
Conversely, S. epidermidis produces a set of pro-inflammatory peptides termed phenol-soluble
modulins (PSMs), which are produced in a tightly regulated manner by the accessory gene
regulator (agr) system. It has been demonstrated that PSM δ is able to lyse neutrophils,
supporting the concept that these peptides are relevant for S. epidermidis pathogenesis.
However, PSM δ is expressed at low levels by the biofilm-producing S. epidermidis 1457 strain,
grown either in biofilm conditions or in planktonic conditions [9].
II. Mechanisms and molecules participating in staphylococci biofilm formation
In this chapter, we will divide the study of the biofilm formation process in three phases.
During primary attachment, bacteria adhere to the biotic or abiotic surface in order to colonize
it, whereas on the accumulation phase, bacteria build a tridimensional multi-cell and multi-
layer array. Then, staphylococci are able to disassemble biofilm structure in order to release
those cells capable to colonize other sites on the surface. S. epidermidis and S. aureus biofilm
models have been the most studied among staphylococci and the overall biofilm formation




mechanism and protection against the host. A biofilm is considered a complex microbial
community (or communities) attached to a defined surface and embedded within a cell matrix.
Regarding the surface, biofilms may be formed on a wide variety of chemical or biological
surfaces. Regarding bacteria of the Staphylococcus genus, biofilm is the main virulence mecha‐
nism of the coagulase-negative staphylococci (CNS) species. Biofilm formation in staphylococ‐
ci is carried out in at least three stages: i) bacterial attachment to a defined surface, a process
termed primary attachment; ii) assembly of these originating bacteria into a small cluster, also
known as microcolony or cellular accumulation; and iii) biofilm growth and disassembly (also
known as detachment or dispersal) mediated by a mechanical process or by active metabo‐
lites produced by the biofilm-embedded bacteria.
I.1. Medical and epidemiological relevance of staphylococci biofilms
Staphylococci are commensal bacteria inhabiting the human skin and mucus. However, they
have been identified as infection-causing agents associated to biofilms. Animal models of
biofilm-associated infections using staphylococci have allowed to determine the importance
of their biofilms as a virulence mechanism. Therefore, staphylococci, particularly Staphylococ‐
cus epidermidis, are currently the most studied microorganisms regarding their biofilm
formation capacity. Nosocomial Infections Surveillance System recognizes that Staphylococ‐
cus aureus and CNS (e.g., S. epidermidis and most of the remaining staphylococci species) are
the most frequent nosocomial pathogens isolated from patients at the intensive care unit.
Epidemiological data show that CNS are the third most common infective agent causing native
valve infective endocarditis (NVIE), and they occupy the first place in prosthetic valve infective
endocarditis (PVIE), demonstrating their importance for these two clinical entities.
Regarding S. epidermidis, it is an inhabitant of the human skin microbiota. S. epidermidis is an
opportunist pathogen that causes disease only in patients subjected to predisposing factors.
This includes patients with particular features such as premature newborns, inborn immuno‐
logical impairments, or concomitant medical conditions, for example, human immunodefi‐
ciency virus (HIV) infection, immunosuppression after solid organ or bone marrow
transplants, and chemotherapy-related neutropenia. Epidemiological data point out S.
epidermidis as the most commonly isolated microorganism from foreign materials-related
infections such as infected prosthetic joints, central venous catheters (CVC), cerebrospinal fluid
shunts, intracardiac devices, artificial heart valves, and vascular grafts. Regarding prosthetic
joints infections, S. epidermidis is the main infective agent of prosthetic joint implants. In UK,
CNS and S. epidermidis are isolated from a 36% of total hip and 49% of total knee arthroplas‐
ty infections [1]. In an additional study on infected total hip and knee arthroplasties, it is
pointed out that nearly 70% of the CNS isolates were identified as S. epidermidis [2].
I.2. Experimental models to study biofilm formation
The clinical relevance of biofilm formation on foreign materials has been demonstrated using
cell culture models, a Caenorhabditis elegans infection model, and animal models of device
infections, for example, CVC or prosthetic device infection models. The first study on the
importance of biofilm formation in vivo using animal models and genetically distinct S.
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evidence that could demonstrate that biofilm-forming isolates are more virulent in compar‐
ing with those possessing a biofilm-negative phenotype. Nevertheless, compelling results
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wild-type strain with its respective isogenic mutant strain. Using a mouse model of subcuta‐
neous catheter infection and a rat model of venous catheter infection, the polysaccharide
intercellular adhesion (PIA)-producing S. epidermidis 1457 strain was more virulent than its
isogenic counterpart, the biofilm-negative 1457-M10 strain [3]. In a different model of CVC
infection, the icaRADBC-expressing S. epidermidis strain and its icaRADBC-negative isogenic
mutant displayed the same result [4]. An infection model of Caenorhabditis elegans was used in
order to study the biofilm-positive phenotype of the S. epidermidis 9142 strain, in comparison
to the icaA mutant, resulting in a higher virulence of the wild type than the mutant [5]. Recently,
using a catheter infection model, icaADBC inactivation apparently had no effect on coloniza‐
tion, whereas aap inactivation completely abolished S. epidermidis ability to establish the
infection [6]. One explanation for the null pathogenicity of the mutant strain regarding biofilm
formation is the lack of protection against the innate immune system. Experiments conduct‐
ed with cell culture showed that the biofilm-positive 1457 strain was less susceptible to
antimicrobial peptides (AMPs) and to phagocytosis performed by polymorphonuclear
granulocytes (PMNs) compared to the biofilm-negative 1457-M10 isogenic strain [7].
Physiological status is also important, when S. epidermidis 1457 grown on biofilm conditions
was less susceptible to phagocytes than it was grown on planktonic conditions [8].
PIA-dependent biofilm formation also interferes with the host’s complement activation.
Biofilm-positive wild-type bacteria pre-opsonized with normal human serum are more
resistant to complement-mediated elimination than the corresponding biofilm-negative
isogenic bacteria [8]. It has been also shown that S. epidermidis biofilm formation interferes with
the phagocytosis process and macrophage activation. This biofilm-forming phenotype may
contribute to the chronic persistence of S. epidermidis in inflammatory conditions.
Conversely, S. epidermidis produces a set of pro-inflammatory peptides termed phenol-soluble
modulins (PSMs), which are produced in a tightly regulated manner by the accessory gene
regulator (agr) system. It has been demonstrated that PSM δ is able to lyse neutrophils,
supporting the concept that these peptides are relevant for S. epidermidis pathogenesis.
However, PSM δ is expressed at low levels by the biofilm-producing S. epidermidis 1457 strain,
grown either in biofilm conditions or in planktonic conditions [9].
II. Mechanisms and molecules participating in staphylococci biofilm formation
In this chapter, we will divide the study of the biofilm formation process in three phases.
During primary attachment, bacteria adhere to the biotic or abiotic surface in order to colonize
it, whereas on the accumulation phase, bacteria build a tridimensional multi-cell and multi-
layer array. Then, staphylococci are able to disassemble biofilm structure in order to release
those cells capable to colonize other sites on the surface. S. epidermidis and S. aureus biofilm
models have been the most studied among staphylococci and the overall biofilm formation




mechanism and protection against the host. A biofilm is considered a complex microbial
community (or communities) attached to a defined surface and embedded within a cell matrix.
Regarding the surface, biofilms may be formed on a wide variety of chemical or biological
surfaces. Regarding bacteria of the Staphylococcus genus, biofilm is the main virulence mecha‐
nism of the coagulase-negative staphylococci (CNS) species. Biofilm formation in staphylococ‐
ci is carried out in at least three stages: i) bacterial attachment to a defined surface, a process
termed primary attachment; ii) assembly of these originating bacteria into a small cluster, also
known as microcolony or cellular accumulation; and iii) biofilm growth and disassembly (also
known as detachment or dispersal) mediated by a mechanical process or by active metabo‐
lites produced by the biofilm-embedded bacteria.
I.1. Medical and epidemiological relevance of staphylococci biofilms
Staphylococci are commensal bacteria inhabiting the human skin and mucus. However, they
have been identified as infection-causing agents associated to biofilms. Animal models of
biofilm-associated infections using staphylococci have allowed to determine the importance
of their biofilms as a virulence mechanism. Therefore, staphylococci, particularly Staphylococ‐
cus epidermidis, are currently the most studied microorganisms regarding their biofilm
formation capacity. Nosocomial Infections Surveillance System recognizes that Staphylococ‐
cus aureus and CNS (e.g., S. epidermidis and most of the remaining staphylococci species) are
the most frequent nosocomial pathogens isolated from patients at the intensive care unit.
Epidemiological data show that CNS are the third most common infective agent causing native
valve infective endocarditis (NVIE), and they occupy the first place in prosthetic valve infective
endocarditis (PVIE), demonstrating their importance for these two clinical entities.
Regarding S. epidermidis, it is an inhabitant of the human skin microbiota. S. epidermidis is an
opportunist pathogen that causes disease only in patients subjected to predisposing factors.
This includes patients with particular features such as premature newborns, inborn immuno‐
logical impairments, or concomitant medical conditions, for example, human immunodefi‐
ciency virus (HIV) infection, immunosuppression after solid organ or bone marrow
transplants, and chemotherapy-related neutropenia. Epidemiological data point out S.
epidermidis as the most commonly isolated microorganism from foreign materials-related
infections such as infected prosthetic joints, central venous catheters (CVC), cerebrospinal fluid
shunts, intracardiac devices, artificial heart valves, and vascular grafts. Regarding prosthetic
joints infections, S. epidermidis is the main infective agent of prosthetic joint implants. In UK,
CNS and S. epidermidis are isolated from a 36% of total hip and 49% of total knee arthroplas‐
ty infections [1]. In an additional study on infected total hip and knee arthroplasties, it is
pointed out that nearly 70% of the CNS isolates were identified as S. epidermidis [2].
I.2. Experimental models to study biofilm formation
The clinical relevance of biofilm formation on foreign materials has been demonstrated using
cell culture models, a Caenorhabditis elegans infection model, and animal models of device
infections, for example, CVC or prosthetic device infection models. The first study on the
importance of biofilm formation in vivo using animal models and genetically distinct S.
Microbial Biofilms - Importance and Applications212
region containing the serine-aspartate repeat sequence. SdrG specifically binds to a 14-amino
acid-long peptide sequence on the N-terminal of fibrinogen’s beta chain. SdrF, display a similar
organization to SdrG and it specifically binds to collagen I [16]. So far, a specific function has
not been assigned to the A region of SdrF. However, it has been demonstrated that its B region
is sufficient to interact with collagen I and apparently, this binding occurs through the alpha1
and alpha2 chains of type I collagen [16]. Using a Lactococcus lactis heterologous expression
system and a murine infection model, it has been established that SdrF may contribute to
cardiac assist device driveline infections [17]. SdrF also participates in binding to unmodi‐
fied Dacron surfaces covering drivelines. Anti-SdrF antibodies inhibited 50% of S. epidermi‐
dis 9491 binding to collagen using an in vivo model [17], indicating that additional collagen-
binding factors may participate.
eDNA function during S. epidermidis and S. aureus biofilm formation has been established as
another crucial component for cell attachment to a surface. Some studies confirm that eDNA
is a structural component of the biofilm’s matrix in both species. Independent studies have
demonstrated that eDNA is released through increased cell lysis. In S. epidermidis, autolysis is
carried out mainly by the autolysin activity of AtlE. A role for eDNA in S. epidermidis 1457 was
evidenced during primary attachment through the addition of DNase I that results in inhibition
of bacterial binding to a glass surface. In spite of the fact that eDNA participates in the primary
attachment phase, a function during intercellular attachment phase (accumulation phase) has
been ascribed [18]. During the surface colonization phase by S. aureus under flow conditions,
eDNA is crucial during the transition between primary attachment and accumulation
phases [19]. This points out that eDNA plays an important role in early stages of staphylococ‐
ci biofilm formation.
II.2. Participating molecules during the biofilm accumulation phase
The main component during the accumulation phase is the expression of molecules possess‐
ing intercellular (cell-cell) adhesion properties leading to cell aggregation and to subsequent
biofilm development having a multi-cell and multi-layer tridimensional structure. Based on
the early electron microscopy studies, it has been shown that S. epidermidis are embedded
within an amorphous matrix. Afterwards, the studies were focused on the biochemical analysis
of the matrix components. These efforts resulted in the discovery of the PIA polymer, a
component participating in great proportion on intercellular adhesion.
The PIA structure was first described in biofilm-forming S. epidermidis 1457 and RP62A strains.
Through biochemical analysis, the existence of the structurally related polysaccharide I (>80%)
and polysaccharide II (<20%) was determined and separated based on their different ionic
properties. Using chemical analysis and NMR spectrometry, it has been demonstrated that
polysaccharide I is a lineal homoglycan consisting of beta-1,6-linked 2-amino-2-deoxy-D-
glucopyranosil residues. Approximately 80–85% of them are N-acetylated (GlcNAc) and the
rest are not N-acetylated, this polymer has an overall negative charge. PIA’s polysaccharide II
has a low proportion of N-acetylated 2-amino-2-deoxy-D-glucopyranosyl residues and it is
modified with succinate residues linked by ester bonds, which confers it with anionic




II.1. Participating molecules on the biofilm primary attachment phase
An essential step performed during the primary attachment stage is the tight binding of
bacteria to the foreign material (medical device). This bacterial tight binding leads to a
successful establishment of a medical device-associated infection. Regarding S. epidermidis, it
has been found that cell wall proteins are the main elements of such interactions and this is
similar for S. aureus. Genetic evidence has allowed establishing that bacterial binding to
unmodified polystyrene (non-biotic surface) is conveyed by the S. epidermidis AtlE autolysin
protein [10]. AtlE is a 115 KDa protein that belongs to the bacterial peptidoglycan (PGN)-
hydrolases group that plays an important role in bacterial cell wall degradation. The protein
is composed by an N-terminal signal peptide, a propeptide, a catalytic domain possessing N-
acetylmuramyl-L-alanine amidase activity, three repeated sequences (R1-3), and one C-
terminal catalytic domain, possessing N-acetylglucosaminidase activity. In addition to its role
during cell wall turnover, AtlE is also important for unmodified polystyrene binding. This
function was demonstrated by the S. epidermidis O-47 strain harboring a mutation caused by
the atlE::Tn917 transposon, which has an impaired ability to adhere to the polystyrene
surface [10]. The binding mechanism of AtlE to the polystyrene surface is unclear; however, it
is thought that the first event is AtlE recruitment on the bacterial cell wall through the R1-3
domain and those domains possessing enzyme activity. Based on AtlE expression and
functional activation studies, it has been suggested that this protein leads to significant changes
in cell wall hydrophobicity contributing to the primary attachment process [11]. Another
assigned function for AtlE is its autolysin activity in order to cleave the cells wall and thus
releasing extracellular DNA (eDNA), which is a common component in staphylococci
biofilm [12]. S. aureus autolysin also shares this function at this biofilm formation phase.
The interaction between S. epidermidis and an artificial unmodified surface (polystyrene) is
mediated by non-specific interactions without the participation of a receptor-specific ligand.
On surfaces coated with the host’s extracellular matrix (ECM), both S. epidermidis and S. aureus
express cell surface proteins leading to a specific interaction with the components of this ECM
of the host. Proteins exhibiting ECM-binding activity are important in order to initiate the
infection of medical devices because once foreign materials are introduced inside the body,
they are covered by ECM materials (e.g., fibronectin; fibrinogen; vitronectin; collagen). It has
been described that S. epidermidis AtlE can adhere to vitronectin-covered surfaces, whereas the
GehD lipase is involved in interactions with collagen [13]. In addition to these proteins, both
S. epidermidis and S. aureus express proteins possessing a specific function for their interac‐
tion with ECM. These belong to the serine-aspartate repeat (Sdr) protein group and they are
members of the microbial surface components family that recognize adhesive matrix mole‐
cules (MSCRAMM) [14]. In S. epidermidis, three Sdr proteins referred to as SdrF, SdrG, and
SdrH have been identified [14]. SdrG (also known as Fbe) is a protein containing the LPXTG
motif that is covalently bound to the bacterial cell wall surface and specifically recognizes
fibrinogen and thus S. epidermidis cells expressing SdrG adhere to fibrinogen-covered
surfaces [15]. The gene coding for SdG/Fbe is found on S. epidermidis clinical isolates. The SdrG
protein contains four distinct regions: an N-terminal export motif sequence, the A region
containing the fibrinogen-binding activity, the B region with unknown function, and the R
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region containing the serine-aspartate repeat sequence. SdrG specifically binds to a 14-amino
acid-long peptide sequence on the N-terminal of fibrinogen’s beta chain. SdrF, display a similar
organization to SdrG and it specifically binds to collagen I [16]. So far, a specific function has
not been assigned to the A region of SdrF. However, it has been demonstrated that its B region
is sufficient to interact with collagen I and apparently, this binding occurs through the alpha1
and alpha2 chains of type I collagen [16]. Using a Lactococcus lactis heterologous expression
system and a murine infection model, it has been established that SdrF may contribute to
cardiac assist device driveline infections [17]. SdrF also participates in binding to unmodi‐
fied Dacron surfaces covering drivelines. Anti-SdrF antibodies inhibited 50% of S. epidermi‐
dis 9491 binding to collagen using an in vivo model [17], indicating that additional collagen-
binding factors may participate.
eDNA function during S. epidermidis and S. aureus biofilm formation has been established as
another crucial component for cell attachment to a surface. Some studies confirm that eDNA
is a structural component of the biofilm’s matrix in both species. Independent studies have
demonstrated that eDNA is released through increased cell lysis. In S. epidermidis, autolysis is
carried out mainly by the autolysin activity of AtlE. A role for eDNA in S. epidermidis 1457 was
evidenced during primary attachment through the addition of DNase I that results in inhibition
of bacterial binding to a glass surface. In spite of the fact that eDNA participates in the primary
attachment phase, a function during intercellular attachment phase (accumulation phase) has
been ascribed [18]. During the surface colonization phase by S. aureus under flow conditions,
eDNA is crucial during the transition between primary attachment and accumulation
phases [19]. This points out that eDNA plays an important role in early stages of staphylococ‐
ci biofilm formation.
II.2. Participating molecules during the biofilm accumulation phase
The main component during the accumulation phase is the expression of molecules possess‐
ing intercellular (cell-cell) adhesion properties leading to cell aggregation and to subsequent
biofilm development having a multi-cell and multi-layer tridimensional structure. Based on
the early electron microscopy studies, it has been shown that S. epidermidis are embedded
within an amorphous matrix. Afterwards, the studies were focused on the biochemical analysis
of the matrix components. These efforts resulted in the discovery of the PIA polymer, a
component participating in great proportion on intercellular adhesion.
The PIA structure was first described in biofilm-forming S. epidermidis 1457 and RP62A strains.
Through biochemical analysis, the existence of the structurally related polysaccharide I (>80%)
and polysaccharide II (<20%) was determined and separated based on their different ionic
properties. Using chemical analysis and NMR spectrometry, it has been demonstrated that
polysaccharide I is a lineal homoglycan consisting of beta-1,6-linked 2-amino-2-deoxy-D-
glucopyranosil residues. Approximately 80–85% of them are N-acetylated (GlcNAc) and the
rest are not N-acetylated, this polymer has an overall negative charge. PIA’s polysaccharide II
has a low proportion of N-acetylated 2-amino-2-deoxy-D-glucopyranosyl residues and it is
modified with succinate residues linked by ester bonds, which confers it with anionic




II.1. Participating molecules on the biofilm primary attachment phase
An essential step performed during the primary attachment stage is the tight binding of
bacteria to the foreign material (medical device). This bacterial tight binding leads to a
successful establishment of a medical device-associated infection. Regarding S. epidermidis, it
has been found that cell wall proteins are the main elements of such interactions and this is
similar for S. aureus. Genetic evidence has allowed establishing that bacterial binding to
unmodified polystyrene (non-biotic surface) is conveyed by the S. epidermidis AtlE autolysin
protein [10]. AtlE is a 115 KDa protein that belongs to the bacterial peptidoglycan (PGN)-
hydrolases group that plays an important role in bacterial cell wall degradation. The protein
is composed by an N-terminal signal peptide, a propeptide, a catalytic domain possessing N-
acetylmuramyl-L-alanine amidase activity, three repeated sequences (R1-3), and one C-
terminal catalytic domain, possessing N-acetylglucosaminidase activity. In addition to its role
during cell wall turnover, AtlE is also important for unmodified polystyrene binding. This
function was demonstrated by the S. epidermidis O-47 strain harboring a mutation caused by
the atlE::Tn917 transposon, which has an impaired ability to adhere to the polystyrene
surface [10]. The binding mechanism of AtlE to the polystyrene surface is unclear; however, it
is thought that the first event is AtlE recruitment on the bacterial cell wall through the R1-3
domain and those domains possessing enzyme activity. Based on AtlE expression and
functional activation studies, it has been suggested that this protein leads to significant changes
in cell wall hydrophobicity contributing to the primary attachment process [11]. Another
assigned function for AtlE is its autolysin activity in order to cleave the cells wall and thus
releasing extracellular DNA (eDNA), which is a common component in staphylococci
biofilm [12]. S. aureus autolysin also shares this function at this biofilm formation phase.
The interaction between S. epidermidis and an artificial unmodified surface (polystyrene) is
mediated by non-specific interactions without the participation of a receptor-specific ligand.
On surfaces coated with the host’s extracellular matrix (ECM), both S. epidermidis and S. aureus
express cell surface proteins leading to a specific interaction with the components of this ECM
of the host. Proteins exhibiting ECM-binding activity are important in order to initiate the
infection of medical devices because once foreign materials are introduced inside the body,
they are covered by ECM materials (e.g., fibronectin; fibrinogen; vitronectin; collagen). It has
been described that S. epidermidis AtlE can adhere to vitronectin-covered surfaces, whereas the
GehD lipase is involved in interactions with collagen [13]. In addition to these proteins, both
S. epidermidis and S. aureus express proteins possessing a specific function for their interac‐
tion with ECM. These belong to the serine-aspartate repeat (Sdr) protein group and they are
members of the microbial surface components family that recognize adhesive matrix mole‐
cules (MSCRAMM) [14]. In S. epidermidis, three Sdr proteins referred to as SdrF, SdrG, and
SdrH have been identified [14]. SdrG (also known as Fbe) is a protein containing the LPXTG
motif that is covalently bound to the bacterial cell wall surface and specifically recognizes
fibrinogen and thus S. epidermidis cells expressing SdrG adhere to fibrinogen-covered
surfaces [15]. The gene coding for SdG/Fbe is found on S. epidermidis clinical isolates. The SdrG
protein contains four distinct regions: an N-terminal export motif sequence, the A region
containing the fibrinogen-binding activity, the B region with unknown function, and the R
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terminal end, the A domain, and within the C-terminal, the LPXTG-anchoring domain
separated by tandem repeats, which are involved in binding to fibronectin. Both, FnBPA and
FnBPB are involved in the biofilm’s accumulation phase in isolates from hospitals and under
flow conditions. This concept of multifunctional proteins with important roles during some
of the biofilm formation and surface colonization phases is also applied to S. epidermidis with
its respective proteins participating in the accumulation phase: the accumulation-associated
protein (Aap) and the extracellular matrix-binding protein (Embp).
The Embp protein and its S. aureus orthologue, designated as Ebh, were simultaneously
pinpointed during identification studies of protein factors [27]. In a clinically relevant S.
epidermidis isolates collection, the embp gene was detected in 90% of all strains [2]. Further‐
more, studies conducted in vivo indicated the presence of anti-Embp antibodies in patients
with prosthetic joint infections by S. epidermidis, suggesting that the Embp protein is ex‐
pressed and it has a role during the infection. Surprisingly, when using a bacterial cell model
in flow conditions, it was observed that addition of anti-Embp antibodies to the system
inhibited biofilm formation by the S. epidermidis 1457 strain [28]. This result leads to propose
the Embp protein as a potential candidate for preventive strategies against biofilm forma‐
tion. Experimental evidences suggest that Embp has a defined role during the primary
attachment phase. This proposal is supported by the fact that Embp overexpression had no
effect on bacterial attachment on an unmodified polystyrene surface, although it had a negative
effect on bacterial binding to fibronectin-covered surfaces [29]. Additionally, it was observed
that the Embp-fibronectin interaction is necessary for the biofilm’s accumulation phase on
plastic surfaces [29].
The Aap protein is covalently bound to the cell wall and consists of an A domain and a B
domain. The A domain has 584 amino acids and includes an export signal at its N-terminal,
16 amino acid repeats and a globular region of 212 amino acids with alpha-helical and beta-
sheet contents. This 212-amino acid-long region is highly conserved between Aap and its S.
aureus orthologue, SasG. Through bioinformatics analysis, it has been shown that this domain
possess lectin-type activity [6]. The B domain consists in a variable number of repeats of 128
amino acids, the G5 subdomains [2]. The number of G5 subdomains in the B domain is different
among the S. epidermidis strains, for example, the RP62A reference strain possesses 13 G5
subdomains, whereas the S. epidermidis 1457 strain has only seven [6]. This fact has been also
observed in clinic isolates with clonal genotypes subsequently recovered from ongoing
infections on devices in patients [2]. This observation leads to the hypothesis stating that the
number of G5 subdomains of the Aap B domain may represent a mechanism contributing to
the immune evasion of S. epidermidis mediated by the modification of the major epitopes on
the cell’s surface [2]. Aap is detected on the bacterial cell wall and its retention mechanism is
through anchoring of its C-terminal by a covalent bond with the cell wall PGN [30]. A more
detailed analysis by confocal microscopy showed that Aap is strictly localized at the bacteri‐
al cell surface, whereas minimal amounts of Aap are released within the biofilm matrix [30].
This result is supported by electron microscopy observations in which Aap appears as




all four icaADBC genes [21] constituting the ica operon. The icaR gene confines the repres‐
sion of the ica operon expression. The synthesis process has been studied in detail using S.
carnosus recombinant strains expressing different combinations of the icaADBC genes and
using UDP-GlcNAc as the sugar donor [21]. The IcaA protein belongs to the glycosyltransfer‐
ase family 2. It is an integral membrane protein consisting of 412 amino acids and four
transmembrane domains. This protein performs the synthesis of beta-1,6-linked GlcNAc
oligosaccharide composed by up to 20 GlcNAc units. The IcaD protein is required for IcaA full
activity in vitro. IcaD is a membrane protein of 101 amino acids possessing two putative
membrane space domains and it is thought that it may be a chaperone guiding IcaA protein
folding and its membrane insertion and it also may act as a link between the IcaA and IcaC
proteins [21]. Essential to PIA synthesis is the presence of the IcaB, an integral membrane
protein of 355 amino acids possessing 10 predicted transmembrane domains, which may be
involved in the externalization and elongation of the nascent polysaccharide [21]. IcaB is a
member of the polysaccharide deacetylase family that includes chitin deacetylases or the
chitooligosaccharide deacetylase NodB of Rhizobium melioti. IcaB in its mature form is a
secreted protein consisting of 259 amino acids with a predicted signal sequence, which is
responsible for PIA N-deacetylation and it is crucial for PIA activity during biofilm forma‐
tion and for S. epidermidis virulence [22]. A strain harboring an icaB deletion mutation, in which
the icaB gene has been eliminated, produces a weakly retained PIA at the cell’s surface, as it
does not contain N-deacetylated GlcNAc [22].
Conversely, the first observation made through biochemical analysis on biofilm matrix extracts
indicated the presence of oligosaccharide, proteins, and nucleic acids. The specific proteins
that comprise a biofilm have been identified and characterized; one of them is the biofilm-
associated protein Bap [23]. The Bap is rarely found in invasive S. epidermidis biofilms from
human infections [23] and it similarly occurs for S. aureus. Another protein found in biofilms
is SesC, which has been proposed as playing an important role during biofilm formation [24].
SesC is a surface protein of 68 KDa containing the S. epidermidis LPXTG motif and it is related
to the S. aureus clumping factor A (ClfA). SesC protein is strongly expressed in biofilm
conditions in contrast to planktonic conditions by the S. epidermidis 1457 strain [24]. An anti-
SesC antibody inhibited biofilm formation in vitro in several S. epidermidis isolates. All 105 S.
epidermidis isolates collected from nose swabs of infection possessed the sesC gene in their
genomes [24]. Actively or passively immunized animals using SesC as antigen displayed a
decreased biofilm formation using the in vivo CVC infection model [25]. Nevertheless, a
specific role of SesC during the intercellular adhesion of the accumulation phase of the biofilm
remains to be demonstrated.
II.3. Multifunction proteins during the biofilm accumulation phase
Protein factors contributing to the accumulation phase of staphylococci biofilm have fea‐
tures of multifunctional proteins. In S. aureus, it has been found that fibronectin-binding
proteins (FnBPs) (FnBPA and FnBPB), ClfA protein and S. aureus surface protein (SasG), may
be considered multifunctional proteins as they do not have an exclusive role in either of the
biofilm phases: primary attachment or accumulation [26]. FnBPs are constituted by an N-
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terminal end, the A domain, and within the C-terminal, the LPXTG-anchoring domain
separated by tandem repeats, which are involved in binding to fibronectin. Both, FnBPA and
FnBPB are involved in the biofilm’s accumulation phase in isolates from hospitals and under
flow conditions. This concept of multifunctional proteins with important roles during some
of the biofilm formation and surface colonization phases is also applied to S. epidermidis with
its respective proteins participating in the accumulation phase: the accumulation-associated
protein (Aap) and the extracellular matrix-binding protein (Embp).
The Embp protein and its S. aureus orthologue, designated as Ebh, were simultaneously
pinpointed during identification studies of protein factors [27]. In a clinically relevant S.
epidermidis isolates collection, the embp gene was detected in 90% of all strains [2]. Further‐
more, studies conducted in vivo indicated the presence of anti-Embp antibodies in patients
with prosthetic joint infections by S. epidermidis, suggesting that the Embp protein is ex‐
pressed and it has a role during the infection. Surprisingly, when using a bacterial cell model
in flow conditions, it was observed that addition of anti-Embp antibodies to the system
inhibited biofilm formation by the S. epidermidis 1457 strain [28]. This result leads to propose
the Embp protein as a potential candidate for preventive strategies against biofilm forma‐
tion. Experimental evidences suggest that Embp has a defined role during the primary
attachment phase. This proposal is supported by the fact that Embp overexpression had no
effect on bacterial attachment on an unmodified polystyrene surface, although it had a negative
effect on bacterial binding to fibronectin-covered surfaces [29]. Additionally, it was observed
that the Embp-fibronectin interaction is necessary for the biofilm’s accumulation phase on
plastic surfaces [29].
The Aap protein is covalently bound to the cell wall and consists of an A domain and a B
domain. The A domain has 584 amino acids and includes an export signal at its N-terminal,
16 amino acid repeats and a globular region of 212 amino acids with alpha-helical and beta-
sheet contents. This 212-amino acid-long region is highly conserved between Aap and its S.
aureus orthologue, SasG. Through bioinformatics analysis, it has been shown that this domain
possess lectin-type activity [6]. The B domain consists in a variable number of repeats of 128
amino acids, the G5 subdomains [2]. The number of G5 subdomains in the B domain is different
among the S. epidermidis strains, for example, the RP62A reference strain possesses 13 G5
subdomains, whereas the S. epidermidis 1457 strain has only seven [6]. This fact has been also
observed in clinic isolates with clonal genotypes subsequently recovered from ongoing
infections on devices in patients [2]. This observation leads to the hypothesis stating that the
number of G5 subdomains of the Aap B domain may represent a mechanism contributing to
the immune evasion of S. epidermidis mediated by the modification of the major epitopes on
the cell’s surface [2]. Aap is detected on the bacterial cell wall and its retention mechanism is
through anchoring of its C-terminal by a covalent bond with the cell wall PGN [30]. A more
detailed analysis by confocal microscopy showed that Aap is strictly localized at the bacteri‐
al cell surface, whereas minimal amounts of Aap are released within the biofilm matrix [30].
This result is supported by electron microscopy observations in which Aap appears as




all four icaADBC genes [21] constituting the ica operon. The icaR gene confines the repres‐
sion of the ica operon expression. The synthesis process has been studied in detail using S.
carnosus recombinant strains expressing different combinations of the icaADBC genes and
using UDP-GlcNAc as the sugar donor [21]. The IcaA protein belongs to the glycosyltransfer‐
ase family 2. It is an integral membrane protein consisting of 412 amino acids and four
transmembrane domains. This protein performs the synthesis of beta-1,6-linked GlcNAc
oligosaccharide composed by up to 20 GlcNAc units. The IcaD protein is required for IcaA full
activity in vitro. IcaD is a membrane protein of 101 amino acids possessing two putative
membrane space domains and it is thought that it may be a chaperone guiding IcaA protein
folding and its membrane insertion and it also may act as a link between the IcaA and IcaC
proteins [21]. Essential to PIA synthesis is the presence of the IcaB, an integral membrane
protein of 355 amino acids possessing 10 predicted transmembrane domains, which may be
involved in the externalization and elongation of the nascent polysaccharide [21]. IcaB is a
member of the polysaccharide deacetylase family that includes chitin deacetylases or the
chitooligosaccharide deacetylase NodB of Rhizobium melioti. IcaB in its mature form is a
secreted protein consisting of 259 amino acids with a predicted signal sequence, which is
responsible for PIA N-deacetylation and it is crucial for PIA activity during biofilm forma‐
tion and for S. epidermidis virulence [22]. A strain harboring an icaB deletion mutation, in which
the icaB gene has been eliminated, produces a weakly retained PIA at the cell’s surface, as it
does not contain N-deacetylated GlcNAc [22].
Conversely, the first observation made through biochemical analysis on biofilm matrix extracts
indicated the presence of oligosaccharide, proteins, and nucleic acids. The specific proteins
that comprise a biofilm have been identified and characterized; one of them is the biofilm-
associated protein Bap [23]. The Bap is rarely found in invasive S. epidermidis biofilms from
human infections [23] and it similarly occurs for S. aureus. Another protein found in biofilms
is SesC, which has been proposed as playing an important role during biofilm formation [24].
SesC is a surface protein of 68 KDa containing the S. epidermidis LPXTG motif and it is related
to the S. aureus clumping factor A (ClfA). SesC protein is strongly expressed in biofilm
conditions in contrast to planktonic conditions by the S. epidermidis 1457 strain [24]. An anti-
SesC antibody inhibited biofilm formation in vitro in several S. epidermidis isolates. All 105 S.
epidermidis isolates collected from nose swabs of infection possessed the sesC gene in their
genomes [24]. Actively or passively immunized animals using SesC as antigen displayed a
decreased biofilm formation using the in vivo CVC infection model [25]. Nevertheless, a
specific role of SesC during the intercellular adhesion of the accumulation phase of the biofilm
remains to be demonstrated.
II.3. Multifunction proteins during the biofilm accumulation phase
Protein factors contributing to the accumulation phase of staphylococci biofilm have fea‐
tures of multifunctional proteins. In S. aureus, it has been found that fibronectin-binding
proteins (FnBPs) (FnBPA and FnBPB), ClfA protein and S. aureus surface protein (SasG), may
be considered multifunctional proteins as they do not have an exclusive role in either of the
biofilm phases: primary attachment or accumulation [26]. FnBPs are constituted by an N-
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is inactivated [38]. Additionally, protease inhibitors have a promoter role during biofilm
formation in S. aureus under conditions that normally accelerate its disassembly [38]. Similarly,
mutations leading to extracellular protease overexpression, such as those on the sarA and sigB
genes, enhance a planktonic growth in S. aureus [40]. This leads to a concept of an inverse
correlation between protease expression and biofilm formation.
S. aureus secretes a potent DNAse, also known as thermonuclease or micrococcal nuclease,
which has been implicated on cell detachment from the biofilm. S. aureus mature biofilm is
disintegrated by the exogenous addition of DNAse I or restriction enzymes [41]. It has been
shown that a nuclease-mutant S. aureus strain exhibited an increase of biofilm formation under
flow conditions regarding to the wild-type strain [41]. These findings suggest that nucleases
may function as endogenous mediators for biofilm disassembly in this species.
PSMs are peptides possessing surfactant features, which are produced by both S. aureus and
S. epidermidis, and they are capable of contributing for mature biofilm disassembly. PSMs are
regulated by the agr system and their amphiphilic alpha-helix structure confers it with a
surfactant-type property. PSMs promote both disassembly of the mature biofilm of S.
epidermidis in vitro and dissemination from colonized catheters on a mouse model of device-
related infection [9]. Additionally, antibodies against PSMs inhibit bacterial dispersal from the
implanted catheter, indicating that the disassembly manipulation strategy may prevent the
spreading of the infection.
III. Regulation of biofilm formation in staphylococci
Biofilms are a lifestyle adopted by a wide variety of microorganisms that requires the
consumption of an enormous amount of energy. Thus, it is expected that biofilm growth may
be controlled by more regulatory mechanisms regarding planktonic growth. Some of the
factors that impact on biofilm formation are mentioned in the following sections.
III.1. Regulation of the factors participating on the primary attachment phase
The agr is a quorum-sensing system in staphylococci that regulates the expression of adhe‐
sion molecules, thus it participates in the primary attachment phase. These adhesion mole‐
cules, such as the MSCRAMMs, display an increased expression when cell density is low, a
situation favoring the onset of the infection by staphylococci. Once the colonization has
concluded, the increased activity of the agr quorum-sensing system represses the expression
of unnecessary colonization factors. Among these, the MSCRAMMs are included, which are
negatively regulated by agr in S. aureus [42]. In S. epidermidis, the knowledge regarding
colonization factors and their regulation is more limited. Results obtained by transcriptional
profiling and the assessment of MSCRAMM expression [43], suggest that some of the latter do
not follow the classic notion of regulation mediated by the agr system.
III.2. Regulation of PIA synthesis
The regulation of PIA expression is probably the best-studied system among those regula‐




The importance of Aap for S. epidermidis biofilm formation was recognized during studies in
which the expression of the B domain does not modify the primary adherence properties,
although it is very important to cellular aggregation, indicating that Aap is a protein that
participates in the intercellular adhesion [32]. Similarly, the importance of the B domain for
intercellular adhesion was also described for SasG in S. aureus [33]. Another fact that eviden‐
ces the properties of Aap in intercellular adhesion is the ability of the B domain to undergo
homodimerization in the presence of Zn [34]. The proposed mechanism of intercellular
adhesion through Aap is that the protein must undergo proteolytic processing in order to
remove the A domain [32–33]. Thus, Aap proteolytic processing does not normally occur under
in vitro growth conditions [32].
Although the intercellular adhesion property of Aap was recognized, currently there is
evidence supporting its significant role in the primary attachment phase as well. The bind‐
ing of S. epidermidis NCTC 11047 strain expressing Aap to squamous epithelial cells was
partially inhibited by the addition of the recombinant A domain of Aap [35]. In a clinical isolate,
the binding of S. epidermidis CSF41498 strain expressing a non-processed Aap (thus contain‐
ing the A domain) to polystyrene was completely impaired by the addition of an anti-A domain
antiserum, whereas an anti-B domain antiserum did not affect its adhesion ability [36]. Thus,
a new bifunctional role of Aap during the biofilm formation is suggested: its participation on
the primary attachment phase through its A domain and also its participation on the accu‐
mulation phase through its B domain [32, 35–36].
II.4. Molecular mechanisms for mature biofilm disassembly
A primary biofilm disassembly mechanism used by S. aureus and S. epidermidis is the produc‐
tion of extracellular enzymes or surfactants that degrade or solubilize the adhesive compo‐
nents of the biofilm matrix. Because this matrix cover bacterial cells within the biofilm colony,
its degradation results in cell detachment from the colony and its release toward the environ‐
ment. The products of the matrix-degrading genes, which are implicated on the dispersion of
the staphylococcal biofilm, include proteases, DNases, and surfactants.
The agr system is a putative regulator controlling the production of the enzymes degrading
the biofilm matrix. The agr is controlled by a cyclic autoinducing peptide (AIP) that is
synthesized and secreted within the environment. When the AIP concentration reaches a
critical threshold level, it activates a two-component signal transduction cascade leading to
the production of secretory virulence factors [37]. The extracellular proteins induced by the
agr system are multiple proteases and pore-forming toxins termed PSMs. S. aureus does not
form a biofilm when the agr system is highly active and its reactivation within the mature
biofilm results in its disassembly [38]. Furthermore, the agr system of S. aureus is more active
in cells detached from the biofilm [39]; the same phenomenon was observed in S. epidermidis
[9], contributing evidence showing that induction of the agr system results in biofilm disas‐
sembly.
Extracellular protease production has been implicated on the disassembly of the mature
biofilm. In S. aureus, the mutation of the protease-coding genes results in a significant increase
of biofilm formation under flow conditions and the disassembly decrease when the agr system
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is inactivated [38]. Additionally, protease inhibitors have a promoter role during biofilm
formation in S. aureus under conditions that normally accelerate its disassembly [38]. Similarly,
mutations leading to extracellular protease overexpression, such as those on the sarA and sigB
genes, enhance a planktonic growth in S. aureus [40]. This leads to a concept of an inverse
correlation between protease expression and biofilm formation.
S. aureus secretes a potent DNAse, also known as thermonuclease or micrococcal nuclease,
which has been implicated on cell detachment from the biofilm. S. aureus mature biofilm is
disintegrated by the exogenous addition of DNAse I or restriction enzymes [41]. It has been
shown that a nuclease-mutant S. aureus strain exhibited an increase of biofilm formation under
flow conditions regarding to the wild-type strain [41]. These findings suggest that nucleases
may function as endogenous mediators for biofilm disassembly in this species.
PSMs are peptides possessing surfactant features, which are produced by both S. aureus and
S. epidermidis, and they are capable of contributing for mature biofilm disassembly. PSMs are
regulated by the agr system and their amphiphilic alpha-helix structure confers it with a
surfactant-type property. PSMs promote both disassembly of the mature biofilm of S.
epidermidis in vitro and dissemination from colonized catheters on a mouse model of device-
related infection [9]. Additionally, antibodies against PSMs inhibit bacterial dispersal from the
implanted catheter, indicating that the disassembly manipulation strategy may prevent the
spreading of the infection.
III. Regulation of biofilm formation in staphylococci
Biofilms are a lifestyle adopted by a wide variety of microorganisms that requires the
consumption of an enormous amount of energy. Thus, it is expected that biofilm growth may
be controlled by more regulatory mechanisms regarding planktonic growth. Some of the
factors that impact on biofilm formation are mentioned in the following sections.
III.1. Regulation of the factors participating on the primary attachment phase
The agr is a quorum-sensing system in staphylococci that regulates the expression of adhe‐
sion molecules, thus it participates in the primary attachment phase. These adhesion mole‐
cules, such as the MSCRAMMs, display an increased expression when cell density is low, a
situation favoring the onset of the infection by staphylococci. Once the colonization has
concluded, the increased activity of the agr quorum-sensing system represses the expression
of unnecessary colonization factors. Among these, the MSCRAMMs are included, which are
negatively regulated by agr in S. aureus [42]. In S. epidermidis, the knowledge regarding
colonization factors and their regulation is more limited. Results obtained by transcriptional
profiling and the assessment of MSCRAMM expression [43], suggest that some of the latter do
not follow the classic notion of regulation mediated by the agr system.
III.2. Regulation of PIA synthesis
The regulation of PIA expression is probably the best-studied system among those regula‐




The importance of Aap for S. epidermidis biofilm formation was recognized during studies in
which the expression of the B domain does not modify the primary adherence properties,
although it is very important to cellular aggregation, indicating that Aap is a protein that
participates in the intercellular adhesion [32]. Similarly, the importance of the B domain for
intercellular adhesion was also described for SasG in S. aureus [33]. Another fact that eviden‐
ces the properties of Aap in intercellular adhesion is the ability of the B domain to undergo
homodimerization in the presence of Zn [34]. The proposed mechanism of intercellular
adhesion through Aap is that the protein must undergo proteolytic processing in order to
remove the A domain [32–33]. Thus, Aap proteolytic processing does not normally occur under
in vitro growth conditions [32].
Although the intercellular adhesion property of Aap was recognized, currently there is
evidence supporting its significant role in the primary attachment phase as well. The bind‐
ing of S. epidermidis NCTC 11047 strain expressing Aap to squamous epithelial cells was
partially inhibited by the addition of the recombinant A domain of Aap [35]. In a clinical isolate,
the binding of S. epidermidis CSF41498 strain expressing a non-processed Aap (thus contain‐
ing the A domain) to polystyrene was completely impaired by the addition of an anti-A domain
antiserum, whereas an anti-B domain antiserum did not affect its adhesion ability [36]. Thus,
a new bifunctional role of Aap during the biofilm formation is suggested: its participation on
the primary attachment phase through its A domain and also its participation on the accu‐
mulation phase through its B domain [32, 35–36].
II.4. Molecular mechanisms for mature biofilm disassembly
A primary biofilm disassembly mechanism used by S. aureus and S. epidermidis is the produc‐
tion of extracellular enzymes or surfactants that degrade or solubilize the adhesive compo‐
nents of the biofilm matrix. Because this matrix cover bacterial cells within the biofilm colony,
its degradation results in cell detachment from the colony and its release toward the environ‐
ment. The products of the matrix-degrading genes, which are implicated on the dispersion of
the staphylococcal biofilm, include proteases, DNases, and surfactants.
The agr system is a putative regulator controlling the production of the enzymes degrading
the biofilm matrix. The agr is controlled by a cyclic autoinducing peptide (AIP) that is
synthesized and secreted within the environment. When the AIP concentration reaches a
critical threshold level, it activates a two-component signal transduction cascade leading to
the production of secretory virulence factors [37]. The extracellular proteins induced by the
agr system are multiple proteases and pore-forming toxins termed PSMs. S. aureus does not
form a biofilm when the agr system is highly active and its reactivation within the mature
biofilm results in its disassembly [38]. Furthermore, the agr system of S. aureus is more active
in cells detached from the biofilm [39]; the same phenomenon was observed in S. epidermidis
[9], contributing evidence showing that induction of the agr system results in biofilm disas‐
sembly.
Extracellular protease production has been implicated on the disassembly of the mature
biofilm. In S. aureus, the mutation of the protease-coding genes results in a significant increase
of biofilm formation under flow conditions and the disassembly decrease when the agr system
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Phagocytosis, mainly performed by neutrophils, is a major mechanism by which the innate
immune system eliminates microorganisms invading the human body. Staphylococci in a
biofilm are not readily subjected to phagocytosis by neutrophils. The responsible elements for
this constraint are the PIA exopolysaccharide and the PGA exopolymer, and therefore they
contribute to biofilm resistance toward the host’s innate defense mechanisms.
IV. Therapeutic strategies against biofilm formation in medical devices
Medical devices are widely used for diagnostic and therapeutic treatment in most medical
specialties. Infection risk is a frequent complication linked to the permanent use of medical
devices such as orthopedic or heart prostheses, vascular catheters, urinary catheters, and
endotracheal tubes. A promising solution in order to prevent medical device-associated
infections is to develop devices possessing materials or surfaces that act against microorgan‐
ism adhesion or their viability. The first strategy was the use of biocides in coatings. A number
of clinical assays have been conducted producing conflicting results. Some authors suggest
that the extended use of biocide on the coating may lead to an increase of microbial resist‐
ance toward the microbiocide agent. The other strategy consists in the development of
materials impeding bacterial adhesion.
IV.1. Biological strategies for biofilm treatment
The chemical diversity of the biofilm matrix, including protein material, eDNA, and polysac‐
charides, is susceptible to degradation by a wide variety of exogenously added enzymes. Some
research groups have observed that proteinase K and trypsin may disperse the mature biofilm
of S. aureus and S. epidermidis [53]. Bovine DNase addition has also been successful for
dispersing the mature biofilm of S. aureus [54]. Similarly, the enzymes able to degrade PNAG
cleave biofilms containing this polysaccharide as their primary component. An enzyme called
dispersin B (DspB) inhibits biofilm formation and promotes its disassembly in several S.
epidermidis and S. aureus strains having PNAG as the main component of their respective
biofilm matrices [54]. Finally, the treatment with lysostaphin was effective in a catheter mouse
model of S. aureus biofilm [55], suggesting that it may be a general therapy against staphylo‐
coccal biofilm infections.
A current topic is the development of an antimicrobial coating interfering with quorum-
sensing mechanisms. This has been observed for halogenated furanones synthesized by the
red algae Delisea pulchra possessing anti-adhesive properties against a wide range of bacteria
[56].
IV.2. Anti-adhesive chemical strategies
IV.2.1. Hydrophobicity and surface charge
Bacterial adhesion depends on hydrophobocity of the cell and material constituting the surface.
The self-autoassembled monolayers (SAMs) can modulate the exposure of their different




es PIA expression [44]. This constitutes an important finding for biofilm physiology, as the
oxygen concentration would restrict biofilm formation at the oxygen-loaded arterial blood‐
stream. In an already established biofilm, PIA expression would be higher at the most deep
biofilm sections because oxygen concentration significantly decreases. Conversely, it has been
found that sub-inhibitory concentrations of specific antibiotics increase the transcription of the
ica operon in S. epidermidis [45].
Some overall regulators of S. aureus or S. epidermidis participate in the ica operon transcrip‐
tion regulation or PIA expression, such as the SarA DNA-binding protein and the alterna‐
tive sigma factor SigB that increase the expression of the ica operon, whereas the luxS quorum-
sensing system represses the expression of this operon [46]. Contrastingly, the agr system does
not regulate PIA. The exact mechanism explaining the influence of SarA and SigB on the ica
operon transcription is complex. Briefly, the SigB regulator represses the icaR gene transcrip‐
tion, as its protein product, IcaR, in turn, represses the transcription of the icaADBC operon
[47]. Besides, SarA regulates positively the icaA gene, independently from IcaR [48].
III.3. Regulation of the PSMs expression
It has been discussed that the agr quorum-sensing system represses the expression of surface
proteins after the primary attachment. The major agr control relies on the expression of the
PSMs. The expression of the agr system within a biofilm is limited to its periphery, in which
the agr regulator controls cell detachment from the biofilm by regulating the increased
expression of the PSM effector molecules [49]. The staphylococcal PSM δ is a major effector
molecule for cell detachment from the biofilm and it is tightly controlled by the agr system of
S. aureus [50]. In S. epidermidis, the PSM β is the most important.
III.4. Biofilm regulation against host’s defenses and antibiotics
One of the advantages possessed by bacteria in the biofilm state is high resistance toward
antibiotics and the host innate defense, such as AMPs and the phagocytosis performed by
neutrophils. However, the molecular basis of this phenomenon has been recently investigat‐
ed. Two of the main mechanisms contributing to biofilm resistance are: (1) keeping antibacte‐
rial substances from reaching their target, for example, by limited diffusion or repulsion and
(2) biofilm’s specific physiology that limits the efficiency of antibiotics, mainly those target‐
ing active cells, and it may include specific subpopulations of resistant cells (“persistent”).
Limited antibiotic diffusion provided by the biofilm is mainly due to the nature of the biofilm
matrix. However, this limited diffusion is the resistance mechanism toward some antibiotics,
such as ciprofloxacin in P. aeruginosa [51], whereas some others (e.g., rifampicin and vanco‐
mycin) are able to cleave the exopolysaccharide envelope of S. epidermidis [52]. Interestingly,
PIA has the ability to protect the cells within the biofilm from both cationic or anionic AMPs,
as it possess an overall positive or negative charge, and thus PIA interacts or repels mole‐
cules depending on its charge. Similarly, the poly-gamma-glutamic acid (PGA) exopolymer,
of S. epidermidis and a number of CNS species, contributes to the resistance toward AMPs of
either charge.
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diameter (30, 70, and 120 nm) [65]. The nanofeature’s array is also important for bacterial
adhesion and it may form large patterns having several effects on microbial adhesion. For
instance, the crest-shaped array (2 μm wide, 3 μm spacing, and different lengths) in polydi‐
methyl siloxane elastomer was bioinspired from the shark’s skin. This elastomer structure
exhibited no signs of S. aureus biofilm formation after 14 days, unlike the smooth surface, which
allowed the formation of a mature biofilm [66].
As mentioned above, the nanoscale level, size, and bacterial shape regarding nanofeature
dimensions play a significant role. Bacterial features (adhesion, surface charge) are also
important to the adhesion process. The surface of a nanostructure must be tested with several
bacterial strains, as they exhibit different adhesion behaviors. For instance, a titanium surface
nanostructured by femtosecond laser ablation and mimicking the superhydrophobic surface
of the lotus leafs was not colonized after 18 hours by P. aeruginosa, whereas S. aureus adhe‐
sion was stronger when compared to the smooth surface [67]. This result suggests that some
nanostructure surfaces may not be appropriate for medical applications in which the adhe‐
sion properties of the microorganisms are unknown.
Conversely, silver nanoparticles (AgNPs) are gaining interest for biomedical applications
because of their features having a higher surface/mass ratio and a potent antibacterial activity.
These AgNPs may be applied as monolayers at the surface of biomaterials. A study on glass
surfaces modified with AgNPs was carried out and it was found that they possess a great
stability in aqueous media, an extended Ag+ release without AgNPs detachment and a strong
anti-biofilm activity against S. epidermidis RP62A [68]. These AgNP-coated surfaces could be
applied on a great variety of biomaterials. Nevertheless, it is important to conduct more studies
to verify the anti-biofilm capacity with clinical isolates of different staphylococci species.
5. Conclusions
Staphylococcus biofilms is a virulence factor widely distributed in this genus, currently there
are many studies about this subject; however, there are still questions to be answered about
the process of biofilm formation. Some molecules involved in biofilm formation are recog‐
nized; nevertheless, the interaction between them is unknown, such as the formation of the
structural network of the biofilm, the assembly and disassembly process, and the mecha‐
nisms of intrinsic and extrinsic regulation during these events. Many molecular pieces remain
to be resolved, which allow us to fully understand the construction of a biofilm. Further‐
more, it is evident that a strain of Staphylococcus can form different types of biolfilm (PIA-
dependent or dependent protein), suggesting that staphylococcal biofilm is dynamic and
adaptable to growth conditions. In fact, biofilm dynamics can be interpreted as a mechanism
of resistance to environmental variations. The use of medical devices covered with anti-biofilm
materials represents an alternative strategy but it is not decisive. The picture is complicated
by the biological and physical characteristics of the different types of biofilm, the high genetic
diversity into the genus, and the lack of comprehensive knowledge on biofilm formation




with chemically controlled properties. SAMs with hydrophilic residues (OH, NH2) tend to
decrease bacterial adhesion when compared to those with hydrophobic surfaces containing
methyl groups (CH3) [57]. Some hydrophilic linings, such as hydrogels or medical devices with
chemically modified surfaces have been developed in order to restrict biofilm development.
Some clinical studies have reported that urinary catheters lined with heparin can reduce
Proteus mirabilis biofilm [58]. However, it has been observed that heparin may stimulate biofilm
formation by S. aureus [59]. This demonstrates that initial adhesion is not always sufficient to
avoid biofilm development. Treatment with plasma can also create hydrophilic residues at the
surface of medical devices producing antimicrobial activity.
IV.2.2. Steric barriers
The chemical modifications of the surface may also consist on grafting long-chain polymers
in order to form brush-type structures on it. The density of the chains provides a steric barrier
that repels bacterial adhesion. The most widely studied polymers are derivatives of polyethy‐
lene oxides. In fact, residues of SAMs with ethylene glycol (4EG and 3EG) have lower bacterial
adhesion in comparison to hydrophilic surfaces [57]. Polymers with ester residues (CHO2-) or
cyclic hydrocarbons (C4H-, C6H-) exhibit less bacterial attachment strength than materials
containing ethylglycol or hydroxyl group fragments [60].
IV.2.3. Anti-adhesive strategies based on topographic modifications of the surface
In the theories of bacterial adhesion, the appearance of the surface of the material was not
considered. The relief of a surface depends on the scale, that is, for bacterial adhesion, the
submicron scale is used. The reliefs are divided into: i) areas with irregular or random traits
defined as rough; ii) areas with organized features, often made by an engineering process,
defined by the term surface topography.
One study showed that adherence of S. epidermidis was similar on titanium surfaces, both rough
and smooth [61]. SEM observations showed that this strain tends to adhere to grooves and
depressions possessing dimensions similar to that of bacteria [62]. Regarding surface topog‐
raphy, it has been found that a surface constituted by titanium nanotubes is more hydrophil‐
ic than a conventional titanium surface. These properties have a biomedical application in
orthopedics by decreasing bacterial adhesion [63]. Additionally, nanotubes could be filled with
biocides in order to enhance its activity against biofilm. Superhydrophobic surfaces are being
developed with nano or micro-features in order to create bacteria-free medical devices.
IV.2.4. The influence of nanofeature physical structure on bacterial response
Nanofeatures may adopt different shapes: nanotubes, notches, channels or grooves, holes or
pillars. There are few studies regarding the relationship between nanofeatures and bacterial
adhesion. Ercan et al. compared S. aureus and S. epidermidis adhesion on commercial titani‐
um surfaces with nanotubes of 20–80 nm of diameter. A decreased bacterial adhesion was
observed for larger diameters (60 and 80 nm) [64]. However, the study conducted by Yu et al.
produced opposite results: staphylococci adhesion increased proportionally to nanotube
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to verify the anti-biofilm capacity with clinical isolates of different staphylococci species.
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the process of biofilm formation. Some molecules involved in biofilm formation are recog‐
nized; nevertheless, the interaction between them is unknown, such as the formation of the
structural network of the biofilm, the assembly and disassembly process, and the mecha‐
nisms of intrinsic and extrinsic regulation during these events. Many molecular pieces remain
to be resolved, which allow us to fully understand the construction of a biofilm. Further‐
more, it is evident that a strain of Staphylococcus can form different types of biolfilm (PIA-
dependent or dependent protein), suggesting that staphylococcal biofilm is dynamic and
adaptable to growth conditions. In fact, biofilm dynamics can be interpreted as a mechanism
of resistance to environmental variations. The use of medical devices covered with anti-biofilm
materials represents an alternative strategy but it is not decisive. The picture is complicated
by the biological and physical characteristics of the different types of biofilm, the high genetic
diversity into the genus, and the lack of comprehensive knowledge on biofilm formation
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Abstract
Salmonella spp. may form biofilm, and bacteria in biofilm are more resistant to drug,
chemical, physical and mechanical stresses, and host immune system. The progress on
biofilm research will be helpful for the development of new tools and strategies to prevent
biofilm-related disease and decontaminate biofilm-derived Salmonella in food produc‐
tion. In this review, we present a comprehensive overview of biofilm formation in
Salmonella, included that (1) the component of Salmonella biofilm, (2) the detection methods
for biofilm, (3) the identification of biofilm-formation-associated genes, (4) the regula‐
tion mechanism of biofilm formation, and (5) virulence or resistance of Salmonella in biofilm.
Keywords: Salmonella, biofilm, component, mechanism, gene, pathogenicity, drug re‐
sistance
1. Introduction
Salmonella enteric is an intracellular gram-negative pathogen that infects various hosts, which is
classified into more than 2500 serovars [1]. Many serovars, such as those most commonly
associated with human infections, including Salmonella enteritidis, Salmonella typhimurium, have
a broad host range [2]. In contrast, other serovars, such as Salmonella typhi, Salmonella paraty‐
phi, Salmonella gallinarum, Salmonella choleraesuis, Salmonella abortusovis, and Salmonella dublin,
have restricted host ranges and are associated primarily with one or a few hosts [3]. Salmonella
can cause disease in domestic animals, ranging in severity of asymptom, diarrhea and enteri‐
tis to systemic syndrome, and result in a huge economic loss in pig and poultry industry.
Salmonellosis is also a growing public health concern in both the developed and developing
countries, since nontyphoidal Salmonella disease, a major cause of diarrheal disease globally, is
estimated to cause 93 million enteric infections and 155,000 diarrheal deaths each year [4]. The
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solved in Salmonella. Cellulose is a polysaccharide composed of β(1 → 4)-linked D-glucose
units [35], which is an important exopolysaccharide normally synthesized in the Salmonella
biofilms. The production of cellulose and curli by Salmonella leads to a matrix of tightly packed
cells covered in a hydrophobic network. The operons, bcsABZD and bcsEFG, are required for
cellulose biosynthesis [36]. Cellulose biosynthesis is positively regulated by CsgD, which
stimulates the transcription of AdrA that harbours a cytoplasmic GGDEF domain. AdrA
activates cellulose production on the post-transcriptional level either by direct interaction with
bcs operons or indirect interaction with bis-3′-5′-cyclic dimeric guanosine monophosphate (c-
di-GMP) [25, 37, 38]. BapA, a large cell-surface protein required for biofilm formation, is
encoded by bapA gene and secreted through a type-I protein secretion system (bapBCD
operons) situated downstream of the bapA gene. The expression of bapA is coordinated with
that of genes encoding curli fimbriae and cellulose, through the action of csgD [26, 39]. The
bapA gene is also highly conserved in Salmonella [40]. Salmonella produces an O-antigen capsule
coregulated with the fimbria- and cellulose-associated extracellular matrix. The operons yihU-
yshA and yihVW are responsible for capsule assembly and translocation [41] and regulated
by CsgD. Although the O-antigen capsule do not appear to be important for multicellular
behavior, they play an important role in attachment and environmental persistence [14].
However, the O-antigen capsule is required for biofilm formation of Salmonella typhimurium
and Salmonella Typhi on cholesterol gallstones, and the operons are regulated in a csgD-
independent manner [42]. Extracellular DNA is shown to be a matrix component of Salmonel‐
la biofilms cultivated in flow chambers and on glass surfaces [28]. However, the presence of
extracellular DNA plays an inhibitive and destabilizing effect during biofilm development of
Salmonella on abiotic surfaces [29].
3. The detection methods for biofilm
3.1. Quantification of biofilm formation
Biofilm formation of Salmonella can be quantitated by microplate-based crystal violet stain‐
ing [43]. Briefly, the overnight broth cultures of bacterium are diluted 1:100 in the diluted
tryptic soy broth (TSB). One hundred μl of bacterial suspension is added into 96-well U-
bottomed polystyrene microtiter plates. Plates are incubated at 28°C for 24 h under static
conditions. Then, non-adherent bacteria are removed and the wells are washed gently three
times with 200 μl of distilled water. One hundred μl of 0.4% crystal violet (v/v) is added into
each well and stained for 20 min. After discard of staining liquid, all loosely adhering bacteria
and dye are gently washed off with distilled water for three times. The dye bound to the
adherent cells is solubilized with 100 μl of anhydrous ethanol per well. The optical density
(OD) is measured at 590 nm, and OD value of biofilm-formation strain is significantly higher
than that of negative control. It provides more reproducible results with an addition of a fixtion
step (80°C for 30 min) prior crystal violet staining [19]. Combined with resazurin assay, the
number of metabolically active cells is able to be evaluated [44]. With wheat germ agglutinin-
Alexa Fluor 488 conjugate, which selectively binds to N-acetylglucosamine residues in
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illnesses and outbreaks are most commonly attributed to exposure to contaminated food, and
the eggs, broiler chickens, and pigs are among the top sources [5]. Salmonella often exist not only
as planktonic cells but also as sessile, multicellular forms such as biofilms attached to surfa‐
ces. Biofilm formation is important for the spread of Salmonella because bacteria in the biofilm
are resistant to disinfectants and chemical, physical, and mechanical stresses [6–8]. The biofilm
formation is also contributed to Salmonella virulence, since bacteria in the biofilm are more
resistant to antibiotics and host immune system, resulting in a chronic infection and the
development of Salmonella carrier state [9, 10]. In our review, we present a comprehensive
overview of biofilm formation in Salmonella.
2. The component of Salmonella biofilm
The biofilm formation is a multistep developmental process that always has several distin‐
guishable steps: (a) attachment to the carrier surface, reversible, (b) irreversible attachment,
binding to the surface with the participation of adhesions or exopolysaccharides, (c) the
development of microcolonies, a distinct mushroom shape, (d) the maturation of biofilm
architecture [11, 12], (e) under favorable conditions, the synthesis of martrix compounds
decreases and the matrix is enzymatically cleaved, leading to biofilm dispersion [13]. In natural
environments, Salmonella forms biofilms on plant [14], abiotic surfaces, including plastics,
metal and glass [15–17], meat and meat-processing environments [18, 19]. In addition,
Salmonella can colonize gallstones under laboratory conditions [20], and the Salmonella biofilm
can be directly visualized by confocal micrographs of extracellular matrix on the surface of
human cholesterol gallstones [21]. They can also form biofilms on chicken intestinal epitheli‐
um [22] or HEp-2 cells that are suspended in once-flow-through continuous culture condi‐
tions [23].
The extracellular matrix of Salmonella biofilm is majorly composed of curli (amyloid fim‐
briae), cellulose [24, 25], biofilm-associated protein (Bap) [26], O-antigen capsule [14, 27],
extracellular DNA [28, 29]. The expression pattern of the biofilm is serovar specific and
correlates with contact surface [30]. Curli were first discovered in the late 1980s on Escheri‐
chia coli strains that caused bovine mastitis, and they are mainly involved in adhesion to
surfaces, cell aggregation and biofilm formation. Curli also mediate host cell adhesion and
invasion, and they are potent inducers of the host inflammatory response [12]. The curli protein
is encoded by the divergently transcribed csgBAC (agfBAC) and csgDEFG (agfDEFG) operons
[31, 32]. The csgBAC operon encodes the major structural subunit, CsgA, and the surface-
exposed nucleator protein CsgB. A third gene, csgC, is in the csgBAC operon, but no tran‐
script for csgC has been detected in curli biogenesis [32]. The other study shows that both CsgC
and CsgE facilitate extracellular thin aggregative fimbriae synthesis in Salmonella enteritidis
[33]. The csgDEFG operon encodes accessory proteins required for curli assembly. The csgD
gene encodes a transcriptional regulator belonging to the LuxR family, CsgD, for active
transcription of csgBAC promoter [24]. Although Giaouris et al. [34] found that CsgF was
expressed in biofilm growth when compared with planktonic and biofilm cells of Salmonella
enteritidis on stainless steel surface, the function of csgF and csgG genes has not been re‐
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solved in Salmonella. Cellulose is a polysaccharide composed of β(1 → 4)-linked D-glucose
units [35], which is an important exopolysaccharide normally synthesized in the Salmonella
biofilms. The production of cellulose and curli by Salmonella leads to a matrix of tightly packed
cells covered in a hydrophobic network. The operons, bcsABZD and bcsEFG, are required for
cellulose biosynthesis [36]. Cellulose biosynthesis is positively regulated by CsgD, which
stimulates the transcription of AdrA that harbours a cytoplasmic GGDEF domain. AdrA
activates cellulose production on the post-transcriptional level either by direct interaction with
bcs operons or indirect interaction with bis-3′-5′-cyclic dimeric guanosine monophosphate (c-
di-GMP) [25, 37, 38]. BapA, a large cell-surface protein required for biofilm formation, is
encoded by bapA gene and secreted through a type-I protein secretion system (bapBCD
operons) situated downstream of the bapA gene. The expression of bapA is coordinated with
that of genes encoding curli fimbriae and cellulose, through the action of csgD [26, 39]. The
bapA gene is also highly conserved in Salmonella [40]. Salmonella produces an O-antigen capsule
coregulated with the fimbria- and cellulose-associated extracellular matrix. The operons yihU-
yshA and yihVW are responsible for capsule assembly and translocation [41] and regulated
by CsgD. Although the O-antigen capsule do not appear to be important for multicellular
behavior, they play an important role in attachment and environmental persistence [14].
However, the O-antigen capsule is required for biofilm formation of Salmonella typhimurium
and Salmonella Typhi on cholesterol gallstones, and the operons are regulated in a csgD-
independent manner [42]. Extracellular DNA is shown to be a matrix component of Salmonel‐
la biofilms cultivated in flow chambers and on glass surfaces [28]. However, the presence of
extracellular DNA plays an inhibitive and destabilizing effect during biofilm development of
Salmonella on abiotic surfaces [29].
3. The detection methods for biofilm
3.1. Quantification of biofilm formation
Biofilm formation of Salmonella can be quantitated by microplate-based crystal violet stain‐
ing [43]. Briefly, the overnight broth cultures of bacterium are diluted 1:100 in the diluted
tryptic soy broth (TSB). One hundred μl of bacterial suspension is added into 96-well U-
bottomed polystyrene microtiter plates. Plates are incubated at 28°C for 24 h under static
conditions. Then, non-adherent bacteria are removed and the wells are washed gently three
times with 200 μl of distilled water. One hundred μl of 0.4% crystal violet (v/v) is added into
each well and stained for 20 min. After discard of staining liquid, all loosely adhering bacteria
and dye are gently washed off with distilled water for three times. The dye bound to the
adherent cells is solubilized with 100 μl of anhydrous ethanol per well. The optical density
(OD) is measured at 590 nm, and OD value of biofilm-formation strain is significantly higher
than that of negative control. It provides more reproducible results with an addition of a fixtion
step (80°C for 30 min) prior crystal violet staining [19]. Combined with resazurin assay, the
number of metabolically active cells is able to be evaluated [44]. With wheat germ agglutinin-
Alexa Fluor 488 conjugate, which selectively binds to N-acetylglucosamine residues in
Biofilm Formation of Salmonella
http://dx.doi.org/10.5772/62905
233
illnesses and outbreaks are most commonly attributed to exposure to contaminated food, and
the eggs, broiler chickens, and pigs are among the top sources [5]. Salmonella often exist not only
as planktonic cells but also as sessile, multicellular forms such as biofilms attached to surfa‐
ces. Biofilm formation is important for the spread of Salmonella because bacteria in the biofilm
are resistant to disinfectants and chemical, physical, and mechanical stresses [6–8]. The biofilm
formation is also contributed to Salmonella virulence, since bacteria in the biofilm are more
resistant to antibiotics and host immune system, resulting in a chronic infection and the
development of Salmonella carrier state [9, 10]. In our review, we present a comprehensive
overview of biofilm formation in Salmonella.
2. The component of Salmonella biofilm
The biofilm formation is a multistep developmental process that always has several distin‐
guishable steps: (a) attachment to the carrier surface, reversible, (b) irreversible attachment,
binding to the surface with the participation of adhesions or exopolysaccharides, (c) the
development of microcolonies, a distinct mushroom shape, (d) the maturation of biofilm
architecture [11, 12], (e) under favorable conditions, the synthesis of martrix compounds
decreases and the matrix is enzymatically cleaved, leading to biofilm dispersion [13]. In natural
environments, Salmonella forms biofilms on plant [14], abiotic surfaces, including plastics,
metal and glass [15–17], meat and meat-processing environments [18, 19]. In addition,
Salmonella can colonize gallstones under laboratory conditions [20], and the Salmonella biofilm
can be directly visualized by confocal micrographs of extracellular matrix on the surface of
human cholesterol gallstones [21]. They can also form biofilms on chicken intestinal epitheli‐
um [22] or HEp-2 cells that are suspended in once-flow-through continuous culture condi‐
tions [23].
The extracellular matrix of Salmonella biofilm is majorly composed of curli (amyloid fim‐
briae), cellulose [24, 25], biofilm-associated protein (Bap) [26], O-antigen capsule [14, 27],
extracellular DNA [28, 29]. The expression pattern of the biofilm is serovar specific and
correlates with contact surface [30]. Curli were first discovered in the late 1980s on Escheri‐
chia coli strains that caused bovine mastitis, and they are mainly involved in adhesion to
surfaces, cell aggregation and biofilm formation. Curli also mediate host cell adhesion and
invasion, and they are potent inducers of the host inflammatory response [12]. The curli protein
is encoded by the divergently transcribed csgBAC (agfBAC) and csgDEFG (agfDEFG) operons
[31, 32]. The csgBAC operon encodes the major structural subunit, CsgA, and the surface-
exposed nucleator protein CsgB. A third gene, csgC, is in the csgBAC operon, but no tran‐
script for csgC has been detected in curli biogenesis [32]. The other study shows that both CsgC
and CsgE facilitate extracellular thin aggregative fimbriae synthesis in Salmonella enteritidis
[33]. The csgDEFG operon encodes accessory proteins required for curli assembly. The csgD
gene encodes a transcriptional regulator belonging to the LuxR family, CsgD, for active
transcription of csgBAC promoter [24]. Although Giaouris et al. [34] found that CsgF was
expressed in biofilm growth when compared with planktonic and biofilm cells of Salmonella
enteritidis on stainless steel surface, the function of csgF and csgG genes has not been re‐
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smooth, brown, and mucoid, indicating a lack of cellulose synthesis but overproduced capsular
polysaccharide (SBAM), and (e) smooth and white, indicating a lack of both curli and cellulose
production (SAW) [19, 31, 50].
3.6. Confocal laser microscopy
Bacteria cultured on coverslipes, dish, or microplate are stained by 0.1 M phosphate-buf‐
fered saline (pH 7.2) containing SYTO 9 and propidium iodide. After 10 min incubation in the
dark at room temperature, stained samples are examined using a confocal scanning laser
microscopy. Fluorochromes are excited using an argon laser source at 488 nm. Images are
collected in two channels, 490–515 and 620–640 nm, corresponding to the emission maxima
for SYTO 9 and propidium iodide, respectively. Optical sections approximately 1 μm in height
are collected starting from below the focal plane to upward through the entire biofilm. The
biofilm cells are clearly observed in a multilayer community [20, 51].
4. Identification of biofilm-formation–associated genes
The most common biofilm-formation–associated genes are the genes encode adhesins. The
best characterized of the Salmonella fimbriae is type-1 fimbriae. This fimbrial type is encoded
by the fim gene cluster and is assembled by the chaperone–usher system [52]. The fimA gene
encodes the major structural subunit, while the fimH gene encodes the adhesin protein that is
located at the tip of the assembled fimbrial structure and mediates binding to the receptor. The
FimH adhesin is involved in biofilm formation on HEp-2 tissue culture cells, murine intesti‐
nal epithelium, and chicken intestinal epithelium [22, 23]. The long polar fimbriae (Lpf) are
encoded by the lpfABCDE genes and have been implicated in the colonization of the murine
intestinal mucosa [53, 54]. Plasmid-encoded fimbriae (Pef) are encoded on the 90-kb Salmonel‐
la virulence plasmid and are majorly encoded by pefBCD, orf5, and orf6 genes. Both Lpf and
Pef contribute to the early steps of biofilm formation [55]. Salmonella enteritidis produce a
variety of potentially adherent fimbrial types including SEF14 (SefA), SEF17 (CsgA), SEF18
(SefD), and SEF21 (type I, FimA), the role of each fimbrial in biofilm formation is different. The
SEF17 encoded by csgA gene stabilize cell–cell interactions during biofilm formation, while
SEF21 fimbriae may involve cell surface adherence [56]. SadA is trimeric autotransporter
adhesin of Salmonella typhimurium, the expression of SadA resulted in cell aggregation, biofilm
formation, and increased adhesion to human intestinal Caco-2 epithelial cells [57]. Salmonella
may persist on post-harvest lettuce during cold storage, the genes stfC, bcsA, misL, and yidR,
encoding a fimbrial outer membrane usher, a cellulose synthase catalytic subunit, an adhe‐
sin of the autotransporter family expressed from the Salmonella pathogenicity island-3, and a
putative ATP-/GTP-binding protein, respectively, have a role in persistence of the pathogen.
The bcsA, misL, and yidR knockout mutants are impaired in attachment and biofilm forma‐
tion, suggesting that these functions are required for biofilm formation [58].
Salmonella flagella are not required for the formation of the multicellular morphotype on plates.
However, the global behavior of the bacterial community on air–liquid, surface–liquid, or cell–
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biofilms, the spectrofluorometric assay provides a more sensitive method for quantification
and characterization of bacterial biofilms [45].
3.2. Biofilm formation in glass tube
The overnight cultures of bacteria are diluted 1:100 in the diluted TSB. Two milliliters of each
bacterial suspension are added into borosilicate glass tubes and incubated at 28°C for 48 h.
Then, the liquid is decanted and the tubes are washed gently three times with distilled water.
Two ml of 0.4% crystal violet (v/v) are added into each tube and stained at room tempera‐
ture for 20 min. The stained biofilm is observed at the liquid–air interface on the glass test tube
walls or at the bottom of the tube [46]. The glass tubes may also be incubated at 37°C at
200 rpm by using an orbital shaker, and biofilm is observed at interphase without staining [47].
3.3. Congo red/carbol fuchsin staining
The overnight culture (1:100 diluted in TSB) is inoculated into 3 ml of fresh TSB in a 6-well
plate containing sterile polystyrene coverslip (20 × 20 mm). After incubation at 28°C for 24
or 48 h without agitation, the coverslips are removed carefully, treated with cetylpyridinium
chloride (10 mM) for 30 s, rinsed with distilled water and air dried for 20–30 min. After fixation
by gentle heating, the coverslips are stained with a mixture of saturated aqueous Congo red
solution and 10% Tween-80 (2:1, V/V) for 30 min and rinsed with distilled water. After staining
with 10% (v/v) Ziehl carbol fuchsin for 6 min and rinsing in distilled water, the coverslips are
air dried and mounted on slides [48]. Under a light microscope, bacterial cells on slides show
purple staining, while the exopolysaccharides of biofilm show pink staining [46].
3.4. Field emission scanning electron microscopy
The coverslips with cultured bacteria are fixed in 3% glutaraldehyde in 0.1 M phosphate-
buffered saline at 4°C for 2 h. The samples are then dehydrated with increasing concentra‐
tions of ethanol (50, 70, 80, 90, and 100%) followed by isoamyl acetate (100%), each for 15 min.
The samples are critical point dried for 5 h, coated with gold palladium alloy, and observed
under a field emission scanning electron microscope [49]. The biofilm-formation strain exhibits
increased clusters of bacteria cells with curli fimbriae and has meshwork-like structures
surrounding the cell surfaces.
3.5. Congo red and calcofluor plates
LB agar plate without salt supplemented with 40 mg/L Congo red and 20 mg/L brilliant blue
is used to determine the Congo red-binding property of the colonies. LB agar plate supple‐
mented with 200 mg/L calcofluor (fluorescent brightener) is used to determine the cellulose
production by comparing the fluorescence of the test strains under UV light [49]. Biofilm of
Salmonella is mainly composed of curli and cellulose, and Salmonella strains were grouped into
distinct morphotypes according to Congo red binding: (a) red, dry, and rough indicating curli
and cellulose production (RDAR), (b) brown, dry, and rough, indicating a lack of cellulose
synthesis (BDAR), (c) pink, dry, and rough, indicating a defect in curli expression (PDAR), (d)
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smooth, brown, and mucoid, indicating a lack of cellulose synthesis but overproduced capsular
polysaccharide (SBAM), and (e) smooth and white, indicating a lack of both curli and cellulose
production (SAW) [19, 31, 50].
3.6. Confocal laser microscopy
Bacteria cultured on coverslipes, dish, or microplate are stained by 0.1 M phosphate-buf‐
fered saline (pH 7.2) containing SYTO 9 and propidium iodide. After 10 min incubation in the
dark at room temperature, stained samples are examined using a confocal scanning laser
microscopy. Fluorochromes are excited using an argon laser source at 488 nm. Images are
collected in two channels, 490–515 and 620–640 nm, corresponding to the emission maxima
for SYTO 9 and propidium iodide, respectively. Optical sections approximately 1 μm in height
are collected starting from below the focal plane to upward through the entire biofilm. The
biofilm cells are clearly observed in a multilayer community [20, 51].
4. Identification of biofilm-formation–associated genes
The most common biofilm-formation–associated genes are the genes encode adhesins. The
best characterized of the Salmonella fimbriae is type-1 fimbriae. This fimbrial type is encoded
by the fim gene cluster and is assembled by the chaperone–usher system [52]. The fimA gene
encodes the major structural subunit, while the fimH gene encodes the adhesin protein that is
located at the tip of the assembled fimbrial structure and mediates binding to the receptor. The
FimH adhesin is involved in biofilm formation on HEp-2 tissue culture cells, murine intesti‐
nal epithelium, and chicken intestinal epithelium [22, 23]. The long polar fimbriae (Lpf) are
encoded by the lpfABCDE genes and have been implicated in the colonization of the murine
intestinal mucosa [53, 54]. Plasmid-encoded fimbriae (Pef) are encoded on the 90-kb Salmonel‐
la virulence plasmid and are majorly encoded by pefBCD, orf5, and orf6 genes. Both Lpf and
Pef contribute to the early steps of biofilm formation [55]. Salmonella enteritidis produce a
variety of potentially adherent fimbrial types including SEF14 (SefA), SEF17 (CsgA), SEF18
(SefD), and SEF21 (type I, FimA), the role of each fimbrial in biofilm formation is different. The
SEF17 encoded by csgA gene stabilize cell–cell interactions during biofilm formation, while
SEF21 fimbriae may involve cell surface adherence [56]. SadA is trimeric autotransporter
adhesin of Salmonella typhimurium, the expression of SadA resulted in cell aggregation, biofilm
formation, and increased adhesion to human intestinal Caco-2 epithelial cells [57]. Salmonella
may persist on post-harvest lettuce during cold storage, the genes stfC, bcsA, misL, and yidR,
encoding a fimbrial outer membrane usher, a cellulose synthase catalytic subunit, an adhe‐
sin of the autotransporter family expressed from the Salmonella pathogenicity island-3, and a
putative ATP-/GTP-binding protein, respectively, have a role in persistence of the pathogen.
The bcsA, misL, and yidR knockout mutants are impaired in attachment and biofilm forma‐
tion, suggesting that these functions are required for biofilm formation [58].
Salmonella flagella are not required for the formation of the multicellular morphotype on plates.
However, the global behavior of the bacterial community on air–liquid, surface–liquid, or cell–
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biofilms, the spectrofluorometric assay provides a more sensitive method for quantification
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3.2. Biofilm formation in glass tube
The overnight cultures of bacteria are diluted 1:100 in the diluted TSB. Two milliliters of each
bacterial suspension are added into borosilicate glass tubes and incubated at 28°C for 48 h.
Then, the liquid is decanted and the tubes are washed gently three times with distilled water.
Two ml of 0.4% crystal violet (v/v) are added into each tube and stained at room tempera‐
ture for 20 min. The stained biofilm is observed at the liquid–air interface on the glass test tube
walls or at the bottom of the tube [46]. The glass tubes may also be incubated at 37°C at
200 rpm by using an orbital shaker, and biofilm is observed at interphase without staining [47].
3.3. Congo red/carbol fuchsin staining
The overnight culture (1:100 diluted in TSB) is inoculated into 3 ml of fresh TSB in a 6-well
plate containing sterile polystyrene coverslip (20 × 20 mm). After incubation at 28°C for 24
or 48 h without agitation, the coverslips are removed carefully, treated with cetylpyridinium
chloride (10 mM) for 30 s, rinsed with distilled water and air dried for 20–30 min. After fixation
by gentle heating, the coverslips are stained with a mixture of saturated aqueous Congo red
solution and 10% Tween-80 (2:1, V/V) for 30 min and rinsed with distilled water. After staining
with 10% (v/v) Ziehl carbol fuchsin for 6 min and rinsing in distilled water, the coverslips are
air dried and mounted on slides [48]. Under a light microscope, bacterial cells on slides show
purple staining, while the exopolysaccharides of biofilm show pink staining [46].
3.4. Field emission scanning electron microscopy
The coverslips with cultured bacteria are fixed in 3% glutaraldehyde in 0.1 M phosphate-
buffered saline at 4°C for 2 h. The samples are then dehydrated with increasing concentra‐
tions of ethanol (50, 70, 80, 90, and 100%) followed by isoamyl acetate (100%), each for 15 min.
The samples are critical point dried for 5 h, coated with gold palladium alloy, and observed
under a field emission scanning electron microscope [49]. The biofilm-formation strain exhibits
increased clusters of bacteria cells with curli fimbriae and has meshwork-like structures
surrounding the cell surfaces.
3.5. Congo red and calcofluor plates
LB agar plate without salt supplemented with 40 mg/L Congo red and 20 mg/L brilliant blue
is used to determine the Congo red-binding property of the colonies. LB agar plate supple‐
mented with 200 mg/L calcofluor (fluorescent brightener) is used to determine the cellulose
production by comparing the fluorescence of the test strains under UV light [49]. Biofilm of
Salmonella is mainly composed of curli and cellulose, and Salmonella strains were grouped into
distinct morphotypes according to Congo red binding: (a) red, dry, and rough indicating curli
and cellulose production (RDAR), (b) brown, dry, and rough, indicating a lack of cellulose
synthesis (BDAR), (c) pink, dry, and rough, indicating a defect in curli expression (PDAR), (d)
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ompR mutant showed a complete loss of production of curli and biofilm formation. The other
mutants showed a modified production of curli and cellulose with less effect related to biofilm
formation [68]. Therefore, an integral LPS, at both the O-antigen and core polysaccharide
levels, are important in the modulation of curli protein and cellulose production, as well as in
biofilm formation.
5. Regulation mechanism of biofilm formation
Biofilm formation is majorly regulated by CsgD protein, a regulator belonging to the LuxR
family [69]. CsgD has an N-terminal receiver domain with a conserved aspartate (D59) as a
putative target site for phosphorylation and a C-terminal LuxR-like helix-turn-helix DNA
binding motif. The unphosphorylated CsgD directly binds the csgBA and adrA promoter
regions to activate transcription [70]. Multiple factors bind to the promoter sequence of csgD
and regulate its transcription, such as OmpR, RpoS, RpoE, integration host factor (IHF),
histone-like nucleoid structuring protein (H-NS), and MlrA. OmpR is one of first discovered
to be required for csgD transcription [71]. Six binding sites (D1–D6) for OmpR are identified
in csgD promoter regions. Binding of OmpR-P to D2 centered immediately upstream of D1 is
proposed to repress promoter activity. IHF competes with OmpR-P for binding at its up‐
stream site IHF1, which overlaps with D3–D6 and thereby activate the transcription of csgD
[72]. The mutant of ompR in Salmonella enteritidis and Salmonella pullorum has inability to
produce cellulose, curli, and biofilm [68, 73]. RpoS, encodes an alternative sigma factor of RNA
polymerase, is critical for bacterial endurance under the most-stressful conditions, including
stationary-phase entrance and host adaptation. RpoS is required for transcriptional activa‐
tion of the csgD promoter in Salmonella typhimurium strains that rdar morphotype are normal‐
ly expressed at low temperature [31]. However, in two Salmonella typhimurium strains,
spontaneous mutants are found forming rdar colonies independent of temperature, the
regulation of csgD is independent of rpoS [71]. Partially independent of rpoS for regulation of
csgD is observed in Salmonella enteritidis. The rpoS mutant in Salmonella pullorum also shows
similar biofilm forming ability as the wild-type strain [68], suggests that another sigma factor
may recognize the csgD promoter. RpoE is an another regulator in the expression of thin
aggregative fimbriae in Salmonella [74], since the rpoE deletion mutant shows significantly
reduced amounts of csgD expression and modulated biofilm formation. Compared the
expression of six different Sigma factors during biofilm formation in a rpoS-independent
biofilm-formation strain, the expression of rpoE gene was the highest, and the rpoE mutant
could not produce biofilm [75]. Therefore, RpoE acts as a regulator for csgD expression. IHF
is a histone-like heterodimeric protein composed of two homologous subunits. IHF interacts
with a define DNA sequence that has a supportive A-tract upstream of the consensus sequence
by binding to the minor groove of the DNA. The ihf mutants show altered and reduced biofilm
morphotypes on Congo Red agar plates [72]. H-NS prefers to bind AT-rich sites in the
intergenic csgBAC and csgDEFG regions and causes moderate activation of csgD promoter. The
inactivation of hns gene result in reduced expression of the rdar morphotype on agar plate [72].
MlrA (MerR-like regulator) acts directly or indirectly on the csgD promoter, the mlrA mu‐
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liquid interfaces is changed in the absence of flagella. In a mutant lacking flagella and thin
aggregative fimbriae, the contribution of the latter to the multicellular morphotype is
dominant [59]. Biofilm formation of an flgK mutant in meat and poultry broths and their
attachment on surfaces of stainless steel and glass are significantly reduced compared with
that of the wild-type strain, suggest that expression of flagella could be involved in biofilm
formation and attachment of Salmonella on contact surfaces [60]. The presence of the flagellar
filament enhances binding and biofilm formation in the presence of bile, while flagellar
motility and expression of type-1 fimbriae were unimportant in biofilm formation on choles‐
terol gallstones [61].
Pathogenicity islands accommodate large clusters of genes that contribute to a particular
virulence phenotype. Salmonella possess at least seven salmonella pathogenicity islands (SPIs).
Among these, SPI1 is primarily required for bacterial motility and invasion of host cells.
Salmonella typhimurium cultures containing cloned SPI-1 display an adherent biofilm and cell
clumps in the media. This phenotype was associated with hyper-expression of SPI-1 type-III
secretion functions. Surprisingly, mutations in genes essential for known bacterial biofilm
pathways (bcsA, csgBA, bapA) did not affect the biofilms formation, indicating that this
phenomenon is independent of established biofilm mechanisms [62]. Salmonella biofilm cells
exposed to superheated steam show decreased transcription of flagella and SPI-1 genes,
respectively, whereas increased transcription of SPI-2 genes, important for bacterial survival
and replication inside host cells, is detected [63]. In contrast, when compared biofilms of
Salmonella typhimurium with planktonic cells, the most highly downregulated genes in the
biofilm are located on SPI-2 and that a functional SPI2 secretion system regulator (ssrA) is
required for Salmonella typhimurium biofilm formation. Genes involved in tryptophan (trp)
biosynthesis and transport are upregulated in the biofilm. Deletion of trpE results in de‐
creased bacterial attachment and biofilm formation, indicating that aromatic amino acids make
an important contribution to biofilm formation [64]. The aro mutants of Salmonella are
frequently used as live vaccines for the oral vaccination of domestic animals, and they are
unable to synthesize chorismate, which is a key intermediate in the synthesis of aromatic amino
acids. The aro mutants exhibit a decreased production of cellulose, N-acetyl-D-glucosamine,
or N-acetylneuraminic acid-containing capsular polysaccharide and fimbriae, which ex‐
plains their inability to form biofilms [65].
Lipopolysaccharide (LPS) synthesis also involves the biofilm formation of Salmonella. Two Tn5
insertion mutations in genes that are involved in ddhC and waaG result in diminished
expression of colony rugosity. Both mutants have impaired biofilm formation when grown in
rich medium with low osmolarity, they constitutively form larger amounts of biofilms when
the growth medium was supplemented with either glucose or a combination of glucose and
NaCl [49]. The rfbA gene also involve in lipopolysaccharide biosynthesis. Biofilm formation
by the rfbA mutant in meat and poultry broths and their attachment on surfaces of stainless
steel and glass is significantly reduced [60]. Using transposon mutagenesis, the genes metE,
ompR, rpoS, rfaG, rfaJ, rfaK, rfaP, rfbH, rhlE, spiA, and steB are found to be associated with biofilm
formation of Salmonella enteritidis [66, 67]. When eight mutants with knockout of genes ompR,
rpoS, rfaG, rfbH, rhlE, metE, spiA, or steB from the Salmonella pullorum are constructed. Only the
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ompR mutant showed a complete loss of production of curli and biofilm formation. The other
mutants showed a modified production of curli and cellulose with less effect related to biofilm
formation [68]. Therefore, an integral LPS, at both the O-antigen and core polysaccharide
levels, are important in the modulation of curli protein and cellulose production, as well as in
biofilm formation.
5. Regulation mechanism of biofilm formation
Biofilm formation is majorly regulated by CsgD protein, a regulator belonging to the LuxR
family [69]. CsgD has an N-terminal receiver domain with a conserved aspartate (D59) as a
putative target site for phosphorylation and a C-terminal LuxR-like helix-turn-helix DNA
binding motif. The unphosphorylated CsgD directly binds the csgBA and adrA promoter
regions to activate transcription [70]. Multiple factors bind to the promoter sequence of csgD
and regulate its transcription, such as OmpR, RpoS, RpoE, integration host factor (IHF),
histone-like nucleoid structuring protein (H-NS), and MlrA. OmpR is one of first discovered
to be required for csgD transcription [71]. Six binding sites (D1–D6) for OmpR are identified
in csgD promoter regions. Binding of OmpR-P to D2 centered immediately upstream of D1 is
proposed to repress promoter activity. IHF competes with OmpR-P for binding at its up‐
stream site IHF1, which overlaps with D3–D6 and thereby activate the transcription of csgD
[72]. The mutant of ompR in Salmonella enteritidis and Salmonella pullorum has inability to
produce cellulose, curli, and biofilm [68, 73]. RpoS, encodes an alternative sigma factor of RNA
polymerase, is critical for bacterial endurance under the most-stressful conditions, including
stationary-phase entrance and host adaptation. RpoS is required for transcriptional activa‐
tion of the csgD promoter in Salmonella typhimurium strains that rdar morphotype are normal‐
ly expressed at low temperature [31]. However, in two Salmonella typhimurium strains,
spontaneous mutants are found forming rdar colonies independent of temperature, the
regulation of csgD is independent of rpoS [71]. Partially independent of rpoS for regulation of
csgD is observed in Salmonella enteritidis. The rpoS mutant in Salmonella pullorum also shows
similar biofilm forming ability as the wild-type strain [68], suggests that another sigma factor
may recognize the csgD promoter. RpoE is an another regulator in the expression of thin
aggregative fimbriae in Salmonella [74], since the rpoE deletion mutant shows significantly
reduced amounts of csgD expression and modulated biofilm formation. Compared the
expression of six different Sigma factors during biofilm formation in a rpoS-independent
biofilm-formation strain, the expression of rpoE gene was the highest, and the rpoE mutant
could not produce biofilm [75]. Therefore, RpoE acts as a regulator for csgD expression. IHF
is a histone-like heterodimeric protein composed of two homologous subunits. IHF interacts
with a define DNA sequence that has a supportive A-tract upstream of the consensus sequence
by binding to the minor groove of the DNA. The ihf mutants show altered and reduced biofilm
morphotypes on Congo Red agar plates [72]. H-NS prefers to bind AT-rich sites in the
intergenic csgBAC and csgDEFG regions and causes moderate activation of csgD promoter. The
inactivation of hns gene result in reduced expression of the rdar morphotype on agar plate [72].
MlrA (MerR-like regulator) acts directly or indirectly on the csgD promoter, the mlrA mu‐
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liquid interfaces is changed in the absence of flagella. In a mutant lacking flagella and thin
aggregative fimbriae, the contribution of the latter to the multicellular morphotype is
dominant [59]. Biofilm formation of an flgK mutant in meat and poultry broths and their
attachment on surfaces of stainless steel and glass are significantly reduced compared with
that of the wild-type strain, suggest that expression of flagella could be involved in biofilm
formation and attachment of Salmonella on contact surfaces [60]. The presence of the flagellar
filament enhances binding and biofilm formation in the presence of bile, while flagellar
motility and expression of type-1 fimbriae were unimportant in biofilm formation on choles‐
terol gallstones [61].
Pathogenicity islands accommodate large clusters of genes that contribute to a particular
virulence phenotype. Salmonella possess at least seven salmonella pathogenicity islands (SPIs).
Among these, SPI1 is primarily required for bacterial motility and invasion of host cells.
Salmonella typhimurium cultures containing cloned SPI-1 display an adherent biofilm and cell
clumps in the media. This phenotype was associated with hyper-expression of SPI-1 type-III
secretion functions. Surprisingly, mutations in genes essential for known bacterial biofilm
pathways (bcsA, csgBA, bapA) did not affect the biofilms formation, indicating that this
phenomenon is independent of established biofilm mechanisms [62]. Salmonella biofilm cells
exposed to superheated steam show decreased transcription of flagella and SPI-1 genes,
respectively, whereas increased transcription of SPI-2 genes, important for bacterial survival
and replication inside host cells, is detected [63]. In contrast, when compared biofilms of
Salmonella typhimurium with planktonic cells, the most highly downregulated genes in the
biofilm are located on SPI-2 and that a functional SPI2 secretion system regulator (ssrA) is
required for Salmonella typhimurium biofilm formation. Genes involved in tryptophan (trp)
biosynthesis and transport are upregulated in the biofilm. Deletion of trpE results in de‐
creased bacterial attachment and biofilm formation, indicating that aromatic amino acids make
an important contribution to biofilm formation [64]. The aro mutants of Salmonella are
frequently used as live vaccines for the oral vaccination of domestic animals, and they are
unable to synthesize chorismate, which is a key intermediate in the synthesis of aromatic amino
acids. The aro mutants exhibit a decreased production of cellulose, N-acetyl-D-glucosamine,
or N-acetylneuraminic acid-containing capsular polysaccharide and fimbriae, which ex‐
plains their inability to form biofilms [65].
Lipopolysaccharide (LPS) synthesis also involves the biofilm formation of Salmonella. Two Tn5
insertion mutations in genes that are involved in ddhC and waaG result in diminished
expression of colony rugosity. Both mutants have impaired biofilm formation when grown in
rich medium with low osmolarity, they constitutively form larger amounts of biofilms when
the growth medium was supplemented with either glucose or a combination of glucose and
NaCl [49]. The rfbA gene also involve in lipopolysaccharide biosynthesis. Biofilm formation
by the rfbA mutant in meat and poultry broths and their attachment on surfaces of stainless
steel and glass is significantly reduced [60]. Using transposon mutagenesis, the genes metE,
ompR, rpoS, rfaG, rfaJ, rfaK, rfaP, rfbH, rhlE, spiA, and steB are found to be associated with biofilm
formation of Salmonella enteritidis [66, 67]. When eight mutants with knockout of genes ompR,
rpoS, rfaG, rfbH, rhlE, metE, spiA, or steB from the Salmonella pullorum are constructed. Only the
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due to the repression of CsgD expression, through a mechanism dependent on the accumula‐
tion of the sRNA RprA [86].
Many gram-negative bacteria utilize N-acyl-L-homoserine lactones (AHLs) to bind to
transcriptional regulators leading to activation or repression of target genes. Salmonella do not
synthesize AHLs but do contain the AHL receptor, SdiA. The Salmonella sdiA gene regulates
the rck gene, which mediates its adhesion and invasion of epithelial cells and the resistance of
the organism to complement [87]. The rck gene is located on the virulence plasmid of pRST98,
AHLs increase rck expression in pRST98-carrying strains, thereby enhancing bacterial
adherence, serum resistance, and bacterial biofilm formation [88].
6. Virulence or resistance for biofilm
Biofilm formation may involve in the virulence of Salmonella. Salmonella enteritidis stains
isolated from either the environment, dairy products, or infected patients are divided into two
groups on the basis of their virulence (50% lethal dose) in chickens infected intraperitoneally.
Only the virulent strains produce aggregates and formed visible filaments attached to the glass
tube [47]. Further study confirms that the virulence of the biofilm-producing strain in infected
chickens increases proportionally to the amount of stored glycogen, suggesting a possible role
of the glycogen depot in the virulence of Salmonella enteritidis [89]. When tested for infection
in Caco-2 cells and HEp-2 cells, the more virulent strains of Salmonella enteritidis, which are
biofilm producers in adherence test medium, are able to disrupt monolayers. In contrast, the
low-virulence strains of Salmonella enteritidis, which do not produce biofilms in adherence test
medium, have no effect on the same cells. The high-virulence Salmonella enteritidis strains
incubated under optimum biofilm-forming conditions may release a soluble factor, which
enables the disruption of the integrity of Caco-2 monolayers [90]. The relationship between
biofilm-forming ability and the pathogenicity is also evaluated in Salmonella pullorum.
Although the virulence of Salmonella pullorum strains is independent of their ability of biofilm
formation, prior growth as a biofilm for a biofilm producer of Salmonella pullorum leads to
enhanced virulence in chickens, suggested that biofilm formation may be one of important
virulence factor for Salmonella pullorum infection [46].
The csgBAC operon is required for curli biosynthesis in Salmonella. The csgA mutation is not
reduced in ability to attach or colonize alfalfa sprouts, whereas the csgB mutation is reduced.
Thus, csgB alone can play a role in attachment of Salmonella to plant tissue [91]. Competitive
infection experiments in mice shows that csgA mutant cells outcompeted rdar-positive wild-
type cells, indicating that aggregation via the rdar morphotype is not a virulence adaptation
in Salmonella typhimurium. Furthermore, in vivo imaging experiments show that thin aggre‐
gative fimbriae genes are not expressed during infection but are expressed once Salmonella was
passed out of the mice into the feces [92]. However, Salmonella typhimurium strains isolated
from water buffalo calves affected by lethal gastroenteritis are tested in vivo in a mouse model
of mixed infection. The most pathogenic strain is characterized by a high number of viru‐
lence factors and the presence of the locus csgA, coding for a thin aggregative fimbria [93].
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tants of Salmonella typhimurium no longer produce curli or rugose colony morphology.
However, inactivation of mlrA did not affect curli production and aggregative morphology in
an upregulated curli producing Salmonella typhimurium derivative containing a temperature-
and RpoS-independent csgD promoter region. Therefore, MlrA acts as a positive regulator of
RpoS-dependent curli and extracellular matrix production by Salmonella typhimurium [76].
c-di-GMP is recognized as a ubiquitous bacterial second messenger and a key regulator in
bacterial transition from a motile and planktonic to a sessile and biofilm lifestyle. High
intracellular c-di-GMP levels promote extracellular matrix production and subsequent biofilm
formation and repress motility, whereas low intracellular c-di-GMP levels suppress matrix
production and promote single-cell motility [77]. The synthesis/degradation of c-di-GMP
depends on diguanylate cyclase/phosphodiesterase enzymatic activities. The cyclase activity,
which converts two molecules of GTP to c-di-GMP, is encoded in the GGDEF protein domain,
while phosphodiesterase activity, which hydrolyzes c-di-GMP to linear 5′-pGpG or two GMP
molecules, is encoded in the EAL and HD-GYP domains. For example, Adar, containing a
GGDEF domain, encodes diguanylate cyclase synthesizing c-di-GMP, is required for cellu‐
lose production and biofilm formation. In another seven GGDEF family (GcpA-G), only GcpA
and GcpE are critical for biofilm formation [37]. The EAL domain protein STM4264, STM3611,
and the GGDEF-EAL domain protein STM1703 play a determinative role in the expression
level of multicellular behavior of Salmonella typhimurium [78, 79]. In contradiction, the EAL-
like protein STM1697, neither degrade nor bind c-di-GMP, promotes biofilm formation and
CsgD expression through interaction with proteins that regulate flagella function [80]. High
intracellular amounts of c-di-GMP in Salmonella typhimurium inhibited invasion and abolish‐
ed induction of a pro-inflammatory immune response in the colonic epithelial cell line HT-29.
Inhibition of the invasion and IL-8 induction phenotype by c-di-GMP requires the major
biofilm activator CsgD and/or BcsA. Therefore, c-di-GMP signaling is at least equally impor‐
tant in the regulation of Salmonella–host interaction as in the regulation of biofilm formation
at ambient temperature [81].
CsgD synthesis is also regulated at the post-transcriptional level by sRNA. sRNAs have
emerged as a diverse group of trans- or cis-encoded regulatory molecules of approximately
50–250 nt in size. The RNA chaperone Hfq protects sRNAs form degradation and facilitates
their binding to the target mRNAs. All these sRNA may negatively regulate csgD gene
expression by binding to the overlapping 5′-region of the transcript, masking the ribosome
binding site, resulting in the inhibition of translation or the degradation of mRNA [82]. In
Escherichia coli, sRNAs, OmrA/B, McaS, RprA, and GcvB are identified, which downregulate
CsgD translation [83]. In E. coli and Salmonella, RydC’s 5′-domain interacts with csgD mRNA
translation initiation signals to prevent initiation, stimulation of RydC expression reduces
biofilm formation by impairing curli synthesis [84]. Surprisingly, two Hfq-dependent sRNAs
(ArcZ and SdsR) are responsible for positively regulation of rdar morphotype expression in
Salmonella typhimurium [85]. Salmonella biofilm development depends on the phosphoryla‐
tion status of RcsB. The unphosphorylated RcsB is essential to activate the expression of the
biofilm matrix compounds. The inhibition of biofilm development by phosphorylated RcsB is
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due to the repression of CsgD expression, through a mechanism dependent on the accumula‐
tion of the sRNA RprA [86].
Many gram-negative bacteria utilize N-acyl-L-homoserine lactones (AHLs) to bind to
transcriptional regulators leading to activation or repression of target genes. Salmonella do not
synthesize AHLs but do contain the AHL receptor, SdiA. The Salmonella sdiA gene regulates
the rck gene, which mediates its adhesion and invasion of epithelial cells and the resistance of
the organism to complement [87]. The rck gene is located on the virulence plasmid of pRST98,
AHLs increase rck expression in pRST98-carrying strains, thereby enhancing bacterial
adherence, serum resistance, and bacterial biofilm formation [88].
6. Virulence or resistance for biofilm
Biofilm formation may involve in the virulence of Salmonella. Salmonella enteritidis stains
isolated from either the environment, dairy products, or infected patients are divided into two
groups on the basis of their virulence (50% lethal dose) in chickens infected intraperitoneally.
Only the virulent strains produce aggregates and formed visible filaments attached to the glass
tube [47]. Further study confirms that the virulence of the biofilm-producing strain in infected
chickens increases proportionally to the amount of stored glycogen, suggesting a possible role
of the glycogen depot in the virulence of Salmonella enteritidis [89]. When tested for infection
in Caco-2 cells and HEp-2 cells, the more virulent strains of Salmonella enteritidis, which are
biofilm producers in adherence test medium, are able to disrupt monolayers. In contrast, the
low-virulence strains of Salmonella enteritidis, which do not produce biofilms in adherence test
medium, have no effect on the same cells. The high-virulence Salmonella enteritidis strains
incubated under optimum biofilm-forming conditions may release a soluble factor, which
enables the disruption of the integrity of Caco-2 monolayers [90]. The relationship between
biofilm-forming ability and the pathogenicity is also evaluated in Salmonella pullorum.
Although the virulence of Salmonella pullorum strains is independent of their ability of biofilm
formation, prior growth as a biofilm for a biofilm producer of Salmonella pullorum leads to
enhanced virulence in chickens, suggested that biofilm formation may be one of important
virulence factor for Salmonella pullorum infection [46].
The csgBAC operon is required for curli biosynthesis in Salmonella. The csgA mutation is not
reduced in ability to attach or colonize alfalfa sprouts, whereas the csgB mutation is reduced.
Thus, csgB alone can play a role in attachment of Salmonella to plant tissue [91]. Competitive
infection experiments in mice shows that csgA mutant cells outcompeted rdar-positive wild-
type cells, indicating that aggregation via the rdar morphotype is not a virulence adaptation
in Salmonella typhimurium. Furthermore, in vivo imaging experiments show that thin aggre‐
gative fimbriae genes are not expressed during infection but are expressed once Salmonella was
passed out of the mice into the feces [92]. However, Salmonella typhimurium strains isolated
from water buffalo calves affected by lethal gastroenteritis are tested in vivo in a mouse model
of mixed infection. The most pathogenic strain is characterized by a high number of viru‐
lence factors and the presence of the locus csgA, coding for a thin aggregative fimbria [93].
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tants of Salmonella typhimurium no longer produce curli or rugose colony morphology.
However, inactivation of mlrA did not affect curli production and aggregative morphology in
an upregulated curli producing Salmonella typhimurium derivative containing a temperature-
and RpoS-independent csgD promoter region. Therefore, MlrA acts as a positive regulator of
RpoS-dependent curli and extracellular matrix production by Salmonella typhimurium [76].
c-di-GMP is recognized as a ubiquitous bacterial second messenger and a key regulator in
bacterial transition from a motile and planktonic to a sessile and biofilm lifestyle. High
intracellular c-di-GMP levels promote extracellular matrix production and subsequent biofilm
formation and repress motility, whereas low intracellular c-di-GMP levels suppress matrix
production and promote single-cell motility [77]. The synthesis/degradation of c-di-GMP
depends on diguanylate cyclase/phosphodiesterase enzymatic activities. The cyclase activity,
which converts two molecules of GTP to c-di-GMP, is encoded in the GGDEF protein domain,
while phosphodiesterase activity, which hydrolyzes c-di-GMP to linear 5′-pGpG or two GMP
molecules, is encoded in the EAL and HD-GYP domains. For example, Adar, containing a
GGDEF domain, encodes diguanylate cyclase synthesizing c-di-GMP, is required for cellu‐
lose production and biofilm formation. In another seven GGDEF family (GcpA-G), only GcpA
and GcpE are critical for biofilm formation [37]. The EAL domain protein STM4264, STM3611,
and the GGDEF-EAL domain protein STM1703 play a determinative role in the expression
level of multicellular behavior of Salmonella typhimurium [78, 79]. In contradiction, the EAL-
like protein STM1697, neither degrade nor bind c-di-GMP, promotes biofilm formation and
CsgD expression through interaction with proteins that regulate flagella function [80]. High
intracellular amounts of c-di-GMP in Salmonella typhimurium inhibited invasion and abolish‐
ed induction of a pro-inflammatory immune response in the colonic epithelial cell line HT-29.
Inhibition of the invasion and IL-8 induction phenotype by c-di-GMP requires the major
biofilm activator CsgD and/or BcsA. Therefore, c-di-GMP signaling is at least equally impor‐
tant in the regulation of Salmonella–host interaction as in the regulation of biofilm formation
at ambient temperature [81].
CsgD synthesis is also regulated at the post-transcriptional level by sRNA. sRNAs have
emerged as a diverse group of trans- or cis-encoded regulatory molecules of approximately
50–250 nt in size. The RNA chaperone Hfq protects sRNAs form degradation and facilitates
their binding to the target mRNAs. All these sRNA may negatively regulate csgD gene
expression by binding to the overlapping 5′-region of the transcript, masking the ribosome
binding site, resulting in the inhibition of translation or the degradation of mRNA [82]. In
Escherichia coli, sRNAs, OmrA/B, McaS, RprA, and GcvB are identified, which downregulate
CsgD translation [83]. In E. coli and Salmonella, RydC’s 5′-domain interacts with csgD mRNA
translation initiation signals to prevent initiation, stimulation of RydC expression reduces
biofilm formation by impairing curli synthesis [84]. Surprisingly, two Hfq-dependent sRNAs
(ArcZ and SdsR) are responsible for positively regulation of rdar morphotype expression in
Salmonella typhimurium [85]. Salmonella biofilm development depends on the phosphoryla‐
tion status of RcsB. The unphosphorylated RcsB is essential to activate the expression of the
biofilm matrix compounds. The inhibition of biofilm development by phosphorylated RcsB is
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emrAB, mdfA, mdtK, and macAB are compromised in their ability to form biofilms. The mutants
expressed significantly less csgB or csgD than wild type, indicating that loss of all multidrug
resistance efflux pumps of Salmonella typhimurium results in impaired ability to form a
biofilm [97]. Further study confirms that mutants of Salmonella typhimurium that lack TolC or
AcrB, but surprisingly not AcrA, are compromised in their ability to form biofilms. The biofilm
defect results from transcriptional repression of curli biosynthesis genes and consequent
inhibition of production of curli. Therefore, the inhibition of efflux is a promising antibiofilm
strategy [98]. However, recent studies offer contradictory findings about the role of multi‐
drug efflux pumps in bacterial biofilm development. When no selective pressure is applied,
Salmonella typhimurium is able to produce biofilms even when the AcrAB efflux pumps are
inactivated. Upon exposure to chloramphenicol, the formation of biofilms on solid surfaces as
well as the production of curli are either reduced or delayed more significantly in both AcrA
and AcrAB mutants, implying that the use of efflux pump inhibitors to prevent biofilm
formation is not a general solution and that combined treatments might be more efficient [99].
Triclosan is a potent biocide that is included in a diverse range of products. Salmonella biofilm-
derived cells are more resistant to Triclosan. Within biofilms, triclosan upregulate the
transcription of acrAB, marA, bcsA, and bcsE genes. Thus, Salmonella within biofilms could
experience reduced influx, increased efflux and enhanced exopolysaccharides production. The
data suggest that tolerance of Salmonella towards triclosan in the biofilm is attributed to low
diffusion through the extracellular matrix, while changes of gene expression might provide
further resistance to triclosan and to other antimicrobials [100].
In summary, Salmonella biofilm formation is major controlled by CsgD regulatory network and
regulated by multiple transcriptional factors, c-di-GMP, and sRNAs. More and more genes are
found to be associated with both biofilm formation and virulence. Dissection of their func‐
tion and relationship will helpful for development of new tools and strategies to prevent
biofilm-related disease and decontaminate biofilm-derived Salmonella in food production.
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The bcsABZC and bcsEFG operons are required for cellulose biosynthesis in Salmonella.
Bacterial adherence and invasion assays of eukaryotic cells and in vivo virulence studies of
cellulose-deficient mutants of bcsC and bcsE genes indicate that the production of cellulose is
not involved in the virulence of Salmonella enteritidis. However, cellulose-deficient mutants are
more sensitive to chlorine treatments, suggesting that cellulose production and biofilm
formation may be an important factor for the survival of S. enteritidis on surface environ‐
ments [36]. Salmonella typhimurium makes cellulose when inside macrophages. An attenuat‐
ed mutant lacking the mgtC gene exhibits increased cellulose levels due to increased expression
of the cellulose synthase gene bcsA and of cyclic diguanylate, the allosteric activator of the BcsA
protein. Inactivation of bcsA restore wild-type virulence to the Salmonella mgtC mutant,
indicating that Salmonella promotes virulence by repressing cellulose production [94].
BapA, a large cell-surface protein, is required for biofilm formation by Salmonella. Studies on
the contribution of BapA to Salmonella enteritidis pathogenesis reveal that orally inoculated
animals with a bapA-deficient strain survived longer than those inoculated with the wild-type
strain. Also, a bapA mutant strain showed a significantly lower colonization rate at the
intestinal cell barrier and consequently a decreased efficiency for organ invasion compared
with the wild-type strain [26]. Osmoregulated periplasmic glucans (OPGs) are major
periplasmic constituents of Gram-negative bacteria. An opgGH mutant strain in Salmonella
typhimurium, which is defective in OPG biosynthesis, severely impaires biofilm formation. The
opgGH mutant strain poorly colonizes mouse organs when introduced orally along with the
wild-type strain [95].
Besides, the constitutional components of biofilm, there are many regulation proteins involved
in both biofilm formation and virulence. An ompR mutant of Salmonella enteritidis has no ability
to produce cellulose, curli, and biofilm and shows similar adherence percentage to and
invasion percentage of epithelial cells as wild-type strain. Intraperitoneal challenge of bacteria
in BALB/c mice reveals that the ompR mutant strain is significant attenuated [73]. A spiA gene
mutant shows reduced biofilm formation and significantly decreased curli production, and
reduced intracellular proliferation of macrophages during the biofilm phase. In addition, the
spiA mutant was attenuated in a mouse model in both the exponential growth and biofilm
phases [67]. Deletion of genes ompR and spiA in Salmonell pullorum strains contribute to
attenuation of virulence in 1-day-old chickens [68]. DksA is a conserved gram-negative
regulator that binds directly to the RNA polymerase secondary channel. In Salmonella
typhimurium, expression of the dksA gene is induced during the logarithmic phase and DksA
plays an important role in motility and biofilm formation. DksA positively regulates the
Salmonella pathogenicity island 1 and motility-chemotaxis genes and is necessary for Salmonella
typhimurium invasion of human epithelial cells and uptake by macrophages. The dksA gene is
induced at the midcecum during the early stage of the infection and required for gastrointes‐
tinal colonization and systemic infection in a colitis mouse model [96].
Salmonella in biofilm is resistant to antibiotic. One of key mechanisms of antibiotic resistance
is efflux. There are five families of multidrug resistance (MDR) efflux pumps, in which the
AcrAB–TolC efflux system is the best characterized MDR system. Ten mutants of Salmonella
typhimurium lacking MDR efflux systems, such as tolC, acrB, acrD, acrEF, mdtABC, mdsABC,
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emrAB, mdfA, mdtK, and macAB are compromised in their ability to form biofilms. The mutants
expressed significantly less csgB or csgD than wild type, indicating that loss of all multidrug
resistance efflux pumps of Salmonella typhimurium results in impaired ability to form a
biofilm [97]. Further study confirms that mutants of Salmonella typhimurium that lack TolC or
AcrB, but surprisingly not AcrA, are compromised in their ability to form biofilms. The biofilm
defect results from transcriptional repression of curli biosynthesis genes and consequent
inhibition of production of curli. Therefore, the inhibition of efflux is a promising antibiofilm
strategy [98]. However, recent studies offer contradictory findings about the role of multi‐
drug efflux pumps in bacterial biofilm development. When no selective pressure is applied,
Salmonella typhimurium is able to produce biofilms even when the AcrAB efflux pumps are
inactivated. Upon exposure to chloramphenicol, the formation of biofilms on solid surfaces as
well as the production of curli are either reduced or delayed more significantly in both AcrA
and AcrAB mutants, implying that the use of efflux pump inhibitors to prevent biofilm
formation is not a general solution and that combined treatments might be more efficient [99].
Triclosan is a potent biocide that is included in a diverse range of products. Salmonella biofilm-
derived cells are more resistant to Triclosan. Within biofilms, triclosan upregulate the
transcription of acrAB, marA, bcsA, and bcsE genes. Thus, Salmonella within biofilms could
experience reduced influx, increased efflux and enhanced exopolysaccharides production. The
data suggest that tolerance of Salmonella towards triclosan in the biofilm is attributed to low
diffusion through the extracellular matrix, while changes of gene expression might provide
further resistance to triclosan and to other antimicrobials [100].
In summary, Salmonella biofilm formation is major controlled by CsgD regulatory network and
regulated by multiple transcriptional factors, c-di-GMP, and sRNAs. More and more genes are
found to be associated with both biofilm formation and virulence. Dissection of their func‐
tion and relationship will helpful for development of new tools and strategies to prevent
biofilm-related disease and decontaminate biofilm-derived Salmonella in food production.
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The bcsABZC and bcsEFG operons are required for cellulose biosynthesis in Salmonella.
Bacterial adherence and invasion assays of eukaryotic cells and in vivo virulence studies of
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Abstract
Diabetes  mellitus  is  a  major  health problem that  affects  approximately 171 million
people globally. One of its most severe complications is the development of diabetic
foot ulcers (DFU). Ischemic and neurophatic lesions are of major importance for DFU
onset;  however,  it  is  the  infection  by  multidrug-resistant  and  biofilm-producing
microorganisms,  along  with  local  microenvironmental  conditions  unfavorable  to
antibiotics action that ultimately cause infection chronicity and lower limbs amputa‐
tion.  Novel  therapeutic  protocols  for  DFU  management  are  extremely  urgent.
Bacteriophages,  probiotics  and  antimicrobial  peptides  (AMP)  have  recently  been
proposed as alternatives to currently available antibiotics. Bacteriophages are viruses
that  specifically  infect  and  multiply  within  bacterial  cells.  Their  ability  to  diffuse
through polymeric matrixes makes them particularly efficient to eradicate biofilm-
based  bacteria.  Promising  results  were  also  observed  with  probiotic  therapy.
Probiotics are well-characterized strains with the ability to compete with pathogen‐
ic  microorganisms  and  modulate  the  host  immune  response.  AMP  are  molecules
produced  by  living  organisms  as  part  of  their  innate  immune  response.  Unlike
conventional antibiotics, AMP also act as immunomodulators and resistance to AMP
was  rarely  observed,  supporting  their  potential  as  therapeutic  agents.  These
innovative  therapeutic  strategies  may  in  the  future  substitute  or  complement
antibiotherapy,  ultimately  contributing  for  the  decrease  in  multidrug-resistant
bacteria dissemination.
Keywords: antimicrobial peptides, antimicrobial resistance, bacteriophages, biofilm,
diabetic foot ulcer, probiotics
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trations [5]. Even when topically applied, antibiotics rarely reach bacteria that reside within
mature biofilms at therapeutic concentrations [12].
Biofilm formation is a major mechanism of adaptation that is able to protect bacteria from
antibiotics, due to several physiological traits. Firstly, biofilm spatial structure provides a
protective coat against antimicrobial compounds. Secondly, in most cases, biofilms are
polymicrobial, formed by complex mixtures of different species. It was proposed that, in such
biofilms, the chemical interactions that occur between polymeric substances produced by
different bacterial strains might lead to a more viscous matrix, impairing the contact be‐
tween the bacterial cell wall and the antibiotic. Lastly, the production of degradative en‐
zymes by different pathogenic species can act synergistically against antimicrobial
compounds. These biofilm features are responsible for a reduced diffusion of the antibiotic
within the biofilm matrix [13, 14].
In addition, patients suffering from DFU face the emergence and dissemination of antibiotic
resistant bacteria, which is not a recent biological phenomenon. Seventy years ago, after the
discovery of penicillin and the beginning of the antibiotic era, Alexander Fleming noticed the
emergence of bacterial strains resistant to penicillin. Indeed, resistance began to appear in
target microorganisms, including S. aureus isolates from hospitals, a few years after the
introduction of penicillin into medical practice [15]. Fleming described the occurrence of
antibiotic resistance and warned the scientific and medical community of this phenomenon in
his Nobel Prize lecture in 1945 [16].
Several causes can explain the emergence and dissemination of antibiotic resistance. Firstly,
the overuse and, most importantly, the misuse of antibiotics in different but interconnected
areas, like human and veterinary medicine, agriculture and animal production. Secondly, the
effects of antibiotic compounds in the environment are not yet completely described and
understood. Finally, antibiotic compounds are stable and static chemical substances that are
used to fight living and evolving bacterial cells [17]. Microorganisms, namely bacteria, are
ubiquitous and interact with all other living beings. Considering that nature is a highly
complex system supported by extremely dynamic interactions and exchanges between all its
elements, the emergence and evolution of bacterial populations able to resist against antibi‐
otic substances is not surprising. In fact, over the last decades, microbiologists have demon‐
strated the influence that antibiotics exert upon bacterial populations. Previously seen as
miracle drugs, capable of virtually eradicating all species of bacteria, antibiotics are now seen
as substances with limited antimicrobial capacity and multifaceted proprieties. These
compounds have the ability to induce or inhibit different bacterial responses and to influ‐
ence bacterial virulence and survival strategies [18, 19].
As mentioned above, biofilm formation is a well-known virulence factor of some bacterial
strains that, along with many other advantages, confers them a protective layer against adverse
elements. Recently, it was demonstrated that some antibiotics are able to induce this adapta‐
tive strategy. In 2005, when Hoffman et al. [18] were testing the efficacy of aminoglycosides, a
widely exploited antibacterial therapeutic agent, against biofilm-forming bacteria, they
observed an unexpected bacterial response. Aminoglycosides not only did not eliminate the
P. aeruginosa strain used in the study, but also stimulated their ability to form biofilm. In fact,




Diabetes mellitus is a serious health problem in rapid expansion worldwide. It is estimated that
there are 171 million diabetic patients worldwide and this number is expected to double by the
year 2030 [1]. Diabetic foot ulcers (DFU) are one of the most frequent complications of diabe‐
tes, resulting from a complex interaction of factors, namely ischemia and neuropathy [2].
Neuropathy, which is characterized by modifications in sensitive and autonomic functions,
causes ulceration due to trauma or excessive pressure in a deformed foot without protective
sensibility. Autonomic neuropathy causes dryness of the skin by decreasing sweating, and
therefore the vulnerability of the skin to break down increases. Once the protective layer of
skin is damaged, deep tissues are exposed to bacterial colonization [3].
Diabetes-associated ischemia is caused by peripheral arterial disease. Poor arterial inflow
decreases blood supply to ulcer area and is associated with reduced oxygenation, nutrition,
and ulcer healing [3].
These ulcers are frequently colonized by pathogenic bacteria and infection is facilitated by
immunological deficits related to diabetes [4], rapidly progressing to deeper tissues, increas‐
ing the presence of necrotic tissue, rendering amputation inevitable [5]. In fact, diabetic patients
frequently require minor or major amputations of the lower limbs (15-27%) [2], which not only
contribute dramatically to high morbidity among diabetic patients, but is also associated with
severe clinical depression and increased mortality rates [6].
Although ischemic and neuropathic changes have the initial role in DFU pathophysiology, in
the majority of cases it is the infection by multidrug-resistant microorganisms and the
unfavorable microenvironmental conditions to the action of antibiotics that leads to amputa‐
tion [5].
Diabetes-associated foot ulcer infections are predominantly polymicrobial and several
bacterial genera can be part of the DFU microbiota, namely Staphylococcus, Pseudomonas,
Streptococcus, Enterococcus, Corynebacterium, Acinetobacter, Prevotella, Porphyromonas, and
members of the family Enterobacteriaceae. The predominant Gram-positive and Gram-nega‐
tive species present in DFU are Staphylococcus aureus and Pseudomonas aeruginosa, respective‐
ly [7–9].
There is, to date, little understanding of the ecology of such chronic infections, but bacterial
biofilms seem to play a major role [10]. These are ubiquitous and complex structures consist‐
ing of an interactive community of polymicrobial cells embedded in a self-produced extracel‐
lular matrix of hydrated polymeric substances, such as proteins, polysaccharides, nucleic acids
and others, irreversibly attached to the biological surface of the ulcer. These characteristics
make them recalcitrant to the action of most antibiotics and also resistant to the innate immune
system [11].
administration of biofilm-based infections generally requires local surgical procedures as well
as antibiotic administration. However, in infected DFU, because of deficient vascularization,
antibiotics frequently reach the local ulcer microenvironment only at subtherapeutic concen‐
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P. aeruginosa strain used in the study, but also stimulated their ability to form biofilm. In fact,
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unfavorable microenvironmental conditions to the action of antibiotics that leads to amputa‐
tion [5].
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bacterial genera can be part of the DFU microbiota, namely Staphylococcus, Pseudomonas,
Streptococcus, Enterococcus, Corynebacterium, Acinetobacter, Prevotella, Porphyromonas, and
members of the family Enterobacteriaceae. The predominant Gram-positive and Gram-nega‐
tive species present in DFU are Staphylococcus aureus and Pseudomonas aeruginosa, respective‐
ly [7–9].
There is, to date, little understanding of the ecology of such chronic infections, but bacterial
biofilms seem to play a major role [10]. These are ubiquitous and complex structures consist‐
ing of an interactive community of polymicrobial cells embedded in a self-produced extracel‐
lular matrix of hydrated polymeric substances, such as proteins, polysaccharides, nucleic acids
and others, irreversibly attached to the biological surface of the ulcer. These characteristics
make them recalcitrant to the action of most antibiotics and also resistant to the innate immune
system [11].
administration of biofilm-based infections generally requires local surgical procedures as well
as antibiotic administration. However, in infected DFU, because of deficient vascularization,
antibiotics frequently reach the local ulcer microenvironment only at subtherapeutic concen‐
Microbial Biofilms - Importance and Applications252
2. Bacteriophages
Bacteriophages were discovered almost a century ago by two independent microbiologists,
Twork in 1915 in the United Kingdom and D’Herelle in 1917 in France. D’Herelle named these
bacteria-eating entities as bacteriophages and explored them as antibacterial agents [29, 30].
Bacteriophages are bacteria-specific viruses that infect and multiply within bacterial cells. In
contrast to lysogenic bacteriophages, the replication of lytic bacteriophages and release of the
newly formed virus particles always involves lysis of the host bacterial cell. Bacteriophage
therapy is the use of lytic bacteriophages to reduce or eliminate pathogenic bacteria [31].
Lytic bacteriophages seem to be efficient therapeutical agents in biofilm microenvironment
due to several particular characteristics: specificity and efficiency in lysing pathogenic bacteria;
absence of pathogenicity to man and animals; efficiency over bacteria organized in polymer‐
ic matrixes, namely biofilms; action in microaerophilic environments with high bacterial load;
and rapid and economical accessible production capability [32, 33].
Bacteriophage therapy has become a broadly relevant technology for veterinary, agricultural
and food microbiological applications; however, the treatment of human infections with
bacteriophage-based protocols attracts the greatest interest [34].
Bacteriophages are viruses that specifically infect prokaryotic bacterial cells. In fact, the
prokaryotic biochemical machinery that enables the interaction between bacteriophages and
bacterial cells has particular characteristics that are not present in eukaryotic cells. For instance,
the outer membrane receptors of bacterial cells, with which bacteriophage capsid coat or
molecular appendages first connect with the purpose of being anchored on the bacterial cell
wall, as well as the polymerases required for the bacteriophage genome replication, are specific
of prokaryotic bacterial cells and are structurally and functionally different from those
presented by eukaryotic cells [31]. For that reason, bacteriophages can only directly interact
and infect bacterial cells, and not eukaryotic cells. The bacterio-specificity features allow
classifying bacteriophages as ‘safe’ for use in eukaryotic organisms, namely plants and
animals, including humans.
The use of bacteriophages as antibacterial agents for suppurative infections began shortly after
their discovery, with Bruynoghe’s and Maisin’s application for treating S. aureus skin infec‐
tions [35]. However, following the discovery and general application of antibiotics, interest in
the therapeutic uses of bacteriophages waned. Recently, the increase in antibiotic-resistant
bacterial strains has reinvigorated enthusiasm about these bacteria-specific viruses [36]. This
interest is particularly true in cases in which bacteriophages can be applied topically, as is the
case of DFU.
Recently, a topically delivered bacteriophage suspension was tested for its antimicrobial
activity and wound healing capability against ulcers chronically infected with S. aureus, P.
aeruginosa and Acinetobacter baumannii. In this study, conducted by Mendes et al. in 2013 [37],
the bacteriophage suspension was applied in debrided infected cutaneous wounds and
microbiologic, histological and planimetric parameters were evaluated. It was shown that the
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they demonstrated that aminoglycosides interact with the P. aeruginosa aminoglycoside
response regulator gene, arr, which encodes for an inner-membrane phosphodiesterase
essential to the regulation of cyclic di-guanosine monophosphate levels, which represents a
bacterial second messenger that regulates cell surface adherence [18]. Later on, Kaplan et al.
[19] also reported that in Escherichia coli, not only sub inhibitory antibiotic concentrations but
also disinfectants such as chlorhexidine are responsible for the induction of biofilm forma‐
tion. From their work, one can conclude that, for some bacterial strains, biofilm formation can
be a specific defensive reaction to the presence of antibiotics.
Despite all the evidences showing that biofilms provide advantages to microorganisms,
namely enhanced resistance towards environmental stresses including the presence of
antimicrobial compounds, many antibiotics that are currently in use were developed, tested,
and regulated using in vitro tests against planktonic bacteria.
It is known that microbial cells growing within a biofilm are physiologically distinct from
planktonic cells of the same strain. The overall resistance level in biofilms is distinct from the
one observed at a cellular level [20]. As a consequence, the antimicrobial concentration
required to inhibit biofilms can be up to hundreds or even a thousand times higher than the
corresponding concentration necessary to eliminate free-living bacterial cells [21]. Such
phenomena cannot be overlooked in the development of novel strategies to combat infec‐
tious diseases.
Taking into account that biofilm formation is a threatening characteristic of the microbiome
that colonizes diabetic foot wounds, it is not unexpected that in the past few decades a major
problem in treating DFU infections has been the increasing rate of colonisation by antibiotic
resistant pathogens. This is the case of methicillin-resistant S. aureus (MRSA), and to a lesser
degree, glycopeptide-intermediate S. aureus, vancomycin-resistant enterococci, extended-
spectrum β-lactamase- or carbapenamase–producing gram-negative bacilli, and highly
resistant strains of P. aeruginosa. In fact, the infection by polymicrobial communities of
multidrug-resistant bacteria is an important cause of DFU healing impediment [7, 22–27].
The rates of isolation of these multidrug-resistant pathogens vary widely among geographi‐
cal area and treatment center. However, the increasing incidence of multidrug-resistant
microorganisms together with the incapacity of antibiotics to act on resistant and biofilm-
producing bacteria at therapeutical concentrations emphasizes the importance of develop‐
ing new treatment strategies to effectively eradicate these infections.
Considering that biofilms were only described by the scientific community by the end of the
twentieth century, it is comprehensible that research on biofilms is still an expanding area [28].
The lack of understanding of the mechanisms behind the biofilm mode of life has impaired
the development of antimicrobial compounds that specifically operate on biofilm polymicro‐
bial communities [28]. However, in recent years, the increased failure in infectious diseases
therapeutic protocols and the dissemination of antibiotic resistance has demonstrated the
importance of developing such substances and several novel therapeutic strategies, namely
bacteriophages, probiotics and antimicrobial peptides (AMP), are recently been explored and
proposed as potential alternatives to eradicate bacterial biofilms in DFU.
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Health Organization as: ‘live microorganisms that, when administered in adequate amounts,
confer a health benefit on the host” [43]. Probiotics are either a single strain or a mixture of
commensal microorganisms with the ability to outcompete pathogenic bacteria through
several mechanisms of action. The two most common are direct modification of the microbi‐
al populations and modulation of host immune system [43].
Direct modification of the microbiome includes competition with pathogenic bacteria for
adhesion to epithelial receptor, production of antimicrobial substances like acids, hydrogen
peroxide and bacteriocins, and inhibition of toxic substances produced by pathogens.
Immunomodulation includes strengthening of host immune response, promotion of anti-
inflammatory action, and enhancement of the wound healing process by stimulating the
accumulation of inflammatory cells like lymphocytes, macrophages and polymorphonuclear
cells in the site of wound [44].
As one would expect, not all commensal bacteria are suitable to be used as a probiotic. The
screening and selection of probiotics includes a rigorous evaluation of the probiotic candi‐
date strain in order to determine whether it fulfills all the required criteria.
Firstly, it is important to assess its safety. An evaluation that includes strain identification and
typing, antimicrobial resistance profiling, and determination of virulence and pathogenic
properties, including metabolic activities associated with toxic compounds production, is
mandatory [45]. Secondly, it is relevant to determine its technological potential. It is essen‐
tial for a probiotic strain to be genetically stable and bacteriophage-resistant. In addition, it
must present viability during processing and storage and be adequate for large-scale produc‐
tion [46]. Thirdly, it is required to establish its physiological properties. To survive the host
inner environment, which is rather complex and hostile, a probiotic strain must possess specific
characteristics such as gastric acid and bile tolerance and mucosal surface adhesion stability
[47]. Lastly, the functional properties must be evaluated. Validated and documented health
effects are mandatory, namely antagonistic activity towards pathogens, immunomodulatory
activity, and anticarcinogenic properties. Some probiotic strains are also able to interfere with
the host cholesterol and lactose metabolism, preventing damages by its metabolites [48].
Probiotics have already been exploited for prevention as well as treatment of a number of
health disorders including irritable bowel syndrome, hypersensitivity such as food allergies,
hypercholesterolemia, renal failure, gastritis and gut infection, parasitic infections, urogeni‐
tal infections, colorectal cancer, and dental disorders [49, 50]. Since the putative probiotic
mechanisms of action should be the same in the peripheral wounds as they are in other parts
of the body, these can be considered as a potential DFU treatment alternative.
Lactic acid bacteria (LAB), in particular Lactobacillus and Bifidobacterium species, have been
extensively used as probiotic strains. The genus Lactobacillus is formed by ubiquitous and
usually harmless bacteria. In animals, including humans, they are present in the gastrointes‐
tinal and genitourinary tracts where they act as health promoters [51]. The genus Bifidobacte‐
rium includes anaerobic bacteria that produce acetic and lactic acid without release of carbon
dioxide. Bifidobacterium is the third most abundant genus in the complex microbiome of the
human intestinal tract where it exerts beneficial functions of paramount importance [52].
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bacteriophage treatment successfully decreased bacterial colony counts and improved wound
healing, as indicated by smaller epithelial and dermal gaps. The bacteriophage therapy
protocol developed was proven to be an effective methodology in the treatment of two animal
models of Diabetes mellitus, rodents and porcines [37].
The same bacteriophage suspension also demonstrated in vitro activity against both plank‐
tonic cells and established biofilms. Using metabolic activity as a measure of cell viability, it
was observed that bacteriophage treatment significantly increased cell impairment within
biofilms. Moreover, bacteriophage exposure repeated every four hours caused a further
decrease in cell activity [9].
There is still much to unravel regarding bacteriophage therapy. For instance, not all phages
are suitable for clinical application. More information is required, namely detailed studies of
potentially useful phages with respect to their interaction with target bacteria and their genetic
content.
Nonetheless, despite the paucity of experimental data regarding bacteriophage therapy in
DFU, a consensus appears to have emerged on the feasibility of this potential alternative to
treat biofilm-infected DFU.
3. Probiotics
The increasing global antimicrobial drug resistance problem led to an urge in researching
alternatives to drug therapies, making the concept of bacteriotherapy more interesting and
pertinent than ever. Bacteriotherapy is a promising alternative approach to fight infections by
employing harmless bacteria to displace pathogenic microorganisms [38].
The concept of ‘probiotic’ arose in 1907 from a hypothesis proposed by Noble Prize-winning
Ilya Mechnikov. At the turn of the twentieth century, Mechnikov noticed that peasant
populations in Bulgaria had increased average life spans in comparison with wealthier
European populations [39]. He also observed that yogurt and other fermented milk products
were a substantial part of their diets and described the beneficial effects of the ‘Bulgarian
bacillus’ present in those foods [40, 41]. These healthy bacteria, later classified Lactobacillus
bulgaricus, helped digestion, impaired the putrefactive effects of gastrointestinal metabolism,
and contributed to the improvement of the immune system [41].
Mechnikov was not the only one to notice the health benefits of lactic acid bacteria. A few years
before, in 1899, another important discovery was made at the Pasteur Institute in Paris. Henri
Tissier demonstrated that children suffering from diarrhea had a low number of bacteria
characterized by a peculiar Y-shaped morphology. On the other hand, these “bifid” bacteria
were abundant in the gut flora of healthy breast-fed infants. Moreover, Tissier demonstrated
that the administration of these Y-shaped bacteria, later classified Bifidobacterium, to patients
with diarrhea allowed them to re-establish a healthy intestinal microbiome [42].
The definition of probiotic as well as their characteristics have evolved in the last century and
nowadays probiotics are defined By the Food and Agriculture Organization and the World
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charged. On the other hand, hydrophobicity derives from the abundant presence of hydro‐
phobic amino acids, such as tryptophan, tyrosine and phenylalanine [66, 67].
The distinctive physical-chemical properties of AMP are what confers them their potential as
antimicrobial compounds. It has been generally accepted that AMP exert their bactericidal
activity through electrostatic interactions with the negatively charged bacterial cytoplasmic
membrane, followed by permeabilization of the membrane, which causes cell lysis. Membrane
permeabilization can occur through pore formation in the lipid membrane, membrane
dissolution, narrowing of the membrane bilayer or lipid-peptide domain formation [68]. The
AMP amphipathic structure, namely their cationic and hydrophobic regions, interacts with
the negatively charged phospholipids present in the surface of the microorganisms’ cytoplas‐
mic membranes. Bacterial membranes are rich in lipids such as phosphatidilglycerol and
cardiolipin, whereas host cells have eukaryotic membranes that are rich in phosphatidylcho‐
line, cholesterol, and sphingomyelin [69].
It is the difference in the lipids that constitute the membranes of bacteria and host cells that
allows AMP to selectively target the microbial cells over mammal cells and confers them the
criterion of safety to be use in eukaryotic organisms, including humans.
Additionally to their role as membrane disruptors, several studies have also suggested
alternative targets for AMP. In fact, it was proven that some AMP are able to translocate into
the cytoplasm of pathogens and attack intracellular targets. This way, AMP impair essential
bacterial metabolic processes, including nucleic acids synthesis and cell wall assembly [70–72].
AMP can present multiple and simultaneous mechanisms of action, including both mem‐
brane permeabilization and intracellular effects. This property is probably the reason why they
present antimicrobial activity against such a wide range of pathogens.
Regarding their immunological functions, AMP are also known as host-defense peptides [73–
76]. By interacting with a variety of host cell receptors, AMP promote the recruitment of
leukocytes to the site of infection through direct chemotactic activity and stimulation of
chemokine production by leukocytes, epithelial cells, and other cell types [77, 78]. Finally, some
AMP also play a role in angiogenesis and wound healing [79, 80].
The production of AMP is not limited to multicellular organisms; bacteria can also synthe‐
size AMP that are active against other bacteria. These AMP of bacterial origin include non-
ribosomally synthesized peptides such as gramicidins, and ribosomally synthesized peptides
such as bacteriocins, and have been used for years [81, 82]. Gramicidin S is a cyclic decapep‐
tide produced by Bacillus aneurinolyticus and has been used as a topical antimicrobial agent
against Gram-positive bacteria since 1946 [83]. Nisin is a bacteriocin produced by L. lactis that
acts primarily against Gram-positive bacteria and has been used safely as a food preserva‐
tive for over 50 years [84].
Several studies have analyzed the in vitro activity of different AMP against DFU clinical
isolates. In 2013, Okuda et al. [85] evaluated the antimicrobial activity and mode of action of
three bacteriocins, nisin A, lacticin Q, and nukacin ISK-1, against a clinically isolated and
biofilm-producing MRSA strain. Nukacin ISK-1, produced by Staphylococcus warneri, present‐
ed only bacteriostatic effects. However, both nisin A and lacticin Q, produced by L. lactis,
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However, other species of bacteria, and even some fungi, also present probiotic properties,
such as Enterococcus faecium, Bacillus cereus, E. coli strain Nissle, Propionibacterium freudenrei‐
chii, Propionibacterium acnes and the yeasts Saccharomyces cerevisae and Saccharomyces boulardii
[53–55].
LAB commonly produce antimicrobial substances with effect against gastric and intestinal
pathogens and compete for cell surface and mucin binding sites [56]. Recent studies have
demonstrated the efficacy of LAB-based therapy for DFU infections control. A study on
effectiveness of bacteriotherapy using Lactobacillus plantarum on infected chronic DFU
demonstrated that topical application of this bacterial culture induced debridement, granula‐
tion tissue formation and total healing in half of the diabetic patients treated [57, 58].
Lactobacillus fermentum also showed promising applications in treating DFU infections. When
co-incubated in vitro with S. aureus and P. aeruginosa, L. fermentum reduced the cytotoxicity and
biofilm formation ability of several pathogenic strains [59].
Additional studies have suggested that Lactobacillus reuteri, Lactobacillus rhamnosus, Lactobacil‐
lus casei, Lactobacillus acidophilus and Lactococcus lactis are also promising probiotics with the
ability to naturally eliminate pathogenic microorganisms, including MRSA clinical isolates
[60].
In the last years, probiotics have been widely studied and all these recent data point out the
beneficial effects of probiotics to human and animal health. Naturally, no probiotic strain will
provide all the proposed benefits. However, one can no longer ignore the emergence of
probiotics as a novel approach to fight multidrug-resistant and biofilm-producing bacteria
commonly present in DFU.
4. Antimicrobial peptides
Antimicrobial peptides are major components of the host innate immune system that act as
endogenous antibiotics [61, 62]. These multifunctional molecules are produced by living
organisms from all kingdoms, including bacteria, fungi, plants, insects and vertebrates, as part
of their defense strategy against pathogens. Most AMP act as the first defense barrier against
dissemination of a wide spectrum of microorganisms, such as bacteria, fungi, viruses and
protozoan parasites [62].
In addition to their antimicrobial activity, AMP serve as modulators of the immune system
and even show antitoxic activity, since they neutralize bacterial toxins, including lipopolysac‐
charide lipid A [63, 64]. Some AMP are also able to prevent biofilm formation and act on pre-
formed biofilms [65].
The majority of AMP are polypeptides with ten to forty amino acid residues; however, some
can have up to a hundred. AMP are amphipathic molecules, with two regions in their structure,
a polar or hydrophilic region and a nonpolar or hydrophobic region. Due to the presence of
multiple lysine, arginine, and histidine residues, the polar region of AMP is cationically
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charged. On the other hand, hydrophobicity derives from the abundant presence of hydro‐
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such as bacteriocins, and have been used for years [81, 82]. Gramicidin S is a cyclic decapep‐
tide produced by Bacillus aneurinolyticus and has been used as a topical antimicrobial agent
against Gram-positive bacteria since 1946 [83]. Nisin is a bacteriocin produced by L. lactis that
acts primarily against Gram-positive bacteria and has been used safely as a food preserva‐
tive for over 50 years [84].
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ed only bacteriostatic effects. However, both nisin A and lacticin Q, produced by L. lactis,
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ability to naturally eliminate pathogenic microorganisms, including MRSA clinical isolates
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beneficial effects of probiotics to human and animal health. Naturally, no probiotic strain will
provide all the proposed benefits. However, one can no longer ignore the emergence of
probiotics as a novel approach to fight multidrug-resistant and biofilm-producing bacteria
commonly present in DFU.
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Antimicrobial peptides are major components of the host innate immune system that act as
endogenous antibiotics [61, 62]. These multifunctional molecules are produced by living
organisms from all kingdoms, including bacteria, fungi, plants, insects and vertebrates, as part
of their defense strategy against pathogens. Most AMP act as the first defense barrier against
dissemination of a wide spectrum of microorganisms, such as bacteria, fungi, viruses and
protozoan parasites [62].
In addition to their antimicrobial activity, AMP serve as modulators of the immune system
and even show antitoxic activity, since they neutralize bacterial toxins, including lipopolysac‐
charide lipid A [63, 64]. Some AMP are also able to prevent biofilm formation and act on pre-
formed biofilms [65].
The majority of AMP are polypeptides with ten to forty amino acid residues; however, some
can have up to a hundred. AMP are amphipathic molecules, with two regions in their structure,
a polar or hydrophilic region and a nonpolar or hydrophobic region. Due to the presence of
multiple lysine, arginine, and histidine residues, the polar region of AMP is cationically
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As mentioned before, a major factor responsible for healing impediment of DFU are infec‐
tions by multidrug-resistant or biofilm-producing bacteria. Dissemination of these strains,
coupled with disinvestment in new antibiotics development, calls for increasing research to
find new approaches to prevent and control these pathogens. In this chapter, the potentiali‐
ties of bacteriophage viruses, probiotic strains and antimicrobial peptides as novel strategies
for management of DFU, were reviewed. Several studies, conducted by independent re‐
search teams, have demonstrated promising results, both in vitro as in vivo, regarding their
competence to eradicate the pathogenic microorganisms present in DFU. However, further
investigation is required so that in the future, these strategies could be applied in clinical
practice alongside with conventional therapeutics.
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showed bactericidal efficacy against planktonic and biofilm cells [85]. Synthetic cationic
antimicrobial peptides, namely NP101 and NP108, also showed in vitro activity against
bacterial species commonly associated with DFU infections, such as S. aureus and P. aerugino‐
sa, as demonstrated by O’Driscoll et al. [86] in 2013. These results suggest that bacteriocins that
act on biofilm-producer cells are highly suitable for the treatment of DFU infections.
However, there are some limitations in the use of AMP as a clinical alternative for Antibiot‐
ics, in spite of the fact that bacteria resistance to AMP is rare, in opposition to what is ob‐
served towards classic antibiotics [87]. This characteristic of AMP is likely to be related to the
ionic interaction between the positively charged AMP and the negatively charged bacteria
membrane. Since these interactions are not dependent of specific protein binding sites, in order
to develop resistance to AMP, bacteria would have to change the basic structure, namely the
lipid bilayer, of its cytoplasmic membrane [88]. Moreover, attachment of the AMP with the
bacterial membrane and consequent cell lysis happens in such a short period of time, render‐
ing the possibility to develop AMP resistance quite scarce [89]. However, there are reports of
distinct species of bacteria, which present resistance towards AMP. The mechanisms of
resistance include degradation of AMP through secretion of proteases; removal of AMP from
their site of action via efflux pumps; production of inhibitors that bind to AMP and prevent
them from reaching their target; and modulation of AMP gene expression [90–92].
Another obstacle to the successful implementation of AMP as an alternative to conventional
antibiotics is the production costs. AMP discovery and development is time consuming,
reaching up to 10 years, and can cost millions of euros or dollars. In fact, production costs are
estimated to be approximately 50-400 American dollars per gram of amino acid [93].
Even so, AMP are still a promising alternative to antibiotics. A possible solution to reduce costs
associated with AMP production is the reduction of the peptide size, maintaining its antimi‐
crobial activity [94]. Moreover, AMP exhibit physiological and functional advantages over
other molecules that make them so attractive to be used in clinical practice. For instance,
physiological concentrations of AMP in vivo are much lower than the minimal inhibitory
concentrations required for its antimicrobial activity in vitro [95]. In fact, AMP are antimicro‐
bial agents with a broad-spectrum activity displayed at micromolar concentrations, usually in
the 1-50 μg/ml range [96]. A plausible justification for this fact may be the synergistic effect
that some AMP possess, which enhances their antimicrobial activity in vivo [97].
For all these reasons, the development of AMP-based therapies to eliminate microbial
pathogens, such as those present in DFU infections, is extremely promising and deserves
further exploration.
5. Conclusive remarks
The severity of diabetic foot infections and the economic burden associated with its preven‐
tion, treatment and control have compelled scientists and clinicians to invest substantial time
and effort in not only understanding how these mechanisms work, but also how they can
interfere with them.
Microbial Biofilms - Importance and Applications260
As mentioned before, a major factor responsible for healing impediment of DFU are infec‐
tions by multidrug-resistant or biofilm-producing bacteria. Dissemination of these strains,
coupled with disinvestment in new antibiotics development, calls for increasing research to
find new approaches to prevent and control these pathogens. In this chapter, the potentiali‐
ties of bacteriophage viruses, probiotic strains and antimicrobial peptides as novel strategies
for management of DFU, were reviewed. Several studies, conducted by independent re‐
search teams, have demonstrated promising results, both in vitro as in vivo, regarding their
competence to eradicate the pathogenic microorganisms present in DFU. However, further
investigation is required so that in the future, these strategies could be applied in clinical
practice alongside with conventional therapeutics.
Acknowledgements
Authors would like to acknowledge the Interdisciplinary Centre of Research in Animal
Health (CIISA) from Faculty of Veterinary Medicine from University of Lisbon (Project
UID/CVT/00276/2013, funded by Fundação para a Ciência e Tecnologia (FCT), Portugal). This
study was also conducted with the financial support of the project PTDC/SAU-MIC/
122816/2010: Biofilms in diabetic foot: microbial virulence characterization and cross-talk of
major isolates, funded by FCT, Portugal. Raquel Santos and Ana Salomé Veiga acknowledge
FCT, Portugal, respectively, for a PhD fellowship (SFRH/BD/100571/2014) and a fellowship
IF/00803/2012 under the FCT Investigator Programme.
Author details
Raquel Santos1, Ana Salomé Veiga2, Luis Tavares1, Miguel Castanho2 and Manuela Oliveira1*
*Address all correspondence to: moliveira@fmv.ulisboa.pt
1 CIISA/Faculty of Veterinary Medicine of University of Lisbon, Lisbon, Portugal
2 Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon,
Portugal
References
[1] Hadaegh F, Zabetian A, Tohidi M, Ghasemi A, Sheikholeslami F, Azizi F. Prevalence
of metabolic syndrome by the Adult Treatment Panel III, International Diabetes
Federation, and World Health Organization definitions and their association with
Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics
http://dx.doi.org/10.5772/63085
261
showed bactericidal efficacy against planktonic and biofilm cells [85]. Synthetic cationic
antimicrobial peptides, namely NP101 and NP108, also showed in vitro activity against
bacterial species commonly associated with DFU infections, such as S. aureus and P. aerugino‐
sa, as demonstrated by O’Driscoll et al. [86] in 2013. These results suggest that bacteriocins that
act on biofilm-producer cells are highly suitable for the treatment of DFU infections.
However, there are some limitations in the use of AMP as a clinical alternative for Antibiot‐
ics, in spite of the fact that bacteria resistance to AMP is rare, in opposition to what is ob‐
served towards classic antibiotics [87]. This characteristic of AMP is likely to be related to the
ionic interaction between the positively charged AMP and the negatively charged bacteria
membrane. Since these interactions are not dependent of specific protein binding sites, in order
to develop resistance to AMP, bacteria would have to change the basic structure, namely the
lipid bilayer, of its cytoplasmic membrane [88]. Moreover, attachment of the AMP with the
bacterial membrane and consequent cell lysis happens in such a short period of time, render‐
ing the possibility to develop AMP resistance quite scarce [89]. However, there are reports of
distinct species of bacteria, which present resistance towards AMP. The mechanisms of
resistance include degradation of AMP through secretion of proteases; removal of AMP from
their site of action via efflux pumps; production of inhibitors that bind to AMP and prevent
them from reaching their target; and modulation of AMP gene expression [90–92].
Another obstacle to the successful implementation of AMP as an alternative to conventional
antibiotics is the production costs. AMP discovery and development is time consuming,
reaching up to 10 years, and can cost millions of euros or dollars. In fact, production costs are
estimated to be approximately 50-400 American dollars per gram of amino acid [93].
Even so, AMP are still a promising alternative to antibiotics. A possible solution to reduce costs
associated with AMP production is the reduction of the peptide size, maintaining its antimi‐
crobial activity [94]. Moreover, AMP exhibit physiological and functional advantages over
other molecules that make them so attractive to be used in clinical practice. For instance,
physiological concentrations of AMP in vivo are much lower than the minimal inhibitory
concentrations required for its antimicrobial activity in vitro [95]. In fact, AMP are antimicro‐
bial agents with a broad-spectrum activity displayed at micromolar concentrations, usually in
the 1-50 μg/ml range [96]. A plausible justification for this fact may be the synergistic effect
that some AMP possess, which enhances their antimicrobial activity in vivo [97].
For all these reasons, the development of AMP-based therapies to eliminate microbial
pathogens, such as those present in DFU infections, is extremely promising and deserves
further exploration.
5. Conclusive remarks
The severity of diabetic foot infections and the economic burden associated with its preven‐
tion, treatment and control have compelled scientists and clinicians to invest substantial time
and effort in not only understanding how these mechanisms work, but also how they can
interfere with them.
Microbial Biofilms - Importance and Applications260
[14] Burmølle M, Webb JS, Rao D, Hansen LH, Sorensen SJ, Kjelleberg S. Enhanced biofilm
formation and increased resistance to antimicrobial agents and bacterial invasion are
caused by synergistic interactions in multispecies biofilms. Appl Environ Microbiol.
2006; 72(6):3916–3923. DOI: 10.1128/AEM.03022-05
[15] Wenzel RP. The antibiotic pipeline – Challenges, costs and values. N Engl J Med. 2004;
351:523–526. DOI: 10.1056/NEJMp048093
[16] Fleming A. Penicillin: Nobel prize lecture [Internet]. 1945. Available from: http://
www.nobelprize.org/nobel_prizes/medicine/laureates/1945/fleming-lecture.pdf
[Accessed: 2016/02/05].
[17] Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and
responses. Nat Med. 2004; 10(12):122–129. DOI: 10.1038/nm1145
[18] Hoffman LR, D’Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI. Aminoglyco‐
side antibiotics induce bacterial biofilm formation. Nature. 2005;436(7054):1171–1175.
DOI: 10.1038/nature03912
[19] Kaplan JB. Antibiotic-induced biofilm formation. Int J Artif Organs. 2011; 34(9):737–
751. DOI: 10.5301/ijao.5000027
[20] Stewart P, Costerton W. Antibiotic resistance of bacteria in biofilms. Lancet.
2001;358:135–138. DOI: 10.1016/S0140-6736(01)05321-1
[21] Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary biofilm device:
new technology for rapid determination of antibiotic susceptibilities of bacterial
biofilms. J Clin Microbiol. 1999;37(6):1771–1776.
[22] Lipsky B, Berendt A, Cornia P, Pile J, Peters E, Armstrong D, et al. 2012 Infectious
Diseases Society of America clinical practice guideline for the diagnosis and treat‐
ment of diabetic foot infections. Clin Infect Dis. 2012;54(12):132–173. DOI: 10.1093/cid/
cis346
[23] Dang C, Prasad Y, Boulton A, Jude E. Methicillin-resistant Staphylococcus aureus in the
diabetic foot clinic: a worsening problem. Diabet Med. 2003;20:159–161. DOI: 10.1046/j.
1464-5491.2003.00860.x
[24] Stanaway S, Johnson D, Moulik P, Gill G. Methicillin-resistant Staphylococcus aureus
(MRSA) isolation from diabetic foot ulcers correlates with nasal MRSA carriage.
Diabetes Res Clin Pract. 2007;75:47–50. DOI: 10.1016/j.diabres.2006.05.021
[25] Tascini C, Gemignani G, Palumbo F, Leonildi A, Tedeschi A, Lambelet P, et al. Clinical
and microbiological efficacy of colistin therapy alone or in combination as treatment
for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or with‐
out osteomyelitis. J Chemother. 2006;18:648–651. DOI: 10.1179/joc.2006.18.6.648
Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics
http://dx.doi.org/10.5772/63085
263
coronary heart disease in an elderly Iranian population. Ann Acad Med Singapore.
2009; 38(2):142–149.
[2] Jeffcoate W, Harding K. Diabetic foot ulcers. Lancet. 2003; 361(9368):1545–1551. DOI:
10.1016/S0140-6736(3)13169–8
[3] Vuorisalo S, Venermo M, Lepäntalo M. Treatment of diabetic foot ulcers. J Cardio‐
vasc Surg (Torino). 2009; 50(3):275–291.
[4] Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus
(DM). FEMS Immunol Med Microbiol. 1999; 26(3–4):259–265. DOI: 10.1111/j.1574-695X.
1999.tb01397.x
[5] Lipsky B, Berendt A, Deery H, Embil J, Joseph W, Karchmer A, et al. Diagnosis and
treatment of diabetic foot infections. Clin Infect Dis. 2004; 39(7):885–910. DOI:
10.1086/424846
[6] Ismail K, Winkley K, Stahl D, Chalder T, Edmonds M. A cohort study of people with
diabetes and their first foot ulcer: the role of depression on mortality. Diabetes Care.
2007; 30(6):1473–1479. DOI: 10.2337/dc06-2313
[7] Spichler A, Hurwitz B, Armstrong D, Lipsky B. Microbiology of diabetic foot infec‐
tions: from Louis Pasteur to ‘crime scene investigation’. BMC Med. 2015; 7:2–13. DOI:
10.1186/s12916-014-0232-0
[8] Banu A, Noorul M, Rajkumar J, Srinivasa S. Spectrum of bacteria associated with
diabetic foot ulcer and biofilm formation: a prospective study. Australas Med J.
2015;8(9):280–285. DOI: 10.4066/AMJ.2015.2422
[9] Mendes J, Leandro C, Mottola C, Barbosa R, Silva F, Oliveira M, Vilela C, et al. In vitro
design of a novel lytic bacteriophage cocktail with therapeutic potential against
organisms causing diabetic foot infections. J Med Microbiol. 2014;63(Pt 8):1055–1065.
DOI: 10.1099/jmm.0.071753-0
[10] James G, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, et al. Biofilms in chronic
wounds. Wound Repair Regen. 2008; 16(1):37–44. DOI: 10.1111/j.1524-475X.
2007.00321.x
[11] Dickschat JS. Quorum sensing and bacterial biofilms. Nat Prod Rep. 2010; 27(3):343–
369. DOI: 10.1039/b804469b
[12] Lipsky B, Holroyd K, Zasloff M. Topical versus systemic antimicrobial therapy for
treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded,
multicenter trial of pexiganan cream. Clin Infect Dis. 2008; 47(12):1537–1545. DOI:
10.1086/593185
[13] Bridier A, Dubois-Brissonnet F, Greub G, Thomas V, Briandet R. Dynamics of the action
of biocides in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2011;
55(6):2648–2654. DOI: 10.1128/AAC.01760-10
Microbial Biofilms - Importance and Applications262
[14] Burmølle M, Webb JS, Rao D, Hansen LH, Sorensen SJ, Kjelleberg S. Enhanced biofilm
formation and increased resistance to antimicrobial agents and bacterial invasion are
caused by synergistic interactions in multispecies biofilms. Appl Environ Microbiol.
2006; 72(6):3916–3923. DOI: 10.1128/AEM.03022-05
[15] Wenzel RP. The antibiotic pipeline – Challenges, costs and values. N Engl J Med. 2004;
351:523–526. DOI: 10.1056/NEJMp048093
[16] Fleming A. Penicillin: Nobel prize lecture [Internet]. 1945. Available from: http://
www.nobelprize.org/nobel_prizes/medicine/laureates/1945/fleming-lecture.pdf
[Accessed: 2016/02/05].
[17] Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and
responses. Nat Med. 2004; 10(12):122–129. DOI: 10.1038/nm1145
[18] Hoffman LR, D’Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI. Aminoglyco‐
side antibiotics induce bacterial biofilm formation. Nature. 2005;436(7054):1171–1175.
DOI: 10.1038/nature03912
[19] Kaplan JB. Antibiotic-induced biofilm formation. Int J Artif Organs. 2011; 34(9):737–
751. DOI: 10.5301/ijao.5000027
[20] Stewart P, Costerton W. Antibiotic resistance of bacteria in biofilms. Lancet.
2001;358:135–138. DOI: 10.1016/S0140-6736(01)05321-1
[21] Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary biofilm device:
new technology for rapid determination of antibiotic susceptibilities of bacterial
biofilms. J Clin Microbiol. 1999;37(6):1771–1776.
[22] Lipsky B, Berendt A, Cornia P, Pile J, Peters E, Armstrong D, et al. 2012 Infectious
Diseases Society of America clinical practice guideline for the diagnosis and treat‐
ment of diabetic foot infections. Clin Infect Dis. 2012;54(12):132–173. DOI: 10.1093/cid/
cis346
[23] Dang C, Prasad Y, Boulton A, Jude E. Methicillin-resistant Staphylococcus aureus in the
diabetic foot clinic: a worsening problem. Diabet Med. 2003;20:159–161. DOI: 10.1046/j.
1464-5491.2003.00860.x
[24] Stanaway S, Johnson D, Moulik P, Gill G. Methicillin-resistant Staphylococcus aureus
(MRSA) isolation from diabetic foot ulcers correlates with nasal MRSA carriage.
Diabetes Res Clin Pract. 2007;75:47–50. DOI: 10.1016/j.diabres.2006.05.021
[25] Tascini C, Gemignani G, Palumbo F, Leonildi A, Tedeschi A, Lambelet P, et al. Clinical
and microbiological efficacy of colistin therapy alone or in combination as treatment
for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or with‐
out osteomyelitis. J Chemother. 2006;18:648–651. DOI: 10.1179/joc.2006.18.6.648
Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics
http://dx.doi.org/10.5772/63085
263
coronary heart disease in an elderly Iranian population. Ann Acad Med Singapore.
2009; 38(2):142–149.
[2] Jeffcoate W, Harding K. Diabetic foot ulcers. Lancet. 2003; 361(9368):1545–1551. DOI:
10.1016/S0140-6736(3)13169–8
[3] Vuorisalo S, Venermo M, Lepäntalo M. Treatment of diabetic foot ulcers. J Cardio‐
vasc Surg (Torino). 2009; 50(3):275–291.
[4] Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus
(DM). FEMS Immunol Med Microbiol. 1999; 26(3–4):259–265. DOI: 10.1111/j.1574-695X.
1999.tb01397.x
[5] Lipsky B, Berendt A, Deery H, Embil J, Joseph W, Karchmer A, et al. Diagnosis and
treatment of diabetic foot infections. Clin Infect Dis. 2004; 39(7):885–910. DOI:
10.1086/424846
[6] Ismail K, Winkley K, Stahl D, Chalder T, Edmonds M. A cohort study of people with
diabetes and their first foot ulcer: the role of depression on mortality. Diabetes Care.
2007; 30(6):1473–1479. DOI: 10.2337/dc06-2313
[7] Spichler A, Hurwitz B, Armstrong D, Lipsky B. Microbiology of diabetic foot infec‐
tions: from Louis Pasteur to ‘crime scene investigation’. BMC Med. 2015; 7:2–13. DOI:
10.1186/s12916-014-0232-0
[8] Banu A, Noorul M, Rajkumar J, Srinivasa S. Spectrum of bacteria associated with
diabetic foot ulcer and biofilm formation: a prospective study. Australas Med J.
2015;8(9):280–285. DOI: 10.4066/AMJ.2015.2422
[9] Mendes J, Leandro C, Mottola C, Barbosa R, Silva F, Oliveira M, Vilela C, et al. In vitro
design of a novel lytic bacteriophage cocktail with therapeutic potential against
organisms causing diabetic foot infections. J Med Microbiol. 2014;63(Pt 8):1055–1065.
DOI: 10.1099/jmm.0.071753-0
[10] James G, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, et al. Biofilms in chronic
wounds. Wound Repair Regen. 2008; 16(1):37–44. DOI: 10.1111/j.1524-475X.
2007.00321.x
[11] Dickschat JS. Quorum sensing and bacterial biofilms. Nat Prod Rep. 2010; 27(3):343–
369. DOI: 10.1039/b804469b
[12] Lipsky B, Holroyd K, Zasloff M. Topical versus systemic antimicrobial therapy for
treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded,
multicenter trial of pexiganan cream. Clin Infect Dis. 2008; 47(12):1537–1545. DOI:
10.1086/593185
[13] Bridier A, Dubois-Brissonnet F, Greub G, Thomas V, Briandet R. Dynamics of the action
of biocides in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2011;
55(6):2648–2654. DOI: 10.1128/AAC.01760-10
Microbial Biofilms - Importance and Applications262
[40] Azizpour K, Bahrambeygi S, Mahmoodpour S, Azizpour A. History and basic of
probiotics. Res J Biological Sci. 2009;4(4):409–426.
[41] Kingsley CA, Gregor R. Probiotics: 100 years (1907–2007) after Elie Metchnikoff's
observation. In: Méndez-Vilas A, editor. Communicating Current Research and
Educational Topics and Trends in Applied Microbiology. 1st ed. Spain: Formatex.org;
2007. p. 466–474.
[42] Tissier H. The treatment of intestinal infections by the method of transformation of
bacterial intestinal flora. C R Soc Biol. 1906;60:359–361.
[43] FAO/WHO Working Group. Guidelines for the evaluation of probiotics in food
[Internet]. 2002. Available from http://www.who.int/foodsafety/fs_management/en/
probiotic_guidelines.pdf [Accessed: 2016/02/05]
[44] Oelschlaeger T. Mechanisms of probiotic actions – a review. Int J Med Microbiol.
2010;300(1):57–62. DOI: 10.1016/j.ijmm.2009.08.005
[45] Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach J, Hörmannsperg‐
er G, et al. Safety assessment of probiotics for human use. Gut Microbes. 2010:1(3):164–
185. DOI: 10.4161/gmic.1.3.12127
[46] Conway P. Selection criteria for probiotic microorganisms. Asia Pacific J Clin Nutr.
1996;5:10–14.
[47] Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S. Quality assurance criteria
for probiotic bacteria. Am J Clin Nutr. 2001;73:393–398.
[48] Donovan SM, Schneeman B, Gibson GR, Sanders ME. Establishing and evaluating
health claims for probiotics. Adv Nutr. 2012;3(5):723–725. DOI: 10.3945/an.112.002592
[49] Hickson M. Examining the evidence for the use of probiotics in clinical practice. Nurs
Stand. 2013;27(29):35–41. DOI: 10.7748/ns2013.03.27.29.35.e6363
[50] Singh Y, Ahmad J, Musarrat J, Ehtesham N, Hasnain S. Emerging importance of
holobionts in evolution and in probiotics. Gut Pathog. 2013;5(1):12. DOI:
10.1186/1757-4749-5-12
[51] Salminen S, Isolauri E, Salminen E. Clinical uses of probiotics for stabilizing the gut
mucosal barrier: successful strains and future challenges. Antonie van Leeuwenhoek.
1996;70(2–4):347–358. DOI: 10.1007/BF00395941
[52] Finegold SM, Sutter VL, Mathisen GE. Normal indigenous intestinal flora. In: Hentges
DJ, editors. Human intestinal microflora in health and disease. 2nd ed. New York:
Academic Press; 1983. p. 3–31. DOI: 10.1016/B978-0-12-341280-5.50007-0
[53] Endres JR, Qureshi I, Farber T, Hauswirth J, Hirka G, Pasics I, et al. One-year chronic
oral toxicity with combined reproduction toxicity study of a novel probiotic, Bacillus
coagulans, as a food ingredient. Food Chem Toxicol. 2011;49(5):1174–1182. DOI: 10.1016/
j.fct.2011.02.012
Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics
http://dx.doi.org/10.5772/63085
265
[26] Kandemir O, Akbay E, Sahin E, Milcan A, Gen R. Risk factors for infection of the diabetic
foot with multi-antibiotic resistant microorganisms. J Infect. 2007;54:439–445. DOI:
10.1016/j.jinf.2006.08.013
[27] Richard J, Sotto A, Jourdan N, Combescure C, Vannereau D, Rodier M, et al. Risk factors
and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. Diabetes
Metab. 2008;34:363–369. DOI: 10.1016/j.diabet.2008.02.005
[28] Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial
biofilms. Annu Rev Microbiol. 1995;49:711–745. DOI: 10.1146/annurev.mi.
49.100195.003431
[29] Twort FW. Investigation on the nature of the ultramicroscopic viruses. Lancet.
1915;186:1241–1243. DOI: 10.1016/S0140-6736(01)20383-3
[30] d’Herelle F. Sur le rôle du microbe bactériophage dans la typhose aviaire. C R Acad Sci.
1919;169:932–934.
[31] Sulakvelidze A, Kutter E. Bacteriophage therapy in humans. In: Kutter E, Sulakve‐
lidze A, editors. Bacteriophages: Biology and Application. 1st ed. Florida: CRC Press;
2004. p. 381–436. DOI: 10.1201/9780203491751.ch14
[32] Njoroge J, Sperandio V. Jamming bacterial communication: new approaches for the
treatment of infectious diseases. EMBO Mol Med. 2009;1(4):201–210. DOI: 10.1002/
emmm.200900032
[33] Sillankorva S, Oliveira R, Vieira M, Sutherland I, Azeredo J. Bacteriophage Phi S1
infection of Pseudomonas fluorescens planktonic cells versus biofilms. Biofouling.
2004;20(3):133–138. DOI: 10.1080/08927010410001723834
[34] Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon S. Phage
therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol.
2010;11: 69–86. DOI: 10.2174/138920110790725401
[35] Bruynoghe R, Maisin J. Essais de thérapeutique au moyen du bacteriophage. C R Soc
Biol. 1921;85:1120–1121.
[36] Chopra I, Hodgson J, Metcalf B, Poste G. The search for antimicrobial agents effective
against bacteria resistant to multiple antibiotics. Antimicrob Agents Chemother.
1997;41:497–503.
[37] Mendes J, Leandro C, Corte-Real S, Barbosa R, Cavaco-Silva P, Melo-Cristino, et al.
Wound healing potential of topical bacteriophage therapy on diabetic cutaneous
wounds. Wound Repair Regen. 2013; 21: 595–603. DOI: 10.1111/wrr.12056
[38] Leone S, Pascale R, Vitale M, Esposito S. Epidemiology of diabetic foot. Infez Med. 2012;
20 (Suppl. 1): 8–13.
[39] Metchnikoff E. The prolongation of life: Optimistic studies. 1st ed. New York and
London: G. P. Putman's Sons; 1908. p. 161–183.
Microbial Biofilms - Importance and Applications264
[40] Azizpour K, Bahrambeygi S, Mahmoodpour S, Azizpour A. History and basic of
probiotics. Res J Biological Sci. 2009;4(4):409–426.
[41] Kingsley CA, Gregor R. Probiotics: 100 years (1907–2007) after Elie Metchnikoff's
observation. In: Méndez-Vilas A, editor. Communicating Current Research and
Educational Topics and Trends in Applied Microbiology. 1st ed. Spain: Formatex.org;
2007. p. 466–474.
[42] Tissier H. The treatment of intestinal infections by the method of transformation of
bacterial intestinal flora. C R Soc Biol. 1906;60:359–361.
[43] FAO/WHO Working Group. Guidelines for the evaluation of probiotics in food
[Internet]. 2002. Available from http://www.who.int/foodsafety/fs_management/en/
probiotic_guidelines.pdf [Accessed: 2016/02/05]
[44] Oelschlaeger T. Mechanisms of probiotic actions – a review. Int J Med Microbiol.
2010;300(1):57–62. DOI: 10.1016/j.ijmm.2009.08.005
[45] Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach J, Hörmannsperg‐
er G, et al. Safety assessment of probiotics for human use. Gut Microbes. 2010:1(3):164–
185. DOI: 10.4161/gmic.1.3.12127
[46] Conway P. Selection criteria for probiotic microorganisms. Asia Pacific J Clin Nutr.
1996;5:10–14.
[47] Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S. Quality assurance criteria
for probiotic bacteria. Am J Clin Nutr. 2001;73:393–398.
[48] Donovan SM, Schneeman B, Gibson GR, Sanders ME. Establishing and evaluating
health claims for probiotics. Adv Nutr. 2012;3(5):723–725. DOI: 10.3945/an.112.002592
[49] Hickson M. Examining the evidence for the use of probiotics in clinical practice. Nurs
Stand. 2013;27(29):35–41. DOI: 10.7748/ns2013.03.27.29.35.e6363
[50] Singh Y, Ahmad J, Musarrat J, Ehtesham N, Hasnain S. Emerging importance of
holobionts in evolution and in probiotics. Gut Pathog. 2013;5(1):12. DOI:
10.1186/1757-4749-5-12
[51] Salminen S, Isolauri E, Salminen E. Clinical uses of probiotics for stabilizing the gut
mucosal barrier: successful strains and future challenges. Antonie van Leeuwenhoek.
1996;70(2–4):347–358. DOI: 10.1007/BF00395941
[52] Finegold SM, Sutter VL, Mathisen GE. Normal indigenous intestinal flora. In: Hentges
DJ, editors. Human intestinal microflora in health and disease. 2nd ed. New York:
Academic Press; 1983. p. 3–31. DOI: 10.1016/B978-0-12-341280-5.50007-0
[53] Endres JR, Qureshi I, Farber T, Hauswirth J, Hirka G, Pasics I, et al. One-year chronic
oral toxicity with combined reproduction toxicity study of a novel probiotic, Bacillus
coagulans, as a food ingredient. Food Chem Toxicol. 2011;49(5):1174–1182. DOI: 10.1016/
j.fct.2011.02.012
Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics
http://dx.doi.org/10.5772/63085
265
[26] Kandemir O, Akbay E, Sahin E, Milcan A, Gen R. Risk factors for infection of the diabetic
foot with multi-antibiotic resistant microorganisms. J Infect. 2007;54:439–445. DOI:
10.1016/j.jinf.2006.08.013
[27] Richard J, Sotto A, Jourdan N, Combescure C, Vannereau D, Rodier M, et al. Risk factors
and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. Diabetes
Metab. 2008;34:363–369. DOI: 10.1016/j.diabet.2008.02.005
[28] Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial
biofilms. Annu Rev Microbiol. 1995;49:711–745. DOI: 10.1146/annurev.mi.
49.100195.003431
[29] Twort FW. Investigation on the nature of the ultramicroscopic viruses. Lancet.
1915;186:1241–1243. DOI: 10.1016/S0140-6736(01)20383-3
[30] d’Herelle F. Sur le rôle du microbe bactériophage dans la typhose aviaire. C R Acad Sci.
1919;169:932–934.
[31] Sulakvelidze A, Kutter E. Bacteriophage therapy in humans. In: Kutter E, Sulakve‐
lidze A, editors. Bacteriophages: Biology and Application. 1st ed. Florida: CRC Press;
2004. p. 381–436. DOI: 10.1201/9780203491751.ch14
[32] Njoroge J, Sperandio V. Jamming bacterial communication: new approaches for the
treatment of infectious diseases. EMBO Mol Med. 2009;1(4):201–210. DOI: 10.1002/
emmm.200900032
[33] Sillankorva S, Oliveira R, Vieira M, Sutherland I, Azeredo J. Bacteriophage Phi S1
infection of Pseudomonas fluorescens planktonic cells versus biofilms. Biofouling.
2004;20(3):133–138. DOI: 10.1080/08927010410001723834
[34] Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon S. Phage
therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol.
2010;11: 69–86. DOI: 10.2174/138920110790725401
[35] Bruynoghe R, Maisin J. Essais de thérapeutique au moyen du bacteriophage. C R Soc
Biol. 1921;85:1120–1121.
[36] Chopra I, Hodgson J, Metcalf B, Poste G. The search for antimicrobial agents effective
against bacteria resistant to multiple antibiotics. Antimicrob Agents Chemother.
1997;41:497–503.
[37] Mendes J, Leandro C, Corte-Real S, Barbosa R, Cavaco-Silva P, Melo-Cristino, et al.
Wound healing potential of topical bacteriophage therapy on diabetic cutaneous
wounds. Wound Repair Regen. 2013; 21: 595–603. DOI: 10.1111/wrr.12056
[38] Leone S, Pascale R, Vitale M, Esposito S. Epidemiology of diabetic foot. Infez Med. 2012;
20 (Suppl. 1): 8–13.
[39] Metchnikoff E. The prolongation of life: Optimistic studies. 1st ed. New York and
London: G. P. Putman's Sons; 1908. p. 161–183.
Microbial Biofilms - Importance and Applications264
[67] Hou S, Liu Z, Young AW, Mark SL, Kallenbach NR, Ren D. Effects of Trp- and Arg-
containing antimicrobial-peptide structure on inhibition of Escherichia coli plankton‐
ic growth and biofilm formation. Appl Environ Microbiol. 2010;76(6):1967–1974. DOI:
10.1128/AEM.02321-09
[68] Gaspar D, Veiga AS, Castanho MA. From antimicrobial to anticancer peptides. A
review. Front Microbiol. 2013;4:294. DOI: 10.3389/fmicb.2013.00294
[69] Wimley WC. Describing the mechanism of antimicrobial peptide action with the
interfacial activity model. ACS Chem Biol. 2010;5(10):905–917. DOI: 10.1021/cb1001558
[70] Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, Pag U, et al. Plectasin, a fungal
defensin, targets the bacterial cell wall precursor Lipid II. Science. 2010;328:1168–1172.
DOI: 10.1126/science.1185723
[71] Brogden K. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Nat Rev Microbiol. 2005;3:238–250. DOI: 10.1038/nrmicro1098
[72] Subbalakshmi C, Sitaram N. Mechanism of antimicrobial action of indolicidin. FEMS
Microbiol Lett. 1998;160(1):91–96. DOI: 10.1111/j.1574-6968.1998.tb12896.x
[73] Nijnik A, Hancock R. The roles of cathelicidin LL-37 in immune defences and novel
clinical applications. Curr Opin Hematol. 2009;16:41–47. DOI: 10.1097/MOH.
0b013e32831ac517
[74] Lai Y, Gallo R. AMPed up immunity: how antimicrobial peptides have multiple roles
in immune defense. Trends Immunol. 2009;30:131–141. DOI: 10.1016/j.it.2008.12.003
[75] Bowdish D, Davidson D, Hancock R. A re-evaluation of the role of host defence
peptides in mammalian immunity. Curr Protein Pept Sci. 2005;6:35–51. DOI:
10.2174/1389203053027494
[76] Bowdish D, Davidson D, Hancock R. Immunomodulatory properties of defensins and
cathelicidins. In: Shafer W, editors. Antimicrobial peptides and human disease. 1st ed.
Berlin: Springer; 2006. p. 27–66. DOI: 10.1007/3-540-29916-5_2
[77] Davidson D, Currie A, Reid G, Bowdish D, MacDonald K, Ma R, et al. The cationic
antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-
induced T cell polarization. J Immunol. 2004;172(2):1146–1156. DOI: 10.4049/jimmu‐
nol.172.2.1146
[78] Nijnik A, Pistolic J, Wyatt A, Tam S, Hancock R. Human cathelicidin peptide LL-37
modulates the effects of IFN-gamma on APCs. J Immunol. 2009;183:5788–5798. DOI:
10.4049/jimmunol.0901491
[79] Heilborn J, Nilsson M, Kratz G, Weber G, Sørensen O, Stähle-Bäckdahl M, et al. The
cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human
skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol.
2003;120:379–389. DOI: 10.1046/j.1523-1747.2003.12069.x
Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics
http://dx.doi.org/10.5772/63085
267
[54] Franz CM, Huch M, Abriouel H, Holzapfel W, Gálvez A. Enterococci as probiotics and
their implications in food safety. Int J Food Microbiol. 2011;151(2):125–140. DOI:
10.1016/j.ijfoodmicro.2011.08.014
[55] Psomas E, Andrighetto C, Litopoulou-Tzanetaki E, Lombardi A, Tzanetakis N. Some
probiotic properties of yeast isolates from infant faeces and Feta cheese. Int J Food
Microbiol. 2001;69(1–2):125–133. DOI: 10.1016/S0168-1605(01)00580-3
[56] Ljungh A, Wadström T. Lactic acid bacteria as probiotics. Curr Issues Intest Micro‐
biol. 2006;7(2):73–89.
[57] Peral M, Rachid M, Gobbato N, Huaman M, Valdéz J. Interleukin-8 production by
polymorphonuclear leukocytes from patients with chronic infected leg ulcers treated
with Lactobacillus plantarum. Clin Microbiol Infect. 2010;16(3):281–286. DOI: 10.1111/j.
1469-0691.2009.02793.x
[58] Valdéz J, Peral M, Rachid M, Santana M, Perdigón G. Interference of Lactobacillus
plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use
of probiotics in wound treatment. Clin Microbiol Infect. 2005;11(6):472–429. DOI:
10.1111/j.1469-0691.2005.01142.x
[59] Varma P, Nisha N, Dinesh K, Kumar A, Biswas R. Anti-infective properties of
Lactobacillus fermentum against Staphylococcus aureus and Pseudomonas aeruginosa. J Mol
Microbiol Biotechnol. 2011;20(3):137–143. DOI: 10.1159/000328512
[60] Sikorska H, Smoragiewicz W. Role of probiotics in the prevention and treatment of
methicillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents.
2013;42(6):475–481. DOI: 10.1016/j.ijantimicag.2013.08.003
[61] Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389–
395. DOI: 10.1038/415389a
[62] Hancock R, Sahl H. Antimicrobial and host-defense peptides as new anti-infective
therapeutic strategies. Nat Biotechnol. 2006;24:1551–1557. DOI: 10.1038/nbt1267
[63] Rosenfeld Y, Papo N, Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate
immunity host-defense peptides: Peptide properties and plausible modes of action. J
Biol Chem. 2006;281:1636–1643. DOI: 10.1074/jbc.M504327200
[64] Kirikae T, Hirata M, Yamasu H, Kirikae F, Tamura H, Kayama F, et al. Protective effects
of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide
against murine endotoxemia. Infect Immun. 1998;66:1861–1868.
[65] Overhage J, Campisano A, Bains M, Torfs E, Rehm B, Hancock R. Human host defense
peptide LL-37 prevents bacterial biofilm formation. Infect Immun. 2008;76:4176–4182.
DOI: 10.1128/IAI.00318-08
[66] Baltzer SA, Brown MH. Antimicrobial peptides: promising alternatives to convention‐
al antibiotics. J Mol Microbiol Biotechnol. 2011;20(4): 228–235. DOI: 10.1159/000331009
Microbial Biofilms - Importance and Applications266
[67] Hou S, Liu Z, Young AW, Mark SL, Kallenbach NR, Ren D. Effects of Trp- and Arg-
containing antimicrobial-peptide structure on inhibition of Escherichia coli plankton‐
ic growth and biofilm formation. Appl Environ Microbiol. 2010;76(6):1967–1974. DOI:
10.1128/AEM.02321-09
[68] Gaspar D, Veiga AS, Castanho MA. From antimicrobial to anticancer peptides. A
review. Front Microbiol. 2013;4:294. DOI: 10.3389/fmicb.2013.00294
[69] Wimley WC. Describing the mechanism of antimicrobial peptide action with the
interfacial activity model. ACS Chem Biol. 2010;5(10):905–917. DOI: 10.1021/cb1001558
[70] Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, Pag U, et al. Plectasin, a fungal
defensin, targets the bacterial cell wall precursor Lipid II. Science. 2010;328:1168–1172.
DOI: 10.1126/science.1185723
[71] Brogden K. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Nat Rev Microbiol. 2005;3:238–250. DOI: 10.1038/nrmicro1098
[72] Subbalakshmi C, Sitaram N. Mechanism of antimicrobial action of indolicidin. FEMS
Microbiol Lett. 1998;160(1):91–96. DOI: 10.1111/j.1574-6968.1998.tb12896.x
[73] Nijnik A, Hancock R. The roles of cathelicidin LL-37 in immune defences and novel
clinical applications. Curr Opin Hematol. 2009;16:41–47. DOI: 10.1097/MOH.
0b013e32831ac517
[74] Lai Y, Gallo R. AMPed up immunity: how antimicrobial peptides have multiple roles
in immune defense. Trends Immunol. 2009;30:131–141. DOI: 10.1016/j.it.2008.12.003
[75] Bowdish D, Davidson D, Hancock R. A re-evaluation of the role of host defence
peptides in mammalian immunity. Curr Protein Pept Sci. 2005;6:35–51. DOI:
10.2174/1389203053027494
[76] Bowdish D, Davidson D, Hancock R. Immunomodulatory properties of defensins and
cathelicidins. In: Shafer W, editors. Antimicrobial peptides and human disease. 1st ed.
Berlin: Springer; 2006. p. 27–66. DOI: 10.1007/3-540-29916-5_2
[77] Davidson D, Currie A, Reid G, Bowdish D, MacDonald K, Ma R, et al. The cationic
antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-
induced T cell polarization. J Immunol. 2004;172(2):1146–1156. DOI: 10.4049/jimmu‐
nol.172.2.1146
[78] Nijnik A, Pistolic J, Wyatt A, Tam S, Hancock R. Human cathelicidin peptide LL-37
modulates the effects of IFN-gamma on APCs. J Immunol. 2009;183:5788–5798. DOI:
10.4049/jimmunol.0901491
[79] Heilborn J, Nilsson M, Kratz G, Weber G, Sørensen O, Stähle-Bäckdahl M, et al. The
cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human
skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol.
2003;120:379–389. DOI: 10.1046/j.1523-1747.2003.12069.x
Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics
http://dx.doi.org/10.5772/63085
267
[54] Franz CM, Huch M, Abriouel H, Holzapfel W, Gálvez A. Enterococci as probiotics and
their implications in food safety. Int J Food Microbiol. 2011;151(2):125–140. DOI:
10.1016/j.ijfoodmicro.2011.08.014
[55] Psomas E, Andrighetto C, Litopoulou-Tzanetaki E, Lombardi A, Tzanetakis N. Some
probiotic properties of yeast isolates from infant faeces and Feta cheese. Int J Food
Microbiol. 2001;69(1–2):125–133. DOI: 10.1016/S0168-1605(01)00580-3
[56] Ljungh A, Wadström T. Lactic acid bacteria as probiotics. Curr Issues Intest Micro‐
biol. 2006;7(2):73–89.
[57] Peral M, Rachid M, Gobbato N, Huaman M, Valdéz J. Interleukin-8 production by
polymorphonuclear leukocytes from patients with chronic infected leg ulcers treated
with Lactobacillus plantarum. Clin Microbiol Infect. 2010;16(3):281–286. DOI: 10.1111/j.
1469-0691.2009.02793.x
[58] Valdéz J, Peral M, Rachid M, Santana M, Perdigón G. Interference of Lactobacillus
plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use
of probiotics in wound treatment. Clin Microbiol Infect. 2005;11(6):472–429. DOI:
10.1111/j.1469-0691.2005.01142.x
[59] Varma P, Nisha N, Dinesh K, Kumar A, Biswas R. Anti-infective properties of
Lactobacillus fermentum against Staphylococcus aureus and Pseudomonas aeruginosa. J Mol
Microbiol Biotechnol. 2011;20(3):137–143. DOI: 10.1159/000328512
[60] Sikorska H, Smoragiewicz W. Role of probiotics in the prevention and treatment of
methicillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents.
2013;42(6):475–481. DOI: 10.1016/j.ijantimicag.2013.08.003
[61] Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389–
395. DOI: 10.1038/415389a
[62] Hancock R, Sahl H. Antimicrobial and host-defense peptides as new anti-infective
therapeutic strategies. Nat Biotechnol. 2006;24:1551–1557. DOI: 10.1038/nbt1267
[63] Rosenfeld Y, Papo N, Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate
immunity host-defense peptides: Peptide properties and plausible modes of action. J
Biol Chem. 2006;281:1636–1643. DOI: 10.1074/jbc.M504327200
[64] Kirikae T, Hirata M, Yamasu H, Kirikae F, Tamura H, Kayama F, et al. Protective effects
of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide
against murine endotoxemia. Infect Immun. 1998;66:1861–1868.
[65] Overhage J, Campisano A, Bains M, Torfs E, Rehm B, Hancock R. Human host defense
peptide LL-37 prevents bacterial biofilm formation. Infect Immun. 2008;76:4176–4182.
DOI: 10.1128/IAI.00318-08
[66] Baltzer SA, Brown MH. Antimicrobial peptides: promising alternatives to convention‐
al antibiotics. J Mol Microbiol Biotechnol. 2011;20(4): 228–235. DOI: 10.1159/000331009
Microbial Biofilms - Importance and Applications266
[94] Seo MD, Won HS, Kim JH, Mishig-Ochir T, Lee BJ. Antimicrobial peptides for
therapeutic applications: a review. Molecules. 2012;17(10):12276–12286. DOI: 10.3390/
molecules171012276
[95] Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles
in immune defense. Trends Immunol. 2009;30(3):131–141. DOI: 10.1016/j.it.2008.12.003
[96] Diamond G, Beckloff N, Weinberg A, Kisich KO. The roles of antimicrobial peptides in
innate host defense. Curr Pharm Des. 2009;15(21):2377–2392. DOI:
10.2174/138161209788682325
[97] Cassone M, Otvos L Jr. Synergy among antibacterial peptides and between peptides
and small molecule antibiotics. Expert Rev Anti Infect Ther. 2010;8(6):703–716. DOI:
10.1586/eri.10.38
Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics
http://dx.doi.org/10.5772/63085
269
[80] Koczulla R, von Degenfeld G, Kupatt C, Krötz F, Zahler S, Gloe T, et al. An angiogen‐
ic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest. 2003;111:1665–
1672. DOI: 10.1172/JCI17545
[81] Hancock R, Chapple D. Peptide antibiotics. Antimicrob Agents Chemother.
1999;43:1317–1323. DOI: 10.1016/S0140-6736(97)80051-7
[82] Cotter D, Hill C, Ross P. Bacteriocins: developing innate immunity for food. Nat Rev
Microbiol. 2005;3:777–788. DOI: 10.1038/nrmicro1273
[83] Gause G. Gramicidin S. Lancet. 1946;2:46.
[84] Cleveland J, Montville T, Nes I, Chikindas M. Bacteriocins: safe, natural antimicrobi‐
als for food preservation. Int J Food Microbiol. 2001;71:1–20. DOI: 10.1016/
S0168-1605(01)00560-8
[85] Okuda K, Zendo T, Sugimoto S, Iwase T, Tajima A, Yamada S, et al. Effects of bacter‐
iocins on methicillin-resistant Staphylococcus aureus biofilm. Antimicrob Agents
Chemother. 2013;57(11):5572–5579. DOI: 10.1128/AAC.00888-13
[86] O’Driscoll N, Labovitiadi O, Cushnie TP, Matthews K, Mercer D, Lamb A. Produc‐
tion and evaluation of an antimicrobial peptide-containing wafer formulation for
topical application. Curr Microbiol. 2013;66(3):271–278. DOI: 10.1007/
s00284-012-0268-3
[87] Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance.
Pharmacol Rev. 2003;55(1):27–55. DOI: 10.1124/pr.55.1.2
[88] Wimley WC, Hristova K. Antimicrobial peptides: successes, challenges and unan‐
swered questions. J Membr Biol. 2011;239(1–2):27–34. DOI: 10.1007/s00232-011-9343-0
[89] Fernebro J. Fighting bacterial infections-future treatment options. Drug Resist Updat.
2011;14(2):125–139. DOI: 10.1016/j.drup.2011.02.001
[90] Otto M. Bacterial sensing of antimicrobial peptides. Contrib Microbiol. 2009;16:136–
149. DOI: 10.1159/000219377
[91] Guilhelmelli F, Vilela N, Albuquerque P, Derengowski LdaS, Silva-Pereira I, Kyaw CM.
Antibiotic development challenges: the various mechanisms of action of antimicrobi‐
al peptides and of bacterial resistance. Front Microbiol. 2013;4:353. DOI: 10.3389/
fmicb.2013.00353
[92] Nawrocki KL, Crispell EK, McBride SM. Antimicrobial peptide resistance mecha‐
nisms of grampositive bacteria. Antibiotics (Basel). 2014;3(4):461–492. DOI: 10.3390/
antibiotics3040461
[93] Marr AK, Gooderham WJ, Hancock RE. Antibacterial peptides for therapeutic use:
obstacles and realistic outlook. Curr Opin Pharmacol. 2006;6(5):468–472. DOI: 10.1016/
j.coph.2006.04.006
Microbial Biofilms - Importance and Applications268
[94] Seo MD, Won HS, Kim JH, Mishig-Ochir T, Lee BJ. Antimicrobial peptides for
therapeutic applications: a review. Molecules. 2012;17(10):12276–12286. DOI: 10.3390/
molecules171012276
[95] Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles
in immune defense. Trends Immunol. 2009;30(3):131–141. DOI: 10.1016/j.it.2008.12.003
[96] Diamond G, Beckloff N, Weinberg A, Kisich KO. The roles of antimicrobial peptides in
innate host defense. Curr Pharm Des. 2009;15(21):2377–2392. DOI:
10.2174/138161209788682325
[97] Cassone M, Otvos L Jr. Synergy among antibacterial peptides and between peptides
and small molecule antibiotics. Expert Rev Anti Infect Ther. 2010;8(6):703–716. DOI:
10.1586/eri.10.38
Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics
http://dx.doi.org/10.5772/63085
269
[80] Koczulla R, von Degenfeld G, Kupatt C, Krötz F, Zahler S, Gloe T, et al. An angiogen‐
ic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest. 2003;111:1665–
1672. DOI: 10.1172/JCI17545
[81] Hancock R, Chapple D. Peptide antibiotics. Antimicrob Agents Chemother.
1999;43:1317–1323. DOI: 10.1016/S0140-6736(97)80051-7
[82] Cotter D, Hill C, Ross P. Bacteriocins: developing innate immunity for food. Nat Rev
Microbiol. 2005;3:777–788. DOI: 10.1038/nrmicro1273
[83] Gause G. Gramicidin S. Lancet. 1946;2:46.
[84] Cleveland J, Montville T, Nes I, Chikindas M. Bacteriocins: safe, natural antimicrobi‐
als for food preservation. Int J Food Microbiol. 2001;71:1–20. DOI: 10.1016/
S0168-1605(01)00560-8
[85] Okuda K, Zendo T, Sugimoto S, Iwase T, Tajima A, Yamada S, et al. Effects of bacter‐
iocins on methicillin-resistant Staphylococcus aureus biofilm. Antimicrob Agents
Chemother. 2013;57(11):5572–5579. DOI: 10.1128/AAC.00888-13
[86] O’Driscoll N, Labovitiadi O, Cushnie TP, Matthews K, Mercer D, Lamb A. Produc‐
tion and evaluation of an antimicrobial peptide-containing wafer formulation for
topical application. Curr Microbiol. 2013;66(3):271–278. DOI: 10.1007/
s00284-012-0268-3
[87] Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance.
Pharmacol Rev. 2003;55(1):27–55. DOI: 10.1124/pr.55.1.2
[88] Wimley WC, Hristova K. Antimicrobial peptides: successes, challenges and unan‐
swered questions. J Membr Biol. 2011;239(1–2):27–34. DOI: 10.1007/s00232-011-9343-0
[89] Fernebro J. Fighting bacterial infections-future treatment options. Drug Resist Updat.
2011;14(2):125–139. DOI: 10.1016/j.drup.2011.02.001
[90] Otto M. Bacterial sensing of antimicrobial peptides. Contrib Microbiol. 2009;16:136–
149. DOI: 10.1159/000219377
[91] Guilhelmelli F, Vilela N, Albuquerque P, Derengowski LdaS, Silva-Pereira I, Kyaw CM.
Antibiotic development challenges: the various mechanisms of action of antimicrobi‐
al peptides and of bacterial resistance. Front Microbiol. 2013;4:353. DOI: 10.3389/
fmicb.2013.00353
[92] Nawrocki KL, Crispell EK, McBride SM. Antimicrobial peptide resistance mecha‐
nisms of grampositive bacteria. Antibiotics (Basel). 2014;3(4):461–492. DOI: 10.3390/
antibiotics3040461
[93] Marr AK, Gooderham WJ, Hancock RE. Antibacterial peptides for therapeutic use:
obstacles and realistic outlook. Curr Opin Pharmacol. 2006;6(5):468–472. DOI: 10.1016/
j.coph.2006.04.006
Microbial Biofilms - Importance and Applications268
Chapter 14
Wound Biofilm and Therapeutic Strategies
Daniel Metcalf, Philip Bowler and David Parsons
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/63238
Abstract
Since the turn of the millennium, an evolving body of scientific and clinical evidence
indicates that biofilm is implicitly linked to delayed wound healing and infection.
Currently, wound anti-biofilm strategies rely on non-specific wound bed preparation
techniques involving physical debridement and cleansing, and innovative technologies
designed to specifically manage biofilm have only just begun to emerge. The first output
of anti-biofilm research and product development in wound care show great promise for
patients, clinicians and healthcare institutions. The aim of this chapter is to address the
current clinical biofilm problem, describe existing and emerging strategies to combat
wound biofilm and review the available evidence.
Keywords: wound, anti-biofilm, dressing, healing, infection
1. Introduction: the clinical problem
Fossil evidence of microorganisms existing as surface-attached microcolonies dates back 3.4
billion years [1], establishing biofilm as one of the oldest life-forms on earth. The scientific study
of surface-attached microorganisms dates back to the seventeenth century [2], but it is only in
recent decades that their relevance has been appreciated in both natural and pathogenic
ecosystems [2, 3]. Although the term ‘biofilm’ has been used to describe surface-attached, matrix-
encased microbial communities in industrial and environmental applications since the 1930s,
it was not until 1985 that Bill Costerton introduced the term into medical microbiology [2]. The
importance of biofilm in chronic infections is now widely accepted and there has been an
exponential rise in related medical publications since 1975, reaching a number of 3251 in 2013
alone [2].
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
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existence [7], role in wound healing [8], and the simultaneous and pioneering confirmation of
their clinical existence in 2008 [10, 11], a large body of scientific and clinical evidence now
suggests that biofilm is inextricably linked to wound infection and delayed healing [7, 22–37]
(Table 2).
Wound types No.Methods Observations Ref.
Chronic (mixed) 50 Light microscopy, scanning
electron microscopy (SEM)
30 chronic wounds observed to
contain biofilm (60%)
10
Chronic (mixed) 22 Confocal laser scanning
microscopy (CLSM)
13 chronic wounds observed to
contain biofilm (59%)
11
Chronic (mixed) 9 Fluorescence microscopy, CLSM P. aeruginosa observed deeper in
wound than S. aureus
12
Chronic (mixed) 10 Fluorescence microscopy, CLSM P. aeruginosa elicited greater inflammation
than S. aureus
13
Chronic 1 Fluorescence microscopy Both samples contained biofilm 9
Mixed aetiologies 15 Fluorescence microscopy 7 wounds observed to contain biofilm (47%) 14
Full-thickness
burns
11 Light & transmission electron
microscopy, SEM
Only ulcerated and escharotomy
sites contained biofilm
15
Diabetic foot ulcers (DFU) 2 CLSM Both samples contained biofilm 16
Acute 16 Light microscopy, SEM 1 acute wound contained biofilm (6%) 10
DFU 4 Light & fluorescence microscopy,
environmental SEM
Microcolonies associated with biofilm
observed in all wounds
17
Surgical sternal 6 Light & fluorescence microscopy,
CLSM, SEM
3D biofilm aggregates observed in all
6 infected wounds
18
Venous leg ulcers (VLU) 45 Transmission electron
microscopy
Biofilm matrices of polysaccharides,
proteins & DNA observed
19
Malignant 32 Fluorescence microscopy Biofilm observed in 35% of wounds 20
Mixed &
non-wound
113 Biofilm-forming capacity of
isolates by culture & SEM
Significantly more biofilm formed by
wound isolates than others
21
Table 1. Key scientific evidence for the presence of biofilm in human wounds.
Model Biofilm species Observations Ref.
Porcine acute S. aureus (S.a) Challenge with antimicrobial agents confirmed the recalcitrance of
biofilm bacteria
7







Interactions between MRSA and P.a were observed, delaying
healing due to suppression of epithelialisation and expression of
23
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The refractory nature of many infections has been largely attributed, in recent decades, to the
continuing rise in antibiotic resistance, but the involvement of biofilm in microbial tolerance
to antimicrobial agents and immune cells is increasingly recognised. The combined effect of
biofilm tolerance and antibiotic resistance are the two most important microbial defence
strategies, and in combination present a significant risk to public health. In 1999, Costerton et
al. [4] reported bacterial biofilm as being a common cause of persistent infections that include
conditions such as periodontal disease, otitis media, cystic fibrosis, pneumonia and device
related infections. Although the authors also considered necrotising fasciitis and osteomyeli‐
tis as biofilm infections, wound infections in more general terms were not considered.
Any wound that is not healing and that has not followed a normal wound healing trajectory
is likely to involve biofilm. Healthy skin is an effective microbial barrier; therefore dermal
tissues are intrinsically sterile. However, the surface of the skin is heavily colonised. Damage
to or removal of the epidermal barrier layer will inevitably lead to wound contamination and
opportunistic microbial colonisation. The innate human immune system can usually counter
this invasion but, if the initial contamination event is overwhelming (such as a severe traumatic
wound), or contamination is repetitive (for example for a faecally incontinent subject suffer‐
ing from a sacral pressure ulcer), or if the casualty has a weakened immune system (as a result
of age, disease, malnutrition, obesity, smoking, etc.) then biofilm may become established.
The earliest indirect indication of wound bacteria existing in biofilm form involved the
detection of extracellular polysaccharide capsules surrounding the cells of both aerobic and
anaerobic wound pathogens, using light and scanning electron microscopy [5]. Capsule
production is a key component of a biofilm mode of life that can protect bacterial communi‐
ties from the host immune system [6]. The earliest scientific research into wound biofilm was
reported by Serralta et al. in 2001 [7]. In this in vivo study, both planktonic and biofilm bacterial
lifestyles were observed, with biofilm bacteria (Pseudomonas aeruginosa) exceeding plankton‐
ic bacteria by approximately 100-fold. Whereas the planktonic P. aeruginosa could be re‐
moved by vigorous flushing, adherent biofilm P. aeruginosa could only be removed by forceful
scrubbing with a detergent agent.
The development and evolution of wound biofilm from contamination to a pathogenic state
was proposed in 2004, and the point at which an evolving biofilm begins to interfere with
wound healing and increase the risk of infection has largely replaced the previously-used
term ‘critical colonisation’ [8]. In 2008, a hypothesis (that was considered novel at the time)
relating to why chronic wounds fail to heal was reported [9]. Based on their previous experi‐
ences with chronic P. aeruginosa infections in patients suffering from cystic fibrosis, Bjarn‐
sholt et al. [9] proposed that the inability of polymorphonuclear leukocytes and antibiotic
treatment to eliminate P. aeruginosa biofilm was the cause of recalcitrance in chronic wounds.
Subsequent clinical studies using microscopy and molecular analytical techniques demon‐
strated that biofilm existed in a majority of non-healing chronic wounds [10, 11]. Since 2008,
an increasing number of studies have demonstrated the presence of biofilm in wounds of
varied aetiology [10–21] as indicated in Table 1.
Since the turn of the millennium, wound biofilm has been proposed, investigated and
confirmed, as a factor in chronic wound pathogenesis. From initial evidence of their
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etched membrane cell culture inserts in culture wells for up to 48 hours, and biofilm growth
was examined at various stages of development by light microscopy (LM), scanning electron
microscopy (SEM) and transmission electron microscopy (TEM). Biofilm was shown to form
within 6 hours, and becoming established after 24–48 hours (Figure 1). This favourably
compares with previous work reported [39] in which mature P. aeruginosa biofilm formed
within 5 hours of initial inoculation. Stages of biofilm observed in vitro may correlate with our
understanding of wound biofilm development and its link to chronicity and infection
(Figure 1).
Figure 1. Evolution of P. aeruginosa biofilm over 48 hours, with evidence of microcolony formation, maturation and
dispersal.
Numerous in vivo models have been reported in recent years, and these have been critically
reviewed and compared [40]. The rabbit ear model developed by Tom Mustoe’s team in
Illinois, USA is perhaps the most developed and validated of the models [30], has demon‐
strated clear links between wound biofilm and healing, and has also been used to compare the
effectiveness of anti-biofilm strategies [31, 34, 41–43].
Scientific, clinical and animal evidence strongly suggests that biofilm delays wound healing
[44], and efforts are underway to understand and develop ways to visualise and control biofilm
to aid clinical practice [44, 46]. It has been shown that by targeting and suppressing biofilm
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Model Biofilm species Observations Ref.
virulence factors





P.a Biofilm-colonised wounds highly inflamed; 8 weeks for biofilm-colonised









P.a Biofilm highly-tolerant to antibiotics & sodium hypochlorite once





S.a, P.a, E. faecalis,
F. magna
Polymicrobial biofilm maintained for 12 days, & delayed healing
more than P.a biofilm, by wound closure
28
Murine splinted S.a/S. epidermidis Biofilms significantly delayed epithelialisation; inhibition of biofilm
restored normal healing
29
Rabbit ear S.a Biofilm and active infection significantly delayed healing; biofilm-
colonised wounds expressed significantly lower levels of
inflammatory cytokines than infected wounds
30
Rabbit ear P.a Biofilm significantly delayed healing; debridement, lavage and silver
sulphadiazine in combination were more effective at







K.p biofilm was least virulent, P.a biofilm most virulent,
measured by healing inhibition and inflammation; extracellular polymeric
substances (EPS)-deficient P.a
did not delay healing
32
Rabbit ear S.a, P.a 2-species biofilm elicited significantly elevated inflammatory
response & impaired epithelialisation & granulation tissue
formation compared to single-species
33
Rabbit ear P.a Dressing designed specifically to manage biofilm gave significant
reductions in biofilm count & significantly improved wound




Biofilm developed over time in chronic wounds (similar to humans);
reducing oxidative stress increased their susceptibility to
antibiotics & dismantled biofilm
35
Rabbit ear K.p, P.a Wounds showed increased inflammation and delayed healing
with P.a biofilm infection as determined by of wound healing cells
transcriptome analysis
36
Porcine burn P.a, A. baumannii Biofilm-infected wounds, tolerant to silver dressings, eventually closed, but
skin barrier function compromised
37
Diabetic mouse S.a Diabetic wounds had significantly more biofilm & less neutrophil
activity, thus poorer healing than wild type
38
Table 2. Evidence that biofilm delays wound healing from porcine, murine and rabbit ear models.
In our laboratory, we have used microscopy techniques to better understand the structure and
development of wound biofilm. Planktonic cultures of P. aeruginosa were grown on track-
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providing moisture and nutrients to developing biofilm. Treatment and prevention of wound
infection usually consists of systemic antibiotics and/or topical antiseptics. The polymicrobi‐
al nature of wound bioburden [5] and difficulty in identification of species present means that
antibiotic selection and coverage is imperfect. Chronic wounds are often poorly perfused with
blood (a causative factor) therefore delivery of systemic antibiotics, at a sustained therapeu‐
tic concentration, for the period necessary to diffuse into a biofilm and take effect, is an
additional challenge [47]. Topical antiseptics are preferred because of their broad spectrum of
activity, but they suffer from a lack of selectivity towards bacteria and therefore can be toxic
to host tissues. General reaction with organic matter and continual dilution and removal with
wound exudate mean that an antimicrobial product needs to be continuously instilled [48] or
formulated for slow release and physical retention within the wound or dosed at high
concentration. Clinical evidence suggests that none of the above existing systemic or topical
treatments are particularly effective against wound biofilm. Therefore, different strategies are
required.
It is convenient to consider these strategies in broad groups aligned with the clinical intent as
mentioned above—to prevent, to remove, to kill biofilm-associated organisms (Figure 2)—and
many treatments will involve combinations of these with the best being a combination of all
three. We will also discuss the anti-biofilm effectiveness of existing methods together with
associated devices, and how some of these are providing therapeutic advances in the emerg‐
ing ‘biofilm era’ of wound care.
2.1. Prevention of biofilm
Microbial contamination of breaches in skin integrity is inevitable, unless the wound is created
under aseptic surgical conditions, and wounds that are not successfully managed can become
chronic and at risk of infection. The ideal situation is to prevent bacteria entering the wound
in the first instance. The risk of wound contamination post-surgery can be addressed by
applying effective microbial barrier dressings. In the 1990s DuoDERM® hydrocolloid adhe‐
sive dressings were shown to reduce the rate of infection (compared to traditional gauze
dressings) [49] and these dressings were later shown to provide a physical barrier to both
bacteria and viruses [50]. More recently, combined physical and antimicrobial barrier
dressings have been developed to minimise the risk of post-operative infection [51].
Although barrier dressings have an important role to play in minimising infection, it is most
likely that any open wound will become contaminated to some extent (chronic wounds will
become significantly more contaminated than most surgical wounds). Consequently, an
important infection control strategy at this point is to prevent microbial attachment to the
wound tissue. This might be achieved by chemical or biological treatment of the wound
surface. Examples of the former are lactoferrin and xylitol. Lactoferrin [52, 53] is a protein that
is believed to inhibit the effectiveness of bacterial adhesins by its ability to sequester iron from
acidic environments, particularly for Gram-negative bacteria [54]. It has proven useful in the
preservation of meat but in a living system with a functioning circulating system supplying
an excess of iron and buffering to neutral pH there will be challenges in maintaining efficacy.
If derived from non-human sources there is also the possibility that lactoferrin may be
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healing can be improved, so the onus is now on wound care product developers and manu‐
facturers to offer technologies with anti-biofilm effectiveness.
2. Therapeutic anti-biofilm strategies
With only relatively recent recognition of the existence of biofilm in wounds and consequent
role it plays in delayed healing and chronicity [8, 10, 11], the development of effective
therapeutic treatments and strategies to date has been very limited. However, this late
recognition does mean that wound care researchers can benefit from the knowledge gained in
other industries and in related healthcare areas such as dentistry and indwelling medical
devices. Here treatment strategy options are well developed and broadly similar. Although
the intention to prevent, remove and kill bacterial biofilm is the same, there is a significant
challenge in selecting wound treatments that have an appropriate balance of safety versus
efficacy. There are also challenges in simultaneously addressing the other clinical needs of the
wound as, unlike inert medical devices or tooth enamel, the surface of a wound, particularly
a chronic wound, can be acutely sensitive and fragile.
Wound biofilm is generally initially attached to the wound bed which is a dynamic mixture
of viable and non-viable (slough) tissues. Exudate permeates through this underlying tissue
Figure 2. Anti-biofilm strategies for wound care—prevention, removal, killing.
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providing moisture and nutrients to developing biofilm. Treatment and prevention of wound
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surface. Examples of the former are lactoferrin and xylitol. Lactoferrin [52, 53] is a protein that
is believed to inhibit the effectiveness of bacterial adhesins by its ability to sequester iron from
acidic environments, particularly for Gram-negative bacteria [54]. It has proven useful in the
preservation of meat but in a living system with a functioning circulating system supplying
an excess of iron and buffering to neutral pH there will be challenges in maintaining efficacy.
If derived from non-human sources there is also the possibility that lactoferrin may be
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removing non-viable and necrotic host tissue from wounds (debridement) in order to
encourage the inflammatory, granulation and epithelialisation processes of wound closure.
Surgical debridement techniques can range from aggressive surgical or sharp removal of tissue
to less invasive techniques such as curettage and lavage. This practice is likely to have
coincidentally been removing biofilm with beneficial effect. With increasing familiarity with
the appearance of biofilm or more likely, the symptomatic signs of its presence, clinicians are
seeking methods to physically remove biofilm from wounds. In recent years, debridement
devices utilising a number of very different technologies have emerged.
Sharp debridement is the most radical approach and requires expertise [67]. Excision of
devitalised host tissue (i.e. necrosis) or infected/biofilm tissue via scalpel or other surgical
instrument until the exposed tissue is bleeding would certainly be expected to remove a
majority of any biofilm residing in the wound, but the deleterious effects on healing tissues
need to be balanced with the need to remove unhealthy tissue. However, sharp debridement
has proven successful and advocates such as Wolcott have developed protocols where regular
sharp debridement has provided a ‘healing window’ during which improved effectiveness of
concurrent antimicrobial treatment has been observed [68]. Hurlow has also reported the
atraumatic removal of biofilm above a non-healing surgical wound with exposed tendon using
curettage and antimicrobial cleansers [69, 70] (Table 3).
A number of other devices that can be used for wound debridement are now commercially
available. Examples include devices that emit energy in the form of water jets (lavage),
ultrasound and cold plasma (Table 3). High pressure lavage using hand-held devices [67] has
been assessed in several laboratory and clinical investigations, and there is evidence that
removal of unwanted tissue (which may include biofilm) using this method encourages wound
progression [71]. Ultrasonic wound debridement has proven effective in clinical cases [72], and
scientific studies support the ability of ultrasound to disrupt biofilm and encourage healing in
vivo [42], as well as potentiate the effects of antiseptics via its anti-biofilm action in vitro [73].
Finally, encouraging in vitro anti-biofilm effectiveness of cold atmospheric pressure plasma
technology suggests that the reactive oxygen species produced in precise beams by these
devices may disrupt and kill biofilm while sparing host tissues [74].
Unfortunately, in many clinical institutions the skills, training and equipment for the use of
advanced debridement techniques or devices may not be available. Under these circumstan‐
ces simple cleansing, enhanced with ‘soft debridement’ using engineered textiles, may be
helpful. Recently, debridement pads or wipes have emerged which aim to gently brush and
lift away wound debris. A polyester filament pad has generated encouraging clinical effec‐
tiveness data [75, 76] and cost-saving estimates [77]. In addition to disrupting and lifting
surface-associated wound debris (which is likely to include biofilm), these soft debridement
devices are simple and safe to use, gentle on patients and relatively low-cost, compared to
most other debridement techniques and devices discussed in Table 3.
More thorough biofilm removal may be achieved by degrading the structure of the EPS such
that it flows away from the wound or can be more readily irrigated or absorbed by absorb‐
ent dressings. General proteolytic enzymes have been used for many decades to remove slough
and necrotic tissue, but, as EPS is not primarily comprised of extracellular proteins for its
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identified by the immune system as a threat and illicit an inflammatory response. Xylitol is a
naturally occurring sugar that binds to the surface of Gram-positive bacteria preventing
adhesion [53], inhibiting glycocalyces (exopolymeric substances) and disrupting cell wall
growth [54]. But xylitol faces the same challenge as lactoferrin in that it is a freely soluble
substance and will be difficult to maintain at an effective concentration in an exuding wound.
Gallium is also mooted in this space as Ga3+ is similar to Fe3+ in size but does not undergo the
same redox reactions (Fe3+ ↔  Fe2+) and therefore interferes with bacterial attachment and
proliferation [52].
If microorganisms gain the opportunity to attach to wound tissue and acclimatise to the
environment, then subsequent colonisation will lead to the development and maturation of a
predominantly biofilm population that is protected from the immediate hostilities within the
wound environment (Figure 1). Two potential biological approaches for controlling biofilm
development are quorum sensing (QS) inhibitors and probiotics. Quorum sensing is an active
field of research with over 100 bacterial species identified as having the ability to communi‐
cate by release of small signalling molecules [55]. At a critical concentration, microbial
communication between cells triggers a change in gene expression which results in a change
in behaviour. QS is involved at all stages in the biofilm life cycle (initial attachment, EPS
expression, proliferation, maturation and dispersal) and is implicated in biofilm virulence. In
practical terms, this minimum concentration dependence translates into a minimum thresh‐
old bacterial population density. However, it must be borne in mind that wound biofilms are
polymicrobial [56–58] and although approximately 50% of all known QS bacterial species have
the ‘universal’ autoinducer 2 (AI-2) [55], QS signal molecules vary between species and strains.
Therefore, a universal inhibitor for wound biofilm formation seems unlikely in the near future.
Probiotics [59, 60] offer the interesting possibility of prophylactically colonising the wound
with non-pathogenic bacteria. Lactobacillus species have been shown to successfully out-
compete and inhibit the pathogenic activity of P. aeruginosa and S. aureus possibly through QS
inhibiting effects [59]. However, there are significant challenges, particularly for chronic
wounds, in how to selectively provide conditions for the survival and growth of probiotic
microorganisms in an already contaminated and inflammatory wound.
Finally, often overlooked is the management of the wound environment itself—establishing
the best conditions in which the body’s immune system can function and/or creating condi‐
tions which reduce bacterial proliferation and biofilm development. The optimal moisture
balance in the wound bed is reported to be 100% humidity with no free liquid [61], and it has
recently been suggested that poor exudate control is likely to encourage the development of
biofilm [62]. Chronic, non-healing wounds are often characterised by a high pH (7.15–8.9) and
healing wounds tend to have a lower pH [63]. The increased production of S. aureus EPS with
increasing pH has been reported [64], but other examples describe the opposite, so the
relationship between biofilm and pH appears to be complex [65, 66].
2.2. Removal of biofilm
By the time wounds are presented to a wound care specialist, the majority of non-healing
traumatic and chronic wounds are likely to be biofilm impeded. There is a long history of
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Finally, encouraging in vitro anti-biofilm effectiveness of cold atmospheric pressure plasma
technology suggests that the reactive oxygen species produced in precise beams by these
devices may disrupt and kill biofilm while sparing host tissues [74].
Unfortunately, in many clinical institutions the skills, training and equipment for the use of
advanced debridement techniques or devices may not be available. Under these circumstan‐
ces simple cleansing, enhanced with ‘soft debridement’ using engineered textiles, may be
helpful. Recently, debridement pads or wipes have emerged which aim to gently brush and
lift away wound debris. A polyester filament pad has generated encouraging clinical effec‐
tiveness data [75, 76] and cost-saving estimates [77]. In addition to disrupting and lifting
surface-associated wound debris (which is likely to include biofilm), these soft debridement
devices are simple and safe to use, gentle on patients and relatively low-cost, compared to
most other debridement techniques and devices discussed in Table 3.
More thorough biofilm removal may be achieved by degrading the structure of the EPS such
that it flows away from the wound or can be more readily irrigated or absorbed by absorb‐
ent dressings. General proteolytic enzymes have been used for many decades to remove slough
and necrotic tissue, but, as EPS is not primarily comprised of extracellular proteins for its
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Gallium is also mooted in this space as Ga3+ is similar to Fe3+ in size but does not undergo the
same redox reactions (Fe3+ ↔  Fe2+) and therefore interferes with bacterial attachment and
proliferation [52].
If microorganisms gain the opportunity to attach to wound tissue and acclimatise to the
environment, then subsequent colonisation will lead to the development and maturation of a
predominantly biofilm population that is protected from the immediate hostilities within the
wound environment (Figure 1). Two potential biological approaches for controlling biofilm
development are quorum sensing (QS) inhibitors and probiotics. Quorum sensing is an active
field of research with over 100 bacterial species identified as having the ability to communi‐
cate by release of small signalling molecules [55]. At a critical concentration, microbial
communication between cells triggers a change in gene expression which results in a change
in behaviour. QS is involved at all stages in the biofilm life cycle (initial attachment, EPS
expression, proliferation, maturation and dispersal) and is implicated in biofilm virulence. In
practical terms, this minimum concentration dependence translates into a minimum thresh‐
old bacterial population density. However, it must be borne in mind that wound biofilms are
polymicrobial [56–58] and although approximately 50% of all known QS bacterial species have
the ‘universal’ autoinducer 2 (AI-2) [55], QS signal molecules vary between species and strains.
Therefore, a universal inhibitor for wound biofilm formation seems unlikely in the near future.
Probiotics [59, 60] offer the interesting possibility of prophylactically colonising the wound
with non-pathogenic bacteria. Lactobacillus species have been shown to successfully out-
compete and inhibit the pathogenic activity of P. aeruginosa and S. aureus possibly through QS
inhibiting effects [59]. However, there are significant challenges, particularly for chronic
wounds, in how to selectively provide conditions for the survival and growth of probiotic
microorganisms in an already contaminated and inflammatory wound.
Finally, often overlooked is the management of the wound environment itself—establishing
the best conditions in which the body’s immune system can function and/or creating condi‐
tions which reduce bacterial proliferation and biofilm development. The optimal moisture
balance in the wound bed is reported to be 100% humidity with no free liquid [61], and it has
recently been suggested that poor exudate control is likely to encourage the development of
biofilm [62]. Chronic, non-healing wounds are often characterised by a high pH (7.15–8.9) and
healing wounds tend to have a lower pH [63]. The increased production of S. aureus EPS with
increasing pH has been reported [64], but other examples describe the opposite, so the
relationship between biofilm and pH appears to be complex [65, 66].
2.2. Removal of biofilm
By the time wounds are presented to a wound care specialist, the majority of non-healing
traumatic and chronic wounds are likely to be biofilm impeded. There is a long history of
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the di-sodium salt, are effective but all anionic chelating agents are pH-sensitive. A water-
soluble gel formulation that contains 0.1% EDTA, acetic acid, citric acid and carbopol has
demonstrated anti-biofilm effectiveness against P. aeruginosa and S. epidermidis in vitro [82].
Empirical experience in other industries such as food, laundry, personal washing and dental
products [83] has shown the utility of surfactants as anti-biofilm agents to facilitate penetra‐
tion of combination agents through biofilm EPS [84], leading to detachment from surfaces and
prevention from re-deposition by micelle formation. An anti-biofilm gel comprising a
surfactant and calcium chelator has shown in vitro and in vivo anti-biofilm activity. Although
not yet commercially available, use of this gel has shown clinical superiority to standard
wound care, as well as apparent synergy with standard care [85].
2.3. Killing of biofilm microorganisms
The efficacy of existing antimicrobial therapies in wound care has almost exclusively been
based on their activity against susceptible planktonic bacteria. Whilst associated devices may
be useful in controlling this bacterial phenotype by reducing the risk of contamination and
dispersal, their effectiveness against biofilm is unproven. Indeed, the prevalence and recur‐
rence of chronic wounds suggests that most antimicrobial therapies are ineffective.
Considering the selective and specific action of antibiotics, the polymicrobial nature of wound
bioburden and the increasing threat of multi-drug resistant organisms (MDROs), the effec‐
tiveness of antibiotics in chronic wound care is questionable. However, utilising state of the
art molecular microbiological techniques, personalised cocktails of topically-applied antibiot‐
ics yielded better results than patients receiving systemic antibiotics prescribed using the same
diagnostic techniques who, in turn, yielded better outcomes than a standard-of-care group
treated upon data from standard culture techniques [86]. Unfortunately, this level of diagnos‐
tic sophistication is not within the reach of most health care systems, and therefore we must
await further technological advancements so that it becomes generally affordable.
The majority of wound treatments do not have the benefit of sophisticated microbiological
analysis; therefore any antimicrobial therapy administered must have broad-spectrum
activity. Choice then becomes restricted to antiseptics which can only be applied topically.
Antiseptics are chemically reactive species that are largely non-selective in their action,
therefore potential cytotoxicity (local toxicity to skin cells) and systemic toxicity must be taken
into account. Toxicity is generally managed by limiting the concentration and time of exposure
to the antimicrobial agent. Therefore, antimicrobial cleansing at dressing change may involve
slightly higher concentrations of antiseptic than an antimicrobial dressing which may stay in
situ for several days. However, given that the minimum biofilm eradication concentration
(MBEC) for antiseptics in wound relevant bacteria is often between 10–1000 times greater than
its minimum inhibitory concentration (MIC) for planktonic bacteria (the value upon which
most products are formulated) [87], the balance of safety versus efficacy of antiseptic agents
is challenging. Topical wound antiseptic treatments typically involve 0.5 to 12% for silver in
dressings (depending on the form of silver), approximately 1% for molecular iodine in
dressings (or 10% as povidone iodine), 2 to 4% for chlorhexidine gluconate in cleansers and
Wound Biofilm and Therapeutic Strategies
http://dx.doi.org/10.5772/63238
281
structural integrity, these are ineffective. This fact has been utilised by an aid to detect the
presence of wound biofilm [45]. Alternative enzymatic candidates that are effective against
polysaccharides have been identified and reviewed [78, 79], and include: α-amylase (mam‐
malian), polysaccharide depolymerase (bacteriophage), alginate lyase (bacterial) and glyco‐
side hydrolase (DspB) (bacterial). Generally, the kinetics of enzyme reactions are known to be
sensitive to pH, for example Dispersin B, despite demonstrating some activity in vitro [80], has
optimal activity at pH 5, and as proteins, enzymes will be vulnerable to the high concentra‐
tions of proteolytic enzymes often associated with chronic wounds. Hence, careful formula‐
tion of any enzyme based anti-biofilm treatment would be required. Sun et al. also point out
that the current high cost of industrial enzyme production makes the application of these






Curettage (Clinical) Gentle scraping of suspected biofilm (in combination with other antimicrobials)
improved healing in case studies
69,70
Lavage/water jets (Clinical) Indirect anti-biofilm evidence; debridement with Versajet II (Smith & Nephew)
removed unwanted tissue & encourages healing
71
Ultrasound (In vitro) Anti-biofilm action demonstrated in agar biofilm model using Ultrasonic-Assisted
Wound (UAW) device (Soring)
73
(In vivo) Leporine ear model showed MIST (Celleration) reduced P. aeruginosa biofilm &
inflammation, & improved healing parameters
42
(Clinical) Indirect anti-biofilm evidence; case study evidence that UAW can effectively
debride unwanted tissue
72
Cold plasma (In vitro) Biofilm significantly reduced using Coblation (Smith & Nephew) compared to




(Clinical) Indirect anti-biofilm evidence in case studies where sloughy wounds were well
managed using Debrisoft (Lohmann & Rauscher)
75
(Clinical) Debridement was classed as effective in 94% of patients, removing debris and
slough, in a 57-patient study using Debrisoft
76
Table 3. Biofilm removal using debridement methods and devices.
Structural degradation of biofilm EPS can also be achieved chemically. Divalent cations such
as calcium and magnesium are known to be involved in cross-linking polysaccharides within
EPS and manganese and iron are involved in bacterial metabolism and cell wall structure [81].
Competition for these ions or their removal (chelation) will therefore affect biofilm forma‐
tion and strength. Metal chelating agents are a diverse set of compounds but biocompatibili‐
ty and safety considerations restrict those that can be considered for wound care to
ethylenediamine tetra acetic acid (EDTA) and its homologues and polyanionic compounds
such as phosphates and citrate. The most widely discussed of these as an anti-biofilm agent
and the one with the greatest affinity for calcium and magnesium cations is EDTA. The
literature primarily focuses on the tetra-sodium salt form but only at high pH (>pH 10) [81],
which is incompatible with wound management practices. Lower pH forms of EDTA, such as
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tion of combination agents through biofilm EPS [84], leading to detachment from surfaces and
prevention from re-deposition by micelle formation. An anti-biofilm gel comprising a
surfactant and calcium chelator has shown in vitro and in vivo anti-biofilm activity. Although
not yet commercially available, use of this gel has shown clinical superiority to standard
wound care, as well as apparent synergy with standard care [85].
2.3. Killing of biofilm microorganisms
The efficacy of existing antimicrobial therapies in wound care has almost exclusively been
based on their activity against susceptible planktonic bacteria. Whilst associated devices may
be useful in controlling this bacterial phenotype by reducing the risk of contamination and
dispersal, their effectiveness against biofilm is unproven. Indeed, the prevalence and recur‐
rence of chronic wounds suggests that most antimicrobial therapies are ineffective.
Considering the selective and specific action of antibiotics, the polymicrobial nature of wound
bioburden and the increasing threat of multi-drug resistant organisms (MDROs), the effec‐
tiveness of antibiotics in chronic wound care is questionable. However, utilising state of the
art molecular microbiological techniques, personalised cocktails of topically-applied antibiot‐
ics yielded better results than patients receiving systemic antibiotics prescribed using the same
diagnostic techniques who, in turn, yielded better outcomes than a standard-of-care group
treated upon data from standard culture techniques [86]. Unfortunately, this level of diagnos‐
tic sophistication is not within the reach of most health care systems, and therefore we must
await further technological advancements so that it becomes generally affordable.
The majority of wound treatments do not have the benefit of sophisticated microbiological
analysis; therefore any antimicrobial therapy administered must have broad-spectrum
activity. Choice then becomes restricted to antiseptics which can only be applied topically.
Antiseptics are chemically reactive species that are largely non-selective in their action,
therefore potential cytotoxicity (local toxicity to skin cells) and systemic toxicity must be taken
into account. Toxicity is generally managed by limiting the concentration and time of exposure
to the antimicrobial agent. Therefore, antimicrobial cleansing at dressing change may involve
slightly higher concentrations of antiseptic than an antimicrobial dressing which may stay in
situ for several days. However, given that the minimum biofilm eradication concentration
(MBEC) for antiseptics in wound relevant bacteria is often between 10–1000 times greater than
its minimum inhibitory concentration (MIC) for planktonic bacteria (the value upon which
most products are formulated) [87], the balance of safety versus efficacy of antiseptic agents
is challenging. Topical wound antiseptic treatments typically involve 0.5 to 12% for silver in
dressings (depending on the form of silver), approximately 1% for molecular iodine in
dressings (or 10% as povidone iodine), 2 to 4% for chlorhexidine gluconate in cleansers and
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malian), polysaccharide depolymerase (bacteriophage), alginate lyase (bacterial) and glyco‐
side hydrolase (DspB) (bacterial). Generally, the kinetics of enzyme reactions are known to be
sensitive to pH, for example Dispersin B, despite demonstrating some activity in vitro [80], has
optimal activity at pH 5, and as proteins, enzymes will be vulnerable to the high concentra‐
tions of proteolytic enzymes often associated with chronic wounds. Hence, careful formula‐
tion of any enzyme based anti-biofilm treatment would be required. Sun et al. also point out
that the current high cost of industrial enzyme production makes the application of these
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Table 3. Biofilm removal using debridement methods and devices.
Structural degradation of biofilm EPS can also be achieved chemically. Divalent cations such
as calcium and magnesium are known to be involved in cross-linking polysaccharides within
EPS and manganese and iron are involved in bacterial metabolism and cell wall structure [81].
Competition for these ions or their removal (chelation) will therefore affect biofilm forma‐
tion and strength. Metal chelating agents are a diverse set of compounds but biocompatibili‐
ty and safety considerations restrict those that can be considered for wound care to
ethylenediamine tetra acetic acid (EDTA) and its homologues and polyanionic compounds
such as phosphates and citrate. The most widely discussed of these as an anti-biofilm agent
and the one with the greatest affinity for calcium and magnesium cations is EDTA. The
literature primarily focuses on the tetra-sodium salt form but only at high pH (>pH 10) [81],
which is incompatible with wound management practices. Lower pH forms of EDTA, such as
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ine dioxide (ClO2) are under consideration [52] as potent, fast-acting cleansing solutions, and
some early anti-biofilm effectiveness has been observed in vitro or inferred clinically for various
HOCl formulations [104, 106–108] (Table 4).
Antimicrobial agent Evidence for effectiveness of formulated product against biofilm Ref.
Ionic silver (In vitro) Reduction in S. epidermidis biofilm
EPS mechanical strength after application of dilute (50 ppb [ng/ml])
silver solution
89
(In vitro) Anti-biofilm activity of silver Hydrofiber
(AQUACEL Ag; ConvaTec) shown over 48 hours using
range of biofilm models
90,91
(In vitro) Sustained anti-biofilm activity evident for at
least 7 days, independent of the microbial strain
92
Molecular iodine (In vitro) Povidone iodine dressing (Inadine; Systagenix)
demonstrated greater anti-biofilm activity than silver dressings
94
(In vitro) Cadexomer iodine dressing (Iodoflex; Smith & Nephew)





(In vitro) Biofilm matrix on human dermal cell line was disrupted,
releasing bacteria for killing, by Prontosan (B. Braun)
104
(In vivo) Anti-biofilm effectiveness of Prontosan was
significantly more effective than inactive controls in porcine dermal wounds
100
(Clinical) Signs of biofilm & infection reduced, healing
progression observed in 124-patient study using Prontosan gel
101
Hypochlorous acid (In vitro) 0.01% HOCl killing of CDC reactor-grown P. aeruginosa
biofilm by live-dead staining with confocal microscopy
106
(In vitro) Biofilm matrix on human dermal cell line was
disrupted, releasing bacteria for killing, using a concentrated HOCl solution
104
(Clinical) Signs of infection reduced & progress toward
healing in a 31-patient study using Vashe (PuriCore)
107
(Clinical) Infection contolled & wounds healed in
14 osteomyelitis patients using Dermacyn (Oculus)
108
Table 4. Examples of existing topical antimicrobial products with some anti-biofilm activity.
2.4. State of the art today
2.4.1. Multi-modal strategies
Perhaps the most straightforward way for wound care clinicians to implement more effec‐
tive biofilm management strategies today is to consider how dental care has embraced multiple
strategies to manage dental plaque biofilm. By using combinations of debridement (brush‐
ing, flossing), surfactants with antimicrobials (toothpaste), and antimicrobial rinses (mouth‐
wash), most consumers manage biofilm effectively on a daily basis to maintain oral hygiene,
and prevent conditions such as dental caries and periodontitis.
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0.1% for polyhexamethylene biguanide (PHMB) in cleansers. Increasing the concentration of
the antiseptic component to be effective against biofilm may not be possible, practical or safe.
Clinical experience and safety reviews have limited the number of usable antiseptic substan‐
ces. Currently, silver is the most widely-used topical antiseptic agent, primarily due to its good
safety versus efficacy balance [88]. Silver is the most studied topical antiseptic [52, 53], and
ionic silver—the antimicrobial active form—has a particularly high affinity for sulphur atoms,
binding irreversibly to thiol groups. Ionic silver also binds to nitrogen atoms in amines and
oxygen atoms in carboxylates, although less strongly. These three interactions lead to very
efficient denaturing of peptides, proteins and enzymes—all of which are essential to bacteri‐
al structure and metabolism. However, carboxylate functional groups are also found within
the polysaccharide in EPS. Therefore, although ionic silver may be inactivated by EPS and
other organic matter within the biofilm, there is a theoretical basis for it to have some biofilm
disruptive effects. Evidence for this effect was a reduction in EPS mechanical strength of an S.
epidermidis biofilm after the application of dilute silver ion solution [89] (Table 4). Similar
observations have been made for a silver-containing carboxymethylcellulose dressing [90, 91],
and it was reported wound dressings with hydrophobic base material impregnated with silver
had sustained anti-biofilm activity [92] (Table 4).
Molecular iodine has proven too toxic for direct application but, by complexation with a carrier
molecule and careful formulation, acceptable slow release products have been developed.
Although the mode of action of molecular iodine is not fully understood [52], studies sug‐
gest that in common with silver, sulphur atoms are a reaction target resulting in protein
denaturing and subsequent changes to cell wall structure [93]. Iodine will react with unsatu‐
rated fats and lipids and organic matter within the wound, and is known to be trapped by
polysaccharides. There is limited evidence that molecular iodine has anti-biofilm properties,
aside from in simple in vitro models [94], but ex vivo studies of a formulated cadexomer iodine
product suggest that sustained release may result in biofilm penetration [95] (Table 4).
Evidence for the anti-biofilm effects of the cationic, nitrogen containing, surfactant-like
antibacterials—chlorhexidine (CHG), PHMB and octenidine—in wound care is limited. CHG
has been shown to have limited effect against some biofilms in vitro but to be ineffective against
others, and the theoretical electrostatic effect on bacterial cell walls as the antimicrobial
mechanism is believed to be negated by biofilm, so the observed effects are unexplained [96].
PHMB is similar in structure to CHG and is proposed to accumulate within biofilm by
electrostatic interactions [97], i.e. cationic PHMB binds to the anionic polysaccharide of EPS
[98]—initially, at least, this will have an inactivating effect on the antimicrobial action.
Available anti-biofilm data focus on formulated products [99–104], so laboratory and clinical
results cannot be attributed solely to PHMB (Table 4). Octenidine has been tested in vitro
against S. aureus biofilm, and above a critical concentration bioburden reduction rate was seen
to increase, but biofilm was possibly removed to surfactancy rather than specific anti-bio‐
film activity [105].
The next most popular traditional antiseptic substances are the molecular halogens and related
oxidising compounds. Chlorine itself is too toxic to be used and hypochlorite-based bleaches
are considered too cytotoxic for general wound care. Hypochlorous acid (HOCl) and chlor‐
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ine dioxide (ClO2) are under consideration [52] as potent, fast-acting cleansing solutions, and
some early anti-biofilm effectiveness has been observed in vitro or inferred clinically for various
HOCl formulations [104, 106–108] (Table 4).
Antimicrobial agent Evidence for effectiveness of formulated product against biofilm Ref.
Ionic silver (In vitro) Reduction in S. epidermidis biofilm
EPS mechanical strength after application of dilute (50 ppb [ng/ml])
silver solution
89
(In vitro) Anti-biofilm activity of silver Hydrofiber
(AQUACEL Ag; ConvaTec) shown over 48 hours using
range of biofilm models
90,91
(In vitro) Sustained anti-biofilm activity evident for at
least 7 days, independent of the microbial strain
92
Molecular iodine (In vitro) Povidone iodine dressing (Inadine; Systagenix)
demonstrated greater anti-biofilm activity than silver dressings
94
(In vitro) Cadexomer iodine dressing (Iodoflex; Smith & Nephew)





(In vitro) Biofilm matrix on human dermal cell line was disrupted,
releasing bacteria for killing, by Prontosan (B. Braun)
104
(In vivo) Anti-biofilm effectiveness of Prontosan was
significantly more effective than inactive controls in porcine dermal wounds
100
(Clinical) Signs of biofilm & infection reduced, healing
progression observed in 124-patient study using Prontosan gel
101
Hypochlorous acid (In vitro) 0.01% HOCl killing of CDC reactor-grown P. aeruginosa
biofilm by live-dead staining with confocal microscopy
106
(In vitro) Biofilm matrix on human dermal cell line was
disrupted, releasing bacteria for killing, using a concentrated HOCl solution
104
(Clinical) Signs of infection reduced & progress toward
healing in a 31-patient study using Vashe (PuriCore)
107
(Clinical) Infection contolled & wounds healed in
14 osteomyelitis patients using Dermacyn (Oculus)
108
Table 4. Examples of existing topical antimicrobial products with some anti-biofilm activity.
2.4. State of the art today
2.4.1. Multi-modal strategies
Perhaps the most straightforward way for wound care clinicians to implement more effec‐
tive biofilm management strategies today is to consider how dental care has embraced multiple
strategies to manage dental plaque biofilm. By using combinations of debridement (brush‐
ing, flossing), surfactants with antimicrobials (toothpaste), and antimicrobial rinses (mouth‐
wash), most consumers manage biofilm effectively on a daily basis to maintain oral hygiene,
and prevent conditions such as dental caries and periodontitis.
Wound Biofilm and Therapeutic Strategies
http://dx.doi.org/10.5772/63238
283
0.1% for polyhexamethylene biguanide (PHMB) in cleansers. Increasing the concentration of
the antiseptic component to be effective against biofilm may not be possible, practical or safe.
Clinical experience and safety reviews have limited the number of usable antiseptic substan‐
ces. Currently, silver is the most widely-used topical antiseptic agent, primarily due to its good
safety versus efficacy balance [88]. Silver is the most studied topical antiseptic [52, 53], and
ionic silver—the antimicrobial active form—has a particularly high affinity for sulphur atoms,
binding irreversibly to thiol groups. Ionic silver also binds to nitrogen atoms in amines and
oxygen atoms in carboxylates, although less strongly. These three interactions lead to very
efficient denaturing of peptides, proteins and enzymes—all of which are essential to bacteri‐
al structure and metabolism. However, carboxylate functional groups are also found within
the polysaccharide in EPS. Therefore, although ionic silver may be inactivated by EPS and
other organic matter within the biofilm, there is a theoretical basis for it to have some biofilm
disruptive effects. Evidence for this effect was a reduction in EPS mechanical strength of an S.
epidermidis biofilm after the application of dilute silver ion solution [89] (Table 4). Similar
observations have been made for a silver-containing carboxymethylcellulose dressing [90, 91],
and it was reported wound dressings with hydrophobic base material impregnated with silver
had sustained anti-biofilm activity [92] (Table 4).
Molecular iodine has proven too toxic for direct application but, by complexation with a carrier
molecule and careful formulation, acceptable slow release products have been developed.
Although the mode of action of molecular iodine is not fully understood [52], studies sug‐
gest that in common with silver, sulphur atoms are a reaction target resulting in protein
denaturing and subsequent changes to cell wall structure [93]. Iodine will react with unsatu‐
rated fats and lipids and organic matter within the wound, and is known to be trapped by
polysaccharides. There is limited evidence that molecular iodine has anti-biofilm properties,
aside from in simple in vitro models [94], but ex vivo studies of a formulated cadexomer iodine
product suggest that sustained release may result in biofilm penetration [95] (Table 4).
Evidence for the anti-biofilm effects of the cationic, nitrogen containing, surfactant-like
antibacterials—chlorhexidine (CHG), PHMB and octenidine—in wound care is limited. CHG
has been shown to have limited effect against some biofilms in vitro but to be ineffective against
others, and the theoretical electrostatic effect on bacterial cell walls as the antimicrobial
mechanism is believed to be negated by biofilm, so the observed effects are unexplained [96].
PHMB is similar in structure to CHG and is proposed to accumulate within biofilm by
electrostatic interactions [97], i.e. cationic PHMB binds to the anionic polysaccharide of EPS
[98]—initially, at least, this will have an inactivating effect on the antimicrobial action.
Available anti-biofilm data focus on formulated products [99–104], so laboratory and clinical
results cannot be attributed solely to PHMB (Table 4). Octenidine has been tested in vitro
against S. aureus biofilm, and above a critical concentration bioburden reduction rate was seen
to increase, but biofilm was possibly removed to surfactancy rather than specific anti-bio‐
film activity [105].
The next most popular traditional antiseptic substances are the molecular halogens and related
oxidising compounds. Chlorine itself is too toxic to be used and hypochlorite-based bleaches
are considered too cytotoxic for general wound care. Hypochlorous acid (HOCl) and chlor‐
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in vivo [116–121]. In addition, this dressing has shown some in vitro anti-biofilm activity in
simple models [90, 91]. Using the MBEC method [122] the ability of combinations of anti-
biofilm agents, surfactants and ionic silver to eliminate mature P. aeruginosa biofilm after 30
minutes contact was investigated. Component concentrations were varied, as was pH, and in
all over 60000 tests were performed. Very few combinations proved to be beneficial, but a
number of strong synergistic effects were identified, in particular between ionic silver,
quaternary ammonium surfactants and metal-chelating agents (especially EDTA), all at a
slightly acidic pH [123]. These synergistic components (termed Ag+ Technology) were incor‐
porated into the dressing and subjected to extensive safety testing. We believe that the resultant
dressing, AQUACEL® Ag+ Extra™, is the first commercially available wound dressing
specifically designed to manage biofilm.
In the laboratory AQUACEL Ag+ Extra dressings have demonstrated effectiveness against
biofilm microorganisms in sophisticated in vitro wound models. Here, thick biofilms of multi-
drug-resistant S. aureus or P. aeruginosa were grown on cotton gauze substrates, and placed on
to a simulated wound bed of nutrient agar, within model peri-wound skin [124] (Table 5).
Further studies using isothermal microcalorimetry demonstrated how neither the standard
silver dressing alone (AQUACEL Ag) nor silver nitrate solution showed a marked anti-biofilm
activity, while the AQUACEL Ag+ Extra dressing eradicated the S. aureus biofilm in vitro [125].
Interestingly, in this study the anti-biofilm agents alone, without silver, were also shown to be
ineffective unless combined with silver, demonstrating the synergistic nature of this anti-
biofilm formulation (Table 5).
The efficacy of this combination of ionic silver, metal chelator and surfactant has also been
demonstrated in an FDA-recognised in vivo model of wound healing [30]. Here, the control‐
led formation of P. aeruginosa biofilm and polymicrobial biofilm (P. aeruginosa and S. aureus)
in an acute wound of defined size, and its subsequent treatment, was assessed over time by
measuring parameters such as viable biofilm counts, granulation tissue formation and
epithelialisation. The anti-biofilm dressing was found to be significantly superior to a PHMB-
containing dressing in improving these wound parameters [34] (Table 5).
Most encouraging is the early clinical performance data emerging for this new anti-biofilm
technology. Harding et al. [126] demonstrated the safety and effectiveness of this dressing
containing Ag+ Technology in a 42-patient study in VLU patients. In particular, the authors
highlighted a subset of 10 clinically-infected wounds (where biofilm was assumed to be a
problem) that responded in a more dramatic fashion (Table 5). European and Canadian clinical
evaluations summarised 113 cases which were selected on the basis of being difficult-to-heal
wounds, with suspected involvement of infection or biofilm. Following an average of 4.1 weeks
of use of the new dressing in otherwise standard wound care protocols, an average wound
closure of 73% was achieved, with 17% of wounds healing completely [127] (Table 5). More
detailed individual case studies from these evaluations have also been presented [128]. In more
recent UK-based evaluations of AQUACEL Ag+ EXTRA, a 29-case evaluation reported
reductions in all described signs of clinical infection, including a reduction in suspected biofilm
from 76 to 45%. This was accompanied by an average wound closure of 62%, with 34% of
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Biofilm-based wound care (BBWC) is an emerging and evidently effective way of combining
multiple modes of wound treatment to improve the health of chronic and infected wounds [68,
85, 109]. Practised initially by the pioneering wound care physician, Randall Wolcott in Texas,
a first assumption of BBWC is made that most (if not all) chronic or infected wounds contain
biofilm. A further assumption is that one mode of treatment may not suffice, therefore the use
of combinations of vigorous debridement, cleansers or gels, topical antimicrobial or anti-
biofilm agents, and wound dressings, is required. Wolcott et al. [85, 109–111] have shown how
BBWC can result in significantly improved outcomes compared to standard wound care in
several large patient cohorts. A number of case studies reported by Hurlow and Bowler [69,
70] have also described how protocols of care designed to target biofilm result in improved
wound outcomes. Combining lactoferrin and xylitol (see Section 2.1) in a hydrogel in con‐
junction with a silver wound dressing demonstrated good efficacy against biofilms [53].
We also firmly believe that the multi-modal approach is the most effective way of rapidly
improving wound health in chronic wounds that are likely compromised by biofilm or
infection. A key component in such protocols of care is undoubtedly efficacious wound
dressings which can provide effective, sustained and safe antimicrobial and anti-biofilm
action. Although the focus here is on therapeutic approaches towards wound biofilm, biofilm
cannot be considered in isolation. Other challenging wound conditions must be considered
alongside biofilm—exudate must be managed, infection must be controlled, the wound must
be protected, and pain must be considered—to provide outcomes that can improve quality of
life.
Most established antimicrobial dressings are very efficient at managing planktonic bacteria,
thereby limiting initial contamination and spread of infection. However, they all suffer the
same challenge in the treatment of biofilm in that the antimicrobial agent must penetrate the
EPS in order to reach the target bacteria and, when they do so, they largely rely on metabo‐
lism to draw them into the bacterial cell for them to act. EPS can restrict the movement of
antimicrobial agents by binding them and increasing the likelihood of reaction with other
organic matter. If the agent is able to reach the target bacterial cell it must do so in a concen‐
tration sufficient to be cidal for the sessile (biofilm) phenotype. Therefore, it is clear that
universally successful antimicrobial therapy using a topical antiseptic agent can only be
achieved by a sustained application or release in combination with some form of EPS (biofilm)
disruption.
2.4.2. An anti-biofilm wound dressing
In 2009, the authors of this chapter undertook a substantial research project to design a wound
dressing specifically to manage biofilm. The starting point was taken as an existing antimi‐
crobial dressing, AQUACEL® Ag. This dressing has a well-documented clinical history for
patient acceptance, safety, management of exudate and reducing the risk of infection [112–
115]. In vitro studies have demonstrated this product to be effective against a broad spec‐
trum of pathogenic bacteria in their planktonic form, including pathogenic multi-drug-
resistant species and clinical wound isolates that have shown high levels of antiseptic tolerance
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in vivo [116–121]. In addition, this dressing has shown some in vitro anti-biofilm activity in
simple models [90, 91]. Using the MBEC method [122] the ability of combinations of anti-
biofilm agents, surfactants and ionic silver to eliminate mature P. aeruginosa biofilm after 30
minutes contact was investigated. Component concentrations were varied, as was pH, and in
all over 60000 tests were performed. Very few combinations proved to be beneficial, but a
number of strong synergistic effects were identified, in particular between ionic silver,
quaternary ammonium surfactants and metal-chelating agents (especially EDTA), all at a
slightly acidic pH [123]. These synergistic components (termed Ag+ Technology) were incor‐
porated into the dressing and subjected to extensive safety testing. We believe that the resultant
dressing, AQUACEL® Ag+ Extra™, is the first commercially available wound dressing
specifically designed to manage biofilm.
In the laboratory AQUACEL Ag+ Extra dressings have demonstrated effectiveness against
biofilm microorganisms in sophisticated in vitro wound models. Here, thick biofilms of multi-
drug-resistant S. aureus or P. aeruginosa were grown on cotton gauze substrates, and placed on
to a simulated wound bed of nutrient agar, within model peri-wound skin [124] (Table 5).
Further studies using isothermal microcalorimetry demonstrated how neither the standard
silver dressing alone (AQUACEL Ag) nor silver nitrate solution showed a marked anti-biofilm
activity, while the AQUACEL Ag+ Extra dressing eradicated the S. aureus biofilm in vitro [125].
Interestingly, in this study the anti-biofilm agents alone, without silver, were also shown to be
ineffective unless combined with silver, demonstrating the synergistic nature of this anti-
biofilm formulation (Table 5).
The efficacy of this combination of ionic silver, metal chelator and surfactant has also been
demonstrated in an FDA-recognised in vivo model of wound healing [30]. Here, the control‐
led formation of P. aeruginosa biofilm and polymicrobial biofilm (P. aeruginosa and S. aureus)
in an acute wound of defined size, and its subsequent treatment, was assessed over time by
measuring parameters such as viable biofilm counts, granulation tissue formation and
epithelialisation. The anti-biofilm dressing was found to be significantly superior to a PHMB-
containing dressing in improving these wound parameters [34] (Table 5).
Most encouraging is the early clinical performance data emerging for this new anti-biofilm
technology. Harding et al. [126] demonstrated the safety and effectiveness of this dressing
containing Ag+ Technology in a 42-patient study in VLU patients. In particular, the authors
highlighted a subset of 10 clinically-infected wounds (where biofilm was assumed to be a
problem) that responded in a more dramatic fashion (Table 5). European and Canadian clinical
evaluations summarised 113 cases which were selected on the basis of being difficult-to-heal
wounds, with suspected involvement of infection or biofilm. Following an average of 4.1 weeks
of use of the new dressing in otherwise standard wound care protocols, an average wound
closure of 73% was achieved, with 17% of wounds healing completely [127] (Table 5). More
detailed individual case studies from these evaluations have also been presented [128]. In more
recent UK-based evaluations of AQUACEL Ag+ EXTRA, a 29-case evaluation reported
reductions in all described signs of clinical infection, including a reduction in suspected biofilm
from 76 to 45%. This was accompanied by an average wound closure of 62%, with 34% of
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Biofilm-based wound care (BBWC) is an emerging and evidently effective way of combining
multiple modes of wound treatment to improve the health of chronic and infected wounds [68,
85, 109]. Practised initially by the pioneering wound care physician, Randall Wolcott in Texas,
a first assumption of BBWC is made that most (if not all) chronic or infected wounds contain
biofilm. A further assumption is that one mode of treatment may not suffice, therefore the use
of combinations of vigorous debridement, cleansers or gels, topical antimicrobial or anti-
biofilm agents, and wound dressings, is required. Wolcott et al. [85, 109–111] have shown how
BBWC can result in significantly improved outcomes compared to standard wound care in
several large patient cohorts. A number of case studies reported by Hurlow and Bowler [69,
70] have also described how protocols of care designed to target biofilm result in improved
wound outcomes. Combining lactoferrin and xylitol (see Section 2.1) in a hydrogel in con‐
junction with a silver wound dressing demonstrated good efficacy against biofilms [53].
We also firmly believe that the multi-modal approach is the most effective way of rapidly
improving wound health in chronic wounds that are likely compromised by biofilm or
infection. A key component in such protocols of care is undoubtedly efficacious wound
dressings which can provide effective, sustained and safe antimicrobial and anti-biofilm
action. Although the focus here is on therapeutic approaches towards wound biofilm, biofilm
cannot be considered in isolation. Other challenging wound conditions must be considered
alongside biofilm—exudate must be managed, infection must be controlled, the wound must
be protected, and pain must be considered—to provide outcomes that can improve quality of
life.
Most established antimicrobial dressings are very efficient at managing planktonic bacteria,
thereby limiting initial contamination and spread of infection. However, they all suffer the
same challenge in the treatment of biofilm in that the antimicrobial agent must penetrate the
EPS in order to reach the target bacteria and, when they do so, they largely rely on metabo‐
lism to draw them into the bacterial cell for them to act. EPS can restrict the movement of
antimicrobial agents by binding them and increasing the likelihood of reaction with other
organic matter. If the agent is able to reach the target bacterial cell it must do so in a concen‐
tration sufficient to be cidal for the sessile (biofilm) phenotype. Therefore, it is clear that
universally successful antimicrobial therapy using a topical antiseptic agent can only be
achieved by a sustained application or release in combination with some form of EPS (biofilm)
disruption.
2.4.2. An anti-biofilm wound dressing
In 2009, the authors of this chapter undertook a substantial research project to design a wound
dressing specifically to manage biofilm. The starting point was taken as an existing antimi‐
crobial dressing, AQUACEL® Ag. This dressing has a well-documented clinical history for
patient acceptance, safety, management of exudate and reducing the risk of infection [112–
115]. In vitro studies have demonstrated this product to be effective against a broad spec‐
trum of pathogenic bacteria in their planktonic form, including pathogenic multi-drug-
resistant species and clinical wound isolates that have shown high levels of antiseptic tolerance
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effectiveness of this dressing (AQUACEL Ag+ Extra) [126–130]. It is likely that future efforts
will continue to investigate combination technologies that will disrupt biofilm to enhance the
antimicrobial efficacy of antiseptics and antibiotics. Certainly, eradication of wound biofilm is
critical to promotion of healing and hence improving the lives of patients debilitated by wound
recalcitrance.
Figure 3. The ideal anti-biofilm wound dressing—prevention, removal, killing.
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wounds fully healing after an average of 5.4 weeks of dressing use [129] (Table 5). Finally, a
112-patient post-market surveillance study further demonstrated the safety and effective‐
ness of this dressing, shifting stagnant or deteriorating wounds, that had previously been
managed with a large variety of standard antimicrobial products, onto healing trajectories
[130] (Table 5).
Study type Summary of results Ref.
In vitro Assessed quantitatively by viable counts & confocal scanning laser microscopy, AQUACEL Ag+
Extra gave 6 log10 kill of P. aeruginosa and CA-MRSA biofilm after 4 & 5 days; standard AQUACEL
Ag dressing did not fully eradicate either biofilm
124
Dressing & silver nitrate+EDTA+BC eradicated S. aureus biofilm; silver CMC dressing, CMC
dressing, EDTA+BC, & silver nitrate alone did not eradicate biofilm; demonstrating synergy of
silver with metal chelator & surfactant
125
In vivo The new dressing technology gave 2 log10 reductions in P. aeruginosa or polymicrobial biofilm after
4 & 6 days compared to PHMB gauze & CMC dressings; granulation tissue formation &
epithelialisation significantly better after new dressing
34
Clinical study An acceptable safety profile was demonstrated; after 4 weeks of the new dressing then 4 weeks
CMC 12% of wounds healed, 76% showed improvement; mean ulcer size reduction 55%; subset of




The new dressing resulted in an average wound closure of 73% after average of 4.1 weeks of use in
113 cases; 17% of wounds healed completely
127
62% average wound closure after 5.4 weeks of AQUACEL Ag+ Extra dressing use; 34% of wounds
healed completely; exudate & signs of suspected biofilm & infection reduced in 29-case evaluation
129
Safety & effectiveness demonstrated in 112-case evaluation; suspected biofilm coverage of wound
reduced; 13 of wounds healed completely, 65% improved after 3.9 weeks of AQUACEL Ag+ Extra
dressing use
130
Table 5. Evidence for a dressing designed specifically to manage exudate, infection and biofilm.
3. Conclusions and future perspectives
Biofilm is increasingly accepted as an integral component of wound recalcitrance and infection,
and is likely a key reason for the frequent failure of antibiotics and antiseptics in wound
healing. Strategies for combating wound biofilm are currently limited and non-specific
physical debridement techniques—from physical removal with absorbent dressings, pads and
wipes, to sharp and surgical tissue removal—remain the most effective approach. Despite the
limited available anti-biofilm wound strategies, efforts are in progress to develop durable
medical devices and wound dressings that combine anti-biofilm and antimicrobial activity.
To-date and to our knowledge, only one dressing has been designed to combat biofilm
(Figure 3), and there is a growing body of evidence demonstrating the exceptional clinical
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ness of this dressing, shifting stagnant or deteriorating wounds, that had previously been
managed with a large variety of standard antimicrobial products, onto healing trajectories
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silver with metal chelator & surfactant
125
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34
Clinical study An acceptable safety profile was demonstrated; after 4 weeks of the new dressing then 4 weeks
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Table 5. Evidence for a dressing designed specifically to manage exudate, infection and biofilm.
3. Conclusions and future perspectives
Biofilm is increasingly accepted as an integral component of wound recalcitrance and infection,
and is likely a key reason for the frequent failure of antibiotics and antiseptics in wound
healing. Strategies for combating wound biofilm are currently limited and non-specific
physical debridement techniques—from physical removal with absorbent dressings, pads and
wipes, to sharp and surgical tissue removal—remain the most effective approach. Despite the
limited available anti-biofilm wound strategies, efforts are in progress to develop durable
medical devices and wound dressings that combine anti-biofilm and antimicrobial activity.
To-date and to our knowledge, only one dressing has been designed to combat biofilm
(Figure 3), and there is a growing body of evidence demonstrating the exceptional clinical
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Abstract
The pathology associated with human respiratory tract bacterial agents that exist as
opportunistic commensals in the nasopharynx cause infections. This is particularly true
for the middle ear disease otitis media (OM) and exacerbations of chronic obstructive
pulmonary disease (COPD).  Streptococcus  pneumoniae  and nontypeable  Haemophilus
influenzae (NTHi) are a commonly recurrent combination and the formation of bacterial
biofilms  by  these  pathogens  in  the  bronchial  airway  or  middle  ear  contributes
significantly to the chronic nature of these diseases. While S. pneumoniae and NTHi have
been  extensively  studied  in  mono-culture,  our  knowledge  about  how  they  exist
together, either in their free-living (planktonic) form or as a biofilm, or indeed the
implication of co-infection is still limited. Several key elements are believed to contribute
or are induced:  (1)  a  set  of  sugar metabolic  pathways;  (2)  surface structures in S.
pneumoniae and NTHi when they are able to co-exist equally; (3) epithelial cell contact
that dramatically increases the rate of biofilm formation; (4) chemical modifications of
NTHi surface structures involved in host cell interactions; and (5) transcription factors
that  regulate particular  surface molecules and the switch to a biofilm state.  There
appears to be multiple mechanisms involved and that these are active under specific
conditions.
Keywords: biofilm metabolism, multispecies biofilm, Streptococcus pneumoniae, Haemo‐
philus influenzae, metal ions in biofilm
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infection of the bronchi to cause bronchitis [3, 4], the lungs to cause pneumonia [5], the middle
ear to cause OM [6], the blood to cause septicaemia, and across the blood–brain barrier to cause
meningitis [7]. An increasing number of clinical, diagnostic or epidemiological studies with a
focus either on bacterial carriage or the microbiota within an infection have co-located S.
pneumoniae and H. influenzae together [8]. Further to this, in many diseases there are other
bacteria present – as mentioned, in the middle ear of OM patients there is S. aureus and M.
catarrhalis, but then in different parts of the respiratory tract, these and other microorgan‐
isms are known to co-exist (whole genome sequencing of the bacterial population in patients
with cystic fibrosis has shown the presence of a diverse range of bacteria including S.
pneumoniae and NTHi but also Pseudomonas aeruginosa) [9]. In the case of OM, to some degree,
there is evidence that at least infection with S. pneumoniae alone represents a different clinical
and epidemiological case than compared to S. pneumoniae together with NTHi [10]. There
seems to be a distinction also based on strains; specifically S. pneumoniae serotype variations
effecting their colonisation and interaction with NTHi. Also, there are non-encapsulated S.
pneumoniae strains that obviously have a different molecular pathogenesis but also cause OM,
and have been shown to co-exist with NTHi [11].
Upon entry to their new niche H. influenzae and S. pneumoniae require systems that permit their
adaptation to the specific physical and chemical properties that exist in the lung, middle ear,
blood or cerebrospinal fluid. These include oxygen levels, pH, nutrient availability, the
presence of toxic reactive chemicals (reactive oxygen and nitrogen species), and immune
factors such as antimicrobial compounds. Given the likely inhospitable nature of migration
from nasopharyngaeal niche, it seems necessary that there are eventual benefits from this
switch in lifestyle. However, the specific molecular factors and signals that cause the transit
from the commensal colonisation of the nasopharynx to, for instance, an invasion of sterile
sites of the respiratory tract is not well known. There are clearly host factors such as the
anatomy of the eustachian tubes [12], and then age and immune competence [13]. Within either
their original commensal site or the further migrated locations (in particular the middle ear
and the lung), it is known that H. influenzae and S. pneumoniae have an ability to persist for
prolonged periods of time. In the first instance this requires the bacterial cells to attach and
remain present. This process includes expression of appropriate adhesins and the ability to
evade the host immune response. For both these bacterial species, an essential factor in
colonisation and then their survival and persistence is their formation of a biofilm. In the case
of the lung and middle ear, this is now known to be as a multi-species biofilm.
3. The nature of bacterial persistence and resistance within a biofilm
A biofilm is a bacterial lifestyle in which the cells reside adhered to a substratum and to each
other and are encased in a self-produced extracellular polymeric substance (EPS) matrix [14,
15]. An important feature of bacterial biofilms is their persistent nature and their insensitivi‐
ty to immune mediators and clinically used antimicrobial agents [16]. These features can be
explained both by the changed physiology of the biofilm-resident bacterial cells themselves
and by the physical properties of the EPS matrix components. The presence of an EPS matrix





Human respiratory tract bacterial infections, like otitis media (OM) and exacerbations of chronic
obstructive pulmonary disease (COPD), are caused by bacterial agents that exist as opportun‐
istic commensals in the nasopharynx. Streptococcus pneumoniae and nontypeable Haemophilus
influenzae (NTHi) are a commonly recurrent combination. The formation of bacterial biofilms
in the bronchial airway or middle ear contributes significantly to the chronic nature of these
diseases. Biofilms are very difficult to remove by either the host’s natural processes or antibi‐
otic therapies, making them an important element within the vicious cycle of the infection
exacerbations.
S. pneumoniae and NTHi are extensively studied individually, yet our knowledge about how
they exist together, either in their free-living (planktonic) form or as a biofilm, or indeed the
implication of co-infection is still limited in contrast to a single species. Studies have shown
that in mono- and co-culture planktonic states and in biofilm development several key
elements contribute or are induced. These include: (1) a set of sugar metabolic pathways
employed especially by S. pneumoniae in co-culture when it dominates; (2) surface structures
in S. pneumoniae and NTHi when they are able to co-exist equally; (3) epithelial cell contact that
dramatically increases metabolic process associated with biofilm formation; (4) chemical
modifications of NTHi surface structures that have a direct role in the interaction with host
epithelial cells; and (5) certain transcription factors that have an integral role in the regula‐
tion of particular surface molecules and the switch to a biofilm state. There appears to be
multiple mechanisms involved and that these are active under specific conditions.
2. Co-existence within the multispecies biofilm as a mode of bacterial
resistance and persistence
In most environmental situations that bacteria exist, they are within communities and in a
biofilm. By definition therefore, in nature these are multi-species biofilms. It is surprising,
therefore, that the vast amount of knowledge that exists on bacterial biofilm formation and
function is from mono-species studies. How the individual species function within an
environment, the physical and chemical nature of their biofilm and its eventual impact on the
environment (this is particularly true of bacterial persistence within an anatomical niche) will
be different when as a mono-culture compared to multi-species culture. H. influenzae is a
commensal bacterial species that inhabits the nasopharynx of healthy humans, and it is
accepted knowledge that its asymptomatic nasopharyngeal carriage is in the range of up to
80% [1]. However, H. influenzae is not the only species to colonise the nasopharyngaeal niche;
the other bacterial species within this niche include S. pneumoniae, Staphylococcus aureus, and
Moraxella catarrhalis. Most commonly the species known to co-colonise the nasopharyngaeal
niche with H. influenzae is the Gram-positive species S. pneumoniae. Asymptomatic nasophar‐
yngaeal carriage for S. pneumoniae has been documented to be at least 20% [2].
Both H. influenzae and S. pneumoniae are able to transit from this site of their commensal lifestyle
to other anatomical niches and thereby cause various diseases. This includes the subsequent
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maturation of the biofilm permitting its persistence and, through an extension of the EPS
matrix, the resistance to exogenous antimicrobial compounds. Host neutrophil extracellular
traps (NETs) seem to be incorporated specifically into the EPS matrix and further to this, there
is non-specific binding of host immune factors to EPS matrix components such as to the eDNA,
further protecting the bacteria that exist within the biofilm. The role of eDNA and the
association of NETs in the integrity and structure of biofilm is discussed in the next section of
this chapter.
Figure 1. A model for the development of the H. influenzae-S. pneumoniae multispecies biofilm. Based on the available
literature, there can be identified discrete stages for H. influenzae (Hi) and S. pneumoniae (Spn) response to the host
environment and their survival together and biofilm formation. Stage 1 – Environmental response and initial adhesion: the
bacteria respond to stresses in the host-pathogen environment by switching from a free-living lifestyle (planktonic) to
a biofilm active form (a change in cellular metabolism and surface structures). This includes cell-cell interactions and
specifically the binding of bacterial adhesins to host cell receptors. Stage 2 – Competition and strain selection: As Spn
grows it lowers the local pH and generates hydrogen peroxide, both of which are bactericidal to Hi. The SpnNanA
enzyme desialyates the Hi lipooligosachcaride (LOS) reducing its capacity to attach to host cells. The Hi is known to
stimulate neutrophils and opsonophagocytosis of Spn. The strains that do survive can then co-operate. Stage 3 – Multis‐
pecies biofilm: there is signalling between the bacterial cells by quorum sensing (QS) through AI-2/AI-3 such that the
bacteria recognise the multispecies environment. There is development of the extracellular polymeric substance (EPS)
matrix made up of components from both bacterial species (type IV pili, eDNA, LOS and protein), providing co-opera‐
tive adhesion and stability of the biofilm structure. Stage 4 – Biofilm maturation: the EPS develops providing further
protection to the bacterial cells from antibiotics and host phagocytic cells. There is also incorporation of host immune
factors, such as NET structures into the EPS.
In very particular disease situations, it is apparent that the biofilm formation is a key viru‐
lence factor. For S. pneumoniae and the NTHi, they are clearly present together in middle ear
tissues of recurrent OM (ROM) and chronic OM (COM) patients [6] and in sputum samples
from COPD [26]. The mono-species biofilm formation of both bacterial species has been well
described [27, 28], and although both are known to co-exist in planktonic and biofilm states,
the understanding of the nature of the interplay between these pathogens and the effect of co-




provides protection and biofilm persistence by physically limiting the diffusion of antimicro‐
bial compounds into the biofilm [17]. Additionally, within the biofilm the bacteria have altered
gene expression profiles as compared to their planktonic state [18–20]. This switch in gene
expression has global effects on cellular functions. This includes changes not only in the surface
structures that are expressed for adhesion and cell-cell interactions, but also in the metabolic
and biosynthetic pathways and the systems for maintaining intracellular conditions such as
pH and redox balance [21]. There is a reduced metabolic activity; a reduction in energy
production, cell division, protein synthesis, and other molecular pathways. These changes
create a cellular state with an increased recalcitrance to a broad range of antimicrobial
agents [22], at the very least they have reduced or no targets for many antibiotics (DNA
replication, protein synthesis, and cell wall biosynthesis). The resistance provided by a biofilm
state to the bacterial cells is against effectors of both the innate and acquired immunity as well
as antibiotics. The nature of the biofilm (its chemical composition and physical properties), the
process of its initiation and formation, and the eventual maturation (the structure), will impact
the function and stability of the biofilm. This will be different for a mono-culture compared to
a multi-species biofilm.
In summary, a model for different stages of biofilm development by H. influenzae/S. pneumo‐
niae is well demonstrated [23]. Figure 1 shows this model in the development of the mixed-
species biofilm. Stage 1 involves adaptation and adhesion, where the bacteria recognise the
physical and chemical conditions of their new environment (such as the oxygen level,
nutrients, and pH) and indeed the biological conditions (the immune mediators that are
present and the host cells and their receptors). Specific bacterial adhesins bind to cognate host
cell receptors. These surface exposed adhesins structures are expressed with the particular
function for attachment to host cells. For H. influenzae, these include the type IV pili, lipooli‐
gosaccharide (LOS) decorated to form sialyated LOS or phosphorylcholine LOS (discussed
later), outer membrane proteins (OMP P5, P6, Hap, HMW1, HMW2), and extracellular DNA
(eDNA). For S. pneumoniae, there is also a role for eDNA including a range of surface struc‐
tures and proteins such as capsule, Pht, CbpA, PsrP. Stage 2 is the recognition and response
to the interspecies stresses. This involves the expression of systems designed for survival in
the presence of the stresses generated by the other species such as; chemical stresses, pH, and
immune-mediated stress. S. pneumoniae growth generates acidic by-products that lowers the
local pH. It is also well known that S. pneumoniae can produce H2O2 either naturally or perhaps
by induction, and this has been argued to be a factor in S. pneumoniae out-competing H.
influenzae (although there is evidence that this not the case) [24]. In addition, S. pneumoniae
produces an extracellular enzyme (NanA) that desialyates the sialic acid decorated H.
influenzae LOS, thereby reducing its ability for adhesion. At the same time, H. influenzae
stimulates certain host immune factors that specifically induce opsonophagocytosis of S.
pneumoniae, although capsule-specific strains will survive this process [25]. These events
through Stage 2 will remove the sensitive strains of both species from the niche such that in
Stage 3 there is now co-operation between the strains that have survived and is ready to form
a multi-species biofilm. This co-operation is complex and still poorly understood but does
include quorum sensing (QS; as discussed in the next section of this chapter), co-aggregation
and adhesion, formation of an EPS matrix, and subsequently biofilm formation. Stage 4 is the
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maturation of the biofilm permitting its persistence and, through an extension of the EPS
matrix, the resistance to exogenous antimicrobial compounds. Host neutrophil extracellular
traps (NETs) seem to be incorporated specifically into the EPS matrix and further to this, there
is non-specific binding of host immune factors to EPS matrix components such as to the eDNA,
further protecting the bacteria that exist within the biofilm. The role of eDNA and the
association of NETs in the integrity and structure of biofilm is discussed in the next section of
this chapter.
Figure 1. A model for the development of the H. influenzae-S. pneumoniae multispecies biofilm. Based on the available
literature, there can be identified discrete stages for H. influenzae (Hi) and S. pneumoniae (Spn) response to the host
environment and their survival together and biofilm formation. Stage 1 – Environmental response and initial adhesion: the
bacteria respond to stresses in the host-pathogen environment by switching from a free-living lifestyle (planktonic) to
a biofilm active form (a change in cellular metabolism and surface structures). This includes cell-cell interactions and
specifically the binding of bacterial adhesins to host cell receptors. Stage 2 – Competition and strain selection: As Spn
grows it lowers the local pH and generates hydrogen peroxide, both of which are bactericidal to Hi. The SpnNanA
enzyme desialyates the Hi lipooligosachcaride (LOS) reducing its capacity to attach to host cells. The Hi is known to
stimulate neutrophils and opsonophagocytosis of Spn. The strains that do survive can then co-operate. Stage 3 – Multis‐
pecies biofilm: there is signalling between the bacterial cells by quorum sensing (QS) through AI-2/AI-3 such that the
bacteria recognise the multispecies environment. There is development of the extracellular polymeric substance (EPS)
matrix made up of components from both bacterial species (type IV pili, eDNA, LOS and protein), providing co-opera‐
tive adhesion and stability of the biofilm structure. Stage 4 – Biofilm maturation: the EPS develops providing further
protection to the bacterial cells from antibiotics and host phagocytic cells. There is also incorporation of host immune
factors, such as NET structures into the EPS.
In very particular disease situations, it is apparent that the biofilm formation is a key viru‐
lence factor. For S. pneumoniae and the NTHi, they are clearly present together in middle ear
tissues of recurrent OM (ROM) and chronic OM (COM) patients [6] and in sputum samples
from COPD [26]. The mono-species biofilm formation of both bacterial species has been well
described [27, 28], and although both are known to co-exist in planktonic and biofilm states,
the understanding of the nature of the interplay between these pathogens and the effect of co-
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pneumoniae and the biofilm resident H. influenzae bla-cells, which alone were susceptible to
beta-lactamase treatment. A synergistic interaction was also shown, where H. influenzae and
S. pneumoniae reached higher cell densities in co-culture than in mono-culture, and were able
to modulate each other’s gene expression in the biofilm [35]. Associated with this has been
the demonstration that H. influenzae inhibits autolysis and fratricide of S. pneumoniae, and
thereby H. influenzae improves the biofilm formation by S. pneumoniae, although this effect
was only observed at later stages of culturing, and suggested that bacteria in co-culture
biofilms may have altered biofilm formation processes, as previous study showed that in
mono-cultures of S. pneumoniae autolysis promoted biofilm formation [36].
As is obvious from this array of findings, the nature of the interactions between these species
remains unclear. It is likely, that these interactions are dependent on a multitude of specific
host, genomic, and environmental factors, and that the discrepancy observed between studies
is a result of the variation of one or more of these parameters. In addition, most studies have
investigated the role of H. influenzae/S. pneumoniae interactions from the perspective of biofilm
formation. Our recent study analysed global gene expression patterns in the H. influenzae/S.
pneumoniae co-culture situation. This revealed the potential for either synergistic or antago‐
nistic interactions between H. influenzae and S. pneumoniae, which is largely dependent on the
growth dynamics and environmental conditions. We have shown that both species undergo
vast changes in their transcriptional profile in response to the growth environment, and further
influenced by the presence of the other species, and we thereby proposed that these environ‐
mental parameters and transcriptional patterns determine the synergistic or antagonistic
nature of the H. influenzae/S. pneumoniae interactions [24]. Indeed under conditions of neutral
or lower pH, the presence of different strains of S. pneumoniae induces H. influenzae into a Viable
But Non-Culturable (VBNC) state [24]. For other bacterial species, this VBNC state was
differentiated from the dead state by several observations; firstly, VBNC cells have an intact
membrane, in contrast to dead cells, they are metabolically active and continue respiration,
VBNC cells continue gene transcription and mRNA production, and were shown to have
continued uptake and incorporation of amino acids into proteins [37, 38]. Given these
characteristics, the induction of H. influenzae cells under specific conditions into the VBNC
state by S. pneumoniae does not preclude it from a multi-species biofilm. This switch in cell type
during co-culture highlights the complex nature of the impact of the bacteria being together
than being in mono-culture.
5. Signalling and sensing mechanisms associated with biofilm formation
Most acute respiratory infections are often dominated by one organism, however, chronic
bacterial infections mostly encompass mixed species microbial communities. In the natural
environment, bacteria mostly coexist or compete with various microbial species, therefore, it
is important to understand the impact of co-infections on persistent infections. The nasophar‐
yngeal commensals such as H. influenzae, S. pneumoniae, S. aureus, and M. catarrhalis are linked
with many respiratory tract infections, with several virulence factors of these microbes
involved and recognised in biofilm formation. This highlights the need to understand the




infection on the disease is only just starting to emerge [23]. The persistence of these species
within a biofilm provides a vast array of phenotypes that allow for both the bacterial adapta‐
tion to a host anatomical niche and for the persistence of these species within a niche for a
prolonged period. The switch to a biofilm state is characterised by global changes to their
surface structures, physiology (energy production), metabolic processes, and stress response
(discussed in a later section of this chapter).
4. Antibiotic resistance within a biofilm
Within a biofilm, bacteria display added resistance to host defences and antibiotic therapies;
biofilms are 1000x more resistant to antibiotics than the planktonic state. An unusual stress
response by NTHi that employs nickel [Ni (II)] ion uptake seemingly as a signalling process
that links the cell’s stress response to the cell physiology and the composition of its surface
structures has also been identified [29].
Fluorescence in situhybridization (FISH) techniques have shown that both S. pneumoniae and
H. influenzae are present in middle ear tissues excised from chronic OM patients [6]. The
bacterial aetiological agents in OM are S. pneumoniae, H. influenzae, and M. catarrhalis [6]. All
these bacteria have also been located in tissue samples within a biofilm. While OM is com‐
monly treated with antibiotics [30] or tympanostomy tube placement [31], COM or ROM forms
of OM are often unresponsive to these treatments. The antibiotic treatment is complicated by
the presence of multiple species of bacteria as well as the biofilm lifestyle of these bacteria.
This has been shown in various studies [8, 32]. Firstly by the induction of a polymicrobial
biofilm in the presence of each other and then specifically the antibiotic resistance provided to
the oto-pathogenic bacteria within a polymicrobial biofilm [32]. This can be in a directed role
(through signalling pathways, see later) or passively. In addition to this antibiotic resistance,
there is some thought that the tympanostomy tube insertion has little impact on removing the
bacteria or even on the biofilms formed; it is believed that it could promote biofilm forma‐
tion and particularly in a polymicrobial situation [33].
The formation of bacterial biofilm during COM largely explains the difficulty in treating
COM with antibiotics, as well as the resistance to tympanostomy tube placement, as both
pathogens are able to re-establish the biofilm on the tympanostomy tube. However, while it
has been established that both species are capable of forming a multi-species biofilm, the
physical or molecular interactions between H. influenzae and S. pneumoniae in vivo or
furthermore, when within the biofilm, have not been well defined. Research findings relating
to the outcomes of this interaction are conflicting, as recently reviewed [23]. There are studies
showing that the interaction between H. influenzae and S. pneumoniae is of a synergistic
nature, whereby the formation of a multi-species biofilm would benefit both species, and
protect them from host antimicrobials, shear forces, and antimicrobial agents. It was shown
that a β-lactamase producing strain of H. influenzae could protect S. pneumoniae from β-lactam
treatment [34]. This same study showed that the formation of a multi-species biofilm with
a bla- strain of H. influenzae also had a protective effect on both the biofilm resident S.
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differentiated from the dead state by several observations; firstly, VBNC cells have an intact
membrane, in contrast to dead cells, they are metabolically active and continue respiration,
VBNC cells continue gene transcription and mRNA production, and were shown to have
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characteristics, the induction of H. influenzae cells under specific conditions into the VBNC
state by S. pneumoniae does not preclude it from a multi-species biofilm. This switch in cell type
during co-culture highlights the complex nature of the impact of the bacteria being together
than being in mono-culture.
5. Signalling and sensing mechanisms associated with biofilm formation
Most acute respiratory infections are often dominated by one organism, however, chronic
bacterial infections mostly encompass mixed species microbial communities. In the natural
environment, bacteria mostly coexist or compete with various microbial species, therefore, it
is important to understand the impact of co-infections on persistent infections. The nasophar‐
yngeal commensals such as H. influenzae, S. pneumoniae, S. aureus, and M. catarrhalis are linked
with many respiratory tract infections, with several virulence factors of these microbes
involved and recognised in biofilm formation. This highlights the need to understand the
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6.1. LuxS/RbsB system
The role of luxS gene in NTHi biofilm formation has been extensively studied in both in vivo
and in vitro, with the mutants lacking this gene forming biofilm, although with decreased
biofilm thickness and biomass, that was further shown to be due to decreased phosphoryl‐
choline incorporation into the LOS structure of the NTHi [47–49]. A certain in vivo study
recently demonstrated the involvement of RbsB protein, a known periplasmic binding protein
in mediating the uptake of AI-2 signals in NTHi [50]. Similar to the luxS mutants, the rbsB
mutants also produced biofilms with reduced thickness and biomass, which were reflective
of the decreased phosphorylcholine levels in the LOS of NTHi. These observations strongly
indicate that QS clearly contributes to the establishment of a chronic infection.
6.2. QseB/QseC system
This two-component signalling system in NTHi was first described in enterohemorrhagic
Escherichia coli and shown to regulate expression of virulence genes in a QS system independ‐
ent of AI-2 [51]. A certain study involving the NTHi mutants lacking the qseC gene showed
decreased biofilm production and was AI-2 independent, indicating that there could be other
alternative signalling molecules affecting NTHi biofilm formation [52]. Although much
progress has been done in understanding and identifying the QS system involved, not much
is known about the nature of the QS signal molecules secreted by NTHi, or how does AI-2
affect the gene expression that could further alter the bacterial phenotype to produce biofilm
is yet to be determined.
6.3. Role of extracellular DNA in NTHi biofilms
eDNA has been implicated as a major structural component of NTHi biofilms facilitating
survival and replication of NTHi within a biofilm [53]. The association of NTHi pili and eDNA
in biofilms, and its involvement in increasing bacterial adherence and biofilm formation is also
well recognised [53, 54]. Recently, the protein responsible for providing the stabilisation of
eDNA within the NTHi biofilm was identified as DNABII that binds to the eDNA and offers
stabilization to the biofilm structure [55]. In addition to the bacterial eDNA, host eDNA also
facilitates NTHi biofilm formation. The human neutrophils through making the NETs entrap
the pathogens with the help of their genomic DNA [56]. The presence of these NETs had been
demonstrated in various studies [53, 55, 57] but their role in pathogenesis is still unclear. A
recent review has described the diverse mechanisms by which both gram-positive and gram-
negative bacteria release eDNA, how eDNA and extracellular polymer matrix of a biofilm
interact with each other, and the chemical behavior of eDNA and these interactions are
responsible for the integrity and structure of biofilm development [58]. eDNA is often supplied
by both host and a pathogen, and is linked to bacterial biofilms, QS, structural maintenance of
biofilm, and offers a protective environment to pathogens residing inside, and further
contributes to chronic and persistent infections. This prompts the need for developing
therapeutics to target disruption of the extracellular matrix. A recent study has provided with
a promising result to show an effective way involving human β-defensin to remove the eDNA




complex interactions between these microbes and how they influence each other to form
biofilms that contribute to persistent and chronic infections.
The matrix of microbial biofilm is usually composed of biopolymers that include polysacchar‐
ides, protein, and extracellular DNA (eDNA), referred to as the EPS. It is well established that
bacteria use a signalling network for cell-to-cell communication, known as QS, to carry out co-
ordinated activities including migration to a suitable environment, nutrient acquisition, and
biofilm formation with the release of various signal molecules or autoinducers (AI) [39]. Such
mechanisms have been identified in both S. pneumoniae and NTHi. Although different systems
are used by different bacteria, the principles of QS such as: AI signal molecules are often
undetected when bacteria are in low density, but commonly detected at high density;
availability of receptors for AI are usually cytoplasmic or membrane bound; and their detection
is critical for any co-ordinated gene expression and/or repression to be carried out by the
bacteria [40, 41]. N-acyl homoserine lactones (AHL’s) are the most studied class of AI signal
molecule and are commonly involved in the QS by gram-negative bacteria. The enzymes
involved in the synthesis of autoinducer N-3-(oxo-hexanoyl)-homoserine lactone (3OC6HSL)
AHL’s are; LuxI and LuxR-type synthases, and substrate S-adenosylmethionine. The AHL’s
then traverse across the bacterial membranes through efflux pumps to bind to their respec‐
tive regulators and initiate their activity. LuxR, a receptor for 3OC6HSL, and a well recog‐
nised transcriptional activator of the luciferase luxICDABE operon that activates its
expression [42]. In contrast, in gram-positive bacteria, the modified oligopeptides or autoin‐
ducing peptides (AIPs) are mediated by specialized transporters that act as autoinducers in
the QS systems. The AIP’s bind to the bacterial membrane bound two-component histidine
kinase receptors, which further activates the cytoplasmic regulator that transcribes the genes
associated with QS [43]. A recent review on AI-2 mediated signalling in bacteria has com‐
piled different functions that are regulated by AI-2 including biofilm formation, antibiotic
susceptibility, virulence factor production, motility, in both gram-positive and gram-nega‐
tive bacteria [44]. Some of the noted examples of AIPs based QS include; ComD/ComE in S.
pneumoniae, AgrC/AgrA in S. aureus, and ComA/ComP in Bacillus subtilis [42]. The manipula‐
tion of the identified QS systems in both gram-positive and gram-negative bacteria must be
addressed further to develop newer biotechnological therapies towards treating chronic and
persistent infections.
6. Quorum sensing mechanisms and signalling in H. influenzae biofilm
formation
NTHi biofilm formation is well recognised due to bacterial aggregation involving various
bacterial components such as lipooligosaccharide, proteins, extracellular DNA (eDNA), and
host material derived from inflammation [45]. QS for NTHi was first suggested because of the
presence of luxS gene in H. influenzae Rd genome, with luxS gene known to be involved in the
production of AI-2 [46]. The most studied, identified QS systems in NTHi are the LuxS/RbsB
and QseB/QseC systems.
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bacteria [40, 41]. N-acyl homoserine lactones (AHL’s) are the most studied class of AI signal
molecule and are commonly involved in the QS by gram-negative bacteria. The enzymes
involved in the synthesis of autoinducer N-3-(oxo-hexanoyl)-homoserine lactone (3OC6HSL)
AHL’s are; LuxI and LuxR-type synthases, and substrate S-adenosylmethionine. The AHL’s
then traverse across the bacterial membranes through efflux pumps to bind to their respec‐
tive regulators and initiate their activity. LuxR, a receptor for 3OC6HSL, and a well recog‐
nised transcriptional activator of the luciferase luxICDABE operon that activates its
expression [42]. In contrast, in gram-positive bacteria, the modified oligopeptides or autoin‐
ducing peptides (AIPs) are mediated by specialized transporters that act as autoinducers in
the QS systems. The AIP’s bind to the bacterial membrane bound two-component histidine
kinase receptors, which further activates the cytoplasmic regulator that transcribes the genes
associated with QS [43]. A recent review on AI-2 mediated signalling in bacteria has com‐
piled different functions that are regulated by AI-2 including biofilm formation, antibiotic
susceptibility, virulence factor production, motility, in both gram-positive and gram-nega‐
tive bacteria [44]. Some of the noted examples of AIPs based QS include; ComD/ComE in S.
pneumoniae, AgrC/AgrA in S. aureus, and ComA/ComP in Bacillus subtilis [42]. The manipula‐
tion of the identified QS systems in both gram-positive and gram-negative bacteria must be
addressed further to develop newer biotechnological therapies towards treating chronic and
persistent infections.
6. Quorum sensing mechanisms and signalling in H. influenzae biofilm
formation
NTHi biofilm formation is well recognised due to bacterial aggregation involving various
bacterial components such as lipooligosaccharide, proteins, extracellular DNA (eDNA), and
host material derived from inflammation [45]. QS for NTHi was first suggested because of the
presence of luxS gene in H. influenzae Rd genome, with luxS gene known to be involved in the
production of AI-2 [46]. The most studied, identified QS systems in NTHi are the LuxS/RbsB
and QseB/QseC systems.
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in comparison with planktonic cells [71], and induction of competence a well recognised link
between the switch from planktonic to biofilm form [72]. A certain study demonstrated
competent cells releasing pneumolysin from the neighbouring non-competent cells by a cell-
lysis mechanism, suggesting an indirect relationship between competence and virulence [73].
Further studies are warranted to understand how this mechanism relates to pneumococcal
infections. Various pathogenic bacteria including Ps. aeruginosa, H. influenzae, S. pnuemoniae
form biofilms on different substrates including tissues and human epithelia. Moreover, S.
pneumoniae and H. influenzae upon interaction with human airway epithelial cells have been
shown to produce more biofilm in comparison with no contact of epithelial cells [74, 75].
However, the production, regulation, and the mechanism by which enhanced pneumococcal
biofilms are formed upon host-microbial interactions are not fully elucidated. Recently, an in
vitro study has described a mechanism involved in the regulation of biofilm autolysis, and
studies involving mutant strains lacking the comC and luxS showed that early pneumococcal
biofilm on human cells are regulated by both Com and LuxS/AI-2 QS system [76]. In other
Streptococcus species, such S. gordonii and S. mutans, there are reports about the involvement of
ComCDE QS system in regulating both competence development and biofilm formation [77,
78].
6.6. BlpABCSRH pathway
This pathway is also one of the well characterised QS system in S. pneumoniae. The pathway
consists of a secretion apparatus (BlpAB), a two-component regulatory system (BlpSRH), and
an ABC transporter (BlpA) [79]. Being similar to the Com pathway, it is suggested that both
pathways could converge at a common site where the response regulators of both pathways
bind to the same motif, and activate the transcription of the same target gene [79]. In this QS
system, a peptide pheromone encoded by blpC gene regulates the production of class II
bacteriocins and their immunity proteins [80]. As bacteriocins are known to inhibit growth of
competing bacteria, leading to intense microbial competition, it could be important to further
elucidate how these complex regulatory networks operate during the course of an infection.
6.7. LuxS/AI-2
Autoinducer-2 (AI-2) is one of the most common QS signal in both gram-positive and gram-
negative bacteria synthesised by S-ribosyl homocysteine lyase (LuxS) [81]. LuxS converts S-
ribosylhomocysteine to homocysteine and 4,5-dihydroxy-2,3-pentanedione (DPD), which
further cyclises to active AI-2 [82]. Although its involvement in the biofilm development and
virulence in several bacterial species is widely recognised [83, 84], the regulation and mecha‐
nism of LuxS has not been clear until now. It is believed that LuxS-controlled QS system might
be only a part of the regulatory network that controls competence and LytA-dependent
autolysis. Recently, the role of LuxS in controlling S. pneumoniae biofilms was first demon‐
strated using luxS mutants that failed to form early biofilms [85], and overexpression of luxS
gene resulted in hyper-biofilm-forming phenotype [36]. Another study involving human
respiratory cells showed that both the LuxS/AI-2 and Com QS systems as the main regula‐




from the extra cellular polymer matrix, alter the NTHi biofilm formation, and effectively kill
the NTHi residing within the biofilm [59].
6.4. Quorum sensing mechanisms and signalling in S. pneumoniae biofilm formation
In S. pneumoniae and in most of the gram-positive bacteria, QS often involves recognition of
secreted peptides through the two-component regulatory systems. Over the last 40 years, the
main QS systems in S. pneumoniae that have been identified and deciphered in detail are: LuxS/
Autoinducer 2 (AI-2), the ComABCDE, and the BlpABCSRH systems [60]. Recently, there has
been a growing interest in deciphering QS signalling or bacterial cross-talk between differ‐
ent strains of the same species. It has been suggested that bacteria belonging to the same
pherotype are able to recognise peptides secreted by the same group but not the ones secreted
by the other members. These pherotypes were previously identified for different QS systems
including Agr in S. aureus, ComCDE in S. pneumoniae, ComQXPA in B. subtilis, and PapR/PlcR
in B. cereus [61–63]. A recent study identified a QS mechanism in Streptococci genus that belongs
to the Rgg family and involves a short hydrophobic peptide (SHP) that acts as a pheromone
[64]. The functionality of the SHP/Rgg cell-cell communication mechanism in three different
Streptococci species was demonstrated and cross-talk between strains was observed. More
recently, an in vitro study demonstrated the involvement of a secreted peptide pheromone,
competence-stimulating peptide (CSP) in influencing and development of S. pneumoniae
biofilm [65].
In the recent years, an alternative group of QS peptides have been identified which are secreted
by bacteria upon interaction with an oligotransporter and a cytoplasmic receptor protein, and
initiate the process of QS [66, 67]. One of such peptides is the Phr signalling peptides of the
Bacillus species that regulate different functions such as; sporulation, genetic competence,
virulence gene expression, biofilm formation, and transfer of genetic elements [68]. The role
of pneumococcal oligopeptide permease (Opp) (homologous to the phr peptides in the Bacillus
species) in colonisation and virulence is well known [69, 70]. A recent study has identified TprA/
PhrA signalling system to mediate QS in various strains of the pneumococci and its
involvement in regulating the QS system in media containing galactose, which is one of the
main energy sources required by the pneumococci during nasopharyngeal colonisation [68].
As biofilms are associated with colonisation, further studies are warranted to investigate the
involvement of TprA/PhrA signalling system in biofilm formation, if any.
6.5. ComABCDE pathway
ComABCDE pathway is one of the most studied QS system regulated by the CSP, encoded by
the comC gene and exported by the ATP-dependent ComAB transporter. In this system, the
membrane-bound histidine kinase receptor, ComD, recognises the CSP which further leads to
autophosphorylation of the histidine kinase, involving a transfer of a phosphate group from
ComD to ComE [60]. Although the biological role of the Com QS in colonisation, bacterial
carriage, and disease by S. pneumoniae is not yet fully known, there are certain studies that has
demonstrated genetic transference to be more efficient in competent Streptococci biofilm cells
Microbial Biofilms - Importance and Applications308
in comparison with planktonic cells [71], and induction of competence a well recognised link
between the switch from planktonic to biofilm form [72]. A certain study demonstrated
competent cells releasing pneumolysin from the neighbouring non-competent cells by a cell-
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further cyclises to active AI-2 [82]. Although its involvement in the biofilm development and
virulence in several bacterial species is widely recognised [83, 84], the regulation and mecha‐
nism of LuxS has not been clear until now. It is believed that LuxS-controlled QS system might
be only a part of the regulatory network that controls competence and LytA-dependent
autolysis. Recently, the role of LuxS in controlling S. pneumoniae biofilms was first demon‐
strated using luxS mutants that failed to form early biofilms [85], and overexpression of luxS
gene resulted in hyper-biofilm-forming phenotype [36]. Another study involving human
respiratory cells showed that both the LuxS/AI-2 and Com QS systems as the main regula‐
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ent strains of the same species. It has been suggested that bacteria belonging to the same
pherotype are able to recognise peptides secreted by the same group but not the ones secreted
by the other members. These pherotypes were previously identified for different QS systems
including Agr in S. aureus, ComCDE in S. pneumoniae, ComQXPA in B. subtilis, and PapR/PlcR
in B. cereus [61–63]. A recent study identified a QS mechanism in Streptococci genus that belongs
to the Rgg family and involves a short hydrophobic peptide (SHP) that acts as a pheromone
[64]. The functionality of the SHP/Rgg cell-cell communication mechanism in three different
Streptococci species was demonstrated and cross-talk between strains was observed. More
recently, an in vitro study demonstrated the involvement of a secreted peptide pheromone,
competence-stimulating peptide (CSP) in influencing and development of S. pneumoniae
biofilm [65].
In the recent years, an alternative group of QS peptides have been identified which are secreted
by bacteria upon interaction with an oligotransporter and a cytoplasmic receptor protein, and
initiate the process of QS [66, 67]. One of such peptides is the Phr signalling peptides of the
Bacillus species that regulate different functions such as; sporulation, genetic competence,
virulence gene expression, biofilm formation, and transfer of genetic elements [68]. The role
of pneumococcal oligopeptide permease (Opp) (homologous to the phr peptides in the Bacillus
species) in colonisation and virulence is well known [69, 70]. A recent study has identified TprA/
PhrA signalling system to mediate QS in various strains of the pneumococci and its
involvement in regulating the QS system in media containing galactose, which is one of the
main energy sources required by the pneumococci during nasopharyngeal colonisation [68].
As biofilms are associated with colonisation, further studies are warranted to investigate the
involvement of TprA/PhrA signalling system in biofilm formation, if any.
6.5. ComABCDE pathway
ComABCDE pathway is one of the most studied QS system regulated by the CSP, encoded by
the comC gene and exported by the ATP-dependent ComAB transporter. In this system, the
membrane-bound histidine kinase receptor, ComD, recognises the CSP which further leads to
autophosphorylation of the histidine kinase, involving a transfer of a phosphate group from
ComD to ComE [60]. Although the biological role of the Com QS in colonisation, bacterial
carriage, and disease by S. pneumoniae is not yet fully known, there are certain studies that has
demonstrated genetic transference to be more efficient in competent Streptococci biofilm cells
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Figure 2. Possible mechanisms involved in multispecies biofilm formation. Mixed bacterial species behave differently
and produce more biofilm upon interaction with host epithelial cell contact in comparison with no cell contact on abio‐
tic surfaces. The figure shows increased biofilm production [more extracellular polymeric substance (EPS) matrix] by
H. influenzae-S. pneumoniae in a multispecies environment upon contact with human epithelial cells (left panel). The
right panel shows a decreased production of biofilm when grown on an abiotic surface (tissue-culture polystyrene
plate). The potential role of host cell contact, possibility of any altered metabolic changes, or increased quorum sensing
(QS)/autoinducer-2 (AI-2) signalling, upon host-cell interactions could hold key to further elucidate the mechanisms
involved in increasing multispecies biofilm formation.
8. Future directions in QS signalling research
Despite the progress made in QS system and signalling pathways, there are several challeng‐
es ahead to better understand how these networks function. The challenges include; decipher‐
ing the messages obtained from the chemical properties, different sensing mechanisms and
integration with other QS pathways, environmental factors, and cellular metabolism. A
modern approach that involves developing a chemical probe to identify novel AI-2 recep‐
tors [91] along with the availability of genetic screening and bioinformatics could be a
promising tool to further elucidate the role of different signalling systems in individual
organisms. Therapeutic approaches to combat horizontal gene transfer by bacteria, multi‐
drug resistance, or to target induction of bacterial community behaviours could be helpful in
answering control of bacterial communities within multi-species biofilm that presents a major
problem in chronic disease including cystic fibrosis or OM. Another approach could be the use




tors in the process of biofilm production [76]. Another report confirmed the down regula‐
tion of pneumolysin in mutants lacking the luxS gene but not in a comC knockout mutant,
suggesting that pneumolysin is predominantly regulated by the LuxS/AI-2 system [86]. Future
studies involving molecular interactions between Com and LuxS/AI-2 QS systems could
provide new research directions in further elucidating gene expressions during early biofilm
formation, or how mature biofilms are formed upon activation of either of these systems.
7. Quorum sensing mechanisms and signalling in mixed species biofilm
formation
Although AI-2 signalling has been vastly studied under monospecies experimental set-ups,
the polymicrobial nature of any microbial biofilm cannot be underestimated. There are certain
co-culture studies that have demonstrated how AI-2 signalling by E. coli induced production
of haemagglutinin protease, which facilitates detachment of Vibrio cholera from the intestinal
mucosa [87]. This indicates how the presence of E. coli influences the dynamics and spread of
cholera disease. Similar approaches have also been adopted to investigate interspecies
signalling amongst nasopharyngeal microflora such as M. catarrhalis and H. influenzae, and
demonstrated that biofilm formation by M. catarrhalis is promoted by the AI-2 signalling by
H. influenzae [88]. Both H. influenzae and M. catarrhalis are well recognised causative patho‐
gens of many respiratory infections including OM, and chronic OM is often associated with
multi-species biofilm formation and antibiotic resistance [89]. Although M. catarrhalis lacks
LuxS/AI-2 QS system, there are certain studies that have demonstrated increased biofilm
production, antibiotic resistance by M. catarrhalis in the presence of H. influenzae [88]. Our own
studies have found that nasal co-colonisation of M. catarrhalis, H. influenzae, and S. pneumo‐
niae resulted in increased colonisation load and incidence of OM in mice [90], increased
bacterial adherence to epithelial cells in vitro. The complex microbe-host interactions during
biofilm production in our study suggested the importance of understanding why certain
strains and serotypes differentially influence biofilm formation, in which the epithelial cell
contact was a key contributor to increased biofilm formation [75]. Figure 2 shows the possi‐
ble mechanisms that could be involved in a multi-species biofilm. It shows how mixed bacterial
species could behave differently and produce more biofilm upon interaction with host
epithelial cell contact in comparison with no cell contact on abiotic surfaces. A recent review
has collated the extensive work on H. influenzae and S. pneumoniae multi-species biofilm
including; co-existence within the biofilm to reflect their persistence, changes in gene expres‐
sion and physiology, how they adapt to environmental conditions, and molecular factors
involved in bacterial cross-talk [23]. Another study showed how co-existence of M. catarrha‐
lis and S. pneumoniae within a biofilm confers antibiotic resistance and bacterial persistence,
and facilitates increased M. catarrhalis biofilm production which is not dependent on AI-2
signalling [32]. These observations highlight the importance of interspecies AI-2 signalling and
the resilient nature of multi-species biofilm, and how do they impact on bacterial persistence
and virulence.
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involved in increasing multispecies biofilm formation.
8. Future directions in QS signalling research
Despite the progress made in QS system and signalling pathways, there are several challeng‐
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modern approach that involves developing a chemical probe to identify novel AI-2 recep‐
tors [91] along with the availability of genetic screening and bioinformatics could be a
promising tool to further elucidate the role of different signalling systems in individual
organisms. Therapeutic approaches to combat horizontal gene transfer by bacteria, multi‐
drug resistance, or to target induction of bacterial community behaviours could be helpful in
answering control of bacterial communities within multi-species biofilm that presents a major
problem in chronic disease including cystic fibrosis or OM. Another approach could be the use
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studies involving molecular interactions between Com and LuxS/AI-2 QS systems could
provide new research directions in further elucidating gene expressions during early biofilm
formation, or how mature biofilms are formed upon activation of either of these systems.
7. Quorum sensing mechanisms and signalling in mixed species biofilm
formation
Although AI-2 signalling has been vastly studied under monospecies experimental set-ups,
the polymicrobial nature of any microbial biofilm cannot be underestimated. There are certain
co-culture studies that have demonstrated how AI-2 signalling by E. coli induced production
of haemagglutinin protease, which facilitates detachment of Vibrio cholera from the intestinal
mucosa [87]. This indicates how the presence of E. coli influences the dynamics and spread of
cholera disease. Similar approaches have also been adopted to investigate interspecies
signalling amongst nasopharyngeal microflora such as M. catarrhalis and H. influenzae, and
demonstrated that biofilm formation by M. catarrhalis is promoted by the AI-2 signalling by
H. influenzae [88]. Both H. influenzae and M. catarrhalis are well recognised causative patho‐
gens of many respiratory infections including OM, and chronic OM is often associated with
multi-species biofilm formation and antibiotic resistance [89]. Although M. catarrhalis lacks
LuxS/AI-2 QS system, there are certain studies that have demonstrated increased biofilm
production, antibiotic resistance by M. catarrhalis in the presence of H. influenzae [88]. Our own
studies have found that nasal co-colonisation of M. catarrhalis, H. influenzae, and S. pneumo‐
niae resulted in increased colonisation load and incidence of OM in mice [90], increased
bacterial adherence to epithelial cells in vitro. The complex microbe-host interactions during
biofilm production in our study suggested the importance of understanding why certain
strains and serotypes differentially influence biofilm formation, in which the epithelial cell
contact was a key contributor to increased biofilm formation [75]. Figure 2 shows the possi‐
ble mechanisms that could be involved in a multi-species biofilm. It shows how mixed bacterial
species could behave differently and produce more biofilm upon interaction with host
epithelial cell contact in comparison with no cell contact on abiotic surfaces. A recent review
has collated the extensive work on H. influenzae and S. pneumoniae multi-species biofilm
including; co-existence within the biofilm to reflect their persistence, changes in gene expres‐
sion and physiology, how they adapt to environmental conditions, and molecular factors
involved in bacterial cross-talk [23]. Another study showed how co-existence of M. catarrha‐
lis and S. pneumoniae within a biofilm confers antibiotic resistance and bacterial persistence,
and facilitates increased M. catarrhalis biofilm production which is not dependent on AI-2
signalling [32]. These observations highlight the importance of interspecies AI-2 signalling and
the resilient nature of multi-species biofilm, and how do they impact on bacterial persistence
and virulence.
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The environmental concentration of transition metal ions can have significant influence on the
survival of the bacteria and its lifestyle. For many metals, even though essentially they can
quickly become toxic. Obviously, there is therefore a necessary tight regulation of their
homeostasis; under metal starvation, there is an up-regulation of uptake systems, but as the
metal concentration exceeds the cellular requirement there is activation of efflux systems [98].
In addition to some metal ions, their toxicity is closely linked to other environmental factors
(or stresses) that the cells also required to respond – for instance iron toxicity is associated with
oxidative stress (through Fenton Chemistry) and therefore iron homeostasis is regulated in
conjunction with oxidative stress responses. Nickel levels and nickel function (such as binding
to proteins) is affected by pH. Copper also is linked to pH, as the concentration increases there
is an increase in acidity, and for copper there is also a link to Fenton chemistry and oxidative
stress. Other metals seem to have an anti-oxidant role for the cell (such as zinc and manga‐
nese). The homeostasis of a metal is therefore affected by cellular requirement as well as other
environmental factors that are affecting the metal toxicity or function. The influence of metal
ions on bacteria within the environment is complex. It is further the subject of the metal
bioavailability and cellular requirements. It is known that the correct access to metals
influences cell lifestyle – this can be direct (where their role is either as a co-factor for a
biomolecule or through directly within transcriptional pathways) or indirectly (acting as
signalling system for stresses). As suggested previously, the response of cellular networks to
the environmental level of a metal ion, the metabolic and physiological (energy generation)
cell systems, and cell surface structures, will vary under different growth and environmen‐
tal conditions.
Metal ion uptake is known to be important for bacterial survival within the host. Iron uptake
systems are proven virulence factors for many pathogens [99, 100] and the control of zinc,
copper, and manganese levels within the host environment has been shown to be important
for bacterial survival and virulence. There have been different studies associating the niche-
specific metal ion concentration and subsequent expression and role of particular surface
structures [101]. A key example is the struggle between host and bacteria for iron. Iron is central
for many pathways required in growth and survival, indeed for humans as well as for the
bacteria, but iron chemistry also links it tightly to oxidative stress. Alternatively, an inability
to acquire iron simply in itself can become a stress for the bacteria and induce the bacteria into
a biofilm lifestyle. Iron acquisition and homeostasis is considered a virulence factor for many
pathogens. In addition to the stress, some iron acquisition pathways have surface structures
and of these iron-acquiring systems they have a dual role in adhesion and initiation of biofilm
formation. In the context of multi-species biofilms, there is very little known of the role of
transition metals. For Pneumococcus alone, iron sensing and iron transport is complicated,
overlapping with other transition metal systems. The regulation is predominantly through
RitR and transport is via PiaABCD, PitADBC, and PiuCDA [101]. Disruption of these path‐
ways is shown to affect nasopharyngeal carriage and adhesion (indeed using OM model
assays; these different reports have been well reviewed) [101]. Iron has been suggested through
different studies to act as a signal for numerous processes in Pneumococcus, although the fine
balance required for iron levels seems to be highlighted by its positive and negative effects on
biofilm formation. Certainly, iron-limited conditions altered the protein expression of a




of quorum quenching or cause interference in AI-2 based signalling by developing antagonis‐
tic analogue molecules [92]. Recently, nanotechnology has provided some promising results
with the manipulation of the AI-2 signalling on certain subpopulation of targeted bacteria [93].
9. The host-pathogen environment and role of metal ions in bacterial cells
The exact nature of the properties of an environment will influence if a resident bacterial
species can grow freely in an active, planktonic lifestyle or whether the environmental
properties represent non-optimal or stressed conditions and therefore act as a trigger for the
bacteria to switch to a biofilm lifestyle. These properties include the chemical and physical
properties affecting growth; the pH, oxygen levels, nutrient levels, temperature, osmotic
pressure, redox state, water availability, and the presence of toxic compounds such as reactive
chemicals. In host-pathogen environment the presence, absence, or changes in the levels of
these properties can become a stress for the bacteria. Many host cells either intrinsically or by
induction as a response to the bacterial being present, generate toxic levels of reactive oxygen
or nitrogen species (ROS and RNS respectively). The immune response from cells such as
macrophages (and other cells) stimulates the production of the ROS superoxide and hydro‐
gen peroxide as part of their anti-microbial processes. They are also known to generate nitric
oxide (NO) and other RNS as a response to infection. It is appreciated that there are differen‐
ces in this range of physical and chemical properties between anatomical niches. It has been
well established in numerous bacterial species that the presence of hydrogen peroxide and NO
stimulate biofilm formation [94, 95]. In the context of bacteria such as S. pneumoniae and NTHi,
when acting as a commensal of the nasopharynx and when persisting in niches such as the lung
and middle ear, and perhaps more relevant than the short-lived immune generated toxic
chemicals (ROS and RNS), are the intrinsic features of the environment (the oxygen levels, the
pH nutrients levels, and the availability of essential micro-nutrients such as the metal ions,
iron, copper, manganese, and nickel).
It is not understood how measures of variation observed in the secretions taken from the
middle ear and lungs of patients relate to conditions that favour biofilm formation and
persistence of bacteria. The pH in serous (7.92), mucous (8.55), and serous/mucous (8.33)
middle ear fluids varies slightly across a weak alkaline range [96]; sputum from COPD patients
was lower in pH from those with more significant disease, and this was shown to be associ‐
ated with increased cytokine levels [97]. The contribution to defined growth conditions for the
co-existence of S. pneumoniae and NTHi have been important determinants for understand‐
ing the mechanisms and factors important at different growth phases in planktonic and biofilm
states. Studies ultimately found that at a higher pH, NTHi survived in co-culture with S.
pneumoniae and as part of the competitive microbial environment in batch cultures, S.
pneumoniae drives a decrease in pH that continues below pH 5.75, at which point NTHi is
unable to grow. Such in vitro observations do not appear to be a representative of the host
environment, therefore studies using flow cell chambers have provided a more realistic model
system, showing that even under low pH condition, the NTHi can survive [24].
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copper, and manganese levels within the host environment has been shown to be important
for bacterial survival and virulence. There have been different studies associating the niche-
specific metal ion concentration and subsequent expression and role of particular surface
structures [101]. A key example is the struggle between host and bacteria for iron. Iron is central
for many pathways required in growth and survival, indeed for humans as well as for the
bacteria, but iron chemistry also links it tightly to oxidative stress. Alternatively, an inability
to acquire iron simply in itself can become a stress for the bacteria and induce the bacteria into
a biofilm lifestyle. Iron acquisition and homeostasis is considered a virulence factor for many
pathogens. In addition to the stress, some iron acquisition pathways have surface structures
and of these iron-acquiring systems they have a dual role in adhesion and initiation of biofilm
formation. In the context of multi-species biofilms, there is very little known of the role of
transition metals. For Pneumococcus alone, iron sensing and iron transport is complicated,
overlapping with other transition metal systems. The regulation is predominantly through
RitR and transport is via PiaABCD, PitADBC, and PiuCDA [101]. Disruption of these path‐
ways is shown to affect nasopharyngeal carriage and adhesion (indeed using OM model
assays; these different reports have been well reviewed) [101]. Iron has been suggested through
different studies to act as a signal for numerous processes in Pneumococcus, although the fine
balance required for iron levels seems to be highlighted by its positive and negative effects on
biofilm formation. Certainly, iron-limited conditions altered the protein expression of a




of quorum quenching or cause interference in AI-2 based signalling by developing antagonis‐
tic analogue molecules [92]. Recently, nanotechnology has provided some promising results
with the manipulation of the AI-2 signalling on certain subpopulation of targeted bacteria [93].
9. The host-pathogen environment and role of metal ions in bacterial cells
The exact nature of the properties of an environment will influence if a resident bacterial
species can grow freely in an active, planktonic lifestyle or whether the environmental
properties represent non-optimal or stressed conditions and therefore act as a trigger for the
bacteria to switch to a biofilm lifestyle. These properties include the chemical and physical
properties affecting growth; the pH, oxygen levels, nutrient levels, temperature, osmotic
pressure, redox state, water availability, and the presence of toxic compounds such as reactive
chemicals. In host-pathogen environment the presence, absence, or changes in the levels of
these properties can become a stress for the bacteria. Many host cells either intrinsically or by
induction as a response to the bacterial being present, generate toxic levels of reactive oxygen
or nitrogen species (ROS and RNS respectively). The immune response from cells such as
macrophages (and other cells) stimulates the production of the ROS superoxide and hydro‐
gen peroxide as part of their anti-microbial processes. They are also known to generate nitric
oxide (NO) and other RNS as a response to infection. It is appreciated that there are differen‐
ces in this range of physical and chemical properties between anatomical niches. It has been
well established in numerous bacterial species that the presence of hydrogen peroxide and NO
stimulate biofilm formation [94, 95]. In the context of bacteria such as S. pneumoniae and NTHi,
when acting as a commensal of the nasopharynx and when persisting in niches such as the lung
and middle ear, and perhaps more relevant than the short-lived immune generated toxic
chemicals (ROS and RNS), are the intrinsic features of the environment (the oxygen levels, the
pH nutrients levels, and the availability of essential micro-nutrients such as the metal ions,
iron, copper, manganese, and nickel).
It is not understood how measures of variation observed in the secretions taken from the
middle ear and lungs of patients relate to conditions that favour biofilm formation and
persistence of bacteria. The pH in serous (7.92), mucous (8.55), and serous/mucous (8.33)
middle ear fluids varies slightly across a weak alkaline range [96]; sputum from COPD patients
was lower in pH from those with more significant disease, and this was shown to be associ‐
ated with increased cytokine levels [97]. The contribution to defined growth conditions for the
co-existence of S. pneumoniae and NTHi have been important determinants for understand‐
ing the mechanisms and factors important at different growth phases in planktonic and biofilm
states. Studies ultimately found that at a higher pH, NTHi survived in co-culture with S.
pneumoniae and as part of the competitive microbial environment in batch cultures, S.
pneumoniae drives a decrease in pH that continues below pH 5.75, at which point NTHi is
unable to grow. Such in vitro observations do not appear to be a representative of the host
environment, therefore studies using flow cell chambers have provided a more realistic model
system, showing that even under low pH condition, the NTHi can survive [24].
Microbial Biofilms - Importance and Applications312
infection of human lung epithelial cells, it was adcAII alone that was required for attachment
and colonization on the nasopharynx, presumably through biofilm formation [108]. The Pht
proteins bind zinc and facilitate zinc uptake, have been shown to be essential in attachment of
S. pneumoniae to respiratory epithelial cells [109]. The pht genes along with adc operon are
regulated by AdcR in response to zinc but the PsaR regulator is now also known to be zinc-
responsive (in addition to manganese). Further to the complex nature of the transcriptional
response to environmental metal ion levels, both AdcR and PsaR have been shown to
additionally respond to cellular concentrations of nickel. In PsaR, the nickel competes against
manganese’s binding and has an opposite effect to manganese for PsaR function on its
regulon [110]. AdcR also independently responds to nickel – exogenous nickel levels having
a direct role in regulating the Pht proteins and affecting the AdcR control of the adc operon
[111]. Nickel has clearly been shown for NTHi to directly have a role in cell’s lifestyle. The
maintenance of intracellular nickel has a role in the nature of the cell surface, the surface charge
and hydrophobicity, and the outer membrane protein and LOS composition, and this is
independent of nickel binding proteins [112]. Further to this, it was shown that this nickel-
induced effect on the bacterial cell also translated to a loss in type IV pili-mediated twitching
motility in NTHi [29]. The importance of nickel uptake for the growth of NTHi is well known,
and when limited, the bacteria makes the switch to a biofilm state [112]. This was correlated
to a control of intracellular pH levels. However, it was shown not simply to be pH stress that
was influencing NTHi survival or biofilm formation when in co-culture with S. pneumoniae,
but growth dynamics [24].
The exact nature of the environmental transition metal composition therefore impacts on both
NTHi and S. pneumoniae lifestyle and their ability to attach to host cells and initiate biofilm
formation. There is little analysis of the consequential impact of metal ions in NTHi/S.
pneumoniae co-culture and biofilm formation and much of our discussion has therefore
focussed on mono-culture studies.
10. Bacterial metabolic pathways and mechanisms contributing to the
biofilm production
Several studies have investigated gene and/or expression to identify the unique metabolic
changes associated with transition form planktonic form to biofilm for S. pneumoniae. Yadav
and co-workers [113] identified the exclusive up-regulation of genes involved in the mevalo‐
nate pathway, pyruvate metabolism, carbohydrate metabolism, galactose metabolic process,
cell wall biosynthesis, translation, and purine and pyrimidine nucleotide metabolic path‐
ways in biofilm formation, and suggested that these were also important to the growth and
survival of bacteria in biofilms. In addition, changes to related genes suggested that the cells
in biofilms may be under stress conditions that result in changes in the protein synthesis
required to adapt to a new environment. Protein profiles have been compared between log-
phase planktonic S. pneumoniae serotype 14 and 1-day and 7-day biofilm cultures using
iTRAQ (isobaric tagging for relative and absolute quantification) [114]. This study by Allan
and co-workers identified 244 proteins of which >80% were differentially expressed during




number of surface structures (such as PsaA) and therefore affected biofilm formation [102].
Other work linked iron levels to LuxS regulatory controlled processes, increasing levels of iron
actually enhanced biofilm formation and other processes [36]. For NTHi, there is also a
correlation to iron acquisition pathways, iron regulatory pathways, and biofilm formation.
Iron uptake is up-regulated as NTHi migrates to the middle ear, a niche that it is known to exist
within a biofilm. The central iron-responsive transcription factor (ferric uptake regulator, Fur)
is required for long term survival of NTHi in vivo [103], and by regulating many genes it
controls biofilm initiation and maturation. More directly, culturing NTHi sequentially through
iron-replete and iron-depleted conditions revealed iron restriction induces biofilm formation
[104]. These studies also used an experimental OM model and observed survival in the middle
ear and the biofilms formed in the middle ear of bacterial cells taken from iron-rich and iron
depleted cultures. The iron-depleted cultures survived longer and interestingly showed a
changed architecture in their biofilm [104]. While this work revealed significant outcomes and
raised intriguing questions with regards to the cell biology, it did clearly show that iron levels
play an essential role in NTHi biofilm formation in the middle ear.
Other transition metal ions variously have vital role for bacterial survival. Some of these roles
are as co-factors for important enzymes and then simply for growth, while other functions
includes in stress response. In the case of S. pneumoniae these functions for transition metals
have been intensively studied and this has been well reviewed [101]. In pneumococcal
pathogenesis, transition metal ions such as iron, zinc, copper, and manganese are critical for
its survival within a host, although in differing degrees. Although the exact function is not
always clear and could be direct or indirect such as; the signalling through global transcrip‐
tional pathways or in competition with other metals for specific binding sites in biomole‐
cules [101]. There are a series of surface proteins in S. pneumoniae that function in metal ion
uptake (or even in efflux) but are concurrently essential in adhesion and at least the first stages
of biofilm formation on epithelial cells. These structures include the choline binding protein
PcpA, the serine protease PrtA, and the manganese uptake system PsaBCA. PsaR regulates all
these and this is at least in response to environmental and cellular manganese levels. While
the transport proteins for copper seem to be up-regulated during infection, their role in
virulence is not known [105]. Although the copper export proteins (CopA certainly) do seem
to be involved at various stages during pathogenesis and certainly are linked to pneumococ‐
cal survival in the nasopharynx and lung [106]. Likewise, with other transition metals, there
seems to be a central role in survival as perhaps shown in infection and systems animal model
studies. These however have not always been directly associated with an exact process within
pathogenesis or directly in biofilm formation [101].
The local concentration of zinc has a significant role in the pathogenesis of S. pneumoniae and
this includes in its biofilm formation within the host [107]. There are a number of zinc uptake
and efflux systems that have been studied in pneumococcus (AdcABC and AdcAII regulat‐
ed by AdcR, Pht proteins and CzcD). Metal limiting conditions can result in a growth
limitation. Maintaining cellular zinc (and manganese) levels is important to controlling the
redox balance and defending against oxidative stress. AdcAII has been shown itself to have a
direct role in pathogenesis; while mutants lacking either adcA or adcAII increased invasive
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infection of human lung epithelial cells, it was adcAII alone that was required for attachment
and colonization on the nasopharynx, presumably through biofilm formation [108]. The Pht
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regulated by AdcR in response to zinc but the PsaR regulator is now also known to be zinc-
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manganese’s binding and has an opposite effect to manganese for PsaR function on its
regulon [110]. AdcR also independently responds to nickel – exogenous nickel levels having
a direct role in regulating the Pht proteins and affecting the AdcR control of the adc operon
[111]. Nickel has clearly been shown for NTHi to directly have a role in cell’s lifestyle. The
maintenance of intracellular nickel has a role in the nature of the cell surface, the surface charge
and hydrophobicity, and the outer membrane protein and LOS composition, and this is
independent of nickel binding proteins [112]. Further to this, it was shown that this nickel-
induced effect on the bacterial cell also translated to a loss in type IV pili-mediated twitching
motility in NTHi [29]. The importance of nickel uptake for the growth of NTHi is well known,
and when limited, the bacteria makes the switch to a biofilm state [112]. This was correlated
to a control of intracellular pH levels. However, it was shown not simply to be pH stress that
was influencing NTHi survival or biofilm formation when in co-culture with S. pneumoniae,
but growth dynamics [24].
The exact nature of the environmental transition metal composition therefore impacts on both
NTHi and S. pneumoniae lifestyle and their ability to attach to host cells and initiate biofilm
formation. There is little analysis of the consequential impact of metal ions in NTHi/S.
pneumoniae co-culture and biofilm formation and much of our discussion has therefore
focussed on mono-culture studies.
10. Bacterial metabolic pathways and mechanisms contributing to the
biofilm production
Several studies have investigated gene and/or expression to identify the unique metabolic
changes associated with transition form planktonic form to biofilm for S. pneumoniae. Yadav
and co-workers [113] identified the exclusive up-regulation of genes involved in the mevalo‐
nate pathway, pyruvate metabolism, carbohydrate metabolism, galactose metabolic process,
cell wall biosynthesis, translation, and purine and pyrimidine nucleotide metabolic path‐
ways in biofilm formation, and suggested that these were also important to the growth and
survival of bacteria in biofilms. In addition, changes to related genes suggested that the cells
in biofilms may be under stress conditions that result in changes in the protein synthesis
required to adapt to a new environment. Protein profiles have been compared between log-
phase planktonic S. pneumoniae serotype 14 and 1-day and 7-day biofilm cultures using
iTRAQ (isobaric tagging for relative and absolute quantification) [114]. This study by Allan
and co-workers identified 244 proteins of which >80% were differentially expressed during




number of surface structures (such as PsaA) and therefore affected biofilm formation [102].
Other work linked iron levels to LuxS regulatory controlled processes, increasing levels of iron
actually enhanced biofilm formation and other processes [36]. For NTHi, there is also a
correlation to iron acquisition pathways, iron regulatory pathways, and biofilm formation.
Iron uptake is up-regulated as NTHi migrates to the middle ear, a niche that it is known to exist
within a biofilm. The central iron-responsive transcription factor (ferric uptake regulator, Fur)
is required for long term survival of NTHi in vivo [103], and by regulating many genes it
controls biofilm initiation and maturation. More directly, culturing NTHi sequentially through
iron-replete and iron-depleted conditions revealed iron restriction induces biofilm formation
[104]. These studies also used an experimental OM model and observed survival in the middle
ear and the biofilms formed in the middle ear of bacterial cells taken from iron-rich and iron
depleted cultures. The iron-depleted cultures survived longer and interestingly showed a
changed architecture in their biofilm [104]. While this work revealed significant outcomes and
raised intriguing questions with regards to the cell biology, it did clearly show that iron levels
play an essential role in NTHi biofilm formation in the middle ear.
Other transition metal ions variously have vital role for bacterial survival. Some of these roles
are as co-factors for important enzymes and then simply for growth, while other functions
includes in stress response. In the case of S. pneumoniae these functions for transition metals
have been intensively studied and this has been well reviewed [101]. In pneumococcal
pathogenesis, transition metal ions such as iron, zinc, copper, and manganese are critical for
its survival within a host, although in differing degrees. Although the exact function is not
always clear and could be direct or indirect such as; the signalling through global transcrip‐
tional pathways or in competition with other metals for specific binding sites in biomole‐
cules [101]. There are a series of surface proteins in S. pneumoniae that function in metal ion
uptake (or even in efflux) but are concurrently essential in adhesion and at least the first stages
of biofilm formation on epithelial cells. These structures include the choline binding protein
PcpA, the serine protease PrtA, and the manganese uptake system PsaBCA. PsaR regulates all
these and this is at least in response to environmental and cellular manganese levels. While
the transport proteins for copper seem to be up-regulated during infection, their role in
virulence is not known [105]. Although the copper export proteins (CopA certainly) do seem
to be involved at various stages during pathogenesis and certainly are linked to pneumococ‐
cal survival in the nasopharynx and lung [106]. Likewise, with other transition metals, there
seems to be a central role in survival as perhaps shown in infection and systems animal model
studies. These however have not always been directly associated with an exact process within
pathogenesis or directly in biofilm formation [101].
The local concentration of zinc has a significant role in the pathogenesis of S. pneumoniae and
this includes in its biofilm formation within the host [107]. There are a number of zinc uptake
and efflux systems that have been studied in pneumococcus (AdcABC and AdcAII regulat‐
ed by AdcR, Pht proteins and CzcD). Metal limiting conditions can result in a growth
limitation. Maintaining cellular zinc (and manganese) levels is important to controlling the
redox balance and defending against oxidative stress. AdcAII has been shown itself to have a
direct role in pathogenesis; while mutants lacking either adcA or adcAII increased invasive
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tion and mechanisms of cooperation. Additionally, the role of the human mucosal surface and
respiratory tract environment on metabolic changes have not yet been investigated.
Planktonic Biofilm development Mature biofilm
Up-regulation
Stress response Cell wall organisation Some enzymes involved
in biosynthesis/alteration
or degradation and cell division
Virulence Amino acid, pyruvate,
pyrimidine processes
Transport






Translation Many metabolic processes changed
during biofilm development
return to normal levels
of expression
Pyruvate processes





Table 1. Summary of key metabolic processes altered during biofilm formation and maturation.
11. Conclusion
The biofilm is the dominant factor in persistence; being recalcitrant to antibiotic and host
antimicrobial processes. Understanding the mechanisms that contribute to this persistence will
help to design the next generation therapeutics. Many key questions are still unresolved.
Identifying the genes involved in enabling bacterial co-existence, particularly in the transi‐
tion to a biofilm state, may provide new targets for preventing the transition to a state of
chronic, persistent colonisation. Understanding the specific cell-to-cell factors affecting the
signalling/sensing mechanisms that could alter bacterial cell-surface and the host characteris‐
tics that play a role might enable us to identify individuals likely to be susceptible to chronic
disease situations. Our knowledge is still limited about the differences in the general charac‐




biofilm development. Their results indicated that metabolic regulation appears to play a
central role in the adaptation from the planktonic to biofilm phenotype. Their study found
that 47% of proteins were down-regulated during biofilm development (day 1) and 16% were
up-regulated compared to the bacteria in log-phase. As the biofilm matured, approximately
24% of the proteins expressed during biofilm development returned to expression levels
similar to the planktonic state and a further 16% were up-regulated. In general, up-regula‐
tion was observed with proteins associated with pyruvate, amino acid, and carbohydrate
metabolism and there was a down-regulation in glycolysis and some other metabolic pro‐
teins. By day 7 of the biofilm, the most noticeable difference was the increase in some proteins
that were associated with protein biosynthesis/alteration or degradation and cell division.
Changes in metabolism potentially serve two purposes, firstly changing the bacterial pheno‐
type so as to adapt to the different lifestyle and secondly, the need to utilise alternative
metabolic pathways for survival.
The results of these studies suggest that S. pneumoniae uses a range of carbohydrates during
biofilm formation. The biofilm also has a changing oxygen environment and increases in
pyruvate metabolism, particularly lactate dehydrogenase that indicates an adaptation to this.
The down-regulation of many virulence proteins generally associated with infection, persis‐
tence, and its ability to compete suggest a significant shift in its need to protect and respond
to threats from the external environment. This is accompanied by the down-regulation in
NADH oxidase that acts as an oxygen sensor and improving glucose catabolism. At the same
time, processes important to carbohydrate selection and capsule production were increased,
as was pyruvate oxidase, important to S. pneumoniae aggregate formation.
Comparison of NTHi biofilm to planktonic form in one study has shown that 127 proteins are
significantly differentially expressed [115]. Of particular note was the major down-regula‐
tion in proteins involved in purine, pyrimidine, nucleoside, and nucleotide processes; protein
synthesis; and energy metabolism. Up-regulation was detected for proteins involved in the
cell envelope, DNA metabolism, transcription, and metabolism of phospholipids and fatty
acids. Similar to the conclusions drawn from the metabolic changes to S. pneumoniae, NTHi
appears to enter a state of decreased energy metabolism and protein biosynthesis at the same
time adjusting its metabolism to the changes in the aerobic environment and energy derived
from carbohydrate metabolism. Another study found that one of the triggers for biofilm
formation was exposure to sub-inhibitory concentrations of beta-lactam antibiotics [116].
While very similar gene expression changes were found as reported by Post et al., including
an increase in biofilm biomass and decreased protein production, the concomitant up-
regulation of the genes involved in glycogen production was proposed to be associated with
an ability for the bacteria to be sustained as they become metabolically inactive. This aligns
with recent work reported by Kidd where in mixed S. pneumoniae and NTHi biofilm, S.
pneumoniae is able to convert NTHi to a non-culturable state [29].
It appears that similar changes in metabolic processes might occur as bacteria transition from
the planktonic state, through early biofilm development to the mature biofilm (Table 1). As
yet, very little is known about the metabolic changes that enable mixed biofilm formation,
particularly associated with the shift in the processes associated with interspecies competi‐
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tion and mechanisms of cooperation. Additionally, the role of the human mucosal surface and
respiratory tract environment on metabolic changes have not yet been investigated.
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Table 1. Summary of key metabolic processes altered during biofilm formation and maturation.
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Identifying the genes involved in enabling bacterial co-existence, particularly in the transi‐
tion to a biofilm state, may provide new targets for preventing the transition to a state of
chronic, persistent colonisation. Understanding the specific cell-to-cell factors affecting the
signalling/sensing mechanisms that could alter bacterial cell-surface and the host characteris‐
tics that play a role might enable us to identify individuals likely to be susceptible to chronic
disease situations. Our knowledge is still limited about the differences in the general charac‐
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similar to the planktonic state and a further 16% were up-regulated. In general, up-regula‐
tion was observed with proteins associated with pyruvate, amino acid, and carbohydrate
metabolism and there was a down-regulation in glycolysis and some other metabolic pro‐
teins. By day 7 of the biofilm, the most noticeable difference was the increase in some proteins
that were associated with protein biosynthesis/alteration or degradation and cell division.
Changes in metabolism potentially serve two purposes, firstly changing the bacterial pheno‐
type so as to adapt to the different lifestyle and secondly, the need to utilise alternative
metabolic pathways for survival.
The results of these studies suggest that S. pneumoniae uses a range of carbohydrates during
biofilm formation. The biofilm also has a changing oxygen environment and increases in
pyruvate metabolism, particularly lactate dehydrogenase that indicates an adaptation to this.
The down-regulation of many virulence proteins generally associated with infection, persis‐
tence, and its ability to compete suggest a significant shift in its need to protect and respond
to threats from the external environment. This is accompanied by the down-regulation in
NADH oxidase that acts as an oxygen sensor and improving glucose catabolism. At the same
time, processes important to carbohydrate selection and capsule production were increased,
as was pyruvate oxidase, important to S. pneumoniae aggregate formation.
Comparison of NTHi biofilm to planktonic form in one study has shown that 127 proteins are
significantly differentially expressed [115]. Of particular note was the major down-regula‐
tion in proteins involved in purine, pyrimidine, nucleoside, and nucleotide processes; protein
synthesis; and energy metabolism. Up-regulation was detected for proteins involved in the
cell envelope, DNA metabolism, transcription, and metabolism of phospholipids and fatty
acids. Similar to the conclusions drawn from the metabolic changes to S. pneumoniae, NTHi
appears to enter a state of decreased energy metabolism and protein biosynthesis at the same
time adjusting its metabolism to the changes in the aerobic environment and energy derived
from carbohydrate metabolism. Another study found that one of the triggers for biofilm
formation was exposure to sub-inhibitory concentrations of beta-lactam antibiotics [116].
While very similar gene expression changes were found as reported by Post et al., including
an increase in biofilm biomass and decreased protein production, the concomitant up-
regulation of the genes involved in glycogen production was proposed to be associated with
an ability for the bacteria to be sustained as they become metabolically inactive. This aligns
with recent work reported by Kidd where in mixed S. pneumoniae and NTHi biofilm, S.
pneumoniae is able to convert NTHi to a non-culturable state [29].
It appears that similar changes in metabolic processes might occur as bacteria transition from
the planktonic state, through early biofilm development to the mature biofilm (Table 1). As
yet, very little is known about the metabolic changes that enable mixed biofilm formation,
particularly associated with the shift in the processes associated with interspecies competi‐
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Abstract
Each surface of the human body, which stays in contact with the external environ‐
ment, is covered by a layer of microorganisms. This layer—the human microbiome—
is characterized by a high diversity of species and huge number of cells.  Its name
was  proposed  by  Joshua  Lederberg  at  the  turn  of  the  twentieth  and  twenty-first
centuries and was originally referred to as a group of microorganisms colonizing a
certain habitat.  Currently,  the term also defines a set of genomes of all  organisms
inhabiting a  particular  niche.  Since the human microbiota affects  many aspects  of
human health, it has become the subject of different studies. The use of sequencing
methods  enabled  to  obtain  genetic  material  derived  directly  from  the  human
environment  with  simultaneous  explanation  of  mutual  relationships  between
microorganisms  inhabiting  different  ecological  niches  of  human  organism  (i.e.,
commensal, symbiotic, and pathogenic microorganisms). It is hard to determine the
amount of  microbiota inhabiting human oral  cavity because microbiota represents
distinct  anatomically  limited  ecological  niches;  for  example,  microbiota  of  tongue
surface, cheek, teeth, palate, gingiva, and periodontal pocket. Apart from anatomi‐
cal structure, other factors determine different composition of particular oral cavity
microbiota. These factors are various qualities of saliva—a natural protective barrier
ensuring maintenance of healthy condition of the oral cavity—and habits of diet and
hygiene. Generally, bacteria are passively transported by flowing saliva toward teeth
surfaces. In turn, the pioneering microorganisms initiating changes in the environ‐
ment  of  oral  cavity  through  the  production  and  secretion  of  products  of  their
metabolism induce mutual microbiota–biofilm interactions. The formation of biofilm
of the plaque is a complex and rapidly evolving process in which several stages of
development can be distinguished arbitrarily: (i) reversible binding of bacteria to solid
surfaces, (ii) production of exopolysaccharide matrix, (iii) irreversible binding to the
surface, (iv) maturation of biofilm structure, (v) disintegration and dispersion of an
organized  structure,  and  (vi)  the  formation  of  new  habitats.  An  oral  microbiome
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
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of antibiotics [3,4]. Environmental conditions such as temperature, salinity, availability of
oxygen, nutrients, variable conditions of pH, and redox potential may affect the ecosystem
and contribute to changes in species composition of biofilms present in every place [5]. The
formation of oral cavity microbiota begins at the moment of birth through the contact between
the surface of the newborn’s skin and mucous membrane of its mouth with mother’s vaginal
microbiota. In the case of birth by cesarean section, microflora is transferred from the moth‐
er’s skin to the surface of the skin and mucous membranes of the newborn.
Immediately after the birth (<5 min), the species of bacteria covering most of the body surface
of the newborn (oral cavity, nasopharynx, skin, and intestines) are very similar to each other
[6]. Children born vaginally have the microbiome of the oral cavity similar to the mother’s
vaginal microbiome, with the predominance of the following bacterial species: Lactobacillus,
Prevotella, Corynebacterium, Staphylococcus, Streptococcus, Enterococcus, Bacteroides, and Sneathia
spp., while children born via cesarean section have a flora similar to the one present on the
mother’s skin, with the dominance of the following bacterial species: Staphylococcus,
Corynebacterium, Propionibacterium spp. belonging to the phylum such as Actinobacteria,
Firmicutes, Proteobacteria, and Bacteroidetes (Figure 1) [7].
At the time of birth and in the following hours, newborn’s oral cavity is massively exposed to
microorganisms coming from the external world (breathing, breastfeeding, and contact with
parents and medical staff). The process of permanent colonization of the oral cavity begins in
the postnatal period. The so-called pioneering microorganisms determining the composition
of the oral microbiome are established within 24 hours of birth. The most common coloniz‐
ers of the oral cavity at this stage are gram-positive cocci, including Streptococcus (inter alia S.
sanguinis, S. mitis and S. oralis, S. salivarius) and Staphylococcus genus (Figure 1) [8,9].
Pioneering microorganisms initiate the changes in the environment through the production
and secretion of their metabolism products, which often enhances the growth of other species.
For example, Streptococcus salivarius present in the oral cavity of the newborns, having the
ability to adhere to epithelial cells and to produce extracellular polymers from sucrose,
promotes the growth of other bacterial species including Actinomyces spp., which may adhere
to the so-formed structure [8]. The increase in diversity of the formed complex produces a
more stable structure of the oral cavity microenvironment.
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analysis  depending  on  the  genotypic  characteristics  of  the  host,  as  well  as  its
metabolic  phenotype,  will  allow  us  to  understand  all  these  factors  which  are
responsible  for  maintaining host-microbiota homeostasis.  The formation of  genetic
maps (including host,  as  well  as microbiota)  of  such environments and the detec‐
tion of biofactors indicating the predisposition for a given disease may contribute to
the development of new diagnostic methods in reference to individual persons, and
thus individualized therapy.
Keywords: microbiome, pathogenicity, biofilm, antimicrobial peptides, dental plague
1. Introduction
1.1. Formation of oral cavity microbiome
Each of the human body surfaces, which are in contact with the external environment, is covered
with a layer of microorganisms. This layer, called the human microbiome, is characterized by
high species diversity and cell number. The term proposed by Joshua Lederberg at the turn of
the twentieth and twenty-first centuries originally defined a group of microorganisms living in
a certain habitat. Currently, it also defines a set of genomes of all organisms inhabiting a particular
niche.
The human microbiome became the subject of many studies since it affects many aspects of
human health. The use of sequencing methods enabled the correct identification of bacteria on
the basis of obtained genetic material sourced directly from the human environment. This
allowed explaining the mutual relationships between microorganisms inhabiting different
ecological niches of the human body (i.e., commensal, symbiotic, and pathogenic microorgan‐
isms). In addition, particular attention is paid to the ability of microflora to modulate the
expression of host genes. This phenomenon is a part of the cross-talk process.1
The oral cavity is one of the most numerous in terms of bacterial species diversity micro‐
biome of the human organism [1,2]. Microbiome of the human oral cavity consists of diffi‐
cult-to-determine number of microbiota representing anatomically limited distinct ecological
niches, e.g., microbiota of the surface of the tongue, cheek, teeth, palate, gums, gingival pocket,
etc. Except for the anatomical structure, the factors determining the variable composition of
particular microbiota of the oral cavity are as follows: variable quality of saliva, being a natural
protective barrier ensuring the maintenance of proper condition of the oral cavity, and also
habits of diet and hygiene.
Environment of the oral cavity is subject to constant transformation depending on the age,
appearance of first teeth, their extractions, carious lesions, dentures, fillings, edentulous and
transitional changes that may be induced by diet, variable flow of saliva, and prolonged use
1 Multidirectional network of connections that enables signal transfer and communication of bacteria with bacteria,
bacteria with host, and host with bacteria, thus creating a comprehensive interactive ecosystem determining a wide
variety of biological processes, including health or disease, between the host and their indigenous bacterial flora, leading
to the molecular dialogue with the host cells.
Microbial Biofilms - Importance and Applications330
of antibiotics [3,4]. Environmental conditions such as temperature, salinity, availability of
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contribution of other bacterial species-such as Lactobacillus, Veillonella, Bifidobacterium,
Propionibacterium, acidic species independent of Streptococcus mutans (S. gordonii, S. oralis, S.
mitis, and S. anginosus [18,20], Actinomyces, and Atopobium—in the development and progres‐
sion of caries is suggested, which proves the influence of mixed bacterial flora on the devel‐
opment of dental caries. In the case of white spots the contribution of S. mutans is higher than
in the control, but still quite low at a level up to 10% of the whole microflora [21]. Streptococ‐
cus (except S. mutans) and Actinomyces species are considered as the main reason of damage
to the enamel. In the absence of S. mutans and Lactobacillus, initial enamel demineralization
may be induced by the early colonizers, i.e., S. sanguinis, S. mitis, and S. oralis [18].
On the contrary, in case of the appearance of dentin lesion, the contribution of S. mutans
represents about 30% of the total microflora, which indicates that this species is associated with
advanced stage of caries. However, S. mutans was less common in caries progression, where
Lactobacillus, Bifidobacterium, and Prevotella species dominated [6,18,22] . The studies evaluat‐
ing the composition of microflora associated with early childhood caries show the share of
bacteria of the following genera: Streptococcus, Veillonella, Actinomyces, Propionibacterium,
Granulicatella, Leptotrichia, Thiomonas, Bifidobacterium and Atopobium, suggesting the lack of
pathogenic species. The virulence of cariogenic bacterial population is correlated with the
phenotype adopted for specified environment related to the acidic potential of bacteria that
can induce the changes in the environment leading to the development of dental caries.
Under physiological conditions, oral cavity of children has a higher proportion of bacteria
belonging to the following phylum: Firmicutes (genera Streptococcus, Veillonella, Lactobacillus,
and Granulicatella) and Actinobacteria (genera Rothia and Actinomyces) and a smaller percent‐
age of bacteria from phylum Bacteroidetes (genera Bacteroidales and Prevotella), Fusobacteria
(Fusobacterium genus), Spirochaetes, and TM7 strain, compared to adults [14]. Interestingly, the
share of cariogenic bacteria is also subject to an increase as the child grows. This change
concerns the decrease in aerobic bacterial populations or facultative gram-positive cocci for
the favor of relatively anaerobic gram-negative bacteria [17, 23].
Adolescence is a stage of major hormonal changes that accompany the enrichment of oral
environment with a variety of nutrients, leading to the growth of certain groups of microor‐
ganisms, including gram-negative anaerobic bacteria and spirochete. This change in bacteri‐
al flora of oral cavity may be associated with an increased incidence and severity of gingivitis
during the maturation [24].
The formation of a full oral microbiome takes several years, and in the case of certain surfa‐
ces, e.g., intestines, even longer. In the case of microbiota of oral mucosa, this process can be
considered as complete after the eruption of permanent teeth.
Microorganisms colonizing the oral cavity live not only in the form of single cells (in the form
of plankton), but are also capable of forming the clusters immersed in a mucilaginous
extracellular matrix (ECM). In some diseases, the ability of bacteria to create a multidimen‐
sional, complex structure called “biofilm” plays a very important role. This structure ad‐
heres strongly to the surface so that the microbiome cells, particularly during the new biofilm
formation, communicate with the cells of epithelium or mucous membranes by contact with
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During the first two months of the child’s life, bacteria colonize only the surfaces of mucous
membranes, and further species of microorganisms, which determine the changes within oral
microbiome, occur with the eruption of deciduous teeth [10]. As the child grows, the oral
microbiome is subject to evolution. In about fifth month of life, the microflora of infant’s oral
cavity shows a clear resemblance to the oral microflora of the mother due to environmental
conditions that occur in the first months of life, in particular, through feeding, contact with
other adults and children, contact with pets, hygiene, eating habits, etc. [11]. The microflora of
the newborn’s oral cavity is then composed mainly of bacteria, including those of the follow‐
ing six phyla: Firmicutes, Proteobacteria, Actinobacteria, Bacteroidetes, Fusobacteria, and Spiro‐
chaetes, among which the most widespread genera include Streptococcus, Haemophilus, Neisseria,
and Veillonella (Figure 1) [11]. Interestingly, some of these microorganisms, such as S. mitis and
S. oralis, produce proteases against immunoglobulin (IgA), which specifically degrade the
secretion of salivary IgA. Because of this feature, the microorganisms are able to survive in an
environment rich in IgA, which is excreted with mother’s milk [12]. Although infants during
that period have lower number of microorganisms in the oral cavity than their parents, their
species composition is richer [11].
The formation of a new ecological niche in the oral cavity environment is observed during the
eruption of teeth, with the occurrence of new adhesion surfaces. It was believed that the
colonization of Streptococcus spp. cariogenic strains, such as S. mutans, starts just at this stage
at the moment of the appearance of hard surfaces. Caufield et al. have defined this moment as
a so-called “window of infectivity” [13]. However, recent research overthrew the above view
showing the presence of this species in edentulous children, which suggests that the soft tissues
can act as a reservoir for pathogenic microorganisms such as, e.g., S. mutans [6]. This fact
highlights the importance of oral hygiene habits in a child, even before the eruption of teeth.
At the age of three, oral microbiome seems to be complete, but its maturation process continues
until adulthood [14]. The bacterial flora of the oral cavity in the child varies during the
development of teeth: deciduous, mixed or permanent. The oral cavity microflora in chil‐
dren with deciduous teeth in relation to the other groups demonstrates a higher incidence of
bacteria belonging to the following families: Pseudomonadaceae (Pseudomonas genus)
Moraxellaceae (genera Acinetobacter Moraxella and Enhydrobacter), Enterobacteriaceae and
Pasteurellaceae (Aggregatibacter genus). During the replacement of deciduous teeth on the
permanent ones, population of bacteria belonging to the family Veillonellaceae (genera
Veillonella and Selenomonas) and Prevotella genus is subject to an increase, whereas bacteria of
the family Carnobacteriaceae (Granulicatella genus) decrease [14].
The population of oral cavity microorganisms in children aged 3–12 years is composed of the
species of bacteria inhabiting different ecological niches, e.g., surface of the cheeks, gums,
tongue, etc. One cannot talk about the microflora of teeth focusing only on the selected
anatomical areas associated with certain bacterial species. Also the number of pathogenic
species occupying specific ecological niches is not synonymous with the development of
caries [15–18].
This is proved by the observations [19] that showed there was no presence of S. mutans in 10%
of the examined children and adolescents (aged from 2 to 21 years) with caries. Also the
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system, patients treated for systemic diseases and mentally handicapped, as well as patients
with immunosuppression constitute the group to be at risk of opportunistic infections.
The features that determine the ability of a microorganism to cause disease, but which
themselves are not required for their survival, are referred to as the determinants of pathoge‐
nicity [32]. Henderson et al. defined the determinants of pathogenicity as components of
pathogens that are important in causing an infection in the host organism; they may include
the factors vitally important for the microorganisms. A classic example may be the adhesins
present on the bacterial cell surface that facilitate adhesion to receptors on the host cells surface,
thus facilitating the colonization of bacterial species such as endotoxin lipopolysaccharides
and gram-negative bacteria, which have a resistance towards the bactericidal activity of the
complement and phagocytosis. On the other hand, the activity of heat-labile enterotoxin, for
example, Escherichia coli, results in the activation of adenylate cyclase, increased intracellular
cAMP concentration, and activation of protein kinase that phosphorylates cell proteins and is
involved in ions transport. Increased cAMP concentration directly disturbs the function of the
sodium potassium pump, which results in an excessive secretion of water and potassium ions
from the cell and inhibition of the reabsorption of sodium ions and water. An excessive amount
of water that is not absorbed is accumulated in the intestine, which increases intestinal passage
and leads to the development of secretory diarrhea and tissues dehydration [33].
However, these definitions do not reflect the role of host’s susceptibility to infection, indicat‐
ing that only the features of the pathogen are causing disease. Consequently, only those
organisms are microbe.
New definition of pathogenicity and pathogenicity determinants was created [34]. Pathoge‐
nicity of a specified microorganism is expressed as a range of damages that are caused by the
microorganism itself and by the immune system as a response to the pathogen. They distin‐
guished six classes of pathogens and are as follows.
Class I: This class of microorganisms damages only hosts with a weak immune response
(with reduced host’s immunity) and are commonly referred to as opportunistic or commen‐
sal; they do not cause damages to organisms with an undisturbed immune response; for
example, damages due to Pneumocystis carinii are associated with the host response and those
that are due to Pseudallescheria boydii are mainly associated with the growth of pathogens in
host tissues (Figure 2).
Class II: This class of microorganisms causes damages both to people with impaired and normal
immune responses. In the case of patients with weak immunity, damages are more severe and
more frequent (Figure 2). Infections due to organisms such as Candida albicans and Cryptococ‐
cus neoformans are more often observed in individuals with weakened immune system and
severe infections due to Streptococcus pneumoniae are usually associated with extreme age
groups. This class also includes pathogens secreting toxins. For example, the toxins of
Corynebacterium diphtheriae can cause damage immediately before the immune system
responds, so the damage is regardless of the immune status of the patient.
Class III: This class of microorganisms causes damages to hosts both with impaired and normal
immune responses. In both cases, the form of infection is similar (Figure 2), which distin‐
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their receptors sending various signaling substances [25,26]. In this way, a network of
relationships is created, which results in both control of functioning of mucosal epithelial and
immune cells present in the epithelium under the influence of microbial cells of the micro‐
biome, as well as the control of microorganism populations and their metabolism by the cells
of the host’s organism2. Only the presence and integrity of the microbiome are able to ensure
the proper functioning of the cells of mucous membrane and skin surface, as well as protec‐
tion against infections [2].
2. Definition of pathogenicity and determinants of microorganism’s
pathogenicity
An increasing number of opportunistic bacterial infections [27] have been reported in the past
year. Microorganisms, which were previously considered as saprophytes incapable of causing
human diseases, have now become an etiological factor in even serious conditions such as
heart failure [28]. These microorganisms are referred to as “newly occurring pathogens” or
“microorganisms on the newly acquired pathogenicity,” which are generally called the
emerging pathogens. These particular species develop pathogenicity due to evolutionary
changes progressing slowly, as microorganisms adapt to new habitats, including the ecosys‐
tem, which is the human body.
Bacteria belong to Prokaryota and, thus, do not have complex genome repair and regulation
systems; therefore they undergo changes at a much faster rate compared to the higher
structured fungi (Eukaryota). In contrast to fungi, horizontal gene transfer does not occur in
bacteria; this means that in practice the feature acquired by one strain can be transferred to
other strains [29]. It is possible that an increased number of opportunistic infections record‐
ed might be due to evolutionary adaptation of pathogenic strains to environmental changes
[30,31].
Aggressiveness of current medicine creates an increasing number of the gate infections. The
use of antibiotics and other antimicrobial agents with a wide spectrum of action interferes with
human microbiota ontogenesis. Elimination of one species involves an increase in the number
of surviving species populations. Consequently proliferation mainly concerns opportunistic
microorganisms that are often resistant to the applied chemotherapeutic agents.
The presence of a high content of sugar in the diet, particularly in beverages, facilitates the
formation of dental plaques by microorganisms inhabiting the oral cavity. Demineralization
acquired due to excessive acidity or constant contact of enamel with dietary sugars favors the
infections. Patients from the so-called window of infectivity (between 19 and 31 months of
age), patients during the eruption of teeth, patients with hypercalcemia, patients with different
types of malocclusions subject to treatment, patients with disturbed functioning of the immune
2 Host; organism, the parasite lives at the expense of (including parasitic bacteria). Parasite relationship with the host may
be permanent or temporary.
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immune cells present in the epithelium under the influence of microbial cells of the micro‐
biome, as well as the control of microorganism populations and their metabolism by the cells
of the host’s organism2. Only the presence and integrity of the microbiome are able to ensure
the proper functioning of the cells of mucous membrane and skin surface, as well as protec‐
tion against infections [2].
2. Definition of pathogenicity and determinants of microorganism’s
pathogenicity
An increasing number of opportunistic bacterial infections [27] have been reported in the past
year. Microorganisms, which were previously considered as saprophytes incapable of causing
human diseases, have now become an etiological factor in even serious conditions such as
heart failure [28]. These microorganisms are referred to as “newly occurring pathogens” or
“microorganisms on the newly acquired pathogenicity,” which are generally called the
emerging pathogens. These particular species develop pathogenicity due to evolutionary
changes progressing slowly, as microorganisms adapt to new habitats, including the ecosys‐
tem, which is the human body.
Bacteria belong to Prokaryota and, thus, do not have complex genome repair and regulation
systems; therefore they undergo changes at a much faster rate compared to the higher
structured fungi (Eukaryota). In contrast to fungi, horizontal gene transfer does not occur in
bacteria; this means that in practice the feature acquired by one strain can be transferred to
other strains [29]. It is possible that an increased number of opportunistic infections record‐
ed might be due to evolutionary adaptation of pathogenic strains to environmental changes
[30,31].
Aggressiveness of current medicine creates an increasing number of the gate infections. The
use of antibiotics and other antimicrobial agents with a wide spectrum of action interferes with
human microbiota ontogenesis. Elimination of one species involves an increase in the number
of surviving species populations. Consequently proliferation mainly concerns opportunistic
microorganisms that are often resistant to the applied chemotherapeutic agents.
The presence of a high content of sugar in the diet, particularly in beverages, facilitates the
formation of dental plaques by microorganisms inhabiting the oral cavity. Demineralization
acquired due to excessive acidity or constant contact of enamel with dietary sugars favors the
infections. Patients from the so-called window of infectivity (between 19 and 31 months of
age), patients during the eruption of teeth, patients with hypercalcemia, patients with different
types of malocclusions subject to treatment, patients with disturbed functioning of the immune
2 Host; organism, the parasite lives at the expense of (including parasitic bacteria). Parasite relationship with the host may
be permanent or temporary.
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The state of host’s immune defense is the main factor determining the course and cure of
infection [34].
The determination of pathogenicity determinants for class I microorganisms based on the
classification presented above poses some interpretation problem, since it seems that the key
role in these infections is played by the condition of the host. Human is a complex ecosys‐
tem, in which bacteria–immune system homeostasis is observed in the physiological state.
Bacteremia develops when this system is disturbed, usually through immunodeficiency and
more rarely by the overexpression of bacteria pathogenicity determinants. However, most of
the oral bacteria are rarely pathogens. So that even low-virulence pathogens have a mini‐
mum set of features that determine their pathogenicity and enables them to penetrate and
proliferate in a host’s body.
Writing about biofilm—pathogenicity determinant of Streptococcus genus—Kreikemeyer
relates it with the discovery of long thread-like structures resembling pilus, which are located
on the bacterial surface [35]. In S. pyogenes presented pilus are responsible for bacterial
adherence and microcolonies creation on the surface of host cells, as well as aggregation itself,
especially under the influence of saliva. These construction are involved in the interaction with
pathogen and host; they are also causing bacteria clustering in the biofilm [36]. Pathogenici‐
ty of S. mutans is primarily associated with the ability to adhere to host cells and biofilm
formation.
The bacteria in the biofilm resemble other organisms, for which the clustering is an evolution‐
ary adaptation for survival. Bees and ants die if they are not in their “community;” similarly
birds migrating for the winter organize themselves together to travel, and even most living
mammals, starting from mice to Homo sapiens, are social organisms.
The complexity of relationships between microorganism and host, as well as differentiated
expression of the features that determine the microorganism’s pathogenicity, makes the
pathogenicity an unpredictable phenomenon, since even a complete knowledge of hosts and
microorganisms does not allow identifying all the possible interactions between them.
Due to certain specific characteristics of the host and microorganisms, all kinds of infectious
diseases are often increasingly observed. Opportunities to travel around the world in a very
short time not only contribute to the transfer of microorganisms in environments non-
inhabited by them but also extend their pathogenicity [37].
3. Biofilm formation
The most common diseases of the oral cavity, in which an important causative role is played
by biofilm formed by microorganisms on the surface of teeth and gums, are dental caries and
periodontitis. One of the main etiological factors of these diseases is Streptococcus mutans [38–
40].
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guishes that class from class II. For example in patients with impaired immunity, Histoplas‐
ma capsulatum causes infections that are associated with high mortality rate due to the
proliferation of the cells to different organs; in patients with strong immune response,
mediastinum fibrosis results from chronic inflammation.
Class IV: This class of microorganisms causes damages, especially in extreme cases—im‐
paired immunity or in cases of immune system overactivity (Figure 2). This is a relatively small
group of pathogens that causes symptomatic infections only in people with impaired immun‐
ity or in those with prolonged immune response. For example, Aspergillus fumigatus causes
aspergillosis in patients with neutropenia or bronchial aspergillosis in patients chronically
exposed to antigen.
Class V: This class of pathogens causes damages in any condition of the immune system, but
mostly acute in the case of host’s immune system overactivity (Figure 2). For example,
infections of Salmonella and Campylobacter sp. do not usually cause any permanent changes,
but in the case of increased immune response, they may develop into Reiter’s syndrome,
manifested by intestinal inflammation.
Class VI: This class of microorganisms causes damages only in the conditions of strong immune
response of the host. This is a theoretical class, not reported so far (Figure 2); it includes inter
alia a group of diseases of unknown etiology, for example, Crohn’s disease or Whipple’s
disease. Helicobacter pylori is the closest to meet this criterion. The infection caused by this
species is asymptomatic in most patients; however, in some of them, it leads to the develop‐
ment of ulcers and, consequently, to carcinogenesis. Damages are associated with factors
dependent both on the pathogen and on the host.
Figure 2. Pathogenicity presented as a function of the amount of damage and immune response of the host. Figure
based on the study by Casadevall and Pirofski [34].
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more rarely by the overexpression of bacteria pathogenicity determinants. However, most of
the oral bacteria are rarely pathogens. So that even low-virulence pathogens have a mini‐
mum set of features that determine their pathogenicity and enables them to penetrate and
proliferate in a host’s body.
Writing about biofilm—pathogenicity determinant of Streptococcus genus—Kreikemeyer
relates it with the discovery of long thread-like structures resembling pilus, which are located
on the bacterial surface [35]. In S. pyogenes presented pilus are responsible for bacterial
adherence and microcolonies creation on the surface of host cells, as well as aggregation itself,
especially under the influence of saliva. These construction are involved in the interaction with
pathogen and host; they are also causing bacteria clustering in the biofilm [36]. Pathogenici‐
ty of S. mutans is primarily associated with the ability to adhere to host cells and biofilm
formation.
The bacteria in the biofilm resemble other organisms, for which the clustering is an evolution‐
ary adaptation for survival. Bees and ants die if they are not in their “community;” similarly
birds migrating for the winter organize themselves together to travel, and even most living
mammals, starting from mice to Homo sapiens, are social organisms.
The complexity of relationships between microorganism and host, as well as differentiated
expression of the features that determine the microorganism’s pathogenicity, makes the
pathogenicity an unpredictable phenomenon, since even a complete knowledge of hosts and
microorganisms does not allow identifying all the possible interactions between them.
Due to certain specific characteristics of the host and microorganisms, all kinds of infectious
diseases are often increasingly observed. Opportunities to travel around the world in a very
short time not only contribute to the transfer of microorganisms in environments non-
inhabited by them but also extend their pathogenicity [37].
3. Biofilm formation
The most common diseases of the oral cavity, in which an important causative role is played
by biofilm formed by microorganisms on the surface of teeth and gums, are dental caries and
periodontitis. One of the main etiological factors of these diseases is Streptococcus mutans [38–
40].
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guishes that class from class II. For example in patients with impaired immunity, Histoplas‐
ma capsulatum causes infections that are associated with high mortality rate due to the
proliferation of the cells to different organs; in patients with strong immune response,
mediastinum fibrosis results from chronic inflammation.
Class IV: This class of microorganisms causes damages, especially in extreme cases—im‐
paired immunity or in cases of immune system overactivity (Figure 2). This is a relatively small
group of pathogens that causes symptomatic infections only in people with impaired immun‐
ity or in those with prolonged immune response. For example, Aspergillus fumigatus causes
aspergillosis in patients with neutropenia or bronchial aspergillosis in patients chronically
exposed to antigen.
Class V: This class of pathogens causes damages in any condition of the immune system, but
mostly acute in the case of host’s immune system overactivity (Figure 2). For example,
infections of Salmonella and Campylobacter sp. do not usually cause any permanent changes,
but in the case of increased immune response, they may develop into Reiter’s syndrome,
manifested by intestinal inflammation.
Class VI: This class of microorganisms causes damages only in the conditions of strong immune
response of the host. This is a theoretical class, not reported so far (Figure 2); it includes inter
alia a group of diseases of unknown etiology, for example, Crohn’s disease or Whipple’s
disease. Helicobacter pylori is the closest to meet this criterion. The infection caused by this
species is asymptomatic in most patients; however, in some of them, it leads to the develop‐
ment of ulcers and, consequently, to carcinogenesis. Damages are associated with factors
dependent both on the pathogen and on the host.
Figure 2. Pathogenicity presented as a function of the amount of damage and immune response of the host. Figure
based on the study by Casadevall and Pirofski [34].
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Prevotella loescheii, which produces proteases hydrolyzing own adhesins related to
fimbriae, responsible for co-aggregation with S. mitis.
Figure 3. Stages of bacterial biofilm formation.
Mature biofilm structure is thus the result of the balance between the adhesion, growth, and
removal of microorganisms. The development of plague as the biomass lasts up to the moment
of reaching a critical size, i.e., when the shear forces limit further expansion; however, the
structural development and reorganization may be continued. A classic example of a mature
biofilm structure is dental calculus, which is mineralized dental plaque. It contains intracel‐
lular and extracellular deposits of minerals that grow around each bacterium and mineral‐
ized spaces coalesce and form a hard lodgment coated then with a layer of new bacteria. The
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3.1. Stages of biofilm formation
Biofilm formation is a multi-stage and very complicated process. There is a need for a number
of relevant factors and conditions that must exist in the oral cavity, in order to assure the proper
course of the whole process. However, five characteristic phases can be distinguished in it.
1. The initial phase of the microorganism adherence to a solid surface. S. mutans adheres to
the tooth enamel and other materials such as tooth root or dental implant [41] using two
mechanisms: sucrose dependent (based on the activity of glycosyltransferases and glucan-
binding proteins) (Figure 3) and the sucrose independent (using interactions between
adhesion particles of microorganisms and saliva agglutinins) (Figure 3) [42, 43].
2. Irreversible connection of bacteria with the surface, constituting the start of exopolysac‐
charide (EPS) matrix formation (EPS exopolysaccharide, which is the open architecture of
nutritional channels, spaces, and other properties, including heterogeneity of the
environment (pH and oxygen gradients, co-adhesion) that forms the protection from the
host defense factors and desiccation (Figure 3) [44].
3. Biofilm maturation, when the matrix is still being developed and another bacterial species
join the biofilm [45]. The bacteria synthesize extracellular polymers (soluble and insolu‐
ble glucans, fructans, and heteropolymers), which are constituents of the plaque matrix
(Figure 3). The presence of matrix is a feature of all the biofilms; however, it is much more
than the chemical scaffold retaining the biofilm shape. The matrix is biologically active,
retaining water, nutrients, and enzymes inside the biofilm structure.
4. Bacterial succession associated with the shift of initial dominance of the species of
Streptococcus genus in the direction of the predominance of Actinomyces and other gram-
positive cocci. Newly occurring species of bacteria adhere to the previously attached
pioneering species. The presence of one microorganism creates the ecological niches for
other microorganisms, which facilitates their survival in the new favorable conditions.
In 2003, this phenomenon, referred to as co-aggregation, was proposed by Rickard et al.
[46]. An example of this phenomenon is the elimination of lactate by biofilm-forming
streptococci, which becomes a source of carbon for the growth of Candida albicans. This,
in turn, reduces the availability of oxygen to the level preferred by streptococci, thereby
stimulating the growth of facultative anaerobic bacteria.
5. The formation of a mature biofilm is associated with growth-rate reduction of particular
bacteria. The doubling of the bacteria amount occurs in 1–2 h in the initial stage of mature
biofilm while in 1–3-day dental plate, it last 12–15 hours. A three-dimensional biofilm
structure is formed. At this stage, the interactions between microorganisms (antago‐
nism and synergism), i.e., their mutual influence on each other and microorganism–host
interactions associated with the host’s immune system plays the most important role not
only in the formation of mature biofilm structure, but also in the disconnection of bacterial
species from such formed structure, occupying subsequent ecological niches within the
oral cavity microbiome [47–49]. Bacteria can “feel” the adverse changes in the environ‐
mental conditions and induce the genes related to active detachment. An example is
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Prevotella loescheii, which produces proteases hydrolyzing own adhesins related to
fimbriae, responsible for co-aggregation with S. mitis.
Figure 3. Stages of bacterial biofilm formation.
Mature biofilm structure is thus the result of the balance between the adhesion, growth, and
removal of microorganisms. The development of plague as the biomass lasts up to the moment
of reaching a critical size, i.e., when the shear forces limit further expansion; however, the
structural development and reorganization may be continued. A classic example of a mature
biofilm structure is dental calculus, which is mineralized dental plaque. It contains intracel‐
lular and extracellular deposits of minerals that grow around each bacterium and mineral‐
ized spaces coalesce and form a hard lodgment coated then with a layer of new bacteria. The
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3.1. Stages of biofilm formation
Biofilm formation is a multi-stage and very complicated process. There is a need for a number
of relevant factors and conditions that must exist in the oral cavity, in order to assure the proper
course of the whole process. However, five characteristic phases can be distinguished in it.
1. The initial phase of the microorganism adherence to a solid surface. S. mutans adheres to
the tooth enamel and other materials such as tooth root or dental implant [41] using two
mechanisms: sucrose dependent (based on the activity of glycosyltransferases and glucan-
binding proteins) (Figure 3) and the sucrose independent (using interactions between
adhesion particles of microorganisms and saliva agglutinins) (Figure 3) [42, 43].
2. Irreversible connection of bacteria with the surface, constituting the start of exopolysac‐
charide (EPS) matrix formation (EPS exopolysaccharide, which is the open architecture of
nutritional channels, spaces, and other properties, including heterogeneity of the
environment (pH and oxygen gradients, co-adhesion) that forms the protection from the
host defense factors and desiccation (Figure 3) [44].
3. Biofilm maturation, when the matrix is still being developed and another bacterial species
join the biofilm [45]. The bacteria synthesize extracellular polymers (soluble and insolu‐
ble glucans, fructans, and heteropolymers), which are constituents of the plaque matrix
(Figure 3). The presence of matrix is a feature of all the biofilms; however, it is much more
than the chemical scaffold retaining the biofilm shape. The matrix is biologically active,
retaining water, nutrients, and enzymes inside the biofilm structure.
4. Bacterial succession associated with the shift of initial dominance of the species of
Streptococcus genus in the direction of the predominance of Actinomyces and other gram-
positive cocci. Newly occurring species of bacteria adhere to the previously attached
pioneering species. The presence of one microorganism creates the ecological niches for
other microorganisms, which facilitates their survival in the new favorable conditions.
In 2003, this phenomenon, referred to as co-aggregation, was proposed by Rickard et al.
[46]. An example of this phenomenon is the elimination of lactate by biofilm-forming
streptococci, which becomes a source of carbon for the growth of Candida albicans. This,
in turn, reduces the availability of oxygen to the level preferred by streptococci, thereby
stimulating the growth of facultative anaerobic bacteria.
5. The formation of a mature biofilm is associated with growth-rate reduction of particular
bacteria. The doubling of the bacteria amount occurs in 1–2 h in the initial stage of mature
biofilm while in 1–3-day dental plate, it last 12–15 hours. A three-dimensional biofilm
structure is formed. At this stage, the interactions between microorganisms (antago‐
nism and synergism), i.e., their mutual influence on each other and microorganism–host
interactions associated with the host’s immune system plays the most important role not
only in the formation of mature biofilm structure, but also in the disconnection of bacterial
species from such formed structure, occupying subsequent ecological niches within the
oral cavity microbiome [47–49]. Bacteria can “feel” the adverse changes in the environ‐
mental conditions and induce the genes related to active detachment. An example is
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proteins, statherines, and histatins (present in AEP); cysteine-containing phosphoproteins
(in dental plaque); and low molecular peptides in saliva may play an important role as calcium
ion binding sites. Furthermore, proline-rich proteins and statherines inhibit the precipitation
of calcium phosphates. Thus, calcium-binding proteins play a significant role in the reminer‐
alization of tooth enamel, constituting these ions’ reservoir [62]. Reduced amount of salivary
proteins binding inorganic ions may consequently lead to an advantage of demineralization
processes over remineralization processes and the development of caries disease.
3.2.2. Presence of sucrose
The discovery that the pH of the dental plaque is subject to a decrease after sucrose consump‐
tion and then returns to its original value [63] initiated intensive study on oral cavity micro‐
organisms. They were the subject of research not only due to their importance in the health
care, but also for the recognition of the number of interspecies interactions and the desire to
know the behavior of microorganisms occupying a common ecological niche [45].
Sucrose-dependent way of dental plaque formation are the glucosyltransferases (Gtfs B, C, D)
produced by S. mutans in combination with glucan-binding proteins (Gbp) [39, 55, 64].
Gtfs are responsible for the formation of glucans from sucrose. The synthesized glucans
provide the possibility of bacterial adhesion to the tooth enamel and microorganisms to each
other. This process allows forming microcolonies, which favors biofilm formation [55, 64].
In conditions in vivo, Gtfs adsorb very fast with salivary film (sHA). The highest connection to
sHA is demonstrated by GtfC, which is a hydrophilic compound. However, it has a hydro‐
phobic domain, which is responsible for the affinity to plaque. It enables overlapping of the
interactions with saliva proteins contained in the salivary film such as lysozyme or α-amy‐
lase. GtfB is glucosyltransferase, which in S. mutans is primarily responsible for interactions
with other bacteria. It is responsible for the formation of highly differentiated microcolonies
comprising the biofilm structure. Its activity is significantly increased in the presence of
glucose [64].
The ability of GtfD to bind glucans is due to five of 65-five amino acids sequences repeated at
the C-end of the chain. Glucosyltransferases binding other bacteria, even if they are not
synthesizing their own glycosyltransferases [55, 65, 66]. Among the numerous polymers
forming the plague (α-(1→6)-, α-(1→4)-, and α-(1→3)-glucans; β-(2→6)-fructans), a decisive
role in etiopathology of tooth caries is played by α-(1→3)-glucan. This polymer constitutes 1.3–
1.4% of plate dry matter and exhibits several unique features that allow it to form a skeleton
(matrix), i.e., it easily adsorbs to saliva or pellicle-coated enamel, promotes mutual sticking of
bacteria (aggregation), and greatly improves the consistency of plaque. α-(1→3)-glucans are
insoluble in water and have a fiber structure, which means that they are not dissolved and
washed out by fluids of oral cavity. Moreover, α-(1→3)-glucans are neither subject to the
activity of enzymes nor to those present in the oral cavity or produced by inhabiting its
microorganisms, which ensures the stability and durability of the plaque [67].
Another component of sucrose-dependent mechanism is Gbps mediating in bacteria binding
with glucans. There are four known types of that protein: GbpA, -B, -C, and—D [39, 55, 64].
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calculus is observed both supragingival and subgingival, where it acts as an additional
retention site for the accumulation of plaque causing gingivitis (which is related to the presence
of, inter alia, above-mentioned Prevotella loescheii).
It is believed that in stages 4 and 5 of the biofilm formation (Figure 3), it is impossible to inhibit
further formation of its structure. This is due to the interactions occurring between particu‐
lar species accumulated in its structure and signals from the external environment (derived
from microorganisms of oral cavity microbiome). At this stage, one can talk about hyperad‐
ditive synergism, during which the combination of the effects of particular species forming
biofilm activity is observed.
Keeping in mind the general scheme shown in Figure 3, important aspects for the biofilm
formation such as biocompatibility during microorganism adhesion [50], nutritional condi‐
tions [51] as well as hydrodynamic conditions [52], the type of surface (smooth, rough, and
their combinations) [53, 54], and many other unexplained and undiscovered factors should be
remembered.
3.2. Factors affecting biofilm formation
3.2.1. Saliva and bacterial surface adhesins
The process of biofilm formation begins with the coating of tooth surface by acquired enamel
pellicle (AEP) [44, 55]. The membrane is formed from the components of salivary origin
(such as proline-rich proteins, amylase, lysozyme, histatin, peroxidase, mucin 2) and bacteri‐
al components (e.g., FtF GtF, lipoteichoic acid), specifically adsorbed on the surface of tooth
enamel [55, 56]. AEP constitutes the basis for biofilm formation by microorganisms that
colonize the oral cavity [56]. Single cells of S. mutans or their aggregates connect to the
membranes by two independent mechanisms: sucrose dependent and sucrose independent
[38, 39, 44].
The mechanism of adhesion (sucrose independent) involves an interaction between particles
of S. mutans’ adherence and AEP, which constitutes a diffusion barrier that protects the teeth
against direct activity of organic acids [56]. Agglutinins are involved in the adhesion and
aggregation by the interplay with adhesin P1 placed in bacterial cell wall [38–40, 57–59].
Salivary agglutinins play an equally important role in the process of biofilm formation as
surface bacteria adhesins. The effect of salivary agglutinins on S. mutans’ ability to form the
biofilm was investigated in vitro [38, 40]. In addition to the strain of wild type (WT), the
scientists also used strains of S. mutans with mutated spaP gene, encoding protein P1, which
allowed examination of the differences and interactions observed during the biofilm forma‐
tion [60, 61].
The salivary proteins of high significance in the biofilm formation also include salivary
proteins binding inorganic ions, mainly calcium. About 33% calcium pool in the dental plaque
is in free form, 17% is present in the bonds with phosphate ions and other organic anions. The
remaining 50% is associated with specific proteins. The changes in protein profile may lead to
calcium deficiency in dental plaque, and thus lead to the development of caries. Proline-rich
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proteins, statherines, and histatins (present in AEP); cysteine-containing phosphoproteins
(in dental plaque); and low molecular peptides in saliva may play an important role as calcium
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proteins binding inorganic ions may consequently lead to an advantage of demineralization
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organisms. They were the subject of research not only due to their importance in the health
care, but also for the recognition of the number of interspecies interactions and the desire to
know the behavior of microorganisms occupying a common ecological niche [45].
Sucrose-dependent way of dental plaque formation are the glucosyltransferases (Gtfs B, C, D)
produced by S. mutans in combination with glucan-binding proteins (Gbp) [39, 55, 64].
Gtfs are responsible for the formation of glucans from sucrose. The synthesized glucans
provide the possibility of bacterial adhesion to the tooth enamel and microorganisms to each
other. This process allows forming microcolonies, which favors biofilm formation [55, 64].
In conditions in vivo, Gtfs adsorb very fast with salivary film (sHA). The highest connection to
sHA is demonstrated by GtfC, which is a hydrophilic compound. However, it has a hydro‐
phobic domain, which is responsible for the affinity to plaque. It enables overlapping of the
interactions with saliva proteins contained in the salivary film such as lysozyme or α-amy‐
lase. GtfB is glucosyltransferase, which in S. mutans is primarily responsible for interactions
with other bacteria. It is responsible for the formation of highly differentiated microcolonies
comprising the biofilm structure. Its activity is significantly increased in the presence of
glucose [64].
The ability of GtfD to bind glucans is due to five of 65-five amino acids sequences repeated at
the C-end of the chain. Glucosyltransferases binding other bacteria, even if they are not
synthesizing their own glycosyltransferases [55, 65, 66]. Among the numerous polymers
forming the plague (α-(1→6)-, α-(1→4)-, and α-(1→3)-glucans; β-(2→6)-fructans), a decisive
role in etiopathology of tooth caries is played by α-(1→3)-glucan. This polymer constitutes 1.3–
1.4% of plate dry matter and exhibits several unique features that allow it to form a skeleton
(matrix), i.e., it easily adsorbs to saliva or pellicle-coated enamel, promotes mutual sticking of
bacteria (aggregation), and greatly improves the consistency of plaque. α-(1→3)-glucans are
insoluble in water and have a fiber structure, which means that they are not dissolved and
washed out by fluids of oral cavity. Moreover, α-(1→3)-glucans are neither subject to the
activity of enzymes nor to those present in the oral cavity or produced by inhabiting its
microorganisms, which ensures the stability and durability of the plaque [67].
Another component of sucrose-dependent mechanism is Gbps mediating in bacteria binding
with glucans. There are four known types of that protein: GbpA, -B, -C, and—D [39, 55, 64].
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calculus is observed both supragingival and subgingival, where it acts as an additional
retention site for the accumulation of plaque causing gingivitis (which is related to the presence
of, inter alia, above-mentioned Prevotella loescheii).
It is believed that in stages 4 and 5 of the biofilm formation (Figure 3), it is impossible to inhibit
further formation of its structure. This is due to the interactions occurring between particu‐
lar species accumulated in its structure and signals from the external environment (derived
from microorganisms of oral cavity microbiome). At this stage, one can talk about hyperad‐
ditive synergism, during which the combination of the effects of particular species forming
biofilm activity is observed.
Keeping in mind the general scheme shown in Figure 3, important aspects for the biofilm
formation such as biocompatibility during microorganism adhesion [50], nutritional condi‐
tions [51] as well as hydrodynamic conditions [52], the type of surface (smooth, rough, and
their combinations) [53, 54], and many other unexplained and undiscovered factors should be
remembered.
3.2. Factors affecting biofilm formation
3.2.1. Saliva and bacterial surface adhesins
The process of biofilm formation begins with the coating of tooth surface by acquired enamel
pellicle (AEP) [44, 55]. The membrane is formed from the components of salivary origin
(such as proline-rich proteins, amylase, lysozyme, histatin, peroxidase, mucin 2) and bacteri‐
al components (e.g., FtF GtF, lipoteichoic acid), specifically adsorbed on the surface of tooth
enamel [55, 56]. AEP constitutes the basis for biofilm formation by microorganisms that
colonize the oral cavity [56]. Single cells of S. mutans or their aggregates connect to the
membranes by two independent mechanisms: sucrose dependent and sucrose independent
[38, 39, 44].
The mechanism of adhesion (sucrose independent) involves an interaction between particles
of S. mutans’ adherence and AEP, which constitutes a diffusion barrier that protects the teeth
against direct activity of organic acids [56]. Agglutinins are involved in the adhesion and
aggregation by the interplay with adhesin P1 placed in bacterial cell wall [38–40, 57–59].
Salivary agglutinins play an equally important role in the process of biofilm formation as
surface bacteria adhesins. The effect of salivary agglutinins on S. mutans’ ability to form the
biofilm was investigated in vitro [38, 40]. In addition to the strain of wild type (WT), the
scientists also used strains of S. mutans with mutated spaP gene, encoding protein P1, which
allowed examination of the differences and interactions observed during the biofilm forma‐
tion [60, 61].
The salivary proteins of high significance in the biofilm formation also include salivary
proteins binding inorganic ions, mainly calcium. About 33% calcium pool in the dental plaque
is in free form, 17% is present in the bonds with phosphate ions and other organic anions. The
remaining 50% is associated with specific proteins. The changes in protein profile may lead to
calcium deficiency in dental plaque, and thus lead to the development of caries. Proline-rich
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process [70, 71, 74]. The expression of fabM gene responsible for the synthesis of monounsa‐
turated fatty acids is subject to the changes in an environment of acidic pH, which increases
their share in cell membrane structure. The changes in the membrane lipid profile results in a
decrease in its permeability, which allows for more efficient maintenance of H+ ions out of the
bacterial cell [74].
An additional mechanism supporting ATR is the biofilm formation, which focuses in its
structure the clusters of microorganisms of different species, additionally protecting them with
EPS matrix. As demonstrated by Welin-Neilands and Svensäter [69], the cells of S. mutans in
the planktonic phase are seventy thousand times more sensitive to low pH compared to the
biofilm-forming cells of that microorganism. This feature is explained by an increased
tolerance to the low pH of the cells adhering to the surface. Microorganisms grouped in this
way, mutually affecting their metabolism, weaken the activity of produced glycolytic enzymes,
which results in a decrease in the production of acidic substances that lower the pH of the
environment [69]. A large role in the biofilm resistance to acidic conditions in the oral cavity
is played by glucans as discussed below, which slow down the diffusion of hydrogen ions into
the biofilm [75].
Other microorganisms resist the low pH of the environment by an increase in the gene
expression associated with the production of bases, e.g., S. salivarius activates urease enzyme
which degrades urea into ammonia, while S. sanguinis system of arginine deiminases causing
arginine decomposition to ornithine, carbon dioxide, and ammonia at lower pH (4.0) than that
enables the growth and may cause glycolysis (pH 5,2).
Streptococcus mutans can also use branched-chain amino acid (BCCA) biosynthesis as one of
the ways to deal with cytoplasm acidification [42, 70]. In this mechanism, S. mutans redirects
pyruvate formed in glycolysis for the pathway of biosynthesis of amino acids belonging to the
group of BCAA. This reduces the amount of substrate for organic acid production, mainly
lactic acid. The initial reaction in the biosynthesis of valine and leucine amino acids is
acetylacetonate formation by condensation of two pyruvate molecules. α-keto acid is pro‐
duced during further reactions, which finally is converted by aminotransferase to the BCAA.
In addition, NH3+ ion is secreted during isoleucine biosynthesis, also belonging to BCAA,
whose binding with H+ causes the formation of ammonia and alkalization of cytoplasm [76].
Santiago et al. (2012) obtained an increase in expression ilvE gene encoding a BCAA amino‐
transferase (ILvE) in S. mutans in response to environment acidification. In addition, they
demonstrated that the activity of membrane ATPase is subject to a decrease in microorgan‐
isms lacking genes for ILvE, which is one of the main mechanisms to maintain pH homeosta‐
sis in the bacterial cell [76, 77].
Another important mechanism protecting Streptococcus mutans against the harmful effect of
low pH is the permeability of the cell membrane. During the adaptation to an acidic extracel‐
lular pH, S. mutans can change fatty acid composition in the cell membrane to prevent the
passive penetration of H+ ions into the cell. In turn, the amount of monounsaturated fatty acids
and long-chain fatty acids is subject to an increase, which reduces membrane permeability [42,
68, 70].
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GbpC protein (and possibly GbpB) is associated with a cell wall of bacteria, and therefore is a
specific receptor for glucans. All four types of the proteins play a role in microorganism
adhesion and biofilm formation, but the protein GbpD seems to be the key one [55]. The studies
using strains of S. mutans GS5 (gbpB gene deletion) and UACA2 (strain expressing an anti‐
sense RNA for gbpB gene) demonstrated, in turn, that the absence or mutation of GbpB
encoding gene results in a change in cell shape and its slow growth [64]. This prevents normal
development of the biofilm, which, instead of being a diverse, compact formation, becomes a
creation formed of irregular cell clusters surrounded by a matrix of untypical structure.
Thus, sucrose plays a dual role in the formation of biofilm pathogenicity, provides a source
for organic acid production by acidic species in dental plaque, and serves as a substrate for the
production of extracellular polysaccharides (EPS) [48].
3.2.3. Mechanisms of low pH tolerance
The primary feature distinguishing cariogenic bacteria such as Streptococcus mutans and
Lactobacilli is their ability to tolerate low pH of the environment, which results from the
maintenance of intracellular pH homeostasis.
S. mutans species tolerance to low pH (acid tolerance response, ATR) is associated with a
number of mechanisms regulating its cell physiology involving, inter alia, the changes in the
synthesis and activity of cellular proteins and fatty acids [42, 68, 69]. One of the main mecha‐
nisms enabling S. mutans bacteria to survive at low pH is based on the increase in ATPase
activity, mainly F1F0-ATPase, proton pump, which removes H+ ions outside the cell, thus
contributing to the maintenance of intracellular pH at a level of about 7.5 [69–71]. This
mechanism involves the active removal of H+ ions from the cell through mentioned ATPase.
This process requires energy input, which is obtained from the conversion of L-malate to L-
lactate (during malolactic fermentation, MLF). In addition to ATP, CO2 is also produced during
this process, which additionally reduces the cytoplasm acidity, affecting the regulation of
intracellular pH [70,71].
In the case of a prolonged period of starvation, during which the adequate nutrients such as
sugars are not provided to bacteria, ATPase begins to act as ATP synthase, providing the cell
with energy required for survival, and which the microorganism is not able to obtain from the
food [72]. The neutralization of acidic products of metabolism in the cells additionally requires
CO2, and ammonia resulting from the conversion of urea or arginine by urease or arginine
deiminase system and agmatine deiminase system (AgDS) [70]. The result are products like
ammonia and carbamoyl putrescine, which is subsequently converted to putrescine and CO2.
These reactions are further stage comprising the maintenance of intracellular homeostasis in
the conditions of the external environment decreased pH.
Another process affecting low pH tolerance is the change in stress response proteins synthe‐
sis. The main products are present in the cell just after 30 minutes from the pH change to a
lower value [73]. A large part of them demonstrate an increased glycolytic activity, which
allows microorganisms to preserve the metabolic ability under new conditions [69, 70].
Another concept of S. mutans tolerance to low pH suggests a role of the cell membrane in that
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bacterial cell [74].
An additional mechanism supporting ATR is the biofilm formation, which focuses in its
structure the clusters of microorganisms of different species, additionally protecting them with
EPS matrix. As demonstrated by Welin-Neilands and Svensäter [69], the cells of S. mutans in
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is played by glucans as discussed below, which slow down the diffusion of hydrogen ions into
the biofilm [75].
Other microorganisms resist the low pH of the environment by an increase in the gene
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which degrades urea into ammonia, while S. sanguinis system of arginine deiminases causing
arginine decomposition to ornithine, carbon dioxide, and ammonia at lower pH (4.0) than that
enables the growth and may cause glycolysis (pH 5,2).
Streptococcus mutans can also use branched-chain amino acid (BCCA) biosynthesis as one of
the ways to deal with cytoplasm acidification [42, 70]. In this mechanism, S. mutans redirects
pyruvate formed in glycolysis for the pathway of biosynthesis of amino acids belonging to the
group of BCAA. This reduces the amount of substrate for organic acid production, mainly
lactic acid. The initial reaction in the biosynthesis of valine and leucine amino acids is
acetylacetonate formation by condensation of two pyruvate molecules. α-keto acid is pro‐
duced during further reactions, which finally is converted by aminotransferase to the BCAA.
In addition, NH3+ ion is secreted during isoleucine biosynthesis, also belonging to BCAA,
whose binding with H+ causes the formation of ammonia and alkalization of cytoplasm [76].
Santiago et al. (2012) obtained an increase in expression ilvE gene encoding a BCAA amino‐
transferase (ILvE) in S. mutans in response to environment acidification. In addition, they
demonstrated that the activity of membrane ATPase is subject to a decrease in microorgan‐
isms lacking genes for ILvE, which is one of the main mechanisms to maintain pH homeosta‐
sis in the bacterial cell [76, 77].
Another important mechanism protecting Streptococcus mutans against the harmful effect of
low pH is the permeability of the cell membrane. During the adaptation to an acidic extracel‐
lular pH, S. mutans can change fatty acid composition in the cell membrane to prevent the
passive penetration of H+ ions into the cell. In turn, the amount of monounsaturated fatty acids
and long-chain fatty acids is subject to an increase, which reduces membrane permeability [42,
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GbpC protein (and possibly GbpB) is associated with a cell wall of bacteria, and therefore is a
specific receptor for glucans. All four types of the proteins play a role in microorganism
adhesion and biofilm formation, but the protein GbpD seems to be the key one [55]. The studies
using strains of S. mutans GS5 (gbpB gene deletion) and UACA2 (strain expressing an anti‐
sense RNA for gbpB gene) demonstrated, in turn, that the absence or mutation of GbpB
encoding gene results in a change in cell shape and its slow growth [64]. This prevents normal
development of the biofilm, which, instead of being a diverse, compact formation, becomes a
creation formed of irregular cell clusters surrounded by a matrix of untypical structure.
Thus, sucrose plays a dual role in the formation of biofilm pathogenicity, provides a source
for organic acid production by acidic species in dental plaque, and serves as a substrate for the
production of extracellular polysaccharides (EPS) [48].
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The primary feature distinguishing cariogenic bacteria such as Streptococcus mutans and
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contributing to the maintenance of intracellular pH at a level of about 7.5 [69–71]. This
mechanism involves the active removal of H+ ions from the cell through mentioned ATPase.
This process requires energy input, which is obtained from the conversion of L-malate to L-
lactate (during malolactic fermentation, MLF). In addition to ATP, CO2 is also produced during
this process, which additionally reduces the cytoplasm acidity, affecting the regulation of
intracellular pH [70,71].
In the case of a prolonged period of starvation, during which the adequate nutrients such as
sugars are not provided to bacteria, ATPase begins to act as ATP synthase, providing the cell
with energy required for survival, and which the microorganism is not able to obtain from the
food [72]. The neutralization of acidic products of metabolism in the cells additionally requires
CO2, and ammonia resulting from the conversion of urea or arginine by urease or arginine
deiminase system and agmatine deiminase system (AgDS) [70]. The result are products like
ammonia and carbamoyl putrescine, which is subsequently converted to putrescine and CO2.
These reactions are further stage comprising the maintenance of intracellular homeostasis in
the conditions of the external environment decreased pH.
Another process affecting low pH tolerance is the change in stress response proteins synthe‐
sis. The main products are present in the cell just after 30 minutes from the pH change to a
lower value [73]. A large part of them demonstrate an increased glycolytic activity, which
allows microorganisms to preserve the metabolic ability under new conditions [69, 70].
Another concept of S. mutans tolerance to low pH suggests a role of the cell membrane in that
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phosphate (NADPH), which is necessary in the reduction processes. This is a significant
reaction since S. mutans has neither the enzymes of oxidative pentose pathway portion nor
transhydrogenase, which would generate NADPH [77]. In addition, the expression of other
enzymes, transketolase, increases in the conditions of environment acidification. This enzyme
redirects the two intermediate products of glycolysis, glyceraldehyde 3-phosphate and
fructose 6-phosphate, to the non-oxidative part of the pentose pathway, and consequently, for
the pathway of nucleotide biosynthesis needed for DNA synthesis [77].
Of the three enzymes involved in the final conversion of 3-phosphoglycerate to pyruvate, two
of them demonstrate higher expression in pH=5 than at a neutral pH. The first of them,
phosphoglycerate mutase, exhibits more than twofold increase in expression, while the activity
of pyruvate kinase increases nearly threefold [77]. Pyruvate kinase, the last of the enzymes
involved in glycolysis, is considered as an enzyme conditioning the rate of the whole proc‐
ess since it is activated by glucose-6-phosphate, a substrate of glycolysis in S. mutans.
Len et al. demonstrated nearly 93% reduction in the activity of the enolase, an enzyme that
converts 2-phosphoglycerate into phosphoenolpyruvate (PEP) [77]. PEP is a precursor of
pyruvate, which is involved in carbohydrate transport inside the bacterial cell in phosphoe‐
nolpyruvate-sugar phosphotransferase system (PEP-PTS), where it plays a role of phosphate
donor [80]. In the conditions of reduced pH, the amount of PEP produced is subject to a
decrease as a consequence of reduced enolase activity. However, the amount of pyruvate
produced by pyruvate kinase increases concurrently, which may indicate the conversion of 2-
phosphoglycerate to pyruvate without phosphoenolpyruvate accumulation [77]. In addition,
PEP is also an inhibitor of lactate dehydrogenase, an enzyme that converts pyruvate to lactic
acid. Therefore, a decrease in PEP amount results in an increased production of lactic acid at
low pH, which was confirmed in the studies [69, 77].
Increased expression of some glycolytic enzymes, e.g., glyceraldehyde 3-phosphate dehydro‐
genase, enolase, phosphoglycerate kinase, or aldolase, can be explained by their dual func‐
tion, which is related to adhesion to the substrate [81]. These enzymes are found on the bacterial
cell surface of many species of Streptococcus genus [69]. The study conducted by Ge et al.
revealed the presence of enolase on the surface of S. mutans, and the ability of that enzyme to
bind to salivary mucin MG2, as well as plasma plasminogen [81]. Thus, enolase acts not only
as a glycolytic enzyme, but also as the surface adhesin facilitating cell adhesion to the pellicle
acquired on the surface of the tooth. Double function of enolase may explain the results
demonstrated almost a twofold increase in the expression of the genes for enolase during the
initiation of bacterial biofilm formation. Due to the presence of surface enzymes on the bacterial
cells, S. mutans is considered, next to the streptococcus of viridans group, as one of the etiologi‐
cal factors of bacterial endocarditis or bacteremia [82, 83]. Also rare cases of recurrent
bacteremia in women with Sjogren’s syndrome were noted [84]. In addition to endocarditis and
bacteremia, S. mutans induced sepsis [85], and it was also the etiologic factor of other system‐
ic diseases [86]. Also, a rare case of retroperitoneal abscess caused by S. mutans was descri‐
bed [87].
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The change in the activity of numerous cellular proteins is observed during the adaptation to
stress conditions. The study conducted by Gong et al. demonstrated that during the adapta‐
tion to environment acidification (pH = 5.5) [68], S. mutans alters the expression of about 14%
of their genes, most of which are genes whose expression is subject to an increase (e.g., encoding
subunits of membrane proton pump; two-component regulatory systems: comD, comE, ciaH,
ciaR, and others; transcription factors; protein transporters, e.g., P-type ATPase responsible for
inorganic ion transport). A significant part of genes of an increased expression is the genes that
protein products exhibit glycolytic activity, which protects microorganisms against a decline
in metabolic ability under new conditions [70].
3.2.4. Carbohydrate metabolism
In oral cavity conditions, cariogenic bacteria S. mutans are characterized by altered metabo‐
lism compared to the cells of physiological flora. It is based on glycolysis, which also occurs
in presence of oxygen (a phenomenon known as the Warburg effect). The low concentration
of oxygen (<2%), i.e., hypoxia inside the biofilm, increases an expression of genes encoding
glycolytic enzymes and inhibits the oxidative phosphorylation.
Carbohydrate metabolism is one of the key metabolic pathways that subject to changes during
mixed biofilm development. It was demonstrated that the amount of synthesized glycolytic
enzymes, including glucokinase, aldolase, phosphoglycerate mutase, and pyruvate kinase, is
subject to an increase [77]. Therefore, S. mutans is more resistant compared to other strepto‐
cocci to glycolytic enzyme inactivation in a response to the lowered pH of the environment.
This may be due to an increased amount of ATP produced during glycolysis, and consequent‐
ly, increased proton removal by H+-ATPase [78, 79]. Glycolytic enzymes are sensitive to low
pH, which results in a decrease in their activity when the pH inside the cell is lowered. The
optimum pH for glycolysis process is neutral pH (pH = 7), an increase in the activity of
glycolytic enzymes during ATR can therefore be explained by the need to overcome the
inhibitory effect of environment acidification in relation to the metabolic activity [77].
Furthermore, when the bacterial cells adapt to the new conditions, the optimum pH for the
glycolysis is reduced and the process rate is increased [42]. This means that S. mutans may
continue its metabolism, even when the external pH falls below 4, which for most microor‐
ganisms do not have ATR mechanisms causing stop their metabolism [42].
The glycolytic activity increases in the newly formed biofilm (a few hours), which is caused
by an increased activity of the processes needed to adapt to new environmental conditions,
requiring energy inputs in the form of ATP. However, the glycolytic activity of enzymes
decreases with dental plaque biofilm aging. The probable cause is the desire to avoid further
acidification of the environment, when biofilm becomes thicker. Reduced rate of glycolysis
process, combined with decreased rate of cell growth in the biofilm, can make the structure
more stable and resistant to external factors [78].
Glycolysis provides not only ATP, but also intermediate products involved in anabolic
processes [77]. An example would be an increased activity of NADP-dependent glyceralde‐
hyde-3-phosphate dehydrogenase. This enzyme bypasses the stage of first ATP molecule
formation, in order to provide the reduced form of nicotinamide adenine dinucleotide
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phosphate (NADPH), which is necessary in the reduction processes. This is a significant
reaction since S. mutans has neither the enzymes of oxidative pentose pathway portion nor
transhydrogenase, which would generate NADPH [77]. In addition, the expression of other
enzymes, transketolase, increases in the conditions of environment acidification. This enzyme
redirects the two intermediate products of glycolysis, glyceraldehyde 3-phosphate and
fructose 6-phosphate, to the non-oxidative part of the pentose pathway, and consequently, for
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Of the three enzymes involved in the final conversion of 3-phosphoglycerate to pyruvate, two
of them demonstrate higher expression in pH=5 than at a neutral pH. The first of them,
phosphoglycerate mutase, exhibits more than twofold increase in expression, while the activity
of pyruvate kinase increases nearly threefold [77]. Pyruvate kinase, the last of the enzymes
involved in glycolysis, is considered as an enzyme conditioning the rate of the whole proc‐
ess since it is activated by glucose-6-phosphate, a substrate of glycolysis in S. mutans.
Len et al. demonstrated nearly 93% reduction in the activity of the enolase, an enzyme that
converts 2-phosphoglycerate into phosphoenolpyruvate (PEP) [77]. PEP is a precursor of
pyruvate, which is involved in carbohydrate transport inside the bacterial cell in phosphoe‐
nolpyruvate-sugar phosphotransferase system (PEP-PTS), where it plays a role of phosphate
donor [80]. In the conditions of reduced pH, the amount of PEP produced is subject to a
decrease as a consequence of reduced enolase activity. However, the amount of pyruvate
produced by pyruvate kinase increases concurrently, which may indicate the conversion of 2-
phosphoglycerate to pyruvate without phosphoenolpyruvate accumulation [77]. In addition,
PEP is also an inhibitor of lactate dehydrogenase, an enzyme that converts pyruvate to lactic
acid. Therefore, a decrease in PEP amount results in an increased production of lactic acid at
low pH, which was confirmed in the studies [69, 77].
Increased expression of some glycolytic enzymes, e.g., glyceraldehyde 3-phosphate dehydro‐
genase, enolase, phosphoglycerate kinase, or aldolase, can be explained by their dual func‐
tion, which is related to adhesion to the substrate [81]. These enzymes are found on the bacterial
cell surface of many species of Streptococcus genus [69]. The study conducted by Ge et al.
revealed the presence of enolase on the surface of S. mutans, and the ability of that enzyme to
bind to salivary mucin MG2, as well as plasma plasminogen [81]. Thus, enolase acts not only
as a glycolytic enzyme, but also as the surface adhesin facilitating cell adhesion to the pellicle
acquired on the surface of the tooth. Double function of enolase may explain the results
demonstrated almost a twofold increase in the expression of the genes for enolase during the
initiation of bacterial biofilm formation. Due to the presence of surface enzymes on the bacterial
cells, S. mutans is considered, next to the streptococcus of viridans group, as one of the etiologi‐
cal factors of bacterial endocarditis or bacteremia [82, 83]. Also rare cases of recurrent
bacteremia in women with Sjogren’s syndrome were noted [84]. In addition to endocarditis and
bacteremia, S. mutans induced sepsis [85], and it was also the etiologic factor of other system‐
ic diseases [86]. Also, a rare case of retroperitoneal abscess caused by S. mutans was descri‐
bed [87].
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in metabolic ability under new conditions [70].
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In oral cavity conditions, cariogenic bacteria S. mutans are characterized by altered metabo‐
lism compared to the cells of physiological flora. It is based on glycolysis, which also occurs
in presence of oxygen (a phenomenon known as the Warburg effect). The low concentration
of oxygen (<2%), i.e., hypoxia inside the biofilm, increases an expression of genes encoding
glycolytic enzymes and inhibits the oxidative phosphorylation.
Carbohydrate metabolism is one of the key metabolic pathways that subject to changes during
mixed biofilm development. It was demonstrated that the amount of synthesized glycolytic
enzymes, including glucokinase, aldolase, phosphoglycerate mutase, and pyruvate kinase, is
subject to an increase [77]. Therefore, S. mutans is more resistant compared to other strepto‐
cocci to glycolytic enzyme inactivation in a response to the lowered pH of the environment.
This may be due to an increased amount of ATP produced during glycolysis, and consequent‐
ly, increased proton removal by H+-ATPase [78, 79]. Glycolytic enzymes are sensitive to low
pH, which results in a decrease in their activity when the pH inside the cell is lowered. The
optimum pH for glycolysis process is neutral pH (pH = 7), an increase in the activity of
glycolytic enzymes during ATR can therefore be explained by the need to overcome the
inhibitory effect of environment acidification in relation to the metabolic activity [77].
Furthermore, when the bacterial cells adapt to the new conditions, the optimum pH for the
glycolysis is reduced and the process rate is increased [42]. This means that S. mutans may
continue its metabolism, even when the external pH falls below 4, which for most microor‐
ganisms do not have ATR mechanisms causing stop their metabolism [42].
The glycolytic activity increases in the newly formed biofilm (a few hours), which is caused
by an increased activity of the processes needed to adapt to new environmental conditions,
requiring energy inputs in the form of ATP. However, the glycolytic activity of enzymes
decreases with dental plaque biofilm aging. The probable cause is the desire to avoid further
acidification of the environment, when biofilm becomes thicker. Reduced rate of glycolysis
process, combined with decreased rate of cell growth in the biofilm, can make the structure
more stable and resistant to external factors [78].
Glycolysis provides not only ATP, but also intermediate products involved in anabolic
processes [77]. An example would be an increased activity of NADP-dependent glyceralde‐
hyde-3-phosphate dehydrogenase. This enzyme bypasses the stage of first ATP molecule
formation, in order to provide the reduced form of nicotinamide adenine dinucleotide
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This example proves that the existence of the relationship between oral cavity bacterial
microbiome, inter alia, absolute anaerobes, which occur at different locations of the oral cavity,
and, as evidenced by the studies, can survive oxygen exposure due to the interactions with the
bacterial biofilm species, metabolizing oxygen and having appropriate enzymes removing
toxic products of free radical reactions.
3.2.7. Production of intracellular polysaccharides
Since bacteria found in the oral cavity are subject to continuous “feeding” and “hunger” cycles
with respect to dietary sugar supply, the resident microflora develops, as a consequence, a
mechanism for carbohydrate storage. They help avoid the lethal effects of excessive amounts
of intermediate products of intracellular glycolysis and provide a source of carbon and energy
during the “starvation” period. Intracellular polysaccharide (IPS) repositories are created and
are a source of energy during starvation; they can promote tooth decay, by extending the time
in which the teeth are exposed to organic acids [48, 91]. IPS are high molecular polymers
containing α-1,4 and α-1,6-glycosidic bonds in their molecules, which are readily metabo‐
lized in the absence of other carbohydrate sources.
It was proved that the strains of S. mutans, which have an increased repository of these
polysaccharides, are considered to be more cariogenic than other strains of the microorgan‐
isms colonizing the dental plaque. The studies demonstrated that organic acid production by
S. mutans from intracellular substrates resulted in an increased and prolonged drop in
environment pH, leading to the acceleration of demineralization processes [62].
3.2.8. Production of extracellular polysaccharides (EPS)
EPS promote biochemical and physiological changes in bacterial biofilm matrix. EPS allow
adhesion and clustering of microorganisms accumulated in the biofilm structure, and they
provide structural integrity and stability and increase the biofilm biomass, matrix acidity, as
well as reduce the concentration of inorganic ion. With an access to sugars, especially sucrose,
EPS are produced in a continuous manner, which, as a consequence, leads to the formation of
bacterial microcolonies and then three-dimensional structures [48]. Polysaccharide EPS matrix
provides the protection for bacterial microcolonies present in the biofilm against adverse
external factors, including bactericides or host’s defense mechanisms. It also provides the
protection for all kinds of microorganisms contained in the biofilm, creating environmental
niches in which they can communicate with each other, adapt to the conditions, and even
change the surrounding microenvironment. The matrix of EPS biofilm may also affect the
availability of nutrients, metabolites, or signaling substances [92]. Moreover, EPS increases the
mass and porosity of biofilm matrix, allowing more nutrients to diffuse into the surface of the
teeth. Therefore, the deeper layers of biofilm are exposed to acidic pH activity, increasing thus
the risk of caries [62]. In addition, the polysaccharide matrix is a place of accumulation of
organic acids produced from carbohydrates fermented by acid-forming bacteria, including
streptococci from mutans group and bacteria of Lactobacillus genus [55]. It constitutes an
impermeable barrier for the buffering activity of saliva, which causes the formation of acid
niches, mainly inside the biofilm structure [48]. Due to a limited diffusion to and from biofilm,




Metabolism of nitrogen compounds is related to an activity of many endopeptidases and
exopeptidases. S. sanguinis, S. gordonii, and some lactobacilli species release arginine from
peptides decomposing it using arginine deiminase to ammonia, ornithine, and carbon diox‐
ide with the release of energy. Urea present in saliva at a relatively high concentration (200
mg/L) is decomposed by certain bacteria having enzyme urease (e.g., S. salivarius, A. naeslun‐
di) to carbon dioxide and ammonia. This example is proof of the existence of interspecies
interactions associated with the ability of some bacterial species to the reduction of the
environment acidity through the production of ammonia, creating more favorable condi‐
tions for the survival of bacteria sensitive to low pH. Such ability is demonstrated by micro‐
organisms such as Fusobacterium nucleatum and Prevotella intermedia, which, through the
production of ammonia during glutamate and aspartate fermentation, enable the growth of
sensitive species such as, e.g., Porphyromonas gingivalis [88].
3.2.6. Oxygen metabolism
Expression of S. mutans pathogenicity determinants and biofilm formation in specific condi‐
tions of the oral cavity can be modulated, inter alia, by the environment and the presence of
oxygen [39].
The culture of S. mutans strains under aerobic conditions produces 80% reduction in bacteri‐
al ability to biofilm formation [38]. The availability of oxygen is the causative agent of the
changes in the bacterial cell surface composition, as well as modifications that occur in
autolysin production and specific system of signal transduction VicRK. The production of
autolysin AtlA is conditional by an expression of gene SMu0629 demonstrating oxidoreduc‐
tase activity. An increased expression of this gene can be observed under aerobic conditions,
and therefore the overproduction of autolysin AtlA, which inhibits biofilm formation.
Transducer of kinase VicK constitutes a system regulating the expression and activity of
autolysin AtlA. The study on the strains mutated for the gene SMu0629 and vicK was
conducted in order to confirm the changes in autolysin affected by oxygen. Strains with the
removal of the above-mentioned genes adapted better to the aerobic conditions and showed
a greater ability to biofilm formation compared to the parent strain UA159 [89].
Multi-species biofilm formation is conditioned by physiological relationships favoring the
connection of microorganisms with different environmental requirements or different type of
metabolism. An example of such relationship is oxygen absorption by the early colonizers such
as Neisseria genus, providing thus favorable conditions for the growth of the absolute anaerobic
bacteria like Porphyromonas gingivalis [78]. Another example of interspecies cooperation in
biofilms is an increase in expression of gene amyB for α-amylase in Streptococcus gordonii caused
by the co-aggregation with Veillonella atypica species. Decomposing carbohydrates, such as α-
amylase, contribute to the formation of acidic end products of S. gordonii metabolism, mainly
lactic acid. The resulting acid then becomes a source of carbon for V. atypica, bacteria, which
itself cannot ferment carbohydrates [90].
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with respect to dietary sugar supply, the resident microflora develops, as a consequence, a
mechanism for carbohydrate storage. They help avoid the lethal effects of excessive amounts
of intermediate products of intracellular glycolysis and provide a source of carbon and energy
during the “starvation” period. Intracellular polysaccharide (IPS) repositories are created and
are a source of energy during starvation; they can promote tooth decay, by extending the time
in which the teeth are exposed to organic acids [48, 91]. IPS are high molecular polymers
containing α-1,4 and α-1,6-glycosidic bonds in their molecules, which are readily metabo‐
lized in the absence of other carbohydrate sources.
It was proved that the strains of S. mutans, which have an increased repository of these
polysaccharides, are considered to be more cariogenic than other strains of the microorgan‐
isms colonizing the dental plaque. The studies demonstrated that organic acid production by
S. mutans from intracellular substrates resulted in an increased and prolonged drop in
environment pH, leading to the acceleration of demineralization processes [62].
3.2.8. Production of extracellular polysaccharides (EPS)
EPS promote biochemical and physiological changes in bacterial biofilm matrix. EPS allow
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provide structural integrity and stability and increase the biofilm biomass, matrix acidity, as
well as reduce the concentration of inorganic ion. With an access to sugars, especially sucrose,
EPS are produced in a continuous manner, which, as a consequence, leads to the formation of
bacterial microcolonies and then three-dimensional structures [48]. Polysaccharide EPS matrix
provides the protection for bacterial microcolonies present in the biofilm against adverse
external factors, including bactericides or host’s defense mechanisms. It also provides the
protection for all kinds of microorganisms contained in the biofilm, creating environmental
niches in which they can communicate with each other, adapt to the conditions, and even
change the surrounding microenvironment. The matrix of EPS biofilm may also affect the
availability of nutrients, metabolites, or signaling substances [92]. Moreover, EPS increases the
mass and porosity of biofilm matrix, allowing more nutrients to diffuse into the surface of the
teeth. Therefore, the deeper layers of biofilm are exposed to acidic pH activity, increasing thus
the risk of caries [62]. In addition, the polysaccharide matrix is a place of accumulation of
organic acids produced from carbohydrates fermented by acid-forming bacteria, including
streptococci from mutans group and bacteria of Lactobacillus genus [55]. It constitutes an
impermeable barrier for the buffering activity of saliva, which causes the formation of acid
niches, mainly inside the biofilm structure [48]. Due to a limited diffusion to and from biofilm,




Metabolism of nitrogen compounds is related to an activity of many endopeptidases and
exopeptidases. S. sanguinis, S. gordonii, and some lactobacilli species release arginine from
peptides decomposing it using arginine deiminase to ammonia, ornithine, and carbon diox‐
ide with the release of energy. Urea present in saliva at a relatively high concentration (200
mg/L) is decomposed by certain bacteria having enzyme urease (e.g., S. salivarius, A. naeslun‐
di) to carbon dioxide and ammonia. This example is proof of the existence of interspecies
interactions associated with the ability of some bacterial species to the reduction of the
environment acidity through the production of ammonia, creating more favorable condi‐
tions for the survival of bacteria sensitive to low pH. Such ability is demonstrated by micro‐
organisms such as Fusobacterium nucleatum and Prevotella intermedia, which, through the
production of ammonia during glutamate and aspartate fermentation, enable the growth of
sensitive species such as, e.g., Porphyromonas gingivalis [88].
3.2.6. Oxygen metabolism
Expression of S. mutans pathogenicity determinants and biofilm formation in specific condi‐
tions of the oral cavity can be modulated, inter alia, by the environment and the presence of
oxygen [39].
The culture of S. mutans strains under aerobic conditions produces 80% reduction in bacteri‐
al ability to biofilm formation [38]. The availability of oxygen is the causative agent of the
changes in the bacterial cell surface composition, as well as modifications that occur in
autolysin production and specific system of signal transduction VicRK. The production of
autolysin AtlA is conditional by an expression of gene SMu0629 demonstrating oxidoreduc‐
tase activity. An increased expression of this gene can be observed under aerobic conditions,
and therefore the overproduction of autolysin AtlA, which inhibits biofilm formation.
Transducer of kinase VicK constitutes a system regulating the expression and activity of
autolysin AtlA. The study on the strains mutated for the gene SMu0629 and vicK was
conducted in order to confirm the changes in autolysin affected by oxygen. Strains with the
removal of the above-mentioned genes adapted better to the aerobic conditions and showed
a greater ability to biofilm formation compared to the parent strain UA159 [89].
Multi-species biofilm formation is conditioned by physiological relationships favoring the
connection of microorganisms with different environmental requirements or different type of
metabolism. An example of such relationship is oxygen absorption by the early colonizers such
as Neisseria genus, providing thus favorable conditions for the growth of the absolute anaerobic
bacteria like Porphyromonas gingivalis [78]. Another example of interspecies cooperation in
biofilms is an increase in expression of gene amyB for α-amylase in Streptococcus gordonii caused
by the co-aggregation with Veillonella atypica species. Decomposing carbohydrates, such as α-
amylase, contribute to the formation of acidic end products of S. gordonii metabolism, mainly
lactic acid. The resulting acid then becomes a source of carbon for V. atypica, bacteria, which
itself cannot ferment carbohydrates [90].
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er in the local environment reaches the threshold concentration, it causes an induction of
corresponding genes expression, concerning, inter alia, the division and differentiation of cells,
virulence (e.g., bacteriocins), responsible for the production of enzymes (e.g., glycosyltrans‐
ferases). Communication can occur between the cells of the same or different species. This
system differs in gram-positive and gram-negative bacteria. Autoinducers of gram-positive
bacteria are peptide molecules, whereas in gram-negative bacteria, these functions are played
by acylated homoserine lactone (HSL) [101].
Quorum sensing (QS) in S. mutans is mediated by a two-component regulatory system (TCS)
ComDE. ComDE genes are included in the operon comCDE, which together with operon comAB
play a significant role in the biofilm formation, bacteriocin production, response to stress
conditions, e.g., low pH of the environment, and in the so-called genetic competence. This
process involves the ability of bacteria to the heterologous DNA uptake and is quite often
found in the biofilm environment [102]. Competence stimulating peptide (CPS) is an autoin‐
ducer in QS system in S. mutans, and its protein precursor is the product of gene comC. CPS is
a signaling molecule and is secreted outside the cells of the bacteria by ABC transporter, comAB
gene product. Once a sufficient threshold concentration in the biofilm environment is reached,
CPS mediator combines with the bacterial cell surface receptor ComD, which is a membrane
histidine kinase. After joining to ligands, the receptor is subject to autophosphorylation with
the participation of ATP. Then, the signal is transmitted to the response regulator (ComE),
which after conformation change affects the transcription of genes comAB, comCDE, and comX.
ComX is an alternative sigma subunit of RNA polymerase that recognizes other promoter
sequences and determines the level of expression of the genes associated with the genetic
competence and response of the increase in the density of the microorganism population [103–
104]. Competences stimulating peptide (CSP) is involved in the regulation of bacterial biofilm
formation, which was demonstrated constructing the mutants lacking genes comC and comDE.
Strains of S. mutans devoid of gene comC formed the biofilm with altered structure com‐
pared to the wild strains, while the biofilm of mutants of genes comDE had changed the
structure and significantly decreased biomass. It was also demonstrated that the presence of
CPS increases the expression of genes for glycosyltransferases (gtfB/C/D), fructosyltransferas‐
es (ftf), and glucan-binding protein B, i.e., the factors involved in the biofilm formation of S.
mutans [78, 105]. Interestingly, other studies demonstrated that an excess of CPS may contrib‐
ute to the death of bacterial cells. This might be a way of a selective control of S. mutans survival
in mixed biofilms and its virulence control [104,105], but on the contrary, bacterial cell death
leads to the release of chromosomal DNA into the biofilm matrix and provides the nutrients,
which increases the ability of bacteria to survive in the biofilm [42]. Zhang et al. pointed out
the role of CPS in the late stages of the biofilm formation, i.e., its maturation without affect‐
ing the growth and division of bacterial cells [104].
An important signaling molecule participating in interspecies communication is autoinduc‐
er AI-2—affecting the expression of gtfB and gtfC [39, 55]. It is produced by both gram-positive
and gram-negative bacteria. It is formed during the spontaneous conversion of 4,5-dihy‐
droxy-2,3-pentanedione, whose biosynthesis is catalyzed by LuxS protein. LuxS protein, the
product of luxS gene, is present in many species of bacteria observed in biofilms (dental
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it is possible to collect the nutrients or metal ions inside it that are necessary for microorgan‐
ism survival and to reduce the penetration of external bactericidal substances, and also
antibiotics [55]. The composition and structure of biofilm matrix may change over time, and
this may be due to both effects of bacterial populations and microenvironment factors. An
example can be the presence of extracellular DNA (eDNA), which enhances the adhesion of
S. mutans to biofilm surface. The eDNA is a component of the (ECM) and is formed from
chromosomal DNA during the processes such as autolysis or active secretion [93]. It is
incorporated in the matrix, affecting the biofilm architecture and development. It was
demonstrated in the studies that eDNA is involved in several stages of biofilm formation,
including the initial bacterial adhesion, aggregation, and mechanical stabilization of biofilm
structure. eDNA is also involved in genetic competence, the process in which genetic infor‐
mation can be transferred from one bacterial species to another related one. This is a kind of
horizontal gene transfer, inter alia, encoding virulence factors or genes of resistance to
bactericidal agents [94].
3.2.9. Proteases
Also other features of S. mutans, such as production of proteases, which can decompose the
proteins derived from the host, are not without significance [95]. Some examples include
collagenases, proteins degrading collagen in the dentin and teeth cement, which may in turn
lead to caries of the root surface of the tooth [96], and proteases degrading the components
involved in host’s immune response, e.g., proteases IgA1, which degrade secretory immuno‐
globulins A1 (sIgA1) present in the saliva. Secretory antibodies IgA1 are the first line of host’s
defense against bacterial agents, preventing their adhesion and colonization on tooth surfa‐
ces. These antibodies block surface adhesins AGI/II [97–99]. In the conditions prevailing in the
oral cavity, the expression of pathogenicity determinants, in particular species of bacteria, both
those forming oral cavity microbiome and those contained in the biofilm, is affected by both
the environment in which the biofilm grows and the influence of accompanying bacterial flora.
3.3. Mixed biofilm
The interactions observed between microorganisms of oral cavity microbiome is another major
factor affecting the development of the biofilm [39, 100]. The interactions that occur between
the microorganisms can result in both acceleration and inhibition of this process. This way,
the pathogenicity of S. mutans depends not only on the environmental conditions of the oral
cavity, but also on the composition of its bacterial flora.
In a response to rapidly changing environmental conditions of the biofilm, such as pH, the
content of EPS, or the amount of available nutrient substrates, bacteria had to develop
molecular adaptation pathways that would ensure their survival and optimal metabolism. The
interactions that occur between the microorganisms can result in both acceleration and
inhibition of this process. Microorganisms can change the expression of their genes and
communicate with each other in response to the density of their distribution. “Quorum sensing”,
i.e., density signaling, “overcrowding sense”, is based on the interactions between chemical
molecules, autoinducers and their receptors. In the case when the concentration of autoinduc‐
Microbial Biofilms - Importance and Applications348
er in the local environment reaches the threshold concentration, it causes an induction of
corresponding genes expression, concerning, inter alia, the division and differentiation of cells,
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process involves the ability of bacteria to the heterologous DNA uptake and is quite often
found in the biofilm environment [102]. Competence stimulating peptide (CPS) is an autoin‐
ducer in QS system in S. mutans, and its protein precursor is the product of gene comC. CPS is
a signaling molecule and is secreted outside the cells of the bacteria by ABC transporter, comAB
gene product. Once a sufficient threshold concentration in the biofilm environment is reached,
CPS mediator combines with the bacterial cell surface receptor ComD, which is a membrane
histidine kinase. After joining to ligands, the receptor is subject to autophosphorylation with
the participation of ATP. Then, the signal is transmitted to the response regulator (ComE),
which after conformation change affects the transcription of genes comAB, comCDE, and comX.
ComX is an alternative sigma subunit of RNA polymerase that recognizes other promoter
sequences and determines the level of expression of the genes associated with the genetic
competence and response of the increase in the density of the microorganism population [103–
104]. Competences stimulating peptide (CSP) is involved in the regulation of bacterial biofilm
formation, which was demonstrated constructing the mutants lacking genes comC and comDE.
Strains of S. mutans devoid of gene comC formed the biofilm with altered structure com‐
pared to the wild strains, while the biofilm of mutants of genes comDE had changed the
structure and significantly decreased biomass. It was also demonstrated that the presence of
CPS increases the expression of genes for glycosyltransferases (gtfB/C/D), fructosyltransferas‐
es (ftf), and glucan-binding protein B, i.e., the factors involved in the biofilm formation of S.
mutans [78, 105]. Interestingly, other studies demonstrated that an excess of CPS may contrib‐
ute to the death of bacterial cells. This might be a way of a selective control of S. mutans survival
in mixed biofilms and its virulence control [104,105], but on the contrary, bacterial cell death
leads to the release of chromosomal DNA into the biofilm matrix and provides the nutrients,
which increases the ability of bacteria to survive in the biofilm [42]. Zhang et al. pointed out
the role of CPS in the late stages of the biofilm formation, i.e., its maturation without affect‐
ing the growth and division of bacterial cells [104].
An important signaling molecule participating in interspecies communication is autoinduc‐
er AI-2—affecting the expression of gtfB and gtfC [39, 55]. It is produced by both gram-positive
and gram-negative bacteria. It is formed during the spontaneous conversion of 4,5-dihy‐
droxy-2,3-pentanedione, whose biosynthesis is catalyzed by LuxS protein. LuxS protein, the
product of luxS gene, is present in many species of bacteria observed in biofilms (dental
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ces. These antibodies block surface adhesins AGI/II [97–99]. In the conditions prevailing in the
oral cavity, the expression of pathogenicity determinants, in particular species of bacteria, both
those forming oral cavity microbiome and those contained in the biofilm, is affected by both
the environment in which the biofilm grows and the influence of accompanying bacterial flora.
3.3. Mixed biofilm
The interactions observed between microorganisms of oral cavity microbiome is another major
factor affecting the development of the biofilm [39, 100]. The interactions that occur between
the microorganisms can result in both acceleration and inhibition of this process. This way,
the pathogenicity of S. mutans depends not only on the environmental conditions of the oral
cavity, but also on the composition of its bacterial flora.
In a response to rapidly changing environmental conditions of the biofilm, such as pH, the
content of EPS, or the amount of available nutrient substrates, bacteria had to develop
molecular adaptation pathways that would ensure their survival and optimal metabolism. The
interactions that occur between the microorganisms can result in both acceleration and
inhibition of this process. Microorganisms can change the expression of their genes and
communicate with each other in response to the density of their distribution. “Quorum sensing”,
i.e., density signaling, “overcrowding sense”, is based on the interactions between chemical
molecules, autoinducers and their receptors. In the case when the concentration of autoinduc‐
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Bacteria in the biofilm compete with each other due to limited space for growth and the amount
of nutrient substrates. Many species evolved their own mechanisms assuring their survival,
e.g., the production of bacteriocins, specific or non-specific proteins involved in inter-bacteri‐
al interactions [88]. The analysis of the interactions between the physiological flora and
cariogenic factors of dental caries was possible due to the studies using double cultures. The
control group for double cultures in the study was single cultures of each bacterial species.
The results of the experiments are summarized in Table 1.
Double culture  Biofilm growth
and formation 
Expression of S. mutans pathogenicity factors References





Decrease in expression of genes involved in
the transport and metabolism of carbo
hydrates (e.g., sucrose phosphotransferase),
biosyntheses, and cell division (e.g., sucrose-6-
phosphate hydrolase)
[118]
Inactivation of the competence stimulating
peptide (CSP), and in a consequence, a
decrease in the amount of produced bacteriocins
[113]





Inactivation of CSP, a decline in the ability to
produce the biofilm
[114]





Decrease in the expression of genes of







Spatial biofilm change, resulting in an
increased resistance to antibacterial agents
[115]


















A larger decrease in the extracellular pH [116, 117]
Table 1. Results obtained in the experiments using double cultures [112–117] with modification.
Some contradictory relations based on antagonism are observed between the streptococci of
oral cavity (Table 1). Species from the group of “mitis”, i.e., an important group considered
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plaque), including S. mutans, S. gordonii, S. oralis, L. casei, and P. gingivalis. LuxS enzyme plays
a dual function, except AI-2synthesis, it also participates in the conversion of toxic S-adeno‐
syl-L-homocysteine to homocysteine [106]. AI-2 regulates, inter alia, the biofilm formation,
tolerance of oxidative stress or stress induced by environment acidification, and the expres‐
sion of virulence factors in response to the increase in bacterial density in the local environ‐
ment, e.g., the production of bacteriocins [39, 106–108].
Bacteria present in mixed biofilm can not only interfere with each other on the changes in gene
expression, but they may also provide each other with plasmids, e.g., antibiotic resistance
genes [78]. Among the S. mutans species, inter alia, erythromycin or kanamycin resistance
gene (gene aphA3) can be transferred, which causes the changes in above bacterial pheno‐
type in the direction of multidrug resistance phenotype, impeding an effective targeted
therapy [82, 107]. An example of such plasmids may be a new transposon vector called
“pMN100,” containing, among others, selective kanamycin resistance gene, an aminoglyco‐
side antibiotic [82]. As the multi-species biofilm develops, S. mutans increases the expression
of genes related to the synthesis, alterations, and adhesion of EPS, particularly genes for surface
enzymes, glycosyltransferases. These changes can be caused by the presence of other bacteri‐
al species in the biofilm [109, 49]. There is also an increase in the activity of enzymes decom‐
posing extracellular glucans, mainly dextranases. Dextranase, hydrolyzing α-1,6-glycosidic
bonds during the synthesis of glucans, leads to an increase in the ratio between α-1,3 and α-1,6
bonds, resulting in an increase in insoluble matrix components. Due to its activity, this enzyme
also provides the primers for insoluble glucan production. Moreover, the degradation of
soluble glucans and fructans (via fructanase) provides the substrates for organic acid produc‐
tion, thus leading to acidification of biofilm microenvironment [48, 110].
Also, an expression of factors involved in response to stress related to a decrease in environ‐
ment pH is increased in mixed biofilms. This starts a complex mechanism of ATR, compris‐
ing many processes, whose aim is to maintain the pH at an appropriate level, inter alia, the
activity of proton pumps is subject to an increase, e.g., F1F0-ATPase, whose task is to re‐
move H+ ions outside the cell, an increase also involves fatty acid biosynthesis, BCAA
metabolism, and other processes that were mentioned in the section concerning factors of S.
mutans pathogenicity (Section 2.3) [48, 109].
Also a decrease in the expression of proteins aimed in repairing DNA was observed in a mixed
biofilm, which may indicate a decreased DNA susceptibility to damage, which is caused, e.g.,
by chemical agents or radiation [111]. In turn, the share of proteins involved in the synthesis
is increased, inter alia, ribosomal proteins, including factors affecting translation initiation and
elongation (e.g., aminoacyl-tRNA synthetase) or factors involved in the translation elonga‐
tion, e.g., factors Tu and G [77], proteins involved in protein folding and secretion, e.g.,
chaperone protein DnaK, whose task is to prevent erroneous folding of proteins and their
aggregation [42, 77]. Also the number of proteins involved in biosynthesis of amino acids and
fatty acids is subject to an increase, e.g., BCAA aminotransferase [76], or fabM, involved in the
production of monounsaturated fatty acids [42]. The change in membrane lipid profile results
in a decrease in its permeability, which allows more efficient maintenance of H+ ions outside
the bacterial cell [68, 74].
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Also, an expression of factors involved in response to stress related to a decrease in environ‐
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ing many processes, whose aim is to maintain the pH at an appropriate level, inter alia, the
activity of proton pumps is subject to an increase, e.g., F1F0-ATPase, whose task is to re‐
move H+ ions outside the cell, an increase also involves fatty acid biosynthesis, BCAA
metabolism, and other processes that were mentioned in the section concerning factors of S.
mutans pathogenicity (Section 2.3) [48, 109].
Also a decrease in the expression of proteins aimed in repairing DNA was observed in a mixed
biofilm, which may indicate a decreased DNA susceptibility to damage, which is caused, e.g.,
by chemical agents or radiation [111]. In turn, the share of proteins involved in the synthesis
is increased, inter alia, ribosomal proteins, including factors affecting translation initiation and
elongation (e.g., aminoacyl-tRNA synthetase) or factors involved in the translation elonga‐
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fatty acids is subject to an increase, e.g., BCAA aminotransferase [76], or fabM, involved in the
production of monounsaturated fatty acids [42]. The change in membrane lipid profile results
in a decrease in its permeability, which allows more efficient maintenance of H+ ions outside
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bacterial species inhabiting the same ecological niches. Bacteriocins are proteins of an
antagonistic effect toward closely related species. S. mutans produces several different
mutacins, which belong to the following two groups: lantibiotics and non-lantibiotic bacter‐
iocins. Mutacin IV, belonging to non-lantibiotic bacteriocins, demonstrates an activity against
streptococci of the groups of mitis and salivarius observed in the biofilm of dental plaque [121,
122]. Mutacins not only cause the inhibition of the growth of microorganisms present in the
biofilm, but they can also participate in the mechanism of genetic competence. S. mutans can
obtain DNA from closely related species, including S. gordonii. High level of mutacin IV causes
the death of neighboring microorganisms, which, as a consequence, causes the release of DNA
into the local environment, which can then be incorporated into the genome of S. mutans [123].
Under in vitro culture conditions, the result of the above interactions between these two groups
of streptococci depends on which one of the first will inhabit particular environmental niche.
However, under in vivo conditions, both groups can coexist together. This is caused, inter alia,
by the presence of other bacterial species in the biofilm [39, 112]. As demonstrated by Liu et
al. [112], the growth and formation of biofilm by S. mutans was significantly inhibited during
the double culture with S. gordonii. However, after the introduction of third species into the
culture, i.e., V. parvula, the growth rate was comparable to that observed in a single biofilm of
S. mutans. This suggests that V. parvula, belonging to the early colonizers in the dental plaque,
can affect the mutual competition between S. mutans and streptococci from mitis group. Kara
et al. [115] have also demonstrated that in the double culture with V. parvula, S. mutans exhibits
higher resistance to bactericidal agents, e.g., chlorhexidine, increasing thereby its ability to
survive in such formed structure.
Another example of a protective effect of one species to another is the ability of Actinomyces
naeslundii microorganism to neutralize toxic hydrogen peroxide, protecting other microor‐
ganisms from the damaging effect of this metabolite [107]. Relationships between bacteria
living in the biofilm of dental plaque are complex and subject to dynamic changes with the
changes occurring in the biofilm environment. Interspecies interactions play a significant role
in the formation, growth, and maturation and stabilization of the biofilm. In the future, a better
understanding of these mechanisms may allow to improve the fight with dental biofilm.
3.4. Modification of already existing biofilm
A number of substances demonstrating an effective antibacterial activity and inhibiting the
development of biofilm are known today, e.g., chlorhexidine, delmopinol, and phenolic
compounds. Unfortunately, most of them cause side effects such as vomiting, diarrhea,
addiction, and discoloration of the teeth. Therefore, there is still a search for alternative
substances demonstrating antibacterial activity that would be safe for the users [124].
For years, the primary role in the fight against tooth decay is played by calcium phosphate
having remineralization properties [125, 126]. A special calcium-phosphate resin was formed
very quickly, whose aim was the gradual release of large amounts of these elements in sites
requiring reconstruction. Later, this compound gained the form of nanoparticle composite
(nanoparticles of amorphous calcium phosphate, NACP), which also found a wide applica‐
tion in dentistry as its predecessor. The benefits of nanoparticle composite are as follows: better
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as non-cariogenic, have the ability to suppress the growth and development of the cariogen‐
ic biofilm with the participation of S. mutans species and also cause a decrease in the expres‐
sion of virulence factors in this microorganism; therefore, the species such as S. gordonii, S.
oralis, S. mitis, and S. sanguinis are considered by many researchers as the species promoting
the health of oral cavity [71, 93, 118]. Epidemiological studies demonstrated a reverse
correlation between these two groups of streptococci: the high number of the species from
“mitis” is accompanied by a low percentage of microorganisms from “mutans” group [112].
Competition between these two groups of microorganisms is caused by mutual competition
for nutrients and a place to live in the biofilm environment [71, 88]. Microorganisms from
“mitis” group produce significant quantities of hydrogen peroxide (H2O2), which inhibits
protein glycolysis and synthesis in S. mutans and also causes oxidative damage to DNA and
proteins, leading to impaired metabolic processes [119]. Glycolytic enzyme, which is most
sensitive to the toxic effects of H2O2, is glyceraldehyde 3-phosphate dehydrogenase, as well as
glucose transport system dependent on the phosphoenolpyruvate (PEP-PTS) [88]. Hydrogen
peroxide in S. sanguinis and S. gordonii species is formed in the reaction catalyzed by pyru‐
vate oxidase, in which, next to H2O2, also and CO2 and acetyl phosphate are formed from
pyruvate [88, 118]. In turn, H2O2 production in S. oligofermentas species is mediated by two
additional enzymes, lactate oxidase, which converts lactate to pyruvate, and L-amino acid
oxidase, which catalyzes the oxidative deamination of L-amino acids [71, 118].
Another example of antagonism between these two groups of streptococci is the ability to
inactivate the CSP, which is part of QS mechanism in S. mutans. This mechanism mediates,
inter alia, the capability for the biofilm formation and bacteriocin production by S. mutans in
response to increasing bacterial density in the biofilm. S. gordonii produces specific serine
proteases encoded by gene sgc, which are able to inactivate CSP. Wang et al. [113] demon‐
strated that bacteria lacking gene sgc did not cause CSP inactivation and did not inhibit biofilm
formation by S. mutans. Also Tamura et al. [114] proved the inhibitory effect of S. salivarius on
the biofilm formation by S. mutans, which depends on CSP inactivation. In S. mutans, CSP
regulates an expression of gene glrA responsible for the morphology of the newly formed
biofilm. Causing CSP inactivation, S. salivarius causes, as a consequence, a decrease in the
expression of gene glrA and the inhibition of proper biofilm formation. S. sanguinis species can
also reduce the amount of mutacins produced by S. mutans and show faster growth, thus often
gaining an advantage over its competitor. S. mutans grow more slowly in mixed biofilm than
in the single-species one [39, 88].
S. mutans has its own mechanisms enabling it to compete with other species in the microen‐
vironment of the biofilm. It produces higher amounts of organic acid during carbohydrate
metabolism, which causes a decrease in the growth rate of other streptococci [71, 88].
Streptococci from the group of non-mutans have the ability to survive and adapt in low pH
conditions; however, in contrast to S. mutans, they are unable to proliferate under conditions
of considerable acidity. Therefore, an increase in the count of bacteria from the group of
mutans, with concurrent reduction in the number of bacteria from the group of mitis, is
observed in the case of frequent drop in pH that occurs in the oral cavity [120]. In addition, S.
mutans produces special bacteriocins, called mutacins, which inhibit the growth of other
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bacterial species inhabiting the same ecological niches. Bacteriocins are proteins of an
antagonistic effect toward closely related species. S. mutans produces several different
mutacins, which belong to the following two groups: lantibiotics and non-lantibiotic bacter‐
iocins. Mutacin IV, belonging to non-lantibiotic bacteriocins, demonstrates an activity against
streptococci of the groups of mitis and salivarius observed in the biofilm of dental plaque [121,
122]. Mutacins not only cause the inhibition of the growth of microorganisms present in the
biofilm, but they can also participate in the mechanism of genetic competence. S. mutans can
obtain DNA from closely related species, including S. gordonii. High level of mutacin IV causes
the death of neighboring microorganisms, which, as a consequence, causes the release of DNA
into the local environment, which can then be incorporated into the genome of S. mutans [123].
Under in vitro culture conditions, the result of the above interactions between these two groups
of streptococci depends on which one of the first will inhabit particular environmental niche.
However, under in vivo conditions, both groups can coexist together. This is caused, inter alia,
by the presence of other bacterial species in the biofilm [39, 112]. As demonstrated by Liu et
al. [112], the growth and formation of biofilm by S. mutans was significantly inhibited during
the double culture with S. gordonii. However, after the introduction of third species into the
culture, i.e., V. parvula, the growth rate was comparable to that observed in a single biofilm of
S. mutans. This suggests that V. parvula, belonging to the early colonizers in the dental plaque,
can affect the mutual competition between S. mutans and streptococci from mitis group. Kara
et al. [115] have also demonstrated that in the double culture with V. parvula, S. mutans exhibits
higher resistance to bactericidal agents, e.g., chlorhexidine, increasing thereby its ability to
survive in such formed structure.
Another example of a protective effect of one species to another is the ability of Actinomyces
naeslundii microorganism to neutralize toxic hydrogen peroxide, protecting other microor‐
ganisms from the damaging effect of this metabolite [107]. Relationships between bacteria
living in the biofilm of dental plaque are complex and subject to dynamic changes with the
changes occurring in the biofilm environment. Interspecies interactions play a significant role
in the formation, growth, and maturation and stabilization of the biofilm. In the future, a better
understanding of these mechanisms may allow to improve the fight with dental biofilm.
3.4. Modification of already existing biofilm
A number of substances demonstrating an effective antibacterial activity and inhibiting the
development of biofilm are known today, e.g., chlorhexidine, delmopinol, and phenolic
compounds. Unfortunately, most of them cause side effects such as vomiting, diarrhea,
addiction, and discoloration of the teeth. Therefore, there is still a search for alternative
substances demonstrating antibacterial activity that would be safe for the users [124].
For years, the primary role in the fight against tooth decay is played by calcium phosphate
having remineralization properties [125, 126]. A special calcium-phosphate resin was formed
very quickly, whose aim was the gradual release of large amounts of these elements in sites
requiring reconstruction. Later, this compound gained the form of nanoparticle composite
(nanoparticles of amorphous calcium phosphate, NACP), which also found a wide applica‐
tion in dentistry as its predecessor. The benefits of nanoparticle composite are as follows: better
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as non-cariogenic, have the ability to suppress the growth and development of the cariogen‐
ic biofilm with the participation of S. mutans species and also cause a decrease in the expres‐
sion of virulence factors in this microorganism; therefore, the species such as S. gordonii, S.
oralis, S. mitis, and S. sanguinis are considered by many researchers as the species promoting
the health of oral cavity [71, 93, 118]. Epidemiological studies demonstrated a reverse
correlation between these two groups of streptococci: the high number of the species from
“mitis” is accompanied by a low percentage of microorganisms from “mutans” group [112].
Competition between these two groups of microorganisms is caused by mutual competition
for nutrients and a place to live in the biofilm environment [71, 88]. Microorganisms from
“mitis” group produce significant quantities of hydrogen peroxide (H2O2), which inhibits
protein glycolysis and synthesis in S. mutans and also causes oxidative damage to DNA and
proteins, leading to impaired metabolic processes [119]. Glycolytic enzyme, which is most
sensitive to the toxic effects of H2O2, is glyceraldehyde 3-phosphate dehydrogenase, as well as
glucose transport system dependent on the phosphoenolpyruvate (PEP-PTS) [88]. Hydrogen
peroxide in S. sanguinis and S. gordonii species is formed in the reaction catalyzed by pyru‐
vate oxidase, in which, next to H2O2, also and CO2 and acetyl phosphate are formed from
pyruvate [88, 118]. In turn, H2O2 production in S. oligofermentas species is mediated by two
additional enzymes, lactate oxidase, which converts lactate to pyruvate, and L-amino acid
oxidase, which catalyzes the oxidative deamination of L-amino acids [71, 118].
Another example of antagonism between these two groups of streptococci is the ability to
inactivate the CSP, which is part of QS mechanism in S. mutans. This mechanism mediates,
inter alia, the capability for the biofilm formation and bacteriocin production by S. mutans in
response to increasing bacterial density in the biofilm. S. gordonii produces specific serine
proteases encoded by gene sgc, which are able to inactivate CSP. Wang et al. [113] demon‐
strated that bacteria lacking gene sgc did not cause CSP inactivation and did not inhibit biofilm
formation by S. mutans. Also Tamura et al. [114] proved the inhibitory effect of S. salivarius on
the biofilm formation by S. mutans, which depends on CSP inactivation. In S. mutans, CSP
regulates an expression of gene glrA responsible for the morphology of the newly formed
biofilm. Causing CSP inactivation, S. salivarius causes, as a consequence, a decrease in the
expression of gene glrA and the inhibition of proper biofilm formation. S. sanguinis species can
also reduce the amount of mutacins produced by S. mutans and show faster growth, thus often
gaining an advantage over its competitor. S. mutans grow more slowly in mixed biofilm than
in the single-species one [39, 88].
S. mutans has its own mechanisms enabling it to compete with other species in the microen‐
vironment of the biofilm. It produces higher amounts of organic acid during carbohydrate
metabolism, which causes a decrease in the growth rate of other streptococci [71, 88].
Streptococci from the group of non-mutans have the ability to survive and adapt in low pH
conditions; however, in contrast to S. mutans, they are unable to proliferate under conditions
of considerable acidity. Therefore, an increase in the count of bacteria from the group of
mutans, with concurrent reduction in the number of bacteria from the group of mitis, is
observed in the case of frequent drop in pH that occurs in the oral cavity [120]. In addition, S.
mutans produces special bacteriocins, called mutacins, which inhibit the growth of other
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(inhibits capabilities of bacterial DNA replication). All these pathways increase silver
compounds efficacy. The other advantages of these compounds are low toxicity, long-term
antibacterial effect (gradual silver release). In the fight against microorganisms significant is
lower bacterial resistance to silver compounds than to antibiotics [128–130]. Therefore, many
mechanisms and properties that make up the activity of substances containing silver parti‐
cles cause the inability of formation of the systems of full protection against their effects by
microorganisms. An additional difficulty is an activity of silver compounds as catalysts, not
as substances incorporating into chemical reactions [131]. Silver nanoparticles have a large
active surface, and therefore they represent only 0.05 to 0.1% wt. of the filling in the dental
composites. This amount provides both effective antibacterial activity and no effect on color
and mechanical properties of the filling [128].
The study of both teams demonstrated that the combination of NAg with MDPB and Nag with
QADM give much better results than the use of these substances alone. It can be noticed as
shown in Table 2 that the combination of silver nanoparticles with MDPB and QADM does
not affect the mechanical properties of dental material and is not toxic to the cells of the human
body. The big advantage of such combinations is an increased ability for inhibiting the growth
of microorganisms, as well as a significant reduction in their metabolic activity and vitality.








Strength of dental material binding 30–32 MPa no changes no changes
Metabolic activity of bacteria determined by
measuring the absorbance of the result of
enzymatic MTTa reduction at wave length of 540 nm
0.5 A540/cm2 0.05 A540/cm2 No data
Viability of bacteria determined by the ratio of the










CFU (colony-forming unit, the number of microorganisms
in examined material) after the application of antibacterial
agents
23 × 106 for MDPB
control
2.5 × 106 for QADM
control
0.5 × 106 0.9 × 104
aMTT – tetrazolium dye.
Table 2. An effect of MDPB+NAg and QADM+NAg on the selected features; [128, 129] with modification.
Silver also found a combination with fluoride forming silver diamine fluoride (SDF) demon‐
strating antibacterial properties, which in turn are the result of metal component and remi‐
neralization properties due to the presence of fluoride [132]. It was demonstrated that SDF can
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mechanical opportunities; increase in ions release in acidic environment, rapid neutraliza‐
tion and increase of low pH to a safe value (pH=6) [125, 126].
NACP was enriched with compounds of quaternary ammonium salts (QAS) that in addition
to the remineralization properties would have antibacterial properties. Special application was
found for quaternary ammonium dimethacrylate (QADM). The compound has two active
antibacterial domains at its ends, which enhance the desired properties, and, in addition, easily
mixes with other dental media [125, 126]. This modification created a completely new
composite, demonstrating a strong antibacterial activity. Its application results in lowered
viability of microorganisms, both in the planktonic form and in biofilms (including Strepto‐
coccus spp. and Lactobacillus spp.), decreased acidity, and depletion of pathogens’ metabolic
activity [125, 126]. The mechanism of that feature is connected with QAS compounds amphi‐
philicity, which allows entering the reactions interfering cell membrane functions. This process
is connected with lipid part of membrane and also affects indirectly in taking part in the
transport of substances enzymes activity. QAS influence on lipid membrane alter the bacteri‐
al cell metabolism activity. Lethal properties of QAS toward a broad spectrum of microorgan‐
isms were also used in antibacterial nanoemulsions. In this case, the salt used was
cetylpyridinium chloride (CPC) [127]. An antimicrobial nanoemulsion is a dispersing
substance, i.e., water and a lipid substance containing surfactant that forms nano-droplets of
the emulsion. It is not toxic to humans or animals; however, it exhibits an antibacterial,
antifungal, and antiviral properties. The antibacterial properties of the emulsion result from
nano-droplets’ effect on bacterial cell membrane destabilizing its lipid integration [127]. CPC
is capable of inhibiting bacterial fructosyltransferases, which play an important role in the
biofilm formation by microorganisms in the oral cavity. Due to this feature, CPC plays a role
of the antimicrobial substance (affecting microorganism cell membrane) inhibiting the
development of biofilm. An increase in nanoemulsion’s efficiency enriching them with CPC
resulted in the extension of their use in products for oral hygiene such as toothpastes,
mouthwashes, and dental materials, e.g., varnishes and dental fillings [127].
Among QAS, 12-methacryloyloxydodecylpyridinium bromide (MDPB) also found its
application in the fight against tooth decay [128, 129]. MDPB properties and the possibility of
its use attracted the attention of a team of scientists [129]. In their experiments, the authors
studied the effect of MDPB on the bacterial flora of the oral cavity, interactions with dental
materials, and the possibility of synergistic action of that compound with silver nanoparti‐
cles (NAg). MDPB is a monomer demonstrating antibacterial properties with respect to aerobic
and anaerobic bacteria isolated from caries lesions (i.e., Actinomyces, S. mutans), as well as
antifungal activity (e.g., Candida albicans) [129]. Hardened by the polymerization of binding
layer of the filling, it remains active in its against bacteria, concurrently not affecting adverse‐
ly either the human cells or the binding capacity of the filling material [129].
Silver compounds became the aim of studies conducted by Cheng et al. (2013), who drew the
attention to their use combined with QADM. Silver is known for its lethal activity against a
wide range of bacteria, viruses, and fungi. Its antibacterial properties are because of the ability
of disintegration of microorganism cell membrane, penetration through the membrane, and
organelles destruction. Another mechanism causes the bacterial enzymes inactivation
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(inhibits capabilities of bacterial DNA replication). All these pathways increase silver
compounds efficacy. The other advantages of these compounds are low toxicity, long-term
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cles cause the inability of formation of the systems of full protection against their effects by
microorganisms. An additional difficulty is an activity of silver compounds as catalysts, not
as substances incorporating into chemical reactions [131]. Silver nanoparticles have a large
active surface, and therefore they represent only 0.05 to 0.1% wt. of the filling in the dental
composites. This amount provides both effective antibacterial activity and no effect on color
and mechanical properties of the filling [128].
The study of both teams demonstrated that the combination of NAg with MDPB and Nag with
QADM give much better results than the use of these substances alone. It can be noticed as
shown in Table 2 that the combination of silver nanoparticles with MDPB and QADM does
not affect the mechanical properties of dental material and is not toxic to the cells of the human
body. The big advantage of such combinations is an increased ability for inhibiting the growth
of microorganisms, as well as a significant reduction in their metabolic activity and vitality.
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Table 2. An effect of MDPB+NAg and QADM+NAg on the selected features; [128, 129] with modification.
Silver also found a combination with fluoride forming silver diamine fluoride (SDF) demon‐
strating antibacterial properties, which in turn are the result of metal component and remi‐
neralization properties due to the presence of fluoride [132]. It was demonstrated that SDF can
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mechanical opportunities; increase in ions release in acidic environment, rapid neutraliza‐
tion and increase of low pH to a safe value (pH=6) [125, 126].
NACP was enriched with compounds of quaternary ammonium salts (QAS) that in addition
to the remineralization properties would have antibacterial properties. Special application was
found for quaternary ammonium dimethacrylate (QADM). The compound has two active
antibacterial domains at its ends, which enhance the desired properties, and, in addition, easily
mixes with other dental media [125, 126]. This modification created a completely new
composite, demonstrating a strong antibacterial activity. Its application results in lowered
viability of microorganisms, both in the planktonic form and in biofilms (including Strepto‐
coccus spp. and Lactobacillus spp.), decreased acidity, and depletion of pathogens’ metabolic
activity [125, 126]. The mechanism of that feature is connected with QAS compounds amphi‐
philicity, which allows entering the reactions interfering cell membrane functions. This process
is connected with lipid part of membrane and also affects indirectly in taking part in the
transport of substances enzymes activity. QAS influence on lipid membrane alter the bacteri‐
al cell metabolism activity. Lethal properties of QAS toward a broad spectrum of microorgan‐
isms were also used in antibacterial nanoemulsions. In this case, the salt used was
cetylpyridinium chloride (CPC) [127]. An antimicrobial nanoemulsion is a dispersing
substance, i.e., water and a lipid substance containing surfactant that forms nano-droplets of
the emulsion. It is not toxic to humans or animals; however, it exhibits an antibacterial,
antifungal, and antiviral properties. The antibacterial properties of the emulsion result from
nano-droplets’ effect on bacterial cell membrane destabilizing its lipid integration [127]. CPC
is capable of inhibiting bacterial fructosyltransferases, which play an important role in the
biofilm formation by microorganisms in the oral cavity. Due to this feature, CPC plays a role
of the antimicrobial substance (affecting microorganism cell membrane) inhibiting the
development of biofilm. An increase in nanoemulsion’s efficiency enriching them with CPC
resulted in the extension of their use in products for oral hygiene such as toothpastes,
mouthwashes, and dental materials, e.g., varnishes and dental fillings [127].
Among QAS, 12-methacryloyloxydodecylpyridinium bromide (MDPB) also found its
application in the fight against tooth decay [128, 129]. MDPB properties and the possibility of
its use attracted the attention of a team of scientists [129]. In their experiments, the authors
studied the effect of MDPB on the bacterial flora of the oral cavity, interactions with dental
materials, and the possibility of synergistic action of that compound with silver nanoparti‐
cles (NAg). MDPB is a monomer demonstrating antibacterial properties with respect to aerobic
and anaerobic bacteria isolated from caries lesions (i.e., Actinomyces, S. mutans), as well as
antifungal activity (e.g., Candida albicans) [129]. Hardened by the polymerization of binding
layer of the filling, it remains active in its against bacteria, concurrently not affecting adverse‐
ly either the human cells or the binding capacity of the filling material [129].
Silver compounds became the aim of studies conducted by Cheng et al. (2013), who drew the
attention to their use combined with QADM. Silver is known for its lethal activity against a
wide range of bacteria, viruses, and fungi. Its antibacterial properties are because of the ability
of disintegration of microorganism cell membrane, penetration through the membrane, and
organelles destruction. Another mechanism causes the bacterial enzymes inactivation
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discussion of this issue. AMPS are alternative to the conventional antibiotic therapy. The works
on dozens of antimicrobial peptides that can be used for a more targeted approach associat‐
ed with selective control or elimination of the strains that cause tooth decay in children have
been conducted currently. In addition, their features cause that they are much safer for the
youngest users. A number of features of these substances, such as a broad antibacterial
spectrum, stability, low toxicity, lack of staining on the teeth, odorless nature, suggest that
these compounds should be studied further. Their potential use in the oral therapy should be
discussed [124,136].
Within the limitations of the existing data, presented overview of AMPs has been elaborated
based on the following features of selected peptides: documented antimicrobial activity with
respect to cariogenic microorganisms, broad spectrum of antibacterial activity (gram-posi‐
tive bacteria and other microorganisms that colonize oral cavity), profitable structural
characteristics (i.e., size and conformation), durability (resistance to proteases or other salivary
protein activity), and low cytotoxicity (only those peptides for which the data were available)
[137,138]. The first large group consists of eukaryotic antimicrobial peptides, which include
beta defensins of a structure of beta harmonica stabilized by the presence of two or three
disulfide bridges, linear peptides that adopt an amphipathic alpha helical structure when
associated with the cell membrane lipids, which include magainins, histatins; rope peptides
modified by the presence of cysteine binding bridges, such as cathelicidins, peptides with loop
structure; and peptides with cyclized peptide chain. One can include those with cationic
residues, like histidine, arginine or lysine [137].
A range of histatin derivatives, like its derivative PAC113, demonstrates an increased activity
against S. mutans and S. sobrinus [139]. PAC113 found practical application of for the treat‐
ment of dental caries. The results of the second phase of the clinical trials using the above
discussed derivative of PAC113, in which the children are given lotions and jellies, confirm
that the PAC113 is safe and effectively inhibits the growth of fungi and cariogenic bacteria in
accordance with its intended purpose, which makes it an ideal candidate for further clinical
trials with the indication for caries prevention [137]. A high therapeutic potential was
demonstrated for the derivative of histatin 5, called Dhvar1-5, used as a scaffold for the design
of analogues of histatin 5. Due to the fact that histatin 5 is a poorly amphipathic peptide, its
derivatives Dhvar 1 and 2 are designed to improve amphipathic properties of alpha-helical
conformation by the change of histidine to lysine or glutamic acid with lysine at the hydro‐
phobic end. This way, derivatives Dhvar 1 and 2 at higher ionic strength demonstrate lethal
concentrations LC50 against S. mutans in the range between 15.6 and 16.3 μg/ml, compared to
the concentration of 200 μg/ml for the natural form of histatin 5 [140]. Competitive deriva‐
tives Dhvar 3 and 4, in which glutamic acid replaced lysine, have lower lethal concentra‐
tions LC50 against S. mutans at a level of 0.7 and 7.6 μg/ml. Moreover, the analysis of protein
proteolysis during S. mutans incubation with the examined derivatives showed no proteoly‐
sis fragments, suggesting that the derivatives Dhvar 3 and 4 are resistant to cleavage by the
proteases excreted by S. mutans. Also in the case of Dhvar 4, the number of strains of S. mutans,
S. sanguinis, and Actinomyces naeslundii in a multi-species bacterial biofilm is decreased by more
than 90% (100 μg/ml peptide after 30 min). Such a strong antibacterial activity of the dis‐
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be used as an element in the prevention of caries [133], as well as a substance inhibiting the
development of the disease in children, reducing the number of cariogenic microorganisms in
oral cavity and corrective action in the sites of tooth enamel demineralization [132]. As
described above, the study on the compound also demonstrated the sensitivity of S. mutans
and Actinomyces naeslundii to its activity [134]. However, there are the studies verifying SDS
effect on two-species bacterial biofilm formed by Streptococcus mutans and Lactobacillus
acidophilus. Oral biofilm is not a single species structure, so such studies better illustrate the
activity of oral cavity biofilm compound [132]. This is confirmed by the ratio of live to dead
cells, which for the control was 0.02 while for the sample containing SDF was 6.74. These
studies, in addition to the confirmation of antibacterial SDF activity on S. mutans and L.
acidophilus, also proved that the substance slows down the process of enamel demineraliza‐
tion and protects collagen against destruction. This dual activity of SDF can contribute to widen
its use in the products for oral cavity hygiene, as well as clinical success in the fight against
dental caries.
There is still a search for antibacterial substances that may be included in the formulations for
oral cavity hygiene and would not exert adverse effects. One of such substances is chitosan—
a polysaccharide formed as a result of N-acetylation of chitin [135]. Both of these com‐
pounds are present in the world of plants, fungi, and animals and demonstrate the natural
antibacterial and antifungal properties. However, a limitation of chitosan use in formula‐
tions for oral cavity hygiene is its insolubility in water since the compound is soluble only in
acids. Attempts aimed to modify that the property, as a result of Millard reaction or sugar
modification, caused the formation of chitosan soluble in water with unchanged antibacteri‐
al properties. The studies [135] demonstrated that such modified chitosan exhibits the highest
antimicrobial activity with respect to microorganism isolated from the oral cavity in an
environment of pH ranges between 5 (for e.g. Staphylococcus aureus, Streptococcus mutans)
and 8 (for e.g. Staphylococcus saprophyticus). The optimum temperature in which the antimi‐
crobial activity remained at a level of 50–96% in relation to the above bacterial species for
chitosan activity is 37 °C. The minimum concentration of chitosan inactivate K. pneumoniae, L.
brevis and S. saprophyticus was 400 μg/ml, while other species need 500 μg/ml. It was also found
that only 5s is sufficient for chitosan to exhibit antimicrobial activity with respect to the
microorganisms of the above species at a level of 99.6% and 20s caused that this level was
99.9%. It was proved therefore that the water-soluble chitosan demonstrates comparable
efficacy in the fight against dental caries like the commonly used antibacterial substances used
in the fluids of the oral cavity care. A very strong argument for the use of chitosan in such
formulations is also its much lower toxicity than that of the conventionally used alcohols,
chlorhexidine, and cetylpyridinium chloride [135], which are commonly used in composi‐
tions for oral cavity disinfection in upper respiratory tract diseases, e.g., Tantum Verde.
Another safe, potential solution for humans for the problem of dental plaque is antimicrobi‐
al peptides (AMPS). Currently, the information from more than 2600 characterized antimi‐
crobial peptides is available. An ever-increasing number of antimicrobial peptides allowed to
create a database gathering all available and characterized antimicrobial peptides (http://
aps.unmc.edu/AP/main.php/). The vast number and variety of AMPs exclude a general
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discussion of this issue. AMPS are alternative to the conventional antibiotic therapy. The works
on dozens of antimicrobial peptides that can be used for a more targeted approach associat‐
ed with selective control or elimination of the strains that cause tooth decay in children have
been conducted currently. In addition, their features cause that they are much safer for the
youngest users. A number of features of these substances, such as a broad antibacterial
spectrum, stability, low toxicity, lack of staining on the teeth, odorless nature, suggest that
these compounds should be studied further. Their potential use in the oral therapy should be
discussed [124,136].
Within the limitations of the existing data, presented overview of AMPs has been elaborated
based on the following features of selected peptides: documented antimicrobial activity with
respect to cariogenic microorganisms, broad spectrum of antibacterial activity (gram-posi‐
tive bacteria and other microorganisms that colonize oral cavity), profitable structural
characteristics (i.e., size and conformation), durability (resistance to proteases or other salivary
protein activity), and low cytotoxicity (only those peptides for which the data were available)
[137,138]. The first large group consists of eukaryotic antimicrobial peptides, which include
beta defensins of a structure of beta harmonica stabilized by the presence of two or three
disulfide bridges, linear peptides that adopt an amphipathic alpha helical structure when
associated with the cell membrane lipids, which include magainins, histatins; rope peptides
modified by the presence of cysteine binding bridges, such as cathelicidins, peptides with loop
structure; and peptides with cyclized peptide chain. One can include those with cationic
residues, like histidine, arginine or lysine [137].
A range of histatin derivatives, like its derivative PAC113, demonstrates an increased activity
against S. mutans and S. sobrinus [139]. PAC113 found practical application of for the treat‐
ment of dental caries. The results of the second phase of the clinical trials using the above
discussed derivative of PAC113, in which the children are given lotions and jellies, confirm
that the PAC113 is safe and effectively inhibits the growth of fungi and cariogenic bacteria in
accordance with its intended purpose, which makes it an ideal candidate for further clinical
trials with the indication for caries prevention [137]. A high therapeutic potential was
demonstrated for the derivative of histatin 5, called Dhvar1-5, used as a scaffold for the design
of analogues of histatin 5. Due to the fact that histatin 5 is a poorly amphipathic peptide, its
derivatives Dhvar 1 and 2 are designed to improve amphipathic properties of alpha-helical
conformation by the change of histidine to lysine or glutamic acid with lysine at the hydro‐
phobic end. This way, derivatives Dhvar 1 and 2 at higher ionic strength demonstrate lethal
concentrations LC50 against S. mutans in the range between 15.6 and 16.3 μg/ml, compared to
the concentration of 200 μg/ml for the natural form of histatin 5 [140]. Competitive deriva‐
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be used as an element in the prevention of caries [133], as well as a substance inhibiting the
development of the disease in children, reducing the number of cariogenic microorganisms in
oral cavity and corrective action in the sites of tooth enamel demineralization [132]. As
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environment of pH ranges between 5 (for e.g. Staphylococcus aureus, Streptococcus mutans)
and 8 (for e.g. Staphylococcus saprophyticus). The optimum temperature in which the antimi‐
crobial activity remained at a level of 50–96% in relation to the above bacterial species for
chitosan activity is 37 °C. The minimum concentration of chitosan inactivate K. pneumoniae, L.
brevis and S. saprophyticus was 400 μg/ml, while other species need 500 μg/ml. It was also found
that only 5s is sufficient for chitosan to exhibit antimicrobial activity with respect to the
microorganisms of the above species at a level of 99.6% and 20s caused that this level was
99.9%. It was proved therefore that the water-soluble chitosan demonstrates comparable
efficacy in the fight against dental caries like the commonly used antibacterial substances used
in the fluids of the oral cavity care. A very strong argument for the use of chitosan in such
formulations is also its much lower toxicity than that of the conventionally used alcohols,
chlorhexidine, and cetylpyridinium chloride [135], which are commonly used in composi‐
tions for oral cavity disinfection in upper respiratory tract diseases, e.g., Tantum Verde.
Another safe, potential solution for humans for the problem of dental plaque is antimicrobi‐
al peptides (AMPS). Currently, the information from more than 2600 characterized antimi‐
crobial peptides is available. An ever-increasing number of antimicrobial peptides allowed to
create a database gathering all available and characterized antimicrobial peptides (http://
aps.unmc.edu/AP/main.php/). The vast number and variety of AMPs exclude a general
Microbial Biofilms - Importance and Applications356
The production of large, active enzymes on an industrial scale can be expensive, and this seems
to be reflected in the high cost of the product. On the contrary, antimicrobial peptides are
extensively studied and seem to have a great possibility of purposeful treatment of dental
caries. The oral cavity, due to the availability, is appropriate for oral therapy involving these
antimicrobial peptides. One of these proteins is α-helical protein, chrysoidine-1—amphipath‐
ic. Chrysoidine-1 has a hydrophilic domain at the C-end of polypeptide chain. Electrostatic
interactions of chrysoidine-1 with negatively charged phospholipids of bacterial cell mem‐
branes cause tight adhesion to microorganisms. It demonstrates a wide demonstrating a broad
spectrum of activity against both gram-negative and gram-positive bacteria. The hydrophil‐
ic domain penetrates the bacterial membrane structure, forming the numerous pores in it.
Changes in the cell shape were first observed by Wang et al. [124] during their studies using
chrysoidine-1 at the concentrations of 2–4 mg/ml (depending on bacterial species). Thus,
chrysoidine-1 exhibits a strong destructive effect with respect to the lipid components of cell
membrane of microorganisms such as S. mutans, S. sanguinis, S. sobrinus, S. gordonii,
Actinomyces spp. and Lactobacillus spp., and therefore is able to induce its disintegration and
bacterial lysis. This contributes to the reduced viability of these pathogens, both in the
planktonic form and grouped in the biofilm. In relation to S. mutans, chrysoidine-1 demon‐
strates lethal activity after 30 min using the concentration eightfold higher than the minimal
inhibitory concentration (MIC). For comparison, E. faecalis is killed after 5 min and L. fermen‐
tis after 60 min using only fourfold MIC. A. viscosus proved to be more resistant than S. mutans.
Its eradication required the use of eightfold MIC for 60 min. [124].
Biofilm structure microorganisms demonstrate about 1000 times higher resistance compared
to planktonic phase. Therefore, AMPs could be used most effectively in the early stages of
biofilm formation. This would prevent its development and colonization of the oral cavity by
another pathogen. In the phase of biofilm maturation, AMPs would only slow down the
process of cariogenesis [124].
The problem of infectious diseases inevitably involves a growing number of microorgan‐
isms resistant to increasingly broader spectrum of antibiotics (multidrug resistance).
Therefore, the attention of scientists is increasingly focused on antimicrobial, antifungal, and
antiviral substances of natural origin. Such properties are demonstrated by many metabo‐
lites of plant origin, such as polyphenols, alkaloids, tannins, terpenoids, steroids, and
flavonoids [146,147]. Despite the proved antibacterial activity, these compounds so far are the
only additives in formulations intended for oral cavity hygiene.
Most of the above-presented substances found their application in dentistry and are includ‐
ed in the composites and resins for dental fillings, whose properties allow the reduction of
biofilm formation on them and reduce the likelihood of repeated episodes of dental caries in
the same place. They were introduced to the treatment, since the commonly used methods for
developing of tooth occupied by caries usually do not allow for the removal of bacteria from
the hard tissues of the tooth. In such situations, it is suggested to use the antimicrobial agents
on already developed dentin. These are usually the fillings releasing ions [148] in the form of
nanoparticle of dicalcium phosphate anhydrous (DPCA) or tetracalcium phosphate (TTCP),
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
359
cussed histatin derivatives, in particular Dhvar4, constitutes a promising tool against caries
[137, 141].
Another large group is bacteriocins, which owes their name to the organism from which they
originate. Based on the structure and composition, they are classified into three groups. Most
bacteriocins exhibit a cationic character, but there are neutral and anionic bacteriocins also,
which have strong antibacterial properties [142]. Class I bacteriocins include the so-called
lantibiotics, thermostable, polycyclic peptides having a molecular weight of less than 5 kDa,
which contain untypical amino acids in their structure: lanthionine, 3-methylanthionine,
dehydroalanin, dehydrobutyric acid. Best known bacteriocin is nisin (derived from Lactococcus
lactis) [143]. The main object of interest in the case of nisin is its use in food industry, and also
as an antibiotic and a probiotic in a number of infectious diseases. Also there are a large number
of patent applications that present the use of nisin as a component of chewing gum with an
emphasis on its anticariogenic effects. The studies also prove that the activity of nisin is
comparable to the fluorine ions that are used in oral formulations. However, despite the
existing scientific evidences, there is a lack of commercial application of nisin against dental
caries or other diseases of the oral cavity. The MIC values for nisin at neutral pH with respect
to S. mutans and S. sobrinus are in the range between 625–1250 and 1250–2500 μg/ml, respec‐
tively, and its stronger activity is demonstrated against Lactobacillus (39–1250 μg/ml).
Furthermore, research on the activity of nisin in the saliva suggests that the needed concen‐
trations for the growth inhibition of cariogenic bacteria are lower (0.1–100 μg/ml). In addi‐
tion, it was found that the presence of dental caries may enhance the antibacterial activity of
nisin at acidic pH, assuring its effective mechanism. More importantly, antibacterial activity
against bacteria that cause dental caries is maintained particularly at low pH at the site of
cariogenic bacterial action. There are some trials using nisin, by its dilution with saliva [137,
143]. Another quite well-known bacteriocin is poly-lysine, originally isolated from Streptomy‐
ces albulus, sold by Japan mainly for food applications. Like nisin, it exhibits a relatively broad
spectrum of antimicrobial activity and is also stable over a wide pH range and is highly soluble
in water. The reported MIC values against S. mutans for poly-L-lysine are 20 μg/ml. Moreover,
poly-lysine and nisin exert a synergistic effect with respect to S. mutans in partial inhibition.
Complete inhibition of the growth of S. mutans is observed in the case of combination of 10
and 50 or 5 and 200 μg/ml [144]. Both nisin and poly-lysine seem to have a common mecha‐
nism of action on the same species of oral cavity microorganisms, and further research on the
application of the above-described peptides may explain the degree of specificity of the
synergistic action. The use two or more active substances in combination, considerably better
cope with many obstacles, such as salivary proteases. Thus such complexes can provide better
effectiveness and reduce the likelihood of resistance development. Commercialization is
preferred in this case since the application of lower concentrations of the peptides in the
combination will cause their lower cost. Combination therapy using poly-lysine and nisin may
have significant anti-caries potential, hence the specificity of above peptides action [137]. The
group of bacteriocins also includes mutacins, as the name implies, it is derived from S. mutans,
proposed as anticariogenic agents [145].
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supragingival plaque, unlike subgingival plague, involved in the pathogenesis of periodon‐
tal diseases or gingivitis [154].
More than 1000 different species of bacteria forming plaque have been indentified so far, and
more than half of them failed to grow using the classical microbiology methods [19, 71, 103,
155, 156]. In recent studies using advanced methods of identification with molecular biology
techniques, a number of species identified in dental plaque biofilm increased to about 1500
species [71], and some researchers estimate that this number may be as high as 10,000 [118].
The studies conducted using molecular biology methods demonstrated five dominant phylum
of bacteria in dental plaque: Firmicutes, Actinobacteria, Bacteroidetes, Fusobacteria, and Proteo‐
bacteria. They constitute 80–95% of the oral cavity microflora (Table 3) [93, 118].
Molecular biology technique Bacterial microflora compositions
(the most often isolated species)
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often enriched with fluorine [148], or modifications of such filling, e.g., with an addition of
QAS and silver nanoparticles [125, 126, 128, 129].
Iodine compounds (potassium iodine or povidone iodine PVP-I) also reduce the incidence of
dental caries. Free iodine ions are the active element of PVP-I complex, which consists of iodine
and polyvinylpyrrolidone. Iodine, slowly released from the complex, is able to penetrate
bacterial membranes and get into the cytosol, where it inactivates the key proteins in cell
metabolism, fatty acids, and nucleotides [149]. No side effects such as discoloration of the teeth,
tongue, or change of taste were reported [151]. Moreover, the slow release of iodine minimiz‐
es its toxic effect for human cells [150], and its short-term use does not damage even irritated
oral cavity mucosa. Hosaka et al. [151] examined the antibacterial activity of PVP-I on two
microorganisms associated with the diseases. They demonstrated that PVP-I at a concentra‐
tion of 7% obtains an activity that allows to kill 100% microorganisms of P. gingivalis species
after 3 min of activity, while the same effectiveness with respect to F. nucleatum was already
produced by 5% PVP-I after 30 s. The results obtained for two-species biofilm formed by the
examined microorganisms demonstrated that it is two-hundred times more resistant to the
action of the examined substance compared to single-species cultures. Despite the activity of
5% PVP-I already allowing for the killing of biofilm-forming bacteria, unfortunately, it was
demonstrated that concentrations of PVP-I used in common mouthwash fluids (0.23–0.47%)
are not sufficient for a significant decrease of the biofilm-forming ability of P. gingivalis and F.
nucleatum in a time of 30 s–1 min, which was defined as an average mouthwash time [151]. It
can thus be concluded on the basis of these reports that mixed bacterial biofilm will be much
more resistant to PVP-I compared to planktonic cells.
In children with early childhood caries antibacterial activity of PVP-I was also verified for
strains of S. mutans. It was concluded that the application of 10% PVP-I in healthy and cariously
damaged teeth every three months for one year significantly reduced the number of these
microorganisms in the oral cavity compared to baseline levels [152]. Lower number of
cariogenic bacteria may therefore help to reduce the likelihood of caries levels in children. In
the research conducted on a group of 127 children it was demonstrated, that combined
treatment with 10%PVP-I and 5% fluoride varnish reduces the incidence of new caries lesions
by 31% in relation to the application of the varnish alone [133]. An increasing range of
substances that protect from the onset of caries, and concurrently not causing side effects,
becomes the hope of creating a formulation for oral cavity hygiene allowing for an effective
fight with this disease and complete protection of children from the development of the first
changes in deciduous teeth.
4. Dental plague
Biofilms present in the oral cavity are three-dimensional structures consisting of the bacteria
strains anchored to a solid surface, such as tooth enamel, root cement, or dental implant and
are embedded in exopolysaccharides matrix [44]. One of the best known and most common‐
ly reported types of biofilm in the human body is a dental plaque [153]. This is an example of
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of extracellular exopolysaccharides (EPS) forming a biofilm matrix (Figure 5). All these
processes contribute to an increased risk of dental caries development [62].
Figure 4. The ecological plaque hypothesis—effect of fermentable carbohydrates on caries development (based on Paes
Leme et al. [62]).
Figure 5. Sucrose effect on caries development (based on Paes Leme et al. [62]).
The species involved in the cariogenic process include Streptococcus sobrinus, Lactobacillus
acidophilus, Actinomyces viscosus, and S. mutans species which is the most known and wide‐
spread 129]. However, studies indicate that the induction of carious lesions on the dental
plaque can occur even in the absence of S. mutans [163]. The factors initiating the formation of
the above lesions are acidity and acidophilic bacteria other than S. mutans [164, 165]. Except
the species mentioned above, some authors have also classified Actinomyces naeslundii,
Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, Prevotella intermedia, and
Porphyromonas gingivalis as caries-forming species [166], as well as bacteria of the genera
Bifidobacterium or Selenomonas [71].
The six types of bacteria, that is, Streptococcus, Veillonella, Actinomyces, Granulicatella, Leptotri‐
chia, and Thiomonas demonstrate a large differentiation between the dental plaques with active
caries and caries without lesions [15]. Studies showed that three types of bacteria, including
Streptococcus, Granulicatella, and Actinomyces, occurred predominantly in patients with severe
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Table 3. Composition of dental plague microflora.
In the studies conducted using the latest methods of molecular biology, the largest group of
microorganisms are the bacteria belonging to the Firmicutes phylum. The second place is
occupied by bacteria belonging to the Proteobacteria phylum, further Actinobacteria, Bacteroi‐
detes, and Fusobacteria. Many studies confirmed the dominant share of Streptococcus genus,
which constitutes more than half of all bacteria in dental plaque biofilms [71, 93, 118, 155, 157,
158]. Another position in this ranking is occupied by bacteria of the genus Veilonella,
Granulicatella, Fusobacterium, Neisseria, Actinomyces, Capnocythophaga, Kingella, Camphylobacter,
Gemella, Haemophilus, and Prevotella.
Plaque-forming microorganisms can be divided into the so-called early and late colonizers,
forming early and late biofilm, respectively. The species of the early colonizers include
streptococci, as well as bacteria of the genus Veillonella, Haemophilus, Propionibacterium,
Capnocytophaga, Prevotella, Eikenella, or Actinomyces [107]. Late colonizers are microorganisms
of the genera Eubacterium, Treponema, and Porphyromonas gingivalis, Aggregatibacter actinomy‐
cetemcomitans, Fusobacterium nucleatum, and Prevotella intermedia [107]. As the biofilm ma‐
tures, the domination of bacteria is transferred from one group to another. Streptococci give
way to genera such as Actinomyces, Fusobacterium, or Veillonella [107]. The entire flora of dental
plaque was considered for many years as the etiological factor of caries formation (nonspecif‐
ic plague theory), or only specific microorganisms were considered as pathogenic (specific
plague theory). Currently, the main hypothesis of dental caries formation is the so-called
ecological plaque hypothesis [162]. The ecological plaque hypothesis combines elements of
nonspecific plaque theory and specific plaque theory of caries formation. This theory as‐
sumes that changes occurring in the oral environment initiate the changes in the balance of
bacterial flora, resulting in the development of more cariogenic species, and are responsible
for enamel demineralization over the remineralization. Carbohydrates from the diet are
considered to be the most important factor responsible for biochemical and physiological
changes observed in the biofilm. Consumption of sugar causes a rapid pH decrease in the
dental plaque. In addition, frequent consumption of carbohydrates increases the percentage
of streptococcus from Mutans group, and bacteria from of the Lactobacillus genus, as well as
reduces the number of streptococci from mitis group, including S. sanguinis. This is caused by
a decrease in the pH of oral cavity, which is accompanied by carbohydrates metabolism and
organic acid production (Figure 4). Additionally, frequent consumption of sucrose promotes
tooth decay not only through the acidification of the environment but also by the production
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Table 3. Composition of dental plague microflora.
In the studies conducted using the latest methods of molecular biology, the largest group of
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ecological plaque hypothesis [162]. The ecological plaque hypothesis combines elements of
nonspecific plaque theory and specific plaque theory of caries formation. This theory as‐
sumes that changes occurring in the oral environment initiate the changes in the balance of
bacterial flora, resulting in the development of more cariogenic species, and are responsible
for enamel demineralization over the remineralization. Carbohydrates from the diet are
considered to be the most important factor responsible for biochemical and physiological
changes observed in the biofilm. Consumption of sugar causes a rapid pH decrease in the
dental plaque. In addition, frequent consumption of carbohydrates increases the percentage
of streptococcus from Mutans group, and bacteria from of the Lactobacillus genus, as well as
reduces the number of streptococci from mitis group, including S. sanguinis. This is caused by
a decrease in the pH of oral cavity, which is accompanied by carbohydrates metabolism and
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the microbiota species under in vitro conditions. Both the interpretation of culture results and
molecular tests pose numerous problems, in particular, due to the fact that the mere pres‐
ence of an occasional isolation or determination of bacterial DNA does not mean that a given
species colonizes the oral cavity and its individual anatomical areas—it can occur there
temporarily. Bacteria in the oral cavity can (which we discussed in subchapter) occur acciden‐
tally as a result of age-dependent transformation, coming through primary teeth, their
extractions, carious lesions, dentures, restorations, edentulism, and also temporary changes,
which can be induced by diet, variable saliva flow, or lasting antibiotic treatment. Environ‐
mental conditions, such as temperature, salinity, availability of oxygen and nutrients, variable
pH conditions, and redox, may have an effect on the ecosystem and contribute to the modifi‐
cation of the species composition of biofilms found on every location.
This is corroborated by taxonomic studies comparing bacterial species composition of the oral
microbiome with species forming the dental plaque, and in these studies, more attention was
paid to the occurrence of species diversity, however, with a very similar metabolic activity
characteristic of individual representatives of the oral microbiome and the dental plaque [155].
The presented data suggest that modifications in the taxon proportions occur between the oral
microbiome and biofilm. However, it is important to note that these constitute changes caused
by the functional abilities of certain taxonomic groups (induced by their metabolic activity, i.e.,
the use of carbohydrates and tolerance to low pH). Populations of microorganisms exhibit
similar stability, which enables us to gather the basic knowledge on the behavior of the above-
mentioned microbes under in vivo conditions.
As a result of the evaluation of phylogenetic relationship of bacteria found in saliva samples
of healthy persons and bacteria forming the biofilm model imitating the dental plaque in vivo,
attention was paid to the occurrence of affinities between species, in particular, within the
Streptococcus genus and to a lesser degree in Veillonella (Figure 6) [2, 4, 155, 174]. In the case of
the Streptococcus genus, the most dominant units within the human oral taxa (HOT) were S.
vestibularis, S. salivarius, S. mitis, S. parasanguinis, and different undiscovered Streptococcus spp.
The strains of S. vestibularis constituted approximately 40% of the total biofilm microbes,
whereas S. salivarius (HOT-755) and various other undiscovered Streptococcus sp. (HOT-C65)
each occupied 10%. S. vestibularis is the representative of physiological flora of the oral cavity,
and its presence is uncommonly associated with the disease, except for few cases of infec‐
tious endocarditis, neonatal sepsis, bacteraemia, and in patients with cancer [175]. Further‐
more, a few studies demonstrated that S. vestibularis may be the etiological factor of caries in
rats, compared to other Streptococcus species (e.g., S. salivarius), which are associated with the
development of the disease much more commonly [176]. S. salivarius, which has extensive
functions from being highly cariogenic [177] to the protective function against caries devel‐
opment (i.e., through hydrolysis of urea to ammonia [178], influences the health state of the
human oral cavity. The strains of S. parasanguinis (HOT-721 and HOT-711) constituted a
considerable participation (10%) in the presented in vitro biofilm model. The role of S.
parasanguinis in the health of oral cavity is poorly known. Due to the ability of this microor‐
ganism for carbohydrate fermentation to lactate and other organic acids, S. parasanguinis is
considered to be an organism with moderate tolerance to low pH and a low cariogenic
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forms of caries. In control (free of caries) noted predominant numbers of the Aestuariimicrobi‐
um genus [167]. Microbiome of bacteria associated with the formation of dental caries is much
more differentiated than previously believed [168].
The microflora of oral cavity demonstrates specificity depending on the stages of caries
progression [169]. The study conducted by Gomar-Vercher et al. in 2014 on saliva samples of
children with caries showed that the dominant caries-forming species found were bacteria
classified to genera Porphyromonas and Prevotella [169]. Using pyrosequencing techniques,
attention was paid to species variability on the dental plaque depending on the activity of
caries process—in the case of intact plaque, in the presence of the so-called white spots, in the
case of damage to the dentin. Diversity of dental plaque microflora of healthy individuals
exhibits a much more homogeneity compared to the plague of individuals with caries. Thirteen
bacteria of genera Capnocytophaga, Fusobacterium, Porphyromonas, Abiotrophia, Comamonas,
Tannerella, Eikenella, Paludibacter, Treponema, Actinobaculum, Stenotrophomonas, Aestuariimicrobi‐
um, and Peptococcus were associated with healthy teeth. Eight bacteria of genera Cryptobacte‐
rium, Lactobacillus, Olsenella, Megasphaera, Scardovia, Shuttleworthia, Cryptobacterium, and
Streptococcus increased significantly in dentine damage, while Actinomyces and Corynebacteri‐
um were present predominantly in the so-called “white spots” and Flavobacterium, Neisseria,
Bergeyella, and Derxia were numerous with intact dental plaque of individuals with caries [159].
In case of damaged dentin, the study by Obata et al. reported a relatively high percentage of
bacteria of the genus Atopobium, Prevotella, or Propionibacterium along with Streptococcus or
Actinomyces [170].
However, taking into account the complexity of microorganism–microorganism interactions
and the number of microorganisms, which is essential for the formation of biofilm and creation
of specific conditions for caries development, it can be concluded that particular species of
bacteria acts as the forefront of cariogenic factors [71, 164]. An increasing attention is paid to
the study of relations between the course of biofilm formation and its maturation, develop‐
ment of resistance to increased spectrum antibiotics, analysis of microorganisms genome, and
mechanisms of action of specific bacterial proteins [171–173]. Considerable focus is also on the
structure of biofilm and its relationship with the species forming the microbiota of human oral
cavity.
5. Role of oral microbiome in the formation of dental plaque
The knowledge of the microbial diversity in human oral cavity has recently been improved
and was subjected to a considerable transformation in the last two decades. Understanding
biological characteristics and functions of individual bacterial species colonizing oral cavity,
which are subject to dynamic changes, has become the fundamental objective of studies on
human microbiome. The function of the oral microbiome can be determined on the basis of
characteristics of microbes isolated in vitro. Currently, no efficient referential method exists for
the evaluation of the actual presence of bacteria in the oral cavity. The culture methods carry
their limitations related to the lack of ensuring all the necessary growth conditions for each of
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characteristic of individual representatives of the oral microbiome and the dental plaque [155].
The presented data suggest that modifications in the taxon proportions occur between the oral
microbiome and biofilm. However, it is important to note that these constitute changes caused
by the functional abilities of certain taxonomic groups (induced by their metabolic activity, i.e.,
the use of carbohydrates and tolerance to low pH). Populations of microorganisms exhibit
similar stability, which enables us to gather the basic knowledge on the behavior of the above-
mentioned microbes under in vivo conditions.
As a result of the evaluation of phylogenetic relationship of bacteria found in saliva samples
of healthy persons and bacteria forming the biofilm model imitating the dental plaque in vivo,
attention was paid to the occurrence of affinities between species, in particular, within the
Streptococcus genus and to a lesser degree in Veillonella (Figure 6) [2, 4, 155, 174]. In the case of
the Streptococcus genus, the most dominant units within the human oral taxa (HOT) were S.
vestibularis, S. salivarius, S. mitis, S. parasanguinis, and different undiscovered Streptococcus spp.
The strains of S. vestibularis constituted approximately 40% of the total biofilm microbes,
whereas S. salivarius (HOT-755) and various other undiscovered Streptococcus sp. (HOT-C65)
each occupied 10%. S. vestibularis is the representative of physiological flora of the oral cavity,
and its presence is uncommonly associated with the disease, except for few cases of infec‐
tious endocarditis, neonatal sepsis, bacteraemia, and in patients with cancer [175]. Further‐
more, a few studies demonstrated that S. vestibularis may be the etiological factor of caries in
rats, compared to other Streptococcus species (e.g., S. salivarius), which are associated with the
development of the disease much more commonly [176]. S. salivarius, which has extensive
functions from being highly cariogenic [177] to the protective function against caries devel‐
opment (i.e., through hydrolysis of urea to ammonia [178], influences the health state of the
human oral cavity. The strains of S. parasanguinis (HOT-721 and HOT-711) constituted a
considerable participation (10%) in the presented in vitro biofilm model. The role of S.
parasanguinis in the health of oral cavity is poorly known. Due to the ability of this microor‐
ganism for carbohydrate fermentation to lactate and other organic acids, S. parasanguinis is
considered to be an organism with moderate tolerance to low pH and a low cariogenic
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forms of caries. In control (free of caries) noted predominant numbers of the Aestuariimicrobi‐
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The microflora of oral cavity demonstrates specificity depending on the stages of caries
progression [169]. The study conducted by Gomar-Vercher et al. in 2014 on saliva samples of
children with caries showed that the dominant caries-forming species found were bacteria
classified to genera Porphyromonas and Prevotella [169]. Using pyrosequencing techniques,
attention was paid to species variability on the dental plaque depending on the activity of
caries process—in the case of intact plaque, in the presence of the so-called white spots, in the
case of damage to the dentin. Diversity of dental plaque microflora of healthy individuals
exhibits a much more homogeneity compared to the plague of individuals with caries. Thirteen
bacteria of genera Capnocytophaga, Fusobacterium, Porphyromonas, Abiotrophia, Comamonas,
Tannerella, Eikenella, Paludibacter, Treponema, Actinobaculum, Stenotrophomonas, Aestuariimicrobi‐
um, and Peptococcus were associated with healthy teeth. Eight bacteria of genera Cryptobacte‐
rium, Lactobacillus, Olsenella, Megasphaera, Scardovia, Shuttleworthia, Cryptobacterium, and
Streptococcus increased significantly in dentine damage, while Actinomyces and Corynebacteri‐
um were present predominantly in the so-called “white spots” and Flavobacterium, Neisseria,
Bergeyella, and Derxia were numerous with intact dental plaque of individuals with caries [159].
In case of damaged dentin, the study by Obata et al. reported a relatively high percentage of
bacteria of the genus Atopobium, Prevotella, or Propionibacterium along with Streptococcus or
Actinomyces [170].
However, taking into account the complexity of microorganism–microorganism interactions
and the number of microorganisms, which is essential for the formation of biofilm and creation
of specific conditions for caries development, it can be concluded that particular species of
bacteria acts as the forefront of cariogenic factors [71, 164]. An increasing attention is paid to
the study of relations between the course of biofilm formation and its maturation, develop‐
ment of resistance to increased spectrum antibiotics, analysis of microorganisms genome, and
mechanisms of action of specific bacterial proteins [171–173]. Considerable focus is also on the
structure of biofilm and its relationship with the species forming the microbiota of human oral
cavity.
5. Role of oral microbiome in the formation of dental plaque
The knowledge of the microbial diversity in human oral cavity has recently been improved
and was subjected to a considerable transformation in the last two decades. Understanding
biological characteristics and functions of individual bacterial species colonizing oral cavity,
which are subject to dynamic changes, has become the fundamental objective of studies on
human microbiome. The function of the oral microbiome can be determined on the basis of
characteristics of microbes isolated in vitro. Currently, no efficient referential method exists for
the evaluation of the actual presence of bacteria in the oral cavity. The culture methods carry
their limitations related to the lack of ensuring all the necessary growth conditions for each of
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pH) [22]. Two Lactobacillus species (L. fermentum HOT-608 and Lactobacillus sp. HOT-A89) were
identified in the presented model with a relatively low growth (X̄ =0.8%). This means that the
opportunity to alter the view on the participation of this genus is only as normal physiologi‐
cal flora exhibiting an increased possibility to cause the disease as a result of the movement of
this genus from the physiological flora to the disease conditions [155, 188].
Interestingly, Fusobacterium genus, which appears to play a less significant role in the oral
microbiome in children, similar to the TM7 strain [14], constituted approximately 10% of the
total diversity of microbial genes forming the presented biofilm model. Similar to the majority
of other microbes, microorganisms belonging to the Fusobacterium genus are known not only
as the normal physiological flora of the oral cavity, but also as the flora responsible for causing
the diseases of oral cavity under special conditions [189]. Their ability to grow in different
environments can be explained by their universal metabolism, which enables them to obtain
energy from fermentation of simple sugars, simple and branch-chained amino acids [189].
Many bacteria of the oral microbiome, including species forming the dental plaque, are
opportunistic species (until recently considered to be non-pathogenic), and due to this fact,
their appearance in sites normally unavailable to them in the case of habitat disturbance
(disturbance of the immune system functioning of the host) may initiate the development of
infection. This is corroborated by the results described above, indicating an increased
frequency of the occurrence of the bacteria of physiological flora in the dental plaque, which
are exposed not only to the changes in the oxidation-reduction potential, local pH, but also in
the response to diet and all types of environmental conditions constituting the source or
nourishment for bacteria. In children, studies on the oral microbiome independent of cul‐
tures demonstrated that apart from the DNA of Streptococcus, Veillonella, Lactobacillus and
Granulicatella, Rothia and Actinomyces, the most common type of DNA belonged to Bacteroi‐
dales and Prevotella, and also Fusobacterium, Spirochaetes, and the TM7 strain [14]. Streptococ‐
cus, and to a lesser degree Veillonella, also dominated in the studies evaluating phylogenetic
relationships of bacteria forming the dental plaque with the oral microbiome species [155, 190].
6. Conclusion
As it was mentioned earlier, only approximately 40% of the oral microbiome bacteria are
cultured in vitro. Due to this fact, studies on the function of non-cultured bacteria should be
carried out using other methods, and thus looking for such a solution that enables under‐
standing their properties without the need for in vitro isolation. Such possibilities are provid‐
ed by metagenomics, which studies sequences of DNA obtained directly from the environment
of the oral cavity, treated as one common gene set [191]. An oral microbiome analysis
depending on the genotypic characteristics of the host, as well as its metabolic phenotype, will
allow us to understand all these factors which responsible for maintaining host- microbiota
homeostasis. The formation of genetic maps (including host, as well as microbiota) of such
environments and the detection of biofactors indicating the predisposition for a given disease
may contribute to the development of new diagnostic methods in reference to individual
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species [179,180]. The previous studies suggested that these bacteria were significantly related
to both caries in small children and the physiological flora of the oral cavity [181, 182]. This
fact is not confirmed by recent study Krzyściak et al.’s [183] in which, apart from a detailed
description of S. mutans, constituting 24% of natural physiological flora of children without
symptoms of the caries disease and 77% of cariogenic flora in children with early childhood
caries (ECC), presence of S. parasanguinis constituted only 2%.
Figure 6. Results of phylogenetic relationship evaluation of bacteria found in saliva samples (oral microbiome) of
healthy persons and bacteria forming the biofilm model imitating in vivo dental plaque.
The presence of S. mutans bacteria onto the teeth surfaces is usually related to poor hygiene
and diet. These bacteria dwell in the oral cavity, occupying hard tissues; but they also colonize
soft tissues from which they can be easily transferred to the oral cavity, in particular, with
shared use of personal care products or during kissing. It appears also that maintaining the
oral cavity in the state of lowered moisture (frequent snacking) may favor colonization and
the resulting infection. It is possible that irrigation itself, without the use of disinfectants, may
also constitute the source of colonization [157, 184].
The presence of the Veillonella genus in the presented biofilm model and saliva samples creates
new opportunities related to the role of this genus in the interspecific relations between the
oral microbiome and caries development. In earlier studies, the role of Veillonella remained
unexplained, and all the available laboratory tests demonstrated that the growth effects of
microbes of the Veillonella genus can be mixed [185, 186]. It is also suggested that the pres‐
ence of the Veillonella genus can be used for forecasting the possibility of caries development
in children without symptoms of the disease due to its close relationship with S. mutans, which
was identified in all samples of the above study (HOT-686) [187].
On the contrary, the lactic acid bacteria of the Lactobacillus genus were identified in the few
samples obtained from the supragingival area of healthy persons. The representatives of this
genus are considered to be late colonizers [2]; they commonly occur in advanced caries (low
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cal flora exhibiting an increased possibility to cause the disease as a result of the movement of
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ed by metagenomics, which studies sequences of DNA obtained directly from the environment
of the oral cavity, treated as one common gene set [191]. An oral microbiome analysis
depending on the genotypic characteristics of the host, as well as its metabolic phenotype, will
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ence of the Veillonella genus can be used for forecasting the possibility of caries development
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persons, and thus individualized therapy. So far, numerous active bacterial factors and
molecular mechanisms of their interactions with the host have been discovered. However, the
problem of the presence of healthy oral microbiome bacteria and relating teeth colonization
with a potential infection development requires further study.
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persons, and thus individualized therapy. So far, numerous active bacterial factors and
molecular mechanisms of their interactions with the host have been discovered. However, the
problem of the presence of healthy oral microbiome bacteria and relating teeth colonization
with a potential infection development requires further study.
Author details
Wirginia Krzyściak1*, Anna Jurczak2 and Jakub Piątkowski3
*Address all correspondence to: wirginiakrzysciak@cm-uj.krakow.pl
1 Department of Medical Diagnostics, Pharmacy Faculty, Medical College, Jagiellonian
University, Krakow, Poland
2 Department of Pediatric Dentistry, Institute of Dentistry, Medical College, Jagiellonian
University, Krakow, Poland
3 Genetics Laboratory, Department of Endocrinology, Medical College, Jagiellonian Univer‐
sity, Krakow, Poland
References
[1] Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan A, Wade
WG. The human oral microbiome. J Bacteriol. 2010;192:5002–5017. DOI: 10.1128/JB.
00542-10.
[2] Human Microbiome Project Consortium. Structure, function and diversity of the
healthy human microbiome. Nature. 2012;486:207–214.
[3] Sheiham A. Dietary effects on dental diseases. Public Health Nutr. 2001;4:569–591.
[4] Nasidze I, Li J, Quinque D, Tang K, Stoneking M. Global diversity in the human salivary
microbiome. Genome Res. 2009;19:636–643. DOI: 10.1101/gr.084616.108.
[5] Takahashi N, Nyvad B. The role of bacteria in the caries process: ecological perspec‐
tives. J Dent Res. 2011;90:294–303. DOI: 10.1177/0022034510379602.
[6] Sampaio-Maia B, Monteiro-Silva F. Acquisition and maturation of oral microbiome
throughout childhood: An update. Dent Res J (Isfahan). 2014;11:291–301.
[7] Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N,
Knight R. Delivery mode shapes the acquisition and structure of the initial microbio‐
ta across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010;107:11971–
11975.
Microbial Biofilms - Importance and Applications368
[34] Casadevall A, Pirofski LA. Host-pathogen interactions: redefining the basic concepts
of virulence and pathogenicity. Infect Immun. 1999;67:3703–3713.
[35] Kreikemeyer B, Gámez G, Margarit I, Giard JC, Hammerschmidt S, Hartke A,
Podbielski A. Genomic organization, structure, regulation and pathogenic role of pilus
constituents in major pathogenic Streptococci and Enterococci. Int J Med Microbiol.
2011;301:240–251.
[36] Bagnoli F, Moschioni M, Donati C, Dimitrovska V, Ferlenghi I, Facciotti C, Muzzi A,
Giusti F, Emolo C, Sinisi A, Hilleringmann M, Pansegrau W, Censini S, Rappuoli R,
Covacci A, Masignani V, Barocchi MA. A second pilus type in Streptococcus pneumo‐
niae is prevalent in emerging serotypes and mediates adhesion to host cells. J Bacteriol.
2008;190:5480–5492.
[37] Casadevall A, Fang FC, Pirofski LA. Microbial virulence as an emergent property:
consequences and opportunities. PLoS Pathog. 2011 Jul;7(7):e1002136. doi: 10.1371/
journal.ppat.1002136. Epub 2011 Jul 21.
[38] Ahn SJ, Ahn SJ, Wen ZT, Brady LJ, Burne RA. Characteristics of biofilm formation by
Streptococcus mutans in presence of saliva. Infect Immun. 2008;76:4259–4268.
[39] Wen ZT, Yates D, Ahn SJ, Burne RA. Biofilm formation and virulence expression by
Streptococcus mutans are altered when grown in dual-species model. BMC Microbiolo‐
gy, 2010;10:111–119.
[40] Khan AU, Islam B, Khan SN, Akram M. A proteomic approach for exploring biofilm
In Streptococcus mutans. Bioinformation. 2011;5:440–445.
[41] Socransky SS, Haffajee AD. Dental biofilms: difficult therapeutic targets. Periodontol
2000. 2002;28:12–55.
[42] Matsui R, Ccitkovitch D. Acid tolerance mechanisms utilized by Streptococcus mutans.
Future Microbiol. 2010;5:403–417.
[43] Banas JA. Virulence properties of Streptococcus mutans. Front Biosci. 2004;1:1267–1277.
[44] Zijnge V, van Leeuwen MB, Degener JE, Abbas F, Thurnheer T, Gmür R, Harmsen HJ.
Oral biofilm architecture on natural teeth. PLoS ONE. 2010;5:e9321.
[45] Kolenbrander PE, Palmer RJ Jr, Rickard AH, Jakubovics NS, Chalmers NI, Diaz PI.
Bacterial interactions and successions during plaque development. Periodontol 2000.
2006;42:47–79.
[46] Rickard AH, Gilbert P, High NJ, Kolenbrander PE, Handley PS. Bacterial coaggrega‐
tion: an integral process in the development of multi-species biofilms. TRENDS in
Microbiology, 2003;11:94–100.
[47] Huang L, Xu QA, Liu C, Fan MW, Li YH. Anti-caries DNA vaccine-induced secretory
immunoglobulin A antibodies inhibit formation of Streptococcus mutans biofilms in
vitro. Acta Pharmacol Sin. 2013;34:239–246.
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
371
[21] Van Houte J, Sansone C, Joshipura K, Kent R. Mutans streptococci and non-mutans
streptococci acidogenic at low pH, and in vitro acidogenic potential of dental plaque
in two different areas of the human dentition. J Dent Res. 1991;70:1503–1507.
[22] Gross EL, Leys EJ, Gasparovich SR, Firestone ND, Schwartzbaum JA, Janies DA, Asnani
K, Griffen AL. Bacterial 16S sequence analysis of severe caries in young permanent
teeth. J Clin Microbiol. 2010;48:4121–4128. DOI: 10.1128/JCM.01232-10.
[23] Tanner AC, Milgrom PM, Kent R Jr, Mokeem SA, Page RC, Liao SI, Riedy CA, Bruss
JB. Similarity of the oral microbiota of pre-school children with that of their caregiv‐
ers in a population-based study. Oral Microbiol Immunol. 2002;17:379–387.
[24] Mombelli A, Gusberti FA, van Oosten MA, Lang NP. Gingival health and gingivitis
development during puberty. A 4-year longitudinal study. J Clin Periodontol.
1989;16:451–456.
[25] Krzyściak W, Jurczak A, Piątkowski J, Kościelniak D, Gregorczyk-Maga I, Kołodziej I,
Papież MA, Olczak-Kowalczyk D. Effect of histatin-5 and lysozyme on the ability of
Streptococcus mutans to form biofilms in in vitro conditions. Postepy Hig Med Dosw
(Online). 2015;69:1056–1066.
[26] Krzyściak W, Jurczak A, Kościelniak D, Bystrowska B, Skalniak A. The virulence of
Streptococcus mutans and the ability to form biofilms. Eur J Clin Microbiol Infect Dis.
2014;33:499–515. DOI: 10.1007/s10096-013-1993-7.
[27] Report WHO. Weekly Epidemiological Record (WER) 2016;91:21–32.
[28] Nakano K, Inaba H, Nomura R, Nemoto H, Takeda M, Yoshioka H, Matsue H,
Takahashi T, Taniguchi K, Amano A, Ooshima T. Detection of cariogenic Streptococ‐
cus mutans in extirpated heart valve and atheromatous plaque specimens. J Clin
Microbiol. 2006;44:3313–3317.
[29] Delorme C, Poyart C, Ehrlich SD, Renault P. Extent of horizontal gene transfer in
evolution of Streptococci of the salivarius group. J Bacteriol. 2007;189:1330–1341.
[30] Kilian M, Poulsen K, Blomqvist T, Håvarstein LS, Bek-Thomsen M, Tettelin H, Sørensen
UB. Evolution of Streptococcus pneumoniae and its close commensal relatives. PLoS One.
2008;3:2683. DOI: 10.1371/journal.pone.0002683.
[31] Fitzgerald JR, Musser JM. Evolutionary genomics of pathogenic bacteria. Trends
Microbiol. 2001;9:547–553.
[32] Sørensen UB, Poulsen K, Ghezzo C, Margarit I, Kilian M. (2010) Emergence and global
dissemination of host-specific Streptococcus agalactiae clones. MBio. 2010;1:e00178-10.
DOI: 10.1128/mBio.00178-10.
[33] Henderson B, Poole S, Wilson M. Bacterial modulins: a novel class of virulence factors
which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev.
1996;60:316–341.
Microbial Biofilms - Importance and Applications370
[34] Casadevall A, Pirofski LA. Host-pathogen interactions: redefining the basic concepts
of virulence and pathogenicity. Infect Immun. 1999;67:3703–3713.
[35] Kreikemeyer B, Gámez G, Margarit I, Giard JC, Hammerschmidt S, Hartke A,
Podbielski A. Genomic organization, structure, regulation and pathogenic role of pilus
constituents in major pathogenic Streptococci and Enterococci. Int J Med Microbiol.
2011;301:240–251.
[36] Bagnoli F, Moschioni M, Donati C, Dimitrovska V, Ferlenghi I, Facciotti C, Muzzi A,
Giusti F, Emolo C, Sinisi A, Hilleringmann M, Pansegrau W, Censini S, Rappuoli R,
Covacci A, Masignani V, Barocchi MA. A second pilus type in Streptococcus pneumo‐
niae is prevalent in emerging serotypes and mediates adhesion to host cells. J Bacteriol.
2008;190:5480–5492.
[37] Casadevall A, Fang FC, Pirofski LA. Microbial virulence as an emergent property:
consequences and opportunities. PLoS Pathog. 2011 Jul;7(7):e1002136. doi: 10.1371/
journal.ppat.1002136. Epub 2011 Jul 21.
[38] Ahn SJ, Ahn SJ, Wen ZT, Brady LJ, Burne RA. Characteristics of biofilm formation by
Streptococcus mutans in presence of saliva. Infect Immun. 2008;76:4259–4268.
[39] Wen ZT, Yates D, Ahn SJ, Burne RA. Biofilm formation and virulence expression by
Streptococcus mutans are altered when grown in dual-species model. BMC Microbiolo‐
gy, 2010;10:111–119.
[40] Khan AU, Islam B, Khan SN, Akram M. A proteomic approach for exploring biofilm
In Streptococcus mutans. Bioinformation. 2011;5:440–445.
[41] Socransky SS, Haffajee AD. Dental biofilms: difficult therapeutic targets. Periodontol
2000. 2002;28:12–55.
[42] Matsui R, Ccitkovitch D. Acid tolerance mechanisms utilized by Streptococcus mutans.
Future Microbiol. 2010;5:403–417.
[43] Banas JA. Virulence properties of Streptococcus mutans. Front Biosci. 2004;1:1267–1277.
[44] Zijnge V, van Leeuwen MB, Degener JE, Abbas F, Thurnheer T, Gmür R, Harmsen HJ.
Oral biofilm architecture on natural teeth. PLoS ONE. 2010;5:e9321.
[45] Kolenbrander PE, Palmer RJ Jr, Rickard AH, Jakubovics NS, Chalmers NI, Diaz PI.
Bacterial interactions and successions during plaque development. Periodontol 2000.
2006;42:47–79.
[46] Rickard AH, Gilbert P, High NJ, Kolenbrander PE, Handley PS. Bacterial coaggrega‐
tion: an integral process in the development of multi-species biofilms. TRENDS in
Microbiology, 2003;11:94–100.
[47] Huang L, Xu QA, Liu C, Fan MW, Li YH. Anti-caries DNA vaccine-induced secretory
immunoglobulin A antibodies inhibit formation of Streptococcus mutans biofilms in
vitro. Acta Pharmacol Sin. 2013;34:239–246.
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
371
[21] Van Houte J, Sansone C, Joshipura K, Kent R. Mutans streptococci and non-mutans
streptococci acidogenic at low pH, and in vitro acidogenic potential of dental plaque
in two different areas of the human dentition. J Dent Res. 1991;70:1503–1507.
[22] Gross EL, Leys EJ, Gasparovich SR, Firestone ND, Schwartzbaum JA, Janies DA, Asnani
K, Griffen AL. Bacterial 16S sequence analysis of severe caries in young permanent
teeth. J Clin Microbiol. 2010;48:4121–4128. DOI: 10.1128/JCM.01232-10.
[23] Tanner AC, Milgrom PM, Kent R Jr, Mokeem SA, Page RC, Liao SI, Riedy CA, Bruss
JB. Similarity of the oral microbiota of pre-school children with that of their caregiv‐
ers in a population-based study. Oral Microbiol Immunol. 2002;17:379–387.
[24] Mombelli A, Gusberti FA, van Oosten MA, Lang NP. Gingival health and gingivitis
development during puberty. A 4-year longitudinal study. J Clin Periodontol.
1989;16:451–456.
[25] Krzyściak W, Jurczak A, Piątkowski J, Kościelniak D, Gregorczyk-Maga I, Kołodziej I,
Papież MA, Olczak-Kowalczyk D. Effect of histatin-5 and lysozyme on the ability of
Streptococcus mutans to form biofilms in in vitro conditions. Postepy Hig Med Dosw
(Online). 2015;69:1056–1066.
[26] Krzyściak W, Jurczak A, Kościelniak D, Bystrowska B, Skalniak A. The virulence of
Streptococcus mutans and the ability to form biofilms. Eur J Clin Microbiol Infect Dis.
2014;33:499–515. DOI: 10.1007/s10096-013-1993-7.
[27] Report WHO. Weekly Epidemiological Record (WER) 2016;91:21–32.
[28] Nakano K, Inaba H, Nomura R, Nemoto H, Takeda M, Yoshioka H, Matsue H,
Takahashi T, Taniguchi K, Amano A, Ooshima T. Detection of cariogenic Streptococ‐
cus mutans in extirpated heart valve and atheromatous plaque specimens. J Clin
Microbiol. 2006;44:3313–3317.
[29] Delorme C, Poyart C, Ehrlich SD, Renault P. Extent of horizontal gene transfer in
evolution of Streptococci of the salivarius group. J Bacteriol. 2007;189:1330–1341.
[30] Kilian M, Poulsen K, Blomqvist T, Håvarstein LS, Bek-Thomsen M, Tettelin H, Sørensen
UB. Evolution of Streptococcus pneumoniae and its close commensal relatives. PLoS One.
2008;3:2683. DOI: 10.1371/journal.pone.0002683.
[31] Fitzgerald JR, Musser JM. Evolutionary genomics of pathogenic bacteria. Trends
Microbiol. 2001;9:547–553.
[32] Sørensen UB, Poulsen K, Ghezzo C, Margarit I, Kilian M. (2010) Emergence and global
dissemination of host-specific Streptococcus agalactiae clones. MBio. 2010;1:e00178-10.
DOI: 10.1128/mBio.00178-10.
[33] Henderson B, Poole S, Wilson M. Bacterial modulins: a novel class of virulence factors
which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev.
1996;60:316–341.
Microbial Biofilms - Importance and Applications370
[60] Gibbons RJ, Cohen L, Hay DI. Strains of Streptococcus mutans and Streptococcus sobrinus
attach to different pellicle receptors. Infect Immun. 1986;52:555–561.
[61] Gibbons RJ, Hay DI. Adsorbed salivary acidic proline-rich proteins contribute to the
adhesion of Streptococcus mutans JBP to apatitic surfaces. J Dent Res. 1989;68:1303–
1307.
[62] Paes Leme AF, Koo H, Bellato CM, Bedi G, Cury JA. The role of sucrose in cariogenic
dental biofilm formation—new insight. J Dent Res. 2006;85(10):878–887.
[63] Stephan RM, Hemmens ES. Studies of changes in pH produced by pure cultures of oral
micro-organisms; effects of varying the microbic cell concentration; comparison of
different micro-organisms and different substrates; some effects of mixing certain
micro-organisms. J Dent Res. 1947;26:15–41.
[64] Duque C, Stipp RN, Wang B, Smith DJ, Höfling JF, Kuramitsu HK, Duncan MJ, Mattos-
Graner RO. Downregulation of GbpB, a component of the VicRK regulon, affects
biofilm formation and cell surface characteristics of Streptococcus mutans. Infect Immun.
2011;79: 786–96.
[65] Xiao J, Klein MI, Falsetta ML, Lu B, Delahunty CM, Yates JR 3rd, Heydorn A, Koo H.
The exopolysaccharide matrix modulates the interaction between 3D architecture and
virulence of a mixed-species oral biofilm. PLoS Pathog. 2012;8:e1002623.
[66] Gimmarinaro P, Paton JC. Role of RegM, a homologue of the catabolite repressor
protein CcpA, in the virulence of Streptococcus pneumonia. Infect Immun. 2002;70:5454–
5461.
[67] Hotz J, Hartmann W, Goberna R, Clodi PH. Enzyme substitution. Med Welt.
1972;23:1611–1613.
[68] Gong Y, Tian XL, Sutherland T, Sisson G, Mai J, Ling J, Li YH. Global transcriptional
analysis of acid-inducible genes in Streptococcus mutans: multiple two-component
systems involved in acid adaptation. Microbiology. 2009;155:3322–3332.
[69] Welin-Neilands J, Svensater G. Acid tolerance of biofilm cells of Streptococcus mutans.
Appl Environ Microbiol. 2007;73:5633–5638.
[70] Lemos JA, Burne RA. A model of efficiency: stress tolerance by Streptococcus mutans.
Microbiology. 2008;157:3247–3255.
[71] Peterson SN, Snesrud E, Schork NJ, Bretz WA. Dental caries pathogenicity: a genom‐
ic and metagenomic perspective. Int Dent J. 2011;61:11–22.
[72] Sheng J, Marquis RE. Enhance acid resistance of oral streptococci at lethal pH values
associated with acid-tolerant catabolism and with ATP synthase activity. FEMS
Microbiol lett. 2006;262:93–98.
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
373
[48] Klein MI, Xiao J, Lu B, Delahunty CM, Yates JR 3rd, Koo H. Streptococcus mutans protein
synthesis during mixed-species biofilm development by kigh-throughput quantita‐
tive proteomics. PLoS ONE. 2012;7:e45795.
[49] Postollec F, Norde W, de Vries J, Busscher HJ, van der Mei HC. Interactive forces
between co-aggregating and non-co-aggregating oral bacterial pairs. J Dent Res.
2006;85:231–234.
[50] Franková J, Pivodová V, Růžička F, Tománková K, Šafářová K, Vrbková J, Ulrichová J.
Comparing biocompatibility of gingival fibroblasts and bacterial strains on a differ‐
ent modified titanium discs. J Biomed Mater Res A. 2013;101:2915–2924. DOI: 10.1002/
jbm.a.34598.
[51] Signoretto C, Marchi A, Bertoncelli A, Burlacchini G, Milli A, Tessarolo F, Caola I,
Papetti A, Pruzzo C, Zaura E, Lingström P, Ofek I, Spratt DA, Pratten J, Wilson M,
Canepari P. Effects of mushroom and chicory extracts on the shape, physiology and
proteome of the cariogenic bacterium Streptococcus mutans. BMC Complement Altern
Med. 2013;13:117. DOI: 10.1186/1472-6882-13-117.
[52] Soell M, Hemmerlé J, Hannig M, Haïkel Y, Sano H, Selimovic D. Molecular force probe
measurement of antigen I/II-matrix protein interactions. Eur J Oral Sci. 2010;118:590–
595. DOI: 10.1111/j.1600-0722.2010.00785.x.
[53] Compagnoni MA, Pero AC, Ramos SM, Marra J, Paleari AG, Rodriguez LS. Antimi‐
crobial activity and surface properties of an acrylic resin containing a biocide poly‐
mer. Gerodontology. 2014;31:220–226. DOI: 10.1111/ger.12031.
[54] Busscher HJ, van Hoogmoed CG, Geertsema-Doornbusch GI, van der Kuijl-Booij M,
van der Mei HC. Streptococcus thermophilus and its biosurfactants inhibit adhesion
by Candida spp. on silicone rubber. Appl Environ Microbiol. 1997;63:3810–3817.
[55] Bowen WH, Koo H. Biology of Streptococcus mutans-derived glucosyltransferases:
role in extracellular matrix formation of cariogenic biofilms. Caries Res. 2011;45:69–86.
[56] Siqueira WL, Bakkal M, Xiao Y, Sutton JN, Mendes FM. Quantitative proteomic analysis
of the effect of fluoride on the acquired enamel pellicle. PLoS ONE. 2012;7:e42204.
[57] Brady LJ, Maddocks SE, Larson MR, Forsgren N, Persson K, Deivanayagam CC,
Jenkinson HF. The changing faces of Streptococcus antigen I/II polypeptide family
adhesins. Mol Microbiol. 2010;77:276–286.
[58] Esberg A, Löfgren-Burström A, Ohman U, Strömberg N. Host and bacterial pheno‐
type variation in adhesion of Streptococcus mutans to matched human hosts. Infect
Immun. 2012;80:3869–3879.
[59] Crowley PJ, Seifert TB, Isoda R, van Tilburg M, Oli MW, Robinette RA, McArthur WP,
Bleiweis AS, Brady LJ. Requirements for surface expression and function of adhesin P1
from Streptococcus mutans. Infect Immun. 2008;76:2456–2468.
Microbial Biofilms - Importance and Applications372
[60] Gibbons RJ, Cohen L, Hay DI. Strains of Streptococcus mutans and Streptococcus sobrinus
attach to different pellicle receptors. Infect Immun. 1986;52:555–561.
[61] Gibbons RJ, Hay DI. Adsorbed salivary acidic proline-rich proteins contribute to the
adhesion of Streptococcus mutans JBP to apatitic surfaces. J Dent Res. 1989;68:1303–
1307.
[62] Paes Leme AF, Koo H, Bellato CM, Bedi G, Cury JA. The role of sucrose in cariogenic
dental biofilm formation—new insight. J Dent Res. 2006;85(10):878–887.
[63] Stephan RM, Hemmens ES. Studies of changes in pH produced by pure cultures of oral
micro-organisms; effects of varying the microbic cell concentration; comparison of
different micro-organisms and different substrates; some effects of mixing certain
micro-organisms. J Dent Res. 1947;26:15–41.
[64] Duque C, Stipp RN, Wang B, Smith DJ, Höfling JF, Kuramitsu HK, Duncan MJ, Mattos-
Graner RO. Downregulation of GbpB, a component of the VicRK regulon, affects
biofilm formation and cell surface characteristics of Streptococcus mutans. Infect Immun.
2011;79: 786–96.
[65] Xiao J, Klein MI, Falsetta ML, Lu B, Delahunty CM, Yates JR 3rd, Heydorn A, Koo H.
The exopolysaccharide matrix modulates the interaction between 3D architecture and
virulence of a mixed-species oral biofilm. PLoS Pathog. 2012;8:e1002623.
[66] Gimmarinaro P, Paton JC. Role of RegM, a homologue of the catabolite repressor
protein CcpA, in the virulence of Streptococcus pneumonia. Infect Immun. 2002;70:5454–
5461.
[67] Hotz J, Hartmann W, Goberna R, Clodi PH. Enzyme substitution. Med Welt.
1972;23:1611–1613.
[68] Gong Y, Tian XL, Sutherland T, Sisson G, Mai J, Ling J, Li YH. Global transcriptional
analysis of acid-inducible genes in Streptococcus mutans: multiple two-component
systems involved in acid adaptation. Microbiology. 2009;155:3322–3332.
[69] Welin-Neilands J, Svensater G. Acid tolerance of biofilm cells of Streptococcus mutans.
Appl Environ Microbiol. 2007;73:5633–5638.
[70] Lemos JA, Burne RA. A model of efficiency: stress tolerance by Streptococcus mutans.
Microbiology. 2008;157:3247–3255.
[71] Peterson SN, Snesrud E, Schork NJ, Bretz WA. Dental caries pathogenicity: a genom‐
ic and metagenomic perspective. Int Dent J. 2011;61:11–22.
[72] Sheng J, Marquis RE. Enhance acid resistance of oral streptococci at lethal pH values
associated with acid-tolerant catabolism and with ATP synthase activity. FEMS
Microbiol lett. 2006;262:93–98.
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
373
[48] Klein MI, Xiao J, Lu B, Delahunty CM, Yates JR 3rd, Koo H. Streptococcus mutans protein
synthesis during mixed-species biofilm development by kigh-throughput quantita‐
tive proteomics. PLoS ONE. 2012;7:e45795.
[49] Postollec F, Norde W, de Vries J, Busscher HJ, van der Mei HC. Interactive forces
between co-aggregating and non-co-aggregating oral bacterial pairs. J Dent Res.
2006;85:231–234.
[50] Franková J, Pivodová V, Růžička F, Tománková K, Šafářová K, Vrbková J, Ulrichová J.
Comparing biocompatibility of gingival fibroblasts and bacterial strains on a differ‐
ent modified titanium discs. J Biomed Mater Res A. 2013;101:2915–2924. DOI: 10.1002/
jbm.a.34598.
[51] Signoretto C, Marchi A, Bertoncelli A, Burlacchini G, Milli A, Tessarolo F, Caola I,
Papetti A, Pruzzo C, Zaura E, Lingström P, Ofek I, Spratt DA, Pratten J, Wilson M,
Canepari P. Effects of mushroom and chicory extracts on the shape, physiology and
proteome of the cariogenic bacterium Streptococcus mutans. BMC Complement Altern
Med. 2013;13:117. DOI: 10.1186/1472-6882-13-117.
[52] Soell M, Hemmerlé J, Hannig M, Haïkel Y, Sano H, Selimovic D. Molecular force probe
measurement of antigen I/II-matrix protein interactions. Eur J Oral Sci. 2010;118:590–
595. DOI: 10.1111/j.1600-0722.2010.00785.x.
[53] Compagnoni MA, Pero AC, Ramos SM, Marra J, Paleari AG, Rodriguez LS. Antimi‐
crobial activity and surface properties of an acrylic resin containing a biocide poly‐
mer. Gerodontology. 2014;31:220–226. DOI: 10.1111/ger.12031.
[54] Busscher HJ, van Hoogmoed CG, Geertsema-Doornbusch GI, van der Kuijl-Booij M,
van der Mei HC. Streptococcus thermophilus and its biosurfactants inhibit adhesion
by Candida spp. on silicone rubber. Appl Environ Microbiol. 1997;63:3810–3817.
[55] Bowen WH, Koo H. Biology of Streptococcus mutans-derived glucosyltransferases:
role in extracellular matrix formation of cariogenic biofilms. Caries Res. 2011;45:69–86.
[56] Siqueira WL, Bakkal M, Xiao Y, Sutton JN, Mendes FM. Quantitative proteomic analysis
of the effect of fluoride on the acquired enamel pellicle. PLoS ONE. 2012;7:e42204.
[57] Brady LJ, Maddocks SE, Larson MR, Forsgren N, Persson K, Deivanayagam CC,
Jenkinson HF. The changing faces of Streptococcus antigen I/II polypeptide family
adhesins. Mol Microbiol. 2010;77:276–286.
[58] Esberg A, Löfgren-Burström A, Ohman U, Strömberg N. Host and bacterial pheno‐
type variation in adhesion of Streptococcus mutans to matched human hosts. Infect
Immun. 2012;80:3869–3879.
[59] Crowley PJ, Seifert TB, Isoda R, van Tilburg M, Oli MW, Robinette RA, McArthur WP,
Bleiweis AS, Brady LJ. Requirements for surface expression and function of adhesin P1
from Streptococcus mutans. Infect Immun. 2008;76:2456–2468.
Microbial Biofilms - Importance and Applications372
[87] Ioannidis O, Kakoutis E, Katsifa H, Rafail S, Chatzopoulos S, Kotronis A, Makranto‐
nakis N. Streptococcus mutans: a rare cause of retroperitoneal abscess. Adv Med Sci.
2011;56:113–118.
[88] Huang R, Li M, Ye M, Yang K, Xu X, Gregory RL. Effects of nicotine on Streptococcus
gordonii growth, biofilm formation, and cell aggregation. Appl Environ Microbiol.
2014;80:7212–7218. DOI: 10.1128/AEM.02395-14.
[89] Ahn SJ, Burne RA. Effects of oxygen on biofilm formation and the AtlA autolysin of
Streptococcus mutans. J Bacteriol. 2007;189:6293–6302.
[90] Eglan PG, Palmer RJ Jr, Kolenbrander PE. Interspecies communication in Streptococ‐
cus gordonii - Veillonella atypica biofilms: signaling in flow conditions requires
juxtaposition. PNAS. 2004;101:16917–16922.
[91] Struzycka I. The oral microbiome in dental caries. Pol J Microbiol. 2014;63(2):127–35.
[92] Koo H, Xiao J, Klein MI, Jeon JG. Exopolysaccharides produced by Streptococcus mutans
glucosyltransferases modulate the establishment of microcolonies within multispe‐
cies biofilms. J Bacteriol. 2010;192:3024–3032.
[93] Peterson BW, van der Mei HC, Sjollema J, Busscher HJ, Sharma PK. A distinguisha‐
ble role of eDNA in the viscoelastic relaxation of biofilms. mBio, 2013;4:e00497-13.
[94] Montanaro L, Poggi A, Visai L, Ravaioli S, Campoccia D, Speziale P, Arciola CR.
Extracellular DNA in biofilms. Int J Artif Organs. 2011;34:824–831.
[95] Ajdić D, McShan WM, McLaughlin RE, Savić G, Chang J, Carson MB, Primeaux C, Tian
R, Kenton S, Jia H, Lin S, Qian Y, Li S, Zhu H, Najar F, Lai H, White J, Roe BA, Ferretti
JJ. Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc
Natl Acad Sci USA. 2002;99:14434–14439.
[96] Harrington DJ. Bacterial collagenases and collagen-degrading enzymes and their
potential role in human disease. Infect Immun. 1996;64:1885–1891.
[97] Marsh PD. Role of the oral microflora in health. Microb Ecol Health Dis. 2000;12:130–
137.
[98] Tyler BM, Cole MF. Effect of IgA1 protease on the ability of secretory IgA1 antibod‐
ies to inhibit the adherence of Streptococus mutans. Microbiol Immunol. 1998;42:503–
508.
[99] Hajishenngallis G, Nikolova E, Russell MW. Inhibition of Streptococcus mutans
adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-
IgA) antibodies to cell surface protein antigen I/II: reversal by IgA1 protease cleavage.
Infect Immun. 1992;60:5057–5064.
[100] Ogawa A, Furukawa S, Fujita S, Mitobe J, Kawarai T, Narisawa N, Sekizuka T, Kuroda
M, Ochiai K, Ogihara H, Kosono S, Yoneda S, Watanabe H, Morinaga Y, Uematsu H,
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
375
[73] Svensäter G, Sjögreen B, Hamilton IR. Multiple stress responses in Streptococcus mutans
and the induction of general and stress-specific proteins. Microbiology. Jan;
2000;146:107–117.
[74] Fozo EM, Scott-Anne K, Koo H, Quivey RG Jr. Role of unsaturated fatty acid biosyn‐
thesis in virulence of Streptococcus mutans. Infect Immun. 2007;75:1537–1539.
[75] Hata S, Mayanagi H. Acid diffusion through extracellular polysaccharides produced
by various mutants of Streptococcus mutans. Arch Oral Biol. 2003;48:431–438.
[76] Santiago B, MacGilvray M, Faustoferri RC, Quivey RG. The branched-chain amino acid
aminotransferase encoded by ilvE is involved in acid tolerance in Streptococcus
mutans. J Bacteriol. 2012;194:2010–2019.
[77] Len AC, Harty DW, Jacques NA. Proteome analysis of Streptococcus mutans metabol‐
ic phenotype during acid tolerance. Microbiology. 2004;150:1353–1366.
[78] Marsh PD, Moter A, Devine DA. Dental plaque biofilms: communities, conflict and
control. Peridontology. 2000. 2011;55:16–35.
[79] Wilkins JC, Homer KA, Beighton D. Analysis of Streptococcus mutans proteins modu‐
lated by culture under acidic conditions. Appl Environ Microbiol. 2002;68:2382–2390.
[80] Schachtele CF, Mayo JA. Phosphoenolpyruvate-dependent glucose transport in oral
streptococci. J Dent Res. 1973;52:1209–1215.
[81] Ge J, Catt DM, Gregory RL. Streptococcus mutans surface α-enolase binds salivary mucin
MG2 and human plasminogen. Infect Immun. 2004;72:6748–6752.
[82] Nilsson M, Christiansen N, Hoiby N, Twetman S, Givskov M, Tolkier-Nielsen T. A
mariner transposon vector adapted for mutagenesis in oral streptococci. Mirobiology
Open. 2014;3:333–340.
[83] Jung CJ, Yeh CY, Shun CT, Hsu RB, Cheng HW, Lin CS, Chia JS. Platelets enhance
biofilm formation and resistance of endocarditis-inducing streptococci on the injured
heart valve. J Infect Dis. 2012;205:1066–1075.
[84] Nomura R, Hamada M, Nakano K, Nemoto H, Fujimoto K, Ooshima T. Repeated
bacteraemia caused by Streptococcus mutans in a patient with Sjogren's syndrome. J Med
Microbiol. 2007;56:988–992.
[85] Fujiwara T, Nakano K, Kawaguchi M, Ooshima T, Sobue S, Kawabata S, Nakagawa I,
Hamada S. Biochemical and genetic characterization of serologically untypable
Streptococcus mutans strains isolated from patients with bacteremia. Eur J Oral Sci.
2001;109:330–334.
[86] Nakano K, Nomura R, Matsumoto M, Ooshima T. Roles of oral bacteria in cardiovas‐
cular diseases — from molecular mechanisms to clinical cases: cell-surface structures
of novel serotype k Streptococcus mutans strains and their correlation to virulence. J
Pharmacol Sci. 2010;113:120–125.
Microbial Biofilms - Importance and Applications374
[87] Ioannidis O, Kakoutis E, Katsifa H, Rafail S, Chatzopoulos S, Kotronis A, Makranto‐
nakis N. Streptococcus mutans: a rare cause of retroperitoneal abscess. Adv Med Sci.
2011;56:113–118.
[88] Huang R, Li M, Ye M, Yang K, Xu X, Gregory RL. Effects of nicotine on Streptococcus
gordonii growth, biofilm formation, and cell aggregation. Appl Environ Microbiol.
2014;80:7212–7218. DOI: 10.1128/AEM.02395-14.
[89] Ahn SJ, Burne RA. Effects of oxygen on biofilm formation and the AtlA autolysin of
Streptococcus mutans. J Bacteriol. 2007;189:6293–6302.
[90] Eglan PG, Palmer RJ Jr, Kolenbrander PE. Interspecies communication in Streptococ‐
cus gordonii - Veillonella atypica biofilms: signaling in flow conditions requires
juxtaposition. PNAS. 2004;101:16917–16922.
[91] Struzycka I. The oral microbiome in dental caries. Pol J Microbiol. 2014;63(2):127–35.
[92] Koo H, Xiao J, Klein MI, Jeon JG. Exopolysaccharides produced by Streptococcus mutans
glucosyltransferases modulate the establishment of microcolonies within multispe‐
cies biofilms. J Bacteriol. 2010;192:3024–3032.
[93] Peterson BW, van der Mei HC, Sjollema J, Busscher HJ, Sharma PK. A distinguisha‐
ble role of eDNA in the viscoelastic relaxation of biofilms. mBio, 2013;4:e00497-13.
[94] Montanaro L, Poggi A, Visai L, Ravaioli S, Campoccia D, Speziale P, Arciola CR.
Extracellular DNA in biofilms. Int J Artif Organs. 2011;34:824–831.
[95] Ajdić D, McShan WM, McLaughlin RE, Savić G, Chang J, Carson MB, Primeaux C, Tian
R, Kenton S, Jia H, Lin S, Qian Y, Li S, Zhu H, Najar F, Lai H, White J, Roe BA, Ferretti
JJ. Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc
Natl Acad Sci USA. 2002;99:14434–14439.
[96] Harrington DJ. Bacterial collagenases and collagen-degrading enzymes and their
potential role in human disease. Infect Immun. 1996;64:1885–1891.
[97] Marsh PD. Role of the oral microflora in health. Microb Ecol Health Dis. 2000;12:130–
137.
[98] Tyler BM, Cole MF. Effect of IgA1 protease on the ability of secretory IgA1 antibod‐
ies to inhibit the adherence of Streptococus mutans. Microbiol Immunol. 1998;42:503–
508.
[99] Hajishenngallis G, Nikolova E, Russell MW. Inhibition of Streptococcus mutans
adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-
IgA) antibodies to cell surface protein antigen I/II: reversal by IgA1 protease cleavage.
Infect Immun. 1992;60:5057–5064.
[100] Ogawa A, Furukawa S, Fujita S, Mitobe J, Kawarai T, Narisawa N, Sekizuka T, Kuroda
M, Ochiai K, Ogihara H, Kosono S, Yoneda S, Watanabe H, Morinaga Y, Uematsu H,
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
375
[73] Svensäter G, Sjögreen B, Hamilton IR. Multiple stress responses in Streptococcus mutans
and the induction of general and stress-specific proteins. Microbiology. Jan;
2000;146:107–117.
[74] Fozo EM, Scott-Anne K, Koo H, Quivey RG Jr. Role of unsaturated fatty acid biosyn‐
thesis in virulence of Streptococcus mutans. Infect Immun. 2007;75:1537–1539.
[75] Hata S, Mayanagi H. Acid diffusion through extracellular polysaccharides produced
by various mutants of Streptococcus mutans. Arch Oral Biol. 2003;48:431–438.
[76] Santiago B, MacGilvray M, Faustoferri RC, Quivey RG. The branched-chain amino acid
aminotransferase encoded by ilvE is involved in acid tolerance in Streptococcus
mutans. J Bacteriol. 2012;194:2010–2019.
[77] Len AC, Harty DW, Jacques NA. Proteome analysis of Streptococcus mutans metabol‐
ic phenotype during acid tolerance. Microbiology. 2004;150:1353–1366.
[78] Marsh PD, Moter A, Devine DA. Dental plaque biofilms: communities, conflict and
control. Peridontology. 2000. 2011;55:16–35.
[79] Wilkins JC, Homer KA, Beighton D. Analysis of Streptococcus mutans proteins modu‐
lated by culture under acidic conditions. Appl Environ Microbiol. 2002;68:2382–2390.
[80] Schachtele CF, Mayo JA. Phosphoenolpyruvate-dependent glucose transport in oral
streptococci. J Dent Res. 1973;52:1209–1215.
[81] Ge J, Catt DM, Gregory RL. Streptococcus mutans surface α-enolase binds salivary mucin
MG2 and human plasminogen. Infect Immun. 2004;72:6748–6752.
[82] Nilsson M, Christiansen N, Hoiby N, Twetman S, Givskov M, Tolkier-Nielsen T. A
mariner transposon vector adapted for mutagenesis in oral streptococci. Mirobiology
Open. 2014;3:333–340.
[83] Jung CJ, Yeh CY, Shun CT, Hsu RB, Cheng HW, Lin CS, Chia JS. Platelets enhance
biofilm formation and resistance of endocarditis-inducing streptococci on the injured
heart valve. J Infect Dis. 2012;205:1066–1075.
[84] Nomura R, Hamada M, Nakano K, Nemoto H, Fujimoto K, Ooshima T. Repeated
bacteraemia caused by Streptococcus mutans in a patient with Sjogren's syndrome. J Med
Microbiol. 2007;56:988–992.
[85] Fujiwara T, Nakano K, Kawaguchi M, Ooshima T, Sobue S, Kawabata S, Nakagawa I,
Hamada S. Biochemical and genetic characterization of serologically untypable
Streptococcus mutans strains isolated from patients with bacteremia. Eur J Oral Sci.
2001;109:330–334.
[86] Nakano K, Nomura R, Matsumoto M, Ooshima T. Roles of oral bacteria in cardiovas‐
cular diseases — from molecular mechanisms to clinical cases: cell-surface structures
of novel serotype k Streptococcus mutans strains and their correlation to virulence. J
Pharmacol Sci. 2010;113:120–125.
Microbial Biofilms - Importance and Applications374
[114] Tamura S, Yonezawa H, Motegi M, Nakao R, Yoneda S, Watanabe H, Yamazaki T,
Senpuku H. Inhibiting effects of Streptococcus salivarius on competence-stimulating
peptide-dependent biofilm formation by Streptococcus mutans. Oral Microbiol Immun.
2009;24:125–161.
[115] Kara D, Luppens SBI, van Marle J, Ozok R, ten Cate JM. Microstructural differences
between single-species and dual-species biofilms of Streptococcus mutans and Veillonella
parvula before and after exposure to chlorhexidine. FEMS Microbiol Lett. 2007;271:90–
97.
[116] Standar K, Kreikemeyer B, Redanz S, Munter WJ, Laue M, Podbielski A. Setup of an in
vitro test system for basic studies on biofilm behavior of mixed-species cultures with
dental and peridontal pathogens. PLoS ONE. 2010;5:e13135.
[117] Redanz S, Standar K, Podbielski A, Kreikemeyer B. A five-species transcriptome array
for oral mixed-biofilm studies. PLoS ONE. 2011;6:e27827.
[118] Liu L, Tong H, Dong H. Function of the pyruvate oxidase-lactate oxidase cascade in
interspecies competition between Streptococcus oligofermentas and Streptococcus mutans.
Appl Environ Microbiol. 2012;78:2120–2127.
[119] Jakubovics NS, Gill SR, Vickerman MM, Kolenbrander PE. Role of hydrogen peroxi‐
den competition and cooperation between Streptococcus gordonii and Actinomyces
naeslundii. FEMS Microbiol Ecol. 2008;66:367–379.
[120] de Soet JJ. Dissertation 25 years after date 42. Dental caries and the role of specific
bacteria. Ned Tijdschr Tandheelkd. 2015;122:525–531. DOI: 10.5177/ntvt.2015.10.15177.
[121] Hossain MS, Biswas I. Mutacins from Streptococcus mutans UA159 are active against
multiple streptococcal species. Appl Environ Microbiol. 2011;77:2428–2434.
[122] Kamiya RU, Taiete T, Gonealves RB. Mutacons of Streptococcus mutans. Braz J
Microbiol. 2011;42:1248–1258.
[123] Kreth J, Zhang J, Herzberg MC. Streptococcal antagonism in oral biofilms: Streptococ‐
cus sanguinis and Streptococcus gordonii interfernce with Streptococus mutans. J Bacteriol.
2008;190:4632–4640.
[124] Wang W, Tao R, Tong Z, Ding Y, Kuang R, Zhai S, Liu J, Ni L. Effect of a novel
antimicrobial peptide chrysophsin-1 on oral pathogens and Streptococcus mutans
biofilms. Peptides. 2012;33:212–219.
[125] Cheng L, Weir MD, Zhang K, Xu SM, Chen Q, Zhou X, Xu HHK. Antibacterial
Nanocomposite with Calcium Phosphate and Quaternary Ammonium. Dentres.
2012;91: 460.
[126] Cheng L, Weir MD, Zhang K, Wu EJ, Xu SM, Zhou X, Xu HH. Dental plaque micro‐
cosm biofilm behavior on calcium phosphate nanocomposite with quaternary ammo‐
nium. Dent Mater. 2012;28:853–862.
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
377
Senpuku H. Inhibition of Streptococcus mutans biofilm formation by Streptococcus
salivarius FruA. Appl Environ Microbiol. 2011;77:1572–1580.
[101] Goh SY, Khan SA, Tee KK, Abu Kasim NH, Yin WF, Chan KG. Quorum sensing activity
of Citrobacter amalonaticus L8A, a bacterium isolated from dental plaque. Sci Rep.
2016;6:20702. DOI: 10.1038/srep20702.
[102] Leung V, Dufour D, Lévesque CM. Death and survival in Streptococcus mutans: differing
outcomes of a quorum-sensing signaling peptide. Front Microbiol. 2015;6:1176. DOI:
10.3389/fmicb.2015.01176. eCollection 2015.
[103] Zhang S. Dental caries and vaccination strategy against the major cariogenic patho‐
gen, Streptococcus mutans. Curr Pharm Biotechnol. 2013;14:960–966.
[104] Zhang K, Ou M, Wang W, Ling J. Effects of quorum sensing on cell viability in
Streptococcus mutans biofilm formation. Biochem Biophys Res Commun. 2009;379:933–
938.
[105] Senadheera D, Cvitkovitch DG. Quorum sensing and biofilm formation by Streptococ‐
cus mutans. Adv Exp Med Biol. 2008;631:178–188.
[106] Sztajer H1, Lemme A, Vilchez R, Schulz S, Geffers R, Yip CY, Levesque CM, Cvitko‐
vitch DG, Wagner-Döbler I. Autoinducer-2-regulated genes in Streptococcus mutans
UA159 and global metabolic effect of the luxS mutation. J Bacteriol. 2008;190:401–415.
[107] Mahajan A, Singh B, Kashyap D, Kumar A, Mahajan P. Interspecies communication
and peridontal disease. Sci World J. 2013;2013:765434. DOI: 10.1155/2013/765434.
eCollection 2013.
[108] Kołwzan B. Analysis of biofilms – their formation and functioning. Environmental
Pollution Control 2011;33:3–14.
[109] Koo H, Falsetta ML, Klein MI. The exopolysaccharide matrix: a virulence determi‐
nant of cariogenic biofilm. J Dent Res. 2013;XX:1–9.
[110] Klein MI, Falsetta ML, Xiao J, Bowen WH, Koo H. The role of extracellular polysac‐
charides matrix in virulent oral biofilms. In: Oral Microbial Ecology: Current Research
and New Perspectives, Jakubovics NS, Palmer RJ Jr (editors) Caister Academic Press,
Norfolk, UK. 2013; 63–84.
[111] Kuboniwa M, Tribble GD, Hendrickson EL, Amano A, Richard JL, Hackett M. Insights
into the virulence of oral biofilms: discoveries from proteomics. Expert Rev Proteo‐
misc. 2012;9:311–323.
[112] Liu J, Wu C, Huang I-H, Merritt J, Qi F. Differential response of Streptococcus mutans
towards friend and foe in mixed-species cultures. Microbiology. 2011;157:2433–2444.
[113] Wang B-Y, Deutch A, Hong J, Kuramitsu HK. Proteases of an early colonizer can hinder
Streptococcus mutans colonization in vitro. J Dent Res. 2011;90:201–505.
Microbial Biofilms - Importance and Applications376
[114] Tamura S, Yonezawa H, Motegi M, Nakao R, Yoneda S, Watanabe H, Yamazaki T,
Senpuku H. Inhibiting effects of Streptococcus salivarius on competence-stimulating
peptide-dependent biofilm formation by Streptococcus mutans. Oral Microbiol Immun.
2009;24:125–161.
[115] Kara D, Luppens SBI, van Marle J, Ozok R, ten Cate JM. Microstructural differences
between single-species and dual-species biofilms of Streptococcus mutans and Veillonella
parvula before and after exposure to chlorhexidine. FEMS Microbiol Lett. 2007;271:90–
97.
[116] Standar K, Kreikemeyer B, Redanz S, Munter WJ, Laue M, Podbielski A. Setup of an in
vitro test system for basic studies on biofilm behavior of mixed-species cultures with
dental and peridontal pathogens. PLoS ONE. 2010;5:e13135.
[117] Redanz S, Standar K, Podbielski A, Kreikemeyer B. A five-species transcriptome array
for oral mixed-biofilm studies. PLoS ONE. 2011;6:e27827.
[118] Liu L, Tong H, Dong H. Function of the pyruvate oxidase-lactate oxidase cascade in
interspecies competition between Streptococcus oligofermentas and Streptococcus mutans.
Appl Environ Microbiol. 2012;78:2120–2127.
[119] Jakubovics NS, Gill SR, Vickerman MM, Kolenbrander PE. Role of hydrogen peroxi‐
den competition and cooperation between Streptococcus gordonii and Actinomyces
naeslundii. FEMS Microbiol Ecol. 2008;66:367–379.
[120] de Soet JJ. Dissertation 25 years after date 42. Dental caries and the role of specific
bacteria. Ned Tijdschr Tandheelkd. 2015;122:525–531. DOI: 10.5177/ntvt.2015.10.15177.
[121] Hossain MS, Biswas I. Mutacins from Streptococcus mutans UA159 are active against
multiple streptococcal species. Appl Environ Microbiol. 2011;77:2428–2434.
[122] Kamiya RU, Taiete T, Gonealves RB. Mutacons of Streptococcus mutans. Braz J
Microbiol. 2011;42:1248–1258.
[123] Kreth J, Zhang J, Herzberg MC. Streptococcal antagonism in oral biofilms: Streptococ‐
cus sanguinis and Streptococcus gordonii interfernce with Streptococus mutans. J Bacteriol.
2008;190:4632–4640.
[124] Wang W, Tao R, Tong Z, Ding Y, Kuang R, Zhai S, Liu J, Ni L. Effect of a novel
antimicrobial peptide chrysophsin-1 on oral pathogens and Streptococcus mutans
biofilms. Peptides. 2012;33:212–219.
[125] Cheng L, Weir MD, Zhang K, Xu SM, Chen Q, Zhou X, Xu HHK. Antibacterial
Nanocomposite with Calcium Phosphate and Quaternary Ammonium. Dentres.
2012;91: 460.
[126] Cheng L, Weir MD, Zhang K, Wu EJ, Xu SM, Zhou X, Xu HH. Dental plaque micro‐
cosm biofilm behavior on calcium phosphate nanocomposite with quaternary ammo‐
nium. Dent Mater. 2012;28:853–862.
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
377
Senpuku H. Inhibition of Streptococcus mutans biofilm formation by Streptococcus
salivarius FruA. Appl Environ Microbiol. 2011;77:1572–1580.
[101] Goh SY, Khan SA, Tee KK, Abu Kasim NH, Yin WF, Chan KG. Quorum sensing activity
of Citrobacter amalonaticus L8A, a bacterium isolated from dental plaque. Sci Rep.
2016;6:20702. DOI: 10.1038/srep20702.
[102] Leung V, Dufour D, Lévesque CM. Death and survival in Streptococcus mutans: differing
outcomes of a quorum-sensing signaling peptide. Front Microbiol. 2015;6:1176. DOI:
10.3389/fmicb.2015.01176. eCollection 2015.
[103] Zhang S. Dental caries and vaccination strategy against the major cariogenic patho‐
gen, Streptococcus mutans. Curr Pharm Biotechnol. 2013;14:960–966.
[104] Zhang K, Ou M, Wang W, Ling J. Effects of quorum sensing on cell viability in
Streptococcus mutans biofilm formation. Biochem Biophys Res Commun. 2009;379:933–
938.
[105] Senadheera D, Cvitkovitch DG. Quorum sensing and biofilm formation by Streptococ‐
cus mutans. Adv Exp Med Biol. 2008;631:178–188.
[106] Sztajer H1, Lemme A, Vilchez R, Schulz S, Geffers R, Yip CY, Levesque CM, Cvitko‐
vitch DG, Wagner-Döbler I. Autoinducer-2-regulated genes in Streptococcus mutans
UA159 and global metabolic effect of the luxS mutation. J Bacteriol. 2008;190:401–415.
[107] Mahajan A, Singh B, Kashyap D, Kumar A, Mahajan P. Interspecies communication
and peridontal disease. Sci World J. 2013;2013:765434. DOI: 10.1155/2013/765434.
eCollection 2013.
[108] Kołwzan B. Analysis of biofilms – their formation and functioning. Environmental
Pollution Control 2011;33:3–14.
[109] Koo H, Falsetta ML, Klein MI. The exopolysaccharide matrix: a virulence determi‐
nant of cariogenic biofilm. J Dent Res. 2013;XX:1–9.
[110] Klein MI, Falsetta ML, Xiao J, Bowen WH, Koo H. The role of extracellular polysac‐
charides matrix in virulent oral biofilms. In: Oral Microbial Ecology: Current Research
and New Perspectives, Jakubovics NS, Palmer RJ Jr (editors) Caister Academic Press,
Norfolk, UK. 2013; 63–84.
[111] Kuboniwa M, Tribble GD, Hendrickson EL, Amano A, Richard JL, Hackett M. Insights
into the virulence of oral biofilms: discoveries from proteomics. Expert Rev Proteo‐
misc. 2012;9:311–323.
[112] Liu J, Wu C, Huang I-H, Merritt J, Qi F. Differential response of Streptococcus mutans
towards friend and foe in mixed-species cultures. Microbiology. 2011;157:2433–2444.
[113] Wang B-Y, Deutch A, Hong J, Kuramitsu HK. Proteases of an early colonizer can hinder
Streptococcus mutans colonization in vitro. J Dent Res. 2011;90:201–505.
Microbial Biofilms - Importance and Applications376
[140] Helmerhorst EJ, Van't Hof W, Veerman EC, Simoons-Smit I, Nieuw Amerongen AV.
Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochem J.
1997;326:39–45.
[141] Groenink J, Ruissen AL, Lowies D, van 't Hof W, Veerman EC, Nieuw Amerongen AV.
Degradation of antimicrobial histatin-variant peptides in Staphylococcus aureus and
Streptococcus mutans. J Dent Res. 2003;82:753–757.
[142] Alvarez-Sieiro P, Montalbán-López M, Mu D, Kuipers OP. Bacteriocins of lactic acid
bacteria: extending the family. Appl Microbiol Biotechnol. 2016 Feb 10. [Epub ahead of
print].
[143] Tong Z, Ni L, Ling J. Antibacterial peptide nisin: a potential role in the inhibition of
oral pathogenic bacteria. Peptides. 2014;60:32–40. DOI: 10.1016/j.peptides.2014.07.020.
[144] Bajjar MB, Kashtanov D, Chikindas ML. Natural antimicrobials e-Poly-L-lysine and
nisin A for control of oral microflora. Probiotics and Antimicro Prot. 2009;1:143–147.
[145] Merritt J, Qi F. The mutacins of Streptococcus mutans: regulation and ecology. Mol Oral
Microbiol. 2012;27:57–69. DOI: 10.1111/j.2041-1014.2011.00634.x.
[146] Shafiei Z, Shuhairi NN, Md Fazly Shah Yap N, Harry Sibungkil CA, Latip J. Antibac‐
terial Activity of Myristica fragrans against Oral Pathogens. Evid Based Complement
Alternat Med. 2012;2012:825362. DOI: 10.1155/2012/825362.
[147] Noumedem JA, Mihasan M, Lacmata ST, Tefan M, Kuiate JR, Kuete V. Antibacterial
activities of the methanol extracts of ten Cameroonian vegetables against gram-
negative multidrug-resistant bacteria. BMC Complement Altern Med. 2013;13:26.
[148] Chen MH. Update on dental nanocomposites. J Dent Res. 2010;89:549–560.
[149] Durani P, Leaper D. Povidone-iodine: use in hand disinfection, skin preparation and
antiseptic irrigation. Int Wound J. 2008;5:376–387.
[150] Anderson MJ, Horn ME, Lin YC, Parks PJ, Peterson ML. Efficacy of concurrent
application of chlorhexidine gluconate and povidone iodine against six nosocomial
pathogens. Am J Infect Control. 2010;38:826–831.
[151] Hosaka Y, Saito A, Maeda R, Fukaya C, Morikawa S, Makino A, Ishihara K, Nakaga‐
wa T. Antibacterial activity of povidone-iodine against an artificial biofilm of
Porphyromonas gingivalis and Fusobacterium nucleatum. Arch Oral Biol. 2012;57:364–
368.
[152] Simratvir M, Singh N, Chopra S, Thomas AM. Efficacy of 10% Povidone Iodine in
children affected with early childhood caries: an in vivo study. J Clin Pediatr Dent.
2010;34:233–238.
[153] Yoshida A, Kuramitsu HK. Multiple Streptococcus mutans are involved in biofilm
formation. Appl Environ Microbiol. 2002;68:6283–6291.
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
379
[127] Lee VA, Karthikeyan R, Rawls HR, Amaechi BT. Anti-cariogenic effect of a cetylpyri‐
dinium chloride-containing nanoemulsion. J Dent. 2010;38:742–749.
[128] Cheng L, Zhang K, Weir MD, Liu H, Zhou X, Xu HH. Effects of antibacterial primers
with quaternary ammonium and nano-silver on Streptococcus mutans impregnated in
human dentin blocks. Dent Mater. 2013;29:462–472. DOI: 10.1016/j.dental.2013.01.011.
[129] Zhang K, Cheng L, Imazato S, Antonucci JM, Lin NJ, Lin-Gibson S, Bai Y, Xu HH. Effects
of dual antibacterial agents MDPB and nano-silver in primer on microcosm biofilm,
cytotoxicity and dentine bond properties. J Dent. 2013;41:464–474. DOI: 10.1016/j.jdent.
2013.02.001.
[130] Kim YJ, Lee DY, Lee JY, Lim YK. The effect of silver ion-releasing elastomers on mutans
streptococci in dental plaque. Korean J Orthod. 2012;42:87–93.
[131] You C, Han C, Wang X, Zheng Y, Li Q, Hu X, Sun H. The progress of silver nanopar‐
ticles in the antibacterial mechanism, clinical application and cytotoxicity. Mol Biol
Rep. 2012;39:9193–9201.
[132] Mei ML1, Chu CH, Low KH, Che CM, Lo EC. Caries arresting effect of silver dia‐
mine fluoride on dentine carious lesion with S. mutans and L. acidophilus dual-species
cariogenic biofilm. Med Oral Patol Oral Cir Bucal. 2013;18:e824-31.
[133] Milgrom P, Chi DL. Prevention-centered caries management strategies during critical
periods in early childhood. J Calif Dent Assoc. 2011;39:735–741.
[134] Chu CH, Mei L, Seneviratne CJ, Lo EC. Effects of silver diamine fluoride on dentine
carious lesions induced by Streptococcus mutans and Actinomyces naeslundii biofilms. Int
J Paediatr Dent. 2012;22:2–10.
[135] Chen CY, Chung YC. Antibacterial effect of water-soluble chitosan on representative
dental pathogens Streptococcus mutans and Lactobacilli brevis. J Appl Oral Sci.
2012;20:620–627.
[136] Wang W, Tao R, Tong Z, Ding Y, Kuang R, Zhai S, Liu J, Ni L. Effect of a novel
antimicrobial peptide chrysophsin-1 on oral pathogens and Streptococcus mutans
biofilms. Peptides. 2012;33:212–219. DOI: 10.1016/j.peptides.2012.01.006.
[137] Pepperney A, Chikindas ML. Antibacterial peptides: opportunities for the prevention
and treatment of dental caries. Probiotics Antimicrob Proteins. 2011;3:68. DOI: 10.1007/
s12602-011-9076-5.
[138] Frenkel ES, Ribbeck K. Salivary mucins protect surfaces from colonization by cario‐
genic bacteria. Appl Environ Microbiol. 2015;81:332–338. DOI: 10.1128/AEM.02573-14.
[139] Huo L, Zhang K, Ling J, Peng Z, Huang X, Liu H, Gu L. Antimicrobial and DNA-binding
activities of the peptide fragments of human lactoferrin and histatin 5 against
Streptococcus mutans. Arch Oral Biol. 2011;56:869–876. DOI: 10.1016/j.archoralbio.
2011.02.004. Epub 2011 Mar 5.
Microbial Biofilms - Importance and Applications378
[140] Helmerhorst EJ, Van't Hof W, Veerman EC, Simoons-Smit I, Nieuw Amerongen AV.
Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochem J.
1997;326:39–45.
[141] Groenink J, Ruissen AL, Lowies D, van 't Hof W, Veerman EC, Nieuw Amerongen AV.
Degradation of antimicrobial histatin-variant peptides in Staphylococcus aureus and
Streptococcus mutans. J Dent Res. 2003;82:753–757.
[142] Alvarez-Sieiro P, Montalbán-López M, Mu D, Kuipers OP. Bacteriocins of lactic acid
bacteria: extending the family. Appl Microbiol Biotechnol. 2016 Feb 10. [Epub ahead of
print].
[143] Tong Z, Ni L, Ling J. Antibacterial peptide nisin: a potential role in the inhibition of
oral pathogenic bacteria. Peptides. 2014;60:32–40. DOI: 10.1016/j.peptides.2014.07.020.
[144] Bajjar MB, Kashtanov D, Chikindas ML. Natural antimicrobials e-Poly-L-lysine and
nisin A for control of oral microflora. Probiotics and Antimicro Prot. 2009;1:143–147.
[145] Merritt J, Qi F. The mutacins of Streptococcus mutans: regulation and ecology. Mol Oral
Microbiol. 2012;27:57–69. DOI: 10.1111/j.2041-1014.2011.00634.x.
[146] Shafiei Z, Shuhairi NN, Md Fazly Shah Yap N, Harry Sibungkil CA, Latip J. Antibac‐
terial Activity of Myristica fragrans against Oral Pathogens. Evid Based Complement
Alternat Med. 2012;2012:825362. DOI: 10.1155/2012/825362.
[147] Noumedem JA, Mihasan M, Lacmata ST, Tefan M, Kuiate JR, Kuete V. Antibacterial
activities of the methanol extracts of ten Cameroonian vegetables against gram-
negative multidrug-resistant bacteria. BMC Complement Altern Med. 2013;13:26.
[148] Chen MH. Update on dental nanocomposites. J Dent Res. 2010;89:549–560.
[149] Durani P, Leaper D. Povidone-iodine: use in hand disinfection, skin preparation and
antiseptic irrigation. Int Wound J. 2008;5:376–387.
[150] Anderson MJ, Horn ME, Lin YC, Parks PJ, Peterson ML. Efficacy of concurrent
application of chlorhexidine gluconate and povidone iodine against six nosocomial
pathogens. Am J Infect Control. 2010;38:826–831.
[151] Hosaka Y, Saito A, Maeda R, Fukaya C, Morikawa S, Makino A, Ishihara K, Nakaga‐
wa T. Antibacterial activity of povidone-iodine against an artificial biofilm of
Porphyromonas gingivalis and Fusobacterium nucleatum. Arch Oral Biol. 2012;57:364–
368.
[152] Simratvir M, Singh N, Chopra S, Thomas AM. Efficacy of 10% Povidone Iodine in
children affected with early childhood caries: an in vivo study. J Clin Pediatr Dent.
2010;34:233–238.
[153] Yoshida A, Kuramitsu HK. Multiple Streptococcus mutans are involved in biofilm
formation. Appl Environ Microbiol. 2002;68:6283–6291.
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
379
[127] Lee VA, Karthikeyan R, Rawls HR, Amaechi BT. Anti-cariogenic effect of a cetylpyri‐
dinium chloride-containing nanoemulsion. J Dent. 2010;38:742–749.
[128] Cheng L, Zhang K, Weir MD, Liu H, Zhou X, Xu HH. Effects of antibacterial primers
with quaternary ammonium and nano-silver on Streptococcus mutans impregnated in
human dentin blocks. Dent Mater. 2013;29:462–472. DOI: 10.1016/j.dental.2013.01.011.
[129] Zhang K, Cheng L, Imazato S, Antonucci JM, Lin NJ, Lin-Gibson S, Bai Y, Xu HH. Effects
of dual antibacterial agents MDPB and nano-silver in primer on microcosm biofilm,
cytotoxicity and dentine bond properties. J Dent. 2013;41:464–474. DOI: 10.1016/j.jdent.
2013.02.001.
[130] Kim YJ, Lee DY, Lee JY, Lim YK. The effect of silver ion-releasing elastomers on mutans
streptococci in dental plaque. Korean J Orthod. 2012;42:87–93.
[131] You C, Han C, Wang X, Zheng Y, Li Q, Hu X, Sun H. The progress of silver nanopar‐
ticles in the antibacterial mechanism, clinical application and cytotoxicity. Mol Biol
Rep. 2012;39:9193–9201.
[132] Mei ML1, Chu CH, Low KH, Che CM, Lo EC. Caries arresting effect of silver dia‐
mine fluoride on dentine carious lesion with S. mutans and L. acidophilus dual-species
cariogenic biofilm. Med Oral Patol Oral Cir Bucal. 2013;18:e824-31.
[133] Milgrom P, Chi DL. Prevention-centered caries management strategies during critical
periods in early childhood. J Calif Dent Assoc. 2011;39:735–741.
[134] Chu CH, Mei L, Seneviratne CJ, Lo EC. Effects of silver diamine fluoride on dentine
carious lesions induced by Streptococcus mutans and Actinomyces naeslundii biofilms. Int
J Paediatr Dent. 2012;22:2–10.
[135] Chen CY, Chung YC. Antibacterial effect of water-soluble chitosan on representative
dental pathogens Streptococcus mutans and Lactobacilli brevis. J Appl Oral Sci.
2012;20:620–627.
[136] Wang W, Tao R, Tong Z, Ding Y, Kuang R, Zhai S, Liu J, Ni L. Effect of a novel
antimicrobial peptide chrysophsin-1 on oral pathogens and Streptococcus mutans
biofilms. Peptides. 2012;33:212–219. DOI: 10.1016/j.peptides.2012.01.006.
[137] Pepperney A, Chikindas ML. Antibacterial peptides: opportunities for the prevention
and treatment of dental caries. Probiotics Antimicrob Proteins. 2011;3:68. DOI: 10.1007/
s12602-011-9076-5.
[138] Frenkel ES, Ribbeck K. Salivary mucins protect surfaces from colonization by cario‐
genic bacteria. Appl Environ Microbiol. 2015;81:332–338. DOI: 10.1128/AEM.02573-14.
[139] Huo L, Zhang K, Ling J, Peng Z, Huang X, Liu H, Gu L. Antimicrobial and DNA-binding
activities of the peptide fragments of human lactoferrin and histatin 5 against
Streptococcus mutans. Arch Oral Biol. 2011;56:869–876. DOI: 10.1016/j.archoralbio.
2011.02.004. Epub 2011 Mar 5.
Microbial Biofilms - Importance and Applications378
[168] Yang F, Zeng X, Ning K, Liu KL, Lo CC, Wang W, Chen J, Wang D, Huang R, Chang
X, Chain PS, Xie G, Ling J, Xu J. Saliva microbiomes distinguish caries-active from
healthy human populations. ISME J. 2012;6:1–10. DOI: 10.1038/ismej.2011.71.
[169] Gomar-Vercher S, Cabrera-Rubio R, Mira A, Almerich-Silla J. Relationship of chil‐
dren’s salivary microbiota with their caries status: a pyrosequencing study. Clin Oral
Investig. 2014;18:2087–2094. DOI: 10.1007/s00784-014-1200-y.
[170] Obata J, Takeshita T, Shibata Y, Yamanaka W, Unemori M, Akamine A, Yamashita Y.
Identification of the microbiota in carious dentin lesions using 16S rRNA gene
sequencing. PLo SONE 2014;9:e103712. DOI:10.1371/journal.pone.0103712.
[171] Costa MT, Dorta ML, Ribeiro-Dias F, Pimenta FC. Biofilms of black tooth stains: PCR
analysis reveals presence of Streptococcus mutans. Braz Dent J. 2012;23:555–558.
[172] Kim do K, Kim KH, Cho EJ, Joo SJ, Chung JM, Son BY, Yum JH, Kim YM, Kwon HJ,
Kim BW, Kim TH, Lee EW. Gene cloning and characterization of MdeA, a novel
multidrug efflux pump in Streptococcus mutans. J Microbiol Biotechnol. 2013;23:430–435.
[173] Koyanagi S, Lévesque CM. Characterization of a Streptococcus mutans intergenic region
containing a small toxic peptide and its cis-encoded antisense small RNA antitoxin.
PLoS One. 2013;8:e54291.
[174] Lazarevic V, Whiteson K, Huse S, Hernandez D, Farinelli L, Osterås M, Schrenzel J,
François P. Metagenomic study of the oral microbiota by Illumina high-throughput
sequencing. J Microbiol Methods. 2009;79:266–271. DOI: 10.1016/j.mimet.2009.09.012.
[175] Simsek AD, Sezer S, Ozdemir NF, Mehmet H. Streptococcus vestibularis bacteremia
following dental extraction in a patient on long-term hemodialysis: a case report. NDT
Plus 2008;1:276–277.
[176] Willcox MD, Knox KW, Green RM, Drucker DB. An examination of strains of the
bacterium Streptococcus vestibularis for relative cariogenicity in gnotobiotic rats and
adhesion in vitro. Arch Oral Biol. 1991;36:327–333.
[177] Matsumoto M, Tsuji M, Sasaki H, Fujita K, Nomura R, Nakano K, Shintani S, Ooshima
T. Cariogenicity of the probiotic bacterium Lactobacillus salivarius in rats. Caries Res.
2005;39:479–483.
[178] Sheng J, Baldeck JD, Nguyen PT, Quivey RG Jr, Marquis RE. Alkali production
associated with malolactic fermentation by oral streptococci and protection against
acid, oxidative, or starvation damage. Can J Microbiol. 2010;56:539–47. DOI: 10.1139/
w10-039.
[179] Whiley RA, Fraser HY, Douglas CW, Hardie JM, Williams AM, Collins MD. Strepto‐
coccus parasanguis sp. nov, an atypical viridans Streptococcus from human clinical
specimens. FEMS Microbiol Lett. 1990;56:115–121.
[180] Garnett JA, Simpson PJ, Taylor J, Benjamin SV, Tagliaferri C, Cota E, Chen YY, Wu H,
Matthews S. Structural insight into the role of Streptococcus parasanguinis Fap1 within
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
381
[154] Dalwi F, Spratt DA, Pratten J. Use of quantitative PCR and culture methods to
characterize ecological flux in bacterial biofilms. J Clin Microbiol. 2007;45:3072–3076.
[155] Edlund A, Yang Y, Hall AP, Guo L, Lux R, He X, Nelson KE, Nealson KH, Yooseph S,
Shi W, McLean JS. An in vitro biofilm model system maintaining a highly reproduci‐
ble species and metabolic diversity approaching that of the human oral microbiome.
Microbiome. 2013;1:25. DOI: 10.1186/2049-2618-1-25.
[156] Wade WG. The oral microbiome in health and disease. Pharmacol Res. 2013;69:137–
143.
[157] Johansson I, Witkowska E, Kaveh B, Lif Holgerson P, Tanner AC. The microbiome in
populations with a low and high prevalence of caries. J Dent Res. 2016;95:80–86. DOI:
10.1177/0022034515609554.
[158] Benitez-Paez A, Belda-Ferre P, Mira A. Microbiota diversity and gene expression
dynamics in human oral biofilm. BMC Genomics. 2014;15:311–323.
[159] Jiang W, Ling Z, Lin X, Chen Y, Zhang J, Yu J, Xiang C, Chen H. Pyrosequencing analysis
of oral microbiota shitfig in vorious caries states in childhood. Microb Ecol. 2014;67:962–
969.
[160] Zaura E, Keijser BJF, Huse SM, Crielaard W. Defining the healthy "core microbiome"
of oral microbial communities. BMC Microbiol. 2009;9:259–270.
[161] Keijser BJF, Zaura E, Huse SM, Van der Vossen JMBM, Schuren FHJ, Montijn RC, ten
Cate JM, Crielaard W. Pyrosequencing analysis of the oral microflora of healthy adults.
J Dent Res. 2008;87:1016–1020.
[162] Usha C, Sathyanarayanan R. Dental caries—a complete changeover (part I). J Conserv
Dent. 2009;12:46–54.
[163] Bowden G. Does assessment of microbial composition of plaque/saliva allow for
diagnosis of disease activity of individuals? Community Dent Oral Epidemiol.
1997;25:76–81.DOI:10.1111/j.1600-0528.1997.tb00902.x
[164] Chen H, Jiang W. Application of high-throughput sequencing in understanding human
oral microbiome related with health and disease. Front Microbiol. 2014;5:508. DOI:
10.3389/fmicb.2014.00508. Collection Review.
[165] Kashket S, Zhang J, Van Houte J. Accumulation of fermentable sugars and metabolic
acids in food particles that become entrapped on the dentition. J Dent Res 1996;75:1885–
1891.DOI:10.1177/00220345960750111101.
[166] Heinrich-Weltzien R, Bartsch B, Eick S. Dental caries and microbiota in children with
black stain and non-discoloured dental plaque. Caries Res. 2014;48:118–125.
[167] Jiang W, Zhang J, I Chen H. Pyrosequencing analysis of oral microbiota in children
with severe early childhood dental caries. Curr Microbiol. 2013;67:537–542. DOI:
10.1007/s00284-013-0393-7.
Microbial Biofilms - Importance and Applications380
[168] Yang F, Zeng X, Ning K, Liu KL, Lo CC, Wang W, Chen J, Wang D, Huang R, Chang
X, Chain PS, Xie G, Ling J, Xu J. Saliva microbiomes distinguish caries-active from
healthy human populations. ISME J. 2012;6:1–10. DOI: 10.1038/ismej.2011.71.
[169] Gomar-Vercher S, Cabrera-Rubio R, Mira A, Almerich-Silla J. Relationship of chil‐
dren’s salivary microbiota with their caries status: a pyrosequencing study. Clin Oral
Investig. 2014;18:2087–2094. DOI: 10.1007/s00784-014-1200-y.
[170] Obata J, Takeshita T, Shibata Y, Yamanaka W, Unemori M, Akamine A, Yamashita Y.
Identification of the microbiota in carious dentin lesions using 16S rRNA gene
sequencing. PLo SONE 2014;9:e103712. DOI:10.1371/journal.pone.0103712.
[171] Costa MT, Dorta ML, Ribeiro-Dias F, Pimenta FC. Biofilms of black tooth stains: PCR
analysis reveals presence of Streptococcus mutans. Braz Dent J. 2012;23:555–558.
[172] Kim do K, Kim KH, Cho EJ, Joo SJ, Chung JM, Son BY, Yum JH, Kim YM, Kwon HJ,
Kim BW, Kim TH, Lee EW. Gene cloning and characterization of MdeA, a novel
multidrug efflux pump in Streptococcus mutans. J Microbiol Biotechnol. 2013;23:430–435.
[173] Koyanagi S, Lévesque CM. Characterization of a Streptococcus mutans intergenic region
containing a small toxic peptide and its cis-encoded antisense small RNA antitoxin.
PLoS One. 2013;8:e54291.
[174] Lazarevic V, Whiteson K, Huse S, Hernandez D, Farinelli L, Osterås M, Schrenzel J,
François P. Metagenomic study of the oral microbiota by Illumina high-throughput
sequencing. J Microbiol Methods. 2009;79:266–271. DOI: 10.1016/j.mimet.2009.09.012.
[175] Simsek AD, Sezer S, Ozdemir NF, Mehmet H. Streptococcus vestibularis bacteremia
following dental extraction in a patient on long-term hemodialysis: a case report. NDT
Plus 2008;1:276–277.
[176] Willcox MD, Knox KW, Green RM, Drucker DB. An examination of strains of the
bacterium Streptococcus vestibularis for relative cariogenicity in gnotobiotic rats and
adhesion in vitro. Arch Oral Biol. 1991;36:327–333.
[177] Matsumoto M, Tsuji M, Sasaki H, Fujita K, Nomura R, Nakano K, Shintani S, Ooshima
T. Cariogenicity of the probiotic bacterium Lactobacillus salivarius in rats. Caries Res.
2005;39:479–483.
[178] Sheng J, Baldeck JD, Nguyen PT, Quivey RG Jr, Marquis RE. Alkali production
associated with malolactic fermentation by oral streptococci and protection against
acid, oxidative, or starvation damage. Can J Microbiol. 2010;56:539–47. DOI: 10.1139/
w10-039.
[179] Whiley RA, Fraser HY, Douglas CW, Hardie JM, Williams AM, Collins MD. Strepto‐
coccus parasanguis sp. nov, an atypical viridans Streptococcus from human clinical
specimens. FEMS Microbiol Lett. 1990;56:115–121.
[180] Garnett JA, Simpson PJ, Taylor J, Benjamin SV, Tagliaferri C, Cota E, Chen YY, Wu H,
Matthews S. Structural insight into the role of Streptococcus parasanguinis Fap1 within
The Role of Human Oral Microbiome in Dental Biofilm Formation
http://dx.doi.org/10.5772/63492
381
[154] Dalwi F, Spratt DA, Pratten J. Use of quantitative PCR and culture methods to
characterize ecological flux in bacterial biofilms. J Clin Microbiol. 2007;45:3072–3076.
[155] Edlund A, Yang Y, Hall AP, Guo L, Lux R, He X, Nelson KE, Nealson KH, Yooseph S,
Shi W, McLean JS. An in vitro biofilm model system maintaining a highly reproduci‐
ble species and metabolic diversity approaching that of the human oral microbiome.
Microbiome. 2013;1:25. DOI: 10.1186/2049-2618-1-25.
[156] Wade WG. The oral microbiome in health and disease. Pharmacol Res. 2013;69:137–
143.
[157] Johansson I, Witkowska E, Kaveh B, Lif Holgerson P, Tanner AC. The microbiome in
populations with a low and high prevalence of caries. J Dent Res. 2016;95:80–86. DOI:
10.1177/0022034515609554.
[158] Benitez-Paez A, Belda-Ferre P, Mira A. Microbiota diversity and gene expression
dynamics in human oral biofilm. BMC Genomics. 2014;15:311–323.
[159] Jiang W, Ling Z, Lin X, Chen Y, Zhang J, Yu J, Xiang C, Chen H. Pyrosequencing analysis
of oral microbiota shitfig in vorious caries states in childhood. Microb Ecol. 2014;67:962–
969.
[160] Zaura E, Keijser BJF, Huse SM, Crielaard W. Defining the healthy "core microbiome"
of oral microbial communities. BMC Microbiol. 2009;9:259–270.
[161] Keijser BJF, Zaura E, Huse SM, Van der Vossen JMBM, Schuren FHJ, Montijn RC, ten
Cate JM, Crielaard W. Pyrosequencing analysis of the oral microflora of healthy adults.
J Dent Res. 2008;87:1016–1020.
[162] Usha C, Sathyanarayanan R. Dental caries—a complete changeover (part I). J Conserv
Dent. 2009;12:46–54.
[163] Bowden G. Does assessment of microbial composition of plaque/saliva allow for
diagnosis of disease activity of individuals? Community Dent Oral Epidemiol.
1997;25:76–81.DOI:10.1111/j.1600-0528.1997.tb00902.x
[164] Chen H, Jiang W. Application of high-throughput sequencing in understanding human
oral microbiome related with health and disease. Front Microbiol. 2014;5:508. DOI:
10.3389/fmicb.2014.00508. Collection Review.
[165] Kashket S, Zhang J, Van Houte J. Accumulation of fermentable sugars and metabolic
acids in food particles that become entrapped on the dentition. J Dent Res 1996;75:1885–
1891.DOI:10.1177/00220345960750111101.
[166] Heinrich-Weltzien R, Bartsch B, Eick S. Dental caries and microbiota in children with
black stain and non-discoloured dental plaque. Caries Res. 2014;48:118–125.
[167] Jiang W, Zhang J, I Chen H. Pyrosequencing analysis of oral microbiota in children
with severe early childhood dental caries. Curr Microbiol. 2013;67:537–542. DOI:
10.1007/s00284-013-0393-7.
Microbial Biofilms - Importance and Applications380
Chapter 17
Surface Biofilm Interactions in Epizootic Shell Disease of
the American Lobster (Homarus americanus)
Norman J. Meres
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/63498
Abstract
Epizootic  shell  disease (ESD) is  a persistent malady that affects  American lobsters
(Homarus americanus) in the southern extent of the commercial fishery. Emerging at the
turn of the 21st century, ESD presented as bacterial ulcerations on the carapace of
affected lobsters. The research presented here examined the bacterial community of the
lobster  carapace and represented the first  such attempt to  characterize  the lobster
surface  microbiome.  Culture‐independent  techniques,  such  as  amplicon  length
heterogeneity and pyrosequencing, yielded sequence data of hypervariable regions of
the genes for ribosomal RNA that upon comparison revealed the likely identities of the
taxa present on the lobster carapace. Although some researchers have identified a novel
chitinolytic bacterium of the genus Aquimarina (A. homaria) as consistently appearing
on lobsters with shell disease, this research found no evidence of a correlation of this
species with the disease.  Instead, analysis revealed that the genus Aquimarina  was
ubiquitous and correlated only weakly with the diseased state. The data suggest that
this disease is not caused by a single pathogen but by a state of dysbiosis where normally
occurring microflora emerge as potential opportunistic pathogens when there is some
apparent environmental stressor that alters the interaction of the surface biofilm of the
lobster.
Keywords: epizootic shell disease, lobster microbiome, next‐generation sequencing,
multitag pyrosequencing, amplicon length heterogeneity
1. Introduction
Since the end of the 20th century, American lobsters (Homarus americanus) have suffered from
a host of problems that have led to morbidity and mortality. Some appear to be environmen‐
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
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Abstract
Epizootic  shell  disease (ESD) is  a persistent malady that affects  American lobsters
(Homarus americanus) in the southern extent of the commercial fishery. Emerging at the
turn of the 21st century, ESD presented as bacterial ulcerations on the carapace of
affected lobsters. The research presented here examined the bacterial community of the
lobster  carapace and represented the first  such attempt to  characterize  the lobster
surface  microbiome.  Culture‐independent  techniques,  such  as  amplicon  length
heterogeneity and pyrosequencing, yielded sequence data of hypervariable regions of
the genes for ribosomal RNA that upon comparison revealed the likely identities of the
taxa present on the lobster carapace. Although some researchers have identified a novel
chitinolytic bacterium of the genus Aquimarina (A. homaria) as consistently appearing
on lobsters with shell disease, this research found no evidence of a correlation of this
species with the disease.  Instead, analysis revealed that the genus Aquimarina  was
ubiquitous and correlated only weakly with the diseased state. The data suggest that
this disease is not caused by a single pathogen but by a state of dysbiosis where normally
occurring microflora emerge as potential opportunistic pathogens when there is some
apparent environmental stressor that alters the interaction of the surface biofilm of the
lobster.
Keywords: epizootic shell disease, lobster microbiome, next‐generation sequencing,
multitag pyrosequencing, amplicon length heterogeneity
1. Introduction
Since the end of the 20th century, American lobsters (Homarus americanus) have suffered from
a host of problems that have led to morbidity and mortality. Some appear to be environmen‐
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mation in the underlying connective tissue or other evidence of an immune response is rarely
observed at this stage. Bacteria are found in the leading edges of the lesion and in the crystalline
chitin lattice.
Category 2 lesions are moderately deep, penetrating the calcified endocuticle. The crystal‐
line lattice structure of the chitin takes on a “pillar‐like” appearance as the bacteria degrade
the protein structure between the lattice crystals. The endocuticle exhibits melanization,
especially in the vertical areas of bacterial incursion. Evidence of immune response to the
infection includes inflammation of the underlying cuticular epithelium and “moderate
numbers” of hemocytes in the tissues. Secondary invasion by small protists occurs during this
stage. These organisms are apparently responsible for the degradation of the crystal lattice
structure of the chitin. In some category 2 lesions, an “inflammatory cuticle” forms between
the uncalcified endocuticle and the cuticular epithelium. The latter has some areas of hyper‐
plasia and hypertrophy.
Deeper erosions into the uncalcified endocuticle are characterized as category 3 lesions. At this
stage, the overlying structures of the carapace are absent, and the exposed areas are melan‐
ized. The cuticular epithelium is hyperplastic and hypertrophic and exhibits an intense
inflammatory response accompanied by greater hemocyte infiltration. The underlying
connective tissue also exhibited signs of inflammation and immune response. The most
extreme types of category 3 lesions had no more tissue than the inflammatory cuticle overly‐
ing the cuticular epithelium. In some cases, the lesions progressed to ulcerations, which were
characterized by a complete absence of cuticular tissue and cuticular epithelium. Degranulat‐
ed hemocytes developed a multilayered pseudomembrane to cover the connective tissue. The
outer layer of the pseudomembrane was necrotic and melanized.
Certain groups of bacteria have been found as common constituents on the carapaces of
moribund lobsters, and overall populations of bacteria are higher than on the carapaces of
healthy lobsters [11]. Using a combination of culture‐dependent techniques, polymerase chain
reaction (PCR), and denaturing gradient gel electrophoresis, the group of Chisosterdov
isolated three novel bacteria that were ubiquitous in ESD lesions: Aquimarina homaria I32.4,
Thalassobius sp. 131.1, and Pseudoalteromonas gracilis ISA7.3 [11]. Quinn et al. [12] were
successful at initiating lesions that are histologically similar to ESD in captive lobsters using
these three bacteria. The abrasion of the carapace was necessary for lesions to form. Research‐
ers were also able to isolate A. homaria from lesions in “diet‐induced” shell disease. These
lobsters were fed strictly herring and were deprived of sources of astaxanthan, rendering them
nearly colorless [13].
The characterization of microbial communities using terminal restriction fragment length
polymorphism revealed that, although no grossly significant difference in communities on
healthy lobsters was present compared to diseased lobsters, there were some minor differen‐
ces [14]. More anaerobic bacteria and greater numbers of α‐ and β‐proteobacteria were found
in the lesions. Bell et al. used lobsters from eastern and western Long Island Sound. Lobsters
from a coastal Maine site were used as reference specimens. This study also elucidated the
activities of four bacterial ectohydrolases on shell samples from healthy and diseased
specimens and found that, whereas chitinase activity was high in all samples, cellulase and
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tal, such as increased bottom temperatures during the summer season, and general effects of
eutrophication [1]. Others are possibly the result of intoxication from anthropogenic substan‐
ces [2]. Emergent pathogens, such as paramoebiasis, have significantly reduced commercially
important populations in western Long Island Sound and elsewhere [1]. What makes this
situation especially problematic is that the observed decline in lobster health and viability may
have causes that can be linked to a convergence of environmental stressors and pathogenic
microorganisms.
One such challenge to lobster health that is reducing the quality, and possibly the quantity, of
commercial landings is epizootic shell disease (ESD), a condition that is manifesting itself in
geographically isolated portions of the commercial lobster fishing grounds [3].
Documentation of diseases that cause lesions and ulcerations in the carapace of lobsters can
be found at least as early as 1937 [4]. Initial reports of shell disease in other crustaceans are
contemporary with Sindermann [5]. In many cases, the pathology appeared to be linked to
degraded environments, such as the proximity to pollution sources, for example, the munici‐
pal waste dump site in an offshore canyon used by New York City where lobsters and crabs
presented with shell disease [6, 7]. Another common place to find crustacean shell diseases is
in commercial impoundment facilities [5]. In this situation, chitinolytic bacteria appeared to
be eroding the carapace faster than it could be replaced by molting, leading to a pitting of the
cuticle. However, there has only been one report of an infectious process after the lobster's
carapace was abraded and swabbed with Vibrio sp. [8]. Waddy et al. described the integu‐
ment during the intermolt phase as consisting of four layers, beginning externally: the
epicuticle, the exocuticle, the endocuticle, and the membranous layer [9]. Beneath these four
layers are the epidermis, the basement membrane, and the connective tissue. The transport to
the epicuticle of extracellular substances, presumably with protective properties, from the
epidermis occurs through pore canals that transverse the exoskeleton. All but the membra‐
nous layer is calcified either with regularly organized calcite crystals or with amorphous
calcium carbonate and all but the epicuticle contains the acetyl‐aminated polysaccharide,
chitin.
In the epicuticle, calcification consists of spherulitic calcite surrounded by a lipid‐protein
matrix; in the exocuticle and endocuticle, calcite crystals are dispersed throughout chitin‐
protein fibers that are referred to as lamellae. In addition, the exocuticle contains trabeculae
that are composed of apatite (calcium phosphate) that resembles spongy bone tissue in
vertebrates [10]. The endocuticle is the most calcified layer of the exoskeleton [11].
According to Smolowitz et al. [3], ESD is identifiable by erosions of the carapace that have a
unique histology. The presence of lesions on the carapace of an infected lobster is the most
visible sign of the disease. Histological examination revealed bacteria as the most common
organisms in the lesions, whereas some protist constituents were found in more advanced
cases. The lesions were grouped into three categories based on the depth of the bacterial
incursion, presuming that depth reflects a progressive erosion of the cuticle.
Category 1 is the least severe erosion, with shallow lesions extending into the epicuticle and
exocuticle. The margins of the lesions often exhibited evidence of melanization, but inflam‐
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mation in the underlying connective tissue or other evidence of an immune response is rarely
observed at this stage. Bacteria are found in the leading edges of the lesion and in the crystalline
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the protein structure between the lattice crystals. The endocuticle exhibits melanization,
especially in the vertical areas of bacterial incursion. Evidence of immune response to the
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extreme types of category 3 lesions had no more tissue than the inflammatory cuticle overly‐
ing the cuticular epithelium. In some cases, the lesions progressed to ulcerations, which were
characterized by a complete absence of cuticular tissue and cuticular epithelium. Degranulat‐
ed hemocytes developed a multilayered pseudomembrane to cover the connective tissue. The
outer layer of the pseudomembrane was necrotic and melanized.
Certain groups of bacteria have been found as common constituents on the carapaces of
moribund lobsters, and overall populations of bacteria are higher than on the carapaces of
healthy lobsters [11]. Using a combination of culture‐dependent techniques, polymerase chain
reaction (PCR), and denaturing gradient gel electrophoresis, the group of Chisosterdov
isolated three novel bacteria that were ubiquitous in ESD lesions: Aquimarina homaria I32.4,
Thalassobius sp. 131.1, and Pseudoalteromonas gracilis ISA7.3 [11]. Quinn et al. [12] were
successful at initiating lesions that are histologically similar to ESD in captive lobsters using
these three bacteria. The abrasion of the carapace was necessary for lesions to form. Research‐
ers were also able to isolate A. homaria from lesions in “diet‐induced” shell disease. These
lobsters were fed strictly herring and were deprived of sources of astaxanthan, rendering them
nearly colorless [13].
The characterization of microbial communities using terminal restriction fragment length
polymorphism revealed that, although no grossly significant difference in communities on
healthy lobsters was present compared to diseased lobsters, there were some minor differen‐
ces [14]. More anaerobic bacteria and greater numbers of α‐ and β‐proteobacteria were found
in the lesions. Bell et al. used lobsters from eastern and western Long Island Sound. Lobsters
from a coastal Maine site were used as reference specimens. This study also elucidated the
activities of four bacterial ectohydrolases on shell samples from healthy and diseased
specimens and found that, whereas chitinase activity was high in all samples, cellulase and
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be found at least as early as 1937 [4]. Initial reports of shell disease in other crustaceans are
contemporary with Sindermann [5]. In many cases, the pathology appeared to be linked to
degraded environments, such as the proximity to pollution sources, for example, the munici‐
pal waste dump site in an offshore canyon used by New York City where lobsters and crabs
presented with shell disease [6, 7]. Another common place to find crustacean shell diseases is
in commercial impoundment facilities [5]. In this situation, chitinolytic bacteria appeared to
be eroding the carapace faster than it could be replaced by molting, leading to a pitting of the
cuticle. However, there has only been one report of an infectious process after the lobster's
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epidermis occurs through pore canals that transverse the exoskeleton. All but the membra‐
nous layer is calcified either with regularly organized calcite crystals or with amorphous
calcium carbonate and all but the epicuticle contains the acetyl‐aminated polysaccharide,
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matrix; in the exocuticle and endocuticle, calcite crystals are dispersed throughout chitin‐
protein fibers that are referred to as lamellae. In addition, the exocuticle contains trabeculae
that are composed of apatite (calcium phosphate) that resembles spongy bone tissue in
vertebrates [10]. The endocuticle is the most calcified layer of the exoskeleton [11].
According to Smolowitz et al. [3], ESD is identifiable by erosions of the carapace that have a
unique histology. The presence of lesions on the carapace of an infected lobster is the most
visible sign of the disease. Histological examination revealed bacteria as the most common
organisms in the lesions, whereas some protist constituents were found in more advanced
cases. The lesions were grouped into three categories based on the depth of the bacterial
incursion, presuming that depth reflects a progressive erosion of the cuticle.
Category 1 is the least severe erosion, with shallow lesions extending into the epicuticle and
exocuticle. The margins of the lesions often exhibited evidence of melanization, but inflam‐
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In response to the ESD crisis, a group of scientists, fisheries managers, and lobstermen formed
the New England Lobster Health Initiative. It was this ad hoc committee that ultimately
received funding that was awarded to several university and institutional researchers,
including the award that funded the study reported here. The findings of each group were
published as a special edition of the Journal of Shellfish Research [22]. Included in that edition
was an article that summarizes some of what is contained herein [23].
A systems approach to ESD was employed in this study to elucidate the surface biofilms of
lobsters in three states of health: Healthy, Diseased, and Healthy‐on‐Diseased (areas of the
carapace on a lobster presenting with ESD that do not yet have the characteristic lesions). Using
culture‐independent molecular techniques coupled with multivariate statistical and network
analysis models, this study surveyed the biofilms of the carapaces of lobsters from the
geographic area that is most affected by ESD.
This study represents the first survey of the surface microbiome of the American lobster.
Although the sequencing techniques can provide a comprehensive overview of bacteria in a
sample, this study cannot be regarded as a global assessment of the lobster microbiome. The
lobsters surveyed here are from a one geographic location and represent a statistically small
sample of lobsters. Elucidating the complete lobster microbiome should make use of lobsters
from as much of the natural range as possible and should include a statistically large sample
of specimens. Bell et al. [14], for example, have demonstrated that there is a biochemical activity
in the lobster surface microbiome that varies geographically.
This survey does, however, offer a glimpse into the subtle microbiome differences between
lobsters that present with ESD (“Diseased”) and those that do not (“Healthy”). In addition, a
third class, “Healthy‐on‐Diseased,” has been defined as a region of the shell of a lobster with
ESD that does not present with lesions. This third class may provide some insight into the
disease progression.
As described previously, Quinn et al. [12] were successful in initiating lesions similar to ESD
with three bacteria that were isolated from ESD lesions. Some of the infections were initiated
with only one bacterium (A. homaria), whereas other lesions were initiated as “coinfections”
with Thalassobius sp. and P. gracilis. The removal of the epicuticle by abrasion was necessary
to initiate the infection. These authors acknowledge that ESD lesions present with many more
bacteria and that ESD appears to be a polymicrobial disease.
The polymicrobial nature of ESD, and the desire to illuminate something of its etiology, is the
focus of this research. To that end, culture‐independent techniques were employed to elucidate
the bacterial community, and multivariate statistics were used to interpret the results.
Specifically, length heterogeneity‐PCR (LH‐PCR) was used to survey a typical lobster. This
provided an overview of the distribution of bacteria on different regions of the lobster carapace.
LH‐PCR data do not provide sequence information but identify PCR amplicons by size
(basepair length) that indicate different taxa. The number of representative fragments found
in the cephalothorax region of the carapace, combined with the knowledge that this region
had the highest incidence of ESD lesions, led to the decision to focus the next phase of molecular
interrogation on the cephalothorax. This phase used multitag pyrosequencing (MTPS) to
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proteinase activities were significantly higher in diseased specimens. Lipase activity was
higher in Long Island Sound lobsters compared to those from Maine but was apparently
similar between healthy and diseased lobsters. They concluded that chitin degradation was
not as important to the progression of the disease as the degradation of lipids and protein in
the carapace. Bell et al. [14] interpreted the spatial difference in lipase activity in bacteria to
indicate that the degradation of the lipid moieties in the epicuticle may be an important initial
step in disease progression and hypothesized that it should correlate positively with geo‐
graphic areas of ESD prevalence.
The works of Smolowitz et al. [3] and Bell et al. [14] make clear that ESD differs from earlier
types of shell disease. ESD is ostensibly bacterial in origin, but other research indicates that
the bacterial infection may only be a proximate cause.
Shields et al. [15] found that some idiopathic conditions were more prevalent in lobsters from
Rhode Island compared to lobsters from Maine. Rhode Island lobsters presented with vibriosis,
hepatopancreatitis, and eye lesions at a significantly higher rate than did Maine lobsters. When
Rhode Island lobsters with and without ESD were compared, these and other idiopathic
conditions were present but did not occur more frequently in lobsters with the disease.
Laufer et al. [16] found that ESD lobsters had higher levels of alkylphenols than did unaffect‐
ed lobsters and that bottom sediments had higher than normal levels of these compounds in
areas where diseased lobsters resided. Using gas chromatography‐mass spectrometry, Laufer
et al. identified four alkylphenol species: 2‐t‐butyl‐4‐(dimethylbenzyl) phenol, 2,6‐bis‐(t‐
butyl)‐4‐(dimethylbenzyl) phenol, 2,4‐bis‐(dimethylbenzyl) phenol, and 2,4‐bis‐(dimethylben‐
zyl)‐6‐t‐butyl phenol. The second compound, 2,6‐bis‐(t‐butyl)‐4‐(dimethylbenzyl) phenol, was
developed but never used by Monsanto Corporation as a mosquito larvicide. Biggers and
Laufer [17] have identified alkylphenols as endocrine disrupters having juvenile hormone
activity. This hormone, also referred to as methyl farnesoate in crustaceans, is important to the
metamorphosis of larvae [18]. Laufer et al. [19] confirmed that alkylphenols do inhibit larval
development in lobsters. In adult lobsters, however, these compounds displace tyrosine
molecules and delay the hardening of the shell by preventing the tyrosine cross‐linking of
proteins and chitin [19]. Kunkel et al. [10] found that, in lobsters with ESD, the exocuticular
apatite layer was greatly reduced or absent. Another group of researchers found that several
measurements of immune response in lobsters, including phenoloxidase activity and antimi‐
crobial activity of the hemolymph, phagocytic activity, and reactive oxygen species produc‐
tion, was depressed in lobsters from eastern Long Island Sound (one of the prime ESD areas)
compared to lobsters from western Long Island Sound and Maine [20].
Tarrant et al. found that lobsters with ESD had gene expression patterns that were consis‐
tent with exposure to xenobiotics. Specifically, they found an elevated expression of ecdyste‐
roid receptors and elevated expression of CYP450 (a cytochrome P450 moiety that is positively
correlated with increased ecdysteroid levels). In addition, decreased arginine kinase expres‐
sion in thoracic muscles was observed in lobsters presenting with ESD. Arginine kinase is
analogous to creatine kinase in vertebrates [21]. These findings suggest that lobsters from
Rhode Island waters that were sampled for these studies were subjected to atypical environ‐
mental stress factors.
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ESD that does not present with lesions. This third class may provide some insight into the
disease progression.
As described previously, Quinn et al. [12] were successful in initiating lesions similar to ESD
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the carapace. Bell et al. [14] interpreted the spatial difference in lipase activity in bacteria to
indicate that the degradation of the lipid moieties in the epicuticle may be an important initial
step in disease progression and hypothesized that it should correlate positively with geo‐
graphic areas of ESD prevalence.
The works of Smolowitz et al. [3] and Bell et al. [14] make clear that ESD differs from earlier
types of shell disease. ESD is ostensibly bacterial in origin, but other research indicates that
the bacterial infection may only be a proximate cause.
Shields et al. [15] found that some idiopathic conditions were more prevalent in lobsters from
Rhode Island compared to lobsters from Maine. Rhode Island lobsters presented with vibriosis,
hepatopancreatitis, and eye lesions at a significantly higher rate than did Maine lobsters. When
Rhode Island lobsters with and without ESD were compared, these and other idiopathic
conditions were present but did not occur more frequently in lobsters with the disease.
Laufer et al. [16] found that ESD lobsters had higher levels of alkylphenols than did unaffect‐
ed lobsters and that bottom sediments had higher than normal levels of these compounds in
areas where diseased lobsters resided. Using gas chromatography‐mass spectrometry, Laufer
et al. identified four alkylphenol species: 2‐t‐butyl‐4‐(dimethylbenzyl) phenol, 2,6‐bis‐(t‐
butyl)‐4‐(dimethylbenzyl) phenol, 2,4‐bis‐(dimethylbenzyl) phenol, and 2,4‐bis‐(dimethylben‐
zyl)‐6‐t‐butyl phenol. The second compound, 2,6‐bis‐(t‐butyl)‐4‐(dimethylbenzyl) phenol, was
developed but never used by Monsanto Corporation as a mosquito larvicide. Biggers and
Laufer [17] have identified alkylphenols as endocrine disrupters having juvenile hormone
activity. This hormone, also referred to as methyl farnesoate in crustaceans, is important to the
metamorphosis of larvae [18]. Laufer et al. [19] confirmed that alkylphenols do inhibit larval
development in lobsters. In adult lobsters, however, these compounds displace tyrosine
molecules and delay the hardening of the shell by preventing the tyrosine cross‐linking of
proteins and chitin [19]. Kunkel et al. [10] found that, in lobsters with ESD, the exocuticular
apatite layer was greatly reduced or absent. Another group of researchers found that several
measurements of immune response in lobsters, including phenoloxidase activity and antimi‐
crobial activity of the hemolymph, phagocytic activity, and reactive oxygen species produc‐
tion, was depressed in lobsters from eastern Long Island Sound (one of the prime ESD areas)
compared to lobsters from western Long Island Sound and Maine [20].
Tarrant et al. found that lobsters with ESD had gene expression patterns that were consis‐
tent with exposure to xenobiotics. Specifically, they found an elevated expression of ecdyste‐
roid receptors and elevated expression of CYP450 (a cytochrome P450 moiety that is positively
correlated with increased ecdysteroid levels). In addition, decreased arginine kinase expres‐
sion in thoracic muscles was observed in lobsters presenting with ESD. Arginine kinase is
analogous to creatine kinase in vertebrates [21]. These findings suggest that lobsters from
Rhode Island waters that were sampled for these studies were subjected to atypical environ‐
mental stress factors.
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The technique employed in this research is called LH‐PCR [25]. The variability, or heteroge‐
neity, of the basepair lengths of the variable regions can be used to define the OTUs that
represent individual taxa, but the technique does not assign a taxon name to them.
An LH‐PCR survey of the diversity of the bacteria in the shell microbiome of a store‐bought
lobster was initially performed to determine the compositional patterns throughout the surface
of the lobster. In this procedure, bacterial DNA was extracted from various regions of the
lobster carapace (claw, abdomen, cephalothorax, and telson). The carapace samples were
dissolved in EDTA and proteinase K to recover all microorganisms from the surface and
subsurface, and DNA was extracted using the FastDNA Spin Kit (MP Biomedicals, Solon, OH).
PCR was employed to amplify the bacterial genes for the first two hypervariable regions (V1
and V2) of the 16S rRNA subunit using universal primers 27F (5'‐AGA GTT TGA TCM TGG
CTC AG‐3') and 355R (5'‐GCT GCC TCC CGT AGG AGT‐3'; Invitrogen Corporation, Carlsbad,
CA) [26].
The LH‐PCR products were diluted according to their intensity on agarose gel electrophore‐
sis and mixed with ILS‐600 size standards (Promega, Madison, WI) and HiDi Formamide
(Applied Biosystems, Foster City, CA). The diluted samples were then separated on an ABI
3130xl fluorescent capillary sequencer (Applied Biosystems) and processed using the
Genemapper™ software package (Applied Biosystems). Normalized peak areas were
calculated using a custom PERL script, and OTUs constituting less than 1% of the total
community from each sample were eliminated from the analysis to remove the variable low
abundance components within the communities.
2.2. MTPS
The technique described above employed a culture‐independent technique that is capable of
resolving amplified fragments of DNA by size (OTUs). This can be useful in making observa‐
tions on gross changes of microbial communities over time, such as in a site that is contami‐
nated by petroleum or some other organic material. In this case, LH‐PCR was used to
demonstrate that the biofilm on the cephalothorax was the best representative sample of the
shell microbiome. The next phase of interrogation employed MTPS [27] to further elucidate
the nature of the microbial community. The OTUs from the lobster samples were sequenced
using next‐generation sequencing technology, and the sequence reads were matched as closely
as possible to known bacterial taxa. This provided us with data that could be used in a variety
of ways to demonstrate the correlation between bacterial taxa and various states of health in
the lobster.
Cuticle samples (0.5 cm2) were harvested as part of the “100 Lobsters” Project [28] and in a
manner described therein. The lobsters were collected from within Narragansett Bay, Rhode
Island. A total of 55 lobsters had ESD, whereas 47 were categorized as apparently healthy (i.e.,
the lobsters did not have visible ESD lesions). The samples were shipped in plastic vials on
dry ice and stored at ‐80°C until processed. Three types of carapace samples were taken: those
from lesions of diseased lobsters (Diseased), those from lesion‐free areas of diseased lobsters
(Healthy‐on‐Diseased), and those from apparently healthy lobsters (Healthy). The carapace
samples were dissolved in EDTA and proteinase K to recover all microorganisms from the
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generate raw sequence data of each PCR amplicon, which could be identified by comparing
these sequences to known sequences in a standard database.
Discriminant analysis (DA) was chosen as a means of determining if there is a statistically
significant difference between the bacterial communities found on the three classes of data
(Healthy, Diseased, and Healthy‐on‐Diseased). In addition, DA assigns each variable
(bacterial taxon) with coefficients that indicate its contribution to the discriminant function.
Correlational network analysis, which uses techniques similar to social network analysis to
create a visual image of correlations between the bacterial taxa, was employed to identify
which taxa are positively and negatively correlated in each of the three states examined. Using
correlational difference analysis to compare the states, it may be possible to more clearly
identify the changes in bacterial population on the lobster carapace that are correlated with a
decline in health.
We approached the problem using the following hypothesis:
H: The bacterial communities on lobsters with ESD are significantly different in quality and
quantity than unaffected lobsters.
HA: The bacterial communities on the carapaces of healthy and shell‐diseased lobsters are
similar.
2. Materials and methods
2.1. LH‐PCR
We initially performed a survey of the microbiome on normal lobsters using a culture‐
independent method to characterize the taxa composition of the biofilm on various locations
of the lobster shell. Characterizing a microbial population using molecular techniques is
advantageous over culture‐dependent techniques in that the latter relies on the growth of
bacteria on artificial media usually at a controlled temperature. Many bacteria have particu‐
lar nutritional and environmental conditions that render them difficult to grow in laboratory
cultures and would not be present in cultures taken from the environment. Existence in culture
medium, as discussed in the previous chapter, requires that the bacteria assume a plankton‐
ic phase rather than embedding in a biofilm, which may be an abnormal state for most
species [24]. These molecular techniques are sometimes referred to as “culture independent”
in that they identify bacteria from a sample without first attempting to grow them under
artificial conditions. Identifying bacteria by amplifying and sequencing the entire genome of
each individual would be impractical and inordinately time‐consuming. Several techniques
exist that enable the identification of bacteria by taking advantage of variable regions within
genes that are ubiquitous in all prokaryotes. This research used the first two variable regions
of the genes encoding for the small (16S) subunit of ribosomal RNA (rRNA) to discriminate
between different operational taxonomic units (OTUs) that are surrogates for taxa identifica‐
tion. There are nine such variable regions within this gene.
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species [24]. These molecular techniques are sometimes referred to as “culture independent”
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exist that enable the identification of bacteria by taking advantage of variable regions within
genes that are ubiquitous in all prokaryotes. This research used the first two variable regions
of the genes encoding for the small (16S) subunit of ribosomal RNA (rRNA) to discriminate
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2.3. DA
DA, sometimes referred to as discriminant function analysis, is a multivariate statistical
method that identifies variables of different cases that are useful in the discrimination of those
cases into different classes. The analysis of the data results in the construction of a linear
equation in which the variables are factors of both unstandardized and standardized coeffi‐
cients. The products of these variable coefficient pairs are summed to produce a score for each
case, and that score determines the membership of that case in a specific class [33]. The
summation of the unstandardized coefficients includes a constant. Standardizing the coeffi‐
cients eliminates the constant. These coefficients are partial coefficients that compare the
relative importance of the independent variables [34]. We define the cases as individual
lobsters in the study and the variables as the bacterial taxa that were identified by MTPS.
In addition to producing unstandardized and standardized linear coefficients that can be used
to discriminate classes, DA produces full coefficients that are referred to as structure coeffi‐
cients. These are measurements of the importance of the independent variables and the
discriminant function itself [34, 35]. Structure coefficients are a more definitive coefficient for
determining relative importance of the variables [35]. In this research, the structure coeffi‐
cients are useful in providing us with a ranking of the variables, which reflects their relative
importance to ESD.
The abundance data for the 170 variables (taxa) from the 102 lobster samples were analyzed
by DA with PASW version 18 (IBM, Chicago, IL). In the first analysis, we compared the taxa
on the cuticle from Diseased versus Healthy animals, the second analysis compared the taxa
on the cuticle from Diseased animals versus Healthy‐on‐Diseased animals, and the third
analysis compared the taxa on the cuticle from Healthy animals versus Healthy‐on‐Diseased
animals.
2.4. Correlational network analysis
The computations described above are useful in identifying variables (bacterial taxa) that are
likely candidates for determining the class of each sample, in this case, the state of health of
the lobster being sampled. DA, however, does not account for the effects of one variable upon
another. The members of a microbial community interact not only with their host or source of
food but also with each other [36].
Network analysis is a statistical‐graphical technique that has wide applications in fields as
diverse as the social sciences and epidemiology and has gained some popularity among people
working in “homeland security.” Arguably the most common of these types of applications is
social network analysis, which can be defined as a “study of human relationships by means
of graph theory” [37].
Microbes occupying a biofilm are exposed to the biochemical output of their neighboring
microorganisms. Some of these molecules are metabolic wastes of one microbe but serve as
nutritive material for another, which can be viewed as metabolic cooperativity [36]. Members
of a community also secrete antimicrobial agents in an effort to reduce competition, and still
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surface and subsurface, and DNA was extracted using the FastDNA Spin Kit (MP Biomedi‐
cals).
PCR was employed to amplify the bacterial genes for two hypervariable regions of the rRNA
subunit using modified primers 27F (5'‐AGA GTT TGA TCM TGG CTC AG‐3') and 355R (5'‐
GCT GCC TCC CGT AGG AGT‐3'; Invitrogen Corporation). The forward primer listed above
was modified with a “barcode” sequence that was unique to each DNA sample extracted from
individual lobsters, allowing us to track the various bacterial sequence reads to their specific
sample origin (i.e., the lobster and carapace region from which the bacteria were sampled).
MTPS was employed to characterize the microbiome from a subset of the carapace samples
that were used in the LH‐PCR analysis. We generated a set of 96 fusion primers that con‐
tained the emulsion PCR linkers (454 Life Sciences) on the 27F and 355R universal 16S rRNA
primers along with different eight‐base “barcodes” on the 27F primer. Each lobster DNA
sample was then amplified with a unique set of tagged 16S rRNA primers, pooled, subjected
to emulsion PCR, and pyrosequenced using a GS‐FLX pyrosequencer as per manufacturer's
instructions (Roche, Branchburg, NJ). Data from the pooled sample were “deconvoluted” by
sorting the sequences into sample bins based on the barcodes using custom PERL scripts. This
technique allows the rapid sequencing of multiple samples at one time, yielding thousands of
sequence reads per sample. The sequence reads were identified using the Bayesian analysis
from the Ribosomal Database Project [29]. We used a custom PERL script to normalize the
abundances of the taxa in a sample based on the total reads in that sample.
The sequences were aligned that were identified as Aquimarina spp. using the RDP 10
analysis [29] with reference sequences available in GenBank and constructed a neighbor
joining tree for the genus. The clades in the tree were labeled by the major species present
therein. Dr. Andrei Chisosterdov, a colleague from Louisiana State University and a partici‐
pant in the New England Lobster Health Initiative, supplied an rRNA sequence for A. homaria.
None of the bacteria from our samples that were identified as members of the genus Aquimarina
were greater than 95% similar to Dr. Chisosterdov's reference sequence, indicating that we
identified similar examples of the same genus.
The software program Quantitative Insights into Microbial Ecology (QIIME) [30] was used to
compare the microbial communities on the three types of carapace samples and to construct
a UniFrac neighbor joining tree that graphically displays the similarities in microbiome
structure between each lobster sample in the study. The technique was validated using
jackknifing to estimate the dispersion of the data [31]. According to Lozupone and Knight [32],
the UniFrac metric “measures the phylogenetic distance between sets of taxa in a phylogenet‐
ic tree as a fraction of the branch length that leads to descendents from either one environ‐
ment or the other, but not both.” In the process, UniFrac was able to depict the evolutionary
differences between environments. In this application, UniFrac was used to compare phylo‐
genetic differences between bacterial communities and provide a graphic representation of the
differences. Each terminal node, therefore, represents a unique phylogenetic tree of that
sample. The distance between the nodes is the distance between these trees.
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plotted as a stacked histogram to demonstrate the distribution of the microbiome on the lobster
carapace.
Figure 1. Replicate LH‐PCR fingerprint analysis of various regions of the carapace. The normalized OTU abundance
for each sample was plotted as a stacked histogram to demonstrate the distribution of the microbiome on the lobster
carapace. Multiple bars of the same color represent OTU abundances from several samples of the same region of the
shell. Therefore, OTU abundances from multiple samples may add up to greater than 100%.
3.2. MTPS
MTPS was performed on 102 lobster samples and the resulting sequence reads were sorted
based on their tags or barcodes. The analysis yielded 212,019 reads with an average of 1594
reads per sample. We identified 170 bacteria present on the cuticle of lobsters from Narragan‐
sett Bay, Rhode Island, having culled taxa that were less than 1% of the total community under
the a priori assumption that rare taxa will not contribute to the disease process. Of these 170
bacteria, 167 were identified to the level of genus, 1 was identified to the level of family, and
2 were identified as OTUs whose complete identities are unknown.
Figure 2 is a histogram of the average abundance of the taxa found in each sample class (i.e.,
Diseased, Healthy‐on‐Diseased, and Healthy) rank ordered by the average abundance of the
Disease class (red bars). The entire histogram for all 170 taxa is depicted in the insert. The most
abundant taxa found in the carapace microbiome include the genera Jannaschia, Aquimarina,
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other bacteria engage in quorum sensing, the detection of chemical signals as a means of
monitoring population density [36]. It would be incorrect to equate human interactions with
those of microorganisms, but it is arguably valid to recognize that biofilms exhibit a social
structure that is mediated via biochemical signaling. Therefore, network analysis has the
potential to elucidate microbial interactions within a biofilm. Within this study, the chemical
interaction between various members of the biofilm was not directly investigated. Instead, we
calculated the statistical correlations between bacterial taxa as a means of inferring their
interactions and relationships.
The pyrosequencing abundance data were analyzed using Spearman rank correlation using a
custom R module [38]. Spearman rank correlation is a nonparametric statistical function that
allows the comparison of nonlinear data [36]. All possible correlation coefficients between
variables are calculated, and correlations between variables are ranked in an output table. The
parameters for the ranking were set as follows: p≤0.01, four minimum pairs per variable (taxa)
and five minimum nonzero pairs.
The correlation tables were generated by the R module into the networking software
Cytoscape [39] version 2.8.2 to construct correlational network diagrams of the three states of
health of the lobster microbiome: Diseased, Healthy, and Healthy‐on‐Diseased. In addition,
the data were used to construct correlation difference networks that plot edges between
features whose correlations have significantly changed between the two states being com‐
pared. One can interpret these correlation difference networks as a depiction of what correla‐
tions were altered between the two states. The author constructed two such maps: Healthy
versus Diseased and Healthy‐on‐Diseased versus Diseased.
3. Results
3.1. LH‐PCR
Initially, the lobster carapace was surveyed to determine the bacterial community distribu‐
tion on various regions of the carapace. Figure 1 is a histogram of the normalized abun‐
dance of OTUs that were present on the various regions of the carapace (pink and red:
cephalothorax, yellow: claws, green: abdomen, and tail: blue). The LH‐PCR profiles revealed
that, with a few exceptions, the OTUs present on the cephalothorax are representative of the
microbiome present on other regions, such as the claw and the abdomen. Of the 29 OTUs
identified, 22 are present on the cephalothorax, 17 are present on the claws, 17 are present on
the tail (telson), and 13 are present on the abdomen. Using the Shannon index of diversity [40],
the cephalothorax region had a index of 2.81 and an eveness score of 0.85. The claw region had
an index value of 2.80 and a eveness score of 0.833. The tail had an index value of 2.37 and an
eveness score of 0.75. The abdomen had an index value of 1.95 and a eveness score of 0.61.
The peaks in the fingerprints are described as OTUs, because this method alone does not
identify the bacteria. In fact, a peak may contain more than one species, and strains of the same
species may show up in different peaks. The normalized OTU abundance for each sample was
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plotted as a stacked histogram to demonstrate the distribution of the microbiome on the lobster
carapace.
Figure 1. Replicate LH‐PCR fingerprint analysis of various regions of the carapace. The normalized OTU abundance
for each sample was plotted as a stacked histogram to demonstrate the distribution of the microbiome on the lobster
carapace. Multiple bars of the same color represent OTU abundances from several samples of the same region of the
shell. Therefore, OTU abundances from multiple samples may add up to greater than 100%.
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bacteria, 167 were identified to the level of genus, 1 was identified to the level of family, and
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Figure 2 is a histogram of the average abundance of the taxa found in each sample class (i.e.,
Diseased, Healthy‐on‐Diseased, and Healthy) rank ordered by the average abundance of the
Disease class (red bars). The entire histogram for all 170 taxa is depicted in the insert. The most
abundant taxa found in the carapace microbiome include the genera Jannaschia, Aquimarina,
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other bacteria engage in quorum sensing, the detection of chemical signals as a means of
monitoring population density [36]. It would be incorrect to equate human interactions with
those of microorganisms, but it is arguably valid to recognize that biofilms exhibit a social
structure that is mediated via biochemical signaling. Therefore, network analysis has the
potential to elucidate microbial interactions within a biofilm. Within this study, the chemical
interaction between various members of the biofilm was not directly investigated. Instead, we
calculated the statistical correlations between bacterial taxa as a means of inferring their
interactions and relationships.
The pyrosequencing abundance data were analyzed using Spearman rank correlation using a
custom R module [38]. Spearman rank correlation is a nonparametric statistical function that
allows the comparison of nonlinear data [36]. All possible correlation coefficients between
variables are calculated, and correlations between variables are ranked in an output table. The
parameters for the ranking were set as follows: p≤0.01, four minimum pairs per variable (taxa)
and five minimum nonzero pairs.
The correlation tables were generated by the R module into the networking software
Cytoscape [39] version 2.8.2 to construct correlational network diagrams of the three states of
health of the lobster microbiome: Diseased, Healthy, and Healthy‐on‐Diseased. In addition,
the data were used to construct correlation difference networks that plot edges between
features whose correlations have significantly changed between the two states being com‐
pared. One can interpret these correlation difference networks as a depiction of what correla‐
tions were altered between the two states. The author constructed two such maps: Healthy
versus Diseased and Healthy‐on‐Diseased versus Diseased.
3. Results
3.1. LH‐PCR
Initially, the lobster carapace was surveyed to determine the bacterial community distribu‐
tion on various regions of the carapace. Figure 1 is a histogram of the normalized abun‐
dance of OTUs that were present on the various regions of the carapace (pink and red:
cephalothorax, yellow: claws, green: abdomen, and tail: blue). The LH‐PCR profiles revealed
that, with a few exceptions, the OTUs present on the cephalothorax are representative of the
microbiome present on other regions, such as the claw and the abdomen. Of the 29 OTUs
identified, 22 are present on the cephalothorax, 17 are present on the claws, 17 are present on
the tail (telson), and 13 are present on the abdomen. Using the Shannon index of diversity [40],
the cephalothorax region had a index of 2.81 and an eveness score of 0.85. The claw region had
an index value of 2.80 and a eveness score of 0.833. The tail had an index value of 2.37 and an
eveness score of 0.75. The abdomen had an index value of 1.95 and a eveness score of 0.61.
The peaks in the fingerprints are described as OTUs, because this method alone does not
identify the bacteria. In fact, a peak may contain more than one species, and strains of the same
species may show up in different peaks. The normalized OTU abundance for each sample was
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Figure 3. Neighbor joining tree of Aquimarina spp. identified in the lobster microbiome.
The weighted UniFrac tree is displayed in Figure 4. Although a cursory inspection of the figure
may lead one to conclude that there is indeed a clustering of the three disease classes
(Diseased, Healthy, and Healthy‐on‐Diseased), significance tests reveal that the differences
between the three classes are not significant (Diseased vs. Healthy‐on‐Diseased: p=0.45,
Diseased vs. Healthy: p=1.0, and Healthy‐on‐Diseased vs. Healthy: p=0.85). This demon‐
strates that, although there is some clustering, there is no clear separation between the three
disease classes (Diseased, Healthy, and Healthy‐on‐Diseased), that is, they are more or less
equally distributed throughout the neighbor joining tree.
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Cardiobacterium, Thalassobius, and Loktanella and the suborder Micrococcineae. However,
essentially all genera are found in all disease classes (i.e., Healthy, Healthy‐on‐Diseased, and
Diseased).
Figure 2. MTPS analysis of the cephalothorax microbiome. The normalized abundances of the most prominent taxa
found on the cephalothorax of 102 lobsters is plotted as a histogram, rank ordered by those taxa in the disease state.
The histogram of all 170 taxa is plotted in the insert.
Figure 3 is a neighbor joining tree that displays all of the members of the genus Aquimarina
that were found in GenBank along with all the Aquimarina sequences found in these lobster
samples. They are labeled according to their sample origin, and clades were labeled by the
most abundant identified species in that clade. This tree is included here to illustrate the
diversity of the genus and to demonstrate its ubiquity in samples of all three sampling classes
of this study. There are three clades in that represent known Aquimarina species: A. interme‐
dia, A. mulleri, and A. laterculi. We see an additional two clades that represent previously
identified Aquimarina species. In addition, we can see that there are at least three clades of
previously unidentified Aquimarina species (unlabeled clades). There are representatives of
Healthy, Healthy‐on‐Diseased, and Diseased samples in all clades.
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Figure 5. PCO of the normalized abundances of the genera from each disease class. The Healthy samples are yellow
dots (n = 47), the Diseased samples are red dots (n = 55), and the Healthy‐on‐Diseased samples are blue dots (n = 33).
3.3. DA
The DA for the first comparison, the bacterial taxa on cuticle from Diseased versus apparent‐
ly Healthy lobsters, included a tolerance test that eliminated 112 variables because they lacked
variance between groups and thus did not significantly contribute to the discriminant function.
Thus, the analysis between the two groups relied on 58 variables. The functions at the group
centroids were 1.463 for disease class 1 (Diseased) and ‐1.1712 for disease class 2 (Healthy).
The group centroids are a central measure of a set of multivariate data similar to the mean in
univariate analyses. These scores demonstrate that the centroids were well separated. Such a
separation between centroids demonstrates that the function is able to discriminate one class
from another. The canonical correlation coefficient (Rc2=0.848) is equivalent to the coefficient
of determination (r2) in univariate statistical analyses [35]. Wilks’ λ (=0.281) is indicative of the
contribution of the independent variable to the discriminant function. The lower the value of
Wilks’ λ is, the greater is the contribution. When Wilks’ λ approaches 1, then the group means
are nearly the same, and the contribution of the independent variable to the discriminant
function approaches zero. The χ2 test (χ2=91.287; p=0.002; df=56) also indicates that the function
is discriminating between classes [34]. In the second analysis (Diseased vs. Healthy‐on‐
Diseased), the functions at group centroids were 2.060 for disease class 1 (Diseased) and ‐3.541
for disease class 3 (Healthy‐on‐Diseased). Again, these scores demonstrate that the function
was discriminating between the classes (Rc2=0.939; Wilks’ λ=0.118; χ2=131.382; p=0.000; df=47).
In the third analysis (Healthy vs. Healthy‐on‐Diseased), the functions at group centroids
were 2.439 for disease class 2 and ‐3.582 for disease class 3 (Rc2=0.948; Wilks’ λ=0.100;
χ2=122.991; p=0.000; df=47).
The classification results (confusion matrix) of all three analyses are displayed in Table 1. The
confusion matrix is run as a test of the ability of the discriminant function to predict the
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Figure 4. Weighted UniFrac tree. The disease classes are color coded. Healthy samples are blue (n = 47), diseased sam‐
ples are green (n = 55), and healthy‐on‐diseased samples are red (n = 33).
Figure 5 is a principal coordinate analysis (PCO) of the normalized abundances of the genera
identified in each disease class using a Bray‐Curtis distance metric. The PCO performs an Eigen
analysis that clusters the data based on the variance of all features (genera) of the data
matrix [33]. One can see a clustering of the Diseased samples (red dots) that is somewhat
distinct from the Healthy (yellow) and Healthy‐on‐Diseased (blue) samples.
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number of taxa have a number higher than 1, indicating that their correlation with the disease
is not strong.
Diseased vs. Healthy Diseased vs. Healthy‐on‐Diseased Healthy vs. Healthy‐on‐Diseased
Taxon Coefficient  Taxon  Coefficient  Taxon Coefficient
Anaerococcus 2.769 Anaerococcus 1.601 Leucothrix 1.082
Fluoribacter 2.613 Leucothrix 0.805 Fluviicola 1.064
Alkalilimnicola 2.031 Jannaschia 0.786 Burkholderia 1.045
Crenothrix 1.745 Corynebacterineae 0.748 Corynebacterineae 1
Burkholderia 0.831 Cellulophaga 0.747 Turicibacter 0.784
Pasteuriaceae
Incertae Sedis
0.691 Filomicrobium 0.609 Jannaschia 0.708
Cellulophaga 0.472 Aquimarina 0.552 Cycloclasticus 0.705
Haliscomenobacter 0.433 Crenothrix 0.493 Carnobacteriaceae_1 0.647
Fluviicola 0.378 Cycloclasticus 0.456 Alishewane 0.63
Ahrensia 0.361 Glycomycineae 0.447 Branhamella 0.612
Jannaschia 0.359 Hyphomicrobium 0.413 Erythrobacter 0.607
Devosia 0.349 Alkalilimnicola 0.297 Frankineae 0.597
Kangiella 0.335 Geothermobacter 0.297 Frateuria 0.479
Frateuria 0.324 Achromobacter 0.244 Fluoribacter 0.443
Hyphomicrobium 0.296 Leisingera 0.213 Lactococcus 0.429
Hirschia 0.253 Hirschia 0.186 Leisingera 0.423
Aquimarina 0.249 Haliscomenobacter 0.114 Erythromicrobium 0.347
Glycomycineae 0.192 Caldilineacea 0.113 Flexithrix 0.344
Hydrogenovibrio 0.166 Brumimicrobium 0.106 Glycomycineae 0.293
Lacinutrix 0.164 Achromatium 0.103 Algibacter 0.24
Branhamella 0.159 Flexithrix 0.099 Cardiobacterium 0.229
Aminomonas 0.155 Geopsychrobacter 0.021 Aquimarina 0.19
Brumimicrobium 0.149 Erythrobacter 0.015 Kaistia 0.157
Oceanibulbus 0.122 Agrobacterium 0.012 Hydrogenovibrio 0.097
Kaistia 0.11 Delftia -1.584 Chrysiogenes 0.037
Caldilineacea 0.101 Dokdonia -0.684 Haliscomenobacter -1.52
Algibacter 0.087 Erythromicrobium -0.559 Oceanibulbus -0.78
Leisingera 0.087 Kangiella -0.474 Abiotrophia -0.73
Colwellia 0.078 Ahrensia -0.423 Acidimicrobineae -0.578
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membership of the cases accurately. In the first analysis (Diseased vs. Healthy), the function
predicted 94.1% of the original grouped cases correctly. The second analysis (Diseased vs.
Healthy‐on‐Diseased) predicted 98.9% and the third analysis (Healthy vs. Healthy‐on‐
Diseased) predicted 100% of original grouped cases correctly. This is further evidence that the
respective functions for each of these comparisons are reliably discriminating between cases.
Classification results: Diseased vs. Healthy
Disease class Predicted group membership
Diseased Healthy Total
Original  Count  Diseased 52 3 55
Healthy 3 44 47
% Diseased 94.5 5.5 100.0
Healthy 6.4 93.6 100.0
Diseased vs. Healthy‐on‐Diseased
Disease class Predicted group membership Total
Diseased Healthy‐on‐Diseased
Original Count Diseased 54 1 55
Healthy‐on‐Diseased 0 32 32
% Diseased 98.2 1.8 100.0
Healthy‐on‐Diseased 0 100.0 100.0
Healthy vs. Healthy‐on‐Diseased
Disease class Predicted group membership Total
Healthy Healthy‐on‐Diseased
Original Count Healthy 47 0 47
Healthy‐on‐Diseased 0 32 32
% Healthy 100.0 0 100.0
Healthy‐on‐Diseased 0 100.0 100.0
Table 1. DA confusion matrices.
Table 2 displays the standardized canonical discriminant coefficients for all three classes.
These coefficients are semipartial coefficients that compare the relative importance of the
variable to the independent variable. They are analogous to the β weights of regression
analysis [34]. In this table, the variables with positive correlation coefficients are listed in
descending order, whereas those with negative coefficients are listed in ascending order. This
is done to reflect that the magnitude conveys the quantity of the correlation, and the sign
indicates the quality (positive or negative). An inspection of this table reveals that only a small
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discriminant coefficient, the absolute value represents the quantity and the sign indicates
quality of the correlation. In the case of structure coefficients, however, the largest absolute
is 1.0. If a taxon had a correlation close to +1, then it could be identified as a cause of the disease.
An examination of the table reveals that Aquimarina spp. have a structure coefficient of 0.268,
indicating that it has a weak correlation with the function. Aquimarina ranks second in the
structure coefficient table to the genus Jannaschia, which has a structure coefficient of 0.325.
This table has been arranged to display a descending order of importance, with the positive
coefficients listed first. In the case of the negative coefficients, they appear to be listed in
ascending order because the absolute value is indicative of a stronger correlation. These weak
correlations indicate that there is no one pathogen that correlates definitively with the disease.
Diseased vs. Healthy Diseased vs. Healthy‐on‐Diseased Healthy vs. Healthy‐on‐Diseased
Taxon Coefficient  Taxon  Coefficient  Taxon  Coefficient
Jannaschia 0.325 Jannaschia 0.315 Jannaschia 0.248
Aquimarina 0.268 Aquimarina 0.156 Leisingera 0.127
Hirschia 0.173 Cycloclasticus 0.125 Corynebacterineae 0.113
Oceanicola 0.152 Hirschia 0.112 Frankineae 0.112
Methylosarcina 0.148 Corynebacterineae 0.076 Leucothrix 0.094
Schineria 0.148 Filomicrobium 0.073 Cycloclasticus 0.09
Shigella 0.143 Cardiobacterium 0.066 Hirschia 0.063
Tenacibaculum 0.142 Leisingera 0.059 Kaistia 0.062
Terasakiella 0.141 Leucothrix 0.055 Aminomonas 0.057
Filomicrobium 0.139 Haliscomenobacter 0.051 Crenothrix 0.057
Thalassobacter 0.125 Kaistia 0.043 Hoeflea 0.054
Microbulbifer 0.105 Glycomycineae 0.043 Erythrobacter 0.052
Photobacterium 0.104 Burkholderia 0.043 Cardiobacterium 0.048
Lacinutrix 0.099 Frankineae 0.04 Glycomycineae 0.045
Streptococcus 0.092 Brumimicrobium 0.03 Hydrogenovibrio 0.045
Woodsholea 0.089 Geopsychrobacter 0.03 Frateuria 0.044
Vibrio 0.073 Agrobacterium 0.03 Fluviicola 0.044
Haliscomenobacter 0.065 Fluviicola 0.03 Haliscomenobacter 0.044
Ruegeria 0.063 Achromatium 0.03 Lactococcus 0.036
Psychrobacter 0.06 Caldilineacea 0.03 Chrysiogenes 0.035
Roseovarius 0.058 Flexithrix 0.03 Chromatium 0.031
Shinella 0.058 Alkalilimnicola 0.03 Branhamella 0.031
Fluoribacter 0.058 Chromatium 0.03 Alkalilimnicola 0.031
Ralstonia 0.058 Colwellia 0.03 Flexithrix 0.031
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Diseased vs. Healthy Diseased vs. Healthy‐on‐Diseased Healthy vs. Healthy‐on‐Diseased
Taxon Coefficient  Taxon  Coefficient  Taxon Coefficient




Agrobacterium 0.011 Chrysiogenes -0.384 Devosia -0.448
Turicibacter 0.01 Devosia -0.371 Dokdonia -0.348
Delftia -3.464 Oceanibulbus -0.308 Ahrensia -0.341
Flexithrix -2.637 Algibacter -0.301 Cellulophaga -0.257
Chromatium -1.586 Kaistia -0.255 Hirschia -0.246
Hoeflea -1.11 Gaetbulibacter -0.247 Achromobacter -0.235
Chrysiogenes -1.072 Frankineae -0.23 Crenothrix -0.228
Gaetbulibacter -1.015 Kordiimonas -0.207 Pasteuriaceae
Incertae Sedis
-0.212
Erythrobacter -0.867 Acidimicrobineae -0.176 Delftia -0.16
Frankineae -0.78 Burkholderia -0.176 Alkalilimnicola -0.144
Geothermobacter -0.771 Lactococcus -0.162 Hyphomicrobium -0.124
Dokdonia -0.452 Fluviicola -0.078 Kordiimonas -0.082
Carnobacteriaceae_1 -0.429 Fluoribacter -0.059 Geothermobacter -0.051
Corynebacterineae -0.378 Lacinutrix -0.028 Gaetbulibacter -0.031
Leucothrix -0.267 Cardiobacterium -0.018 Lacinutrix -0.013








Table 2. Standardized canonical discriminant coefficients for all three classes.
Table 3 displays the structure coefficient table. The structure coefficients are full coefficients,
meaning that they are pooled as within‐groups correlations between the independent variable
and the standardized canonical discriminant coefficients [34]. According to Klecka [35], the
structure coefficient is the authoritative coefficient for determining the importance of the
independent variable to the discriminant function. As with the standardized canonical
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Hirschia 0.173 Cycloclasticus 0.125 Corynebacterineae 0.113
Oceanicola 0.152 Hirschia 0.112 Frankineae 0.112
Methylosarcina 0.148 Corynebacterineae 0.076 Leucothrix 0.094
Schineria 0.148 Filomicrobium 0.073 Cycloclasticus 0.09
Shigella 0.143 Cardiobacterium 0.066 Hirschia 0.063
Tenacibaculum 0.142 Leisingera 0.059 Kaistia 0.062
Terasakiella 0.141 Leucothrix 0.055 Aminomonas 0.057
Filomicrobium 0.139 Haliscomenobacter 0.051 Crenothrix 0.057
Thalassobacter 0.125 Kaistia 0.043 Hoeflea 0.054
Microbulbifer 0.105 Glycomycineae 0.043 Erythrobacter 0.052
Photobacterium 0.104 Burkholderia 0.043 Cardiobacterium 0.048
Lacinutrix 0.099 Frankineae 0.04 Glycomycineae 0.045
Streptococcus 0.092 Brumimicrobium 0.03 Hydrogenovibrio 0.045
Woodsholea 0.089 Geopsychrobacter 0.03 Frateuria 0.044
Vibrio 0.073 Agrobacterium 0.03 Fluviicola 0.044
Haliscomenobacter 0.065 Fluviicola 0.03 Haliscomenobacter 0.044
Ruegeria 0.063 Achromatium 0.03 Lactococcus 0.036
Psychrobacter 0.06 Caldilineacea 0.03 Chrysiogenes 0.035
Roseovarius 0.058 Flexithrix 0.03 Chromatium 0.031
Shinella 0.058 Alkalilimnicola 0.03 Branhamella 0.031
Fluoribacter 0.058 Chromatium 0.03 Alkalilimnicola 0.031
Ralstonia 0.058 Colwellia 0.03 Flexithrix 0.031
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Agrobacterium 0.011 Chrysiogenes -0.384 Devosia -0.448
Turicibacter 0.01 Devosia -0.371 Dokdonia -0.348
Delftia -3.464 Oceanibulbus -0.308 Ahrensia -0.341
Flexithrix -2.637 Algibacter -0.301 Cellulophaga -0.257
Chromatium -1.586 Kaistia -0.255 Hirschia -0.246
Hoeflea -1.11 Gaetbulibacter -0.247 Achromobacter -0.235
Chrysiogenes -1.072 Frankineae -0.23 Crenothrix -0.228
Gaetbulibacter -1.015 Kordiimonas -0.207 Pasteuriaceae
Incertae Sedis
-0.212
Erythrobacter -0.867 Acidimicrobineae -0.176 Delftia -0.16
Frankineae -0.78 Burkholderia -0.176 Alkalilimnicola -0.144
Geothermobacter -0.771 Lactococcus -0.162 Hyphomicrobium -0.124
Dokdonia -0.452 Fluviicola -0.078 Kordiimonas -0.082
Carnobacteriaceae_1 -0.429 Fluoribacter -0.059 Geothermobacter -0.051
Corynebacterineae -0.378 Lacinutrix -0.028 Gaetbulibacter -0.031
Leucothrix -0.267 Cardiobacterium -0.018 Lacinutrix -0.013








Table 2. Standardized canonical discriminant coefficients for all three classes.
Table 3 displays the structure coefficient table. The structure coefficients are full coefficients,
meaning that they are pooled as within‐groups correlations between the independent variable
and the standardized canonical discriminant coefficients [34]. According to Klecka [35], the
structure coefficient is the authoritative coefficient for determining the importance of the
independent variable to the discriminant function. As with the standardized canonical
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Diseased vs. Healthy Diseased vs. Healthy‐on‐Diseased Healthy vs. Healthy‐on‐Diseased
Taxon Coefficient  Taxon  Coefficient  Taxon  Coefficient
Carnobacteriaceae_2  0.058 Anaerococcus 0.03 Alishewane 0.031
Curvibacter 0.058 Hoeflea 0.03 Burkholderia 0.031
Schlegelella 0.058 Delftia 0.025 Turicibacter 0.031
Diaphorobacter 0.058 Hyphomicrobium 0.025 Carnobacteriaceae_1 0.019
Pseudomonas 0.058 Ahrensia 0.023 Ahrensia 0.013
Asticcacaulis 0.058 Lactococcus 0.021 Acidimicrobineae 0.011
Stenotrophomonas 0.058 Lacinutrix 0.019 Delftia 0.007
Staphylococcus 0.058 Crenothrix 0.015 Algibacter 0.004
Colwellia 0.058 Dokdonia 0.001 Aquimarina -0.002
Methylobacterium 0.058 Achromobacter -0.274 Abiotrophia -0.004
Hyphomicrobium 0.058 Cellulophaga -0.191 Dokdonia --0.016
Achromatium 0.058 Chrysiogenes ‐0.131 Achromobacter -0.018
Geopsychrobacter 0.058 Abiotrophia -0.116 Cellulophaga -0.046
Brumimicrobium 0.058 Fluoribacter -0.115 Hyphomicrobium -0.046
Spirochaeta 0.058 Erythrobacter -0.109 Lacinutrix -0.046
Caldilineacea 0.058 Algibacter -0.091 Erythromicrobium -0.063
Agrobacterium 0.058 Hydrogenovibrio -0.079 Fluoribacter -0.066
Cellulophaga 0.058 Carnobacteriaceae_1 -0.068 Gaetbulibacter -0.069
Anaerococcus 0.058 Acidimicrobineae -0.052 Geothermobacter -0.072
Roseobacter 0.049 Erythromicrobium -0.052 Oceanibulbus -0.09
Nereida -0.263 Geothermobacter -0.046 Kordiimonas -0.103
Glycomycineae -0.236 Oceanibulbus -0.042 Devosia -0.118
Silicibacter -0.206 Kordiimonas -0.037 Pasteuriaceae
Incertae Sedis
-0.169
Stappia -0.179 Gaetbulibacter -0.015 Kangiella -0.258
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signs of the disease and carapace samples without lesions that are taken from lobsters that
have the disease.
3.4. Correlational network analysis
Figure 6 is the network diagram of bacteria from the lobsters identified as Diseased. The
edges (connecting links) between the nodes (taxa) are either red (negative correlation) or
blue (positive). The width of the edge corresponds to the magnitude of the correlation
coefficient. An inspection of the map reveals that the genera Aquimarina and Jannaschia are
negatively correlated with several other taxa. Jannaschia is positively correlated with
Thalassobacter and Thalassobius and, by extension, is negatively correlated with Cardiobacteri‐
um. Jannaschia is also negatively correlated with Uvibacter, Pibocella, and Leucothrix. Aquimari‐
na is also negatively correlated with Leucothrix as well as with Loktanella and Micrococcineae.
Figure 6. Correlational network map of the Diseased microbiome.
Figure 7 is the network diagram of bacteria from the lobsters identified as Healthy. In this
diagram, Corynebacterineae appear to occupy a central point that connects most of the nodes
and is negatively correlated with Cycloclasticus and Cardiobacterium but positively correlated
with Maribacter, Propionibacterineae, Frankineae, and Micrococcineae. Cardiobacterium also
appears to occupy a hub‐like position and is negatively correlated with Micrococcineae and
positively correlated with Cycloclasticus and Psychroserpens. There is a secondary cluster that
is disconnected from the larger one. In this disconnected cluster, Ahrensia occupies a central
position between Erythrobacter, Sphingocinella, and Parvibaculum. Erythrobacter and Parvibacu‐
lum are also linked to form a clique with Ahrensia, and Erythrobacter is also linked to Sphingo‐
pyxis, which in turn is linked to Rubellimicrobium. All of these taxa are positively correlated
with one another. There are also three unconnected dyads. Leucothrix is associated with
Crenothrix, Thalassobacter is associated with Nereida, and Ulvibacter is associated with
Marinimicrobium. The pairs in all three dyads are positively correlated with one another.
Figure 8 represents the Healthy‐on‐Diseased microbiome correlations. In this map, there are
five unconnected clusters. The largest consists of four taxa in which all are positively corre‐
lated. The connection is an unbranched chain with Micrococcineae, Marinimicrobium, Algibact‐
er, and Cycloclasticus in sequence. There are two triads that do not form a complete clique.
Ulvibacter, Rubellimicrobium, and Ahrensia are all positively correlated. In the second triad,
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Table 3. Structure coefficient table.
For the second comparison of the bacterial taxa on the cuticle of Diseased lobsters versus
Healthy cuticle on Diseased lobsters, the functions at the group centroids were well separat‐
ed with a value of 2.060 for disease class 1 (Diseased) and ‐3.541 for disease class 3 (Healthy‐
on‐Diseased; Rc2=0.939; Wilks’ λ=0.118; χ2=131.382; p<0.001; df=47). As in the first comparison,
these data indicate that the function is discriminating between the classes.
Jannaschia spp. appears to have roughly the same structure coefficient as in the previous
analysis (0.315). Aquimarina spp. has a structure coefficient of 0.156.
Although these are the taxa with the highest positive structure coefficients, they are consid‐
erably less than 1. This indicates that, although they do discriminate for the disease com‐
pared to Healthy‐on‐Diseased samples, they do so weakly. Aquimarina spp. discriminated
more weakly between Diseased and Healthy‐on‐Diseased classes than between Diseased and
Healthy classes. This might indicate that, as a Healthy lobster converts to a Diseased lobster,
the abundance of Aquimarina spp. increases. There would be more of these bacteria present on
the unblemished surface of a lobster with ESD compared to Healthy lobsters but still less than
in the lesions.
For the third comparison of the bacterial taxa on the cuticle of Healthy lobsters versus Healthy
cuticle on Diseased lobsters, the discriminant functions at the group centroids demonstrated
a good separation with values of 2.439 for disease class 2 (Healthy) and ‐3.582 for disease
class 3 (Healthy‐on‐Diseased; Rc2= 0.948; Wilks’ λ=0.100; χ2=122.991; p<0.001; df=47). In this
analysis, Aquimarina spp. have a structure coefficient of ‐0.002, which indicates that it corre‐
lates weakly and negatively in discriminating between carapace from lobsters that show no
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pyxis, which in turn is linked to Rubellimicrobium. All of these taxa are positively correlated
with one another. There are also three unconnected dyads. Leucothrix is associated with
Crenothrix, Thalassobacter is associated with Nereida, and Ulvibacter is associated with
Marinimicrobium. The pairs in all three dyads are positively correlated with one another.
Figure 8 represents the Healthy‐on‐Diseased microbiome correlations. In this map, there are
five unconnected clusters. The largest consists of four taxa in which all are positively corre‐
lated. The connection is an unbranched chain with Micrococcineae, Marinimicrobium, Algibact‐
er, and Cycloclasticus in sequence. There are two triads that do not form a complete clique.
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the abundance of Aquimarina spp. increases. There would be more of these bacteria present on
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tions and range from 0 to 1 [41]. In other words, the clustering coefficient is the probability
that one node is connected to another.
Figure 9 is a correlational difference network diagram that compares Healthy and Diseased
microbiomes. This map displays taxa whose correlation coefficient changes significantly from
Healthy to Diseased class. They are color coded to reflect the nature of the change. Red edge
color indicates that the taxa correlate positively with the Healthy state and negatively with the
Diseased state. Blue indicates that they correlate with both states positively but have a larger
positive correlation coefficient in the Healthy state. Green indicates a negative correlation with
both states but a larger negative correlation coefficient with the Healthy state.
Figure 9. Correlational difference map of the Healthy versus Diseased microbiomes.
The network consists of three disconnected groups of taxa. Ahrensia, Erythrobacter, and
Roseobacter are connected in one group. Erythrobacter bridges this triad, and they all are
positively correlated to the Healthy state and negatively correlated to the Diseased state.
Frankineae and Micrococcineae form a dyad that has a higher positive correlation with the
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Cardiobacterium is negatively correlated with Leucothrix, which is positively correlated with
Nitratireductor. There are two dyads in which all taxa are positively correlated: Thalassobius
and Loktanella form one and Krokinobacter and Piscrikettsia form the second.
Figure 8. Correlational network map of the Healthy‐on‐Diseased microbiome.
Comparing the three maps, the average clustering coefficient of the Diseased microbiome is
0.289, the Healthy microbiome has an average clustering coefficient of 0.337, and the Healthy‐
on‐Diseased microbiome has an average clustering coefficient of 0.0. Clustering coefficients
are the ratios of the actual number of connections in comparison to the total possible connec‐
Figure 7. Correlational network map of the Healthy microbiome.
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and Kaistia in a linear fashion. Krokinobacter is a terminal end of its branch, and Piscirickettsia
connects to two taxa: Saprospira and Parvibaculum. To this point, the edge color of this group
is red, indicating that all are positively correlated with the Healthy‐on‐Diseased state and
negatively with the Diseased state. Parvibaculum connects to Propionibacterineae with a blue‐
colored edge, indicating that this edge‐node combination correlates positively more positive‐
ly with Healthy‐on‐Diseased than with Diseased.
The triad, similar to the triad in the Healthy versus Diseased correlational difference map,
forms an incomplete clique [37], with Ulvibacter bridging between Kordia and Leucothrix.
Between Ulvibacter and Kordia, the red edge color reveals that they correlate positively with
the Healthy‐on‐Diseased state but negatively with the Diseased state. The second edge of the
triad, however, between Ulvibacter and Leucothrix, is colored blue. The three dyads have red
edge colors. They consist of the pairs Thassobius and Cardiobacerium, Paracoccus and Kordimo‐
nas, and Windgradskyella and Rubellimicrobium.
4. Discussion and conclusion
Smolowitz et al. [3] found that, although more advanced cases of ESD presented with extensive
lesions throughout the dorsal surface, most cases were restricted to the cephalothorax.
The bacterial diversity as measured by the Shannon index appears to be roughly similar on all
regions, with the claw and cephalothorax regions having the most similar indices (see
Figure 1). Smolowitz et al.'s observations that ESD lesions were more prevalent on the upper
cephalothorax, however, influenced the decision that a further molecular study would be
focused on this region of the carapace. Furthermore, as the taxa distribution is relatively similar
in all regions, we would be unlikely to miss key taxa by focusing on the cephalothorax.
As mentioned previously, the inset histogram (Figure 2) represents 170 taxa that were
identified and at a normalized abundance greater than 1%. The most abundant taxa include
the genera Jannaschia, Aquimarina, Cardiobacterium, Thalassobius, and Loktanella and the
suborder Micrococcineae.
Jannaschia are characterized as rod‐shaped, nonmotile, Gram‐negative, catalase‐positive, strict
aerobes that do not reduce nitrate to nitrite and found to use a wide variety of carbon sources
but not chitin. Their growth appears to be restricted to seawater and cannot be cultured in the
absence of seasalts [42].
Aquimarina are described as rod‐shaped bacteria that possess gliding motility. They are Gram‐
negative, catalase‐positive, strict aerobes and are capable of degrading chitin. They are also
known to produce various flexirubin and carotenoid pigments. Similar to Jannaschia,
Aquimarina appear to be dependent on seawater to grow [43].
Cardiobacterium are described exclusively in the literature as human pathogens implicated in
endocarditis and peritonitis. They are also found as normal constituents in human nasal and
oral cavity microflora. They are catalase‐negative, Gram‐negative pleomorphic bacilli. They
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Healthy state than the Diseased state. Cycloclasticus and Corynebacterineae form the second dyad
that correlates negatively with both states but more negatively with the Healthy state. Neither
Aquimarina nor Jannaschia appears in this correlation difference network, suggesting that the
observed correlation between these two taxa in the Diseased state (Figure 6) was not statisti‐
cally different from the Healthy state. Correlational difference maps illustrate differences in
the microbial community when comparing one state (disease class) to another. If there is no
significant difference in the correlations between taxa when one state is compared to the other,
then those taxa will not be visible on the diagram.
Figure 10 is a correlational difference diagram that compares Healthy‐on‐Diseased to Diseased
microbiomes. The color coding is the same as Figure 9.
Figure 10. Correlational difference map of the Healthy‐on‐Diseased versus Diseased microbiomes.
This network is more complex, with a large group consisting of 10 taxa, 3 dyads, and 1 triad,
suggesting that a number of potentially pathogenic processes or interactions are different in
the Healthy‐on‐Diseased biofilm that do not occur in the Healthy biofilm. Within the large
group, Aquimarina is connected to three taxa: Staleya, Krokinobacter, and Piscirickettsia.
Following the first branch, Staleya is connected to Jannaschia, which is connected to Pibocella
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and Kaistia in a linear fashion. Krokinobacter is a terminal end of its branch, and Piscirickettsia
connects to two taxa: Saprospira and Parvibaculum. To this point, the edge color of this group
is red, indicating that all are positively correlated with the Healthy‐on‐Diseased state and
negatively with the Diseased state. Parvibaculum connects to Propionibacterineae with a blue‐
colored edge, indicating that this edge‐node combination correlates positively more positive‐
ly with Healthy‐on‐Diseased than with Diseased.
The triad, similar to the triad in the Healthy versus Diseased correlational difference map,
forms an incomplete clique [37], with Ulvibacter bridging between Kordia and Leucothrix.
Between Ulvibacter and Kordia, the red edge color reveals that they correlate positively with
the Healthy‐on‐Diseased state but negatively with the Diseased state. The second edge of the
triad, however, between Ulvibacter and Leucothrix, is colored blue. The three dyads have red
edge colors. They consist of the pairs Thassobius and Cardiobacerium, Paracoccus and Kordimo‐
nas, and Windgradskyella and Rubellimicrobium.
4. Discussion and conclusion
Smolowitz et al. [3] found that, although more advanced cases of ESD presented with extensive
lesions throughout the dorsal surface, most cases were restricted to the cephalothorax.
The bacterial diversity as measured by the Shannon index appears to be roughly similar on all
regions, with the claw and cephalothorax regions having the most similar indices (see
Figure 1). Smolowitz et al.'s observations that ESD lesions were more prevalent on the upper
cephalothorax, however, influenced the decision that a further molecular study would be
focused on this region of the carapace. Furthermore, as the taxa distribution is relatively similar
in all regions, we would be unlikely to miss key taxa by focusing on the cephalothorax.
As mentioned previously, the inset histogram (Figure 2) represents 170 taxa that were
identified and at a normalized abundance greater than 1%. The most abundant taxa include
the genera Jannaschia, Aquimarina, Cardiobacterium, Thalassobius, and Loktanella and the
suborder Micrococcineae.
Jannaschia are characterized as rod‐shaped, nonmotile, Gram‐negative, catalase‐positive, strict
aerobes that do not reduce nitrate to nitrite and found to use a wide variety of carbon sources
but not chitin. Their growth appears to be restricted to seawater and cannot be cultured in the
absence of seasalts [42].
Aquimarina are described as rod‐shaped bacteria that possess gliding motility. They are Gram‐
negative, catalase‐positive, strict aerobes and are capable of degrading chitin. They are also
known to produce various flexirubin and carotenoid pigments. Similar to Jannaschia,
Aquimarina appear to be dependent on seawater to grow [43].
Cardiobacterium are described exclusively in the literature as human pathogens implicated in
endocarditis and peritonitis. They are also found as normal constituents in human nasal and
oral cavity microflora. They are catalase‐negative, Gram‐negative pleomorphic bacilli. They
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cally different from the Healthy state. Correlational difference maps illustrate differences in
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This network is more complex, with a large group consisting of 10 taxa, 3 dyads, and 1 triad,
suggesting that a number of potentially pathogenic processes or interactions are different in
the Healthy‐on‐Diseased biofilm that do not occur in the Healthy biofilm. Within the large
group, Aquimarina is connected to three taxa: Staleya, Krokinobacter, and Piscirickettsia.
Following the first branch, Staleya is connected to Jannaschia, which is connected to Pibocella
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species in any of the samples, although we did find related species. Furthermore, the in‐
duced shell disease studied here does not conform to the histological profile that has been
described for ESD [12].
An inspection of the UniFrac data that are depicted by the tree (Figure 4) reveals that, although
there is some clustering, the lobsters identified as Healthy and Diseased show enough
similarity that they exist as neighbors on all of the major branches of the tree. There is no
statistically significant difference between the three classes as demonstrated by the enumera‐
tion of their p values. Again, this supports the hypothesis that this disease is not caused by a
discrete pathogen.
The PCO reveals much the same pattern; although there are identifiable regions, there is an
overlap between the classes.
Our original simple hypothesis is that there is a significant difference between the bacterial
communities in the Healthy and Disease states, indicating that this difference is associated
with the etiology of the disease. The null hypothesis asserts that the bacterial communities are
similar on the Healthy and Diseased lobsters. The phylogenetic metrics employed to com‐
pare the microbiomes of subjects in this study indicate that there is no significant difference
between the three classes, which leads us to accept the null hypothesis and reject the origi‐
nal hypothesis. However, these data suggest that, although there may not be a gross differ‐
ence between the microbiomes of Healthy and Diseased lobsters, there is a subtle shift that
requires further investigation and the definition of a more complex hypothesis. A major avenue
of inquiry would be to determine whether this shift is one of the metabolic activities among
essentially the same bacteria, if there is an emergence of some members of the population that
displace other extant members, or if there are new recruits to the community from outside the
biofilm. Wahl et al. [48] suggested the use of emergent techniques, such as desorption
electrospray ionization‐mass spectrometry, as a means of surveying the surface of the biofilm
to elucidate the metabolic compounds that are present in biofilms. Coupled with confocal
microscopy techniques, as suggested by Costerton [24], researchers could begin to develop a
spatial representation of the lobster surface microbiome that would include both the identity
of the bacterial cells and the metabolic activity that was occurring in their vicinity.
From the perspective of disease etiology, this kind of shift may point to a cause other than
bacterial. If the same microflora, albeit in different abundances, are found on lobsters that have
the disease as well as on those that are apparently healthy, then perhaps this dysbiosis
represents a sign of some kind of disorder that is caused by something other than bacteria.
Laufer et al. [16] established a correlation between lobsters with ESD and high tissue concen‐
trations of alkylphenols. As noted earlier, these compounds retard the cross‐linking of tyrosine
moieties in the carapace, which makes shell hardening take longer. Tarrant et al. [21] found
evidence to suggest that gene expression in lobsters affected by ESD might indicate in‐
creased exposure to xenobiotics. Homerding et al. [20] found that lobsters living in the
geographic area with a high incidence of ESD presented with reduced immunocompetence.
This evidence supports an assertion that ESD is not primarily a bacterial disease but that
bacterial lesions are a manifestation of a systemic dysfunction.
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are facultative anaerobes that ferment carbohydrates but do not reduce nitrate to nitrite.
Although implicated in serious infections, members of this genus are not exceptionally
virulent (a large inoculate is necessary to initiate an infection) [44].
Thalassobius are Gram‐negative, strict aerobes that do not produce pigments and tend to favor
organic acids as a carbon and energy source rather than carbohydrates. Some members of the
genus exhibit motility; others do not [45].
Loktanella are Gram‐negative, strict aerobes that do not use carbohydrates but can degrade
urea, Tween 80, citrate, and aesculin [46].
The suborder Micrococcineae includes 15 families that collectively include more than 90 genera
as well as 4 genera that have not been classified as members of a family. This group is a
metabolically diverse, Gram‐positive taxon [47]. What this specific OTU represents is un‐
clear from these data.
These taxa do conform, however, to what has been observed about ESD. There is some, but
not extensive, degradation of chitin. In these six genera, only one genus (Aquimarina) is
observed to be chitinovorous. As mentioned above, there is high lipase activity in lesions [14],
and lipids appear to be the preferential carbon and energy source of Loktanella. There are
generalists in the group, such as Jannaschia, and there are those that use organic acids, including
amino acids (Thalassobius). The presence of a fermenter, such as Cardiobacterium, could indicate
that anaerobic conditions develop concomitantly with the progression of the lesions.
Bell et al. [14] found that ectohydrolase activity differed within the biofilms of lobsters from
the geographic areas with high ESD incidence compared to lobsters inhabiting areas of little
to no ESD. This could indicate that there is a shift in metabolic activity of the bacteria that are
present or could indicate a shift in population.
The neighbor joining tree (Figure 3) of Aquimarina species reveals that the genus is present in
all samples. There is no emergent pattern of members of the genus that correlates with either
state of health. These data suggest that members of the genus Aquimarina are ubiquitous but
do not eliminate them as opportunists if there is an underlying susceptibility in the lobster.
This supports the dysbiosis model of ESD. A discrete pathogenic microorganism does not
cause the disease; rather, the bacterial infection is the result of a change in the biofilm, either
in community structure or in metabolic activity, which could have a different underlying cause.
Laufer et al. [16], as explained in Section 1, found that lobsters with ESD had higher tissue
concentrations of alkylphenols than did lobsters that did not present with the disease. Other
studies of the same lobsters used in this study also found a higher incidence of idiopathic
ailments such as hepatopancreatitis and ocular lesions in Rhode Island lobsters compared to
their Maine counterparts [15], and other researchers found differences in bacterial ectohydro‐
lase activity on the surface of lobsters from these distinct regions [14]. This suggests that there
may be environmental conditions present in Rhode Island waters that are causing the native
lobsters to be more susceptible to disease.
Researchers have implicated a novel species (A. homaria) in the initiation of a laboratory‐
induced form of shell disease [12]. The author's investigation found no evidence of this specific
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species in any of the samples, although we did find related species. Furthermore, the in‐
duced shell disease studied here does not conform to the histological profile that has been
described for ESD [12].
An inspection of the UniFrac data that are depicted by the tree (Figure 4) reveals that, although
there is some clustering, the lobsters identified as Healthy and Diseased show enough
similarity that they exist as neighbors on all of the major branches of the tree. There is no
statistically significant difference between the three classes as demonstrated by the enumera‐
tion of their p values. Again, this supports the hypothesis that this disease is not caused by a
discrete pathogen.
The PCO reveals much the same pattern; although there are identifiable regions, there is an
overlap between the classes.
Our original simple hypothesis is that there is a significant difference between the bacterial
communities in the Healthy and Disease states, indicating that this difference is associated
with the etiology of the disease. The null hypothesis asserts that the bacterial communities are
similar on the Healthy and Diseased lobsters. The phylogenetic metrics employed to com‐
pare the microbiomes of subjects in this study indicate that there is no significant difference
between the three classes, which leads us to accept the null hypothesis and reject the origi‐
nal hypothesis. However, these data suggest that, although there may not be a gross differ‐
ence between the microbiomes of Healthy and Diseased lobsters, there is a subtle shift that
requires further investigation and the definition of a more complex hypothesis. A major avenue
of inquiry would be to determine whether this shift is one of the metabolic activities among
essentially the same bacteria, if there is an emergence of some members of the population that
displace other extant members, or if there are new recruits to the community from outside the
biofilm. Wahl et al. [48] suggested the use of emergent techniques, such as desorption
electrospray ionization‐mass spectrometry, as a means of surveying the surface of the biofilm
to elucidate the metabolic compounds that are present in biofilms. Coupled with confocal
microscopy techniques, as suggested by Costerton [24], researchers could begin to develop a
spatial representation of the lobster surface microbiome that would include both the identity
of the bacterial cells and the metabolic activity that was occurring in their vicinity.
From the perspective of disease etiology, this kind of shift may point to a cause other than
bacterial. If the same microflora, albeit in different abundances, are found on lobsters that have
the disease as well as on those that are apparently healthy, then perhaps this dysbiosis
represents a sign of some kind of disorder that is caused by something other than bacteria.
Laufer et al. [16] established a correlation between lobsters with ESD and high tissue concen‐
trations of alkylphenols. As noted earlier, these compounds retard the cross‐linking of tyrosine
moieties in the carapace, which makes shell hardening take longer. Tarrant et al. [21] found
evidence to suggest that gene expression in lobsters affected by ESD might indicate in‐
creased exposure to xenobiotics. Homerding et al. [20] found that lobsters living in the
geographic area with a high incidence of ESD presented with reduced immunocompetence.
This evidence supports an assertion that ESD is not primarily a bacterial disease but that
bacterial lesions are a manifestation of a systemic dysfunction.
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are facultative anaerobes that ferment carbohydrates but do not reduce nitrate to nitrite.
Although implicated in serious infections, members of this genus are not exceptionally
virulent (a large inoculate is necessary to initiate an infection) [44].
Thalassobius are Gram‐negative, strict aerobes that do not produce pigments and tend to favor
organic acids as a carbon and energy source rather than carbohydrates. Some members of the
genus exhibit motility; others do not [45].
Loktanella are Gram‐negative, strict aerobes that do not use carbohydrates but can degrade
urea, Tween 80, citrate, and aesculin [46].
The suborder Micrococcineae includes 15 families that collectively include more than 90 genera
as well as 4 genera that have not been classified as members of a family. This group is a
metabolically diverse, Gram‐positive taxon [47]. What this specific OTU represents is un‐
clear from these data.
These taxa do conform, however, to what has been observed about ESD. There is some, but
not extensive, degradation of chitin. In these six genera, only one genus (Aquimarina) is
observed to be chitinovorous. As mentioned above, there is high lipase activity in lesions [14],
and lipids appear to be the preferential carbon and energy source of Loktanella. There are
generalists in the group, such as Jannaschia, and there are those that use organic acids, including
amino acids (Thalassobius). The presence of a fermenter, such as Cardiobacterium, could indicate
that anaerobic conditions develop concomitantly with the progression of the lesions.
Bell et al. [14] found that ectohydrolase activity differed within the biofilms of lobsters from
the geographic areas with high ESD incidence compared to lobsters inhabiting areas of little
to no ESD. This could indicate that there is a shift in metabolic activity of the bacteria that are
present or could indicate a shift in population.
The neighbor joining tree (Figure 3) of Aquimarina species reveals that the genus is present in
all samples. There is no emergent pattern of members of the genus that correlates with either
state of health. These data suggest that members of the genus Aquimarina are ubiquitous but
do not eliminate them as opportunists if there is an underlying susceptibility in the lobster.
This supports the dysbiosis model of ESD. A discrete pathogenic microorganism does not
cause the disease; rather, the bacterial infection is the result of a change in the biofilm, either
in community structure or in metabolic activity, which could have a different underlying cause.
Laufer et al. [16], as explained in Section 1, found that lobsters with ESD had higher tissue
concentrations of alkylphenols than did lobsters that did not present with the disease. Other
studies of the same lobsters used in this study also found a higher incidence of idiopathic
ailments such as hepatopancreatitis and ocular lesions in Rhode Island lobsters compared to
their Maine counterparts [15], and other researchers found differences in bacterial ectohydro‐
lase activity on the surface of lobsters from these distinct regions [14]. This suggests that there
may be environmental conditions present in Rhode Island waters that are causing the native
lobsters to be more susceptible to disease.
Researchers have implicated a novel species (A. homaria) in the initiation of a laboratory‐
induced form of shell disease [12]. The author's investigation found no evidence of this specific
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ces are similar in both classes are not contributing to the disease state. The structure matrix
indicates that the genus Aquimarina is weakly correlated with the Diseased state. Its struc‐
ture coefficient is second only to the genus Jannaschia.
This analysis supports the affirmative hypothesis that there is a difference between the
microbial taxa in shell‐diseased lobsters compared to healthy lobsters. The study identifies 58
bacteria that are significantly different between the two classes and rejects 112 that do not
contribute to discrimination between them. The relatively low correlation coefficients for
these 58 taxa, however, do indicate that they are present on all three classes but in slightly
different abundances.
This analysis also provides additional evidence that ESD in the American lobster correlates
with dysbiosis rather than the presence of a single overt pathogen. In a disease caused by a
single pathogen, one would expect a structure coefficient of one of the variables to approach
1. An inspection of the structure coefficients reveals that none of the bacterial taxa have a
coefficient greater than 0.325.
The role of Aquimarina spp. in the disease lesions is unclear. In the DA that compared the
bacteria on cuticle from Diseased animals to Healthy cuticle from Diseased animals,
Aquimarina spp. had a smaller structure coefficient (0.156) than that on Diseased versus
apparently Healthy animals (0.268). One possible interpretation is that, if Aquimarina spp. were
present at the initiation of the disease, then it should be strongly negatively correlated with
the Diseased cuticle bacteria. Instead, the genus correlates weakly and positively, indicating
that it discriminates the Diseased state more strongly than the pre‐Diseased state. Moreover,
in the analysis of taxa from Healthy lobsters versus Healthy cuticle on Diseased lobsters, the
structure coefficient of Aquimarina spp. was negative and the lowest value of all the struc‐
ture coefficients in the structure coefficient table. This indicates a weakly negative correla‐
tion. If this bacterial taxon was definitive in the initiation of the disease, a more likely scenario
would be that it would correlate strongly with the unaffected surface of a Diseased lobster and
would therefore have a more negative coefficient compared to the surface of Healthy lobsters.
This analysis supports the observations that were articulated above. The weak correlations of
some of the taxa with the three states of health reinforce the assertion that, although there are
differences in the abundances of these taxa when comparing these three states, none of them
are exclusive to one or the other state. The weak correlations also demonstrate that this is not
a disease caused by a discrete pathogen, which would have a much stronger correlation. The
works of the author's colleagues within the New England Lobster Health Initiative strongly
suggest that there are underlying causes that render some lobsters, particularly within the
waters of eastern Long Island Sound and Rhode Island, susceptible to an opportunistic
infection [10, 14–16, 21]. Exposure to abnormally high levels of endocrine‐disrupting com‐
pounds such as alkylphenols appears to fit the profile of intervening agents, which is descri‐
bed by Laufer et al. and Tarrant et al.; not only are they capable of eliciting a response consistent
with an endocrine‐disrupting compound, but they also appear to retard proper shell devel‐
opment. Hitherto, there is a correlation, but no direct evidence, linking alkylphenol expo‐
sure to ESD. Obtaining such evidence would require an experiment in which a group of
lobsters was exposed to alkylphenols, whereas a control group would be kept in an alkylphe‐
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Kunkel et al. [10] discovered that lobsters with ESD had a loss of calcification in and around
the disease lesions, particularly in the trabecular structures that are composed of apatite. One
question that needs to be investigated further is whether the decalcification is related to the
presence of alkylphenols. Could exposure of the underlying structure to the environment lead
to decalcification? Alternatively, could acidic metabolic products of bacterial action produce
the same results?
To use an analogy, suppose there is a house whose roof is defective. Imagine the nails were
weak and could not hold the protective components of the roof in place, similar to the protein‐
chitin structures in the lobster carapace in which the tyrosine cross‐linking was not complete.
Rainwater would leak into the underlying structure, analogous to seawater getting into the
trabecular apatite of the lobster carapace. In both cases, this would physically weaken the
underlying structure. In both cases, normal microflora would have access to parts of the
structure from which they would normally be excluded and may start to use these energy and
carbon sources. This would further weaken and disfigure the structure and increase the
likelihood of a breach in the outer protective structure. In this analogy, it is not the micro‐
flora that causes the problem in the roof. Rather, the rot that would ensue from its invasion is
the result of the ineffectiveness of barriers whose function is to keep these organisms out of
the underlying structure. In the case of ESD, perhaps the bacterial lesions are not the cause of
the disease but merely the inevitable result of structural weaknesses in the lobster carapace.
Additionally, the trabecular apatite and the other calcium moieties present in the lobster cuticle
may have antimicrobial properties themselves [10]. Their physical dissolution could be the
result of the intrusion of acidified seawater, as there is now evidence that ocean acidification
is affecting organisms that produce calcareous shells [49]. The absence calcium moieties from
the site of lesions could represent an additional reduction in the ability to exclude microbio‐
ta from the exoskeleton.
Although there have been other studies of biofilms related to crustaceans [50, 51], this
represents the first survey of the surface microbiome of the lobster that uses high‐through‐
put, culture‐independent molecular techniques. As mentioned above, it is by no means an
exhaustive analysis of the lobster microbiome, as the subjects of this study are geographical‐
ly restricted and are not a large enough size to yield a global generalization. It is comprehen‐
sive enough, however, to demonstrate that, although there is no gross difference between the
microbiomes of lobsters with and without ESD in Rhode Island samples, there may be a subtle
shift in the microbial population that correlates with dysfunction. As mentioned previously,
Bell et al.'s work indicates a variance in the metabolic activity of bacteria in eastern Long Island
Sound, an area of high ESD occurrence, compared to those found on the surface of lobsters in
regions that have little to no ESD incidence [14]. This shift may be more closely related to a
shift in activity rather than of population.
Considering the first DA analysis (Diseased vs. Healthy), the canonical correlation coeffi‐
cient (Rc2) value of 0.848 indicates a high correlation of the discriminant function and the
groups [34]. The second and third analyses have lower values. This indicates that the 58
bacteria that were retained after the initial tolerance test are useful in discriminating be‐
tween disease classes. Presumably, the 112 bacteria that were rejected because their abundan‐
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ces are similar in both classes are not contributing to the disease state. The structure matrix
indicates that the genus Aquimarina is weakly correlated with the Diseased state. Its struc‐
ture coefficient is second only to the genus Jannaschia.
This analysis supports the affirmative hypothesis that there is a difference between the
microbial taxa in shell‐diseased lobsters compared to healthy lobsters. The study identifies 58
bacteria that are significantly different between the two classes and rejects 112 that do not
contribute to discrimination between them. The relatively low correlation coefficients for
these 58 taxa, however, do indicate that they are present on all three classes but in slightly
different abundances.
This analysis also provides additional evidence that ESD in the American lobster correlates
with dysbiosis rather than the presence of a single overt pathogen. In a disease caused by a
single pathogen, one would expect a structure coefficient of one of the variables to approach
1. An inspection of the structure coefficients reveals that none of the bacterial taxa have a
coefficient greater than 0.325.
The role of Aquimarina spp. in the disease lesions is unclear. In the DA that compared the
bacteria on cuticle from Diseased animals to Healthy cuticle from Diseased animals,
Aquimarina spp. had a smaller structure coefficient (0.156) than that on Diseased versus
apparently Healthy animals (0.268). One possible interpretation is that, if Aquimarina spp. were
present at the initiation of the disease, then it should be strongly negatively correlated with
the Diseased cuticle bacteria. Instead, the genus correlates weakly and positively, indicating
that it discriminates the Diseased state more strongly than the pre‐Diseased state. Moreover,
in the analysis of taxa from Healthy lobsters versus Healthy cuticle on Diseased lobsters, the
structure coefficient of Aquimarina spp. was negative and the lowest value of all the struc‐
ture coefficients in the structure coefficient table. This indicates a weakly negative correla‐
tion. If this bacterial taxon was definitive in the initiation of the disease, a more likely scenario
would be that it would correlate strongly with the unaffected surface of a Diseased lobster and
would therefore have a more negative coefficient compared to the surface of Healthy lobsters.
This analysis supports the observations that were articulated above. The weak correlations of
some of the taxa with the three states of health reinforce the assertion that, although there are
differences in the abundances of these taxa when comparing these three states, none of them
are exclusive to one or the other state. The weak correlations also demonstrate that this is not
a disease caused by a discrete pathogen, which would have a much stronger correlation. The
works of the author's colleagues within the New England Lobster Health Initiative strongly
suggest that there are underlying causes that render some lobsters, particularly within the
waters of eastern Long Island Sound and Rhode Island, susceptible to an opportunistic
infection [10, 14–16, 21]. Exposure to abnormally high levels of endocrine‐disrupting com‐
pounds such as alkylphenols appears to fit the profile of intervening agents, which is descri‐
bed by Laufer et al. and Tarrant et al.; not only are they capable of eliciting a response consistent
with an endocrine‐disrupting compound, but they also appear to retard proper shell devel‐
opment. Hitherto, there is a correlation, but no direct evidence, linking alkylphenol expo‐
sure to ESD. Obtaining such evidence would require an experiment in which a group of
lobsters was exposed to alkylphenols, whereas a control group would be kept in an alkylphe‐
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Kunkel et al. [10] discovered that lobsters with ESD had a loss of calcification in and around
the disease lesions, particularly in the trabecular structures that are composed of apatite. One
question that needs to be investigated further is whether the decalcification is related to the
presence of alkylphenols. Could exposure of the underlying structure to the environment lead
to decalcification? Alternatively, could acidic metabolic products of bacterial action produce
the same results?
To use an analogy, suppose there is a house whose roof is defective. Imagine the nails were
weak and could not hold the protective components of the roof in place, similar to the protein‐
chitin structures in the lobster carapace in which the tyrosine cross‐linking was not complete.
Rainwater would leak into the underlying structure, analogous to seawater getting into the
trabecular apatite of the lobster carapace. In both cases, this would physically weaken the
underlying structure. In both cases, normal microflora would have access to parts of the
structure from which they would normally be excluded and may start to use these energy and
carbon sources. This would further weaken and disfigure the structure and increase the
likelihood of a breach in the outer protective structure. In this analogy, it is not the micro‐
flora that causes the problem in the roof. Rather, the rot that would ensue from its invasion is
the result of the ineffectiveness of barriers whose function is to keep these organisms out of
the underlying structure. In the case of ESD, perhaps the bacterial lesions are not the cause of
the disease but merely the inevitable result of structural weaknesses in the lobster carapace.
Additionally, the trabecular apatite and the other calcium moieties present in the lobster cuticle
may have antimicrobial properties themselves [10]. Their physical dissolution could be the
result of the intrusion of acidified seawater, as there is now evidence that ocean acidification
is affecting organisms that produce calcareous shells [49]. The absence calcium moieties from
the site of lesions could represent an additional reduction in the ability to exclude microbio‐
ta from the exoskeleton.
Although there have been other studies of biofilms related to crustaceans [50, 51], this
represents the first survey of the surface microbiome of the lobster that uses high‐through‐
put, culture‐independent molecular techniques. As mentioned above, it is by no means an
exhaustive analysis of the lobster microbiome, as the subjects of this study are geographical‐
ly restricted and are not a large enough size to yield a global generalization. It is comprehen‐
sive enough, however, to demonstrate that, although there is no gross difference between the
microbiomes of lobsters with and without ESD in Rhode Island samples, there may be a subtle
shift in the microbial population that correlates with dysfunction. As mentioned previously,
Bell et al.'s work indicates a variance in the metabolic activity of bacteria in eastern Long Island
Sound, an area of high ESD occurrence, compared to those found on the surface of lobsters in
regions that have little to no ESD incidence [14]. This shift may be more closely related to a
shift in activity rather than of population.
Considering the first DA analysis (Diseased vs. Healthy), the canonical correlation coeffi‐
cient (Rc2) value of 0.848 indicates a high correlation of the discriminant function and the
groups [34]. The second and third analyses have lower values. This indicates that the 58
bacteria that were retained after the initial tolerance test are useful in discriminating be‐
tween disease classes. Presumably, the 112 bacteria that were rejected because their abundan‐
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There are no major shifts in the microbiome between the Healthy and Diseased states, so we
accept the alternative hypothesis and reject the original simple hypothesis. However, there are
minor differences in the microbiomes of Healthy and Diseased lobsters. Furthermore, the
microbiomes of lesion‐free carapace on Diseased lobsters exhibited different microbiome
compositions. However, the microbiomes of all three classes of the Diseased state that were
identified here were similar enough that they occupied the same branches on a weighted
UniFrac tree, and the difference between the microbiomes was determined to be statistically
insignificant. Although there appears from these data to be a subtle difference between the
microbiomes of samples from these three sample classes, the difference is not enough to fully
support the original simple hypothesis. We must move forward with a more complicated
hypothesis where environmental factors play a major role in the etiology of the disease. As
such, we can start to define ESD as a complex environmental disease.
Arguably one of the most important advances in health and disease prevention has been the
recognition that multiple pathogens are the cause of many diseases and it is now well accepted
that these “polymicrobial disease” are in fact quite common [52]. As the body of knowledge
has increased and we have extended our limits of detection and sequencing throughput, a
growing number of diseases and syndromes have emerged that have been shown to be
polymicrobial in nature. ESD is an example of one such polymicrobial disease.
This research has employed culture‐independent techniques coupled with multivariate
statistical treatment of the resultant data that present a shift in the lobster microbiome that
correlates with the disease. This phenomenon is defined here as a dysbiosis. Although this
research has elucidated this subtle shift in the microbiome of the lobster, it has not ad‐
dressed the etiology of the disease. Indeed, it is not clear that the bacterial manifestations of
this disease are anything more than a proximal cause. Researchers have successfully in‐
duced a condition that resembles ESD in captive lobsters but under extraordinary conditions.
The evidence of involvement of alkylphenol contamination, for example, is circumstantial at
this point. A direct evidence might be obtained through controlled experimentation as long as
the confounding effects of captivity can eliminated.
The bulk method of extracting bacterial DNA from the lobster samples is itself confounding
to the process of understanding the disease. Removing the biofilm and extracting the micro‐
biomic DNA in bulk fashion precludes the interrogation of the spatial aspect of the biofilm. If
microbes are cooperatively harvesting material and energy from a site, understanding their
positional relationship may be useful. In addition, the nature of bulk extraction is that a
relatively large amount of microbiota is captured. Such an approach can obscure members of
the microbial community whose importance to the ecological function is disproportional to
their relative abundance. It may be that minority members of the community, when ob‐
served in their spatial context within the biofilm, play a pivotal role in metabolic function. In
the research described here, these bacteria may have been discarded due to insufficient
abundance. In situ techniques, such as the use of laser capture microdissection on prepared
sections of ESD lesions, coupled with DNA extraction of captured microbes, might shed some
light on the spatial arrangements of the biofilm. In addition, visualization of intact biofilm
colonies using confocal microscopy [24] combined with in situ hybridization techniques could
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nol‐free environment. As discussed previously, however, captive lobsters are more suscepti‐
ble to impoundment shell diseases [5]. Designing an experiment that would mitigate such
confounding results is likely to prove challenging.
The abundance tables, as well as the DA computations reported in the previous chapter, reveal
that Aquimarina and Jannaschia are more abundant (and correlate positively in DA) when the
Diseased and Healthy states are compared. An inspection of the correlation network of the
Diseased microbiome indicates that these two genera are negatively correlated with several of
the other taxa present, indicating that, although these two are more abundant in the Diseased
state, most of the others are reduced in abundance, with the exception of Thalassobacter and
Thalassobius, which are positively correlated with Jannaschia. The average clustering coeffi‐
cient for the Diseased microbiome was 0.289. For the Healthy microbiome, the coefficient
was 0.337. Both of these are well below 1; therefore, neither network demonstrates a great deal
of connectivity or interaction between members of the community. With a difference in the
coefficients of less than 0.05, the difference between the two is negligible. In the Healthy‐on‐
Diseased microbiome, the average clustering coefficient is 0.0, indicating that the associa‐
tions between the taxa are essentially random.
The correlational difference networks may shed some light on the role of Aquimarina and, for
that matter, Jannaschia. Neither can be found in the correlational difference network map that
compared Healthy and Diseased lobsters. In the comparison of Healthy‐on‐Diseased to
Diseased, however, both appear as taxa that correlate positively with the Healthy‐on‐Diseased
state but negatively with the Diseased state. This may indicate that both are early opportun‐
ists in the lesion formation and there is a shift in their function when they move to the Diseased
state.
The only data used in these correlational networks were those derived from MTPS of sam‐
ple lobsters from the “100 Lobsters” Project [28]. As described in Section 1, samples from these
lobsters were used in other investigations, and the data obtained have been recorded [14, 16,
20]. Integrating these data by means of correlational network analysis with alkylphenol
concentrations in the tissues and ectohydrolases on the surface of the same lobster, for example,
may produce a more definitive correlation between ESD and alkylphenols and may allow
researchers to correlate which bacterial taxa are involved in what metabolic activity.
When comparing the data obtained using previous methods, a slightly different picture
emerges. Taxa such as Aquimarina and Jannaschia appear to correlate with ESD, albeit weakly.
In the DA analysis, they serve as reliable factors in discriminating cases of the disease. They
appear, however, to have somewhat weaker interactions with other constituents of the biofilm
as demonstrated by these correlational diagrams.
As stated above, the hypotheses addressed are as follows:
H: The bacterial communities on lobsters with ESD are significantly different in quality and
quantity than unaffected lobsters.
HA: The bacterial communities on the carapaces of healthy and shell‐diseased lobsters are
similar.
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microbes are cooperatively harvesting material and energy from a site, understanding their
positional relationship may be useful. In addition, the nature of bulk extraction is that a
relatively large amount of microbiota is captured. Such an approach can obscure members of
the microbial community whose importance to the ecological function is disproportional to
their relative abundance. It may be that minority members of the community, when ob‐
served in their spatial context within the biofilm, play a pivotal role in metabolic function. In
the research described here, these bacteria may have been discarded due to insufficient
abundance. In situ techniques, such as the use of laser capture microdissection on prepared
sections of ESD lesions, coupled with DNA extraction of captured microbes, might shed some
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round out the picture in a way that would be the best of systems biology. In addition, the
emergent field of metabolomics, the study of the net metabolic effects of epibiotic communi‐
ties, would shed light on the changes in metabolic activity of a dysbiotic shift [48]. It is possible
that what is described here is not a change in microbial organisms but merely a change in
metabolic output of the same actors.
As noted previously, this research did not subdivide the disease lesions based on severity.
Doing so would have yielded a more complete picture of the disease process and may have
provided us with more insight into the roles of Aquimarina and Jannaschia and other taxa in the
colonization of the lesions. A larger sample size, with more geographic diversity, would also
be advantageous to increasing statistical confidence.
In response to the ESD crisis, a group of scientists, fisheries managers, and lobstermen formed
the New England Lobster Health Initiative. It was this ad hoc committee that ultimately
received funding that was awarded to several university and institutional researchers,
including the award that funded what is reported here. The findings of each group were
published as a special edition of the Journal of Shellfish Research [22]. Included in that edition
was an article that summarizes some of what is contained herein [23]. A synthesis of all the
research is summarized in the final article of the journal [53]. This research contributed a broad
molecular‐based survey that helped integrate studies such as those that elucidated immune
response [20], potentially pathogenic microorganisms [12], gene expression [21], and xenobi‐
otics [16]. Although the integration of these data is far from complete, there is sufficient
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Abstract
Antimicrobial measures, such as topical antiseptics and local drug delivery, have proven
effective as complements to mechanical control. However, recent investigations have
reported some adverse influences of antimicrobial strategy.
One possible negative reaction is that residual structure may serve as a scaffold for
redevelopment of biofilm. It is reported that no or little biofilm structure was removed
when oral biofilms were treated with chemical compounds and that the secondary
adhesion was promoted in the presence of residual structure.
Second, residual structure may also act as pathogens. It is well known that various
microbial components in the biofilm can play a role in disease pathogenesis, even if the
microorganisms in the biofilm are completely killed.
Third, low-dose antibiotics may promote bacterial biofilm formation. The short-time
exposure of chemical agents will cause gradient of concentration inside biofilm. In this
case, the cells in deeper area may be exposed to subminimal inhibitory concentrations
(sub-MICs) of antimicrobial agents. Recent studies have demonstrated that a variety of
antibiotics or antimicrobial agents at sub-MIC levels can induce biofilm formation in
vitro, interfering with bacterial biofilm virulence expression.
This chapter reviews studies demonstrating adverse influences of antimicrobial strategy
against mature oral biofilm.
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that bind to the EPS strands and partially cross-link them to the matrix. Diffusion limitation
arises readily in these polymer strands because the fluid flow is reduced and the diffusion
distance is increased in the biofilm mode of growth [17]. On the other hand, prolonged
antimicrobial stress causes the biofilms facilitating the spread of antibiotic resistance by
promoting horizontal gene transfer [18]. The existence of tolerant or dormant cells is critical
factor in chronic infection [19, 20] (Figure 2).
Figure 2. Mechanisms of biofilm tolerance. Antimicrobial penetration is retarded in the presence of EPS (yellow). The
some microorganisms in the biofilm change activity in response to antimicrobial stress (green). The microenvironment
in deeper area is altered to resist eradicating (pink). Persister cells are present in higher concentration in biofilm (vio‐
let). This image was modified from CBE Image Library by the Center for Biofilm Engineering at Montana State Univer‐
sity.
This chapter is focusing to the studies demonstrating adverse influences of antimicrobial
strategy against mature oral biofilm.
2. Adverse influences of antimicrobial strategy
2.1. Residual structure
Recent investigations have demonstrated that chemical disinfection for oral biofilm may leave
intact biofilm structures. We performed a direct time-lapse microscopic observation through‐
out continuous exposure of commercial mouthrinses to an oral biofilm model [10]. Conse‐
quently, no removal of biomass was observed in control, ethanol (EtOH), 0.12% chlorhexidine
gluconate (CHG), and Biotene, which contains lysozyme, lactoferrin, lactoperoxidase, glucose




Mechanical approach by procedures such as self-performed oral hygiene, scaling and root
planning (SRP), or periodontal surgery is fundamental in the control of mature oral biofilms
[1]. Chemical approaches such as topical antiseptics, local drug delivery, and systemic
antibiotics are used with the expectation of producing an adjunctive effect [2‒5]. In fact, it has
been demonstrated that adjunctive antimicrobials improve clinical parameters, including
plaque index, gingival inflammation, and probing pocket depth [3, 5‒7]. It has also been
reported that antiplaque biocides do not cause the microbial resistance and alterations of
microbial flora [8].
However, recent investigations have demonstrated that antimicrobial compounds do not work
as intended [9‒12. Especially in short-time exposure, the antimicrobials failed to penetrate into
deeper area inside biofilm. Wakamatsu et al. have reported the penetration kinetics of
mouthrinses into in vitro Streptococcus mutans biofilms by direct time-lapse microscopic
analysis. The antimicrobial penetration was critically restricted within 30 s of exposure; the
average penetration velocity was ranging from 4.2 to 30.1 μm/min [13]. This phenomenon can
be explained by retarded penetration due to degradation and/or modification by the biofilm
matrix. Extracellular polymeric substance (EPS) produced by microorganisms make up the
intercellular space of microbial aggregates and form the structure and architecture of the
biofilm matrix that reduces antimicrobial penetration [14,15]. Representative four models of
how these polymer strands might interact are shown in Figure 1 [16]. Panel A is the alginate
paradigm. Calcium forms a complex with negatively charged polymer strands. Panel B shows
tight adhesion of a negatively charged polymer and a positively charged polymer. Panel C
indicates an insoluble polymer. Polymer complex formation is probably driven by hydrogen
bonding or hydrophobic interactions. Panel D indicates that bacteria have surface receptors
Figure 1. Conceptual models of matrix cohesion. (A) Alginate paradigm. Calcium is cross-linked between alginate. (B)
Adhesion of a negatively charged polymer and positively charged polymer. (C) Hydrogen bonding or hydrophobic
interaction. (D) Bacteria are partially cross-linked to the matrix. Reproduced from Takenaka et al. [16] with permission.
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EtOH: ethanol; CHG: chlorhexidinegluconate; SLS: sodium lauryl sulfate; TRN: triclosan; CPC; cetylpyridinium
chloride; IPMP: isopropyl methyl phenol; QAC: quaternary ammonium compound
Table 1. A summary of representative experiments demonstrating that chemical approach failed to detach the biofilm
structure.
In contrast, there are some reports that the biofilm structure has been successfully degraded
by repeated exposures of mouthrinse [23‒25]. Although it is likely that biofilm reduction may
be enhanced by repeated pulse of a mouthrinse, this approach may not always be effective.
Pratten and Wilson have reported that anaerobic counts in dental plaque biofilm returned to
pretreatment levels with altered bacterial composition after 4 days, despite the continuous
pulsing of CHG [26].
Summarizing the above, these results suggest that chemical approach such as the mouth‐
rinse, especially without repeated use, may not be sufficient to eradicate oral biofilm struc‐
ture. Residual structure may cause adverse effects in oral environment, even if the
microorganisms in the biofilm are completely killed.
2.1.1. Antigen and host inflammatory reaction
As the remaining biofilm matrix contains carbohydrates, proteins, polysaccharide, lipids, and
nucleic acid [27], dead bacteria and biofilm components could work as antigens and induce
inflammatory reactions.
For example, Actinobacillus actinomycetemcomitans, P. gingivalis, Tannerella forsythia, and
Treponema denticola have been implicated in the development of various forms of periodonti‐
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oxidase, and potassium thiocyanate, even after 20 min exposure. Treatments with CHG and
EtOH resulted in only a slight contraction of the biofilm (Figure 3).
Figure 3. Transmission images of biofilm cluster before (A) and after (B) 0.12% chlorhexidine (CHG) treatment. The
biofilm was exposed to CHG continuously inside glass capillary biofilm reactor for 20 min. Scale bar, 30 μm. Repro‐
duced from Takenaka et al. [10] with permission.
Davison et al. investigated the dynamic antimicrobial action of chlorine, a quaternary
ammonium compound, glutaraldehyde, and nisin within biofilm cell clusters of Staphylococ‐
cus epidermidis using time-lapse confocal scanning laser microscopy [21]. Chlorine among these
chemicals was the only antimicrobial agent that caused any biofilm removal. Yamaguchi et al.
showed that treatment of Porphyromonas gingivalis biofilms with CHG for 5 min does not
degrade their external structure, or reduce the volumes of protein and carbohydrate constit‐
uents [22]. A summary of representative experiments demonstrating that chemical approach
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gingivalis adherent with the residual biofilm developed in saliva-coated well following a CHG
treatment for 5 min using a confocal laser microscopy [22]. The volume of P. gingivalis adhering
to the residual structure was greater than that in saliva-coated wells. This result indicates that
the residual biofilm could serve as a scaffold for the secondary biofilm formation. Outer
membrane vesicles produced by P. gingivalis promote autoaggregation and coaggregation of
another bacterial species [41, 42]. In addition, they also enhance the attachment to and invasion
of epithelial cells by T. forsythia [43].
Our research group has demonstrated that residual structure of S. mutans biofilm following
complete disinfection favors secondary bacterial adhesion and biofilm redevelopment [40]. At
first, S. mutans biofilm generated on a resin-composite disc in a rotating disc reactor was
disinfected completely with 70% isopropyl alcohol, and returned to the reactor. The same
bacterial strains in the logarithmic phase were then flowed into the reactor for 4 h. The amount
of secondary adhered cells on the remaining structure was compared with that on a disc
without structure using confocal laser scanning microscopic (CLSM) analysis and quantita‐
tive analysis. Three-dimensional reconstruction revealed that viable bacteria appear to get
caught to upstream edges of disinfected biofilm structure (Figure 4). The cryosectioned sample
demonstrated stratified patterns of viable cells beside the structure. Mean viable count adhered
on the structure was significantly higher than that on plane surface. This result showed that
Figure 4. Three-dimensional reconstructed images of 4-h secondary biofilm (green) on disinfected 72-h biofilm struc‐
ture (red). Fresh planktonic S. mutans cells flowed into the completely disinfected 72-h biofilm structure for 4 h. Viable
bacteria were stained green by calcein fluorescence and appeared to get caught in upstream edges of disinfected bio‐
film structure.
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tis. An extensive review of the literature revealed that lipopolysaccharide or outer mem‐
brane lipids, polysaccharide, fimbriae and outer membrane, and secreted proteins are antigens
of all four bacteria that may play a role in disease pathogenesis [28].
In addition, even if the microorganisms in the biofilm are completely eradicated, various
microbial components in the biofilm could play a role in disease pathogenesis. Augustin et al.
reported that injection of dead components of Enterococcus faecalis into rats following mechan‐
ical aortic damage by a catheter produced endocarditic vegetation enriched with polymor‐
phonuclear cells [29]. Bacterial components have also been attracted considerable attention as
an adjuvant. It has been reported that injection of structural components of the outer surface
membrane led a variety of immunopotentiative actions following the activation of phago‐
cytes and leukocytes [30‒32].
2.1.2. Calculus formation
The remaining dental biofilm structure will absorb calcium and phosphate from saliva for the
formation of supragingival calculus and from crevicular fluid for the formation of subgingi‐
val calculus. Calculus formation begins with the deposition of kinetically favored precursor
phases of calcium phosphate, octacalcium phosphate, and dicalcium phosphate dihydrate,
which are gradually hydrolyzed and transformed into less soluble hydroxyapatite and
whitlockite mineral phases [33].
The calculus surface may not in itself induce inflammation in the adjacent periodontal tissue
[34, 35]. Jepsen et al. stated that periodontal healing occurs even in the presence of calculus as
long as the bacteria is removed or disinfected [34]. For example, it has been reported that
autoclaved calculus does not cause pronounced inflammation or abscess formation in
connective tissues [36]. Listgarten et al. have demonstrated that a normal epithelial attach‐
ment can be formed on its structure when microorganisms on calculus surface were com‐
pletely disinfected with CHG [37]. Johnson et al. investigated the clinical outcomes of treatment
with locally delivered controlled-release doxycycline (DH) or SRP in adult periodontitis
patients. Treatment with either DH or SRP resulted in significant statistical and clinical
improvements in clinical attachment levels, pocket depth, and bleeding on probing. These
clinical outcomes were equivalent regardless of the extent of subgingival calculus present at
baseline, suggesting that positive clinical change depend on altering the subgingival biofilm
rather than the removal of calculus [38].
However, calculus is known to be a plaque retention factor as well as a reservoir for toxic
bacterial products and antigens. Histological section of a human tooth root showed that
calculus is covered with viable bacterial plaque [34]. Nichols et al. reported that the dihydro‐
ceramide lipids produced by P. gingivalis were found in subgingival calculus [39]. Hence, the
presence of calculus will be a secondary etiological factor.
2.1.3. Scaffold for secondary bacterial adhesion
Recent investigations revealed that residual structure would promote a secondary bacterial
adhesion and biofilm redevelopment [22, 40]. Yamaguchi et al. compared the volume of P.
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gingivalis adherent with the residual biofilm developed in saliva-coated well following a CHG
treatment for 5 min using a confocal laser microscopy [22]. The volume of P. gingivalis adhering
to the residual structure was greater than that in saliva-coated wells. This result indicates that
the residual biofilm could serve as a scaffold for the secondary biofilm formation. Outer
membrane vesicles produced by P. gingivalis promote autoaggregation and coaggregation of
another bacterial species [41, 42]. In addition, they also enhance the attachment to and invasion
of epithelial cells by T. forsythia [43].
Our research group has demonstrated that residual structure of S. mutans biofilm following
complete disinfection favors secondary bacterial adhesion and biofilm redevelopment [40]. At
first, S. mutans biofilm generated on a resin-composite disc in a rotating disc reactor was
disinfected completely with 70% isopropyl alcohol, and returned to the reactor. The same
bacterial strains in the logarithmic phase were then flowed into the reactor for 4 h. The amount
of secondary adhered cells on the remaining structure was compared with that on a disc
without structure using confocal laser scanning microscopic (CLSM) analysis and quantita‐
tive analysis. Three-dimensional reconstruction revealed that viable bacteria appear to get
caught to upstream edges of disinfected biofilm structure (Figure 4). The cryosectioned sample
demonstrated stratified patterns of viable cells beside the structure. Mean viable count adhered
on the structure was significantly higher than that on plane surface. This result showed that
Figure 4. Three-dimensional reconstructed images of 4-h secondary biofilm (green) on disinfected 72-h biofilm struc‐
ture (red). Fresh planktonic S. mutans cells flowed into the completely disinfected 72-h biofilm structure for 4 h. Viable
bacteria were stained green by calcein fluorescence and appeared to get caught in upstream edges of disinfected bio‐
film structure.
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long as the bacteria is removed or disinfected [34]. For example, it has been reported that
autoclaved calculus does not cause pronounced inflammation or abscess formation in
connective tissues [36]. Listgarten et al. have demonstrated that a normal epithelial attach‐
ment can be formed on its structure when microorganisms on calculus surface were com‐
pletely disinfected with CHG [37]. Johnson et al. investigated the clinical outcomes of treatment
with locally delivered controlled-release doxycycline (DH) or SRP in adult periodontitis
patients. Treatment with either DH or SRP resulted in significant statistical and clinical
improvements in clinical attachment levels, pocket depth, and bleeding on probing. These
clinical outcomes were equivalent regardless of the extent of subgingival calculus present at
baseline, suggesting that positive clinical change depend on altering the subgingival biofilm
rather than the removal of calculus [38].
However, calculus is known to be a plaque retention factor as well as a reservoir for toxic
bacterial products and antigens. Histological section of a human tooth root showed that
calculus is covered with viable bacterial plaque [34]. Nichols et al. reported that the dihydro‐
ceramide lipids produced by P. gingivalis were found in subgingival calculus [39]. Hence, the
presence of calculus will be a secondary etiological factor.
2.1.3. Scaffold for secondary bacterial adhesion
Recent investigations revealed that residual structure would promote a secondary bacterial
adhesion and biofilm redevelopment [22, 40]. Yamaguchi et al. compared the volume of P.
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This phenomenon may have clinical relevance because bacteria are exposed to sub-MIC of
antibiotics at the beginning and end of a dosing regimen [63]. In addition, antimicrobials are
retarded to diffuse within the biofilm matrix [14, 15]. In such cases, the bacteria in deeper areas
are exposed to antimicrobials at sub-MICs.
As for oral biofilm, there are a few studies reported that sub-MICs of antimicrobial agents
upregulate the genes related to EPS production and induce biofilm formation. Dong et al.
evaluated the expression of genes related to S. mutans biofilm formation following treatment
with 1/2 MIC of CHG, tea polyphenols, and sodium fluoride (NaF) [64]. The results showed
that expression of gtfB, gtfC, luxS, comD, and comE was significantly upregulated after
treatment with each antimicrobial agent in planktonic cells. Similarly, gtfB, luxS, comD, and
comE were also upregulated in biofilm. Morphological observation using a FE-SEM and CLSM
revealed that the biofilms of S. mutans treated with sub-MICs of NaF or CHG became denser,
containing more EPS and fewer water channels. However, tea polyphenols appear to not
promote S. mutans biofilm formation, as evidenced by SEM and CLSM images. Little EPS was
produced on the surface of teeth after S. mutans was treated with a sub-MIC of tea polyphe‐
nols, although the expressions of gtfB and gtfC genes were upregulated. The inconsistency of
these results can be explained by that sub-MICs of tea polyphenols may prevent from bacterial
adhesion to the surface of teeth in the presence of fluid shear force. Because the gene analy‐
sis was performed using a 24-well plate under a static condition, whereas the biofilm forma‐
tion for morphological analysis was prepared under a controlled flow. It has been reported
that tea polyphenols could decrease the adherence of S. mutans to glass surface [65, 66].
Bedran et al. investigated the effect of triclosan at sub-MICs on S. mutans biofilm formation,
adherence to oral epithelial cells and expression of several genes involved in adherence and
biofilm formation [67]. The authors reported that biofilm formation increased six-fold in the
presence of 1/4 MIC of triclosan. Growth of S. mutans in the presence of triclosan at sub-MICs
also increased its capacity to adhere to a monolayer of gingival epithelial cells. Furthermore,
the expression of comD, gtfC, and LuxS was significantly upregulated in the presence of 1/2
and 1/4 MIC, although the expression of atlA and gtfB was less pronounced.
Even in limited works with regard to oral biofilms, it is likely that short-time exposure of
antimicrobial agents in oral cavity sometimes cause adverse influences because the survived
microorganisms after exposure to the agents will alter gene expressions in a positive and
negative way.
3. Conclusion
Although chemical agents provide some benefits in terms of controlling oral biofilms, they
have the limitation of leaving biofilm structures that may induce adverse reactions such as
biofilm regrowth. Furthermore, sub-MICs of certain antimicrobial agents might induce biofilm
formation and upregulate pathogenic genes. Future strategies for the control of oral biofilms
may therefore shift to the degradation and/or detachment of biofilm matrix.
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the residual structure following antimicrobial disinfection promoted bacterial secondary
adhesion and biofilm formation.
The mechanism of S. mutans adhesion on the residual structure can be explained by cell-cell
aggregation and glucan-dependent aggregation. The cell surface protein antigen c (PAc) of S.
mutans is known to correlate with cellular hydrophobicity, sucrose-independent adhesion to
tooth surface and self-aggregation between cells [44, 45]. The glucan-dependent aggregation
is mediated by glucosyltransferase enzymes and glucan-binding proteins [46]. Glucan-binding
protein C, which is a cell-wall anchoring protein and a cell surface glucan receptor, plays an
important role in sucrose-dependent adhesion by binding to soluble glucan synthesized by
glucosyltranseferase D [47, 48].
Thus, since a numerous and diverse range of microorganisms reside in our intraoral environ‐
ment, the residual biofilm will contribute to biofilm redevelopment.
2.2. Antimicrobials-induced biofilm formation
Numerous studies have shown that subminimum inhibitory concentrations (sub-MICs) of
various antibiotics and chemicals can inhibit biofilm formation. A representative example is
the macrolide antibiotics. Although Pseudomonas aeruginosa that contributes to progress
respiratory infection is resistant to azithromycin, low-dose azithromycin has been shown to
inhibit protein synthesis [49] and improve clinical symptom [50, 51]. Sub-MIC concentra‐
tions of azithromycin have also been shown to inhibit quorum sensing and alginate produc‐
tion [52, 53].
In the field of dentistry, it has also been reported that sub-MICs of antimicrobial agents or
compounds can inhibit bacterial attachment [54, 56, 57], biofilm formation [54, 55, 57, 58], and
downregulate virulence genes [54, 56, 59, 60]. Moon et al. reported N-acetyl cysteine (NAC)
that is an antioxidant possessing anti-inflammatory activities, showed a significant decrease
of Prevotella intermedia biofilm formation in the presence of sub-MIC [55]. NAC was demon‐
strated to present the expression of LPS-induced inflammatory mediators in phagocytic cells
and gingival fibroblasts during the inflammatory process. Lee and Tan showed that treat‐
ment of E. faecalis with 1/2 sub-MIC of (–)-epigallocatechin-3-gallate (EGCG) significantly
inhibited the expression of virulence genes related to collagen adhesion, cytolysins activator,
gelatinase, and serine protease compared with the untreated control [60].
In contrast to the inhibitory effects of sub-MIC antimicrobials against biofilm formation, recent
studies have shown that some antibiotics at sub-MIC can significantly induce biofilm
formation in a variety of bacterial species such as S. epidermidis, Staphylococcus aureus,
Staphylococcus lugdunensis, Escherichia coli, and P. aeruginosa [61]. Kaplan et al. demonstrated
that sub-MIC of four different β-lactam antibiotics significantly induce biofilm formation in
some strains of S. aureus [62]. The amount of biofilm induction was 10-fold in maximum and
sub-MIC β-lactamantibiotics induce autolysin-dependent extracellular DNA release.
However, the pattern of biofilm induction was strain and antibiotic dependent, indicating that
biofilm formation by sub-MICs of antimicrobial agents do not always occur in all the strains
of the same species.
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biofilm formation [67]. The authors reported that biofilm formation increased six-fold in the
presence of 1/4 MIC of triclosan. Growth of S. mutans in the presence of triclosan at sub-MICs
also increased its capacity to adhere to a monolayer of gingival epithelial cells. Furthermore,
the expression of comD, gtfC, and LuxS was significantly upregulated in the presence of 1/2
and 1/4 MIC, although the expression of atlA and gtfB was less pronounced.
Even in limited works with regard to oral biofilms, it is likely that short-time exposure of
antimicrobial agents in oral cavity sometimes cause adverse influences because the survived
microorganisms after exposure to the agents will alter gene expressions in a positive and
negative way.
3. Conclusion
Although chemical agents provide some benefits in terms of controlling oral biofilms, they
have the limitation of leaving biofilm structures that may induce adverse reactions such as
biofilm regrowth. Furthermore, sub-MICs of certain antimicrobial agents might induce biofilm
formation and upregulate pathogenic genes. Future strategies for the control of oral biofilms
may therefore shift to the degradation and/or detachment of biofilm matrix.
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aggregation and glucan-dependent aggregation. The cell surface protein antigen c (PAc) of S.
mutans is known to correlate with cellular hydrophobicity, sucrose-independent adhesion to
tooth surface and self-aggregation between cells [44, 45]. The glucan-dependent aggregation
is mediated by glucosyltransferase enzymes and glucan-binding proteins [46]. Glucan-binding
protein C, which is a cell-wall anchoring protein and a cell surface glucan receptor, plays an
important role in sucrose-dependent adhesion by binding to soluble glucan synthesized by
glucosyltranseferase D [47, 48].
Thus, since a numerous and diverse range of microorganisms reside in our intraoral environ‐
ment, the residual biofilm will contribute to biofilm redevelopment.
2.2. Antimicrobials-induced biofilm formation
Numerous studies have shown that subminimum inhibitory concentrations (sub-MICs) of
various antibiotics and chemicals can inhibit biofilm formation. A representative example is
the macrolide antibiotics. Although Pseudomonas aeruginosa that contributes to progress
respiratory infection is resistant to azithromycin, low-dose azithromycin has been shown to
inhibit protein synthesis [49] and improve clinical symptom [50, 51]. Sub-MIC concentra‐
tions of azithromycin have also been shown to inhibit quorum sensing and alginate produc‐
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and gingival fibroblasts during the inflammatory process. Lee and Tan showed that treat‐
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Abstract
It is generally accepted that bacteria in biofilm are more resistant to antibacterials than
their planktonic counterparts. For numerous antibiotics, it has been shown that minimal
inhibitory concentrations (MICs) for bacteria grown in broth are much lower than the
minimal biofilm inhibition concentrations. While sub‐inhibitory concentrations, that is,
amounts of antibacterials below the MIC, do not either influence or suppress to some
extent or other the bacterial growth in liquid media, these same amounts of drugs, natural
substances, etc., may have diverse effects on bacterial biofilms, ranging from suppres‐
sion to stimulation of the sessile growth and varying with regard to the bacterial species
and strains. This is a source of additional risks for both biofilm infection of host tissues
and contamination indwelling devices. When considering the data for biofilm modula‐
tion, differences in experimental protocols should be taken into account, as well as the
strain‐specific mechanisms of biofilm formation.
Keywords: biofilm, sub‐MIC, antibiotics, bacteriocins, antimicrobial peptides, plant
metabolites
1. Introduction
While the development of antibiotics during the twentieth century resulted in remarkable
advances in the fight against infectious microorganisms, it was unfortunately paralleled with
the highly increasing risks for the development of antibiotic resistance. These risks are a
consequence of the extensive use of antibacterial preparations in both human medicine and
agriculture. Resistance has become a threat to human and animal health worldwide, and it
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substances, etc., may have diverse effects on bacterial biofilms, ranging from suppres‐
sion to stimulation of the sessile growth and varying with regard to the bacterial species
and strains. This is a source of additional risks for both biofilm infection of host tissues
and contamination indwelling devices. When considering the data for biofilm modula‐
tion, differences in experimental protocols should be taken into account, as well as the
strain‐specific mechanisms of biofilm formation.
Keywords: biofilm, sub‐MIC, antibiotics, bacteriocins, antimicrobial peptides, plant
metabolites
1. Introduction
While the development of antibiotics during the twentieth century resulted in remarkable
advances in the fight against infectious microorganisms, it was unfortunately paralleled with
the highly increasing risks for the development of antibiotic resistance. These risks are a
consequence of the extensive use of antibacterial preparations in both human medicine and
agriculture. Resistance has become a threat to human and animal health worldwide, and it
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and reproduction in any medium, provided the original work is properly cited.
The idea on the effects of antibiotic sub‐MICs on biofilms is getting more and more compli‐
cated with the accumulation of experimental data. This puts forward the question of method‐
ology. The conventional approaches to antibiotic sensitivity do not apply to biofilm‐grown
bacteria [9]. Due to the potentially very high intrinsic biofilm resistance, the focus has mainly
been put on their prevention [16]. Probably for this reason, most results have been obtained
while applying the drug during the sessile growth, with only a few studies testing the agent's
effects on pre‐formed biofilms [17–19]. The routinely applied methodology is to test biofilm
biomass on 96‐well plates by the crystal violet assay, with only a few other studies that explore
cell viability as well, for example, the viable cell counts [20] or live‐dead staining for fluores‐
cence microscopy.
We have summarized the available experimental data on the action of sub‐MICs of antibiot‐
ics on biofilms in Table 1–5. We could find no strict pattern with regard to the effects of the
separate groups of antibiotics. All groups were shown to influence some biofilms positively,
and others, negatively. An important observation is the bacterial species and strain specifici‐
ty of the response to the sub‐MICs. Thus, sub‐MICs of ampicillin increased biofilm growth of
Staphylococcus saprophyticus [6], reduced it in Escherichia coli K‐12 [21], and had no effect on E.
coli UTI8 and Mycobacterium avium [6, 22] (Table 1). Sub‐MICs of ciprofloxacin promoted
biofilms of S. saprophyticus [6] and E. coli UTI8 [6], but reduction was registered in Streptococ‐
cus suis, Salmonella enterica serovar Typhimurium clinical strains, Stenotrophomonas maltophil‐
ia, Streptococcus pyogenes, Staphylococcus epidermidis, and Proteus mirabilis [17, 18, 20, 23–25]
(Table 2). Diverse effects have been illustrated for sub‐MICs of erythromycin on biofilms of S.
suis, Corynebacterium diphtheriae, and S. epidermidis [25–27] (Table 3); for gentamycin on S.
enterica serovar Typhimurium, S. saprophyticus, E. coli, Haemophilus influenzae, Staphylococcus
aureus, and Pseudomonas aeruginosa (Table 4); and for tetracyclin on E. coli, Staphylococcus
lugdunensis, M. avium, P. aeruginosa, and S. epidermidis [9, 15, 21, 22, 28] (Table 5).
Antibiotics Amount Bacteria/strains Effect on biofilm Ref.
Penicillins
Dicloxacillin 1/2 MIC S. epidermidis strains 9142, IE186, and M187 32–60% BF inhibition [29]
8 μg/ml S. epidermidis M187
S. haemolyticus M176
BF biomass reduction; decreased synthesis of the EPS,
poly‐N‐acetyl‐glucosamine
[16]
Penicillin 1/16–1/2 MICS. suis NJ‐3 Dose‐dependent BF suppression [25]
1/8 MIC C. diphtheriae subsp. mitis strains No effect [26]





S. lugdunensis—15 isolates from BF‐related
infections (endocarditis, prosthetic joint
infections, etc.)
Increase in 93% of the tested strains, no effect in 7% [9]
1/3–1/8 MIC S. aureus Newman No effect on BF [30]
Cephalosporins
Cefazolin 1/2 MIC S. epidermidis strains 9142, IE186, and M187 32–55% BF inhibition [29]
0.0625–0.5
MIC
S. lugdunensis—15 isolates from BF‐related
infections (endocarditis, prosthetic joint
infections, etc.)
Increase in 13% of the tested strains, no effect in 80%, and
decrease in 7%
[9]
0.5 MIC S. epidermidis strains SE5 and RP62A BF decrease [31]
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necessitates the development of key measures. Among these, the identification of critical points
of control, the development of surveillance measures, and the prevention of environmental
contamination are in focus [1].
In the aquatic and terrestrial environments, the contaminated sites (wastewater systems,
pharmaceutical factories effluents, animal husbandry facilities, etc.) are characterized by the
presence of subtherapeutic concentrations of antibiotics [1–3]. Thus, bacteria present in the
environment are often subjected to drug amounts lower than the minimal inhibitory concen‐
trations (MICs) [4]. Antimicrobial sub‐MICs are encountered in the human body as well,
during treatment, which can occur irregularly at intervals at the site of infection [5] or in
cases of low‐dose antibiotic prophylaxis [6]. When microorganisms grow in the presence of
sub‐MICs, the antibiotics can potentially alter the physicochemical characteristics of micro‐
bial cells, their functions, and the expression of some virulence genes [7]. While sub‐MICs
generally do not interfere with bacterial growth dynamics, the microorganisms are subjected
to stress. As a way to counter stress, microbes would often form biofilms both in external
environments and on indwelling medical devices [3, 8, 9].
It is noteworthy that, when MICs or sub‐MICs are considered, this concerns values obtained
with bacteria grown in liquid media, that is, as plankton. Such will be the use of the term
also in the present review. In biofilms, the inhibitory doses exceed 10 to even 1000 times
these of plankton [1, 9, 10]. Interestingly, when plankton and bacteria dispersed from bio‐
film have been examined, they were shown to have similar antibiotic susceptibility [11].
Hence, increased resistance is likely associated with characteristics that are a consequence of
the structure of the sessile microbial communities. They themselves represent heterologous
microenvironments in which gradients of physical and chemical parameters exist [3]. The
advantages of these structured bacterial communities comprise limited antibiotic diffusion,
enhanced transmission of resistance genes, expression of efflux pumps, drug adsorption by
extracellular matrix, as well as the presence of metabolically inactive persister cells [12].
Provided the growing concern about the wide spread and the role of environments contain‐
ing subinhibitory amounts of antibacterials, the present review will focus on the interplay of
sub‐MICs with biofilm growth and/or detachment. In a previous review, the antibiotic‐in‐
duced biofilm formation has been discussed [13]. However, the sub‐MIC of antibiotics, but
also other antibacterials (e.g. antibacterial peptides, natural and synthetic substances, etc.),
dependent on the combination drug‐bacterial strain or species, may have diverse effects on
biofilm, from suppression through no effect to promotion. This determined the aim of the
present review: to summarize current data and concepts about the modulation of biofilm
growth by sub‐MICs of antibacterial substances.
2. Sub‐MIC of antibiotics and biofilms
While it was initially believed that antibiotics in nature have the role for fighting against
competitors, and that therefore also sub‐MICs would reduce virulence, recent evidence re‐
veals a more complicated picture, showing the capacity of some antibiotics at low dose to
act as chemical signals to modulate metabolic processes [14] or regulate gene (including vir‐
ulence gene) expression [15].
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Antibiotics Amount Bacteria/strains Effect on biofilm Ref.
0.001–100 mg/l P. aeruginosa BF reduction [15]
Norfloxacin 1–10,000 mg/l S. aureus ATCC 25923 BF stimulation by 1 mg/l [8]
1–10,000 mg/l P. aeruginosa NNRL‐B3509 BF stimulation by 1 mg/l [8]
1/2–1/8 MIC S. maltophilia—5 clinical isolates
strains
BF inhibition and reduction of viable cell
counts
[20]
1/2–1/64 MIC S. pyogenes isolates (M56; st38;M89;
M65; M100; M74)
Dose‐dependent BF inhibition [23]
1/2–1/8 MIC Staphylococcus epidermidis—20
clinical isolates
Suppression of BF growth and reduction of
pre‐formed BF
[17]
1/16–1/2 MIC S. suis NJ‐3 Dose‐dependent biofilm suppression [25]
Ofloxacin 1/2–1/8MIC S. maltophilia—5 clinical isolates
strains
BF inhibition and reduction of viable cell
counts
[20]
1/2–1/64 MIC S. pyogenes isolates (M56; st38;M89;
M65; M100; M74)
Dose‐dependent BF inhibition [23]
0.5 × MIC S. epidermidis strains (SE5; RP62A) No effect on BF formation [31]
1/2–1/8 MIC Staphylococcus epidermidis—20
clinical isolates
Suppression of BF growth and reduction of
pre‐formed BF
[17]
1/2–1/8 MIC S. maltophilia—5 clinical isolates
strains
Biofilm inhibition and reduction of viable
cell counts
[20]
Levofloxacin 1/2–1/64 MIC S. pyogenes isolates (M56; st38;
M89; M65; M100; M74)
Dose‐dependent BF inhibition [23]




Increase in 20% of the tested strains, in 47%
no effect, and in 40% decrease
[9]
Moxifloxacin 1 μg/l M. avium strains (104; 101; A5;
3362‐33; 3362‐34)
No effect on BF [22]
1/2–1/8 MIC S. maltophilia—5 clinical isolates
strains
BF inhibition and reduction of viable cell
counts
[20]
0.03–0.06 MIC S. maltophilia strains Sm 132 and
Sm 144
Decrease in adhesion and BF formation [7]
2; 10; 50; 100 x MICS. aureus—6 strains of coagulase
negative
No effect on BF [35]
1 μg/ml M. avium strains (101, 104, 109, and
A5)
BF inhibition [36]
1/2–1/8MIC S. maltophilia —5 clinical isolates
strains
BF inhibition and reduction of viable cell
counts
[20]
Grepafloxacin 1/2–1/8MIC S. maltophilia—5 clinical isolates
strains
BF inhibition and reduction of viable cell
counts
[20]
Pefloxacin 1/2–1/8 MIC S. epidermidis—20 clinical isolates Reduces BF growth and pre‐formed BF [17]
Table 2. Effects of sub‐MIC of fluoroquinolones on biofilms.
Antibiotics Amount Bacteria/strains Effect on biofilm Ref.
Erythromycin 1/16–1/2 MIC S. suis NJ‐3 Dose‐dependent BF suppression [25]
1/8 MIC C. diphtheriae subsp. mitis strains BF increase [26]
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Antibiotics Amount Bacteria/strains Effect on biofilm Ref.
Cefalotin 1/3–1/8 MIC S. aureus Newman Three‐ to fourfold denser BF formed by the strain and its
small‐colony variants
[30]
Cefoperazone 1/3–1/8 MIC S. aureus Newman No effect on BF [30]
Cefotaxime 1/2–1/16 MICSalmonella enterica serovar Typhimurium
clinical isolates 75 strains





E. coli MG1655 wt and MG1655 (pBR322) BF reduction [21]
0.1–1.1 μg/mlS. saprophyticus 15305 Sub‐MIC (0.3–0.7 μg/ml) stimulate BF formation [6]
1/2–1/1024
MIC
E. coli UTI89 BF stimulation at MIC, no effect of
sub‐MIC
[6]
10 μg/l M. avium strains 104; 101, A5; 3362‐33 and
3362‐34)
No effect on BF [22]
Carbapenems
Imipenem 2–4 μg/ml P. aeruginosa PA01 BF induction, changes in BF morphology, upregulation of




73 isolates A. baumannii BF stimulation [33]
Ceftazidime 1/2–1/8 MIC 5 clinical isolates strains S. maltophilia BF inhibition and reduction of viable cell counts [20]
0.125–1.0
MIC
5 strains P. mirabilis BF inhibition [24]
2; 8; 32 mg/l 6 clinical isolates of P. aeruginosa Synergistic effect with polymorphonuclears against
developed 48 h BF
[34]
Abbreviations: BF, biofilm; EPS, exopolysaccharide; MIC, minimal inhibitory concentration.
Table 1. Effects of sub‐MIC of β‐lactam antibiotics on biofilms.
Antibiotics Amount Bacteria/strains Effect on biofilm Ref.
Ciprofloxacin 1/16–1/2 MIC S. suis NJ‐3 Dose‐dependent BF suppression [25]
1/2–1/16MIC Salmonella enterica serovar
Typhimurium clinical isolates 75
strains
Inhibition of BF formation and EPS
synthesis
[5]
0.1–1.1 μg/ml S. saprophyticus 15305 BF stimulation by sub‐MIC (0.4–0.9 μg/ml) [6]
1/2–1/1024 MIC E. coli UTI89 Statistically significant BF increase and
upregulation of BF‐associated genes at 1/4
MIC
[6]
1/2–1/8MIC 5 clinical isolates S. maltophilia BF inhibition and reduction of viable cell
counts
[20]
1/2–1/64 MIC S. pyogenes isolates (M56; st38;M89;
M65; M100; M74)
Dose‐dependent BF inhibition [23]
0.5 × MIC E. coli strains (8; 9; 10; 31 ;1583) Reduction of BF formation and survival of
the BF bacteria
[18]
1/2–1/8 MIC Staphylococcus epidermidis—20
clinical isolates
Reduces BF growth and pre‐formed BF [17]
0.125–1.0 MIC 5 strains P. mirabilis BF inhibition [24]
2; 8; 32 mg/l MIC P. aeruginosa—6 clinical isolates Synergistic effect with
polymorphonuclears against developed 48‐
h BF
[32]
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Antibiotics Amount Bacteria/strains Effect on biofilm Ref.
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h BF
[32]
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Kanamycin 10–110 μg/ml P. aeruginosa PAK and isogenic
mutants
BF increase [40]
Table 4. Effects of sub‐MIC of aminoglycosides on biofilms.
Antibiotics Amount Bacteria/ strains Effect on biofilm Ref.
Streptogramins
Quinupristin‐dalfopristin
0.5 μg/ml S. epidermidis strains 567 and
S. epidermidis 561
Enhancement of icaADBC operon
expression and EPS synthesis
[28]
0.0625–0.5 MIC S. lugdunensis—15 isolates from biofilm‐related
infections (endocarditis, prosthetic joint
infections, etc.)
Increase in 20% of the tested strains; in




1/2 MIC S. epidermidis strains 9142, IE186 and M187 8–24% BF inhibition [29]
0.0625–0.5 MIC S. lugdunensis—15 isolates from biofilm‐related
infections (endocarditis, prosthetic joint
infections, etc.)
Increase in 27% of the tested strains; in
47% no effect and in 27% decrease
[9]
0.5× MIC S. epidermidis strains SE5 and RP62A Decrease in BF [31]
Tetracyclins
Tetracyclin
0.005–500 μg/ml E. coli MG1655 wt and MG1655 (pBR322) Significant BF increase in the presence of
(pBR322)
[21]
0.0625–0.5 MIC S. lugdunensis—15 isolates from biofilm‐related
infections (endocarditis, prosthetic joint
infections, etc.)
Increase 7% of tested strains; decrease
93%
[9]
0.5–2 μg/ml M. avium strains (104; 101; A5; 3362‐33; 3362‐34)BF increase [22]
0.01–100 mg/l P. aeruginosa BF reduction [15]
0.5 μg/ml S. epidermidis strains 567 and
S. epidermidis 561
Enhancement of icaADBC operon





0.0625–0.5 MIC S. lugdunensis—15 isolates from biofilm‐related
infections (endocarditis, prosthetic joint
infections, etc.)
Increase in 20% of the tested strains, in
40% no effect, and in 40% decrease
[9]





0.0625–0.5 MIC S. lugdunensis—15 isolates from biofilm‐related
infections (endocarditis, prosthetic joint
infections, etc.)
In 80% no effect, in 20% decrease [9]
Table 5. Effects of sub‐MIC of streptogramins, glycopeptides, tetracyclins, dihydrofolate reductase (DHFR) inhibitors
and oxazolidonones on biofilms.
Antibiotics with identical mechanisms of antibacterial action, for example, gentamicin and
erythromycin, may have different effects on biofilm [19, 29]. In addition, the sub‐MICs of a
given antibiotic may have diverse effects on different strains of one species of microorgan‐
ism. For example, such is the case with the effects of cefazolin and levofloxacin on 15 isolates
of S. lugdunensis [9] (Table 1), the effects of erythromycin on 69 clinical isolates of S. epidermi‐
dis [27] (Table 3), of vancomycin on 3 strains of S. epidermidis and 15 isolates of S. lugdunensis
[9, 30] (Table 5), and of trimethoprim‐sulfamethoxazole on 15 isolates of S. lugdunensis [9]
(Table 5). Obviously, individual strains use different response mechanisms to oppose the
action of sub‐MICs [9].
Sub‐MICs of antibiotics have the potential to affect the structure of individual bacterial cells.
Changes of morphology have been registered in several studies. For instance, sub‐MIC of
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Antibiotics Amount Bacteria/strains Effect on biofilm Ref.
0.25 MIC S. epidermidis—96 clinical isolates BF inhibition in 4 strains; BF enhancement in
20, other strains—unaffected
[27]
Azithromycin 1/2–1/16 MIC S. suis NJ‐3 BF inhibition by 1/4 and 1/2 MIC [25]
2.5–10 mg/ml S. aureus strains (B1 487; B1 493; B1 412; B 391;
B1 468; B1 483; B1 379; B1 472)
BF reduction [37]
0.125 μg/ml H. influenzae NTHi2019 Decreased BF formation, reduction of
established BF
[19]
8 μg/m M. avium strains (101, 104, 109, and A5) BF inhibition [36]
sub‐MICs P. aeruginosa—35 clinical isolates Dose‐dependent BF reduction [38]
Clarithromycin 1 μg/ml M. avium strains (101, 104, 109, and A5) BF inhibition [36]
MIC b/n 50–550 mg/mlP. aeruginosa Sub‐MIC result in altered structure and
architecture of BF
[39]
Table 3. Effects of sub‐MIC of macrolides on biofilms.
Antibiotics Amount Bacteria/strains Effect on biofilm Ref.
Gentamycin 1/2–1/16 Salmonella enterica serovar
Typhimurium clinical isolates 75
strains
Inhibition of BF formation and EPS
synthesis
[25]
0.1–1.1 μg/ml S. saprophyticus 15305 Statistically significant BF
increase by 0.6—0.7 μg/ml
[6]
1/2–1/1024 MIC E. coli UTI89 Statistically significant BF
increase by 1/32 MIC
[6]
8 μg/ml H. influenzae NTHi2019 No effect on BF [19]
From sub‐MIC up to
100× MIC
S. aureus strains (RN6390 ATCC
25923)
BF increase [11]
0.1–1.5 μg/ml MIC P. aeruginosa PAK and isogenic
mutants
BF increase [40]
Streptomycin 0.5–2 μg/ml M. avium strains (104; 101; A5;
3362‐33; 3362‐34; 8G12; 5G4; 6H9)
BF increase, induction of
BF‐associated genes
[22]
Tobramycin 0.05–2 μg/ml P. aeruginosa PAK and isogenic
mutants
BF increase [40]
0.3; 0.5; 1.0 μg/ml Xylella fastidiosa ATCC 700964 and
3 isogenic mutants
BF reduction [41]
0.001–100 μg/l P. aeruginosa BF reduction [15]
Amikacin 0.5× MIC E. coli strains (8; 9; 10; 31; 1583) Reduction of BF formation
and survival of the BF‐bacteria
[18]
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Antibiotics Amount Bacteria/strains Effect on biofilm Ref.
Kanamycin 10–110 μg/ml P. aeruginosa PAK and isogenic
mutants
BF increase [40]
Table 4. Effects of sub‐MIC of aminoglycosides on biofilms.
Antibiotics Amount Bacteria/ strains Effect on biofilm Ref.
Streptogramins
Quinupristin‐dalfopristin
0.5 μg/ml S. epidermidis strains 567 and
S. epidermidis 561
Enhancement of icaADBC operon
expression and EPS synthesis
[28]
0.0625–0.5 MIC S. lugdunensis—15 isolates from biofilm‐related
infections (endocarditis, prosthetic joint
infections, etc.)
Increase in 20% of the tested strains; in
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0.5× MIC S. epidermidis strains SE5 and RP62A Decrease in BF [31]
Tetracyclins
Tetracyclin
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0.5–2 μg/ml M. avium strains (104; 101; A5; 3362‐33; 3362‐34)BF increase [22]
0.01–100 mg/l P. aeruginosa BF reduction [15]
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dis [27] (Table 3), of vancomycin on 3 strains of S. epidermidis and 15 isolates of S. lugdunensis
[9, 30] (Table 5), and of trimethoprim‐sulfamethoxazole on 15 isolates of S. lugdunensis [9]
(Table 5). Obviously, individual strains use different response mechanisms to oppose the
action of sub‐MICs [9].
Sub‐MICs of antibiotics have the potential to affect the structure of individual bacterial cells.
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reducing the production of C4‐homoserine lactone [53]. Azithromycin also antagonized
quorum sensing in P. aeruginosa [4]. Cephalotin and cephalotaxime suppressed the agr
quorum‐sensing system in S. aureus [54].
Sub‐MICs of antibiotics can interact with bacterial regulation mechanisms and gene expres‐
sion. Transcriptomic studies indicated that the expression of approximately 5% of bacterial
promoters may be affected [13]. Genes related with antibiotic resistance should be men‐
tioned in the first place. There was a correlation between the transcription of the ermC gene
and the biofilm formation of erythromycin‐treated S. epidermidis [27]. In P. aeruginosa, among
the 34 genes influenced by imipenem, the most strongly induced gene was ampC coding for
chromosomal β‐lactamase [54]. Genes related with the synthesis of EPS or bacterial capsules
may be affected, like the genes from the icaADBC operon in S. epidermidis [28, 49]. Other genes
related with adhesion and biofilm development that should be mentioned are comD, gtfC, luxS,
gtfB, and atlA of Streptococcus mutans upregulated by sub‐MIC of triclosan [55] and guaB2 and
gtf in M. avium, upregulated under the action of sub‐MICs of streptomycin and tetracycline
[22]. The biofilm growth and detachment have been related with the intracellular levels of the
second messenger cyclic‐di‐GMP [40]. The eal gene participating in the pathways for its
synthesis was upregulated by sub‐MIC of tobramycin [41]. Definitely, the effects of sub‐MICs
on gene expression are not confined to these related to biofilm, many other genes can be
influenced as well [40].
3. Antibiofilm bacterial metabolites
The capacity of released metabolites of bacterial species and strains to modulate biofilm growth
of other bacteria is continuously in focus because of the potential for the isolation of novel
biofilm modulating substances. As an initial screening step, the action of cell‐free superna‐
tants (CFSs) is tested. The activities may vary from stimulation [56, 57] to suppression [58, 59].
Noteworthy, the effects of CFSs on bacterial growth in liquid media do not predict the effects
on sessile growth. Thus, subinhibitory amounts of 10-2 diluted CFSs from two bacteriocino‐
genic strains of Lactobacillus plantarum slowed down the growth of laboratory and uropatho‐
genic strains of E. coli, but stimulated significantly the biofilm development [59]. The active
substances in CFSs may be proteins/peptides, carbohydrates, low molecular weight metabo‐
lites, etc. [see comments by 57] and for some of them the nature, structure, and mode of action
have been explored. However, we shall restrict our review to molecules which have inhibito‐
ry activity on bacterial growth, and for which there is data on the effects of subinhibitory
amounts on biofilms.
Bacteriocins are proteins/peptides produced by prokaryotes which are active against other
bacterial species or strains. For example, colicins are produced by some strains of E. coli. One
of them, colicin M, is a phosphatase that hydrolyses the peptidoglycan lipid II intermediate,
thus interfering with peptidoglycan synthesis and causing cell lysis. In subinhibitory amounts,
it upregulated in P. aeruginosa PAO1 the ydeH gene related with the synthesis of cyclic‐di‐GMP,
as well as several biofilm‐related genes, ycfJ, rprA, omrA, and omrB. However, no biofilm
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penicillin induced filamentation of cells of C. diphtheriae, while erythromycin reduced cell size
of this microorganism [26]. The sub‐MIC of the drug combination piperacillin/tazobactam
induced the occurrence of filamentous forms in P. aeruginosa, while subinhibitory amounts of
imipenem resulted in the formation of roundish forms (coccobacilli) of this bacterium [43].
Sub‐MICs of ciprofloxacin caused the occurrence of filamentous cells when applied to E. coli
isolated from urinary tract infections. This was accompanied by alterations in the morpholo‐
gy of the outer membrane cardiolipin domains of the strain [44]. The cell‐surface physico‐
chemical characteristics of the bacteria would also be affected. Several studies focus on cell‐
surface hydrophobicity. For example, sub‐MICs of penicillin and streptomycin which
enhanced biofilm formation in C. diphtheriae also rendered the cell surface more hydropho‐
bic [26]. The combination piperacillin/tazobactam applied as sub‐MIC that suppressed biofilm
growth also reduced cell‐surface hydrophobicity of P. aeruginosa [45]. While these examples
appear to show a likely positive correlation between cell‐surface hydrophobicity (which is also
related with cell adhesion) and the effects on biofilm growth, this may not be the rule
throughout. Thus, sub‐MICs of moxifloxacin that reduced biofilm growth had no influence on
the cell‐surface hydrophobicity of S. maltophilia [7]. Changes in zeta potential [8], flagellum‐
mediated swimming [45] and type IV fimbria‐related twitching motility [39, 45] have been
registered as well. When examined, the overall morphology of the biofilm, its thickness,
substratum coverage, and roughness would change as well [16, 39].
The extracellular biofilm matrix is an important component of these structured microbial
consortia. It has both structural and protective functions. In the interplay with the antibiotics,
its barrier role against drug penetration should be underlined [46]. For the time being, available
publications show a strict correlation between the effects of sub‐MICs on the biofilm and on
the extracellular matrix components. More data are available on the extracellular polysac‐
charide (EPS). In cases of biofilm biomass reduction (e.g. by gentamicin and ciprofloxacin on
S. Typhimurium, by fluoroquinolones on P. aeruginosa, and by dicloxacillin on S. epidermidis)
this was accompanied by reduced release of EPS [5, 16, 47]. In cases of biofilm biomass
increase (by sub‐MIC of erythromycin on S. epidermidis, of cefotaxime on S. enterica serovar
Typhimurium, and of azithromycin on representatives of several bacterial genera), this
coincided with EPS increase [5, 48, 49]. While less studied, such correlation might also
characterize another component of the extracellular matrix, the extracellular DNA. It was
registered with increased amounts in S. epidermidis biofilms treated with sub‐MICs of
vancomycin [50, 51].
Sub‐MICs of antibiotics can interact with the bacterial‐host interactions. Together with their
capacity to affect phenotypes, they can influence bacterial sensitivity to oxidative stress [45],
suppress host proinflammatory responses [6], and cooperate with host polymorphonuclear
leucocytes to destroy biofilms [34].
There is evidence that in nature, antibiotics at non‐inhibitory concentrations can have the role
of signalling molecules that can interfere with quorum sensing [4, 42]. It was shown that sub‐
MICs of antibiotics influence quorum‐sensing‐related phenotypes of Chromobacterium
violaceum, like the production of the pigment violacein, of acyl‐homoserine lactones, and of
chitinase [52]. Sub‐MICs of tobramycin inhibited the Rhl/R system of P. aeruginosa thus
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reducing the production of C4‐homoserine lactone [53]. Azithromycin also antagonized
quorum sensing in P. aeruginosa [4]. Cephalotin and cephalotaxime suppressed the agr
quorum‐sensing system in S. aureus [54].
Sub‐MICs of antibiotics can interact with bacterial regulation mechanisms and gene expres‐
sion. Transcriptomic studies indicated that the expression of approximately 5% of bacterial
promoters may be affected [13]. Genes related with antibiotic resistance should be men‐
tioned in the first place. There was a correlation between the transcription of the ermC gene
and the biofilm formation of erythromycin‐treated S. epidermidis [27]. In P. aeruginosa, among
the 34 genes influenced by imipenem, the most strongly induced gene was ampC coding for
chromosomal β‐lactamase [54]. Genes related with the synthesis of EPS or bacterial capsules
may be affected, like the genes from the icaADBC operon in S. epidermidis [28, 49]. Other genes
related with adhesion and biofilm development that should be mentioned are comD, gtfC, luxS,
gtfB, and atlA of Streptococcus mutans upregulated by sub‐MIC of triclosan [55] and guaB2 and
gtf in M. avium, upregulated under the action of sub‐MICs of streptomycin and tetracycline
[22]. The biofilm growth and detachment have been related with the intracellular levels of the
second messenger cyclic‐di‐GMP [40]. The eal gene participating in the pathways for its
synthesis was upregulated by sub‐MIC of tobramycin [41]. Definitely, the effects of sub‐MICs
on gene expression are not confined to these related to biofilm, many other genes can be
influenced as well [40].
3. Antibiofilm bacterial metabolites
The capacity of released metabolites of bacterial species and strains to modulate biofilm growth
of other bacteria is continuously in focus because of the potential for the isolation of novel
biofilm modulating substances. As an initial screening step, the action of cell‐free superna‐
tants (CFSs) is tested. The activities may vary from stimulation [56, 57] to suppression [58, 59].
Noteworthy, the effects of CFSs on bacterial growth in liquid media do not predict the effects
on sessile growth. Thus, subinhibitory amounts of 10-2 diluted CFSs from two bacteriocino‐
genic strains of Lactobacillus plantarum slowed down the growth of laboratory and uropatho‐
genic strains of E. coli, but stimulated significantly the biofilm development [59]. The active
substances in CFSs may be proteins/peptides, carbohydrates, low molecular weight metabo‐
lites, etc. [see comments by 57] and for some of them the nature, structure, and mode of action
have been explored. However, we shall restrict our review to molecules which have inhibito‐
ry activity on bacterial growth, and for which there is data on the effects of subinhibitory
amounts on biofilms.
Bacteriocins are proteins/peptides produced by prokaryotes which are active against other
bacterial species or strains. For example, colicins are produced by some strains of E. coli. One
of them, colicin M, is a phosphatase that hydrolyses the peptidoglycan lipid II intermediate,
thus interfering with peptidoglycan synthesis and causing cell lysis. In subinhibitory amounts,
it upregulated in P. aeruginosa PAO1 the ydeH gene related with the synthesis of cyclic‐di‐GMP,
as well as several biofilm‐related genes, ycfJ, rprA, omrA, and omrB. However, no biofilm
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penicillin induced filamentation of cells of C. diphtheriae, while erythromycin reduced cell size
of this microorganism [26]. The sub‐MIC of the drug combination piperacillin/tazobactam
induced the occurrence of filamentous forms in P. aeruginosa, while subinhibitory amounts of
imipenem resulted in the formation of roundish forms (coccobacilli) of this bacterium [43].
Sub‐MICs of ciprofloxacin caused the occurrence of filamentous cells when applied to E. coli
isolated from urinary tract infections. This was accompanied by alterations in the morpholo‐
gy of the outer membrane cardiolipin domains of the strain [44]. The cell‐surface physico‐
chemical characteristics of the bacteria would also be affected. Several studies focus on cell‐
surface hydrophobicity. For example, sub‐MICs of penicillin and streptomycin which
enhanced biofilm formation in C. diphtheriae also rendered the cell surface more hydropho‐
bic [26]. The combination piperacillin/tazobactam applied as sub‐MIC that suppressed biofilm
growth also reduced cell‐surface hydrophobicity of P. aeruginosa [45]. While these examples
appear to show a likely positive correlation between cell‐surface hydrophobicity (which is also
related with cell adhesion) and the effects on biofilm growth, this may not be the rule
throughout. Thus, sub‐MICs of moxifloxacin that reduced biofilm growth had no influence on
the cell‐surface hydrophobicity of S. maltophilia [7]. Changes in zeta potential [8], flagellum‐
mediated swimming [45] and type IV fimbria‐related twitching motility [39, 45] have been
registered as well. When examined, the overall morphology of the biofilm, its thickness,
substratum coverage, and roughness would change as well [16, 39].
The extracellular biofilm matrix is an important component of these structured microbial
consortia. It has both structural and protective functions. In the interplay with the antibiotics,
its barrier role against drug penetration should be underlined [46]. For the time being, available
publications show a strict correlation between the effects of sub‐MICs on the biofilm and on
the extracellular matrix components. More data are available on the extracellular polysac‐
charide (EPS). In cases of biofilm biomass reduction (e.g. by gentamicin and ciprofloxacin on
S. Typhimurium, by fluoroquinolones on P. aeruginosa, and by dicloxacillin on S. epidermidis)
this was accompanied by reduced release of EPS [5, 16, 47]. In cases of biofilm biomass
increase (by sub‐MIC of erythromycin on S. epidermidis, of cefotaxime on S. enterica serovar
Typhimurium, and of azithromycin on representatives of several bacterial genera), this
coincided with EPS increase [5, 48, 49]. While less studied, such correlation might also
characterize another component of the extracellular matrix, the extracellular DNA. It was
registered with increased amounts in S. epidermidis biofilms treated with sub‐MICs of
vancomycin [50, 51].
Sub‐MICs of antibiotics can interact with the bacterial‐host interactions. Together with their
capacity to affect phenotypes, they can influence bacterial sensitivity to oxidative stress [45],
suppress host proinflammatory responses [6], and cooperate with host polymorphonuclear
leucocytes to destroy biofilms [34].
There is evidence that in nature, antibiotics at non‐inhibitory concentrations can have the role
of signalling molecules that can interfere with quorum sensing [4, 42]. It was shown that sub‐
MICs of antibiotics influence quorum‐sensing‐related phenotypes of Chromobacterium
violaceum, like the production of the pigment violacein, of acyl‐homoserine lactones, and of
chitinase [52]. Sub‐MICs of tobramycin inhibited the Rhl/R system of P. aeruginosa thus
Microbial Biofilms - Importance and Applications448
Invertebrate antibacterial responses are also explored. Thus, thanatin is an insect antimicro‐
bial peptide on the basis of which a shorter synthetic derivative, R‐thanatin, was synthe‐
sized. When applied in sub‐MIC amounts to S. epidermidis (including methicillin‐resistant
staphylococcus epidermidis, MRSE), Staphylococcus haemolyticus, and Staphylococcus hominis, it
inhibited biofilm formation. Parallelly, MRSE underwent serious morphological alterations
like swelling and abnormal divisions [70].
5. Subinhibitory amounts of plant substances
The application of plants for treatment of illness dates back to the very early moments of
mankind history, and has laid the basis of modern phytotherapy. The studies on the antibac‐
terial activities of medicinal plant products have a long tradition, more recently expanded to
biofilm research. Studies include tests on essential oils and plant extracts, partially purified
enriched fractions, as well as isolated pure substances. Also, plant products may be used as a
basis for chemical modifications aiming improved antibiofilm activity.
Among the plant products, essential oils are most popular for their wide use in ethnomedi‐
cine. Some of them that have antibacterial action proved successful against bacterial biofilms
as well. Among the essential oils that at subinhibitory amounts could suppress sessile growth
are, for example, these from Satureja hortensis L. (active against Prevotella nigrescens biofilm)
[71], from Thymus vulgaris (active against P. aeruginosa and E. coli biofilms) [72], and from
Mentha piperita (active against biofilms of P. aeruginosa and A. hydrophylla) [73]. In addition,
peppermint oil suppressed EPS production [73].
Methanol and aqueous branch extracts of five Juniperus sp. were examined for their activi‐
ties against two S. aureus strains. The extracts had minimal activity on planktonic growth of S.
aureus ATCC 3538P but suppressed biofilm formation, while the other strain, S. aureus 810,
was not affected in either mode of growth [74]. The extract from Leonurus cardiaca L. sup‐
pressed the adherence of S. aureus to both abiotic surfaces and surfaces covered with fibrino‐
gen, fibronectin, or collagen [75]. Sub‐MICs (1/2 to 1/32 MIC) of extracts from Boesenbergia
pandurata (Roxb.) Schltr. and Eleutherine americana Merr. significantly prevented biofilm
formation. Together with this, the extract from E. americana also suppressed quorum sensing
in C. violaceum test system [76].
In a study on 14 fractions from plant extracts, the total extract and the phenyl propanoid‐
containing fraction from Rhodiola rosea, and the total extract and the sesquiterpene lactone‐
containing fraction (Am2) from Arnica montana, were shown to have no antibacterial effects.
However, they suppressed the biofilm growth in E. coli urinary tract infection isolates. These
same extracts had the opposite effect—biofilm stimulation, on a multidrug‐resistant E. coli
strain isolated from asymptomatic bacteriuria [77]. Noteworthy, the sesquiterpene lactone‐
containing fraction Am2 also suppressed the quorum‐sensing‐controlled bioluminescence in
Vibrio harveyi bioreporter strains (ATCC1116 and ATCC1117) [78, 79].
Carvacol is an antimicrobial monotherpenic phenol with antibacterial potential that is present
in many essential oils. In subinhibitory doses, it suppressed sessile growth of a number of
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stimulation was confirmed by the crystal violet assay [60]. RIP is an RNAIII‐inhibiting
heptapeptide originally isolated from CFS of Staphylococcus xylosus. It inhibits staphylococcal
pathogenesis. In sub‐MICs, it suppressed biofilm formation by interfering with the quorum‐
sensing mechanisms [61]. Nisin is a polycyclic antibacterial peptide produced by Lactococcus
lactis. At growth inhibitory concentrations, it suppressed sessile growth of S. aureus; howev‐
er, sub‐MICs had no effect on biofilm [62].
Mupirocin is an antibacterial substance of the monoxycarbolic acid class that was originally
isolated from Pseudomonas fluorescens. At sub‐MIC, it can reduce both biofilm formation and
glycocalyx production by P. aeruginosa [63]. Phenyl lactic acid is a metabolite of Lactobacillus
probiotic strains. At subinhibitory amounts, it attenuated the virulence and pathogenicity of
P. aeruginosa and S. aureus, including biofilm formation, by interacting with quorum sensing
[64]. The antifungal and antibacterial molecule, 2,4‐diacetylphloroglucinol, was isolated from
the CFS of Pseudomonas protegens. At subinhibitory amounts, it reduced pellicle and biofilm
formation, and sporulation of B. subtilis [65].
4. Antimicrobial peptides and biofilm modulation
The host‐bacterial interactions are also explored with the aim of identifying of novel mole‐
cules that would help overcoming the bacterial resistance mechanisms and combating
infections. One important group of substances is that of the antibacterial peptides, an impor‐
tant part of the innate immune system.
Colistin is a cationic antimicrobial peptide which is gaining importance in the fight against P.
aeruginosa cystic fibrosis infections. Subinhibitory concentrations altered the expression of 30
genes of the bacterium. Genes related with quorum sensing, lipopolysaccharides (LPSs)
modifications, quinolone biosynthesis, and biofilm formation were upregulated while genes
involved with motility and osmotolerance were downregulated. However, biofilm biomass
remained unaffected [66].
The major human host defence peptide LL‐37 is found in mucosal surfaces, the granules of
phagocytes, as well as in bodily fluids. At very low concentrations, far below those that kill or
inhibit the growth of P. aeruginosa, LL‐37 prevented the in vitro biofilm formation [67]. It
interfered with biofilm growth in at least three ways: by reduction of initial attachment,
promotion of twitching motility, and downregulation of key components of the Las and Rhl
quorum‐sensing systems [67].
The synthetic antimicrobial peptide 1018, derived from the bovine neutrophil defence peptide
bactenecin, has recently been identified as biofilm inhibitory compound. While not reflect‐
ing on bacterial growth, it could prevent the biofilm growth of P. aeruginosa, E. coli, Acineto‐
bacter baumannii, Klebsiella pneumoniae, S. enterica, Burkholderia cenocepacia, and methicillin‐
resistant S. aureus. This co‐related with degradation of ppGpp [68]. In addition, peptide 1018
acted in synergism with conventional antibiotics, like ceftazidime, ciprofloxacin, imipenem,
or tobramycin, to both prevent development and disperse existing biofilms [69].
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Invertebrate antibacterial responses are also explored. Thus, thanatin is an insect antimicro‐
bial peptide on the basis of which a shorter synthetic derivative, R‐thanatin, was synthe‐
sized. When applied in sub‐MIC amounts to S. epidermidis (including methicillin‐resistant
staphylococcus epidermidis, MRSE), Staphylococcus haemolyticus, and Staphylococcus hominis, it
inhibited biofilm formation. Parallelly, MRSE underwent serious morphological alterations
like swelling and abnormal divisions [70].
5. Subinhibitory amounts of plant substances
The application of plants for treatment of illness dates back to the very early moments of
mankind history, and has laid the basis of modern phytotherapy. The studies on the antibac‐
terial activities of medicinal plant products have a long tradition, more recently expanded to
biofilm research. Studies include tests on essential oils and plant extracts, partially purified
enriched fractions, as well as isolated pure substances. Also, plant products may be used as a
basis for chemical modifications aiming improved antibiofilm activity.
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as well. Among the essential oils that at subinhibitory amounts could suppress sessile growth
are, for example, these from Satureja hortensis L. (active against Prevotella nigrescens biofilm)
[71], from Thymus vulgaris (active against P. aeruginosa and E. coli biofilms) [72], and from
Mentha piperita (active against biofilms of P. aeruginosa and A. hydrophylla) [73]. In addition,
peppermint oil suppressed EPS production [73].
Methanol and aqueous branch extracts of five Juniperus sp. were examined for their activi‐
ties against two S. aureus strains. The extracts had minimal activity on planktonic growth of S.
aureus ATCC 3538P but suppressed biofilm formation, while the other strain, S. aureus 810,
was not affected in either mode of growth [74]. The extract from Leonurus cardiaca L. sup‐
pressed the adherence of S. aureus to both abiotic surfaces and surfaces covered with fibrino‐
gen, fibronectin, or collagen [75]. Sub‐MICs (1/2 to 1/32 MIC) of extracts from Boesenbergia
pandurata (Roxb.) Schltr. and Eleutherine americana Merr. significantly prevented biofilm
formation. Together with this, the extract from E. americana also suppressed quorum sensing
in C. violaceum test system [76].
In a study on 14 fractions from plant extracts, the total extract and the phenyl propanoid‐
containing fraction from Rhodiola rosea, and the total extract and the sesquiterpene lactone‐
containing fraction (Am2) from Arnica montana, were shown to have no antibacterial effects.
However, they suppressed the biofilm growth in E. coli urinary tract infection isolates. These
same extracts had the opposite effect—biofilm stimulation, on a multidrug‐resistant E. coli
strain isolated from asymptomatic bacteriuria [77]. Noteworthy, the sesquiterpene lactone‐
containing fraction Am2 also suppressed the quorum‐sensing‐controlled bioluminescence in
Vibrio harveyi bioreporter strains (ATCC1116 and ATCC1117) [78, 79].
Carvacol is an antimicrobial monotherpenic phenol with antibacterial potential that is present
in many essential oils. In subinhibitory doses, it suppressed sessile growth of a number of
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stimulation was confirmed by the crystal violet assay [60]. RIP is an RNAIII‐inhibiting
heptapeptide originally isolated from CFS of Staphylococcus xylosus. It inhibits staphylococcal
pathogenesis. In sub‐MICs, it suppressed biofilm formation by interfering with the quorum‐
sensing mechanisms [61]. Nisin is a polycyclic antibacterial peptide produced by Lactococcus
lactis. At growth inhibitory concentrations, it suppressed sessile growth of S. aureus; howev‐
er, sub‐MICs had no effect on biofilm [62].
Mupirocin is an antibacterial substance of the monoxycarbolic acid class that was originally
isolated from Pseudomonas fluorescens. At sub‐MIC, it can reduce both biofilm formation and
glycocalyx production by P. aeruginosa [63]. Phenyl lactic acid is a metabolite of Lactobacillus
probiotic strains. At subinhibitory amounts, it attenuated the virulence and pathogenicity of
P. aeruginosa and S. aureus, including biofilm formation, by interacting with quorum sensing
[64]. The antifungal and antibacterial molecule, 2,4‐diacetylphloroglucinol, was isolated from
the CFS of Pseudomonas protegens. At subinhibitory amounts, it reduced pellicle and biofilm
formation, and sporulation of B. subtilis [65].
4. Antimicrobial peptides and biofilm modulation
The host‐bacterial interactions are also explored with the aim of identifying of novel mole‐
cules that would help overcoming the bacterial resistance mechanisms and combating
infections. One important group of substances is that of the antibacterial peptides, an impor‐
tant part of the innate immune system.
Colistin is a cationic antimicrobial peptide which is gaining importance in the fight against P.
aeruginosa cystic fibrosis infections. Subinhibitory concentrations altered the expression of 30
genes of the bacterium. Genes related with quorum sensing, lipopolysaccharides (LPSs)
modifications, quinolone biosynthesis, and biofilm formation were upregulated while genes
involved with motility and osmotolerance were downregulated. However, biofilm biomass
remained unaffected [66].
The major human host defence peptide LL‐37 is found in mucosal surfaces, the granules of
phagocytes, as well as in bodily fluids. At very low concentrations, far below those that kill or
inhibit the growth of P. aeruginosa, LL‐37 prevented the in vitro biofilm formation [67]. It
interfered with biofilm growth in at least three ways: by reduction of initial attachment,
promotion of twitching motility, and downregulation of key components of the Las and Rhl
quorum‐sensing systems [67].
The synthetic antimicrobial peptide 1018, derived from the bovine neutrophil defence peptide
bactenecin, has recently been identified as biofilm inhibitory compound. While not reflect‐
ing on bacterial growth, it could prevent the biofilm growth of P. aeruginosa, E. coli, Acineto‐
bacter baumannii, Klebsiella pneumoniae, S. enterica, Burkholderia cenocepacia, and methicillin‐
resistant S. aureus. This co‐related with degradation of ppGpp [68]. In addition, peptide 1018
acted in synergism with conventional antibiotics, like ceftazidime, ciprofloxacin, imipenem,
or tobramycin, to both prevent development and disperse existing biofilms [69].
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antibacterials [1]. As a major risk for human health, biofilm communities provide the bacte‐
ria with prerequisites for rapid resistance development [99]. Among the other more direct risks
that biofilms may cause to human health, should be mentioned the possibility for enhanced
colonization of indwelling medical devices in the presence of subinhibitory amounts of
antibacterial substances, and the contamination of surfaces in medical or food‐processing
environments. Depending on the aim of a given antibiofilm strategy, different effects may be
in the focus. Disinfection of outer surfaces in hospitals and in food industry requires that the
used agents have the capacity to detach established biofilms. On the opposite, if biofilms on
indwelling devices are concerned, once established, their detachment is hazardous. It may be
accompanied with dissemination of the bacteria to other sites in the human body, and there
are risks of sepsis [69]. Therefore, the development of medical materials should be directed to
biofilm prevention. However, when the effects of a given substance are estimated, the biology
of the biofilm as a whole is better to be addressed, starting from the attachment and establish‐
ment of the sessile community, and going as far as its detachment. The methodologies used
by the predominant amount of the present‐day studies search for the effects of sub‐MICs by
applying the tested agents during biofilm growth. It can be recommended that in the future a
more standardized methodology is applied which includes as well tests for dispersion of
established biofilms and for microbial vitality. The present review showed several critical
points in the effects of sub‐MICs of antibacterial substances as biofilm modulators. Among
these, the strain‐ and species‐specific responses of the bacteria in their biofilm development,
the expression of virulence factors and quorum sensing should necessarily be taken into
account when novel antibacterials are tested.
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Gram‐positive and Gram‐negative bacteria [80, 81]. Polyphenols from muscadine grapes with
antioxidant and antibacterial activity, at 0.5 MIC, inhibited biofilm growth of S. aureus [82].
Similar was the effect of the essential oil components eugenol and citral on S. aureus and Listeria
monocytogenes [83], epigallocatechin‐3‐gallate from green tea on S. maltophilia [84], ursolic acid,
genistein, cranberry extract, p‐hydroxybenzoic acid, and resveratol on S. aureus [75, 85].
Menthol, together with biofilm suppression, was shown to inhibit both the las‐ and pqs‐related
quorum sensing [73].
Fenchone is a substance that is present in many essential oils. It had neither antibacterial nor
antibiofilm effects on a panel of Gram‐positive and Gram‐negative strains. This molecule was
used to synthesize its chemical derivatives. While the substitutions did not improve the
antibacterial properties against E. coli ATCC 25922 and six E. coli K‐12 strains, some of the
derivatives showed biofilm modulation potential [86]. Chalcones are a group of flavonoids
with antibacterial potential, found in many plants. Synthetic chalcones are applied as well. The
effects of sub‐MICs of three newly synthesized chalcones on methicillin‐resistant S. aureus were
examined. Both biofilm formation and adherence to human fibronectin were reduced, as well
as the release of EPS [87].
6. Other compounds with biofilm‐modulating potential
Other substances have also proved a good anti‐biofilm potential when applied in sub‐MICs.
For example, sodium ascorbate, together with suppressing P. aeruginosa virulence factors
(elastase, protease and haemolysin activities, pyocyanin production, and quorum sensing) also
reduced biofilm formation [88]. Biofilm growth was inhibited by subinhibitory amounts of
thiourea derivatives [89], thiazolinediones [90], and certain anthraquinones [91]. Organic
complexes of metals are also elaborated as antibacterial and/or antibiofilm substances. Newly
synthesized dimethylguanin‐copper complexes [92], the organo‐tellurium compound AS101
[93], and bismuth thiols [94] have shown anti‐biofilm activity at sub‐MICs. The latter substan‐
ces are considered as possible coating agents for indwelling devices. For prevention of medical
devices from bacterial contamination, other substances may prove useful as coating material,
like ovotransferrin, protamine sulfate, ethylenediaminetetraacetic acid (EDTA) [95], cerium
nitrate, chitosan, hamamelitannin [96], polyvinyl pyrrilidine [97], etc.
As an opposite effect, the biocides used in food processing facilities, trisodium phosphate,
sodium nitrite, and sodium hypochlorite, when applied in sub‐MICs, enhanced the capacity
of E. coli to form biofilms. This was accompanied by a reduction of the antibiotic susceptibili‐
ty [98].
7. Some final considerations
Presently, there is growing concern about the relationship between the rise of widespread
antibiotic resistance and the role of environments containing subinhibitory amounts of
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antibacterials [1]. As a major risk for human health, biofilm communities provide the bacte‐
ria with prerequisites for rapid resistance development [99]. Among the other more direct risks
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used agents have the capacity to detach established biofilms. On the opposite, if biofilms on
indwelling devices are concerned, once established, their detachment is hazardous. It may be
accompanied with dissemination of the bacteria to other sites in the human body, and there
are risks of sepsis [69]. Therefore, the development of medical materials should be directed to
biofilm prevention. However, when the effects of a given substance are estimated, the biology
of the biofilm as a whole is better to be addressed, starting from the attachment and establish‐
ment of the sessile community, and going as far as its detachment. The methodologies used
by the predominant amount of the present‐day studies search for the effects of sub‐MICs by
applying the tested agents during biofilm growth. It can be recommended that in the future a
more standardized methodology is applied which includes as well tests for dispersion of
established biofilms and for microbial vitality. The present review showed several critical
points in the effects of sub‐MICs of antibacterial substances as biofilm modulators. Among
these, the strain‐ and species‐specific responses of the bacteria in their biofilm development,
the expression of virulence factors and quorum sensing should necessarily be taken into
account when novel antibacterials are tested.
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Abstract
Dental implants are used extensively to replace missing teeth. To enhance their integration
with the bones of the jaws, the surfaces of titanium dental implants are modified to make
them hydrophilic, high energy, and microtextured. These same features make biofilm
development occur readily upon exposure to the saliva. The presence of mature biofilms
on dental implant surfaces drives local inflammatory responses in the adjacent soft and
hard tissues (peri-implantitis), which leads to pathological loss of bone and the forma‐
tion of a saucer shaped bone defects. This chapter examines the unique challenges posed
by biofilms formed on highly complex dental implant surfaces, which are difficult to
access for cleaning, and easily damaged by conventional cleaning approaches. We explore
how biofilms can be removed from implant surfaces using a variety of novel methods,
without causing surface damage or other undesirable modifications, and show how
different laboratory and clinical models can be used to assess the performance of both
conventional and novel methods of biofilm removal.
Keywords: biofilms, dental implants, surface characterization, debridement, lasers,
particle beams
1. Introduction
Dental implants have been used for over 40 years to replace missing teeth, with good clinical
success when placed in most sites in the jaws [1]. They are inserted into specially prepared
channels in the bone, and once fully integrated into the bone, can be restored with a ceramic
crown to replace a single missing tooth (Figure 1). Typically, dental implants are fabricated from
commercially pure titanium (Ti), or titanium alloys which include small amounts of vanadi‐
um and aluminum. Dental  implants made from ceramic materials  such as sapphire and
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Figure 2. Scanning electron microscope images of dental implants. (A) The collar (upper) and thread regions of a 3i
Biomet implant. (B) The lower end of an Ankylos implant. Note the difference in thread patterns compared to (A). (C –
L) Implant surfaces of various implant brands. White scale bars represent 20 microns. (C) Non-textured surface show‐
ing lathe cutting marks (3i Biomet). (D) MIS, (E) Neoss, (F) Ankylos, (G) MID, (H) Nobel Biocare, (I) Biohorizons, (J)
Southern (non-textured surface), (K) Southern ITC, (L) Southern (collar region).
3. Biofilm development on implant surfaces
The roughened implant surface which assists in achieving integration of the implant with the
bones of the jaws provides an exceptionally favorable microenvironment for biofilm forma‐
tion, when the surface comes into contact with saliva [2]. In vivo studies have shown that the
extent of bacterial colonization of roughened Ti surfaces is greater than that of smooth
surfaces [5]. Moreover, the extent of bacterial adhesion has been shown to correlate directly
with the extent of surface roughness [5]. Several authors have shown that methods which
increase surface roughness resulted in enhanced attachment of bacteria [6, 7]. Biofilms then
develop quickly and mature rapidly, nourished by nutrients from the host, both through saliva
and through gingival crevicular fluid and blood. The latter is found as a consequence of the
development of inflammatory reactions in the adjacent host tissues and contributes to the
growth of Gram-negative species, which utilize iron and porphyrins in their normal metabol‐
ic pathways.
Bacteria from the oral cavity readily adhere to the surfaces of dental implants, and mature
biofilms develop over several days. Such biofilms can be seen on the surfaces of implants
removed because of clinical failure from peri-implant inflammation, and are identical to those
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zirconium oxide exist but are not in common use. The use of Ti is favored over other materials
because it is biocompatible when inserted into direct contact with bone, resistant to corrosion,
lightweight, and durable.
Figure 1. An overview of dental implant placement. (A) Radiograph of the site of a missing tooth showing adequate
bone levels. (B) Post-operative radiograph of the same area after placement of a titanium dental implant. (C) Pre-opera‐
tive clinical view of the site of the missing lower incisor tooth. (D) Immediately after placing the implant into a site
prepared in the bone. The collar of the implant can be seen. The soft tissues are being displaced from the bone by the
metal instrument. (E) Implant supported crown in place. (F) Mirror view showing the attachment to the implant which
supports the crown.
2. The complexities of implant surfaces
While early dental implants had simple threaded forms and plain surfaces which were
unmodified after milling, almost all modern dental implants have surface features which
increase the surface area and surface energy, enhancing the adhesion of blood, matrix proteins,
and human cells. Altering the surface of a Ti implant to increase its roughness does not
compromise its biocompatibility but enhances the total area available for integration with
bone [2, 3]. The surfaces of most modern dental implants are microtextured, to support and
enhance osseointegration [4].
A range of methods have been used to achieve modification of the milled surface. Treat‐
ments such as titanium plasma-spraying, grit-blasting, acid-etching, and anodization create a
favorable roughened, high-energy surface, which aid in the process of osseointegration [4].
The roughness of most current implant surfaces created using these methods ranges from 0.5
to 2 μm [3]. Newer surface modifications involving treatment using sulfuric acid and hydro‐
gen peroxide can create nanoscale roughness, while technologies such as micro-arc oxida‐
tion can create nanostructured bioactive titanium oxide layers to enhance cell attachment and
adhesion onto the dental implant surface. Examples of typical implant surfaces are shown in
Figure 2. These patterns are superimposed onto a variety of different types of thread pat‐
terns (Figure 2 A , B). Regions which have only been milled, such as the uppermost collar
region, show typical lathe marks on the surface (Figure 2 C , J), whereas the thread regions
have microtextured surfaces.
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have microtextured surfaces.
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At both the microbial and immunohistological levels, there are numerous similarities between
PIM and gingivitis, and likewise between PI and periodontitis. The microbial flora is domi‐
nated by Gram-negative species, with smaller numbers of streptococci and other Gram positive
bacteria. The profile is similar to biofilms, which develop on implant surface sunder labora‐
tory conditions (Table 1). Key pathogens which have been implicated in PI include anaero‐
bic Gram-negative rods, motile organisms, and spirochetes which numerically are present at
low levels in these biofilms [15, 16]. A point of difference between biofilm formation on implant
surfaces versus teeth is that Staphylococci (particularly Staphylococcus aureus) and yeasts can
be found in biofilms on implant surfaces, whereas these rarely occur in biofilms associated
with teeth [16, 17].









Major groupings in a typical 96 h multispecies biofilm grown on Southern dental implant surfaces from a human
salivary inoculum, showing major groups according to next-gen sequencing analysis.
Table 1. Dominant organisms in the taxonomic analysis of biofilm on dental implants.
Dental implants are increasingly utilized in the restoration of partially dentate or fully
edentulous patients. This raises issues of pathogens being transferred from sites with perio‐
dontitis to the surfaces of implants as a vector for infection of implant surfaces [18]. Demand
for dental implants for single-tooth replacement has been driven by their lower biological cost
than conventional dental bridges, and better long-term outcomes, since implants, unlike teeth,
are not affected by dental caries and its complications. When failures with implant treatment
occur, these may be classified as being either early or late, reflecting surgical or mechanical
factors in the former, and biological factors in the latter [19]. PI accounts for most of the late
failures, since the biofilm-induced inflammatory reaction causes extensive cratering of the
bone, making the implant unsuitable for supporting a crown or other prosthesis [20].
The seminal work of Lang et al. [21] documented how inflammation in the implant-mucosal
unit (i.e., PIM) can, in susceptible patients when biofilms are allowed to accumulate for
prolonged periods of time, progress from PIM to PI, with accompanying loss of circumferen‐
tial bone. This conversion is not merely an expansion in volume of the host immune re‐
sponse to the biofilm but represents fundamental changes in the composition of the biofilm
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which can be developed under laboratory conditions using human saliva as the sole inocu‐
lum (Figure 3).
Once a biofilm has become established on an implant surface, conventional methods of
debridement are not effective for its removal [8]. An implant surface which is positioned below
the position of the oral soft tissues cannot be reached with the bristles of a conventional
toothbrush, as these only penetrate 0.5 mm into crevices around teeth and dental implants.
Likewise, products used in the mouth such as mouthwashes only penetrate to a similar extent.
Figure 3. Rapid development of bacterial biofilm on dental implant surfaces. Scale bars in parts (A–C) and (E –G) rep‐
resent 2 microns. (A) Pristine surface of a new Nobel Biocare implant. (B) The same surface after 4 days incubation in
brain heart infusion broth inoculated with human saliva. (C) Four days biofilm on the surface of a Southern implant
from a human saliva inoculum, which shows similar characteristics to image (B). (D) Biofilm between the threads of an
implant which was removed from the mouth because of peri-implantitis, which had led to bone loss and eventual
failure of the implant. (E) Damage to an abraded titanium surface (Southern implant) caused by an ultrasonic scaler
with a metal tip used for 60 s to remove biofilm. Compare to Figure 2K which is the undamaged surface at the same
magnification. (F–H) High power views showing bacteria still present and surface damage (flattening of irregularities)
on different types of micro-roughened titanium surface after using an ultrasonic scaler.
4. Biofilm-induced peri-implant diseases
Peri-implant inflammatory diseases caused by biofilm accumulation on implant surfaces may
segregated into two forms: peri-implant mucositis (PIM) and peri-implantitis (PI). These differ
in the extent to which the inflammatory reaction of the host immune response extends to
involve the bone surrounding the implant [9–11]. In PIM, inflammation is confined to the soft
tissues surrounding the dental implant, and there is no progressive loss of supporting bone
over time [10]. In peri-implantitis (PI), the biofilm-induced inflammatory process causes both
changes in the soft tissues as well as progressive loss of the supporting bone [12]. Both PIM
and PI are relatively common. The most recent systematic review conducted in 2015 estimat‐
ed that the prevalence to be in the range of 19–65% for both PIM and PI [13]. This is consis‐
tent with recent longitudinal studies conducted in communities, where dental implant
treatments are very commonly performed as the standard of care for single missing teeth [14].
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Although there are many studies of peri-implantitis treatments, including randomized
controlled clinical trials, the latest Cochrane systematic review conducted in 2012 concluded
that based on current evidence, no particular treatment can be established as a gold stand‐
ard approach for the treatment of peri-implantitis [33].
In dental clinical practice, chairside methods to assess the levels of key pathogens present in
biofilms on the surfaces of implants or teeth do not exist, and sampling followed by genetic
analysis is too expensive for routine use. Therefore, the approach taken follows a nonspecif‐
ic approach, namely the removal of all biofilm from the surface, regardless of the pathogenic‐
ity of bacterial species growing within it. Since the treatment of peri-implantitis aims to also
achieve re-osseointegration of the implant surface with bone, it is necessary to remove not only
all viable bacteria but all traces of bacterial products such as endotoxins, in order to maxi‐
mize the likelihood of success.
Treatment of peri-implantitis needs to be implemented as early as the problem is diagnosed,
since the likelihood of implant failure due to PI is reduced significantly when the condition is
detected early so that treatment can be instituted [35]. Such treatment involves decontamina‐
tion of the implant surface, as well as surgical augmentation of the associated bony defects [36].
The desired goal of achieving re-osseointegration of the implant after decontamination, despite
the use of guided bone regeneration (GBR) with or without bone grafting, is regarded as either
difficult or impossible to achieve [37]. The reasons include the challenges of biofilm removal
from the surface of the implant, alterations of the implant surface caused by the cleaning
procedure used.
6. Methods which have attempted to clean implant surfaces
Implant surfaces are notoriously difficult to clean [38, 39]. The difficulty in cleaning the surfaces
of titanium dental implants lies in the complex topography of the implant surface, as is readily
apparent at high magnifications such as those used in Figure 2. Most implants have threads
at the macro-level (e.g., Figure 2 A , B), which impede with the action of hand scalers and
ultrasonic scalers, so that they only touch the outer parts of the threads but do not reach areas
between the threads. On the microscopic level, the highly roughened surfaces mean that there
is a large surface area. The microscopic roughness of the surface is a major obstacle for the
removal of bacteria and their products [38], as these types of surfaces defy effective debride‐
ment by mechanical means alone [39].
The various conventional methods that have been examined for biofilm removal from implant
surfaces include ultrasonic scalers fitted with various types of tips, hand periodontal cur‐
ettes with steel, titanium, plastic or Teflon® tips, abrasive and polishing rubber cups and
brushes, and particle beam (air powder abrasion) devices [40]. Most or all of these are found
in a modern dental office. Ultrasonic scalers used with metallic tips and stainless steel hand
scalers damage and scratch the surfaces of titanium implants [40–42], and for this reason, their
use is contraindicated [41]. Furthermore, plastic hand scalers leave residual scaler material on
implant surfaces during use [43, 44]. Examples of typical damage to surfaces from ultrasonic
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(such as emergence of different pathogens in a cyclical pattern) and accompanying shifts in
the composition of immune cells present in the tissues and their behavior, particularly their
production of inflammatory cytokines and mediators which alter host tissues, such as
proteases. These add to the effects of proteases of bacterial origin, especially those produced
by Porphyromonas species. As expected, an effective treatment would address the fundamen‐
tal driving factors within the host response to the biofilm which accumulates on the surfaces
of implants by removing the microorganisms and their products [22]. Reducing the biofilm
volume and changing its composition should then reduce the intensity of the inflammatory
response and alter its character so that the destruction of tissue no longer outweighs forma‐
tion of tissue [23].
As biofilms develop on implant surfaces, the appearance of key pathogens such as Porphyr‐
omonas species is a relatively early event. As seen in Table 1, such organisms can be present
in saliva and can reach significant levels in the biofilms which form on dental implant surfaces
after a period of several days. Quirynen et al. [24] followed the colonization of newly placed
implants by bacteria, took samples of the microbiota, and examined these using checker‐
board DNA–DNA hybridization, cultural techniques, and by real-time polymerase chain
reaction ( RT–PCR). They found that bacterial species associated with periodontitis can be
detected in peri-implant pockets as early as 2 weeks after implant placement.
The risk factors for peri-implant diseases are strikingly similar to the known predisposing and
modifying factors for periodontal diseases. Various prospective and retrospective analyses
have shown that the systemic health of the host (e.g., type II diabetes mellitus) [25], genetic
traits [26], environmental factors (e.g., smoking) [27, 28], a past history of periodontitis [28],
poor compliance with mechanical cleaning recommendations [27], and infrequent dental
maintenance visits [29] is major risk factors for the development of peri-implantitis.
Adding to this, there are significant effects of the brand of the implant used, which reflects the
different surface topography on which the biofilm will form [29–32], as illustrated in Figure 2.
For implants with PI, on average around 30% of the bone surrounding, the implant had been
lost. Several studies have reported that over periods ranging from 1 to 20 years, the preva‐
lence of bone loss can vary from 27.8 to 47% of patients [30–32]. There is a clear message from
such studies that if PI which is left untreated is a strong predictor of future implant loss.
5. The complexities of biofilm removal and implant debridement
While different protocols for professional care of dental implants have been suggested, it is
unclear at present which is the most effective [33]. Traditional dental treatment modalities,
such as the removal of biofilms using scaling instruments originally designed for debriding
the roots of teeth to remove such deposits, cannot be applied in exactly the same way to
threaded implant surfaces [8]. The implant surface structure has far more areas which are
protected, and much of the surface is inaccessible to conventional professional instruments.
Conventional dental therapies such as and scaling instruments and ultrasonic scalers been
shown to have minimal effectiveness for removing biofilm and eradicating pathogens from
implant surfaces through mechanical means [34].
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available for the attachment of bacteria [53, 54]. This is certainly a compromise since the original
goal has always been to remove biofilm without causing any surface modifications.
In terms of clinical outcomes, Karring et al. treated 11 patients diagnosed with PI and cleaned
the implants either with an ultrasonic scaler or plastic hand scalers. They found no clinically
relevant difference in the outcomes obtained [55]. No instrumentation applied by the dentist
can resolve peri-implantitis (or periodontitis) if the oral hygiene of the patient remains poor,
and bleeding scores remain high, which indicates persisting biofilms and persistent inflam‐
mation. Despite the advent of new ultrasonic scaler inserts made of titanium, plastic, or
graphite, the general consensus in the literature is that ultrasonic scalers have the same
fundamental limitations as hand instruments in that cannot access the undercuts of the implant
found between the threads [56]. Their zealous use causes surface alternations [52, 57].
Moreover, the treated surface is not yet biologically compatible, since biofilm and endotox‐
ins remain [58].
6.2. Particle beam systems for the removal of biofilm
Particle beam (air polishing /air abrasion) units have been marketed for the treatment of the
roots of teeth affected by periodontal disease, because of their ability to disrupt biofilms [59],
while causing little damage to the roots of teeth or the adjacent oral soft tissues [60]. They are
well suited for repeated use at the same site, in contrast to hand instruments which when used
repeatedly on the same tooth can cause significant removal of tooth structure from the root
surface [60, 61].
The principle behind these particle beam devices is that steady flow of compressed air
accelerates abrasive particles, which then impact on the tooth surface and fracture or abrade
away deposits, including biofilms and external stains [62]. Ideally, the powder used should
not damage the target and preferably would also exert some modest antibacterial actions [60].
A number of manufacturers now produce particle beam devices and powders for different
periodontal applications. The tip designs vary according to the mode of clinical application
(supragingival or subgingival tip) since these require different angulations for applying the
particle beam at the appropriate working distance from the surface being cleaned. The powders
available vary in particle size, shape, composition, and density [62], and include sodium
bicarbonate, calcium carbonate, bioactive glass, pumice, and glycine [61]. The choice of powder
type and the application method used both influence the effectiveness of biofilm removal and
the potential for tissue harm [60]. Logically one would want to avoid powders which are harder
than grade 4 or 5 titanium, as these could damage the surface and roughen it even more,
enhancing the problems caused by the attachment and growth of bacteria [63]. This is exactly
the same issue as discussed earlier for stainless steel instruments such as ultrasonic scalers and
hand scalers, which will damage titanium implant surfaces [64].
The first study of implant surface debridement using a particle beam approach was under‐
taken by Barnes et al. [65], who used four different implant systems and exposed samples on
the bench to particle beams for 0.5 s up to 10 s. Using scanning electron microscopy (SEM), no
major differences between the surfaces were found. Since that time, numerous studies have
examined the effects of particle beams on implant surfaces. Most in vitro studies and narra‐
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scalers are shown in Figure 3 (panels E–H), which also show residual bacteria and biofilm
matrix which persist on the surface despite intense professional cleaning. No conventional
cleaning method will remove all traces of biofilm from microscopically rough titanium
surfaces, and the careless application of stainless steel instruments will damage the surface
and encourage further biofilm growth.
Some implant designs use a smooth collar near the attachment point for the overlying crown,
which is designed to be easier to clean by toothbrushing. Hand and ultrasonic scalers can
readily damage this smooth surface, with the resultant scratches promoting the growth of
biofilms in the supragingival areas. As this matures, it can track down the protected areas of
the grooves and scratches created by dental instruments to penetrate into the subgingival
environment, where it can then become established on the threads, leading to peri-implanti‐
tis. For this reason, plastic curettes and rubber polishing cups are recommended for the
removal of plaque from smooth implant collars, rather than metal instruments of any type [40,
42, 45].
Within the group of conventional instruments, particle beam or air-powder abrasive meth‐
ods have been shown to provide the most effective cleaning option to date [46]. The range of
available particles for such devices includes aluminum oxide, calcium carbonate, sodium
bicarbonate, and glycine. Several manufacturers have fabricated tip designed to apply the
particle beam into subgingival implant surfaces; however, the pattern of the threads causes
many regions on the surface to be protected. It must be recognized that air-powder abrasion
causes undesirable microscopic alterations of titanium implant surfaces, and so are not ideal
[47].
6.1. Cavitation-based approaches
Ultrasonic scalers have been used in dental practice for the removal of dental biofilms on the
root surfaces of teeth [48, 49]. Modern ultrasonic scalers fall into two main categories:
piezoelectric and magneto-strictive devices. A part of their cleaning action is through
vibrational energy, which shatters any calcified hard deposits. Only the tip of the ultrasonic is
considered active; thereby, effective debridement is limited by how much contact the tip has
with the surface area of the tooth [48]. Traditional ultrasonic inserts are made from stainless
steel, and these damage implant surfaces through a mechanical vibrating contact action.
Typical patterns of surface damage are shown in Figure 3.
Ultrasonic scalers also create cavitation, with the resultant shock waves from explosions and
implosions disrupting bacterial cell walls. The accompanying stream of irrigant water both
cools the tip and introduces air and thereby oxygen to the area. The movement of fluid can
help remove endotoxins [49]. A number of manufacturers have released the so-called
“implant safe” ultrasonic tip inserts for use in both implant maintenance and for the treat‐
ment of peri-implantitis. These tips are usually made of carbon fiber, titanium, Teflon®,
graphite, or plastic. A number of studies have demonstrated that ultrasonic tips designed for
implant maintenance do not cause significant damage at the macroscopic level [50–52].
Paradoxically, some investigators have proposed the use of instruments that deliberately
flatten the microscopically rough implant surface to reduce its roughness and thereby area
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root surfaces of teeth [48, 49]. Modern ultrasonic scalers fall into two main categories:
piezoelectric and magneto-strictive devices. A part of their cleaning action is through
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help remove endotoxins [49]. A number of manufacturers have released the so-called
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dioxide laser when used for disinfection gave faster initial healing than conventional meth‐
ods. Nevertheless, the long-term outcomes were not significantly different, particularly when
bone levels were compared after 4 years. The authors of this study also pointed out that the
shape of the defect could have prevented the perpendicular delivery of laser energy and that
optimal therapy with this laser when used for disinfection would require changes to the
delivery system of the laser to make laterally emitting or side firing. They also noted that
bleeding from the surgical site during the procedure would have reduced the amount of laser
energy reaching the implant surface, and this attenuation by water absorption may have put
the actual levels of energy reaching the implant surface well below those required for
sterilization.
As well as the Er:YAG and carbon dioxide lasers already mentioned, other lasers have been
found to be of benefit in the treatment of peri-implantitis. Bach et al. [89] found that near
infrared diode laser irradiation reduced the rate of recurrence of peri-implantitis to only 7%,
most likely because of the disinfecting action of this laser. Likewise, several wavelengths of
laser light have been shown to impede the progression of bone resorption in peri-implantitis
treatment regimens [77–80].
6.4. Guided Er: YAG and Er,Cr:YSGG lasers for implant surface decontamination
Sterilization and cleaning of implant surfaces by infrared lasers has been demonstrated in
several reports [39, 70, 81], and surface decontamination has been reported for both CO2 and
Er:YAG lasers. Bone has been found to reattach to implants after infrared laser irradiation in
a peri-implantitis models in dogs, suggesting that laser treatment leaves a biocompatible
surface [78].
A key issue is that while laser irradiation can rapidly reduce the bacterial load on an implant
surface, it may not be able to render the surface sterile in all circumstances, depending on the
geometry of how the laser light interacts with the biofilm on the implant surface. The ability
of laser irradiation to reduce bacterial viability is influenced by the implant surface rough‐
ness. Kreisler et al. [74] found greater bacterial killing for laser energy delivered at right angles
to the surface for microbial deposits on smooth surfaces, and lower effectiveness for those on
rough surfaces. They also showed that intensity (power density) strongly influences the
disinfecting action.
In order to optimize the effect of laser energy, it is important to achieve a side-firing effect so
that laser light applied using a fiber which is parallel to the long axis of the implant is directed
onto the implant surface at an optimal angle. Simplistically, one could consider this angle 90
° to the surface; however, the presence of micro- or nano- roughness on surfaces means that a
spread of angles should be even more effective. Depending on the light wavelengths used,
such the optical fibers used to deliver energy to the side of a dental implant may be plain glass,
glass which has been modified with fluoride, germanium, or other dopants to enhance infrared
light transmission, or rare earth element compounds such as germanium or gallium oxides.
The latter are used with middle infrared lasers (Er:YAG and Er,Cr:YSGG).
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tive reviews based on these have concluded that particle beams are a safe treatment for
decontaminating a titanium implant surface without causing major modifications to the
surface [46, 52, 66]. The extent of surface damage is influenced strongly by the choice of abrasive
powder [46], with sodium bicarbonate and aluminum oxide (alumina) powders being more
likely to damage the implant surface than glycine [46]. There has been emerging support in
the most recent literature for the use of glycine powder as the particle material of choice, due
to it exerting bacteriostatic actions when used at a 10% concentration [67], having a low risk
of air emphysema [68], and causing less damage to implant surfaces than sodium bicarbonate.
6.3. Laser-based methods
As discussed above, the complete removal of biofilm from titanium implants has proved
elusive to date. Traditional dental instruments used to debride root surfaces have proved
particularly ineffective [69]. Lasers have been suggested as an alternative means of decon‐
taminating dental implants [39, 70], with some studies using Er:YAG lasers showing nearly
complete removal bacteria and debris from titanium surfaces [36, 38]. The logic behind using
lasers relates to the various photothermal bactericidal effects of lasers as well as their ability
to create photomechanical effects such as cavitation when used in a way that generates
cavitation in water [71]. The three-dimensional effects created by the scatter of laser energy,
when combined with the shear forces generated by cavitation from a static laser tip would
seem to be a very promising approach. The scatter of laser energy from a microscopically rough
surface would enhance the extent of photothermal disinfection achieved, so that under certain
conditions laser treatment could render the implant surface not only decontaminated but also
sterile. This stands in marked contrast to the effects of hand or ultrasonic scalers or particle
beam devices, none of which can produce a sterile surface [72]. Likewise, decontamination and
detoxification of a titanium implant surface cannot be achieved with hand curettes alone [36].
In contrast, with a laser, the ability to decontaminate the implant is limited primarily by the
degree of access that the laser energy has to affected implant surfaces. The choice of system
used to deliver laser light then becomes an important consideration, with aspects such as the
physical size and light distribution properties of the sapphire tips, glass, and non-glass optic
fibers, or hollow waveguides used to deliver laser light having an effect [73].
The biocompatibility of a laser-treated surface must also be considered. Guided bone regen‐
eration or bone grafting may be used to treat peri-implant bone loss; however, these surgical
techniques both require a meticulously clean implant surface in order to achieve a good
outcome [74]. Romanos et al. [75] established that cell attachment and morphology after laser
irradiation is equal to that of sterile implant surfaces. Kreisler et al. [47] examined the
biocompatibility of contaminated implant surfaces after treatment with either a particle beam
device or the Er:YAG laser. The lowest cell growth and proliferation was seen for contami‐
nated Ti surfaces, while cell growth was significantly greater on sterile (new), air powder-
treated, and Er:YAG laser-cleaned surfaces.
Infrared lasers can exert powerful photothermal effects which can inactivate or destroy
bacteria. The highly water absorbing far infrared energy from a carbon dioxide laser has
potential application for the destruction of bacteria. Deppe et al. [36] found that the carbon
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dioxide laser when used for disinfection gave faster initial healing than conventional meth‐
ods. Nevertheless, the long-term outcomes were not significantly different, particularly when
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shape of the defect could have prevented the perpendicular delivery of laser energy and that
optimal therapy with this laser when used for disinfection would require changes to the
delivery system of the laser to make laterally emitting or side firing. They also noted that
bleeding from the surgical site during the procedure would have reduced the amount of laser
energy reaching the implant surface, and this attenuation by water absorption may have put
the actual levels of energy reaching the implant surface well below those required for
sterilization.
As well as the Er:YAG and carbon dioxide lasers already mentioned, other lasers have been
found to be of benefit in the treatment of peri-implantitis. Bach et al. [89] found that near
infrared diode laser irradiation reduced the rate of recurrence of peri-implantitis to only 7%,
most likely because of the disinfecting action of this laser. Likewise, several wavelengths of
laser light have been shown to impede the progression of bone resorption in peri-implantitis
treatment regimens [77–80].
6.4. Guided Er: YAG and Er,Cr:YSGG lasers for implant surface decontamination
Sterilization and cleaning of implant surfaces by infrared lasers has been demonstrated in
several reports [39, 70, 81], and surface decontamination has been reported for both CO2 and
Er:YAG lasers. Bone has been found to reattach to implants after infrared laser irradiation in
a peri-implantitis models in dogs, suggesting that laser treatment leaves a biocompatible
surface [78].
A key issue is that while laser irradiation can rapidly reduce the bacterial load on an implant
surface, it may not be able to render the surface sterile in all circumstances, depending on the
geometry of how the laser light interacts with the biofilm on the implant surface. The ability
of laser irradiation to reduce bacterial viability is influenced by the implant surface rough‐
ness. Kreisler et al. [74] found greater bacterial killing for laser energy delivered at right angles
to the surface for microbial deposits on smooth surfaces, and lower effectiveness for those on
rough surfaces. They also showed that intensity (power density) strongly influences the
disinfecting action.
In order to optimize the effect of laser energy, it is important to achieve a side-firing effect so
that laser light applied using a fiber which is parallel to the long axis of the implant is directed
onto the implant surface at an optimal angle. Simplistically, one could consider this angle 90
° to the surface; however, the presence of micro- or nano- roughness on surfaces means that a
spread of angles should be even more effective. Depending on the light wavelengths used,
such the optical fibers used to deliver energy to the side of a dental implant may be plain glass,
glass which has been modified with fluoride, germanium, or other dopants to enhance infrared
light transmission, or rare earth element compounds such as germanium or gallium oxides.
The latter are used with middle infrared lasers (Er:YAG and Er,Cr:YSGG).
Novel Models to Manage Biofilms on Microtextured Dental Implant Surfaces
http://dx.doi.org/10.5772/62803
473
tive reviews based on these have concluded that particle beams are a safe treatment for
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powder [46], with sodium bicarbonate and aluminum oxide (alumina) powders being more
likely to damage the implant surface than glycine [46]. There has been emerging support in
the most recent literature for the use of glycine powder as the particle material of choice, due
to it exerting bacteriostatic actions when used at a 10% concentration [67], having a low risk
of air emphysema [68], and causing less damage to implant surfaces than sodium bicarbonate.
6.3. Laser-based methods
As discussed above, the complete removal of biofilm from titanium implants has proved
elusive to date. Traditional dental instruments used to debride root surfaces have proved
particularly ineffective [69]. Lasers have been suggested as an alternative means of decon‐
taminating dental implants [39, 70], with some studies using Er:YAG lasers showing nearly
complete removal bacteria and debris from titanium surfaces [36, 38]. The logic behind using
lasers relates to the various photothermal bactericidal effects of lasers as well as their ability
to create photomechanical effects such as cavitation when used in a way that generates
cavitation in water [71]. The three-dimensional effects created by the scatter of laser energy,
when combined with the shear forces generated by cavitation from a static laser tip would
seem to be a very promising approach. The scatter of laser energy from a microscopically rough
surface would enhance the extent of photothermal disinfection achieved, so that under certain
conditions laser treatment could render the implant surface not only decontaminated but also
sterile. This stands in marked contrast to the effects of hand or ultrasonic scalers or particle
beam devices, none of which can produce a sterile surface [72]. Likewise, decontamination and
detoxification of a titanium implant surface cannot be achieved with hand curettes alone [36].
In contrast, with a laser, the ability to decontaminate the implant is limited primarily by the
degree of access that the laser energy has to affected implant surfaces. The choice of system
used to deliver laser light then becomes an important consideration, with aspects such as the
physical size and light distribution properties of the sapphire tips, glass, and non-glass optic
fibers, or hollow waveguides used to deliver laser light having an effect [73].
The biocompatibility of a laser-treated surface must also be considered. Guided bone regen‐
eration or bone grafting may be used to treat peri-implant bone loss; however, these surgical
techniques both require a meticulously clean implant surface in order to achieve a good
outcome [74]. Romanos et al. [75] established that cell attachment and morphology after laser
irradiation is equal to that of sterile implant surfaces. Kreisler et al. [47] examined the
biocompatibility of contaminated implant surfaces after treatment with either a particle beam
device or the Er:YAG laser. The lowest cell growth and proliferation was seen for contami‐
nated Ti surfaces, while cell growth was significantly greater on sterile (new), air powder-
treated, and Er:YAG laser-cleaned surfaces.
Infrared lasers can exert powerful photothermal effects which can inactivate or destroy
bacteria. The highly water absorbing far infrared energy from a carbon dioxide laser has
potential application for the destruction of bacteria. Deppe et al. [36] found that the carbon
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clinical use, the temperature elevation which occurs in the peri-implant bone as a result of laser
irradiation should be <10° C, since bone temperatures of 47° C or above may result in bone
necrosis [83]. Using fibers and tips, which emit laser energy in a side-firing manner, lowers
the total irradiance of the bone, while still achieving even irradiation along the length of the
exposed threads fiber. Low average powers will also preserve the morphological and chemical
characteristics, which provide titanium with its excellent biocompatibility.
In summary, the concept of using lasers to treat implant surfaces holds considerable prom‐
ise, yet certain technical issues remain to be addressed, including controlling the laser effect
(for example, through fluorescence feedback), achieving the correct geometry for delivery of
laser energy (such as using side-firing fiber tips), and controlling undesirable thermal effects
on the titanium surface and on the adjacent supporting bone [73–75]. The laser-treated surfaces
have high biocompatibility, and this is reflected in the clinical studies that have been under‐
taken to date and produced promising results [89–95].
Figure 4. (A) Laser debridement. Biofilm growing on micro-rough abraded titanium surface from a saliva inoculum
after 4 days, prior to laser treatment. The scale bar represents 2 microns. Individual bacteria are embedded into a dense
matrix. (B) The surface after application of 120 mJ Er:YAG laser pulses with a fine mist water spray. The original
abraded surface can now be seen (1), as well as a large central area where the titanium surface has been melted by laser
pulses (2), and regions with remaining biofilm which have not yet been treated (3).
7. Laboratory models for assessing biofilm removal from implant surfaces
One of the most informative ways to assess how well a particular method can clean biofilm
from an implant surface is to use a physical material which replicates the adhesive nature of
biofilm, covers the surface at the microscopic level, and requires a similar process for its
removal. The model which fulfils these three requirements involves the application of
permanent marker ink of a certain type. The ink model was first described by Sahrmann et
al. [96] . In our laboratory, when the same model is used, an abutment is attached to each
implant so it can be handled without touching the surface, and the implants are dip-coated in
a cyan blue indelible ink (Sharpie Fine Point Permanent Marker, Sanford L.P., Illinois, USA).
This ink forms a uniform, visually detectable biofilm-like layer over the implant surface and
penetrates well to cover fully the regions between the threads. The implants are inspected
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Fibers with plain 90 ° ends (from a right angle cleave of the fiber) emit light with a typical
divergence of 18°–20° . Cone-shaped, periscope, and other specialized applicators have been
developed for the ends of optical fibers, to make them have enhanced side-firing actions [73,
76]. An alternative approach is to modify the end of the fiber itself, through various physical
processes such as acid etching and particle abrasion [73]. Using such methods, it is possible to
create radial-firing tips with cone-shaped ends to provide a broader pattern of light collec‐
tion and emission than a right angle cleaved end. The most interesting modifications to the
surfaces of glass and ceramic optical fibers involve the combination of various processes
including tube etching, particle abrasion, and further etching, which creates unique surface
architectures known as the “honeycomb” surface, to increase transmission and collection of
visible red and infrared light [73, 76]. Various modifications of the parameters used for this
technique are required for doped glass fibers (e.g., a longer primary etch stage for fluoride-
doped glass), or for fibers containing germanium.
The applications of such honeycomb surfaces include broad lateral dispersion of visible red
light as well as near and middle infrared light, for photodynamic and photothermal disinfec‐
tion of subgingival areas and confined spaces, including biofilms present inside the root canals
of teeth. This type of optical fiber technology also reduces thermal stress in adjacent hard and
soft tissues [77]. It can also be used for fluorescence detection of biofilms on complex surfa‐
ces, including those which are only several cell layers thick, and of free-floating planktonic
bacteria [78–81]. There is potential application for the automated detection and removal of
biofilms from implant surfaces [82–84]. The value of laser fluorescence systems for detecting
subgingival deposits on the roots of teeth is well established, even for those which have become
calcified to become subgingival dental calculus [85]. The debriding action to remove bio‐
films then comes from the ability of the laser to generate cavitation in a water irrigant or water-
based fluid. Various optical fiber modifications can enhance dramatically fluid agitation for
cleaning complex surfaces and spaces, which are difficult to access [86, 87].
6.5. Laser-induced damage to implant surfaces
An important issue to consider with lasers is whether irradiation causes adverse changes to
the implant surface [70]. One would expect that higher peak powers would cause greater
alterations, and this has been shown for CO2 lasers, which can cause undesirable implant
surface alterations when used in the super-pulsed mode (when there are very high peak
powers), but less damage occurs when the same laser is used in continuous wave mode [82].
Likewise, the Er:YAG laser, which normally operates in free running pulsed mode, can cause
damage to titanium surfaces when used at very high peak power settings [45, 88]. Such areas
have a melted volcanic appearance, which contrasts with the adjacent surface (Figure 4). For
this reason, laser parameters such as peak power must be kept below the point where melting
or surface ablation of titanium occurs, and water flow rates must be sufficient to minimize
effects of plasma formation.
A further issue when using a powerful laser is the possibility of adverse thermal effects on
bone. If the laser energy is absorbed strongly into titanium, not only can the surface be
damaged, but the heat generated can be transferred to the adjacent bone [70, 71]. For safe
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clinical use, the temperature elevation which occurs in the peri-implant bone as a result of laser
irradiation should be <10° C, since bone temperatures of 47° C or above may result in bone
necrosis [83]. Using fibers and tips, which emit laser energy in a side-firing manner, lowers
the total irradiance of the bone, while still achieving even irradiation along the length of the
exposed threads fiber. Low average powers will also preserve the morphological and chemical
characteristics, which provide titanium with its excellent biocompatibility.
In summary, the concept of using lasers to treat implant surfaces holds considerable prom‐
ise, yet certain technical issues remain to be addressed, including controlling the laser effect
(for example, through fluorescence feedback), achieving the correct geometry for delivery of
laser energy (such as using side-firing fiber tips), and controlling undesirable thermal effects
on the titanium surface and on the adjacent supporting bone [73–75]. The laser-treated surfaces
have high biocompatibility, and this is reflected in the clinical studies that have been under‐
taken to date and produced promising results [89–95].
Figure 4. (A) Laser debridement. Biofilm growing on micro-rough abraded titanium surface from a saliva inoculum
after 4 days, prior to laser treatment. The scale bar represents 2 microns. Individual bacteria are embedded into a dense
matrix. (B) The surface after application of 120 mJ Er:YAG laser pulses with a fine mist water spray. The original
abraded surface can now be seen (1), as well as a large central area where the titanium surface has been melted by laser
pulses (2), and regions with remaining biofilm which have not yet been treated (3).
7. Laboratory models for assessing biofilm removal from implant surfaces
One of the most informative ways to assess how well a particular method can clean biofilm
from an implant surface is to use a physical material which replicates the adhesive nature of
biofilm, covers the surface at the microscopic level, and requires a similar process for its
removal. The model which fulfils these three requirements involves the application of
permanent marker ink of a certain type. The ink model was first described by Sahrmann et
al. [96] . In our laboratory, when the same model is used, an abutment is attached to each
implant so it can be handled without touching the surface, and the implants are dip-coated in
a cyan blue indelible ink (Sharpie Fine Point Permanent Marker, Sanford L.P., Illinois, USA).
This ink forms a uniform, visually detectable biofilm-like layer over the implant surface and
penetrates well to cover fully the regions between the threads. The implants are inspected
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Fibers with plain 90 ° ends (from a right angle cleave of the fiber) emit light with a typical
divergence of 18°–20° . Cone-shaped, periscope, and other specialized applicators have been
developed for the ends of optical fibers, to make them have enhanced side-firing actions [73,
76]. An alternative approach is to modify the end of the fiber itself, through various physical
processes such as acid etching and particle abrasion [73]. Using such methods, it is possible to
create radial-firing tips with cone-shaped ends to provide a broader pattern of light collec‐
tion and emission than a right angle cleaved end. The most interesting modifications to the
surfaces of glass and ceramic optical fibers involve the combination of various processes
including tube etching, particle abrasion, and further etching, which creates unique surface
architectures known as the “honeycomb” surface, to increase transmission and collection of
visible red and infrared light [73, 76]. Various modifications of the parameters used for this
technique are required for doped glass fibers (e.g., a longer primary etch stage for fluoride-
doped glass), or for fibers containing germanium.
The applications of such honeycomb surfaces include broad lateral dispersion of visible red
light as well as near and middle infrared light, for photodynamic and photothermal disinfec‐
tion of subgingival areas and confined spaces, including biofilms present inside the root canals
of teeth. This type of optical fiber technology also reduces thermal stress in adjacent hard and
soft tissues [77]. It can also be used for fluorescence detection of biofilms on complex surfa‐
ces, including those which are only several cell layers thick, and of free-floating planktonic
bacteria [78–81]. There is potential application for the automated detection and removal of
biofilms from implant surfaces [82–84]. The value of laser fluorescence systems for detecting
subgingival deposits on the roots of teeth is well established, even for those which have become
calcified to become subgingival dental calculus [85]. The debriding action to remove bio‐
films then comes from the ability of the laser to generate cavitation in a water irrigant or water-
based fluid. Various optical fiber modifications can enhance dramatically fluid agitation for
cleaning complex surfaces and spaces, which are difficult to access [86, 87].
6.5. Laser-induced damage to implant surfaces
An important issue to consider with lasers is whether irradiation causes adverse changes to
the implant surface [70]. One would expect that higher peak powers would cause greater
alterations, and this has been shown for CO2 lasers, which can cause undesirable implant
surface alterations when used in the super-pulsed mode (when there are very high peak
powers), but less damage occurs when the same laser is used in continuous wave mode [82].
Likewise, the Er:YAG laser, which normally operates in free running pulsed mode, can cause
damage to titanium surfaces when used at very high peak power settings [45, 88]. Such areas
have a melted volcanic appearance, which contrasts with the adjacent surface (Figure 4). For
this reason, laser parameters such as peak power must be kept below the point where melting
or surface ablation of titanium occurs, and water flow rates must be sufficient to minimize
effects of plasma formation.
A further issue when using a powerful laser is the possibility of adverse thermal effects on
bone. If the laser energy is absorbed strongly into titanium, not only can the surface be
damaged, but the heat generated can be transferred to the adjacent bone [70, 71]. For safe
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is then kept under anaerobic conditions (0% O2, 20% CO2, and 80% N2) at 37°C. This medi‐
um is rich in protein and hemoglobin in order to encourage the growth of facultative and
obligate anaerobes. The saliva is collected from healthy adult subjects who have refrained from
toothbrushing and other oral hygiene practices for 12 h prior to the collection of stimulated
saliva, collected whilst chewing on sterile paraffin wax for 5 min. The incubation times of 72–
96 h which we have used in these studies are the same as those used by Sánchez et al. [100] in
their studies of the growth of pure species using the same BHI growth medium . Their work
showed that by 12 h the early colonizers had adhered, the intermediate colonizers appeared
at 24 h, the late colonizers were found after 48 h, and the biofilm reached a steady state
between 72 and 92 h after initiation. Therefore, this model using BHI supports the develop‐
ment of a biofilm that is similar in composition and structure to a subgingival biofilm in vivo.
A key aspect of the process of biofilm formation is the deposition of a glycoprotein pellicle
layer by the adsorption of salivary glycoproteins onto the pristine titanium surface before it is
placed into the broth. Surfaces of titanium discs are abraded with alumina particle beams and
then steam sterilized before being placed into the collected saliva for 5 min, to allow a pellicle
layer to form. The same process is undertaken for titanium implants. The discs or implants are
then placed into the BHI broth and incubated under anaerobic conditions. The resulting
biofilms on the discs and implants can then be treated with various methods, and the extent
of remaining biofilm assessed using vital staining with confocal microscopy, or scanning
electron microscopy. For the latter, an appropriate fixation regimen involves 24 h in 10%
neutral buffered formalin solution, followed by rinsing in 0.1 M cacodylate buffer solution
for 30 min, and then post-fixing in osmium tetroxide for 1 h. The fixed samples can then be
dehydrated with graded ethanol solutions (50–100%), dried, and placed onto aluminum stubs
using conductive carbon tabs, and sputter coated with a 10- nm-gold layer, prior to being
viewed using secondary electron emission or backscatter modes under high vacuum condi‐
tions.
7.2. In situ models
We have also developed an in situ model of biofilm formation on implants, using a special‐
ized removable oral appliance [101]. The rationale behind this work is that past studies of
implant biofilms have been laboratory based and have used only single species biofilms of oral
bacteria. They have little or no direct relevance to clinical patient care. It was desirable to have
a reproducible in situ model with naturally formed complex biofilms of mixed species, which
should form under low oxygen conditions in an environment which is partially protected from
the washing action of saliva, but able to access nutrients from the saliva. There should be
contact with normal host protective mechanisms such as the gingival crevicular fluid pro‐
duced around the gingivae. To meet these objectives, a removable appliance was designed
which uses a removable dental bleaching tray as its base. This appliance carries an implant on
its side, which is located within a tube and held against the oral soft tissues beside the gingival
crevice (Figure 6). Using this model, we have generated realistic biofilms on dental implants
in 48 h and then used these to test the effectiveness of various debridement methods. Other
groups have likewise developed methods for developing dental plaque on implants using in
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under a light microscope to confirm an even distribution of ink over the implant surface. Each
implant is subsequently mounted in an acrylic resin block (Sawbones, Pacific Research
Laboratories, Washington USA) prepared with a 6- mm-deep, circumscribed saucer-shaped
defect at 60° to simulate the bony defects found in sites of peri-implantitis environment.
Implants are fixed into the Sawbones by screwing them in with two revolutions, to the desired
position, typically so the third thread of the implant is level with the base of the intra-bony
defect. After applying particular treatments, ink removal is then assessed by analysis of the
area of ink remaining [96, 97]. We have developed a special system to photograph the ink
distribution across the surface, which involves digitally stitching images from macro-
photography so that the sharply in focus regions are combined into one image which shows
the entire surface. This is suitable for quantitative analyses of the area of ink removed
(Figure 5). At the microscopic level, the ink be identified using SEM in backscatter mode as its
low atomic number signal appears dark which contrasts well with the higher atomic num‐
ber signal from the underlying titanium.
Figure 5. Ink model of biofilm removal from implant surfaces using blue ink placed onto 10- mm-long 4 mm-diameter
Southern implants (ITC 410) fixed into Sawbone with peri-implant defects. Zone 1 represents the implant upper collar,
and Zone 2 represents the area, where the ink has been removed and the underlying grey implant surface can be seen,
and Zone 3 is the ink, which has remained in the deeper regions of the defect. Three different treatments have been
applied in an attempt to clean the surface. (A) Ultrasonic scaler for 15 s. (B) Ultrasonic scaler for 120 s. (C) Particle
beam device with glycine powder for 30 s. Note the persistence of dye on the areas which are shadowed by the
threads, while the adjacent easily accessible areas have little dye. No treatment has reached to the base of the defect.
7.1. Mixed biofilm models
Biofilms which grow on implant surfaces contain multiple species, which are derived from the
approximately 700 species of bacteria which are found in the saliva. These bacteria form a
complex multispecies microorganism community in the biofilm, along with fungi such as
Candida albicans. Using single species models in the laboratory cannot replicate the complexi‐
ty or the biofilms which form in the clinical situation. Some laboratory studies have devel‐
oped a mature anaerobic biofilms from multiple strains of known primary, secondary, and
tertiary colonizers enriched in a high protein broth [98–100]; however, a major limitation in
such studies is that the biofilms have been grown on flat hydroxyapatite (HAP) discs.
To ensure that a biofilm is established with features more like those found in vivo, we have
developed complex multispecies biofilms on titanium disks with surface micro-roughness,
and on dental implants under laboratory conditions (Figures 3 B, C, and 4A). For this purpose,
we have used human stimulated saliva to inoculate a broth of brain heart infusion (BHI)
medium enriched with 5% defibrinated sheep or horse blood and 1 mg/mL menadione, which
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is then kept under anaerobic conditions (0% O2, 20% CO2, and 80% N2) at 37°C. This medi‐
um is rich in protein and hemoglobin in order to encourage the growth of facultative and
obligate anaerobes. The saliva is collected from healthy adult subjects who have refrained from
toothbrushing and other oral hygiene practices for 12 h prior to the collection of stimulated
saliva, collected whilst chewing on sterile paraffin wax for 5 min. The incubation times of 72–
96 h which we have used in these studies are the same as those used by Sánchez et al. [100] in
their studies of the growth of pure species using the same BHI growth medium . Their work
showed that by 12 h the early colonizers had adhered, the intermediate colonizers appeared
at 24 h, the late colonizers were found after 48 h, and the biofilm reached a steady state
between 72 and 92 h after initiation. Therefore, this model using BHI supports the develop‐
ment of a biofilm that is similar in composition and structure to a subgingival biofilm in vivo.
A key aspect of the process of biofilm formation is the deposition of a glycoprotein pellicle
layer by the adsorption of salivary glycoproteins onto the pristine titanium surface before it is
placed into the broth. Surfaces of titanium discs are abraded with alumina particle beams and
then steam sterilized before being placed into the collected saliva for 5 min, to allow a pellicle
layer to form. The same process is undertaken for titanium implants. The discs or implants are
then placed into the BHI broth and incubated under anaerobic conditions. The resulting
biofilms on the discs and implants can then be treated with various methods, and the extent
of remaining biofilm assessed using vital staining with confocal microscopy, or scanning
electron microscopy. For the latter, an appropriate fixation regimen involves 24 h in 10%
neutral buffered formalin solution, followed by rinsing in 0.1 M cacodylate buffer solution
for 30 min, and then post-fixing in osmium tetroxide for 1 h. The fixed samples can then be
dehydrated with graded ethanol solutions (50–100%), dried, and placed onto aluminum stubs
using conductive carbon tabs, and sputter coated with a 10- nm-gold layer, prior to being
viewed using secondary electron emission or backscatter modes under high vacuum condi‐
tions.
7.2. In situ models
We have also developed an in situ model of biofilm formation on implants, using a special‐
ized removable oral appliance [101]. The rationale behind this work is that past studies of
implant biofilms have been laboratory based and have used only single species biofilms of oral
bacteria. They have little or no direct relevance to clinical patient care. It was desirable to have
a reproducible in situ model with naturally formed complex biofilms of mixed species, which
should form under low oxygen conditions in an environment which is partially protected from
the washing action of saliva, but able to access nutrients from the saliva. There should be
contact with normal host protective mechanisms such as the gingival crevicular fluid pro‐
duced around the gingivae. To meet these objectives, a removable appliance was designed
which uses a removable dental bleaching tray as its base. This appliance carries an implant on
its side, which is located within a tube and held against the oral soft tissues beside the gingival
crevice (Figure 6). Using this model, we have generated realistic biofilms on dental implants
in 48 h and then used these to test the effectiveness of various debridement methods. Other
groups have likewise developed methods for developing dental plaque on implants using in
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under a light microscope to confirm an even distribution of ink over the implant surface. Each
implant is subsequently mounted in an acrylic resin block (Sawbones, Pacific Research
Laboratories, Washington USA) prepared with a 6- mm-deep, circumscribed saucer-shaped
defect at 60° to simulate the bony defects found in sites of peri-implantitis environment.
Implants are fixed into the Sawbones by screwing them in with two revolutions, to the desired
position, typically so the third thread of the implant is level with the base of the intra-bony
defect. After applying particular treatments, ink removal is then assessed by analysis of the
area of ink remaining [96, 97]. We have developed a special system to photograph the ink
distribution across the surface, which involves digitally stitching images from macro-
photography so that the sharply in focus regions are combined into one image which shows
the entire surface. This is suitable for quantitative analyses of the area of ink removed
(Figure 5). At the microscopic level, the ink be identified using SEM in backscatter mode as its
low atomic number signal appears dark which contrasts well with the higher atomic num‐
ber signal from the underlying titanium.
Figure 5. Ink model of biofilm removal from implant surfaces using blue ink placed onto 10- mm-long 4 mm-diameter
Southern implants (ITC 410) fixed into Sawbone with peri-implant defects. Zone 1 represents the implant upper collar,
and Zone 2 represents the area, where the ink has been removed and the underlying grey implant surface can be seen,
and Zone 3 is the ink, which has remained in the deeper regions of the defect. Three different treatments have been
applied in an attempt to clean the surface. (A) Ultrasonic scaler for 15 s. (B) Ultrasonic scaler for 120 s. (C) Particle
beam device with glycine powder for 30 s. Note the persistence of dye on the areas which are shadowed by the
threads, while the adjacent easily accessible areas have little dye. No treatment has reached to the base of the defect.
7.1. Mixed biofilm models
Biofilms which grow on implant surfaces contain multiple species, which are derived from the
approximately 700 species of bacteria which are found in the saliva. These bacteria form a
complex multispecies microorganism community in the biofilm, along with fungi such as
Candida albicans. Using single species models in the laboratory cannot replicate the complexi‐
ty or the biofilms which form in the clinical situation. Some laboratory studies have devel‐
oped a mature anaerobic biofilms from multiple strains of known primary, secondary, and
tertiary colonizers enriched in a high protein broth [98–100]; however, a major limitation in
such studies is that the biofilms have been grown on flat hydroxyapatite (HAP) discs.
To ensure that a biofilm is established with features more like those found in vivo, we have
developed complex multispecies biofilms on titanium disks with surface micro-roughness,
and on dental implants under laboratory conditions (Figures 3 B, C, and 4A). For this purpose,
we have used human stimulated saliva to inoculate a broth of brain heart infusion (BHI)
medium enriched with 5% defibrinated sheep or horse blood and 1 mg/mL menadione, which
Microbial Biofilms - Importance and Applications476
References
[1] Adell R, Eriksson B, Lekholm U, Branemark PI, Jemt T. Long-term follow-up study of
osseointegrated implants in the treatment of totally edentulous jaws. Int J Oral
Maxillofac Implants 1990;5:347–59.
[2] Amoroso PF, Adams RJ, Waters MG, Williams DW. Titanium surface modification and
its effect on the adherence of Porphyromonas gingivalis: an in vitro study. Clin Oral
Implants Res 2006;17:633–7.
[3] Albrektsson T, Wennerberg A. Oral implant surfaces: Part 1. Review focusing on
topographic and chemical properties of different surfaces and in vivo responses to
them. Int J Prosthodont 2004;17:536–43.
[4] Le Guehennec L, Soueidan A, Layrolle P, Amouriq Y. Surface treatments of titanium
dental implants for rapid osseointegration. Dent Mater 2007;23(7):844–54.
[5] Bollen CM, Papaioanno W, Van Eldere J, et al. The influence of abutment surface
roughness on plaque accumulation and peri-implant mucositis. Clin Oral Implants
Res 1996;7:201–11.
[6] Drake DR, Paul J, Keller JC. Primary bacterial colonization of implant surfaces. Int J
Oral Maxillofac Implants 1999;14:226–32.
[7] Zitzmann N, Berglundh T, Marinello C, Lindhe J. Experimental peri‐implant mucosi‐
tis in man. J Clin Periodontol 2001;28:517–23.
[8] Renvert S, Samuelsson E, Lindahl C, Persson GR. Mechanical non-surgical treatment
of peri-implantitis: a double-blind randomized longitudinal clinical study. I: clinical
results. J Clin Periodontol 2009;36:604–9.
[9] Mombelli A, Lang NP. The diagnosis and treatment of peri-implantitis. Periodontol
2000 1998;17:63–76.
[10] Lang NP, Berglundh T. Periimplant diseases: where are we now? Consensus of the
seventh European workshop on periodontology. J Clin Periodontol 2011;38 (Suppl 11):
178–81.
[11] Lindhe J, Meyle J, Group DoEWoP. Peri-implant diseases: consensus report of the sixth
European workshop on periodontology. J Clin Periodontol 2008;35 (Suppl 8):282–5.
[12] Sanz M, Chapple IL. On behalf of Working Group 4 of the VEWoP. Clinical research
on peri-implant diseases: consensus report of Working Group 4. J Clin Periodontol
2012;39:202–06.
[13] Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current
epidemiology. J Clin Periodontol 2015;42:S158–71.
Novel Models to Manage Biofilms on Microtextured Dental Implant Surfaces
http://dx.doi.org/10.5772/62803
479
situ appliances [102–104], and this will likely be a productive approach for future studies. A
particular advantage of our own system is that it can use both a flat titanium disc and an actual
commercial titanium implant, whereas other models use flat titanium discs. While flat surfaces
are easier to both clean and analyze, they lack features such as threads which make them hard
to clean.
Figure 6. Removable dental appliance for the development of biofilms on dental implants. (A , B) The appliance design
showing the flat titanium disc (1) and the titanium dental implant (2) mounted into a vacuum-formed removable ap‐
pliance. (C–E) Low, medium, and high power SEM views of a 48 h biofilm on the implant in the in situ model. Scale
bars in panels (D) and (E) are 100 and 10 microns, respectively. (F) Vital staining of biofilm grown on a flat titanium
surface, using confocal microscopy.
8. Conclusions
The complex surface properties of titanium dental implants which give them excellent
biocompatibility also facilitate the attachment of bacteria and the development of biofilms.
The macroscale and microscale topographies of threaded implants make these difficult to
clean with conventional dental instruments. Technologies such as particle beams and pulsed
lasers appear promising in terms of better biofilm removal from surfaces. The develop‐
ment of various clinical and laboratory models for dental implant biofilms allows the
systematic comparison of different approaches to biofilm removal.
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Abstract
Biofilm infections represent a new medical challenge that drives towards the discovery
of new diagnostics and new drugs specifically designed for this purpose. All living
organisms offer a huge source of compounds which represent the biochemical sub‐
strate of the biological competition on the Earth and can be used to this aim. We describe
an innovative diagnostic tool to early diagnose medical device infections sustained by
Staphylococci; then we list new compounds that modulate bacterial phenotype and reduce
virulence without affecting bacterial viability so as to avoid the emergence of genetic
resistances. These compounds are all derived from natural sources: prokaryotes, plants,
and human body. From prokaryotes we studied new compounds extracted from different
environmental  bacterial  species,  including  Antarctic  species  growing  in  extreme
environments. We describe also the anti-biofilm properties of extracts obtained from
plants well known since centuries in folk medicine. The humoral immune response is the
source of the last anti-biofilm compound: transferrin (Tf), a protein derived from human
plasma involved in inflammation and natural immunity. All these compounds can be
used as scaffolds for the design of new drugs active on the sessile form of pathogens
prevalent in human biofilm infections.
Keywords: human, diseases, infection, therapy, diagnosis
1. Introduction
Since 1929, the discovery of penicillin radically changed the history of human infection diseases,
opening the path to the discovery of a wide array of new antibacterial compounds. After a few
decades, the appearance of genotypic resistances undermined the dream of definitive human
victory on infectious diseases. In the 1970s, some unexplainable cases of drug resistance sustained
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
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(LO-SVGI). Antibodies (IgG and IgM) against staphylococcal slime polysaccharide antigens
(SSPA) were titrated in sera collected from 38 patients with active LO-SVGIs caused by
different staphylococcal species (group A). For control purposes, assays were performed on
sera from 10 patients with active LO-SVGIs caused by bacteria other than staphylococcus
(group B); 16 healthy patients with histories of staphylococcal LO-SVGI that had been
eradicated 6–72 months earlier by means of graft replacement (group C); 17 healthy patients
with synthetic vascular grafts and no evidence of current or past graft infections (group D);
and 58 healthy subjects with no implanted medical devices or prostheses of any type (group
E). Infections were classified as late onset only when first manifestations occurred 2 years or
more after implantation of the vascular graft. All infections (ongoing and past) were micro‐
biologically confirmed based on cultures of the explanted graft. The results of this study are
summarized in Table 1 and Figure 1.
Figure 1. IgM and IgG antibody titres against SSPA. Group A = individuals with staphylococcal LO-SVGI; group B =
individuals with non-staphylococcal LO-SVGI; group C = individuals with previous history of staphylococcal LO-
SVGI, with successful graft replacement; group D = individuals with synthetic vascular graft implanted 14–78 months
before study entry and no previous history of graft infections; group E = individuals free of prosthetic devices.
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by strains prone to conventional antibiotics were attributed to biofilm. At the beginning, sessile
phenotype has been related only to medical devices infections, but as long as knowledge on
biofilm behavior increased, the majority of chronic human infections have been attributed to
sessile phenotype. It has been demonstrated that sessile bacteria resist to antibiotics due to a
variety of causes including, a reduced penetration of drugs in the deep layers of biofilm, a favored
diffusion of resistance genes, a drift of bacterial metabolism towards anaerobiosis causing a
reduced cellular division, and a dramatic reduction of susceptibility to drugs. Efforts have been
devoted to restore sensitivity of sessile bacteria to antibiotics and to identify new compounds
to treat biofilm. In this chapter, we describe our efforts in this field. Since the early 1990s, our
lab dedicated many efforts to identify new diagnostics and new therapeutical strategies to
counteract biofilm infections in humans. We shall first describe a diagnostic tool based on
enzyme-linked immunosorbent  assay (ELISA)  technique to  early  identify  Staphylococcal
colonization of medical devices, then we shall list an array of different compounds active on
bacterial biofilms.
2. An ELISA assays for early diagnosis of biofilm infections
Specimen culturing is the gold standard for diagnosing bacterial infections, but growing
bacteria from a biofilm is not reliable. Other testing modalities, such as polymerase chain
reaction Polymerase chain reaction (PCR) and serology assays are nonspecific for biofilm
infections and include the risk of contamination during sampling. In recent years, many
attempts have been performed to create new for early, noninvasive diagnosis. A main feature
of infections on implanted medical devices is the absence or paucity of local signs and general
symptoms of infection/inflammation. The first signs are due to dysfunction of the device itself
(loosening of orthopedic prostheses, cardiac valve regurgitation) and device-related damage
to the surrounding tissues. Prompt detection of biofilm infection in the initial asymptomatic
phases can allow earlier medical/surgical treatment. Highly virulent organisms (e.g.,
Staphylococcus aureus and gram-negative bacilli) induce early appearance of symptoms. Less
virulent bacteria (e.g., coagulase-negative staphylococci) usually induce low-grade, indolent
infections that remain clinically silent for years. Laboratory tests suggesting inflammation and
possible infection by a bacterial pathogen (i.e., C-reactive protein, Complete blood counts,
erythrocyte sedimentation rate) do not demonstrate the presence of bacteria and can mis‐
lead. An interesting alternative is based on the use of immunodiagnostics detecting antibod‐
ies directed against antigens that are specific for the sessile form of bacterial species, especially
those that are traditionally considered saprophytes. Since staphylococci are highly prevalent
in biofilm infections on medical devices, we developed a simple and reliable immunodiag‐
nostic assay devoted to the diagnosis of staphylococcal biofilm infections [1] based on enzyme-
linked immunosorbent assay (ELISA), a simple, rapid, and repeatable technology, that do not
require removal of the implanted device. Our ELISA test allows to detect antigen-bound
immunoglobulins with peroxidase-conjugated antibodies against human immunoglobulin G
(IgG) or immunoglobulin M (IgM), and expresses antibody titers as units of optical density.
The assay was tested in patients with late-onset infections involving synthetic vascular grafts
Microbial Biofilms - Importance and Applications488
(LO-SVGI). Antibodies (IgG and IgM) against staphylococcal slime polysaccharide antigens
(SSPA) were titrated in sera collected from 38 patients with active LO-SVGIs caused by
different staphylococcal species (group A). For control purposes, assays were performed on
sera from 10 patients with active LO-SVGIs caused by bacteria other than staphylococcus
(group B); 16 healthy patients with histories of staphylococcal LO-SVGI that had been
eradicated 6–72 months earlier by means of graft replacement (group C); 17 healthy patients
with synthetic vascular grafts and no evidence of current or past graft infections (group D);
and 58 healthy subjects with no implanted medical devices or prostheses of any type (group
E). Infections were classified as late onset only when first manifestations occurred 2 years or
more after implantation of the vascular graft. All infections (ongoing and past) were micro‐
biologically confirmed based on cultures of the explanted graft. The results of this study are
summarized in Table 1 and Figure 1.
Figure 1. IgM and IgG antibody titres against SSPA. Group A = individuals with staphylococcal LO-SVGI; group B =
individuals with non-staphylococcal LO-SVGI; group C = individuals with previous history of staphylococcal LO-
SVGI, with successful graft replacement; group D = individuals with synthetic vascular graft implanted 14–78 months
before study entry and no previous history of graft infections; group E = individuals free of prosthetic devices.
Compounds from Natural Sources for New Diagnostics and Drugs against Biofilm Infections
http://dx.doi.org/10.5772/62908
489
by strains prone to conventional antibiotics were attributed to biofilm. At the beginning, sessile
phenotype has been related only to medical devices infections, but as long as knowledge on
biofilm behavior increased, the majority of chronic human infections have been attributed to
sessile phenotype. It has been demonstrated that sessile bacteria resist to antibiotics due to a
variety of causes including, a reduced penetration of drugs in the deep layers of biofilm, a favored
diffusion of resistance genes, a drift of bacterial metabolism towards anaerobiosis causing a
reduced cellular division, and a dramatic reduction of susceptibility to drugs. Efforts have been
devoted to restore sensitivity of sessile bacteria to antibiotics and to identify new compounds
to treat biofilm. In this chapter, we describe our efforts in this field. Since the early 1990s, our
lab dedicated many efforts to identify new diagnostics and new therapeutical strategies to
counteract biofilm infections in humans. We shall first describe a diagnostic tool based on
enzyme-linked immunosorbent  assay (ELISA)  technique to  early  identify  Staphylococcal
colonization of medical devices, then we shall list an array of different compounds active on
bacterial biofilms.
2. An ELISA assays for early diagnosis of biofilm infections
Specimen culturing is the gold standard for diagnosing bacterial infections, but growing
bacteria from a biofilm is not reliable. Other testing modalities, such as polymerase chain
reaction Polymerase chain reaction (PCR) and serology assays are nonspecific for biofilm
infections and include the risk of contamination during sampling. In recent years, many
attempts have been performed to create new for early, noninvasive diagnosis. A main feature
of infections on implanted medical devices is the absence or paucity of local signs and general
symptoms of infection/inflammation. The first signs are due to dysfunction of the device itself
(loosening of orthopedic prostheses, cardiac valve regurgitation) and device-related damage
to the surrounding tissues. Prompt detection of biofilm infection in the initial asymptomatic
phases can allow earlier medical/surgical treatment. Highly virulent organisms (e.g.,
Staphylococcus aureus and gram-negative bacilli) induce early appearance of symptoms. Less
virulent bacteria (e.g., coagulase-negative staphylococci) usually induce low-grade, indolent
infections that remain clinically silent for years. Laboratory tests suggesting inflammation and
possible infection by a bacterial pathogen (i.e., C-reactive protein, Complete blood counts,
erythrocyte sedimentation rate) do not demonstrate the presence of bacteria and can mis‐
lead. An interesting alternative is based on the use of immunodiagnostics detecting antibod‐
ies directed against antigens that are specific for the sessile form of bacterial species, especially
those that are traditionally considered saprophytes. Since staphylococci are highly prevalent
in biofilm infections on medical devices, we developed a simple and reliable immunodiag‐
nostic assay devoted to the diagnosis of staphylococcal biofilm infections [1] based on enzyme-
linked immunosorbent assay (ELISA), a simple, rapid, and repeatable technology, that do not
require removal of the implanted device. Our ELISA test allows to detect antigen-bound
immunoglobulins with peroxidase-conjugated antibodies against human immunoglobulin G
(IgG) or immunoglobulin M (IgM), and expresses antibody titers as units of optical density.
The assay was tested in patients with late-onset infections involving synthetic vascular grafts
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not evaluate IgG titers, because they were not associated with current infection both in the
previous study on vascular grafts and in a preliminary analysis on five cases and eight controls.
According to these results, we can affirm that anti-SSPA ELISA assay is effective in detect‐
ing antibodies in DOJP-Is caused by different staphylococcal species.
Group (no. of samples) Mean (SD) IgM titre (EU) % (no.) of positive tests for an IgM titre:
≥0.35 EU ≥0.40 EU
Prosthesis infectiona (29) 0.72 (0.55) 89.7 (26) 69.0 (20)
Prosthesis, no infectiona (34) 0.21 (0.09)b 8.8 (3) 5.9 (2)
No Prosthesis, no infection (27) 0.20 (0.05)b 0 (0) 0 (0)
All controls (61) 0.21 (0.07)b 4.9 (3) 3.3 (2)
a Prosthesis infection is defined by subjects with an ongoing prosthetic infection caused by Staphylococcus epidermidis (n
= 15), Staphylococcus aureus (n = 8), coagulase-negative staphylococci other than S. epidermidis (n = 2), and mixed
infection by one or more staphylococcal species plus enterococci, Pseudomonas aeruginosa, or Escherichia coli (n = 4).
bP<0.001 versus infected subjects (Kruskal-Wallis test).
Table 2. Comparison of titers of IgM antibodies against SSPA, expressed as ELISA units, in sera from subjects with an
ongoing staphylococcal late-onset infection of orthopedic prostheses and in controls.
Periodic testing for IgM antibodies against SSPA could prove useful in the follow-up of patients
with implanted vascular and orthopedic devices. The SSPA ELISA displays a strong advant‐
age over other available methods used to diagnose biofilm-related infections, in fact it is
versatile because it can detect antibodies in biofilm infections caused by different staphylo‐
coccal species. The higher diagnostic value of the IgM titers depends on the choice of the
antigen: a mixture of purified polysaccharide antigens extracted from the biofilm matrix.
Polysaccharide antigens are known to elicit a thymus-independent humoral response based
exclusively on IgM production. This response is maintained as long as the antigenic stimu‐
lus is present, and there is no shift to IgG production. IgMs elicited by antigens of this type are
synthesized by a particular subpopulation of B lymphocytes (B1): blood IgM + IgD + CD27 +
cells that correspond to splenic marginal zone B cells. Because of the absence of thymic
involvement and IgG production, these responses are regarded as expressions of innate
immunity. The peculiar behavior of the immune response to polysaccharide antigens
represents a diagnostic advantage since it can be used at any time to evaluate the possibility
of device infection, even during the post-replacement follow-up. The interest in the develop‐
ment of alternative anti-infective approaches for the prevention and treatment of staphylo‐
coccal infections has increased in recent years [3–5]. But our group has been working on the
search of new compounds active as anti-biofilm drugs since the early 1990s [6].
2.1. New compounds from prokaryotes for the therapy of biofilm infections.
Our first attempt, for the search of new anti-biofilm drugs, was based on the clinical observa‐
tion that the administration of proteolytic enzymes can enhance therapeutic outcomes in the
treatment of contact lens and endo-ocular prosthetic devices infections. The hypothesis was




A (n = 38) B (n = 10) C (n = 16) D (n = 17) E (n = 58) B+C+D+E (n = 101)
IgM titre (mean, SD) (EU) 0.69 (0.37) 0.28 (0.07) 0.26 (0.06) 0.18 (0.05) 0.17 (0.06) 0.19 (0.08)
IgG titre (mean, SD) (EU) 1.13 (0.36) 0.86 (0.46) 0.82 (0.57) 0.46 (0.27) 0.55 (0.26) 0.60 (0.37)
Positive tests for an IgM
titre (number, %) (EU)
≥0.35 38 (100%) 2 (20%) 0 0 0 2 (2%)
≥0.40 37 (97%) 0 0 0 0 0
Group A = patients with an ongoing LO-SVGI caused by Staphylococcus epidermidis (n = 6), S. aureus (n = 2), coagulase-
negative staphylococci other than S. epidermidis (n = 24), and mixed infection by one more staphylococcal species and
enterococci, Pseudomonas aeruginosa, or Escherichia coli (n = 6); group B = patients with LO-SVGI caused by bacteria other
than staphylococcus—P. aeruginosa (n = 2), mixed infections by gram-negative bacilli (Pseudomonas spp. or
Enterobacteriaceae; n = 5), mixed infection by Enterococcus spp and Enterobacter cloacae (n = 1), mixed fungal-bacterial
infections (Candida albicans and Enterococcus spp. or P. aeruginosa) (n = 2); group C = healthy patients with a history of
staphylococcal LO-SVGI, followed by successful graft replacement; group D = healthy patients with a synthetic
vascular graft, with no previous history of graft infections; group E = patients with no prosthetic device.
Table 1. Comparison of titres of IgM and IgG antibodies against staphylococcal slime polysaccharide antigens (SSPA)
(ELISA units [EU]) in sera from patients with an ongoing staphylococcal late-onset infection of synthetic vascular graft
(LO-SVGI) and in controls.
The highest titers of IgG antibody to SSPA were noted in individuals with ongoing staphylo‐
coccal LO-SVGIs (group A). However, high titers were also seen in the control groups, which
precluded the use of IgG titers for diagnostic purposes. In contrast, titers of IgM antibodies
against SSPA were higher in the group A patients. There was virtually no overlap between the
titers of these patients and those of controls. IgM antibody of 0.4 ELISA units (EU) or more
indicated ongoing staphylococcal LO-SVGIs with detection rates of 97% and no false posi‐
tives. When a cutoff of 0.35 ELISA units was used, the detection rate increased to 100%, but
the false-positive rate also rose to 2%. The substantial difference observed between patients
with ongoing versus previous staphylococcal LO-SVGIs (group A vs. group C) suggested that
levels of IgM antibody against SSPA decrease rapidly after successful graft substitution.
Recurrence of graft infection was associated with the return of elevated IgM antibody titers.
We concluded that SSPA ELISA positivity can be used as a marker of active staphylococcal
graft infections. Anti-SSPA ELISA was also tested for the diagnosis of orthopedic joint
prosthetic infections (DOJP-Is). To this aim, we compared the titers of IgM antibodies against
SSPA in the sera of 90 subjects [2]. Studied population included 29 subjects with ongoing
staphylococcal DOJP-Is (group A), 34 subjects with orthopedic joint prostheses implanted at
least 1 year previously without infection (group B), and 27 subjects not previously operated
for orthopedic implants, attending the hospital for noninfectious diseases (group C). All
subjects in group A underwent surgical removal of the infected prosthesis, and staphylococ‐
cal infection had been microbiologically confirmed by intraoperative cultures. For orthope‐
dic applications, we adopted a cutoff value of 0.35 EU. The main results, summarized in
Table 2, show that high anti-SSPA IgM levels may provide for noninvasive detection of the
immune response elicited by biofilm colonization on artificial orthopedic implants. We did
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Figure 3. SEM image of a polystyrene bead incubated for 5 days at 37°C in a culture of P. aeruginosa in TSB with ofloxa‐
cin at a concentration equal to MIC under planktonic growth condition (0.78 mcg/ml) and serratiopeptidase at a con‐
centration of 10 U/ml at a flow rate of 120 ml/h. Magnification × 2220.
Serratiopeptidase is a metalloprotease (containing zinc) cloned from S. marcescens, showing a
strong proteolytic activity and widely used in therapy for decades for its anti-inflammatory
properties and for its ability to enhance the penetration of antibiotics in the site of infection.
We further studied serratiopeptidase (SPEP) trying to understand its mechanism of action on
a molecular level. To this aim, our group examined the effect of two families of proteases on
S. aureus and S. epidermidis strains. In particular, we used three serine proteases (proteinase-K,
PK; trypsin, TRY; chymotrypsin, CHY) and two metalloproteases (SPEP; carboxypeptidase-A,
CpA) in biofilm formation assays and in human cell invasion processes (invasion only for S.
aureus) [4]. The study was intended also at obtaining a broader knowledge on the possible use
of proteases as anti-adhesive molecules whose use could be proposed in combination therapy
with antibiotics. SPEP seems the most promising molecule to be developed as a novel anti-
virulence tool. Its action selectively affects a discrete number of proteins clearly involved in
fundamental mechanisms associated with bacterial virulence, such as adhesion, invasion, and
biofilm formation and would thus hinder staphylococcal virulence properties. Adhesion of
bacterial cells and formation of biofilm are finely tuned in staphylococci by an interplay of
adhesins including sialoprotein binding proteins (SdrC), fibrinogen binding proteins (FnBP-
A/B, Embp, and ClfA), biofilm-associated protein (Aap and Bap), extracellular matrix binding
proteins (SasG), autolysins (Alt and AtlE), proteins involved in polysaccharide intracellular
adhesin (PIA) synthesis (IcaADBC), and others [7]. In order to ascertain the presence of genes
that code for proteins that modulate adhesion and biofilm formation the studied strains were
studied by PCR.
We found no relationship between bacterial gene profile and proteases activity. Cell surface
protein samples from treated and untreated cultures of all staphylococcal strains were
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that proteolytic treatment could damage the proteic structure of biofilm matrix reverting
bacteria to a condition of susceptibility to antibiotics. In our first study [6] four different
proteases were tested on 10 bacterial strains (5 Staphylococcus epidermidis and 5 Pseudomonas
aeruginosa) with ofloxacin (dilution range, 200–0.1 mcg/ml): clostridiopeptidase A, fibrinoly‐
sin, streptokinase, and serratiopeptidase. Experiments were been performed in both plank‐
tonic and sessile form, the last one based on the colonization of polystyrene beads maintained
in constant flow culture. Results showed a strong anti-biofilm activity of serratiopeptidase as
demonstrated by bioluminescence count of adherent bacterial cells. A further confirmation
was obtained by scanning electron microscope (SEM) image of the surface of polystyrene beads
incubated for 5 days in a culture of P. aeruginosa containing ofloxacin alone (Figure 2) or
ofloxacin and serratiopeptidase (Figure 3).
Figure 2. SEM image of a polystyrene bead incubated for 5 days at 37°C in a culture of P. aeruginosa in TSB with ofloxa‐
cin at a concentration equal to MIC under planktonic growth condition (0.78 mcg/ml) at a flow rate of 120 ml/h.
Magnification × 1550.
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influences bacterial viability when used at the concentrations adopted in this work and at
higher concentrations, nor displays a cytotoxic effect on eukaryotic cell lines. Based on these
results, confirmed by the images obtained in SEM [12] (Figure 4), we focused on the molecu‐
lar aspects of SPEP action on S. aureus, a bacterial pathogen often associated with nosoco‐
mial and community-acquired infections, capable to express a multiplicity of virulence factors
secreted or associated to bacterial cell surface; these factors include bacterial products that
mediate adhesion to the surface of host cells and to damaged tissues. It has been ascertained
that in S. aureus surface proteins play a fundamental role in virulence properties, including
biofilm formation.
A successful strategy to hinder bacterial infection should not affect processes essential for
bacterial survival in order to avoid the rapid appearance of escape mutants. A smarter




6538P 1.64 ± 0.15 0.086 ± 0.015
25923 1.68 ± 0.23 0.63 ± 0.12
12598 0.35 ± 0.05 0.21 ± 0.03
BAA1556 2.15 ± 0.08 0.47 ± 0.04
Based on the 590 nm OD absorbance produced by S. aureus strains. Data represent the mean ± SD of three independent
experiments.
Table 3. Effect of SPEP treatment on staphylococcal biofilm formation.
Two steps lead to biofilm formation are adherence to a surface by bacterial cells and progres‐
sive growth of cell clusters in multilayers. The study of the factors that gather cells into a biofilm
has evidenced the existence of strains producing either polysaccharide intercellular adhe‐
sion/poly-N-acetylglucosamine (PIA/PNAG) or a protein-dependent biofilm, even if in
staphylococci the best-known biofilm mechanism depends on the production of PIA/PNAG,
an extracellular polysaccharide adhesin [13, 14]. It has been shown that, besides their best-
known role in the eukaryotic invasion process, fibronectin-binding proteins (FnBPs) play a
relevant role in biofilm-associated foreign-body infections. Some proteins are multifunction‐
al factors involved in metabolic pathways, in adhesion to extracellular matrix and invasion of
host cells, such serine-aspartate repeat-containing protein D (SdrD), Elongation factor-Tu (EF-
Tu), Elongation factor-G (EF-G), Atl, SsA2, and second immunoglobulin-binding protein (Sbi).
In order to understand the molecular mechanism of SPEP action on S. aureus we confirmed its
action on biofilm growth and studied the proteomic patterns of treated and untreated bacterial
cells. Experiments were performed on four S. aureus strains: ATCC 6538P (DSMZ 346),
reference strain for antimicrobial testing; ATCC 25923 (DSMZ 1104); ATCC 12598 (DSMZ
20372); ATCC BAA1556 (FPR3757 strain) is an USA 300 strain [15]. The biofilm-forming ability
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simultaneously analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). The ability of each
protease to interfere with S. aureus capacity to adhere and invade human cells was tested by
antibiotic protection assay on HeLa cell line. We found that only SPEP and CpA had a
comparable action on all tested strains; on the contrary all tested serine proteases showed
different behavior on each bacterial strain suggesting a nonspecific and indiscriminate effect
of these proteases. For this reason, we focused on SPEP and CpA action on surface proteins.
SPEP treatment resulted in an effective and broad-spectrum reduction of biofilm formation
and its action appears to be more selective, sequence-specific [8, 9] and proportional to biofilm
production. Antibiotic protection assay performed on HeLa cells showed that SPEP treat‐
ment strongly impaired S. aureus invasion efficiency. This is similar to what found by our group
for L. monocytogenes [10], thus confirming the broad spectrum of this protease also against
virulence properties different from biofilm formation. The action of CpA results in an increase
of biofilm accumulation, while the action of SPEP impairs surface adhesins/autolysins and
probably impairs also the adhesive moieties of the altruistic suicidal cells. The altruistic suicide
mechanism was found to be responsible for the lysis of a bacterial subfraction in S. aureus
biofilm [11]. SPEP and CpA are able to act both on surface adhesins and on the lysed cellular
debris derived from the suicidal subpopulation. It is important to underline that SPEP neither
Figure 4. Scanning electron microscopy analysis of S. aureus 6538P grown overnight in BHI in presence of a PFTE filter
as a substrate for sessile growth in the absence (A), or in the presence (B) of SPEP. In the magnification box of panel A,
the extracellular matrix is visible and biofilm-embedded bacteria cover the filter surface. In panel B, the PTFE filter
background is visible and only single cells are present.
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comparable action on all tested strains; on the contrary all tested serine proteases showed
different behavior on each bacterial strain suggesting a nonspecific and indiscriminate effect
of these proteases. For this reason, we focused on SPEP and CpA action on surface proteins.
SPEP treatment resulted in an effective and broad-spectrum reduction of biofilm formation
and its action appears to be more selective, sequence-specific [8, 9] and proportional to biofilm
production. Antibiotic protection assay performed on HeLa cells showed that SPEP treat‐
ment strongly impaired S. aureus invasion efficiency. This is similar to what found by our group
for L. monocytogenes [10], thus confirming the broad spectrum of this protease also against
virulence properties different from biofilm formation. The action of CpA results in an increase
of biofilm accumulation, while the action of SPEP impairs surface adhesins/autolysins and
probably impairs also the adhesive moieties of the altruistic suicidal cells. The altruistic suicide
mechanism was found to be responsible for the lysis of a bacterial subfraction in S. aureus
biofilm [11]. SPEP and CpA are able to act both on surface adhesins and on the lysed cellular
debris derived from the suicidal subpopulation. It is important to underline that SPEP neither
Figure 4. Scanning electron microscopy analysis of S. aureus 6538P grown overnight in BHI in presence of a PFTE filter
as a substrate for sessile growth in the absence (A), or in the presence (B) of SPEP. In the magnification box of panel A,
the extracellular matrix is visible and biofilm-embedded bacteria cover the filter surface. In panel B, the PTFE filter
background is visible and only single cells are present.
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genesis. The crystal structure of the domains of this protein has been elucidated and the li‐
gand-binding site of SdrD was characterized. EF-Tu and EF-G, belonging to the so-called
‘moonlight’ proteins, perform different functions unrelated to splice variants, gene fusions,
and generation of proteolytic fragments. Elongation Factor-Tu is considered as a main factor
associated to cell wall in most bacterial species; among them S. aureus [18], M. leprae [23], L.
johnsonii [22], M. pneumoniae, where it mediates fibronectin binding together with the pyru‐
vate dehydrogenase E1 subunit [24]. In L. monocytogenes, EF-Tu was identified together with
EF-G. Recently, EF-Tu has been identified as a surface protein possessing the characteristics
of an adhesion factor and showing the capacity to induce a proinflammatory response. We
used a methicillin-sensible S. aureus strain (6538P) and a methicillin-resistant strain
(BAA1556) to assess serratiopeptidase influence on their ability to adhere and invade eu‐
karyotic cells. Adhesion and invasion efficiency after serratiopeptidase treatment is shown
in Table 4. The test was performed according to the antibiotic protection assay. According to
our experimental data serratiopeptidase does not affect adhesion efficiency of 6538P while,
as regards BAA1556, the adhesion efficiency was partially upset. About the invasion, ex‐
pressed as the percent of the adhered bacteria which invaded HeLa cells, our data showed
that about 50% of the BAA1556 adhering to HeLa cells invaded them. Even if methicillin-
sensible strains are scarcely invasive, SPEP induced a 200-fold reduction of its invasion effi‐
ciency; furthermore, methicillin-resistant strain (BAA1556) showed a drastic reduction of
invasion efficiency (3000-fold) after treatment with serratiopeptidase.
Untreated SPEP-treated
Adhesion a Invasion b Adhesion a Invasion b
6538P 2.75 ± 0.45 0.7 × 10–2 ± 0.1 × 10–2 2.80 ± 1.80 0.3 × 10–4 ± 0.0 × 10–4
BAA1556 4.94 ± 0.97 2.5 ± 0.79 2.82 ± 1.46 0.7 × 10–3 ± 0.1 × 10–3
a Adhesion is expressed as the percentage of the initial inoculum of bacteria that adhered to HeLa cells 1 h post-
infection at 37°C.
b Invasion efficiency is expressed as the percentage of adhered bacteria that were gentamicin-resistant 1 h post-
infection. Data represent the mean ± SD of three independent experiments.
Table 4. Adhesion and invasion capabilities of SPEP-treated and untreated S. aureus.
It is not yet clear if serratiopeptidase action is mediated by its proteolytic function or to the
activation of specific signal transduction pathways that regulate expression of proteins.
In the last years, our group started working also on compounds obtained from marine bacteria.
Marine bacteria from Antarctica represent an untapped reservoir of biodiversity and pro‐
duce several compounds which may be of potential biotechnological interest; culture
supernatants derived from most of them have been shown to exhibit anti-biofilm activity
against both gram-positive and gram-negative bacteria, including Acinetobacter, S. aureus,
Salmonella typhimurium, Shigella sonnei, Listeria monocytogenes, and several Bacillus species [25].
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was tested by quantitative assay. They showed different capabilities to form biofilm: three
strains were strong biofilm producers with biofilm amount higher than 1.6 OD at 590 nm, while
ATCC 12598 is a medium biofilm producer. Biofilm quantification was performed in Static
biofilm assay according to Christensen [16] and in dynamic condition (BioFlux 2000 micro‐
fluidics system) which allows the acquisition of microscopic images over time. Results of SPEP
effect on biofilm formation of four S. aureus strains are summarized in Table 3. We found also
that SPEP is also extremely effective in the dispersal of S. aureus preformed biofilm suggest‐
ing that SPEP affects also mature biofilm.
Experiments in BioFlux system, performed on MSSA 6538P and MRSA BAA1556, showed
that SPEP clearly impairs biofilm formation as already seen in static system. The SPEP ac‐
tion on the proteome of tested strains was assessed on surface proteins extracted according
to the method of Tabouret [17]. Extracted proteins were separated on SDS-PAGE. Many spe‐
cific protein bands detected in the untreated S. aureus protein profiles either disappeared or
drastically diminished in intensity after SPEP incubation. This effect was clearly visible for
all bacterial strains analyzed, and peptide mixtures obtained by in situ digestion were ana‐
lyzed by MALDI-TOF Mass Spectrometry; when necessary, peptide mixtures were analyzed
by LCMS/MS using a 4000Q-Trap coupled to an 1100 nano HPLC system. Analysis of the
results showed the disappearance of specific proteins after SPEP treatment, including some
surface proteins that mediate adhesion and invasion in eukaryotic cells, such as SsA2, SdrD,
Atl, and Sbi, homolog to SpA. Notably, treatment with serratiopeptidase influenced the ex‐
pression of cytoplasmic proteins involved in carbohydrate metabolism (in particular, pro‐
teins of the glycolytic pathway) and in energy production. EF-G, EF-Tu, and the
dihydrolipoyl transacetylase, an enzyme component of the multienzyme pyruvate dehydro‐
genase complex [18], are further examples of factors participating in energetic metabolic
pathways that are also involved in adhesion and invasion in eukaryotic cells. Investigation
of the surface subproteome of Listeria monocytogenes studied previously, revealed a remarka‐
bly high number of proteins with a function in the cytoplasmic compartment. Many reports
suggest that anchorless proteins of the bacterial surface promote bacterial adhesion and in‐
vasion of eukaryotic cells [19]. Proteins may perform different functions that depend on oth‐
er proteins they can transiently associate with. As a consequence, proteins involved in
bacterial metabolism are not only involved in energy production, playing an alternative role
on bacterial cell surface, but also they may facilitate efficient invasion of eukaryotic cells.
Some proteins of the adhesion family, alkyltransferase-like (ATL) protein, Sbi, Elongation
Factor-Tu, Elongation Factor-G, and Serine-aspartate repeat-containing protein D, deserve
particular attention. Atl disappeared after SPEP treatment, confirming that SPEP modulates
adhesins and autolysins in S. aureus. Recently, a novel mechanism involved in staphylococ‐
cal internalization by host cells, which is mediated by the major autolysin/adhesins Atl in S.
aureus has been described [20]. A microbial surface components recognizing adhesive matrix
molecule (MSCRAMMS) member acting as a homologous to SpA is Sbi; this multifunctional
protein binds host complement components Factor H and C3, IgG and b2-glycoprotein I and
hinders innate immune recognition. Sbi inhibits both complement activation and lyses of
rabbit erythrocytes mediated by the alternative pathway of human serum [21]. SdrD, a
MSCRAMM family surface protein, plays an important role in S. aureus adhesion and patho‐
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genesis. The crystal structure of the domains of this protein has been elucidated and the li‐
gand-binding site of SdrD was characterized. EF-Tu and EF-G, belonging to the so-called
‘moonlight’ proteins, perform different functions unrelated to splice variants, gene fusions,
and generation of proteolytic fragments. Elongation Factor-Tu is considered as a main factor
associated to cell wall in most bacterial species; among them S. aureus [18], M. leprae [23], L.
johnsonii [22], M. pneumoniae, where it mediates fibronectin binding together with the pyru‐
vate dehydrogenase E1 subunit [24]. In L. monocytogenes, EF-Tu was identified together with
EF-G. Recently, EF-Tu has been identified as a surface protein possessing the characteristics
of an adhesion factor and showing the capacity to induce a proinflammatory response. We
used a methicillin-sensible S. aureus strain (6538P) and a methicillin-resistant strain
(BAA1556) to assess serratiopeptidase influence on their ability to adhere and invade eu‐
karyotic cells. Adhesion and invasion efficiency after serratiopeptidase treatment is shown
in Table 4. The test was performed according to the antibiotic protection assay. According to
our experimental data serratiopeptidase does not affect adhesion efficiency of 6538P while,
as regards BAA1556, the adhesion efficiency was partially upset. About the invasion, ex‐
pressed as the percent of the adhered bacteria which invaded HeLa cells, our data showed
that about 50% of the BAA1556 adhering to HeLa cells invaded them. Even if methicillin-
sensible strains are scarcely invasive, SPEP induced a 200-fold reduction of its invasion effi‐
ciency; furthermore, methicillin-resistant strain (BAA1556) showed a drastic reduction of
invasion efficiency (3000-fold) after treatment with serratiopeptidase.
Untreated SPEP-treated
Adhesion a Invasion b Adhesion a Invasion b
6538P 2.75 ± 0.45 0.7 × 10–2 ± 0.1 × 10–2 2.80 ± 1.80 0.3 × 10–4 ± 0.0 × 10–4
BAA1556 4.94 ± 0.97 2.5 ± 0.79 2.82 ± 1.46 0.7 × 10–3 ± 0.1 × 10–3
a Adhesion is expressed as the percentage of the initial inoculum of bacteria that adhered to HeLa cells 1 h post-
infection at 37°C.
b Invasion efficiency is expressed as the percentage of adhered bacteria that were gentamicin-resistant 1 h post-
infection. Data represent the mean ± SD of three independent experiments.
Table 4. Adhesion and invasion capabilities of SPEP-treated and untreated S. aureus.
It is not yet clear if serratiopeptidase action is mediated by its proteolytic function or to the
activation of specific signal transduction pathways that regulate expression of proteins.
In the last years, our group started working also on compounds obtained from marine bacteria.
Marine bacteria from Antarctica represent an untapped reservoir of biodiversity and pro‐
duce several compounds which may be of potential biotechnological interest; culture
supernatants derived from most of them have been shown to exhibit anti-biofilm activity
against both gram-positive and gram-negative bacteria, including Acinetobacter, S. aureus,
Salmonella typhimurium, Shigella sonnei, Listeria monocytogenes, and several Bacillus species [25].
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was tested by quantitative assay. They showed different capabilities to form biofilm: three
strains were strong biofilm producers with biofilm amount higher than 1.6 OD at 590 nm, while
ATCC 12598 is a medium biofilm producer. Biofilm quantification was performed in Static
biofilm assay according to Christensen [16] and in dynamic condition (BioFlux 2000 micro‐
fluidics system) which allows the acquisition of microscopic images over time. Results of SPEP
effect on biofilm formation of four S. aureus strains are summarized in Table 3. We found also
that SPEP is also extremely effective in the dispersal of S. aureus preformed biofilm suggest‐
ing that SPEP affects also mature biofilm.
Experiments in BioFlux system, performed on MSSA 6538P and MRSA BAA1556, showed
that SPEP clearly impairs biofilm formation as already seen in static system. The SPEP ac‐
tion on the proteome of tested strains was assessed on surface proteins extracted according
to the method of Tabouret [17]. Extracted proteins were separated on SDS-PAGE. Many spe‐
cific protein bands detected in the untreated S. aureus protein profiles either disappeared or
drastically diminished in intensity after SPEP incubation. This effect was clearly visible for
all bacterial strains analyzed, and peptide mixtures obtained by in situ digestion were ana‐
lyzed by MALDI-TOF Mass Spectrometry; when necessary, peptide mixtures were analyzed
by LCMS/MS using a 4000Q-Trap coupled to an 1100 nano HPLC system. Analysis of the
results showed the disappearance of specific proteins after SPEP treatment, including some
surface proteins that mediate adhesion and invasion in eukaryotic cells, such as SsA2, SdrD,
Atl, and Sbi, homolog to SpA. Notably, treatment with serratiopeptidase influenced the ex‐
pression of cytoplasmic proteins involved in carbohydrate metabolism (in particular, pro‐
teins of the glycolytic pathway) and in energy production. EF-G, EF-Tu, and the
dihydrolipoyl transacetylase, an enzyme component of the multienzyme pyruvate dehydro‐
genase complex [18], are further examples of factors participating in energetic metabolic
pathways that are also involved in adhesion and invasion in eukaryotic cells. Investigation
of the surface subproteome of Listeria monocytogenes studied previously, revealed a remarka‐
bly high number of proteins with a function in the cytoplasmic compartment. Many reports
suggest that anchorless proteins of the bacterial surface promote bacterial adhesion and in‐
vasion of eukaryotic cells [19]. Proteins may perform different functions that depend on oth‐
er proteins they can transiently associate with. As a consequence, proteins involved in
bacterial metabolism are not only involved in energy production, playing an alternative role
on bacterial cell surface, but also they may facilitate efficient invasion of eukaryotic cells.
Some proteins of the adhesion family, alkyltransferase-like (ATL) protein, Sbi, Elongation
Factor-Tu, Elongation Factor-G, and Serine-aspartate repeat-containing protein D, deserve
particular attention. Atl disappeared after SPEP treatment, confirming that SPEP modulates
adhesins and autolysins in S. aureus. Recently, a novel mechanism involved in staphylococ‐
cal internalization by host cells, which is mediated by the major autolysin/adhesins Atl in S.
aureus has been described [20]. A microbial surface components recognizing adhesive matrix
molecule (MSCRAMMS) member acting as a homologous to SpA is Sbi; this multifunctional
protein binds host complement components Factor H and C3, IgG and b2-glycoprotein I and
hinders innate immune recognition. Sbi inhibits both complement activation and lyses of
rabbit erythrocytes mediated by the alternative pathway of human serum [21]. SdrD, a
MSCRAMM family surface protein, plays an important role in S. aureus adhesion and patho‐
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Figure 5. Biofilm formation of S. epidermidis O-47 in a BioFlux system. Each image contains two channels: top channel
was SN-treated sample and bottom channel was the control one. Bright-field microscopic images were collected at 1-
min intervals. The images presented were taken from the complete set of 720 images (see supplementary video bioflux
for a video compilation of these images) taken at 40 × magnification.
The efficacy of P. haloplanktis supernatant was also confirmed on S. epidermidis biofilm
formation in dynamic condition using BioFlux system (Figure 5). Our results demonstrated
that in dynamic condition P. haloplanktis TAC125 anti-biofilm was effective against S. epider‐
midis biofilm formation. The use of P. haloplanktis TAC125 anti-biofilm molecule/s in combi‐
nation therapy with antibiotics during persistent infection by staphylococci could be proposed.
Furthermore, we evaluated the anti-biofilm activity of supernatants derived from cultures of
several cold-adapted bacteria belonging to Pseudoalteromonas, Psychrobacter, and Psychromo‐
nas genera. Supernatants were obtained from bacterial cultures made both in sessile and
planktonic conditions. The potential anti-biofilm activity was tested on bacterial cultures of P.
aeruginosa PAO1, three different strains of S. aureus, and three different strains of S. epidermi‐
dis species [39]. In these species, the matrix composition, the molecules involved in attach‐
ment, development, detachment phases, and the regulation of quorum-sensing systems are
different [40, 41]. Several cold-adapted bacteria produce molecules that are able to interfere
with S. aureus biofilm formation. These molecules seem to be proteinaceous. On the contrary,
only few Polar strains produce anti-biofilm molecules active on S. epidermidis O-47 and RP62A
biofilms, and none were able to interfere with S. epidermidis XX-17 biofilm formation. It is
important to underline that XX-17 strain produces a biofilm characterized by a polysacchar‐
ide ica-independent poorly characterized so far. Moreover, the six staphylococcal strains
considered here were previously investigated to assess the presence of genes coding for
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Marine bacteria belonging to the genus Pseudoalteromonas produce compounds of biotechno‐
logical interest, including anti-biofilm molecules [26]. Starting from these considerations, we
tested on different staphylococcal strains the anti-biofilm activity of cell-free supernatant of
Antarctic marine bacterium P. haloplanktis TAC125 grown in planktonic and sessile form [27,
28]. Our results show that S. epidermidis biofilm growth is inhibited only by P. haloplanktis
TAC125 supernatant grown in static condition. A possible explanation for this result can be
found in the peculiar biofilm microenvironment that lead to production of specific metabo‐
lites or polymers due to metabolic rewiring of sessile bacteria [29] that could inhibit growth
of other microorganisms. In accordance with this hypothesis, many anti-biofilm compounds
were identified from cultured biofilms [25]. It is interesting to note that previously character‐
ized anti-biofilm compounds have often a broad-spectrum biofilm inhibition activity [25, 26,
30] while the P. haloplanktis TAC125 anti-biofilm molecule seemed to be species-specific. P.
haloplanktis TAC125 supernatant was, in fact, inactive against biofilm of S. aureus and P.
aeruginosa. The majority of the anti-biofilm compounds described in literature so far also exert
an antibacterial activity. P. haloplanktis TAC125 supernatant does not show antibacterial
activity against planktonic forms, while its action is directed against sessile forms possibly
mediated by mechanisms other than growth inhibition. Only few natural molecules display
this mode of action. Three hypothetical modes of action could be proposed. (i) anti-biofilm
compounds could be surfactants acting on physical characteristics of biotic and abiotic
surfaces; (ii) they could act by competitive inhibition of multivalent carbohydrate-protein
interactions [31]. Thus, the anti-biofilm compound might block lectins or sugar-binding
proteins present on the surface of bacteria, or block tip adhesins of fimbriae and pili [32]; (iii)
P. haloplanktis TAC125 anti-biofilm compound might act as a signaling molecule that modu‐
lates the gene expression of recipient bacteria [33]. Indeed, bacterial communication is one of
the regulatory mechanisms suggested to be involved in biofilm formation [34]. The results of
the initial attachment assay indicated that the cultured supernatant-inhibited biofilm forma‐
tion by contrasting the initial attachment of bacterial cells to the surface. P. haloplanktis TAC125
anti-biofilm compound affects mature biofilm but its action requires a long time. This
observation suggests a mechanism of action mediated by a signaling system that down-
regulates adhesive properties of biofilm matrix and bacterial cell surface rather than by
surfactant activity that, on the contrary, would rapidly carry on its action. Different systems
have been described so far for bacterial communication. A well-characterized system (acting
for intra- and interspecies communication) is based on the autoinducer-2 (AI-2) produced by
luxS gene, as a signaling molecule [35]. LuxS has also been identified in S. epidermidis [36], but
P. haloplanktis TAC125 genome analysis revealed that the Antarctic bacterium is devoid of luxS
gene [37] suggesting the anti-biofilm activity could be due to a not identified signaling
molecule. The anti-biofilm effects of P. haloplanktis exoproducts could be due to a novel
molecule or the synergistic actions of different molecules. The P. haloplanktis TAC125 anti-
biofilm molecule was active against several S. epidermidis strains, among others it was effective
on the clinical isolate O-47 which is a naturally occurring agr mutant [33], but it was inactive
on S. epidermidis XX-17 ica mutant [38].
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for a video compilation of these images) taken at 40 × magnification.
The efficacy of P. haloplanktis supernatant was also confirmed on S. epidermidis biofilm
formation in dynamic condition using BioFlux system (Figure 5). Our results demonstrated
that in dynamic condition P. haloplanktis TAC125 anti-biofilm was effective against S. epider‐
midis biofilm formation. The use of P. haloplanktis TAC125 anti-biofilm molecule/s in combi‐
nation therapy with antibiotics during persistent infection by staphylococci could be proposed.
Furthermore, we evaluated the anti-biofilm activity of supernatants derived from cultures of
several cold-adapted bacteria belonging to Pseudoalteromonas, Psychrobacter, and Psychromo‐
nas genera. Supernatants were obtained from bacterial cultures made both in sessile and
planktonic conditions. The potential anti-biofilm activity was tested on bacterial cultures of P.
aeruginosa PAO1, three different strains of S. aureus, and three different strains of S. epidermi‐
dis species [39]. In these species, the matrix composition, the molecules involved in attach‐
ment, development, detachment phases, and the regulation of quorum-sensing systems are
different [40, 41]. Several cold-adapted bacteria produce molecules that are able to interfere
with S. aureus biofilm formation. These molecules seem to be proteinaceous. On the contrary,
only few Polar strains produce anti-biofilm molecules active on S. epidermidis O-47 and RP62A
biofilms, and none were able to interfere with S. epidermidis XX-17 biofilm formation. It is
important to underline that XX-17 strain produces a biofilm characterized by a polysacchar‐
ide ica-independent poorly characterized so far. Moreover, the six staphylococcal strains
considered here were previously investigated to assess the presence of genes coding for
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Marine bacteria belonging to the genus Pseudoalteromonas produce compounds of biotechno‐
logical interest, including anti-biofilm molecules [26]. Starting from these considerations, we
tested on different staphylococcal strains the anti-biofilm activity of cell-free supernatant of
Antarctic marine bacterium P. haloplanktis TAC125 grown in planktonic and sessile form [27,
28]. Our results show that S. epidermidis biofilm growth is inhibited only by P. haloplanktis
TAC125 supernatant grown in static condition. A possible explanation for this result can be
found in the peculiar biofilm microenvironment that lead to production of specific metabo‐
lites or polymers due to metabolic rewiring of sessile bacteria [29] that could inhibit growth
of other microorganisms. In accordance with this hypothesis, many anti-biofilm compounds
were identified from cultured biofilms [25]. It is interesting to note that previously character‐
ized anti-biofilm compounds have often a broad-spectrum biofilm inhibition activity [25, 26,
30] while the P. haloplanktis TAC125 anti-biofilm molecule seemed to be species-specific. P.
haloplanktis TAC125 supernatant was, in fact, inactive against biofilm of S. aureus and P.
aeruginosa. The majority of the anti-biofilm compounds described in literature so far also exert
an antibacterial activity. P. haloplanktis TAC125 supernatant does not show antibacterial
activity against planktonic forms, while its action is directed against sessile forms possibly
mediated by mechanisms other than growth inhibition. Only few natural molecules display
this mode of action. Three hypothetical modes of action could be proposed. (i) anti-biofilm
compounds could be surfactants acting on physical characteristics of biotic and abiotic
surfaces; (ii) they could act by competitive inhibition of multivalent carbohydrate-protein
interactions [31]. Thus, the anti-biofilm compound might block lectins or sugar-binding
proteins present on the surface of bacteria, or block tip adhesins of fimbriae and pili [32]; (iii)
P. haloplanktis TAC125 anti-biofilm compound might act as a signaling molecule that modu‐
lates the gene expression of recipient bacteria [33]. Indeed, bacterial communication is one of
the regulatory mechanisms suggested to be involved in biofilm formation [34]. The results of
the initial attachment assay indicated that the cultured supernatant-inhibited biofilm forma‐
tion by contrasting the initial attachment of bacterial cells to the surface. P. haloplanktis TAC125
anti-biofilm compound affects mature biofilm but its action requires a long time. This
observation suggests a mechanism of action mediated by a signaling system that down-
regulates adhesive properties of biofilm matrix and bacterial cell surface rather than by
surfactant activity that, on the contrary, would rapidly carry on its action. Different systems
have been described so far for bacterial communication. A well-characterized system (acting
for intra- and interspecies communication) is based on the autoinducer-2 (AI-2) produced by
luxS gene, as a signaling molecule [35]. LuxS has also been identified in S. epidermidis [36], but
P. haloplanktis TAC125 genome analysis revealed that the Antarctic bacterium is devoid of luxS
gene [37] suggesting the anti-biofilm activity could be due to a not identified signaling
molecule. The anti-biofilm effects of P. haloplanktis exoproducts could be due to a novel
molecule or the synergistic actions of different molecules. The P. haloplanktis TAC125 anti-
biofilm molecule was active against several S. epidermidis strains, among others it was effective
on the clinical isolate O-47 which is a naturally occurring agr mutant [33], but it was inactive
on S. epidermidis XX-17 ica mutant [38].
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Hill-type equation [50], Figure 7, where EC50 (the effective concentration at which 50%
inhibition of biofilm formation is observed) is obtained with a fitting procedure. Experi‐
ments performed with sub-MIC concentration demonstrate that studied compounds had not
antimicrobial activity at sub-MIC concentration. Therefore, we speculated that these com‐
pounds can inhibit biofilm formation but do not kill bacterial cells in the planktonic form. Their
action should be rather based on the prevention of S. aureus transition to the sessile pheno‐
type. On mature biofilm both DHBF and SA were not effective. Both SA and DHBF exhibit‐
ed an inhibitory activity of de novo biofilm formation in S. epidermidis at a concentration about
two-fold lower than the MIC and MBC range. SA also showed an inhibitory activity on the
mature biofilm, DHBF showed no such activity at all. CH and proAc did not possess bacteri‐
cidal activity. On the contrary, planktonic growth of both S. aureus and S. epidermidis was
inhibited by CH (MIC 16–32 μM), while proAc did not show bacteriostatic activity (Table 5).
However, biofilm growth of S. aureus and S. epidermidis was inhibited by both compounds.
The proAc seemed to be the best inhibitor performing similarly on both strains, CH inhibit‐
ed biofilm formation better in S. epidermidis than in S. aureus. While CH and proAc were good
inhibitors of the de novo biofilm formation they displayed no meaningful inhibitory activity
on the mature biofilm.
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various proteins involved in adhesion and biofilm formation [4]. In P. aeruginosa the biofilm
matrix is totally different, because the bacterium produces three exopolysaccharides, the
glucose-rich Pel polysaccharide [42], the mannose-rich Psl polysaccharide [42], and alginate
[43]. We used P. aeruginosa the reference strain PAO1 since the biofilm characterization of this
strain was previously reported [44]. The reported differences in biofilm features of the three
pathogens could explain the different ability of cold-adapted bacteria supernatants to impair
their biofilm formation. It is interesting to note that, in all reported cases, the supernatants
proved to be non-biocidal and specifically directed against biofilm. All studied Polar strains
were able to produce anti-biofilm molecules against P. aeruginosa biofilm. Furthermore in
almost all cases, the anti-biofilm molecules seemed to have the same chemical-physical
features (were not heat-labile and seem to have a non-protein nature). These results could
suggest that the molecule responsible for the anti-biofilm activity is the same for all cold-
adapted strains, in particular could be polysaccharides or a small molecule acting as quo‐
rum sensing inhibitor. The ability of cold-adapted marine bacteria to produce several anti-
biofilm molecules could suggest that the capacity to prevent the biofilm and colonization by
bacterial competitors is a selective advantage in this extreme environment.
2.2. New compounds from Eukaryotes for the therapy of biofilm infections.
2.2.1. Compounds from plants.
Considering that plants have already yielded compounds with inhibiting activities against
gram-positive bacteria [45], and that the use of medicinal and herbal remedies to treat
infectious diseases is common in many countries [46], we have also attempted the discovery
of new leads from plants. We explored several plant extracts searching for specific antibacte‐
rial activity from fractionated pools [47]. We considered extracts from Krameria, Aesculus
hippocastanum, and Chelidonium majus plants; these plants have proved to possess a plethora
of active principles in diverse pathologies. From active fractions, we purified and identified
antimicrobial compounds. We identified and purified a dihydroxybenzofuran (DHBF)
derivative that could be used as a possible active molecule from fractions of compounds
extracted from the Krameria lappacea (Dombey) Burdet (para or Brazilian rhatany) and tested
in microbiological assays. Our results demonstrated that extracts obtained from C. majus are
the most active in a screening study [48], it has been shown that crude extracts C. majus
exhibited antibacterial activity against S. aureus ATCC 25923 [49]. From the preliminary
microbiological assays probing fractions of compounds extracted from Aesculus hippocasta‐
num and C. majus, we identified and successively isolated the proanthocyanidin (proAc) from
the former plant and the cheliritrin (CH) and the sanguinarin (SA) alkaloids from the latter
plant to study their antimicrobial activity. All compounds are described in Figure 6. We tested
bacteriostatic and bactericidal action on the planktonic form and quantified the efficacy on
inhibition of biofilm formation and growth on S. aureus and S. epidermidis. We also presented
proteomic evidence of the alteration of bacterial surface proteome. Both DHBF and SA had a
similar marked bactericidal effect. Interestingly, both DHBF and SA were able to inhibit biofilm
accumulation in S. aureus at concentrations between 1.4 to six-fold lower than those corre‐
sponding to MIC/MBC, Figure 7 and Table 5. The inhibition data were interpreted using a
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Hill-type equation [50], Figure 7, where EC50 (the effective concentration at which 50%
inhibition of biofilm formation is observed) is obtained with a fitting procedure. Experi‐
ments performed with sub-MIC concentration demonstrate that studied compounds had not
antimicrobial activity at sub-MIC concentration. Therefore, we speculated that these com‐
pounds can inhibit biofilm formation but do not kill bacterial cells in the planktonic form. Their
action should be rather based on the prevention of S. aureus transition to the sessile pheno‐
type. On mature biofilm both DHBF and SA were not effective. Both SA and DHBF exhibit‐
ed an inhibitory activity of de novo biofilm formation in S. epidermidis at a concentration about
two-fold lower than the MIC and MBC range. SA also showed an inhibitory activity on the
mature biofilm, DHBF showed no such activity at all. CH and proAc did not possess bacteri‐
cidal activity. On the contrary, planktonic growth of both S. aureus and S. epidermidis was
inhibited by CH (MIC 16–32 μM), while proAc did not show bacteriostatic activity (Table 5).
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on the mature biofilm.
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various proteins involved in adhesion and biofilm formation [4]. In P. aeruginosa the biofilm
matrix is totally different, because the bacterium produces three exopolysaccharides, the
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pathogens could explain the different ability of cold-adapted bacteria supernatants to impair
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proved to be non-biocidal and specifically directed against biofilm. All studied Polar strains
were able to produce anti-biofilm molecules against P. aeruginosa biofilm. Furthermore in
almost all cases, the anti-biofilm molecules seemed to have the same chemical-physical
features (were not heat-labile and seem to have a non-protein nature). These results could
suggest that the molecule responsible for the anti-biofilm activity is the same for all cold-
adapted strains, in particular could be polysaccharides or a small molecule acting as quo‐
rum sensing inhibitor. The ability of cold-adapted marine bacteria to produce several anti-
biofilm molecules could suggest that the capacity to prevent the biofilm and colonization by
bacterial competitors is a selective advantage in this extreme environment.
2.2. New compounds from Eukaryotes for the therapy of biofilm infections.
2.2.1. Compounds from plants.
Considering that plants have already yielded compounds with inhibiting activities against
gram-positive bacteria [45], and that the use of medicinal and herbal remedies to treat
infectious diseases is common in many countries [46], we have also attempted the discovery
of new leads from plants. We explored several plant extracts searching for specific antibacte‐
rial activity from fractionated pools [47]. We considered extracts from Krameria, Aesculus
hippocastanum, and Chelidonium majus plants; these plants have proved to possess a plethora
of active principles in diverse pathologies. From active fractions, we purified and identified
antimicrobial compounds. We identified and purified a dihydroxybenzofuran (DHBF)
derivative that could be used as a possible active molecule from fractions of compounds
extracted from the Krameria lappacea (Dombey) Burdet (para or Brazilian rhatany) and tested
in microbiological assays. Our results demonstrated that extracts obtained from C. majus are
the most active in a screening study [48], it has been shown that crude extracts C. majus
exhibited antibacterial activity against S. aureus ATCC 25923 [49]. From the preliminary
microbiological assays probing fractions of compounds extracted from Aesculus hippocasta‐
num and C. majus, we identified and successively isolated the proanthocyanidin (proAc) from
the former plant and the cheliritrin (CH) and the sanguinarin (SA) alkaloids from the latter
plant to study their antimicrobial activity. All compounds are described in Figure 6. We tested
bacteriostatic and bactericidal action on the planktonic form and quantified the efficacy on
inhibition of biofilm formation and growth on S. aureus and S. epidermidis. We also presented
proteomic evidence of the alteration of bacterial surface proteome. Both DHBF and SA had a
similar marked bactericidal effect. Interestingly, both DHBF and SA were able to inhibit biofilm
accumulation in S. aureus at concentrations between 1.4 to six-fold lower than those corre‐
sponding to MIC/MBC, Figure 7 and Table 5. The inhibition data were interpreted using a
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2.2.2. Compounds from human body.
Studies performed on various fish species and in swine which led to the identification of innate
immuno factors important to be selected for resistance to gram-negative infections, have
pointed the attention on Tf as a candidate gene for disease resistance [51, 52]. Therefore, Tf is
considered as a relevant safeguard for human body, facing infections sustained by bacteria. Tf
is a glycoprotein; its molecular structure shows the presence of two lobes, each binding one
iron III ion. Apo-Tf is the denomination of its iron-depleted form; holo-Tf is the iron-loaded
form; both forms are collectively named Tfs. Tf has been shown to exert both a bacteriostatic
and bactericidal effect in vitro on a variety of microbial pathogens [53, 54]. The antimicrobial
activity of transferrin is conventionally related to the iron-depleted form but some studies
demonstrated that the mechanism of its antibacterial activity could not be referred only to iron
deprivation [55, 56].
We investigated the effect of human apo-Tf and holo-Tf on biofilm formation by S. aureus (CA-
MRSA USA300 type (ST8-IV) and ATCC 6538P strain) and S. epidermidis (A clinical isolate and
ATCC 35984 strain). Our aim was to determine whether Tfs were able to interfere with
microbial adherence of S. aureus and S. epidermidis to abiotic surfaces and to eukaryotic host
cell [47]. A strong reduction in biofilm formation with both Tfs was obtained albeit at very
different concentrations. In particular, the reduction in biofilm formation was higher with apo-
Tf rather than obtained with holo-Tf. The S. aureus biofilm formation was 50% inhibited at
about 50 μg/ml and 65 μg/ml, respectively for 6538P and USA300. The S. epidermidis biofilm
was inhibited at higher concentrations, namely at 95 μg/ml and 250 μg/ml for RP62A and O-47,
respectively. The holo-Tf also inhibited biofilm formation in all the strains, however at very
high concentrations. A 50% reduction of biofilm formation by S. aureus strains (6538P and
USA300) was obtained with concentrations of holo-Tf, respectively of 550 μg/ml and 600
μg/ml. S. epidermidis is a good biofilm former hence higher concentrations of holo-Tf are
necessary to obtain a 50% reduction (2.0 mg/ml for RP62A and 2.5 mg/ml for O-47). As regards,
the activity of holo-Tf on bacterial adhesion on eukaryotic cells our results show a 30%
reduction for 6538P adhesion and an increase of adhesion for USA300. Tfs inhibited invasion,
although with different efficacy. Similarly to the interference with adhesion process, holo-Tf
exerts a stronger inhibition on bacterial invasion than Apo-Tf. Our result demonstrates that
Tfs can be proposed as anti-infective compounds in S. aureus infections thank to their capability
to reduce virulence of bacterial strains depending on adhesion, biofilm formation, and
invasion. Our data suggest that holo-Tf plays a major role, as demonstrated on S. aureus
pathogen strain CA-MRSA USA300 type (ST8-IV) responsible for severe community-associ‐
ated staphylococcal disease, especially in the USA and in Europe.
3. Conclusions
More than four billion years ago, bacteria appeared on the earth and rapidly evolved in
different species which spread and colonized nearly all ecological niches. Since that time
prokaryotes and then eukaryotes (plants and animals, unicellular and multicellular) struggle
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Figure 6. Structural formulas of the inhibitors used in this study, the positive charges in CH and SA are neutralized by
chloride ion.
Figure 7. Inhibitory action of proAc, DHBF, CH, and SA, exerted on the ex-novo biofilm formation on S. aureus 6538P
(panel A) and on S. epidermidis RP62A (panel B). Standard deviations from four replicates are represented as error bars
in dark gray. The fitting curves shown on the curves were obtained with a single-step inhibition model and fitted with
the equation “f={%biofilm formation / [1 + (C/EC50)^slope]}”; where C is the actual concentration of the inhibitor.














383.8 CH 16.3; 32.6 >260 15.2 ± 2.3 2.4 ± 0.7 16.3; 32.6 >260 8.6 ± 0.4 3.1 ± 0.5
367.8 SA 34.0; 68.0 34.0; 68.0 24.5 ± 3.6 2.3 ± 0.7 8.5; 17.0 34.0; 68.0 4.4 ± 1.3 1.0 ± 0.2
226.2 DHBF 55.3; 110.6 55.3; 110.6 8.2 ± 1.2 1.5 ± 0.3 55.3; 110.6 55.3; 110.6 23.5 ± 0.6 4.9 ± 0.6
592.6 proAC >168.7 >168.7 6.9 ± 2.4 0.8 ± 0.2 >168.7 >168.7 7.6 ± 2.7 1.0 ± 0.3
a MIC and MBC were determined using CLSI guidelines.
b EC50 is referred to biofilm formation.
Table 5. Antibacterial activity of natural compounds.
According to our proteomics data, we observed that SA, CH, and proAc down-regulate
proteins involved in S. aureus pathways. Notably the vast majority of down-regulated cell
surface proteins were cytoplasmic. This suggests that SA, CH, and proAc can enter in the
bacterial cells and possibly affect intracellular processes. In conclusion, we showed that two
of these compounds possessed interesting potential to become active principles of new drugs.
In particular, both proAc and CH were molecules which fulfill the requirements for inhibi‐
tion of de novo biofilm formation without bactericidal activity.
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to maintain a perpetual condition of equilibrium between cohabitants. This equilibrium is
obtained by the selection of organisms that can coexist and by the elimination of those who
exert a negative influence on others. From the point of view of bacteria, this means that a
bacterial cell has to defend its position in a niche; in fact in a prokaryotic community, all cells
communicate by means of small molecules in order to allow only the presence of commen‐
sals, while multicellular organisms distinguish and select saprophytes from pathogens in order
to allow the residency of the first ones and to counteract or even kill the last ones. In this
struggle for survival, all living organisms including prokaryotes and all eukaryotes (plants
and animals) produce compounds that counteract undesired bacteria by killing them or by
modulating their virulence. Molecules that modulate bacterial virulence can be considered as
a huge source of molecules to be studied as lead compounds for the development of new
antibacterial drugs. We gave some examples derived from our experience in this field, by the
description of compounds obtained from prokaryotes, from plants and from humans that can
interfere with bacterial phenotype in order to reduce virulence. They represent thus promis‐
ing scaffolds to use for further development of antibacterial drugs, which may overcome the
insurgence of resistance.
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